Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.6635431469623749,-2.2626909034735654,0.0,0.003957456108579916,0.004,14/35,6.57%,PDE7B;RIMS2;AKAP6;PDE4D;CD36;HTR2C;ADGRG6;APOE;PDE9A;PDE7A;ADCY2;RAPGEF2;GUCY1B1;HTR2B
prerank,glutamate receptor signaling pathway (GO:0007215),-0.6482897282549549,-2.2346353768959615,0.0,0.002968092081434937,0.006,17/37,10.33%,GRIK2;GRM7;GRID2;GRIA4;PLCB1;GRM8;GRIN2A;GRM5;GRM1;APP;GRIN2B;GRIA2;HOMER1;GRIA3;GRIK1;GRIK4;GRIN3A
prerank,regulation of cation channel activity (GO:2001257),-0.5361188133361442,-2.17861146346183,0.0,0.0059361841628698744,0.018,29/89,10.06%,DLG2;FGF14;NLGN1;DMD;AHNAK;ANK3;GRIA4;ANK2;LRRC7;SHISA9;GRIN2A;PDE4D;FGF12;APP;GRIA1;SHISA6;GRIN2B;CACNG2;GRIA2;DAPK1;HOMER1;DLG3;NETO1;CALM1;GSG1L;GRIA3;FGF11;OPRM1;ACTN2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.8771559928119352,-2.149059202710586,0.0,0.009151617251091055,0.036,6/11,7.92%,TMEM106A;CIITA;PF4;SIRT1;TAF7;JAK2
prerank,regulation of NMDA receptor activity (GO:2000310),-0.6522920077342421,-2.1327281906405906,0.00234192037470726,0.009300021855162802,0.046,16/32,10.60%,DLG2;NLGN1;GRIA4;LRRC7;GRIN2A;CCR2;APP;GRIA1;GRIN2B;GRIA2;DAPK1;DLG3;GRIA3;OPRM1;ACTN2;CCL2
prerank,regulation of synapse assembly (GO:0051963),-0.5788279756598421,-2.1095823975426775,0.0,0.013191520361933053,0.076,14/46,6.51%,NRXN1;NLGN1;PDLIM5;GRID2;LRFN5;GPC6;PTPRD;BDNF;APP;SLITRK1;IL1RAPL1;CLSTN2;IL1RAPL2;SYNDIG1
prerank,central nervous system neuron development (GO:0021954),-0.7643297134668035,-2.0729768982959937,0.0,0.020211293697390286,0.133,8/15,10.61%,B4GALT5;ARHGAP35;B4GALT6;NTRK2;RAPGEF2;MAP2;ATP7A;HSP90AB1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.5521841702029071,-2.0656968591096745,0.0,0.020281962556472067,0.151,21/57,12.57%,DLG2;NLGN1;GRIA4;LRRC7;SHISA9;GRIN2A;APP;GRIA1;SHISA6;GRIN2B;CACNG2;GRIA2;DAPK1;DLG3;NETO1;GSG1L;GRIA3;OPRM1;ACTN2;DLGAP1;DLGAP2
prerank,neuron cell-cell adhesion (GO:0007158),-0.7527557261849009,-2.0288695137125994,0.0,0.03165964886863933,0.234,9/14,18.96%,NRXN1;NLGN1;NRXN3;ASTN2;NCAM2;RET;ASTN1;CNTN4;NRXN2
prerank,regulation of axonogenesis (GO:0050770),-0.5454280340422093,-2.0120915787431985,0.0,0.037397960226080204,0.295,22/51,16.13%,LRRC4C;ROBO1;ARHGAP35;SLIT2;LINGO1;SLITRK1;PLXNC1;NTRK2;RTN4;PLXND1;ARHGDIA;PLXNA2;PAK3;GSK3B;CHN1;PLXNA1;THY1;TIAM1;PAK1;PLXNB2;PLXNB1;BRSK1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6989639769148045,-2.005127185901789,0.0022222222222222222,0.037056179925793756,0.316,10/18,9.99%,GRIK2;GRID2;CDH8;NAPB;GRIA2;UNC13C;NAPA;GRIK1;GRIK4;UNC13B
prerank,positive regulation of synapse assembly (GO:0051965),-0.6281413829620159,-2.001416252877832,0.0,0.036359127997577984,0.332,9/27,6.51%,NRXN1;NLGN1;GRID2;PTPRD;BDNF;IL1RAPL1;CLSTN2;SEMA4A;SYNDIG1
prerank,chemical synaptic transmission (GO:0007268),-0.41392642133289576,-1.9995858788870362,0.0,0.034551636024909266,0.341,93/284,16.40%,DLG2;NRXN1;GRIK2;GRM7;NLGN1;PDE7B;KCND2;GRID2;GRIA4;PTPRN2;SYN3;RIT2;DTNA;CACNA1E;GRIN2A;SYN1;CDH8;GRM5;GABRB1;GPR176;SYN2;GRM1;SYT1;HTR2C;NAPB;GRIA1;SHISA6;APOE;HRH1;KIF1B;GRIN2B;SNPH;GABBR2;SDCBP;KCNQ3;CAMK4;NOVA1;GRIA2;SYT10;GABRA3;APBA2;UNC13C;ERC2;SLC5A7;HOMER1;GLRA1;NAPA;SLC1A6;CHAT;GABRG1;HTR2B;GABRA2;GABRG3;CALM1;GIPC1;SLC12A4;HSPA8;RIMS1;LRP6;HTR1D;CHRM3;SNAP25;GRIA3;CHRM2;GRIK1;GABRB3;GRIK4;SLC12A5;GRIN2D;UNC13B;RAB3A;HCRTR2;CHRNA4;UNC119;GABRG2;DLGAP1;SYPL1;SLC1A1;DLGAP2;SNCA;HTR4;KCNMB4;PTCHD1;HTR6;PLP1;GLRA2;ERC1;PDLIM4;KCNIP2;CRHBP;BRSK1;GABRA5;GABRQ
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.6257206668857378,-1.994052777630863,0.0,0.034627740950074266,0.362,10/26,7.99%,NRXN1;NLGN1;RIMS2;LRRK2;APP;SLC8A3;PRKCZ;SHANK3;MTMR2;RIMS1
prerank,cAMP-mediated signaling (GO:0019933),-0.636809189796741,-1.9794346978252613,0.0,0.03884902746589284,0.418,8/24,3.38%,PDE7B;RIMS2;AKAP6;PDE4D;ADGRG6;PDE7A;ADCY2;RAPGEF2
prerank,nerve growth factor signaling pathway (GO:0038180),-0.8191905096809371,-1.9785055175078397,0.0,0.03685381001115046,0.422,4/10,3.38%,MAGI2;BDNF;KIDINS220;RAPGEF2
prerank,cellular response to copper ion (GO:0071280),0.7323718940492447,1.9714499113215884,0.0,0.4011863058475055,0.301,9/16,10.42%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT2A
prerank,cGMP-mediated signaling (GO:0019934),-0.7692719131476059,-1.9706328902178303,0.0,0.03742123937966009,0.448,7/13,6.57%,CD36;HTR2C;KCNC2;APOE;PDE9A;GUCY1B1;HTR2B
prerank,receptor clustering (GO:0043113),-0.6099478893743062,-1.9663637892448385,0.006741573033707865,0.03737597435881032,0.462,13/27,14.30%,MAGI2;DLG2;NRXN1;NLGN1;ITGA4;LRRC7;ITGAL;ITGB7;DLG3;DNAJA3;THY1;ITGB1BP1;AGRN
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6583107446925565,-1.965644903854312,0.0,0.035565033186316874,0.464,7/22,7.98%,AKAP6;ANK2;HTT;RYR2;CALM1;VMP1;PKD2
prerank,cellular zinc ion homeostasis (GO:0006882),0.644897605027679,1.9440182042513872,0.0,0.3134898018054628,0.423,12/26,10.42%,SLC30A5;SLC30A10;SLC30A8;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT2A
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.4155874840308788,-1.943942801127519,0.0,0.04491712683238205,0.548,68/224,14.60%,DLG2;NRXN1;GRIK2;GRM7;NLGN1;PDE7B;KCND2;GRIA4;RIT2;DTNA;CACNA1E;GRIN2A;SYN1;GRM5;GABRB1;GPR176;SYN2;GRM1;SYT1;HTR2C;GRIA1;HRH1;GRIN2B;GABBR2;SDCBP;KCNQ3;CAMK4;NOVA1;GRIA2;SYT10;GABRA3;APBA2;UNC13C;HOMER1;GLRA1;SLC1A6;GABRG1;HTR2B;GABRA2;GABRG3;CALM1;GIPC1;SLC12A4;LRP6;HTR1D;CHRM3;SNAP25;GRIA3;CHRM2;GRIK1;GABRB3;GRIK4;SLC12A5;UNC13B;HCRTR2;CHRNA4;UNC119;GABRG2;DLGAP1;SYPL1;SLC1A1;SNCA;HTR4;KCNMB4;PTCHD1;HTR6;PLP1;GLRA2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.8124126758056307,1.9101380021866121,0.0,0.3467539929938238,0.593,5/10,7.73%,VSIR;DDIT3;TLR4;NCKAP1L;IL12B
prerank,synaptic membrane adhesion (GO:0099560),-0.7182746681128063,-1.909590296260779,0.0,0.06774787957307046,0.711,5/14,2.31%,LRRC4C;LRFN5;GPC6;PTPRD;SLITRK1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.47693196317538805,-1.8976485040871585,0.0,0.07514669497087545,0.765,23/72,10.60%,NRXN1;GRIK2;NLGN1;RIMS2;GRIN2A;CCR2;APP;SYT1;ADRA1A;SLC8A3;CLSTN2;PRKCZ;GRIN2B;CACNG2;NPTN;SLC24A2;SHANK3;ADCY8;RIMS1;PLK2;LGI1;GRIN2D;CCL2
prerank,regulation of macrophage migration (GO:1905521),0.8005566095037902,1.8929263421158673,0.0,0.3442339785098571,0.696,4/10,8.98%,CX3CR1;P2RY12;MTUS1;PTK2B
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5294048136208428,-1.8895872348715779,0.0,0.080310549507812,0.8,17/46,10.60%,NRXN1;GRM7;NLGN1;GRM8;LRRK2;CCR2;GRM5;GRM1;SYT1;CACNG2;DGKI;ATAD1;SHANK3;HOMER1;TPRG1L;GRIK1;CCL2
prerank,synapse organization (GO:0050808),-0.435864714714619,-1.8863190765519324,0.0,0.08005603919648122,0.809,28/125,6.02%,LRRC4C;NRXN1;NLGN1;CTNND2;ANK3;LRFN5;GPHN;GPC6;PTPRD;DNM3;KIRREL3;NRCAM;ADGRL3;LRRK2;GPM6A;BDNF;GRM5;APP;SLC8A3;SLITRK1;PPFIA2;PLXND1;UNC13C;CDC42;CAST;SHANK3;PDZRN3;PAK3
prerank,cyclooxygenase pathway (GO:0019371),0.8147652348966775,1.881481362224344,0.0036231884057971015,0.32477946669363383,0.753,3/10,0.63%,TBXAS1;HPGDS;PTGS1
prerank,synapse assembly (GO:0007416),-0.48706763741270737,-1.8768529194439663,0.0,0.08587679755618417,0.844,29/67,20.88%,NRXN1;NLGN1;GRID2;DNM3;KIRREL3;NRCAM;ADGRL3;GPM6A;BDNF;SLITRK1;PLXND1;SHANK3;GABRA2;LRRTM3;GABRB3;GABRG2;PLXNB2;OBSL1;CDH1;ACHE;SDK1;PLXNB1;PCDHB16;NRXN2;DSCAM;PCDHB13;PCDHB6;CBLN4;PCDHB14
prerank,response to copper ion (GO:0046688),0.6604496410774731,1.8744080115459028,0.0038314176245210726,0.29904171876405344,0.793,9/20,10.42%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT2A
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4365510329026549,-1.8737943810144717,0.0,0.08584635558611817,0.856,28/107,9.46%,LRRC4C;GRIK2;GRM7;NLGN1;GRID2;RIMS2;NRG3;GRM8;SYN3;LRRK2;BDNF;SYN1;MCTP2;GRM5;GRM1;APP;SYT1;SLC8A3;CLSTN2;DGKI;HOMER1;CNTNAP4;CPLX2;TPRG1L;RIMS1;LGI1;GRIK1;GRIK4
prerank,tRNA processing (GO:0008033),0.5128996040508895,1.8533323447151433,0.0,0.342721969819477,0.871,28/61,21.10%,ADAT1;FAM98B;TRNT1;QTRT1;TRMT6;POP1;ANKRD16;CSTF2;AARS2;SSB;THUMPD1;KARS1;CPSF1;TSEN2;RPP21;TSEN54;NSUN6;TRMT10B;SARS1;QTRT2;ELAC2;RTCB;CTU2;TRMT61A;CDKAL1;TYW5;TRDMT1;FTSJ1
prerank,positive regulation of cell projection organization (GO:0031346),-0.42912481756093857,-1.8338648885462596,0.0,0.1279943906228671,0.952,44/115,16.14%,MAGI2;PTPRD;CDKL5;ROBO1;RIT2;TENM3;LRRC7;BDNF;ARHGAP35;SLIT2;SLITRK1;KIDINS220;APOE;IL1RAPL1;PLXNC1;ROR1;NTRK2;NPTN;FUT9;RAPGEF2;NTRK3;PLXND1;ARHGDIA;PLXNA2;RET;GRIP1;CUL7;CARMIL1;PLXNA1;SCARF1;P3H1;SERPINI1;MAP3K13;TIAM1;SS18L1;PLXNB2;OBSL1;SS18L2;RELN;CAPRIN2;PLXNB1;CX3CL1;ABL2;STMN2
prerank,regulation of presynapse organization (GO:0099174),-0.6411621966459138,-1.8336105198820882,0.0,0.11950835127892627,0.953,7/18,4.38%,LRFN5;GPC6;PTPRD;APP;SLITRK1;IL1RAPL1;IL1RAPL2
prerank,regulation of presynapse assembly (GO:1905606),-0.6411621966459138,-1.8336105198820882,0.0,0.11950835127892627,0.953,7/18,4.38%,LRFN5;GPC6;PTPRD;APP;SLITRK1;IL1RAPL1;IL1RAPL2
prerank,neurotransmitter secretion (GO:0007269),-0.5084813021785163,-1.8276863460067496,0.0,0.12301092737502571,0.962,15/44,10.29%,NRXN1;RIMS2;PTPRN2;SYN3;SYN1;SYN2;SYT1;SNPH;SYT10;PCLO;CPLX2;HSPA8;RIMS1;SNAP25;RAB3A
prerank,regulation of exocytosis (GO:0017157),-0.500521323946921,-1.8145271177590379,0.002364066193853428,0.1370428752438884,0.978,13/46,12.83%,RIMS2;STXBP5L;CADPS;SYT1;RAB3C;IL1RAPL1;STXBP5;STXBP6;CPLX2;RAB3D;RAB3A;RAB8A;SNCA
prerank,cellular response to zinc ion (GO:0071294),0.6705445360654789,1.8081459193045952,0.0018587360594795538,0.5300850467024044,0.961,10/15,12.80%,MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT2A;HVCN1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.609846205206282,-1.7997627610666902,0.002173913043478261,0.15607217528212042,0.983,7/21,7.13%,DMD;AKAP6;ANK2;PDE4D;RYR2;CALM1;CACNA1C
prerank,acylglycerol homeostasis (GO:0055090),0.634679406172578,1.797268469545086,0.003780718336483932,0.5343550712446814,0.972,6/20,13.16%,LIPC;IL18;MLXIPL;MTLN;APOC4;SCARB1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5079589879755365,-1.7951294175711212,0.0022271714922048997,0.15892783963319798,0.985,13/37,11.16%,NLGN1;GRID2;PTPRD;ALCAM;TENM3;TENM2;IL1RAPL1;ITGAL;FAT4;JAML;NECTIN1;TENM4;VCAM1
prerank,neuron migration (GO:0001764),-0.5023366814892667,-1.794676670415732,0.0,0.15495186601608862,0.985,21/48,17.11%,AUTS2;CDKL5;NRCAM;ADGRL3;GPM6A;SPOCK1;NAV1;MAP1B;ASTN2;NTRK2;RAPGEF2;NR4A2;SH3RF1;DCDC2;TUBB2A;DDIT4;LRP12;RELN;MDGA1;POMGNT2;ASTN1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4669311145114886,1.7900767256635377,0.0,0.5252718190380279,0.98,23/87,12.94%,ITGB5;TGFBR1;F11R;TGFBR2;SMAD3;SMAD7;ARRB2;SKI;SRC;SMURF1;ID1;HPGD;LPXN;CGN;EID2;LEFTY1;APPL1;UBC;RPS27A;GCNT2;SMAD9;USP9Y;ZMIZ2
prerank,response to fatty acid (GO:0070542),-0.6398586291288492,-1.7897527450671498,0.004347826086956522,0.15852438469225835,0.991,9/17,17.82%,PID1;CD36;IRS1;KCNK4;FFAR1;PDK3;FOXO1;NR1H4;GLDC
prerank,zinc ion homeostasis (GO:0055069),0.5828580538877465,1.788369963166375,0.003527336860670194,0.4875082565346571,0.983,12/28,10.42%,SLC30A5;SLC30A10;SLC30A8;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT2A
prerank,protein localization to kinetochore (GO:0034501),-0.6744299879241191,-1.785298389168142,0.004301075268817204,0.16033193706566132,0.995,8/14,14.92%,KNL1;MTBP;CENPT;SPDL1;ZW10;AURKB;TTK;RCC2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.4874175168272049,1.7735211269092375,0.0,0.5342430706009494,0.993,17/65,11.89%,TGFBR1;LDLRAD4;TGFBR2;SMAD3;PMEPA1;SMAD7;SKI;TGFB1I1;SMURF1;SPRY2;PDPK1;ASPN;EID2;UBC;RPS27A;SKIL;MTMR4
prerank,positive regulation of cellular component movement (GO:0051272),0.6080865446640179,1.7731986657872647,0.003883495145631068,0.4955511559086601,0.993,7/24,11.15%,TGFBR1;CSF1R;ETS1;LYN;DUOX1;CCR7;CFAP20
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6812223060340159,1.7693725899933974,0.0071174377224199285,0.4796667569196126,0.993,6/14,7.73%,RASAL3;IL18;TGFBR2;LGALS9;EBI3;IL12B
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.6964989482868713,1.7688720606301855,0.0017452006980802793,0.45010818702957983,0.993,11/13,25.25%,UNC93B1;TLR7;IRAK2;EPG5;PIK3AP1;PIK3C3;TNIP2;MYD88;TRAF6;TLR9;IRAK4
prerank,AMP metabolic process (GO:0046033),-0.6641541948208056,-1.7682596138013515,0.004597701149425287,0.1837543133659539,0.998,5/13,15.51%,XDH;AMPD3;ADSS2;AK3;AK4
prerank,cardiolipin metabolic process (GO:0032048),0.7078235414094237,1.7668664347793885,0.0074211502782931356,0.43111147784461057,0.994,8/13,18.84%,PLSCR3;PLA2G6;PLA2G5;PLA2G4A;PGS1;HADHB;CRLS1;TAMM41
prerank,membrane repolarization during action potential (GO:0086011),-0.682766367800869,-1.7646902207090531,0.006564551422319475,0.18542764740332998,0.998,7/13,17.92%,YWHAE;KCND3;KCNH2;ATP1A1;KCNQ1;KCNIP2;KCNE3
prerank,ceramide catabolic process (GO:0046514),0.6818826290989025,1.764245521092094,0.007518796992481203,0.4169586317942149,0.994,6/14,7.26%,HEXB;HEXA;NEU3;ACER3;ACER2;ASAH1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.6168861888404618,-1.76277427205914,0.006493506493506494,0.18425002382446107,0.998,8/18,11.94%,NLGN1;RIMS2;LRRK2;SYN1;GSK3B;RIMS1;RIMS4;DTNBP1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.615132329988954,-1.7607660362101412,0.0,0.18318074962589284,0.998,6/18,7.99%,NRXN1;NLGN1;RIMS2;PRKCZ;SHANK3;RIMS1
prerank,endocrine system development (GO:0035270),0.6213047271571897,1.7587255930936707,0.00539568345323741,0.41804240272914966,0.995,4/21,5.63%,TGFBR1;SALL1;TG;FOXE1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.7299800496917166,1.7536085137145077,0.0019230769230769232,0.39700308180412064,0.995,2/10,20.24%,REEP6;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.7299800496917166,1.7536085137145077,0.0019230769230769232,0.39700308180412064,0.995,2/10,20.24%,REEP6;CACNA2D4
prerank,positive regulation of cell junction assembly (GO:1901890),-0.4663729149419171,-1.7519567834174798,0.0,0.19403600347006772,0.998,8/56,2.55%,CNTNAP2;NRXN1;NLGN1;GRID2;PTPRD;BDNF;IL1RAPL1;CLSTN2
prerank,positive regulation of endocytosis (GO:0045807),-0.494432448713643,-1.746470016239313,0.002380952380952381,0.19930973889699208,1.0,16/45,12.83%,NLGN1;DAB2;HIP1;STAP1;BICD1;APOE;B2M;SGIP1;NEDD4L;CDC42;TOR1A;GPC3;ANO6;CD151;TFR2;SNCA
prerank,regulation of secretion (GO:0051046),-0.6816493077906826,-1.7430038936191907,0.010121457489878543,0.201554159948605,1.0,7/13,14.22%,OAS2;FGF10;ACSL3;ERBB3;POFUT2;MYO6;KCNQ1
prerank,regulation of potassium ion transport (GO:0043266),-0.5234264406919291,-1.7384972394043194,0.00975609756097561,0.20605754419901331,1.0,12/31,11.35%,KCNIP4;DPP6;ANK3;DPP10;ANK2;KCNIP1;KCNN2;KCNAB2;KCNH2;KIF5B;ACTN2;ADRA2A
prerank,microglial cell activation (GO:0001774),0.607494642839803,1.7378009404543093,0.010810810810810811,0.45245060049277186,0.997,7/21,6.50%,CX3CR1;ITGAM;AIF1;AGER;ITGB2;CLU;C1QA
prerank,triglyceride metabolic process (GO:0006641),0.5063752700240726,1.737674437218092,0.0017035775127768314,0.43238866700353,0.997,12/48,10.53%,LIPC;LIPH;AGMO;LPIN2;DGAT1;SEL1L;LMF1;MOGAT2;PNPLA1;MOGAT1;GK5;APOH
prerank,glucan biosynthetic process (GO:0009250),-0.6803592423382812,-1.7359599697881973,0.019867549668874173,0.20204534067391158,1.0,6/12,16.60%,GBE1;PER2;PGM1;GYG1;PGM2L1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),-0.6803592423382812,-1.7359599697881973,0.019867549668874173,0.20204534067391158,1.0,6/12,16.60%,GBE1;PER2;PGM1;GYG1;PGM2L1;UGP2
prerank,phagosome-lysosome fusion (GO:0090385),0.7432269896911505,1.7334153130740393,0.0038910505836575876,0.43493258676323404,0.997,5/10,14.57%,RAB39A;RAB34;PLA2G5;CLN3;RAB20
prerank,cortical actin cytoskeleton organization (GO:0030866),0.6098025690802529,1.7295882115873478,0.003683241252302026,0.43482849920846145,0.998,9/20,15.97%,NCKAP1L;RHOQ;FHOD1;FMNL3;PLEK;LLGL1;FMNL2;ROCK2;RAB13
prerank,signal release from synapse (GO:0099643),-0.4796173739214175,-1.7272864645690114,0.0022271714922048997,0.21395523344471418,1.0,14/43,10.29%,NRXN1;PTPRN2;SYN3;SYN1;SYN2;SYT1;SNPH;SYT10;PCLO;CPLX2;HSPA8;RIMS1;SNAP25;RAB3A
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5763431340182628,-1.7247045717357465,0.004424778761061947,0.21446526463423973,1.0,9/22,8.62%,MAGI2;BDNF;KIDINS220;NTRK2;RAPGEF2;NTRK3;EHD1;WASF1;SH3GL2
prerank,neurotrophin signaling pathway (GO:0038179),-0.5807682250742451,-1.721745919826694,0.008771929824561403,0.21610537107209613,1.0,7/21,11.44%,MAGI2;BDNF;KIDINS220;NTRK2;RAPGEF2;BCAR1;DDIT4
prerank,axonal fasciculation (GO:0007413),-0.6740481746805415,-1.7202052731476465,0.004415011037527594,0.21475135573208912,1.0,9/12,27.53%,NRCAM;ARHGAP35;RTN4;SEMA5A;CNTN4;EPHA3;EPHA4;EPHB2;AMIGO1
prerank,negative regulation of protein depolymerization (GO:1901880),0.5770211836022051,1.7195838715469631,0.016885553470919325,0.4651341933926455,0.998,8/24,13.44%,NAV3;ARHGEF2;FGF13;CAMSAP1;PLEKHH2;CAMSAP2;CIB1;ATXN7
prerank,neuron fate commitment (GO:0048663),0.6709500931484793,1.7179904118298428,0.005639097744360902,0.4553472325259907,0.999,6/14,10.54%,TGFBR1;EPOP;PAX6;SHH;POU4F1;DLL1
prerank,axon development (GO:0061564),-0.42740023907718316,-1.7156626837372233,0.0,0.21969701191013508,1.0,29/78,20.04%,GRM7;CTNNA2;ANK3;DCC;NRCAM;PLPPR4;ARHGAP35;APP;MAP1B;SLITRK1;RTN4;SEMA5A;PAK3;ACTB;SPTBN4;RAB3A;RAB8A;ZDHHC17;NTNG1;VASH2;PLP1;NTNG2;NEFH;BRSK1;PARD3;KLF7;CNTN4;BRSK2;LMTK2
prerank,water transport (GO:0006833),-0.6714968890377229,-1.7105766317857207,0.008298755186721992,0.22549889326389022,1.0,5/12,29.92%,AQP4;AQP11;CFTR;AQP1;SLC5A1
prerank,signal peptide processing (GO:0006465),-0.6813300500073849,-1.7101872853803626,0.0175054704595186,0.22199088699637903,1.0,4/11,6.83%,PCSK5;SPCS2;PARL;CLN5
prerank,neuron projection fasciculation (GO:0106030),-0.7101433350352545,-1.7078736291438958,0.011160714285714286,0.22290005100455212,1.0,8/10,27.53%,NRCAM;ARHGAP35;RTN4;SEMA5A;CNTN4;EPHA4;EPHB2;AMIGO1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.6132343481998074,-1.7056884337636538,0.01348314606741573,0.2231465592133357,1.0,7/17,11.24%,KNL1;MTBP;SPDL1;ZW10;CTCF;AURKB;TTK
prerank,protein localization to condensed chromosome (GO:1903083),-0.6725621193576916,-1.7022481270052823,0.008565310492505354,0.2264936933571184,1.0,6/12,11.24%,KNL1;MTBP;SPDL1;ZW10;AURKB;TTK
prerank,anterior/posterior axis specification (GO:0009948),0.6471362981912678,1.7013751966249506,0.005385996409335727,0.522259001721641,1.0,5/15,21.30%,DDIT3;SKI;SHH;WLS;TASOR
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.41206206827276753,-1.6965057136705382,0.0,0.23489584876057895,1.0,46/91,26.40%,RPL30;RPL36A;RPS29;RPL35A;RPS3;RPL4;RPS7;RPS2;RPL41;RPL7A;RPLP2;RPL38;RPL18A;RPS14;RPS27;RPL13A;RPL26;RPL22;RPS25;RPS15A;SRP68;RPS15;SEC62;RPL8;RPL23A;RPLP1;RPL37;SRP19;RPS12;RPL24;RPL19;RPS11;RPLP0;SSR1;RPS6;RPS9;RPSA;RPS10;RPS19;RPL23;RPL17;RPS5;SSR2;RPL29;RPL18;RPS21
prerank,phagolysosome assembly (GO:0001845),0.6920350695353165,1.6958571495285917,0.005758157389635317,0.5330910639797075,1.0,5/12,14.57%,RAB39A;RAB34;PLA2G5;CLN3;RAB20
prerank,icosanoid metabolic process (GO:0006690),0.5035732954911841,1.6937717846514846,0.0050335570469798654,0.5258314360475709,1.0,15/40,19.23%,TBXAS1;DAGLB;PTGS1;HPGD;ALOXE3;PLA2G4B;PLA2G4A;FADS1;DPEP1;ABCC10;PON3;PON2;PTGR1;GGT5;GPX4
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.5818970734717908,1.6930710199137544,0.013157894736842105,0.5122685443007594,1.0,7/21,13.44%,NAV3;ARHGEF2;FGF13;CAMSAP1;CAMSAP2;CIB1;ATXN7
prerank,regulation of regulated secretory pathway (GO:1903305),-0.49965317207356064,-1.692472089930463,0.004750593824228029,0.23893141255551245,1.0,11/34,11.94%,RIMS2;LRRK2;SYN1;SYT1;SYT10;GSK3B;RAB3D;RIMS1;RIMS4;RAB3A;DTNBP1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6985605742955195,-1.692246788502121,0.010940919037199124,0.23536802516960892,1.0,7/11,15.53%,KCNJ3;YWHAE;KCND3;KCNH2;ATP1A1;KCNQ1;KCNIP2
prerank,membrane assembly (GO:0071709),-0.5040483309990563,-1.68905709771986,0.0069767441860465115,0.23799151672972468,1.0,6/34,2.42%,NRXN1;NLGN1;ANK3;PTPRD;SPTBN1;IL1RAPL1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.5925503209544689,1.6862034681009455,0.014519056261343012,0.5307638247972792,1.0,6/20,14.31%,FDXR;HSD3B2;CYP46A1;AKR1D1;TSPO;HSD17B10
prerank,neuron projection morphogenesis (GO:0048812),-0.38496463475741366,-1.6832540872394988,0.0,0.24657870991287076,1.0,48/137,20.04%,CNTNAP2;NLGN1;CTNND2;CTNNA2;ANK3;IQGAP1;ALCAM;NYAP2;DCC;NRCAM;LRRK2;GPM6A;PLPPR4;BDNF;APP;MAP1B;SLITRK1;CTTN;MAP2;CDC42;SHANK3;DCLK1;CNTNAP1;PAK3;ACTB;DCDC2;ATP7A;SPTBN4;RAB3A;RAB8A;ZDHHC17;DTNBP1;NTNG1;PAK1;NTNG2;CTNNB1;PLXNB1;NEFH;TNIK;BRSK1;PARD3;KLF7;CNTN4;TNN;EIF2AK4;NRK;BRSK2;LMTK2
prerank,response to cadmium ion (GO:0046686),0.5585671268253926,1.680795959991124,0.007155635062611807,0.5406376073540151,1.0,13/26,19.37%,SUMO1;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT2A;AKT1;MAPK8;JUN
prerank,regulation of membrane repolarization (GO:0060306),-0.6516721141373409,-1.6797990280588826,0.015086206896551725,0.24998994918150388,1.0,8/13,24.52%,AKAP6;YWHAE;NEDD4L;KCNH2;KCNQ1;CACNB3;CACNA2D1;CASQ2
prerank,triglyceride catabolic process (GO:0019433),0.5980397975324412,1.679781152058049,0.014598540145985401,0.5296001348244289,1.0,3/19,7.55%,LIPC;LIPH;PNPLA1
prerank,presynapse assembly (GO:0099054),-0.5985481905966255,-1.679276205100884,0.006423982869379015,0.24708973973173176,1.0,5/16,7.72%,NLGN1;PTPRD;IL1RAPL1;PCLO;LRRTM3
prerank,cellular response to cadmium ion (GO:0071276),0.5640435459322012,1.6790067503567392,0.010771992818671455,0.5173145027145376,1.0,13/24,19.37%,SUMO1;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT2A;AKT1;MAPK8;JUN
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.6541881617693472,-1.678921601854243,0.017857142857142856,0.24409465607217526,1.0,5/12,4.44%,SORBS1;PRKCZ;IRS1;ZBTB7B;SIRT1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5707472991651547,1.678764566310051,0.005385996409335727,0.5040604971244107,1.0,9/24,21.74%,LPCAT4;PLA2G15;PLA2G5;PLA2G4B;PLA2G4A;PGS1;CRLS1;SERAC1;PLA2G3
prerank,regulation of actin filament-based movement (GO:1903115),-0.7085099361817176,-1.6785458896754624,0.014861995753715499,0.24100907701251692,1.0,3/10,1.33%,PDE4B;ANK2;PDE4D
prerank,B cell homeostasis (GO:0001782),0.7092231854888789,1.6778426106068933,0.01764705882352941,0.49381083821374977,1.0,5/10,11.60%,MEF2C;LYN;NCKAP1L;TNFRSF13B;DOCK10
prerank,regulation of secretion by cell (GO:1903530),-0.4472524033495574,-1.6766156640118017,0.0,0.2414797744436131,1.0,18/54,13.16%,RIMS2;STXBP5L;SYN1;MCTP2;SYT1;DISP1;RAB3C;RIC1;STXBP5;CPLX2;RAB3D;RIMS1;RAB3A;MCTP1;RAB8A;P3H1;RHBDF2;KCNMB4
prerank,negative regulation of leukocyte migration (GO:0002686),-0.7065724530555425,-1.6751461968042476,0.010526315789473684,0.24069602451437544,1.0,5/10,18.51%,SLIT2;BMP5;CD200R1;HMOX1;ADTRP
prerank,regulation of mast cell degranulation (GO:0043304),0.6402964211929729,1.6741197055481623,0.016100178890876567,0.497491724234775,1.0,4/14,2.98%,LGALS9;GAB2;CD84;LYN
prerank,response to sterol (GO:0036314),0.6968756422416944,1.6734603757213018,0.024667931688804556,0.4875034335404294,1.0,2/11,0.62%,TGFBR1;TGFBR2
prerank,skeletal muscle organ development (GO:0060538),0.5461911258597077,1.6657605526303392,0.00530035335689046,0.511162322558054,1.0,5/26,4.17%,LARGE1;CFLAR;BASP1;MEF2C;ZBTB18
prerank,positive regulation of cell adhesion (GO:0045785),0.4441603625255687,1.6652712590546186,0.001694915254237288,0.5007520781090314,1.0,17/74,8.19%,ZFHX3;P2RY12;SMAD7;RAC1;TGM2;NPNT;PRKCA;MAGI1;ITGAV;ATM;NCKAP1L;TFE3;FLCN;PDGFB;CCR7;IL12B;FUT7
prerank,positive regulation of potassium ion transport (GO:0043268),-0.48604498707356447,-1.6646694001591018,0.009433962264150943,0.25967895818358216,1.0,14/38,14.22%,AKAP6;ANK2;KCNN2;KCNMB2;KCNJ3;GABBR1;GABBR2;KCNH2;KIF5B;KCNJ6;ACTN2;ADRA2A;KCNMB4;KCNQ1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5567666467866024,-1.663050592004921,0.01545253863134658,0.2594858086846766,1.0,6/20,8.97%,KCNB2;ATP2B1;CTTN;ZDHHC21;CHRM3;CHRM2
prerank,primary alcohol metabolic process (GO:0034308),-0.5242870231277904,-1.6616976557019205,0.014388489208633094,0.2587469606420447,1.0,9/25,19.43%,GPD2;RETSAT;NAPEPLD;GDPD1;RBP4;RDH10;DHRS9;ALDH3A2;RDH12
prerank,response to zinc ion (GO:0010043),0.5600028635454558,1.661344022451868,0.005649717514124294,0.506363105480771,1.0,13/25,15.12%,SLC30A5;SLC30A8;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT2A;HVCN1;KHK
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.5453163266127274,-1.6613237471105502,0.011627906976744186,0.2557575683692809,1.0,7/21,14.88%,XDH;AMPD3;PDE4D;PDE9A;HINT1;NUDT3;PDE2A
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.6109110936351847,-1.660815616628671,0.02262443438914027,0.25334589678433306,1.0,5/15,13.78%,REEP3;RTN4;ATL2;REEP2;REEP4
prerank,androgen receptor signaling pathway (GO:0030521),0.6727912166451998,1.6598462911434682,0.009523809523809525,0.501266881067899,1.0,6/11,13.21%,PMEPA1;DDX5;KDM3A;DDX17;PLPP1;ARID1A
prerank,negative regulation of bone remodeling (GO:0046851),0.6781603743981806,1.659044748158223,0.007326007326007326,0.49359465092468596,1.0,5/11,15.40%,TMEM119;GREM1;UBASH3B;GPR137;CARTPT
prerank,organelle fission (GO:0048285),-0.5193852698348724,-1.6587844767030842,0.019693654266958426,0.25445629602256137,1.0,10/24,12.58%,DNM3;TMCC1;PEX11A;CORO1C;DNM1L;PRKN;MFF;DNM1;FIS1;MTFR2
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.4070927484585302,-1.6585399371511946,0.0,0.2514187909521801,1.0,43/87,26.40%,RPL30;RPL36A;RPS29;RPL35A;RPS3;RPL4;RPS7;RPS2;RPL41;RPL7A;RPLP2;RPL38;RPL18A;RPS14;RPS27;RPL13A;RPL26;RPL22;RPS25;RPS15A;SRP68;RPS15;RPL8;RPL23A;RPLP1;RPL37;SRP19;RPS12;RPL24;RPL19;RPS11;RPLP0;RPS6;RPS9;RPSA;RPS10;RPS19;RPL23;RPL17;RPS5;RPL29;RPL18;RPS21
prerank,diol biosynthetic process (GO:0034312),0.6223978809903562,1.6581526300711706,0.020072992700729927,0.486568978408815,1.0,5/15,7.26%,QDPR;SPTLC3;ACER3;ACER2;ASAH1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6074568780765833,-1.6564195868112135,0.01037344398340249,0.2524725082070367,1.0,5/15,5.19%,GRM7;GRM8;GRM5;GRM1;HOMER1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.443083623024693,-1.652839104790588,0.0,0.25761216754173666,1.0,15/54,8.48%,KCNIP4;DPP6;AKAP6;DPP10;KCNIP1;KCNN2;KCNMB2;KCNJ3;GABBR1;GABBR2;YWHAE;NEDD4L;KCNAB2;KCNH2;KCNJ6
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4195040694832562,1.6526935571742107,0.0,0.5010460797988275,1.0,27/112,12.94%,ITGB5;TGFBR1;F11R;TGFBR2;SMAD3;SMAD7;ARRB2;MEF2C;SKI;SRC;SMURF1;ID1;ZFP36L1;HPGD;LPXN;CGN;ZFP36L2;OVOL2;LEFTY1;APPL1;UBC;RPS27A;GCNT2;SMAD9;LIMS1;USP9Y;ZMIZ2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5997241022668854,1.65254425085881,0.022684310018903593,0.4907892556295925,1.0,11/17,28.51%,LYN;SEMA4C;MID1;PDCD10;EIF2AK2;TAOK2;ARL6IP5;NOD2;RNF13;KLHDC10;TAOK3
prerank,actin cytoskeleton reorganization (GO:0031532),-0.4324165364156445,-1.6494462901858988,0.007042253521126761,0.26175745403892875,1.0,34/63,26.13%,NEDD9;AUTS2;MKLN1;MCU;FGF10;GSN;CTTN;THSD7B;BCAR1;FGF7;PHACTR1;DTNBP1;PAK1;KIT;PDLIM4;CDC42BPG;TNIK;THSD7A;FLNA;RICTOR;CDC42BPA;NRK;BRSK2;EZR;PARVB;GPR65;S1PR2;EFS;MICALL2;FER;PARVG;SYDE1;WHAMM;ANXA1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.6310743621439429,-1.648928981626825,0.015909090909090907,0.25949242650425614,1.0,5/13,4.44%,SORBS1;PRKCZ;IRS1;ZBTB7B;SIRT1
prerank,arachidonic acid metabolic process (GO:0019369),0.5061973367564973,1.6474747389299709,0.004991680532445923,0.5026731870230853,1.0,7/35,9.38%,TBXAS1;HPGDS;DAGLB;PTGS1;ALOXE3;PLA2G4B;PLA2G4A
prerank,positive regulation of locomotion (GO:0040017),0.5393967907637578,1.6459784555400254,0.016304347826086956,0.49887886734261616,1.0,12/27,24.48%,P2RY12;CSF1R;AIF1;DUOX1;PDGFB;CCR7;CFAP20;STX4;THBS1;TWIST1;TGFB1;PPM1F
prerank,detection of calcium ion (GO:0005513),-0.6409330338738493,-1.6452195089037216,0.006507592190889371,0.26443571434387636,1.0,9/13,24.94%,SYT1;KCNMB2;RYR2;CALM1;KCNMB4;KCNIP2;KCNMB3;CASQ2;KCNMB1
prerank,aminoglycan biosynthetic process (GO:0006023),-0.4426388046190338,-1.6434119079003877,0.00963855421686747,0.26475381366399636,1.0,20/49,17.97%,B3GALT1;GPC6;HS3ST5;HS3ST2;GPC5;EXT1;SDC3;HS6ST2;HSPG2;GPC3;HS3ST1;PXYLP1;EXT2;B4GALT7;AGRN;NDST1;HS3ST3B1;B3GALT2;GPC4;SDC4
prerank,cytoplasmic translation (GO:0002181),-0.3980520658209506,-1.6416605565923643,0.0024752475247524753,0.2651617736455598,1.0,44/91,26.40%,RPL30;RPL36A;RPS29;RPL35A;RPS3;RPL4;RPS7;RPS2;RPL41;RWDD1;RPL7A;EIF3M;RPL38;RPL18A;RPS14;RPS27;RPL13A;RPL26;RPL22;RPS25;RPS15A;RPS15;RPL8;RPL23A;RPLP1;RPL37;RPS12;RPL22L1;RPL24;RPL19;RPS11;DRG2;RPLP0;RPS6;RPS9;RPSA;RPS10;RPS19;RPL23;RPL17;RPS5;RPL29;RPL18;RPS21
prerank,cytosolic calcium ion transport (GO:0060401),-0.5058310055322084,-1.6413316753634777,0.008948545861297539,0.26265201837706154,1.0,16/28,26.50%,MCU;ADRA1A;RYR2;ATP2B1;ATP2A2;CACNA1C;MCUB;MICU2;ATP2A3;MICU3;SLC35G1;CACNB3;CACNA2D1;ITPR3;SMDT1;JPH4
prerank,macrophage activation involved in immune response (GO:0002281),0.6546231922392481,1.6382518621987259,0.026365348399246705,0.5244715858672009,1.0,3/13,4.34%,CX3CR1;PLCG2;SBNO2
prerank,regulation of tissue remodeling (GO:0034103),0.6024596326190921,1.6360444426878247,0.0142602495543672,0.5237799704635195,1.0,7/18,16.05%,IL18;CST3;IL12B;CEACAM1;RUNX1;GPNMB;DDR2
prerank,sphingosine biosynthetic process (GO:0046512),0.6717651057318281,1.6353723977381052,0.032196969696969696,0.5073370698029046,1.0,4/11,7.26%,SPTLC3;ACER3;ACER2;ASAH1
prerank,sphingoid biosynthetic process (GO:0046520),0.6717651057318281,1.6353723977381052,0.032196969696969696,0.5073370698029046,1.0,4/11,7.26%,SPTLC3;ACER3;ACER2;ASAH1
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.48101286686092487,-1.635179819408085,0.009302325581395349,0.27314791183165293,1.0,6/33,1.39%,LRRC4C;GRIK2;NLGN1;GRID2;NRG3;BDNF
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.47890570501294594,-1.6330427201708244,0.006944444444444444,0.27464274267817407,1.0,12/39,9.05%,FGF14;DMD;ANK3;UTRN;FGF12;HECW2;HECW1;NEDD4L;FXYD5;NETO1;PTPN3;FGF11
prerank,T cell activation involved in immune response (GO:0002286),-0.6333068526211723,-1.632945433507762,0.03139013452914798,0.27153968693253194,1.0,3/12,2.57%,CD74;LILRB1;ITGAL
prerank,cellular calcium ion homeostasis (GO:0006874),-0.377753962013717,-1.6323395838406507,0.0,0.26982027782160856,1.0,39/133,15.70%,ANK2;CCR2;TRPC5;TRPC4;HTR2C;MCU;SLC8A3;RYR2;ATP2B1;CCR1;NPTN;CD40;ATP13A3;YWHAE;PDZD8;SLC24A2;ATP2A2;TRPC3;TPT1;LETM1;HTR2B;RMDN3;SLC8B1;ADCY8;MCUB;MICU2;TMEM165;CALB1;STIM2;DMPK;HCRTR2;ATP2A3;BAK1;CDH5;MICU3;SELENOK;SLC35G1;CCL5;BCL2
prerank,RNA polyadenylation (GO:0043631),-0.5143883327419424,-1.631685747430878,0.01405152224824356,0.26508210263663995,1.0,8/26,12.09%,SCAF8;APP;PAPOLA;CSTF3;CDC73;GRSF1;PABPC1;TUT1
prerank,mRNA polyadenylation (GO:0006378),-0.5143883327419424,-1.631685747430878,0.01405152224824356,0.26508210263663995,1.0,8/26,12.09%,SCAF8;APP;PAPOLA;CSTF3;CDC73;GRSF1;PABPC1;TUT1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.38685331491662345,-1.6289303253890353,0.0,0.26779527431373645,1.0,54/110,26.40%,PPP2R2A;RPL30;RPL36A;RPS29;SMG7;RPL35A;RPS3;RPL4;RPS7;RPS2;RPL41;EIF4A3;SMG6;RPL7A;RPLP2;RPL38;RPL18A;PABPC1;RPS14;RPS27;EIF3E;RPL13A;RPL26;RPL22;RPS25;RPS15A;RPS15;PPP2R1A;RPL8;RPL23A;SMG5;RPLP1;RPL37;RPS12;HELZ2;UPF1;RPL24;RPL19;RPS11;RPLP0;RPS6;SMG1;RPS9;RPSA;RPS10;RPS19;RPL23;RPL17;RPS5;RNPS1;RPL29;RPL18;PPP2CA;RPS21
prerank,membrane repolarization (GO:0086009),-0.6028816659967373,-1.6284253095577237,0.017391304347826087,0.26582012822658596,1.0,7/15,17.92%,KCND3;KCNH2;ATP1B3;ATP1A1;KCNQ1;KCNIP2;KCNE3
prerank,positive regulation of integrin activation (GO:0033625),0.6711682525170921,1.627867995270238,0.015122873345935728,0.5338817100334373,1.0,5/11,15.60%,P2RY12;SRC;PLEK;RASIP1;PIEZO1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.6421573624418304,-1.6268084687676772,0.024608501118568233,0.2662693888879965,1.0,6/12,15.70%,CD74;CD44;SIRT1;ING2;RPL26;BCL2
prerank,toll-like receptor signaling pathway (GO:0002224),0.4242499506999118,1.6202176610954466,0.006589785831960461,0.5615152273496563,1.0,18/84,10.36%,ITGAM;UNC93B1;TLR7;LGALS9;TLR4;IRAK2;RIPK2;PLCG2;EPG5;ITGB2;LGMN;CTSS;TAB2;PIK3AP1;UBC;RPS27A;TICAM2;PIK3C3
prerank,stress-activated MAPK cascade (GO:0051403),0.4499729475061008,1.620066644567866,0.003278688524590164,0.5519839725680753,1.0,25/61,20.12%,LGALS9;IRAK2;RIPK2;GPS2;ZFP36L1;MAP4K3;MAP3K8;TAB2;ADORA2B;UBC;RPS27A;MAP3K10;GPS1;MAPK14;TNFRSF19;MAP3K11;TNIP2;MAP4K2;TAOK2;NOD2;MINK1;CRKL;TRIB1;MAPK8;CCM2
prerank,acylglycerol catabolic process (GO:0046464),0.5188377247507012,1.619495217390874,0.013888888888888888,0.544791131226696,1.0,5/30,10.21%,LIPC;LIPH;ABHD12;PNPLA1;ABHD6
prerank,protein targeting to ER (GO:0045047),-0.39086313160129094,-1.6193106971409432,0.0,0.27917271896395274,1.0,48/99,27.33%,RPL30;RPL36A;RPS29;RPL35A;RPS3;SPCS2;RPL4;RPS7;RPS2;RPL41;RPL7A;RPLP2;RPL38;RPL18A;RPS14;RPS27;RPL13A;RPL26;RPL22;GET3;RPS25;RPS15A;SRP68;RPS15;SEC62;RPL8;RPL23A;RPLP1;RPL37;SRP19;RPS12;RPL24;RPL19;RPS11;RPLP0;RPS6;RPS9;RPSA;RPS10;RPS19;RPL23;RPL17;RPS5;RPL29;RPL18;RPS21;SPCS1;RPS23
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.5811089289003821,-1.619085784614045,0.028629856850715747,0.27673469288303587,1.0,5/16,9.92%,ANK2;LRRK2;RYR2;VAPA;HSPA5
prerank,peptidyl-threonine modification (GO:0018210),0.44590490670055705,1.6132291216624497,0.0017271157167530224,0.5639880836678411,1.0,24/66,19.17%,TGFBR1;TGFBR2;PRKCA;CSNK2A2;CSNK2A1;PRKCD;PDPK1;GALNT11;GALNT3;WNK1;MAP3K10;GALNT1;MARK2;CDC42BPB;ROCK2;DYRK4;AKT1;ULK1;STK39;WNK3;DYRK1A;TAF1;GALNT2;MAPK8
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.482705002778247,-1.611715267233663,0.011627906976744186,0.2903467665193765,1.0,16/32,16.05%,PTPRD;CDKL5;ADGRB3;IL1RAPL1;HECW2;HECW1;RAPGEF2;NEDD4L;GSK3B;CUL7;SARM1;SS18L1;OBSL1;SS18L2;CAPRIN2;TNIK
prerank,granulocyte differentiation (GO:0030851),-0.5529627764568043,-1.6088532680356313,0.027210884353741496,0.29424727603109724,1.0,10/18,21.42%,LBR;JAGN1;CEBPA;RARA;CDKN1A;CBFA2T3;CDK2;E2F1;LEF1;CDK4
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4361527709228052,1.6080369112101025,0.00641025641025641,0.5793600195690712,1.0,19/67,13.57%,TBC1D16;TWF2;PLD1;SDCCAG8;RAC1;TBC1D9B;TBC1D8;TBC1D17;CAPZB;ABITRAM;FSCN1;TBC1D15;TRPM2;TBC1D10B;CCR7;DYNLT2B;ATG5;IFT20;SGSM3
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.6803625618606168,1.6074187848861194,0.024390243902439025,0.5723593574736939,1.0,3/11,7.94%,GREM1;MEF2C;GPER1
prerank,lipid catabolic process (GO:0016042),0.5774845873989305,1.6071631074422188,0.01509433962264151,0.5640296418014363,1.0,4/18,10.71%,LIPC;LIPH;SIRT2;PPT1
prerank,protein homotrimerization (GO:0070207),-0.6046082976913463,-1.6071376849055166,0.008888888888888889,0.2922499739153101,1.0,6/14,17.57%,DISP1;ALOX5AP;MLKL;SLC1A5;SCARA5;STEAP4
prerank,protein trimerization (GO:0070206),-0.6046082976913463,-1.6071376849055166,0.008888888888888889,0.2922499739153101,1.0,6/14,17.57%,DISP1;ALOX5AP;MLKL;SLC1A5;SCARA5;STEAP4
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.4510230831768615,1.6068908789074485,0.0069084628670120895,0.55605565498676,1.0,20/59,19.17%,TGFBR1;TGFBR2;PRKCA;CSNK2A2;CSNK2A1;PRKCD;PDPK1;WNK1;MAP3K10;MARK2;CDC42BPB;ROCK2;DYRK4;AKT1;ULK1;STK39;WNK3;DYRK1A;TAF1;MAPK8
prerank,postsynaptic membrane organization (GO:0001941),-0.5749589830039091,-1.6067493322190471,0.017582417582417582,0.2902269086975904,1.0,5/17,5.07%,NRXN1;NLGN1;GPHN;APOE;SHANK3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5738929074333114,1.6061670089775604,0.02640845070422535,0.5505012285620252,1.0,6/19,10.07%,ITGAM;LGALS9;TLR4;ITGB2;PIK3AP1;TICAM2
prerank,cortical cytoskeleton organization (GO:0030865),0.4815548069482345,1.6060794306178277,0.013559322033898305,0.5420511154782559,1.0,15/41,12.96%,RAC1;RND1;RHOH;RHOBTB1;NCKAP1L;RND2;RHOQ;FHOD1;RHOB;FMNL3;PLEK;TRPV4;LLGL1;FMNL2;ROCK2
prerank,purine-containing compound catabolic process (GO:0072523),-0.6081159399036553,-1.6054835556048257,0.02412280701754386,0.29023343511459065,1.0,3/13,1.73%,DPYD;XDH;GDA
prerank,integrated stress response signaling (GO:0140467),0.6159366821830119,1.6046263314292015,0.0223463687150838,0.5403541057245689,1.0,5/14,5.42%,NFE2L2;DDIT3;QRICH1;EIF2S1;IMPACT
prerank,prostaglandin biosynthetic process (GO:0001516),0.5804704566716359,1.6011814951821084,0.024179620034542316,0.5484326906183622,1.0,6/18,9.38%,TBXAS1;HPGDS;DAGLB;PTGS1;EDN2;PLA2G4A
prerank,positive regulation of cell communication (GO:0010647),-0.494678797495167,-1.599983835494872,0.009216589861751152,0.30014336491497223,1.0,9/28,8.95%,GRIK2;RIMS2;ANK3;SYT1;CLSTN2;SOX11;HOMER1;RIMS1;LGI1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5216119648404524,-1.5994636702041327,0.016166281755196306,0.298209990874996,1.0,5/24,7.98%,DMD;AKAP6;PDE4D;CALM1;PKD2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5138800309437999,1.5989041424509567,0.010582010582010581,0.5505086186338257,1.0,8/29,9.38%,LPCAT2;TMEM86B;LPCAT4;MBOAT2;PLA2G6;PLA2G5;PLA2G4B;PLA2G4A
prerank,neurotransmitter transport (GO:0006836),-0.40926453140955593,-1.597890268381044,0.004807692307692308,0.29880733549243355,1.0,22/73,12.08%,NRXN1;PTPRN2;SYN3;SYN1;SYN2;SYT1;PPFIA2;GLS;SNPH;SLC5A7;SLC1A6;CHAT;GABRA2;SLC28A2;HSPA8;RIMS1;SNAP25;CASK;UNC13B;RAB3A;SLC6A15;SLC1A1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6587024238353192,1.597008888427332,0.030245746691871456,0.550717195137926,1.0,3/11,1.05%,TGFBR1;TGFBR2;SMAD7
prerank,positive regulation of cation channel activity (GO:2001259),-0.46161035130033945,-1.5948507348162688,0.00702576112412178,0.30288947444623904,1.0,12/40,15.53%,AKAP6;ANK3;ANK2;CCR2;HTT;SHANK3;CALM1;PKD2;ACTN2;CCL2;RELN;KCNIP2
prerank,JNK cascade (GO:0007254),0.48545593314373925,1.5937427098668928,0.006872852233676976,0.5588354472415425,1.0,18/40,19.17%,IRAK2;RIPK2;GPS2;MAP4K3;TAB2;ADORA2B;UBC;RPS27A;MAP3K10;GPS1;TNFRSF19;MAP3K11;MAP4K2;NOD2;MINK1;CRKL;TRIB1;MAPK8
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.6327668762136228,-1.592034369781248,0.038288288288288286,0.30684554514962786,1.0,5/12,10.61%,B4GALT5;ARHGAP35;B4GALT6;SPTBN4;HSP90AB1
prerank,monoacylglycerol metabolic process (GO:0046462),0.6356777827768849,1.5917751392793382,0.032667876588021776,0.5595162593387029,1.0,5/13,10.21%,ABHD12;DGAT1;MOGAT2;PLA2G4A;ABHD6
prerank,response to muscle stretch (GO:0035994),-0.5686851532454327,-1.589541528881933,0.040948275862068964,0.3091621247109896,1.0,3/15,2.41%,DMD;RYR2;GSN
prerank,prostaglandin metabolic process (GO:0006693),0.5251086147504482,1.5883945434050593,0.020833333333333332,0.5664704558301927,1.0,7/26,9.38%,TBXAS1;HPGDS;DAGLB;PTGS1;HPGD;EDN2;PLA2G4A
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.564820434515332,-1.5878873494333505,0.033185840707964605,0.31005361903517975,1.0,9/15,29.69%,EDA;LRP6;HDAC1;FOXC1;WNT6;MSX1;ANKRD11;TBX1;AMELX
prerank,regulation of chemokine production (GO:0032642),0.48199566720218273,1.5869037242800241,0.029038112522686024,0.5652640939669625,1.0,8/36,4.38%,IL18;TLR7;CSF1R;LGALS9;AIF1;AGER;TLR4;IL6R
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.6106748062862041,-1.5851593735146026,0.03090507726269316,0.3132770336794302,1.0,6/13,15.53%,PLXNC1;PLXND1;PLXNA2;PLXNA1;PLXNB2;PLXNB1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.6631444967878207,1.5836464485900854,0.022944550669216062,0.5569095792567368,1.0,5/10,13.15%,NBN;SLX4;BLM;EXO1;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.6631444967878207,1.5836464485900854,0.022944550669216062,0.5569095792567368,1.0,5/10,13.15%,NBN;SLX4;BLM;EXO1;TERF1
prerank,t-circle formation (GO:0090656),0.6631444967878207,1.5836464485900854,0.022944550669216062,0.5569095792567368,1.0,5/10,13.15%,NBN;SLX4;BLM;EXO1;TERF1
prerank,regulation of microtubule depolymerization (GO:0031114),0.5279572845486749,1.5826882819684953,0.022429906542056073,0.5536102219150618,1.0,8/25,13.44%,NAV3;ARHGEF2;FGF13;CAMSAP1;CAMSAP2;TRPV4;CIB1;ATXN7
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.5056822156509043,-1.5814420376613865,0.021176470588235293,0.3191889888686343,1.0,9/25,15.07%,ST13;HSPA8;DNAJB4;HSPA5;ERO1A;DNAJB13;SDF2;HSPA2;HSPA1B
prerank,lymphocyte mediated immunity (GO:0002449),-0.6174681811797303,-1.579438481015887,0.036016949152542374,0.3209351676311208,1.0,10/12,27.73%,MYO1G;JAG1;BTN3A3;KLRD1;CD46;KLRC2;CD55;MSH2;CD8A;SLA2
prerank,in utero embryonic development (GO:0001701),0.5223804710494492,1.5790010761359734,0.018148820326678767,0.5626794445673952,1.0,6/25,9.48%,TGFBR1;SOX8;ZNF568;CHD7;FLCN;WNT7B
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.4057999196162621,1.578802224716339,0.0030959752321981426,0.5561966513262078,1.0,38/95,25.46%,TUBA4A;SDCCAG8;PRKACA;CSNK1E;CEP162;ODF2;TUBB;CEP164;TUBG1;HAUS7;CNTRL;MKS1;CENPJ;TUBA1A;CEP63;HAUS2;CEP135;HAUS6;TCTN1;OFD1;CEP57;MAPRE1;DCTN2;B9D1;CEP70;MARK4;ACTR1A;CEP43;CCP110;NDE1;CEP97;CC2D2A;TCTN2;DYNLL1;HAUS5;TTBK2;CSNK1D;RPGRIP1L
prerank,fatty acid catabolic process (GO:0009062),0.42830268403259836,1.5784095130725444,0.011627906976744186,0.5506813189271326,1.0,23/67,21.01%,ABCD2;LPIN2;PPARD;ECHS1;ACAD10;PHYH;PLA2G15;MTLN;NUDT19;ACADM;SLC27A4;HAO1;CROT;ECI1;HADHB;ECHDC2;HSD17B10;LPIN1;ABCD1;ACAA2;MMUT;ACOT8;HACL1
prerank,phosphatidylserine metabolic process (GO:0006658),0.4996641997267548,1.5774338632131228,0.020338983050847456,0.548048922102985,1.0,9/32,11.90%,ABHD12;LPCAT4;MBOAT2;PLA2G15;PLA2G5;PLA2G4B;PLA2G4A;MBOAT1;OSBPL5
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.48322733517273736,1.5772122708324017,0.01206896551724138,0.542231516515124,1.0,20/37,24.31%,SIRPA;ABCD2;TLR4;PLD4;NOS2;APPL1;MAPK14;GBP5;TICAM1;NOD2;ABCD1;PYCARD;ADCY7;MYD88;HIF1A;PDCD4;CUEDC2;APPL2;MEFV;ZC3H12A
prerank,cell differentiation in spinal cord (GO:0021515),-0.6642915019268074,-1.5771099801022241,0.034261241970021415,0.3238907998319803,1.0,3/10,15.51%,MDGA2;SOX13;MDGA1
prerank,intestinal lipid absorption (GO:0098856),-0.6151313513032959,-1.5769384787430294,0.03925619834710744,0.3212848263285398,1.0,3/11,14.48%,CD36;LDLR;UGCG
prerank,cellular response to fatty acid (GO:0071398),-0.6150322342893186,-1.5768258506120894,0.044642857142857144,0.3186723864219207,1.0,8/12,30.42%,PID1;IRS1;KCNK4;PDK3;NR1H4;PDK4;DGAT2;AKR1C1
prerank,mitochondrion morphogenesis (GO:0070584),-0.6346741113787114,-1.5760403845323143,0.03070175438596491,0.31772593965543483,1.0,5/11,11.56%,PID1;WASF1;DNM1L;MFF;FIS1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5898633801132469,1.5744110012927393,0.0374331550802139,0.5473471459175766,1.0,3/16,7.94%,MRAP;PRKCA;GPER1
prerank,lipid oxidation (GO:0034440),-0.6229099967454148,-1.5732274549037086,0.041928721174004195,0.32175159598572767,1.0,3/12,7.16%,PLA2G7;ADIPOR2;ALOX5
prerank,regulation of dendrite development (GO:0050773),-0.45594989428302246,-1.5718888984960344,0.009592326139088728,0.32187883227480213,1.0,14/37,16.05%,DCC;CDKL5;BCL11A;ADGRB3;HECW2;HECW1;NEDD4L;BMP5;GSK3B;ALK;MFSD2A;SARM1;ZDHHC15;TNIK
prerank,autophagy of peroxisome (GO:0030242),0.6375827894806403,1.57012557931667,0.040892193308550186,0.5598734618159282,1.0,5/12,10.36%,NBR1;ATM;RB1CC1;TRAPPC8;PIK3C3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.5270265099160399,-1.569911276667865,0.035955056179775284,0.32362438487921624,1.0,6/21,3.65%,HS6ST3;HS3ST5;SULF2;EXT1;HS6ST2;HS3ST4
prerank,fatty acid beta-oxidation (GO:0006635),0.4460097615666114,1.5691717826125346,0.008547008547008548,0.557366480612866,1.0,24/51,27.73%,ABCD2;ACOX3;PPARD;ECHS1;ACAD10;MTLN;IVD;ACADM;CROT;ECI1;HADHB;ECHDC2;HSD17B10;ABCD1;ACAA2;ACOT8;ETFB;ETFA;ETFDH;SCP2;CRAT;ACAD11;ACADVL;ACOX1
prerank,positive regulation of chemokine production (GO:0032722),0.4637232787097379,1.5690005304440366,0.0176678445229682,0.5514751696436935,1.0,17/44,22.21%,IL18;TLR7;CSF1R;LGALS9;AIF1;AGER;TLR4;IL6R;IL33;EIF2AK2;MAVS;EGR1;PYCARD;ADAM17;HIF1A;TWIST1;DDX3X
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6637888160860395,1.5679424583984545,0.040968342644320296,0.5493750163964392,1.0,4/10,5.13%,NFE2L2;DDIT3;QRICH1;EIF2S1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.45870534113819056,-1.5678144722425584,0.012594458438287154,0.3258220968369503,1.0,14/34,11.15%,GRID2;LRRK2;GRIN2A;GRIN2B;GABRA3;GLRA1;GABRG1;GSK3B;GABRA2;GABRG3;INSYN2A;GRIN2D;CHRNA4;GABRG2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6344332262605136,1.5677485264296247,0.029357798165137616,0.5438777306280224,1.0,5/13,12.48%,HEXB;ARSB;HEXA;BGN;CSPG5
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5215618512023326,1.5677007673037038,0.02097902097902098,0.5377768840152477,1.0,15/27,27.89%,BRD8;BAG6;TAF6L;CPA4;TAF6;MRGBP;PHF20;MORF4L1;NAA50;ATAT1;KAT6B;MORF4L2;KAT2B;EP300;KAT5
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5492313277277652,-1.5675393321386102,0.038461538461538464,0.32374003234001636,1.0,5/18,5.07%,NRXN1;NLGN1;CCR2;CACNG2;SHANK3
prerank,neuron apoptotic process (GO:0051402),-0.5285744205831717,-1.5675330368970026,0.034858387799564274,0.32101952786657084,1.0,8/19,15.70%,TRPC5;APP;SCN2A;DIABLO;LIG4;ERBB3;BID;BCL2
prerank,osteoclast differentiation (GO:0030316),0.5389062230873455,1.5671686165164251,0.02857142857142857,0.5340139783751343,1.0,7/22,13.85%,CSF1R;GAB2;SRC;SBNO2;OSTM1;MAPK14;OSCAR
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5366025771352483,-1.5664759213535906,0.037825059101654845,0.3206941046988187,1.0,10/20,35.08%,WNT4;SIK1;NCOR1;CDA;CRY1;C1QTNF3;UGT1A8;C1QTNF12;GCK;BCKDK
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6249010566788951,-1.5643358115498385,0.05357142857142857,0.32320315095030355,1.0,5/11,18.23%,PID1;PRKN;TFRC;ADCK1;VAT1
prerank,reticulophagy (GO:0061709),0.6296248259710442,1.5632146934902291,0.04716981132075472,0.5447535130329546,1.0,7/12,23.42%,ULK2;RB1CC1;UBA5;ULK1;RETREG1;UFC1;ATG2A
prerank,retinoid metabolic process (GO:0001523),-0.3951558695375575,-1.5623863866061745,0.01084010840108401,0.3253872313538126,1.0,35/71,33.12%,GPC6;APOE;GPC5;SDC3;RETSAT;HSPG2;GPC3;RDH13;NAPEPLD;DHRS13;RBP4;AGRN;RDH10;DHRS9;ABCA4;GPC4;SDC4;SCPEP1;RDH12;RBP1;GPC1;CYP2S1;RARRES2;UGT1A7;UGT1A8;UGT1A1;LRP2;SDC2;AKR1C1;OPN1MW;PLB1;APOA2;RBP2;LRAT;STRA6
prerank,glycosphingolipid metabolic process (GO:0006687),0.46901520893759324,1.561691128328268,0.01549053356282272,0.545207933622298,1.0,9/42,8.73%,HEXB;LARGE1;ST3GAL5;CPTP;HEXA;NEU3;SMPD2;ASAH1;CERK
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.5587468735798249,-1.5613053590223969,0.04081632653061224,0.32513880248174265,1.0,10/18,23.52%,IRS1;PRKN;ADRA2A;CRHBP;SFRP1;FFAR4;CCN3;CRH;REST;INHBB
prerank,epithelial cell-cell adhesion (GO:0090136),0.6431399032898386,1.5608627561482817,0.04107142857142857,0.5427501964193514,1.0,2/11,1.91%,ITGB5;DSP
prerank,histone modification (GO:0016570),0.39344598259068064,1.5599619865109084,0.003110419906687403,0.5406526726579953,1.0,42/109,21.80%,BRD8;MTA1;PRKCD;PRMT2;HDAC10;SIRT2;SUDS3;RPS6KA5;TAF6L;PADI2;RBM14;EHMT2;PRMT8;CPA4;EYA3;SIN3A;MIDEAS;TAF6;BRMS1L;KDM4A;PRMT1;USP36;MRGBP;UBE2U;PRMT6;PHF20;MORF4L1;CARM1;ATXN7;SIN3B;RPS6KA4;MIER3;EZH2;BAZ1B;NAA50;UBE2A;TAF10;HDAC5;PARK7;PHC1;BRMS1;ATXN7L3
prerank,axonogenesis (GO:0007409),-0.3330100178091366,-1.5597179339592193,0.0,0.3259156595227266,1.0,74/237,20.67%,NRXN1;DAB1;CTNNA2;ANK3;UNC5C;AUTS2;B4GALT5;NRXN3;DCC;ROBO1;NRCAM;KIF5C;SPTBN1;PLPPR4;BDNF;ARHGAP35;APP;SLIT2;DOK6;MAP1B;SLITRK1;B4GALT6;SHC3;NPTN;PALLD;EMB;DOK1;CNTN6;TNR;SEMA5A;SHANK3;SEMA4A;NCAM1;PAK3;ACTB;RET;GFRA2;DOK5;SEMA6D;KIF5B;SPTBN2;LGI1;DOK2;SPTBN4;GRB10;ENAH;RAB3A;HSP90AB1;RAB8A;ZDHHC17;DAG1;NTNG1;EPHA5;PRKCQ;NTNG2;RELN;EFNA5;SEMA6A;NEFH;LAMA5;BRSK1;PARD3;SEMA7A;KLF7;CNTN4;EPHA3;DSCAM;EPHA1;BRSK2;LMTK2;EZR;NOTCH2;FYN;LAMA1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5354570402795532,1.559583556194977,0.04081632653061224,0.5362699209600968,1.0,7/21,11.90%,LPCAT4;MBOAT2;PLA2G5;PLA2G4B;PLA2G4A;MBOAT1;OSBPL5
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.4135015384366411,-1.5578802152964053,0.014814814814814815,0.327526982458291,1.0,21/54,17.97%,GPC6;HS3ST5;HS3ST2;GPC5;EXT1;SDC3;HGSNAT;HS6ST2;HSPG2;GPC3;HS3ST1;PXYLP1;EXT2;B4GALT7;AGRN;NDST1;FUCA1;HS3ST3B1;GPC4;B3GAT2;SDC4
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5394046333859768,-1.5561305208607994,0.026373626373626374,0.32915984141204385,1.0,6/20,7.13%,DMD;ANK2;RYR2;ATP2A2;CALM1;CACNA1C
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.37874852392202213,1.5554644689367234,0.0029585798816568047,0.5480334477344866,1.0,27/140,8.43%,SRGAP2;SRGAP3;CHN2;ARHGAP5;FGD2;ARHGAP45;ARHGAP39;OPHN1;ARHGAP22;ARHGEF2;PREX1;VAV2;RAC1;TGM2;ARAP3;ITGAV;SRC;RHOH;ARHGAP25;CYRIB;ARHGAP28;RHOQ;FLCN;AKAP13;RHOB;ARHGAP8;ARHGAP17
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.6273318669103904,-1.5553577029666077,0.04814004376367615,0.32835979326110915,1.0,4/11,8.01%,CD74;CD44;SIRT1;ING2
prerank,regulation of histone methylation (GO:0031060),-0.5937871500306088,-1.5544385212813243,0.05,0.3282988100699675,1.0,7/13,17.65%,JARID2;CHTOP;TET1;TTLL12;NSD1;PIH1D1;AASS
prerank,error-free translesion synthesis (GO:0070987),0.5343693437689307,1.5534255813225182,0.02717391304347826,0.5506470385681603,1.0,10/22,22.68%,RFC2;PCNA;UFD1;UBC;RPS27A;RFC1;SPRTN;RPA3;POLDIP2;NPLOC4
prerank,negative regulation of myoblast differentiation (GO:0045662),0.62360826869848,1.5532512321148226,0.03090909090909091,0.5457511367443976,1.0,8/13,26.87%,SOX8;ANKRD2;DLL1;EID2B;TGFB1;NOTCH1;SOX9;SRA1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5608704055526119,1.5531865797192788,0.023809523809523808,0.5403534562362998,1.0,7/18,8.98%,MTUS1;LYN;CAMK1D;IL6R;EDN3;EDN2;PTK2B
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5706361227536904,1.5525105245765065,0.03518518518518519,0.5372979453019213,1.0,8/17,26.16%,LPCAT4;PLA2G5;PLA2G4B;PLA2G4A;CRLS1;SERAC1;PLA2G3;LPCAT1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6508313090742887,1.5478641824234305,0.04136690647482014,0.5510635309141336,1.0,3/10,2.98%,GREM1;NBR1;LYN
prerank,sphingosine metabolic process (GO:0006670),0.5622713197166835,1.5474521033267565,0.044642857142857144,0.5471455447588592,1.0,6/17,12.08%,SPTLC3;ACER3;ACER2;ASAH1;PLPP2;PLPP1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.6062323318732081,-1.5463219831183022,0.05747126436781609,0.34207641763163477,1.0,6/12,15.38%,CORO1C;SPRY4;ITGB1BP1;KANK1;RCC2;EFNA5
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.6062323318732081,-1.5463219831183022,0.05747126436781609,0.34207641763163477,1.0,6/12,15.38%,CORO1C;SPRY4;ITGB1BP1;KANK1;RCC2;EFNA5
prerank,negative regulation of glycolytic process (GO:0045820),-0.645773966445663,-1.5459084439603843,0.02586206896551724,0.33782284417786734,1.0,6/10,26.78%,PFKFB1;HDAC4;TIGAR;NCOR1;CBFA2T3;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.645773966445663,-1.5459084439603843,0.02586206896551724,0.33782284417786734,1.0,6/10,26.78%,PFKFB1;HDAC4;TIGAR;NCOR1;CBFA2T3;PPARA
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6316378612891436,1.5457724802650266,0.04924242424242424,0.5486645396280067,1.0,3/11,5.90%,BIN1;CACNB2;NOS1AP
prerank,negative regulation of B cell proliferation (GO:0030889),0.6531130446164259,1.544769838547085,0.038461538461538464,0.5474756172442101,1.0,4/11,7.09%,LYN;ATM;TNFRSF21;TNFRSF13B
prerank,positive regulation of nervous system process (GO:0031646),-0.5366236820626751,-1.5446881095053848,0.02050113895216401,0.33817652660178865,1.0,6/18,10.09%,RIMS2;TPPP;MYRF;RIMS1;UNC13B;TENM4
prerank,mononuclear cell differentiation (GO:1903131),0.5205253770937638,1.544306469784055,0.028469750889679714,0.5442056909686316,1.0,9/24,12.99%,IKZF1;CSF1R;LYN;TRPM2;PDE1B;MT1G;AXL;MYH9;IRF8
prerank,cell junction assembly (GO:0034329),-0.3720390242654771,-1.5397861948517555,0.005449591280653951,0.347436589741502,1.0,30/100,14.60%,NRXN1;NLGN1;CTNND2;DNM3;KIRREL3;NRCAM;ADGRL3;GPM6A;BDNF;CDH8;SLITRK1;PLXND1;FN1;CDC42;SHANK3;PKP4;CDH22;ACTB;VMP1;CDH7;CDH20;CDH11;CDHR3;CDH5;ACTG1;CDH10;OBSL1;CDH1;ACHE;SDK1
prerank,positive regulation of protein maturation (GO:1903319),-0.620525966226007,-1.5376227639907247,0.04700854700854701,0.34970720479484524,1.0,3/11,12.17%,NLRC4;CCBE1;TFR2
prerank,covalent chromatin modification (GO:0016569),-0.5790946702866175,-1.5375864945694329,0.06178489702517163,0.3472303998504191,1.0,6/14,15.17%,SIRT1;HLCS;AURKB;HELLS;SETD5;HDAC1
prerank,regulation of receptor binding (GO:1900120),-0.6353514534417005,-1.5370160372738693,0.05908096280087528,0.34624852295980413,1.0,4/10,11.08%,BDNF;B2M;ATP2A2;ATP2A3
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4345747295975232,-1.5368637041923034,0.030805687203791468,0.3441337874419285,1.0,16/44,16.59%,AKAP6;ANK2;KCNN2;KCNMB2;KCNJ3;GABBR1;GABBR2;KCNH2;KCNJ6;ANO6;ACTN2;ATP1B3;KCNMB4;KCNQ1;KCNIP2;FLNA
prerank,cellular metal ion homeostasis (GO:0006875),-0.36994267498978534,-1.536803370706723,0.005361930294906166,0.34182883024199723,1.0,25/102,12.91%,ANK2;CCR2;HTR2C;SLC8A3;RYR2;ATP2B1;CCR1;NPTN;CD40;ATP13A3;NEDD4L;SLC24A2;ATP2A2;TPT1;LETM1;HTR2B;RMDN3;SLC8B1;TMEM165;STIM2;DMPK;ATP1B3;ATP2A3;ATP1A1;CDH5
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4741011266937134,1.5361133214091414,0.012027491408934709,0.5733323721926336,1.0,9/38,6.10%,CX3CR1;SIRPA;SMAD3;RAC1;TLR4;AGTR2;CLU;NOS1AP;CD34
prerank,RNA modification (GO:0009451),0.43514489607834766,1.5356312741852904,0.02384737678855326,0.5701280768526359,1.0,20/54,21.10%,QTRT1;TRMT6;ANKRD16;AARS2;SSB;THUMPD1;JMJD6;NSUN5;NSUN6;BCDIN3D;FTSJ3;QTRT2;NSUN3;CTU2;TRMT61A;CDKAL1;TYW5;TRDMT1;TFB1M;FTSJ1
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.4392337655924401,-1.533313361846886,0.021176470588235293,0.34773318799782743,1.0,13/41,14.22%,AKAP6;ANK3;ANK2;KCNN2;KCNMB2;KCNJ3;GABBR1;GABBR2;KCNH2;KCNJ6;ACTN2;KCNMB4;KCNQ1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.5466413289530478,1.5310237638340594,0.043875685557586835,0.5852424580632651,1.0,5/19,14.11%,F11R;PRKACA;TJP1;ROCK2;RUNX1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.5422433151117309,-1.5307721605129294,0.06040268456375839,0.3516803194362152,1.0,9/17,18.87%,DNM1L;MFF;GGCT;BID;SOD2;BAK1;FIS1;BCL2;BOK
prerank,synaptic vesicle membrane organization (GO:0048499),0.5693185456061999,1.5296351443082343,0.032667876588021776,0.585538318695151,1.0,6/17,11.91%,SNAP47;SYNGR1;AP3D1;STX1A;STX19;STX4
prerank,neuron development (GO:0048666),-0.3444656662904269,-1.5269690759953864,0.0,0.35860265572623184,1.0,48/141,19.67%,CNTNAP2;NLGN1;FRY;B4GALT5;TENM3;GPM6A;APP;TENM2;APOE;B4GALT6;NTRK2;RAPGEF2;ETV1;MAP2;EHD1;VAPA;RASGRF1;STMN4;TOR1A;GSK3B;CLN5;MYT1L;ALK;SH3GL2;LGI1;ATP7A;ERCC6;POU3F2;TENM4;DTNBP1;PBX1;SRRM4;EPHA5;BTG2;PLP1;UGCG;LRP12;TMEM108;STMN2;HMGB1;SRF;CNTN4;SAMD14;LGI4;PBX3;BICDL1;ACTL6B;BLOC1S3
prerank,response to cholesterol (GO:0070723),0.5569921270243902,1.5268208607964844,0.047524752475247525,0.5923340711498717,1.0,8/17,24.15%,TGFBR1;TGFBR2;GRAMD1A;SMO;CCR5;PTCH1;GPLD1;TGFB1
prerank,regulation of interleukin-17 production (GO:0032660),0.4910994387266155,1.5259620839594057,0.021505376344086023,0.5903122368992627,1.0,7/31,7.73%,IL18;VSIR;DDIT3;TLR4;NCKAP1L;SLC7A5;IL12B
prerank,calcium ion homeostasis (GO:0055074),-0.3713357679699363,-1.5254843055380054,0.005277044854881266,0.3595957714046174,1.0,29/95,19.87%,ANK2;CCR2;HTR2C;SLC8A3;RYR2;ATP2B1;CCR1;NPTN;CD40;ATP13A3;SLC24A2;ATP2A2;TPT1;HTR2B;RMDN3;SLC8B1;TMEM165;STIM2;DMPK;ATP2A3;SNCA;CDH5;TFAP2B;CCL5;CCL14;TRPV6;CCL7;ATP13A5;TMTC2
prerank,defense response to fungus (GO:0050832),0.5568492014168114,1.52360808429734,0.032567049808429116,0.5956672781865097,1.0,3/17,6.62%,CX3CR1;PLCG2;GAPDH
prerank,transcription by RNA polymerase III (GO:0006383),0.4973868569922951,1.5221101022219097,0.02861952861952862,0.5969755392684892,1.0,7/27,14.43%,IVNS1ABP;POLR3G;GTF3C2;BRF1;POLR3H;GTF3C6;GTF3A
prerank,regulation of superoxide anion generation (GO:0032928),0.5862101276889049,1.5210227442074258,0.02936096718480138,0.5963974278376435,1.0,4/14,3.77%,ITGAM;PRKCD;AATF;ITGB2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.47254117592288974,1.5209671712146227,0.033928571428571426,0.5914496294883078,1.0,10/33,13.34%,PDE3B;P2RY12;FERMT3;LYN;PIK3CG;NCKAP1L;ACER2;EPHA8;PTPN11;CIB1
prerank,positive regulation of immune system process (GO:0002684),0.5642000107836729,1.520910261393225,0.05639097744360902,0.5864825287457759,1.0,5/16,10.22%,LGALS9;NCKAP1L;PIK3CB;MIA3;PIK3CD
prerank,negative regulation of protein ubiquitination (GO:0031397),0.44126634414601773,1.5207153894755319,0.024752475247524754,0.5823117990533794,1.0,16/50,19.67%,IVNS1ABP;SENP2;SMAD7;ARRB2;SPRY2;KLHL40;U2AF2;ABL1;USP4;HDAC8;DTX3L;AKT1;SPOPL;TAF1;GNL3L;PARK7
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.37126075940549136,1.5206455889869115,0.0,0.5776481476609974,1.0,25/128,12.94%,ITGB5;TGFBR1;F11R;TGFBR2;SMAD3;SMAD7;ARRB2;SKI;TGFB1I1;DDX5;SRC;SMURF1;ID1;HPGD;LPXN;CGN;EID2;LEFTY1;APPL1;UBC;RPS27A;GCNT2;SMAD9;USP9Y;ZMIZ2
prerank,negative regulation of insulin secretion (GO:0046676),-0.5527762675568513,-1.520501026516471,0.037444933920704845,0.36969235814317386,1.0,9/17,23.52%,IRS1;PRKN;PIM3;ADRA2A;SFRP1;CCN3;KLF7;REST;INHBB
prerank,regulation of neuron projection development (GO:0010975),-0.33988627527417914,-1.519741314056593,0.0,0.36927159413162935,1.0,49/163,16.14%,MAGI2;LRRC4C;PDLIM5;CTNNA2;DCC;CDKL5;RIT2;TENM3;LRRC7;LRRK2;SPOCK1;BDNF;ARHGAP35;KIDINS220;APOE;IL1RAPL1;PPFIA2;ROR1;NTRK2;NPTN;FUT9;RAPGEF2;NTRK3;ABI2;SHANK3;PAK3;GSK3B;RET;CCDC88A;CHN1;FBXO7;SCARF1;SRCIN1;P3H1;SERPINI1;MFSD2A;NTNG1;KANK1;PAK1;PLXNB2;PAQR3;NTNG2;ZDHHC15;RELN;CX3CL1;MINAR1;ABL2;BRSK1;STMN2
prerank,regulation of cation transmembrane transport (GO:1904062),-0.47318828836559446,-1.5195506453133132,0.01909307875894988,0.3672031363214529,1.0,9/29,8.27%,KCNIP4;DPP6;DPP10;KCNIP1;FGF12;KCNN2;HOMER1;KCNAB2;KCNH2
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.4823821474816594,-1.5193533346422121,0.029661016949152543,0.3651358993242817,1.0,7/25,10.50%,RIT2;LRRK2;ITPR1;HTT;CCL4;CDH13;TMBIM4
prerank,positive regulation of cytokinesis (GO:0032467),-0.4602272254220654,-1.5186742414319487,0.04807692307692308,0.36407259220520166,1.0,8/32,9.91%,CUL3;KIF23;CDC42;RACGAP1;PKP4;GIPC1;KIF14;AURKB
prerank,telomere capping (GO:0016233),0.5688185777785684,1.5178819181920076,0.047186932849364795,0.5849965930797464,1.0,8/16,20.75%,CTC1;NBN;DCLRE1B;DCLRE1C;TEN1;TERF1;DCLRE1A;ACD
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5252359512488567,1.5169745200112343,0.04391891891891892,0.5841478998054705,1.0,10/23,17.40%,VSIR;LGALS9;DDIT3;TLR4;INHA;PDCD1LG2;AXL;HAVCR2;LGALS7;C1QBP
prerank,I-kappaB phosphorylation (GO:0007252),0.6374853027654721,1.5163053413397707,0.041749502982107355,0.5818395794594675,1.0,2/10,2.28%,TLR7;TLR4
prerank,triglyceride homeostasis (GO:0070328),0.5009133708121303,1.5159015874123771,0.043936731107205626,0.578460924746286,1.0,6/26,13.16%,LIPC;IL18;MLXIPL;MTLN;APOC4;SCARB1
prerank,cellular response to cAMP (GO:0071320),-0.4634294663736566,-1.5137348146497716,0.03464203233256351,0.3742916835311095,1.0,16/30,24.60%,AKAP6;HCN1;RAPGEF2;PKD2;AHR;KCNQ1;PDE2A;CRHBP;CFTR;HCN2;EZR;SLC26A3;AQP1;SLC5A5;HCN4;WT1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4097801445489122,1.513097873210509,0.011764705882352941,0.5848849484456895,1.0,16/70,10.38%,LIPC;LPCAT2;PCTP;TMEM86B;LPIN2;CSNK2A2;CSNK2A1;LPCAT4;MBOAT2;PLA2G15;PLA2G6;PLA2G5;PLA2G4B;CHKB;PLA2G4A;MBOAT1
prerank,response to histamine (GO:0034776),-0.6240330898902083,-1.5122671055563128,0.0611353711790393,0.3752591797359096,1.0,5/10,18.32%,GABRB1;HRH1;GABRB3;GABRG2;DIAPH1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5429597746394045,1.5114196162716536,0.03356890459363958,0.5870642266534065,1.0,10/19,25.23%,TLR7;TLR4;RIPK2;DHX9;SETD2;IRF3;MAVS;IRF5;DDX3X;TLR9
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.5268606960041928,-1.5112086670406504,0.05726872246696035,0.3756569346511936,1.0,9/19,23.02%,CIITA;VIM;WNT4;CREB3L1;RGCC;SCX;SERPINF2;BMP4;LARP6
prerank,positive regulation of myelination (GO:0031643),-0.6091540582067207,-1.510701269551605,0.04956896551724138,0.3744157035096094,1.0,4/11,16.72%,TPPP;MYRF;TENM4;PARD3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5168661675277634,1.5093618642987836,0.039783001808318265,0.590863493591929,1.0,10/25,22.16%,ETS1;NCKAP1L;PRMT1;ARNT;MAPK14;HMGB2;TAL1;BRD1;HIF1A;STAT5B
prerank,lymphocyte migration (GO:0072676),-0.4572603867419805,-1.5084271048627507,0.03255813953488372,0.37776893114908283,1.0,16/32,33.59%,CCL4;MYO1G;RET;CCL2;MSN;CCL5;CX3CL1;CCL14;CCL7;TBX21;CRTAM;CCL19;CCL8;MSMP;ADAM8;S1PR1
prerank,positive regulation of T cell activation (GO:0050870),0.4133918274913447,1.5078219799644514,0.016051364365971106,0.5928293428136859,1.0,14/62,9.16%,DOCK8;SIRPA;CCDC88B;LGALS9;AIF1;RHOH;CYRIB;NCKAP1L;TNFRSF13C;IL6ST;CCR7;PDCD1LG2;IL12B;CD86
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5813152679297588,1.507244669658603,0.05913978494623656,0.5904575376976924,1.0,6/14,16.10%,FAM98B;CSTF2;CPSF1;TSEN2;TSEN54;RTCB
prerank,negative regulation of secretion by cell (GO:1903531),-0.4344913969003644,-1.5068227432811216,0.017977528089887642,0.37924122004152766,1.0,10/38,14.80%,GRM7;LILRB1;APOE;IL1RAPL1;RSAD2;STXBP6;RHBDF2;SNCA;HMGCR;SERGEF
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.479227288843993,-1.506800648011002,0.034482758620689655,0.37682003446776663,1.0,6/27,6.92%,DMD;AHNAK;ANK2;PDE4D;YWHAE;CALM1
prerank,cardiac muscle cell action potential (GO:0086001),-0.47722327948577875,-1.5059946023554176,0.038461538461538464,0.376414959866082,1.0,12/30,17.11%,DMD;ANK2;FGF12;YWHAE;CACNA1C;KCND3;KCNH2;ATP1A1;CACNA1G;KCNQ1;KCNIP2;HCN2
prerank,negative regulation of innate immune response (GO:0045824),-0.4475189703891942,-1.5029588539195093,0.02733485193621868,0.3818693077511557,1.0,9/34,14.64%,USP15;SERPING1;TRAFD1;VSIG4;PTPN2;TTLL12;SAMHD1;NLRC3;OAS3
prerank,activin receptor signaling pathway (GO:0032924),0.5647733192829351,1.5027870849758291,0.05194805194805195,0.6047554758761331,1.0,2/15,0.98%,TGFBR1;SMAD3
prerank,regulation of plasminogen activation (GO:0010755),0.609726469640888,1.5006456287030099,0.05938697318007663,0.6098117569059804,1.0,7/12,21.44%,PLGRKT;F12;RUNX1;SERPINE2;THBS1;HPN;SERPINE1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.6017560827906884,1.5004127799229832,0.04251386321626617,0.6059689828508529,1.0,4/12,11.91%,SNAP47;STX1A;STX19;STX4
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5492461996835145,-1.5001838670970566,0.04899777282850779,0.3863591761953946,1.0,5/16,9.88%,RBPJ;AKAP6;ZFPM2;ERBB4;PIM1
prerank,positive regulation of GTPase activity (GO:0043547),0.3510419425061143,1.5000498260552868,0.004418262150220913,0.6029437445328428,1.0,42/188,13.59%,SRGAP2;TBC1D16;DOCK8;ARHGAP45;F11R;SIPA1L2;ARHGAP22;ITGA6;ARHGAP27;MAP4K4;RAP1GDS1;RGS10;TBC1D9B;TGM2;SNX18;ASAP3;TBC1D8;TBC1D17;TBCK;GARNL3;ARHGAP25;TBC1D7;SIPA1;TBC1D15;PICALM;FLCN;TAX1BP3;SLC27A4;TBC1D10B;CCR7;TBC1D9;RAB3GAP1;RAPGEF3;CCDC125;LIMS1;DOCK10;SGSM2;SEMA4D;RUNDC1;RTN4R;SGSM3;ADPRH
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.5896266104685326,-1.4997509063264294,0.047619047619047616,0.38503061177155345,1.0,5/12,18.89%,DPYD;DPYSL5;CTPS1;ALDH6A1;CDA
prerank,glycerophospholipid catabolic process (GO:0046475),0.48768644688192503,1.4996482413988221,0.044444444444444446,0.5998875094356032,1.0,7/27,9.38%,LIPC;ABHD12;PLA2G15;PLA2G6;PLA2G5;PLA2G4B;PLA2G4A
prerank,prostanoid biosynthetic process (GO:0046457),0.5715035709056331,1.4993010975112224,0.05366726296958855,0.5968779344161839,1.0,5/15,9.38%,TBXAS1;DAGLB;PTGS1;EDN2;PLA2G4A
prerank,long-term synaptic potentiation (GO:0060291),-0.5044341552671688,-1.49899019068688,0.03464203233256351,0.3846461831784589,1.0,8/21,9.95%,GRIN2A;SLC8A3;PRKCZ;GRIN2B;NPTN;SLC24A2;PLK2;GRIN2D
prerank,negative regulation of transmembrane transport (GO:0034763),0.6407527982434749,1.496401392416666,0.06666666666666667,0.6047805669294367,1.0,6/10,23.46%,CTTNBP2NL;PRKCB;AKT1;THBS1;INPP5K;OAZ3
prerank,outer dynein arm assembly (GO:0036158),-0.5385613772387139,-1.4956053574161445,0.04329896907216495,0.39103230521314564,1.0,10/15,33.59%,ODAD2;DNAH8;DNAAF5;ODAD3;DNAH17;DNAAF1;DNAL1;DNAAF4;CCDC63;ODAD4
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.5106789683604225,1.4954203742632888,0.046762589928057555,0.6042805257779019,1.0,7/23,10.38%,LPCAT4;MBOAT2;PLA2G6;PLA2G5;PLA2G4B;PLA2G4A;MBOAT1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.593531092770845,1.4952143279641654,0.041970802919708027,0.6005533024701042,1.0,4/13,11.91%,ITGAM;GAB2;ITGB2;STX4
prerank,regulation of ion transmembrane transport (GO:0034765),-0.44975515383844095,-1.4943101346036909,0.037209302325581395,0.39190419127111387,1.0,8/33,9.69%,AKAP6;KCNJ3;YWHAE;NEDD4L;CHRM3;KCNH2;KCNJ6;ANO6
prerank,regulation of interferon-alpha production (GO:0032647),0.5162158247386945,1.4942478339282361,0.04634581105169341,0.6005026514327151,1.0,10/23,22.21%,TLR7;TLR4;RIPK2;DHX9;HAVCR2;SETD2;IRF3;MAVS;IRF5;DDX3X
prerank,retinol metabolic process (GO:0042572),-0.5465303074542394,-1.4941751628533724,0.043859649122807015,0.3899368907722386,1.0,5/14,19.43%,RETSAT;RBP4;RDH10;DHRS9;RDH12
prerank,glucose import (GO:0046323),0.5678621483191915,1.4937965428665656,0.07212475633528265,0.5979475543941676,1.0,5/13,18.68%,SORT1;SLC27A4;TRARG1;RAB4B;ZDHHC7
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.5042782200877738,1.4937138532513354,0.033807829181494664,0.5939950052704208,1.0,7/23,10.28%,PREB;SEL1L;TMED9;UFD1;SEC13;OS9;AUP1
prerank,cilium movement (GO:0003341),-0.4106672618239132,-1.4922262532969608,0.031818181818181815,0.3924698506949445,1.0,24/48,33.59%,DNAH9;ODAD2;CFAP53;DNAI4;DNAAF5;CFAP70;DNAI3;CFAP61;CFAP206;CFAP91;ODAD3;SPEF2;SPA17;DNAH17;DNAAF1;TEKT5;CFAP100;CCDC39;DNAH11;DNAAF4;CCDC63;TEKT2;ROPN1L;ODAD4
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.4852006830045244,-1.4919095331061238,0.032467532467532464,0.39094269821712413,1.0,10/24,18.91%,CD74;CD44;SIRT1;TPT1;ING2;CCAR2;BCL2;SNAI2;SFRP2;DDIAS
prerank,positive regulation of histone methylation (GO:0031062),-0.4834928100328707,-1.4905915950894737,0.04269662921348315,0.3920503958168477,1.0,13/24,26.28%,AUTS2;MTF2;JARID2;CHTOP;SIRT1;TET1;DNMT3B;CTNNB1;RIF1;DNMT1;FAM47E;MYB;SNW1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.45683027936339554,-1.4904118189182167,0.0367816091954023,0.39015303815365115,1.0,10/27,16.13%,CTNNA2;IL1RAPL1;HOMER1;GSK3B;CCDC88A;FBXO7;NTNG1;NTNG2;FCGR2B;BRSK1
prerank,axon extension (GO:0048675),-0.4868306872935133,-1.4902593682857668,0.037209302325581395,0.38817815386465054,1.0,5/23,5.02%,AUTS2;ALCAM;SLIT2;MAP1B;SEMA5A
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.47430710397739373,-1.4895409863245144,0.05133928571428571,0.38759652964032404,1.0,8/26,5.53%,PLCB1;EGFR;FGF10;ANKRD17;KMT2E;MTBP;CCND2;UBE2E2
prerank,regulation of actin filament polymerization (GO:0030833),0.4050284601861116,1.4894562946133938,0.008547008547008548,0.6074184477034967,1.0,17/69,12.50%,BIN1;SSH2;TWF2;BAIAP2L2;CDC42EP2;DBN1;PRKCD;CYRIB;ABITRAM;ARHGAP28;NCKAP1L;SSH1;CCR7;PTK2B;FCHSD2;HIP1R;TENM1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6389404668064014,1.489040443595567,0.0683111954459203,0.6048397353532263,1.0,3/10,4.59%,TGFBR2;LGALS9;NCKAP1L
prerank,regulation of microglial cell activation (GO:1903978),-0.5380621835601542,-1.4878354408806038,0.06540084388185655,0.3897395892343821,1.0,5/15,15.69%,STAP1;LDLR;MMP8;TTBK1;CX3CL1
prerank,central nervous system myelination (GO:0022010),-0.5958934990274957,-1.487314732602556,0.07291666666666667,0.38878534814070853,1.0,6/11,14.35%,B4GALT5;B4GALT6;MYRF;CNTNAP1;TENM4;PLP1
prerank,tRNA metabolic process (GO:0006399),0.5455674933850919,1.4869724498239982,0.05786618444846293,0.6092603017679481,1.0,7/17,14.83%,ADAT1;POP1;SSB;KARS1;RPP21;DARS2;SARS1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6183246173902999,1.4851851581786595,0.0637065637065637,0.6124314348878835,1.0,5/10,9.38%,LIPC;PLA2G15;PLA2G6;PLA2G5;PLA2G4A
prerank,regulation of acrosome reaction (GO:0060046),-0.6092363607906724,-1.483587027269455,0.05,0.3956535769950013,1.0,2/10,5.46%,PLCB1;GLRA1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.3919314350723711,1.4818626770279126,0.02113821138211382,0.6223512953192458,1.0,23/84,13.36%,SMOC2;ETS1;RAC1;ANXA3;PRKCA;LGMN;PIK3CG;PDPK1;MET;SPARC;RHOB;GATA2;PDGFB;PIK3CB;PTK2B;PIK3CD;ABL1;PDCD6;MAPK14;ROCK2;PROX1;SCARB1;AKT1
prerank,activation of GTPase activity (GO:0090630),0.38943498208520605,1.4812690855212576,0.009884678747940691,0.6205791192712283,1.0,28/89,18.21%,TBC1D16;ARHGAP45;SIPA1L2;ARHGAP22;TBC1D9B;TBC1D8;TBC1D17;TBCK;GARNL3;ARHGAP25;TBC1D7;SIPA1;TBC1D15;TAX1BP3;SLC27A4;TBC1D10B;CCR7;TBC1D9;CCDC125;SGSM2;RUNDC1;SGSM3;ADPRH;ECT2;GRTP1;SIPA1L1;TBC1D30;GMIP
prerank,protein modification by small protein conjugation (GO:0032446),0.3233171571915561,1.480892981478323,0.0,0.6180615523537767,1.0,94/361,17.83%,SUMO1;NFE2L2;HERC2;PJA2;ARRB2;RNF38;KLHL7;VHL;TRIM11;UBA7;RNF41;ITCH;SPSB1;OTULIN;UBA2;FBXL15;RANBP2;UBE2H;FBXO24;RNF138;TRIM5;PEX10;SMURF1;STX1A;PCNA;HLTF;NUP42;DTX4;TRIM44;KLHL24;ZSWIM8;SPSB2;ENC1;TRIM72;TRPM4;CTR9;CDC34;CUL4B;TRIM69;NUP35;ARRDC1;ANKRD9;ASB11;OS9;MIB2;ASB5;RNF103;RNF8;CRBN;BRCA1;KLHL18;DTX1;WWP2;UBC;RPS27A;FBXO11;NUP50;MSL2;TRIM62;FBXL2;UHRF2;AREL1;UBA5;PIAS2;PIAS3;UBE2V2;PINK1;DTX3L;RRAGA;ANAPC11;MYLIP;DET1;RNF25;SEH1L;TRIM47;LZTR1;MKRN3;RNF187;TNFAIP1;FBH1;MGRN1;CCDC22;NUP62;NUP107;ZNRF3;TOPORS;TRIM14;NUP88;TRAF7;FBXL7;USP5;UBE2A;KLHL3;SYVN1
prerank,transition metal ion homeostasis (GO:0055076),-0.4506441859698046,-1.480609942359497,0.03667481662591687,0.4008868724788201,1.0,11/28,16.71%,ABCB7;NEO1;FTL;B2M;PRKN;FBXL5;TFR2;CUTC;CYBRD1;HMOX1;TMC8
prerank,negative regulation of macrophage activation (GO:0043031),-0.5426140650963652,-1.4804081085204674,0.05203619909502263,0.39911740895050296,1.0,4/16,15.69%,LRFN5;LDLR;FCGR2B;CX3CL1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5071484537916839,-1.4786379967233096,0.04814004376367615,0.401353891514722,1.0,12/19,24.28%,HS6ST3;HS3ST5;NDST4;EXT1;HS6ST2;EXT2;NDST1;HS3ST3B1;CSGALNACT1;NDST3;GLCE;XYLT1
prerank,response to hexose (GO:0009746),0.4953680504447616,1.477719754999852,0.05197132616487455,0.6275496482666091,1.0,15/25,34.67%,PFKL;EIF2B3;SLC30A8;EIF2B4;KHK;SELENOT;THBS1;TCF7L2;GPLD1;EIF2B5;SELENOS;VAMP2;IRS2;EIF2B1;ZBED3
prerank,regulation of leukocyte migration (GO:0002685),0.5484833924058748,1.476802345920292,0.07011070110701106,0.6272074405368733,1.0,4/16,8.55%,RAC1;RHOH;NCKAP1L;MIA3
prerank,transport along microtubule (GO:0010970),-0.5604294083015244,-1.4763355050856628,0.08053691275167785,0.40515019050238676,1.0,6/13,11.18%,APP;BORCS5;DYNC1I2;CDC42;BAG3;COPG2
prerank,positive regulation of lyase activity (GO:0051349),0.5651308662261575,1.4763251360149172,0.06363636363636363,0.6248538771074436,1.0,7/14,19.67%,ISCU;NOS2;AKAP5;CACNA1D;ORAI1;NOS1;PARK7
prerank,"phagocytosis, engulfment (GO:0006911)",0.45297736535585453,1.476312434208835,0.034904013961605584,0.6206795674010087,1.0,9/36,4.49%,ELMO1;ITGAM;BIN2;RAC1;AIF1;RHOH;ARHGAP25;ITGB2;RHOBTB1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3742320313731633,1.4735568834606745,0.011513157894736841,0.6280620259396092,1.0,21/95,11.89%,TGFBR1;LDLRAD4;TGFBR2;SMAD3;PMEPA1;SMAD7;SKI;TGFB1I1;SMURF1;SPRY2;PDPK1;FLCN;ASPN;BCL9;EID2;NREP;UBC;RPS27A;SKIL;LATS2;MTMR4
prerank,negative regulation of complement activation (GO:0045916),-0.6205047053533703,-1.4725161332590473,0.08260869565217391,0.4130510968921207,1.0,8/10,31.84%,SERPING1;VSIG4;CR1L;CR2;CD46;CD55;C4BPB;C4BPA
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5268722927290369,1.4707863250333664,0.05970149253731343,0.6362666969891712,1.0,4/19,4.84%,DAGLB;ABCD2;PRKCD;MTLN
prerank,membrane lipid metabolic process (GO:0006643),0.5158423114902676,1.4704187302189569,0.05,0.6335416545718244,1.0,6/22,18.30%,ST3GAL6;AGMO;ALOXE3;CERK;ST6GALNAC4;B4GALT4
prerank,heart process (GO:0003015),-0.5474513078412656,-1.4703123866793395,0.04946236559139785,0.41661118702598177,1.0,6/14,25.71%,SGCZ;SGCD;PPCS;FYN;ACE;NOX4
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4486396687651032,-1.4702034278605822,0.037383177570093455,0.41452694585373817,1.0,13/30,20.60%,SH3BP5;PRKCZ;CADM4;PARP14;PTPN2;INPP5F;SRCIN1;THY1;PPP2R1A;SFRP1;SH3BP5L;SFRP2;SAMSN1
prerank,diterpenoid metabolic process (GO:0016101),-0.3874061166287313,-1.4692891595878217,0.0375,0.4147139178450878,1.0,27/55,33.12%,GPC6;APOE;GPC5;SDC3;HSPG2;GPC3;NAPEPLD;RBP4;AGRN;RDH10;ABCA4;ALDH3A2;GPC4;SDC4;RDH12;RBP1;GPC1;RARRES2;LRP2;SDC2;AKR1C1;OPN1MW;PLB1;APOA2;RBP2;LRAT;STRA6
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.5334277389125762,-1.467765874028209,0.072,0.4164839927308538,1.0,6/15,15.65%,NTRK3;VEGFD;CDH13;F7;IL16;VEGFC
prerank,regulation of RNA export from nucleus (GO:0046831),0.6121691902450658,1.4663588338186047,0.061567164179104475,0.6472524569727317,1.0,4/11,12.06%,AKAP8L;DHX9;KHDRBS1;SETD2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5736563518800262,-1.4662098258513026,0.05982905982905983,0.4182835408389976,1.0,5/12,9.99%,RIMS2;SYT1;UNC13C;RIMS1;UNC13B
prerank,keratan sulfate catabolic process (GO:0042340),0.6106928447371713,1.462332224506997,0.0687732342007435,0.6605007374525538,1.0,3/11,4.08%,HEXB;PRELP;HEXA
prerank,regulation of establishment of protein localization (GO:0070201),0.5736251952453539,1.4621130136695832,0.05827067669172932,0.6571543224968651,1.0,5/14,12.09%,CTSD;SPIDR;CEP295;CENPJ;CEP135
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5487660735037078,1.4620226899741435,0.059245960502693,0.6533243227710528,1.0,10/16,24.31%,SIRPA;ABCD2;ABCD1;PYCARD;ADCY7;PDCD4;CUEDC2;APPL2;MEFV;ZC3H12A
prerank,import into nucleus (GO:0051170),0.3933895545243063,1.4615192303494788,0.03067484662576687,0.6512105121106059,1.0,29/73,23.24%,BACH2;FAM53A;PHB2;SNRPF;TNPO1;SEC13;SPRN;NUP62CL;SMN1;APPL1;GEMIN6;NUP50;IPO4;TNPO3;AKT1;SNUPN;PTTG1IP;CSE1L;NUP62;NUP107;NUP88;GEMIN2;E2F3;NUP188;IPO7;RPAIN;NUP214;HIKESHI;APPL2
prerank,centromere complex assembly (GO:0034508),-0.4230027026511129,-1.4607059780485463,0.046228710462287104,0.4308328924764119,1.0,13/36,18.78%,CENPP;KNL1;CENPF;CENPT;DLGAP5;MIS18BP1;NASP;CENPE;CENPW;HELLS;NPM1;CENPS;RBBP7
prerank,positive regulation of nervous system development (GO:0051962),-0.41006564458546063,-1.460076721748906,0.0332541567695962,0.43026581223989796,1.0,12/42,9.57%,NRXN1;NLGN1;GRID2;PTPRD;BDNF;IL1RAPL1;CLSTN2;MME;SOX11;SYNDIG1;LIG4;OPRM1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.41732203917950467,1.4598738621003686,0.02512562814070352,0.654099453751755,1.0,12/54,13.36%,IVNS1ABP;SENP2;CAPN3;SMAD7;ARRB2;SPRY2;KLHL40;U2AF2;PIAS3;USP4;HDAC8;AKT1
prerank,negative regulation of protein secretion (GO:0050709),-0.42768554397053105,-1.458606880221548,0.027777777777777776,0.4320739883520232,1.0,14/38,20.68%,APOE;IRS1;RSAD2;PRKN;OPRM1;ADRA2A;RHBDF2;HMGCR;SERGEF;SFRP1;RAB11FIP1;CCN3;ADTRP;REST
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4686733751174069,-1.458517746794022,0.06466512702078522,0.42999037218465486,1.0,6/25,5.36%,PDE4B;SPTBN1;CCR2;PDE4D;RPS3;IRF4
prerank,positive regulation of signaling (GO:0023056),-0.42711473968909497,-1.4581087791642846,0.0413625304136253,0.4288020089414238,1.0,11/37,12.83%,GRIK2;RIMS2;SYT1;CLSTN2;SOX11;HOMER1;RIMS1;LGI1;INPP5F;ANXA2;SNCA
prerank,regulation of neutrophil migration (GO:1902622),0.6155808838479463,1.456836217678252,0.06785714285714285,0.6631976345615058,1.0,3/10,4.59%,RAC1;RHOH;NCKAP1L
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5324072122100914,-1.4546804257825607,0.058577405857740586,0.43594641832267506,1.0,5/16,7.13%,DMD;ANK2;RYR2;CALM1;CACNA1C
prerank,positive regulation of protein polymerization (GO:0032273),0.4013091457638815,1.4512751534015713,0.0297723292469352,0.6841950268003593,1.0,21/65,19.94%,BIN1;NAV3;BAIAP2L2;RAC1;CDC42EP2;NUMA1;NCKAP1L;MET;CCR7;PTK2B;FCHSD2;PINK1;TENM1;MAPRE1;VASP;FES;CCL24;FCHSD1;EVL;PYCARD;MAPT
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5105859482745491,1.4509628768583096,0.05807622504537205,0.6812796157041989,1.0,6/20,5.24%,NUMB;MRAP;ABI3;PICALM;RHOQ;CSK
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.4799597945206938,-1.450647005950918,0.05783132530120482,0.4449416062395181,1.0,5/22,6.15%,DMD;AHNAK;PDE4B;GPR35;CBARP
prerank,inorganic anion transmembrane transport (GO:0098661),-0.374981666295799,-1.4498124454531647,0.03740648379052369,0.44480765224620206,1.0,25/63,17.10%,SLC25A30;GABRB1;GABRA3;GLRA1;SLC12A8;GABRG1;SLC37A4;GABRA2;GABRG3;ANO3;SLC12A4;GABRB3;SLC12A5;ANO6;GABRG2;SLC1A1;ANO5;SLC26A2;XPR1;GLRA2;SLC37A3;SLC4A8;GABRA5;GABRQ;CFTR
prerank,muscle cell development (GO:0055001),-0.4409624843585751,-1.4494961749147195,0.054466230936819175,0.44348372014682996,1.0,5/30,4.05%,SGCZ;DMD;MYOF;ANK2;NEBL
prerank,positive regulation of tissue remodeling (GO:0034105),0.6109033790438629,1.4484884191179643,0.08506616257088846,0.6880046500089972,1.0,3/10,12.96%,IL18;IL12B;ROCK2
prerank,sulfur compound catabolic process (GO:0044273),0.44889847870223626,1.4468716252512057,0.04643449419568822,0.6909755269877107,1.0,12/38,19.37%,HEXB;ARSB;PRELP;HEXA;MPST;BGN;DPEP1;CSPG5;GADL1;GGT5;GNS;TXN2
prerank,sensory perception of pain (GO:0019233),-0.48467767314480237,-1.4451743018442582,0.0577319587628866,0.45271648942109,1.0,7/21,12.08%,CCR2;MME;OPRM1;NIPSNAP1;CCL2;CHRNA4;KCNK4
prerank,intracellular protein transport (GO:0006886),0.3195147582372147,1.4451529062421844,0.0013717421124828531,0.6947695392507868,1.0,118/304,25.28%,TBC1D16;HPS4;UNC93B1;ARHGEF2;PREB;HERC2;YWHAH;TBC1D9B;ARFIP1;TBC1D8;COPA;TRAK1;TBC1D17;AP3D1;TBCK;VPS26B;FAM91A1;FAM53A;PHB2;ARL5C;SMURF1;STX1A;STXBP1;VIPAS39;AP2A1;TBC1D15;TMED9;ARFIP2;NUP42;RAB3GAP2;STX12;TNPO1;STRADA;SEC13;STX19;TBC1D10B;SPRN;NUP62CL;TRARG1;AP1M2;RAB1A;ARFGAP3;TBC1D9;APPL1;SAR1A;TICAM2;SNX31;NUP50;SEC31B;IPO4;TNPO3;SGSM2;STX4;PDCD6;SCG5;VPS36;RUNDC1;AKT1;SGSM3;ADPRH;TMED4;NAPG;PTTG1IP;GGA3;SLU7;LTBP2;RAB20;EIF2D;CSE1L;BCS1L;ARL11;AP4M1;NUP62;NUP107;NUP88;RAB6B;PICK1;MAIP1;GRTP1;E2F3;STX16;TBC1D30;SEC31A;RAB32;CLIP3;KIF13A;NUP188;TBC1D13;COG7;KATNB1;IPO7;RPAIN;ACD;VPS26A;LAMP2;WLS;ARF1;XPO5;STX5;SIL1;ARF4;NUP214;SNX13;HIKESHI;APPL2;KIF13B;VPS29;RAB23;RAB5B;TGFB1;OXA1L;CTSA;CACNG3;VPS35;STX8;TMED7;STX6;XPO1
prerank,regulation of mRNA processing (GO:0050684),0.46475375967495913,1.443775124584883,0.0425531914893617,0.6970605917723617,1.0,11/32,11.32%,SON;NCBP1;QKI;ZFP36L1;JMJD6;SLTM;PABPN1;CDK11B;DHX9;KHDRBS1;RBM39
prerank,pore complex assembly (GO:0046931),-0.5008518842963285,-1.4432950172834693,0.05128205128205128,0.4557020961506738,1.0,5/19,10.08%,RTN4;NUP98;AFDN;ANO6;NUP205
prerank,regulation of amyloid fibril formation (GO:1905906),-0.5257167736805186,-1.441827656304271,0.09574468085106383,0.4574380677465112,1.0,4/15,3.97%,APP;APOE;IAPP;LDLR
prerank,regulation of vasoconstriction (GO:0019229),-0.4535504063750704,-1.4417563834799545,0.06178489702517163,0.4553002516304417,1.0,12/27,22.18%,KCNMB2;ADRA1A;ATP2B1;ZDHHC21;CHRM3;PER2;KCNMB4;SMTNL2;ADM;AVPR2;ACE;ACE2
prerank,regulation of mRNA metabolic process (GO:1903311),0.6004751270766572,1.4409827713014052,0.07850467289719626,0.7056590376448837,1.0,6/11,17.46%,NCBP1;SLTM;CDK11B;DHX9;SAFB;SAFB2
prerank,chloride transmembrane transport (GO:1902476),-0.3990270967263596,-1.439430485995122,0.03608247422680412,0.4593324407046513,1.0,20/48,17.10%,GABRB1;GABRA3;GLRA1;SLC12A8;GABRG1;GABRA2;GABRG3;ANO3;SLC12A4;GABRB3;SLC12A5;ANO6;GABRG2;SLC1A1;ANO5;GLRA2;SLC4A8;GABRA5;GABRQ;CFTR
prerank,calcium ion transmembrane transport (GO:0070588),-0.35030584088175354,-1.4392762487265676,0.02127659574468085,0.4573674210766154,1.0,27/86,13.64%,GRIN2A;TRPC5;TRPC4;MCU;SLC8A3;ATP2B1;RYR3;GRIN2B;TRPM3;SLC24A2;NALCN;PARL;ATP2A2;TRPC3;LETM1;CACNA1C;SLC8B1;MCUB;PKD2;MICU2;TMEM165;ANO6;GRIN2D;ATP2A3;MCOLN3;CACNA1G;MICU3
prerank,endocardial cushion morphogenesis (GO:0003203),0.5257185174411364,1.4392526977755744,0.059149722735674676,0.709411402694898,1.0,12/18,33.83%,TGFBR2;HEYL;MDM4;NOG;ENG;BMP2;NOTCH1;SOX9;BMPR1A;ACVR1;HEY1;ISL1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5297752793865965,1.4388315430278442,0.0718132854578097,0.7069440392602463,1.0,7/18,17.36%,PAG1;MIA3;WNK1;AKT1;TNFAIP8L2;GPNMB;IL4I1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.3037223432156518,-1.4387294454408395,0.0,0.45657650816336015,1.0,65/248,17.85%,CTNND2;DAB2;LRRK2;CUL3;CCDC88C;EGFR;CSNK1G1;CDK14;FGF10;LATS1;SHISA6;APOE;GPC5;PSMD14;PPM1A;UBR5;LIMD1;HECW1;ATP6AP2;RBMS3;APC2;PSMA2;SEMA5A;PSMF1;GSK3B;PRKN;FRZB;PSMD8;IGFBP4;TLE4;COL1A1;LRP6;PSMD6;SIAH2;GPC3;SOX13;PSME2;BTRC;PSMD11;ZEB2;LGR4;AXIN1;MLLT3;CCAR2;TNKS2;LGR5;PSMD1;PSMD5;TLE1;KANK1;IGFBP2;NPHP3;CTNNB1;HDAC1;CAPRIN2;SFRP1;PSMD12;BAMBI;NKD1;SNAI2;ANKRD6;JADE1;MCC;SFRP2;SCYL2
prerank,regulation of myoblast differentiation (GO:0045661),0.4592068682003429,1.4384505855252299,0.04736842105263158,0.7045120492343024,1.0,19/32,26.87%,SOX8;IGFBP3;MEF2C;ZFP36L1;AKIRIN1;RBM24;ANKRD2;DLL1;LRRC8A;MAPK14;FLOT2;EID2B;SMYD1;KLHL41;BTG1;TGFB1;NOTCH1;SOX9;SRA1
prerank,development of primary male sexual characteristics (GO:0046546),0.4469124278121619,1.4381911998107753,0.0466786355475763,0.7015004579604652,1.0,6/34,8.09%,LHFPL2;SOX8;WNT2B;ADAM29;FSHR;LHCGR
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.4879469798034343,1.437654099907159,0.054385964912280704,0.6999473641749132,1.0,10/24,20.75%,SRC;CTC1;HNRNPC;SLX4;ERCC4;TEN1;TERF1;EXOSC10;GNL3L;ACD
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5612509700614485,1.4351540581869586,0.09057301293900184,0.7069598527769156,1.0,6/13,28.45%,CYRIB;IL12B;NECTIN2;FADD;STX7;IL12RB1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.4872010477318828,-1.433933615906606,0.06666666666666667,0.4680586750530857,1.0,11/21,25.08%,CENPF;ZW10;KNTC1;BUB1B;TTK;BUB1;MAD1L1;TEX14;TRIP13;MAD2L1;PLK1
prerank,regulation of endothelial cell migration (GO:0010594),0.37594259962572973,1.4338038321865143,0.0192,0.7091379362870414,1.0,23/85,16.45%,PTPRM;SMOC2;ETS1;RAC1;ANXA3;PRKCA;PIK3CG;SPARC;RHOB;PIK3CB;PTK2B;CEACAM1;PIK3CD;APOH;ABL1;PDCD6;ROCK2;PROX1;SCARB1;AKT1;PRCP;THBS1;GATA3
prerank,regulation of immunoglobulin production (GO:0002637),0.48713455685442114,1.4336600872194327,0.05849056603773585,0.70571476134929,1.0,5/23,11.91%,SASH3;DNAJB9;PHB2;CD86;STX4
prerank,positive regulation of cyclase activity (GO:0031281),0.5617476464693777,1.4336485848539782,0.08113207547169811,0.7017110676182152,1.0,7/14,19.17%,NOS2;AKAP5;MAPK14;CACNA1D;ORAI1;NOS1;MAPK8
prerank,aorta development (GO:0035904),-0.5244490343487328,-1.4336443175555251,0.0823045267489712,0.466495032439129,1.0,6/14,17.68%,ROBO1;PKD2;JAG1;TFAP2B;PDE2A;APLNR
prerank,fatty acid transport (GO:0015908),-0.51401558696548,-1.4329976310269932,0.07675438596491228,0.46607413433981976,1.0,6/17,15.31%,PPARG;CD36;APOE;FABP4;MFSD2A;CPT1B
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.511823626916816,1.4329849912294237,0.07295373665480427,0.7008923484298085,1.0,8/19,20.75%,SRC;CTC1;HNRNPC;TEN1;TERF1;EXOSC10;GNL3L;ACD
prerank,axon guidance (GO:0007411),-0.3097380966523357,-1.4328502565644807,0.003115264797507788,0.4642174380831738,1.0,41/201,10.02%,NRXN1;DAB1;UNC5C;ALCAM;NFIB;NRXN3;DCC;ROBO1;KIF5C;SPTBN1;BDNF;ARHGAP35;SLIT2;DOK6;PLXNC1;SHC3;NPTN;PALLD;EMB;PLXND1;PLXNA2;DOK1;CNTN6;TNR;SEMA5A;SHANK3;SEMA4A;NCAM1;RET;GFRA2;DOK5;SEMA6D;KIF5B;SPTBN2;CHN1;LGI1;DOK2;SPTBN4;PLXNA1;GRB10;ENAH
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.49693557316061526,-1.4326393816630076,0.07373271889400922,0.45796454275044557,1.0,11/20,25.08%,CENPF;ZW10;KNTC1;BUB1B;TTK;BUB1;MAD1L1;TEX14;TRIP13;MAD2L1;PLK1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.49693557316061526,-1.4326393816630076,0.07373271889400922,0.45796454275044557,1.0,11/20,25.08%,CENPF;ZW10;KNTC1;BUB1B;TTK;BUB1;MAD1L1;TEX14;TRIP13;MAD2L1;PLK1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.49693557316061526,-1.4326393816630076,0.07373271889400922,0.45796454275044557,1.0,11/20,25.08%,CENPF;ZW10;KNTC1;BUB1B;TTK;BUB1;MAD1L1;TEX14;TRIP13;MAD2L1;PLK1
prerank,lytic vacuole organization (GO:0080171),0.44985724101234786,1.4324137607242493,0.06196213425129088,0.6995216569152954,1.0,15/32,24.24%,HPS4;HOOK2;ARSB;MYO7A;AKTIP;CLN3;MTOR;MBTPS1;ACP2;ACP4;ABCA1;GAA;HPS1;HOOK3;TMEM106B
prerank,kinetochore organization (GO:0051383),-0.5505714785534243,-1.4323043726157,0.07236842105263158,0.4566011040033994,1.0,6/13,11.62%,CENPF;CENPT;NDC80;DLGAP5;CENPE;CENPW
prerank,positive regulation of neurogenesis (GO:0050769),-0.36767703520351847,-1.432275119908113,0.03826530612244898,0.4545004513685869,1.0,28/68,15.69%,PTPRD;CDKL5;ROBO1;SLIT2;SLITRK1;IL1RAPL1;PLXNC1;NTRK2;MME;NPTN;PLXND1;ARHGDIA;SOX11;PLXNA2;SHANK3;LIG4;CUL7;PLXNA1;OPRM1;TIAM1;SS18L1;PLXNB2;OBSL1;SS18L2;CTNNB1;CAPRIN2;PLXNB1;CX3CL1
prerank,plasma membrane invagination (GO:0099024),0.45811026653791165,1.4322711801675783,0.04647160068846816,0.6961675266972803,1.0,7/29,3.77%,ELMO1;ITGAM;BIN2;AIF1;SNX18;ARHGAP25;ITGB2
prerank,action potential (GO:0001508),-0.3976013716273945,-1.431225975728511,0.03902439024390244,0.45519307052750096,1.0,12/44,14.22%,DMD;KCND2;AKAP6;ANK3;KCNMB2;SCN2A;SCN3A;KCNH2;CHRNA4;CACNA1G;KCNMB4;KCNQ1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.44905431633295934,-1.4309024503671204,0.061124694376528114,0.45392400269345473,1.0,9/25,10.84%,GRID2;LRRK2;GRIN2A;GRIN2B;GLRA1;GSK3B;INSYN2A;GRIN2D;CHRNA4
prerank,focal adhesion assembly (GO:0048041),-0.4823035016933118,-1.4308304894475168,0.07252747252747253,0.45195091011437066,1.0,8/21,16.99%,SORBS1;CTTN;TRIP6;THSD1;ACTN2;THY1;RCC2;PEAK1
prerank,cranial nerve development (GO:0021545),0.5847829906207319,1.4302390827001388,0.08067542213883677,0.7012322551025479,1.0,4/11,13.04%,SALL1;CHD7;POU4F1;PAX2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.6208699091395982,1.4301231936465237,0.0842911877394636,0.6977990497569944,1.0,3/10,1.63%,CX3CR1;LGALS9;ARRB2
prerank,positive regulation of neuron projection development (GO:0010976),-0.3501490927814798,-1.4300376551000906,0.0196078431372549,0.45210653790198524,1.0,27/85,16.14%,MAGI2;RIT2;TENM3;LRRC7;BDNF;ARHGAP35;KIDINS220;APOE;ROR1;NTRK2;NPTN;FUT9;RAPGEF2;NTRK3;BMP5;RET;ALK;SCARF1;P3H1;SERPINI1;PLXNB2;ZDHHC15;RELN;CAPRIN2;CX3CL1;ABL2;STMN2
prerank,hemidesmosome assembly (GO:0031581),0.5909825288468461,1.4292877302017881,0.10093457943925234,0.6975400091619944,1.0,6/11,24.97%,DST;ITGA6;LAMC2;ITGB4;PLEC;LAMA3
prerank,regulation of interleukin-1 production (GO:0032652),0.5518579614862259,1.4285212042325508,0.07775768535262206,0.6969051325848183,1.0,5/15,9.60%,SIRPA;TLR4;CCR7;ORM2;CEACAM1
prerank,spliceosomal snRNP assembly (GO:0000387),0.43472133304814214,1.4280377361728358,0.061224489795918366,0.6952304574261392,1.0,20/38,33.07%,SNRPC;COIL;SNRPF;SART3;SMN1;GEMIN6;USP4;SNUPN;GEMIN2;PRPF3;WDR77;TGS1;CD2BP2;PRPF31;CLNS1A;SNRPD3;PRPF8;LSM2;SRSF10;SNRPG
prerank,central nervous system neuron differentiation (GO:0021953),-0.42612222587852305,-1.4280252752985059,0.05429864253393665,0.45543879609955484,1.0,8/33,8.98%,MDGA2;GRID2;SPOCK1;NTRK2;MAP2;NR4A2;LRP6;ATP7A
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3572180516368454,-1.4279220615918737,0.020512820512820513,0.4535467655706306,1.0,26/75,20.04%,CTNNA2;ANK3;DCC;NRCAM;PLPPR4;APP;MAP1B;SLITRK1;MAP2;PAK3;ACTB;DCDC2;SPTBN4;RAB3A;RAB8A;ZDHHC17;MFSD2A;NTNG1;NTNG2;NEFH;BRSK1;PARD3;KLF7;CNTN4;BRSK2;LMTK2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5328195500603059,1.427804787560269,0.08076923076923077,0.6923787991696952,1.0,5/14,17.47%,DNAJB9;FICD;PTPN1;BFAR;BCL2L11
prerank,response to acidic pH (GO:0010447),0.5566268893054178,1.4274206367399622,0.09210526315789473,0.6901443144807877,1.0,4/13,15.90%,LGMN;IMPACT;CTSS;GPR4
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6063175912722616,1.4258148604873857,0.09293680297397769,0.6936169595869542,1.0,3/11,7.11%,GREM1;MEF2C;FRS2
prerank,nuclear export (GO:0051168),0.37815698637631134,1.424426775488386,0.03547297297297297,0.6958274831900945,1.0,30/80,25.77%,SRRM1;NCBP1;SMURF1;NUP42;SRSF5;STRADA;DHX38;NUP62CL;U2AF2;U2AF1L4;ALYREF;RBM8A;SLU7;CSE1L;DDX39B;WASHC4;NUP62;SRSF9;NEMF;THOC6;NUP188;XPO5;NUP214;MAGOHB;MAGOH;ZC3H11A;THOC3;TGFB1;XPO1;THOC5
prerank,protein localization to membrane (GO:0072657),-0.31118048698561845,-1.4233629350276753,0.002967359050445104,0.4641226854443198,1.0,45/187,14.30%,MAGI2;DLG2;KCNIP4;NRXN1;NLGN1;DPP6;ANK3;ITGA4;KCNB2;DPP10;ANK2;LRRC7;SPTBN1;RAB3C;ITGAL;MYO5A;FRMPD1;RAPGEF2;ITGB7;EHD1;SHANK3;DLG3;P2RY1;WDR19;RAB3D;LRP6;RAB40B;SPTBN4;PIGW;ACTN2;RAB3A;NUP54;ATP1B3;BID;MYADM;RAB8A;ZDHHC23;TMED2;THY1;ITGB1BP1;TESC;ARL5B;EFR3A;CDH1;AGRN
prerank,chondroitin sulfate metabolic process (GO:0030204),0.45892435642875423,1.4211895111100477,0.05518394648829431,0.7061808288792109,1.0,9/30,12.48%,HEXB;ARSB;HEXA;CHPF2;BGN;CHST7;CHST11;CHSY1;CSPG5
prerank,regulation of osteoblast proliferation (GO:0033688),0.5231537792499309,1.420799017477799,0.08833922261484099,0.7041939197462556,1.0,3/17,1.62%,TMEM119;GREM1;SOX8
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5094662925690627,1.4191292521781984,0.0710172744721689,0.7081800703165206,1.0,5/20,5.15%,NUMB;MRAP;ABI3;PICALM;RHOQ
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.41207077997432506,-1.4175338689661563,0.03009259259259259,0.47754990997685803,1.0,13/38,15.98%,NEDD9;SH3BP5;GRM5;APP;NCK2;DLG3;ERBB3;SRCIN1;UNC119;THY1;LILRA5;RELN;SH3BP5L
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.4506340352114607,1.4174737338022547,0.06433823529411764,0.7116255638039559,1.0,11/32,20.48%,NAV3;ARHGEF2;FGF13;CAMSAP1;CAMSAP2;CIB1;ATXN7;MAPRE1;DYRK1A;CLIP3;KATNB1
prerank,positive regulation of leukocyte migration (GO:0002687),0.46713670705989024,1.417249280196583,0.06284658040665435,0.7089394464088387,1.0,6/27,8.55%,AIF1;IL6R;NCKAP1L;EDN3;EDN2;MIA3
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.31699989892161906,-1.416828754724197,0.011695906432748537,0.4773864646535106,1.0,40/159,14.60%,LRRC4C;NLGN1;GRID2;LRFN5;GPC6;PTPRD;ALCAM;ROBO1;KIRREL3;TENM3;ADGRL3;CDH8;PTPRT;TENM2;SLITRK1;IL1RAPL1;ITGAL;NPTN;PALLD;EMB;CNTN6;FAT4;CDH22;JAML;CDH4;CDH13;NECTIN1;CDH7;CDH20;TENM4;VCAM1;CDH11;NTNG1;CDHR3;CDH5;PLXNB2;CDH10;OBSL1;CDH1;SDK1
prerank,cell part morphogenesis (GO:0032990),-0.538945823459331,-1.4165787992269714,0.06888888888888889,0.47591601202535244,1.0,5/13,11.56%,PID1;WASF1;DNM1L;MFF;FIS1
prerank,ruffle organization (GO:0031529),0.5352808511603737,1.4165322683510624,0.07692307692307693,0.708397071563751,1.0,10/16,23.89%,CSF1R;RAC1;AIF1;ARFIP2;CCR7;PLEK;CYFIP1;INPP5K;AIF1L;TPM1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5662157863392476,-1.4164868770877634,0.07505518763796909,0.4740687502179368,1.0,7/11,27.06%,DAB2;MTMR2;PRKN;MSN;EZR;SORL1;EIPR1
prerank,mesenchymal to epithelial transition (GO:0060231),0.6000370946179663,1.4162463852721938,0.1018867924528302,0.7060532187140478,1.0,4/10,16.45%,SALL1;BASP1;PAX2;GATA3
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.492007757905716,-1.416172750656463,0.08295964125560538,0.47285727560382557,1.0,5/18,6.52%,MDFIC;CTNNA1;LATS1;ILRUN;GSK3B
prerank,long-chain fatty acid transport (GO:0015909),-0.4341419072240956,-1.4151288634253694,0.06373626373626373,0.47367601643251583,1.0,9/30,15.31%,PPARG;CD36;APOE;PRKAG2;FABP4;ACSL3;MFSD2A;ABCD4;CPT1B
prerank,ethanol metabolic process (GO:0006067),0.5670892657764507,1.415052233674999,0.08620689655172414,0.7077551606578265,1.0,4/12,19.00%,ACSS1;SULT2A1;ALDH1B1;ACSS2
prerank,protein modification by small protein removal (GO:0070646),0.3213162143133,1.4147440198135588,0.007173601147776184,0.7055265166034891,1.0,62/252,17.45%,TGFBR1;USP35;SENP2;SMAD3;SMAD7;ARRB2;OTUD6B;USP12;OTUD5;INO80C;USP8;INO80E;COPS4;WDR48;SUDS3;UCHL1;UCHL5;JOSD2;ZRANB1;USP25;USP28;UFD1;MYSM1;PSMD3;NFRKB;RCE1;OTULINL;FOXK2;BRCA1;IL33;UBC;RPS27A;STAMBPL1;PSMA7;ABRAXAS1;USP36;DDB2;MDM4;INO80B;OTUB2;USP9Y;GPS1;USP4;USP19;ATXN7;PSMB3;PSMB9;PSMC2;NLRP3;BABAM1;TNIP2;USP50;RNF123;PSME4;PSMC1;COPS6;PSMB7;GATA3;ACTL6A;SNX3;USP5;INO80D
prerank,ceramide metabolic process (GO:0006672),0.409669291891713,1.4143456721689576,0.05181347150259067,0.703675472997448,1.0,16/49,16.49%,CERS3;DEGS2;SPTLC3;PLA2G15;ACER3;SMPD2;ACER2;ALOXE3;ASAH1;PNPLA1;FUT7;CERK;PLPP2;PLPP1;CERS2;ORMDL2
prerank,protein deubiquitination (GO:0016579),0.3213461863283773,1.4121158226952948,0.007267441860465116,0.7101272896301329,1.0,60/242,17.45%,TGFBR1;USP35;SMAD3;SMAD7;ARRB2;OTUD6B;USP12;OTUD5;INO80C;USP8;INO80E;OTULIN;WDR48;SUDS3;UCHL1;UCHL5;JOSD2;ZRANB1;USP25;USP28;UFD1;MYSM1;PSMD3;NFRKB;RCE1;OTULINL;FOXK2;BRCA1;IL33;UBC;RPS27A;STAMBPL1;PSMA7;ABRAXAS1;USP36;DDB2;MDM4;INO80B;MINDY2;OTUB2;USP9Y;USP4;USP19;ATXN7;PSMB3;PSMB9;PSMC2;NLRP3;BABAM1;TNIP2;USP50;RNF123;PSME4;PSMC1;PSMB7;GATA3;ACTL6A;SNX3;USP5;INO80D
prerank,skeletal muscle tissue development (GO:0007519),0.4445875949830469,1.4120449842154226,0.06086956521739131,0.7068106078999812,1.0,5/32,7.52%,CFLAR;MEF2C;SKI;ZBTB18;KLHL40
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.4576957347156779,1.411409598226236,0.043327556325823226,0.7061511139313279,1.0,8/29,10.85%,SSH2;TWF2;PRKCD;CYRIB;SSH1;PLEKHH2;TJP1;HIP1R
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.5797548717796164,-1.4109929292834746,0.11727078891257996,0.48323941423591676,1.0,3/10,4.03%,HECW2;HECW1;NEDD4L
prerank,cardiac muscle tissue development (GO:0048738),-0.3881654862996708,-1.4103001042322187,0.05250596658711217,0.48305921455089446,1.0,22/50,32.86%,SGCZ;SGCD;BMP5;KDM6B;SIK1;CACNA1G;RBP4;HEY2;BMP4;NOTCH2;SMAD1;GJA5;MSX1;HCN4;SHOX2;CBY1;TTN;ZFPM1;NRG1;NPPA;MYOCD;TBX18
prerank,fatty acid oxidation (GO:0019395),0.3986554251911656,1.4095611084731023,0.031914893617021274,0.7107196849131405,1.0,13/57,14.31%,ABCD2;PPARD;ECHS1;ACAD10;PHYH;MTLN;ACADM;HAO1;CROT;ECI1;HADHB;ECHDC2;HSD17B10
prerank,establishment of protein localization to organelle (GO:0072594),0.38016688846426416,1.4090536552096407,0.053208137715179966,0.7093502262958087,1.0,29/72,23.24%,HK2;FAM53A;PHB2;NEURL1B;TNPO1;SEC13;SPRN;NUP62CL;LAMP5;APPL1;NUP50;IL10RA;IPO4;TNPO3;PINK1;AKT1;PTTG1IP;CSE1L;NUP62;NUP107;NUP88;E2F3;NUP188;IPO7;RPAIN;LAMP2;NUP214;HIKESHI;APPL2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.4952235955991602,1.4084194586063512,0.09380863039399624,0.7087628063391056,1.0,10/21,19.67%,ABCD2;COA8;SLC30A10;SIRT2;AATF;BRCA1;PINK1;PAX2;ABCD1;PARK7
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5890942140509376,1.407557104170915,0.09161793372319688,0.7090302820997265,1.0,3/10,10.32%,PDE3B;ACER2;WNK1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.4511264734123147,-1.4069261480363273,0.07439824945295405,0.49038293849489545,1.0,6/25,8.68%,NLGN1;SHISA9;SHISA6;CACNG2;SHANK3;GSG1L
prerank,endocardial cushion development (GO:0003197),0.49184023064059956,1.406127857920744,0.07468123861566485,0.7114593832822578,1.0,12/21,33.83%,HEYL;MDM4;NOG;ENG;BMP2;NOTCH1;SOX9;BMPR1A;BMPR2;ACVR1;HEY1;ISL1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.4427749144480696,1.405522811768003,0.06196213425129088,0.7107817633187211,1.0,12/35,22.16%,ETS1;LYN;NCKAP1L;ZFP36L1;PRMT1;ARNT;MAPK14;HMGB2;TAL1;BRD1;HIF1A;STAT5B
prerank,regulation of developmental growth (GO:0048638),-0.42466014982032624,-1.4055199022329208,0.06373626373626373,0.49227485556001627,1.0,9/29,11.93%,PLCB1;NRCAM;APP;LATS1;APOE;CTTN;GSK3B;FGFR3;MFSD2A
prerank,regulation of proteolysis (GO:0030162),0.41684098116117985,1.4055127990686813,0.054385964912280704,0.7073851919614916,1.0,18/48,24.00%,CST3;CAPN3;GSAP;BAG6;ITCH;ASPH;SHH;CLN3;AKT1;SERPINE2;SPOPL;LTBP4;FGFR4;DNAJC1;STUB1;IST1;FADD;PERP
prerank,icosanoid secretion (GO:0032309),0.5761219855438682,1.4054683763306355,0.11213235294117647,0.7041772647014083,1.0,5/12,16.63%,PLA2G5;NOS2;NMUR2;DRD2;BDKRB2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5085937770875328,1.4054420525616376,0.07861060329067641,0.7008838745349503,1.0,11/20,24.85%,PSEN2;MBTPS2;PSENEN;SPPL2B;MBTPS1;APH1B;ADAM10;ADAM17;TRAF6;TGFB1;APH1A
prerank,eosinophil migration (GO:0072677),-0.528842811797851,-1.4053685489899188,0.08295964125560538,0.48841750063954936,1.0,5/14,18.94%,CCL4;CCL2;CCL5;CX3CL1;CCL7
prerank,eosinophil chemotaxis (GO:0048245),-0.528842811797851,-1.4053685489899188,0.08295964125560538,0.48841750063954936,1.0,5/14,18.94%,CCL4;CCL2;CCL5;CX3CL1;CCL7
prerank,mitochondrial fission (GO:0000266),-0.5020496805972996,-1.4053650708323886,0.09594882729211088,0.4862833154213512,1.0,7/16,12.58%,DNM3;DNM1L;PRKN;MFF;DNM1;FIS1;MTFR2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5877394412025154,1.4048755526882535,0.10654205607476636,0.6999949132238874,1.0,3/11,11.78%,ARRB2;GTF2H2;GRK2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.40244027215795186,-1.4046438448640641,0.0468384074941452,0.486255062078123,1.0,7/40,4.37%,MAGI2;DAB2;HIP1;BICD1;B2M;SGIP1;ATAD1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4824537820230066,1.4026970461991823,0.08228980322003578,0.7059544575246491,1.0,9/22,20.14%,NFE2L2;ENC1;PSMA7;PSMB3;PSMB9;PSME4;PSMB7;PSMB5;PSMB8
prerank,positive regulation of axonogenesis (GO:0050772),-0.40084019193125975,-1.4016435132139164,0.04481132075471698,0.49246998570393824,1.0,16/43,17.21%,CDKL5;ROBO1;BDNF;SLIT2;SLITRK1;PLXNC1;NTRK2;PLXND1;ARHGDIA;PLXNA2;PLXNA1;MAP3K13;TIAM1;PLXNB2;PLXNB1;SEMA7A
prerank,regulation of biosynthetic process (GO:0009889),-0.5581450134800328,-1.4009800033276107,0.09782608695652174,0.4922516193318942,1.0,4/11,26.87%,ALOX5;SNCA;GSTP1;SPHK2
prerank,phagosome maturation (GO:0090382),0.44565659939978736,1.4001498402988517,0.06689536878216124,0.7133289150757576,1.0,10/35,15.01%,ATP6V0B;MCOLN1;ATP6V0A2;TCIRG1;RAB39A;RAB34;ATP6V0A4;ATP6V1D;RAB20;ATP6V0E2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5547337949995829,1.39976930676919,0.08806262230919765,0.7116758639937552,1.0,5/12,26.87%,TLR4;MUC6;NOD2;TLR9;SOX9
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5646288744199484,1.3996725332625661,0.1,0.7087463834306015,1.0,3/12,7.73%,CSF1R;LYN;IL12B
prerank,gonad development (GO:0008406),0.42423383360835126,1.3990705990579793,0.05291005291005291,0.7079403680042347,1.0,7/41,8.09%,SALL1;SOX8;BASP1;WNT2B;ADAM29;FSHR;LHCGR
prerank,energy reserve metabolic process (GO:0006112),-0.46993762964371955,-1.3985732661521242,0.08944954128440367,0.49660934609290186,1.0,8/19,16.60%,PID1;PRKAG2;MYC;GBE1;GSK3B;GFPT2;PYGM;UGP2
prerank,membrane fusion (GO:0061025),-0.4203574900597539,-1.3984864348735353,0.07710280373831775,0.4946905425727236,1.0,7/33,8.15%,DNM3;MYOF;VAPA;NAPA;DNM1L;RIMS1;DNM1
prerank,acylglycerol biosynthetic process (GO:0046463),0.4880885862183475,1.3979808332238624,0.08272058823529412,0.7093453979445586,1.0,7/23,9.38%,AGMO;LPIN2;DGAT1;PLA2G15;MOGAT2;MOGAT1;PLA2G4A
prerank,negative regulation of cilium assembly (GO:1902018),0.5631425578844044,1.3978143389881432,0.09732824427480916,0.7066727283196295,1.0,5/12,21.79%,TBC1D7;MAP4;TBC1D30;CCP110;CEP97
prerank,peptidyl-serine modification (GO:0018209),0.33283862273317655,1.3970288510635136,0.009230769230769232,0.7067607073199188,1.0,44/166,15.04%,TGFBR1;TGFBR2;ULK2;RPS6KA1;PRKCA;PRKACA;CSNK1E;CSNK2A2;CSNK2A1;PRKCD;CAMK1D;RPS6KA5;ATM;PDPK1;MKNK1;PKN3;NEK6;VRK3;PDGFB;NAA11;GALNT3;ULK3;WNK1;MAP3K10;GALNT1;UHMK1;HPF1;LATS2;GRK2;MTOR;MARK2;PINK1;MAPK14;PRKCB;ROCK2;DYRK4;AKT1;ULK1;STK39;MORC3;MAST3;AURKA;RPS6KA4;MASTL
prerank,mesenchyme morphogenesis (GO:0072132),0.5153363868868739,1.3967823713850016,0.09444444444444444,0.7045544347990174,1.0,11/17,33.83%,HEYL;MDM4;NOG;ENG;BMP2;NOTCH1;SOX9;BMPR1A;ACVR1;HEY1;ISL1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4850915521349642,1.3966895559830796,0.07956600361663653,0.7017607457497524,1.0,5/22,5.50%,GSAP;AGER;LYN;PICALM;CLU
prerank,synaptonemal complex assembly (GO:0007130),0.5315409748147001,1.3960025610968492,0.10338345864661654,0.6982789093364787,1.0,6/15,25.73%,BAG6;STAG3;TEX12;SYCP2;SYCE2;HORMAD1
prerank,synaptonemal complex organization (GO:0070193),0.5315409748147001,1.3960025610968492,0.10338345864661654,0.6982789093364787,1.0,6/15,25.73%,BAG6;STAG3;TEX12;SYCP2;SYCE2;HORMAD1
prerank,glial cell differentiation (GO:0010001),-0.4414671122722123,-1.3948751921350002,0.05803571428571429,0.5029323753954195,1.0,7/28,4.70%,NFIB;FGF10;ADGRG6;SLC8A3;TPPP;MYRF;SOX11
prerank,cellular response to organonitrogen compound (GO:0071417),-0.33184283893882816,-1.394873484444228,0.02865329512893983,0.5007873197912815,1.0,33/99,18.32%,AKAP6;CTNNA1;HCN1;GABRB1;SLIT2;HRH1;RYR3;CPEB3;RAPGEF2;GLRA1;P2RY1;ACTB;RRAGB;GOLPH3;PKD2;GABRB3;GABRG2;RELA;AHR;CDH1;KCNQ1;GLRA2;PDE2A;CTNNB1;CRHBP;SFRP1;TSHR;LAMTOR3;CFTR;HCN2;NR1H4;SESN2;DIAPH1
prerank,regulation of glycogen metabolic process (GO:0070873),0.5592094284730952,1.3943440392676294,0.10036496350364964,0.7021850088324413,1.0,7/12,25.61%,PPP1R3E;AKT1;KHK;PPP1R3F;INPP5K;PPP1R3B;RUBCNL
prerank,cellular response to interleukin-6 (GO:0071354),0.46520235006268923,1.394119968982715,0.06678700361010831,0.69993571799877,1.0,8/26,10.30%,SELPLG;ST3GAL6;SRC;SBNO2;IL6R;CTR9;IL6ST;PTPN11
prerank,heme catabolic process (GO:0042167),0.5337793820650675,1.393967925806199,0.07495429616087751,0.694265110339275,1.0,1/14,0.03%,SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.5337793820650675,1.393967925806199,0.07495429616087751,0.694265110339275,1.0,1/14,0.03%,SLCO2B1
prerank,neuron maturation (GO:0042551),-0.4902667419950313,-1.393962139933461,0.10304449648711944,0.5010560439431171,1.0,10/18,19.28%,B4GALT5;ADGRB3;APP;B4GALT6;CLN5;SCARF1;SRRM4;CX3CL1;LGI4;ACTL6B
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4395087405232397,-1.3937362672479703,0.06167400881057269,0.49961625704685236,1.0,7/27,7.13%,CTNNA3;PDE4B;ANK2;PDE4D;RYR2;ATP2A2;CACNA1C
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.5395414961785552,-1.393001057257516,0.0967032967032967,0.4994075835249288,1.0,4/13,6.07%,CCR2;GABBR2;PALM;EDNRB
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.4743253042311585,-1.392999339367344,0.08779443254817987,0.4973092323336476,1.0,6/20,11.35%,HECW2;HECW1;YWHAE;NEDD4L;ACTN2;ADRA2A
prerank,error-prone translesion synthesis (GO:0042276),0.48606271210045504,1.392568960400032,0.08490566037735849,0.6971207501151044,1.0,6/21,13.49%,PRIMPOL;RFC2;PCNA;UBC;RPS27A;RFC1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.5279181162332187,-1.3921999319935967,0.09976798143851508,0.49750108011008676,1.0,7/15,17.92%,CD74;CD44;SIRT1;PRKN;ING2;BCL2;MDM2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5657314245120216,1.3919506061921405,0.09276437847866419,0.6966208144515431,1.0,3/12,13.63%,NELFB;RNF8;NELFE
prerank,regulation of calcium ion transport (GO:0051924),-0.36925129472006435,-1.3916052548505315,0.042222222222222223,0.4972337482925009,1.0,18/54,15.70%,ANK2;LILRB1;ATP2B1;CCR1;CCL4;HOMER1;PLPP4;SLC8B1;PKD2;STIM2;IL16;ADRA2A;FFAR1;EPB41;LILRA5;CTNNB1;CCL5;BCL2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5350695062853682,1.3913480877017332,0.09867172675521822,0.6964082131832304,1.0,7/15,20.56%,TLR4;APPL1;GBP5;TICAM1;NOD2;MYD88;HIF1A
prerank,positive regulation of dendrite development (GO:1900006),-0.5820947922794675,-1.391180234330283,0.09417040358744394,0.4963856902167432,1.0,3/10,15.09%,BMP5;ALK;ZDHHC15
prerank,polyamine metabolic process (GO:0006595),0.5613841930668595,1.391017343481893,0.10961538461538461,0.6949077494914055,1.0,8/13,32.38%,HDAC10;DHPS;OAZ2;SMOX;SRM;ODC1;PAOX;SAT2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.5036404116605757,-1.390550857249193,0.084070796460177,0.496206942424246,1.0,8/16,23.02%,VIM;WNT4;CREB3L1;RGCC;SCX;SERPINF2;BMP4;LARP6
prerank,response to ethanol (GO:0045471),-0.5060713219821842,-1.3896844041712124,0.1136890951276102,0.4964123827557677,1.0,5/14,14.60%,GRIN2A;GRIN2B;GLRA1;GRIN3A;GLRA2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.31179337242658595,1.3884638030362229,0.009735744089012517,0.7024923854522247,1.0,82/264,22.78%,SRRM1;SNRNP70;POLR2H;SRRT;NCBP1;DDX5;RBM19;SNRPA;CSTF2;HNRNPA3;SF3B2;SF3B1;HNRNPC;SNRPC;ZMAT2;COIL;POLR2D;SNRPF;SRSF5;FUS;DHX38;SRRM2;PABPN1;RBM14;POLR2J;SART3;CPSF1;SMN1;DCPS;CWC25;U2AF2;HNRNPH1;SNRNP48;GEMIN6;RBM17;DDX17;PCBP2;DHX9;HNRNPR;SNRPA1;TRA2B;SNRPN;U2AF1L4;ALYREF;RBM8A;SNUPN;METTL14;SLU7;CCAR1;SCNM1;DDX39B;TRA2A;SRSF9;PCF11;SF3A1;GEMIN2;BUD13;RBMX;PRPF3;LSM7;FIP1L1;DDX46;SNIP1;PNN;WBP4;POLR2E;PRPF4;POLR2I;NOVA2;WDR77;SYF2;SNRNP25;HNRNPH3;RBM4;HNRNPUL1;TGS1;SNRNP40;LSM8;CD2BP2;HNRNPA2B1;MAGOHB;MAGOH
prerank,prostanoid metabolic process (GO:0006692),0.5484291386150996,1.3884217723387358,0.10915492957746478,0.6996214756708293,1.0,3/13,5.45%,HPGDS;PTGS1;HPGD
prerank,regulation of cell adhesion (GO:0030155),0.3383049236762399,1.388357793178527,0.01564945226917058,0.6968578673102999,1.0,29/129,12.96%,PDE3B;ZFHX3;NUAK1;IL18;RND1;TGM2;PRKCA;ITGAV;SRC;LYN;PKHD1;SIPA1;ATM;PIK3CG;TFE3;FLCN;LPXN;EPHA8;CCR7;IL12B;FUT7;MIA3;PTK2B;PTPN11;DLL1;ABL1;STX4;SEMA4D;ROCK2
prerank,regulation of glucose import (GO:0046324),-0.4281936407309922,-1.3880672556677522,0.07801418439716312,0.49904494674137473,1.0,7/30,9.70%,PID1;SORBS1;IRS1;PRKAG2;CREBL2;OSBPL8;GRB10
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.48039018692920765,-1.388022469136264,0.09719222462203024,0.4971291752069787,1.0,7/18,11.56%,MCU;DNM1L;PRKN;DDHD1;MFF;RALBP1;FIS1
prerank,protein localization to synapse (GO:0035418),-0.5471693589280195,-1.3874657815652092,0.09502262443438914,0.49675324314151253,1.0,7/12,21.95%,NRXN1;NLGN1;PCLO;ZDHHC15;MPP4;NRXN2;BSN
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5069296807217634,1.3866008080322259,0.10707803992740472,0.7013254386443478,1.0,7/17,15.51%,IL18;BACH2;TLR4;EBI3;IL12B;IL18BP;GNL1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5813528456511158,1.3861641218421217,0.10351201478743069,0.7002151014603591,1.0,4/11,15.33%,VSIR;LGALS9;RUNX1;LGALS7
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.42089955584544625,-1.3858917117448988,0.0585480093676815,0.49921225938099534,1.0,10/30,15.07%,ST13;CCT2;HSPA8;DNAJB4;HSPA5;ERO1A;DNAJB13;SDF2;HSPA2;HSPA1B
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3863521358555206,1.3852891760512125,0.04817275747508306,0.7008814411330754,1.0,5/56,1.05%,TGFBR1;LDLRAD4;GREM1;PMEPA1;SMAD7
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.36616854770307283,1.384746072629414,0.03595890410958904,0.7002778554064396,1.0,25/86,20.48%,BIN1;NAV3;BAIAP2L2;RAC1;CDC42EP2;NUMA1;NCKAP1L;CLU;MET;CCR7;PTK2B;FCHSD2;PLEK;TRPV4;TENM1;PROX1;MAPRE1;VASP;FES;CCL24;FCHSD1;EVL;PYCARD;MAPT;KATNB1
prerank,lipid droplet formation (GO:0140042),0.578638428004371,1.3847439927768512,0.11946050096339114,0.6973273497118706,1.0,3/10,12.54%,CDS1;AUP1;BSCL2
prerank,sister chromatid segregation (GO:0000819),-0.43332396921365635,-1.3846576258654222,0.07600950118764846,0.500670059559363,1.0,10/31,13.33%,LATS1;TOP2A;SMC4;CDCA8;NDC80;ZW10;RAN;NUSAP1;SPAG5;KIF18B
prerank,cellular response to hydroxyurea (GO:0072711),0.5871074286636624,1.3845177303589657,0.10313075506445672,0.6953418788810217,1.0,7/10,31.13%,SPIDR;BLM;RTF2;NSMCE3;DDX11;ATRX;DDI2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.5071008284453846,1.384016123972274,0.10073260073260074,0.6946425197051155,1.0,7/18,18.57%,SEL1L;OS9;RNF103;UBC;RPS27A;SYVN1;MAN1B1
prerank,glycolipid metabolic process (GO:0006664),0.4048379378493077,1.383637749422078,0.0711864406779661,0.6934113854324289,1.0,8/47,8.73%,HEXB;ST3GAL6;CPTP;HEXA;NEU3;SMPD2;ASAH1;CERK
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.3223355824797357,-1.3832556568498686,0.013262599469496022,0.5027598331194202,1.0,34/118,16.49%,LRRC4C;PID1;PDLIM5;ADGRB3;LRRK2;ARHGAP35;PPFIA2;HECW2;HECW1;PLXND1;PDZD8;NEDD4L;ABI2;SHANK3;PAK3;GSK3B;LFNG;SP100;CHN1;SRCIN1;DAG1;BCL9L;SARM1;HTATIP2;SH3D19;PAK1;VASH2;CTNNB1;ZDHHC15;EFNA5;SFRP1;TNIK;BRSK1;HMOX1
prerank,regulation of platelet aggregation (GO:0090330),0.5093813181543898,1.3817091106540482,0.08602150537634409,0.6981004771136152,1.0,9/17,19.21%,F11R;PRKCA;PRKCD;LYN;CD9;CEACAM1;SERPINE2;DMTN;ADAMTS18
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.45664932963875426,-1.3809854387625133,0.0853932584269663,0.5071242555778647,1.0,5/22,7.13%,CCR2;GABBR2;PALM;EDNRB;CACNA1C
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5865667168595975,1.3809295972052595,0.10805500982318271,0.6985063618236147,1.0,3/10,5.14%,HK2;PFKL;GFPT1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3558687167273822,1.3803152683349535,0.032507739938080496,0.6983240136681174,1.0,25/92,16.45%,RREB1;SMOC2;ETS1;RAC1;MAP4K4;ANXA3;PRKCA;SRC;PLCG2;PIK3CG;SPARC;RHOB;PIK3CB;PTK2B;PIK3CD;ABL1;MTOR;PDCD6;ROCK2;PROX1;SCARB1;AKT1;INSL3;THBS1;GATA3
prerank,regulation of astrocyte differentiation (GO:0048710),0.5406749456561173,1.3798462112893772,0.10211946050096339,0.6974821727640018,1.0,5/12,25.27%,BIN1;SERPINE2;NOG;BMP2;NOTCH1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4858750624330822,1.3792627102062494,0.0918918918918919,0.6970010346356277,1.0,11/21,27.73%,LPIN2;PPARD;PLA2G15;NUDT19;HAO1;FAH;LPIN1;ACOT8;AGXT;CEL;ACOX1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5083679451417111,-1.3790804202633187,0.10492505353319058,0.5105276047642139,1.0,8/15,15.53%,KCNN2;KCNJ3;YWHAE;KCND3;KCNH2;ATP1A1;KCNQ1;KCNIP2
prerank,dendritic cell differentiation (GO:0097028),0.48086349240015164,1.377983744458771,0.07829181494661921,0.6993388487692487,1.0,7/22,12.99%,TGFBR2;LGALS9;LYN;TRPM2;CCR7;AXL;IRF8
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.43459440382706355,1.3779807556668107,0.0702054794520548,0.6965401653586392,1.0,12/33,22.16%,ETS1;NCKAP1L;PITHD1;PRMT1;ARNT;MAPK14;HMGB2;FES;TAL1;BRD1;HIF1A;STAT5B
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.514983922138782,-1.3769835270990103,0.09090909090909091,0.5142494354426902,1.0,2/14,0.41%,DMD;ANK3
prerank,synaptic vesicle endocytosis (GO:0048488),-0.41509462247061296,-1.3769158729031206,0.07252747252747253,0.5124358186445773,1.0,6/33,2.84%,NLGN1;DNM3;DNAJC6;SYT1;ITSN1;SNAP91
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.42313921931445153,-1.3768193033248628,0.08292682926829269,0.5106871190352403,1.0,9/29,11.93%,SORBS1;APOE;CREBL2;LDLR;ZBTB20;SLC45A3;ELOVL5;CNEP1R1;MFSD2A
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4615205655741266,-1.3766704671768857,0.07783018867924528,0.5091926859706158,1.0,6/21,12.82%,STAP1;FOXP1;RPS3;CD226;TESPA1;RELA
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.39562135996012937,1.3761499564329467,0.06283662477558348,0.7012712564140613,1.0,15/47,17.78%,GREM1;NBR1;LGALS9;MAP4K4;AGER;IGF1R;SEMA4C;MID1;PDCD10;MAPK8IP1;EIF2AK2;QARS1;TAOK2;ARL6IP5;NOD2
prerank,mammary gland development (GO:0030879),-0.4531450711614767,-1.3750555786740695,0.08830022075055188,0.5115514431759576,1.0,5/21,8.72%,ARHGAP35;ZBTB7B;JAK2;WNT4;ERBB4
prerank,chromatin remodeling at centromere (GO:0031055),-0.40725422792558474,-1.3746366796025868,0.07416267942583732,0.5108236609103062,1.0,12/31,24.29%,CENPP;KNL1;CENPT;MIS18BP1;NASP;CENPW;HELLS;NPM1;CENPS;RBBP7;OIP5;CENPC
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4751287489488706,1.3742101197407262,0.12815884476534295,0.7066039648721977,1.0,9/22,18.63%,SEL1L;OS9;RNF103;UBC;RPS27A;MAN1C1;SYVN1;MAN1B1;EDEM1
prerank,response to hydroxyurea (GO:0072710),0.5758498148055287,1.3735769678399599,0.11406844106463879,0.7062854674271526,1.0,7/11,31.13%,SPIDR;BLM;RTF2;NSMCE3;DDX11;ATRX;DDI2
prerank,DNA biosynthetic process (GO:0071897),-0.5023248520025255,-1.3733956526068059,0.09336609336609336,0.5122106297278372,1.0,7/16,21.13%,POLA1;POLL;SIRT1;PPIA;POLD3;TERT;POLD1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5441409092469275,1.373113418357239,0.09217391304347826,0.705475544811904,1.0,4/13,11.62%,ITGAM;PRKCD;ITGB2;SOD1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.43390301722452795,-1.3729525934555142,0.08893709327548807,0.5094653952857905,1.0,7/23,10.61%,DAB2;SDCBP;GIPC1;HIPK2;ING2;ZEB2;HSP90AB1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.43390301722452795,-1.3729525934555142,0.08893709327548807,0.5094653952857905,1.0,7/23,10.61%,DAB2;SDCBP;GIPC1;HIPK2;ING2;ZEB2;HSP90AB1
prerank,positive regulation of protein binding (GO:0032092),-0.36342920615906715,-1.3728812388411098,0.05783132530120482,0.507695372596201,1.0,17/56,18.10%,LRRK2;BDNF;APP;APOE;B2M;RAPGEF2;MARK3;RAN;GSK3B;PRKN;HIPK2;TIAM1;EPB41;CAPRIN2;BAMBI;ADD2;BMP4
prerank,primary miRNA processing (GO:0031053),0.5844974826269365,1.3723340040455814,0.1150278293135436,0.7059280573729123,1.0,2/10,1.99%,SMAD3;SRRT
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5653345208520001,-1.3710003094726093,0.12526997840172785,0.5113388254951479,1.0,3/10,4.03%,HECW2;HECW1;NEDD4L
prerank,arachidonate transport (GO:1903963),0.5823945584631811,1.370080549280397,0.1200750469043152,0.7096122675245564,1.0,4/10,16.63%,PLA2G5;NMUR2;DRD2;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),0.5823945584631811,1.370080549280397,0.1200750469043152,0.7096122675245564,1.0,4/10,16.63%,PLA2G5;NMUR2;DRD2;BDKRB2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5878486908641481,1.3695362574999745,0.10789980732177264,0.709145911161879,1.0,7/10,27.04%,IVD;ACADM;ETFB;ETFA;ETFDH;ACAD11;ACADVL
prerank,rRNA modification (GO:0000154),0.4869055069578716,1.3691039504690508,0.0918918918918919,0.7082303831056971,1.0,8/21,20.65%,BUD23;THUMPD1;METTL5;FTSJ3;NHP2;NSUN3;FBL;TFB1M
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4351180780888707,1.368443808336122,0.07832422586520947,0.708298607962805,1.0,7/31,13.04%,SASH3;DNAJB9;PHB2;KMT5C;CD86;STX4;SHLD2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5646361791855812,-1.3672648315910163,0.1191919191919192,0.5201948152154448,1.0,6/10,21.40%,MMGT1;EMC3;EMC7;EMC2;EMC4;EMC10
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5475340754973892,1.3671500907533016,0.09608540925266904,0.7109214814218179,1.0,5/13,14.11%,TGFBR2;NCKAP1L;SHH;PNP;RUNX1
prerank,positive regulation of neuron death (GO:1901216),0.40411164256584015,1.3670967501141926,0.06872852233676977,0.7084218014356176,1.0,8/46,6.50%,ITGAM;DDIT3;TLR4;ITGB2;PICALM;EIF2S1;CLU;C1QA
prerank,protein homooligomerization (GO:0051260),-0.32071660731373824,-1.3666914448774088,0.022535211267605635,0.519802116125341,1.0,28/114,15.38%,NLRC4;HCN1;KCNC2;DISP1;B2M;RYR3;GLS;NINJ1;EHD1;AQP4;ALOX5AP;LETM1;MLKL;ATL2;ADCY8;TRMT61B;PKD2;SLC1A5;ACOT13;SCARA5;SOD2;ALDH9A1;AQP11;GNMT;SAMHD1;G3BP2;SHMT1;ATL3
prerank,histone H2A ubiquitination (GO:0033522),0.5145879098766399,1.3663877055768505,0.09187279151943463,0.708783150705846,1.0,10/17,25.66%,BCOR;CUL4B;RNF8;DDB2;DTX3L;UBE2A;RNF2;RING1;KDM2B;PCGF1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5094320183455869,1.366076093268027,0.12408759124087591,0.7073960658103976,1.0,4/16,17.35%,CLDN11;CLDN12;CLDN10;CLDN1
prerank,signal transduction by p53 class mediator (GO:0072331),0.4420008199781687,1.3647004591195995,0.08703374777975133,0.7104247855082609,1.0,13/30,23.60%,GREM1;FHIT;DDX5;NBN;ACER2;POU4F1;PDK2;MDM4;PMAIP1;PYCARD;TP53;RRP8;PAXIP1
prerank,positive regulation of cell development (GO:0010720),0.42663692689946714,1.3643183322602372,0.0868824531516184,0.7091991484170922,1.0,5/31,8.98%,CX3CR1;NUMB;TGM2;GPER1;RGS14
prerank,dorsal/ventral pattern formation (GO:0009953),0.4872739800415124,1.3636040531808484,0.10590277777777778,0.7093191677726571,1.0,6/20,17.51%,GREM1;FBXL15;SHH;MDFI;NOG;PTCH1
prerank,O-glycan processing (GO:0016266),0.3879290833735834,1.3634989240626971,0.06678383128295255,0.7070913395306593,1.0,20/54,18.95%,B3GNT2;XXYLT1;GALNT12;GALNT5;POMGNT1;GALNT10;MUC6;B3GNT4;GALNT11;GALNT3;GXYLT2;GALNT1;ST3GAL3;POFUT1;GCNT1;GALNT15;GALNT7;ST6GALNAC4;GALNT2;GCNT4
prerank,oligodendrocyte development (GO:0014003),-0.5006616116154755,-1.3632839240882304,0.1085972850678733,0.5274616971888402,1.0,5/15,5.48%,B4GALT5;B4GALT6;TPPP;MYRF;CNTNAP1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.4541666765948973,1.3632701235908766,0.10037174721189591,0.705399422755599,1.0,9/26,20.48%,NAV3;RAC1;NUMA1;MET;TRPV4;MAPRE1;FES;MAPT;KATNB1
prerank,regulation of endocytic recycling (GO:2001135),-0.5469616952921577,-1.3632159422103722,0.11279826464208242,0.5256721679866698,1.0,7/11,27.06%,EHD1;INPP5F;ACTN2;EHD2;ARHGAP1;SORL1;EIPR1
prerank,spindle assembly (GO:0051225),0.37187730546748415,1.3631384203256949,0.04869565217391304,0.7033426492546638,1.0,16/67,14.20%,KIF2A;CHEK2;KIF3B;NUMA1;STARD9;GOLGA8B;HAUS7;NEK6;TUBGCP5;ABRAXAS1;CEP63;HAUS2;HAUS6;OFD1;KASH5;MAPRE1
prerank,positive regulation of TOR signaling (GO:0032008),0.41210158009655395,1.3623921085932218,0.07337883959044368,0.7037159252555367,1.0,13/40,13.89%,NCKAP1L;FLCN;LAMTOR2;SEC13;PIP4P1;LAMTOR5;MLST8;WDR24;RPTOR;GPR137C;RRAGA;GPR137;SEH1L
prerank,ganglioside biosynthetic process (GO:0001574),-0.5031204991545772,-1.3614484088281433,0.1,0.5287020552699354,1.0,5/15,9.06%,B4GALT5;ST3GAL1;B4GALT6;ST8SIA4;ST8SIA2
prerank,negative regulation of transferase activity (GO:0051348),0.447131101208265,1.3613450613015723,0.08849557522123894,0.7054316827727513,1.0,13/28,23.78%,SMAD7;SRC;EIF4A2;ERCC4;ABL1;DTX3L;TERF1;INPP5K;CDKN1B;PARK7;MAPT;TP53;BAG5
prerank,regulation of cell differentiation (GO:0045595),0.32798078281644594,1.361085245330427,0.0196078431372549,0.7038979123711727,1.0,36/148,16.45%,BIN1;TGFBR1;ZFHX3;GREM1;SMAD7;YWHAH;RPS6KA1;PRKACA;VHL;MBOAT2;DDX5;CDK9;GPS2;ZFP36L1;SHH;NREP;EDN3;BCL6B;NEUROD4;NOTCH4;CDK5RAP1;PHLDB1;MOSMO;DDX17;DLL1;PLEKHB1;FADS1;TAF8;PRKCB;EIF2AK2;RUNX1;FLOT2;FES;UQCC2;MEGF10;GATA3
prerank,protein homotetramerization (GO:0051289),-0.369308214939683,-1.36080107358392,0.05673758865248227,0.5287375477158194,1.0,12/49,14.45%,HCN1;B2M;RYR3;GLS;AQP4;PKD2;ACOT13;SOD2;ALDH9A1;GNMT;SAMHD1;SHMT1
prerank,protein transport (GO:0015031),0.29998491250716425,1.3606809965790798,0.004189944134078212,0.70288876315158,1.0,95/332,18.41%,TBC1D16;UNC93B1;ARHGEF2;PREB;DNM2;HERC2;YWHAH;TBC1D9B;ARFIP1;TBC1D8;COPA;ATP6V0B;KIF3B;TBC1D17;AP3D1;TBCK;VPS26B;FAM91A1;ARL5C;SEL1L;STX1A;STXBP1;VIPAS39;NEURL1B;AP2A1;TBC1D15;MCOLN1;TMED9;ATP6V0A2;ARFIP2;RAB3GAP2;CLU;STX12;TCIRG1;MACF1;SEC13;SCAMP2;STX19;TBC1D10B;RAB34;ARRDC1;RD3;RAB1A;MIA3;ARFGAP3;TBC1D9;BBS2;SCAMP5;SAR1A;TICAM2;SNX31;SEC31B;ATP6V0A4;PPT1;ATP6V1D;IL10RA;KIF3A;SGSM2;TVP23B;GOLGA4;STX4;MYH9;PDCD6;SCG5;PRKCB;RUNDC1;PPY;SGSM3;ADPRH;TMED4;NAPG;GGA3;SLU7;LRP1;LTBP2;RAB20;PDIA4;EIF2D;ATP6V0E2;CHMP1A;ARL11;AP4M1;RAB13;OPTN;RAB6B;PICK1;CHMP2A;ARL6IP5;GRTP1;STX16;TBC1D30;SEC31A;TOM1;ABCA1;RAB32
prerank,neuromuscular synaptic transmission (GO:0007274),-0.45991394755173887,-1.3599297115448854,0.10344827586206896,0.5293171103889366,1.0,5/18,6.27%,DTNA;KIF1B;ERC2;SLC5A7;CHAT
prerank,homeostasis of number of cells (GO:0048872),0.5508680766678495,1.3598987175799058,0.10780669144981413,0.7034472195847046,1.0,2/12,4.63%,CX3CR1;LRRC19
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.4167667670853143,1.3597208236653997,0.0782312925170068,0.7014206468508575,1.0,10/39,11.69%,TANC2;MYO1F;MYO1B;TRAK1;BICDL2;MYO7A;RAB1A;MYO5B;CLN3;MYO1E
prerank,insulin secretion (GO:0030073),-0.47335094348243534,-1.3596816915808987,0.1085972850678733,0.5280309099096986,1.0,3/19,2.51%,RIMS2;PTPRN2;SNX19
prerank,cytoplasmic translational initiation (GO:0002183),0.5019310888358499,1.359660660026012,0.10242085661080075,0.6990888063849872,1.0,10/17,22.19%,EIF4A2;EIF4G1;EIF2B3;EIF4H;EIF2S2;EIF2D;EIF3D;EIF5;DHX29;RBM4
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4434590641914155,1.359547419368635,0.07583774250440917,0.6969755259175858,1.0,7/28,9.59%,IRAK2;RIPK2;ITCH;OTULIN;TAB2;UBC;RPS27A
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5013148577380542,1.3587667174659224,0.11666666666666667,0.6974121823403439,1.0,9/18,29.25%,SMAD3;FSCN1;RUNX1;DDR2;IER3IP1;BMP2;TGFB1;CLASP1;RB1
prerank,protein tetramerization (GO:0051262),-0.3446261385238803,-1.3586831403439852,0.03768844221105527,0.5290615008183355,1.0,16/67,15.23%,HCN1;B2M;RYR3;GRIN2B;GLS;AQP4;HOMER1;PKD2;ACOT13;SOD2;ALDH9A1;SNCA;GNMT;SAMHD1;SHMT1;CUTC
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3633671827127241,1.358035994430995,0.054514480408858604,0.6977656277872738,1.0,24/72,21.92%,NAV3;SSH2;TWF2;ARHGEF2;FGF13;PRKCD;CAMSAP1;CYRIB;CLU;SSH1;PLEKHH2;CAMSAP2;HIP1R;CIB1;ATXN7;MAPRE1;VBP1;CHADL;DYRK1A;CLIP3;PIK3CA;KATNB1;SSH3;CRYAB
prerank,negative regulation of cytokine production (GO:0001818),0.32399597913241635,1.3569304809848737,0.027190332326283987,0.6998170869978665,1.0,38/163,16.45%,NAV3;SIRPA;ABCD2;VSIR;LGALS9;RAC1;DDIT3;AGER;OTUD5;RNF216;TLR4;CD84;UBA7;ITCH;RPS6KA5;TNFRSF21;NCKAP1L;UFD1;CD34;INHA;CCR7;PDCD1LG2;IL12B;CEACAM1;PCBP2;DLL1;AXL;HAVCR2;IRF3;GPNMB;SARS1;RPS6KA4;MAVS;LGALS7;NLRX1;CD33;THBS1;SYT11
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.45830543164060383,1.3556931149668447,0.10671256454388985,0.7021717777189054,1.0,13/24,31.38%,PPOX;HMBS;FECH;SUCLA2;NFE2L1;TSPO;UROD;ATP5IF1;PGRMC1;CPOX;ALAS2;ABCG2;ALAD
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3767270380461583,1.355289192348542,0.06756756756756757,0.7013596311155498,1.0,10/56,9.59%,UNC93B1;TLR7;TLR4;IRAK2;PLCG2;LGMN;CTSS;TAB2;UBC;RPS27A
prerank,cellular response to cytokine stimulus (GO:0071345),0.2928969488977673,1.354947231036473,0.003942181340341655,0.7002340032936086,1.0,116/416,20.83%,INPP5D;SELPLG;ST3GAL6;DOCK8;ITGAM;IL18;CSF3R;SIRPA;ARHGEF2;CSF1R;SMAD3;NFE2L2;IL1RL2;LGALS9;AIF1;NPNT;LRCH1;PRKACA;CRNN;TLR4;GAB2;IRAK2;PIK3R1;CDK9;CASP1;ITGB2;STX1A;FSCN1;SBNO2;IL6R;TRADD;TNFRSF21;EBI3;MMP2;ZFP36L1;CSK;CDC34;GAPDH;IL6ST;ZFP36L2;IL12RB2;ASAH1;DUOX1;CNTF;CCR7;NOS2;EDN2;IL12B;GPER1;CTF1;CXCL1;POU4F1;PIK3CB;CD86;BRCA1;PDE1B;IFNGR2;UBC;RPS27A;GBP6;MT1X;PIK3CD;PTPN11;WNK1;MT2A;AXL;DHX9;IL10RA;ZEB1;LDLRAP1;BAG4;STX4;IL18BP;SOCS6;TXLNA;IRF8;CIB1;AKT1;TYK2;STK39;IL10RB;EPRS1;GBP5;IL1R2;GHR;GBP7;PTPN23;POU2F1;IL20RA;GATA3;PTPN5;EGR1;CCR5;BCL2L11;IL4R;AIM2;NDUFA13;RBMX;TEC;PTPRJ;INPP5K;CRKL;CDKN1B;CCL24;CEBPD;VAV1;MAPK8;PYCARD;IRF5;SHPK;PIK3CA;HIF1A;PTPN18;TWIST1;CXCL10;HTRA2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.34288317199254037,1.3546871861809338,0.026438569206842923,0.6988375485345901,1.0,42/113,24.19%,SUMO1;ASAP1;TLR4;CDC42EP2;SRC;GTF2H2;SPIDR;ATM;FSCN1;EIF4G1;MTLN;CLU;CUL4B;SH3GLB1;PLEK;ERCC2;RASIP1;DDB2;ERCC4;BMF;TERF1;PSMC2;GBP5;USP50;PIEZO1;TAL1;BCL2L11;ABCA1;GNL3L;MED25;PARK7;SLF2;RPA3;MYD88;RHOC;CUL4A;TP53;STUB1;DDX3X;AJUBA;TGFB1;TPPP3
prerank,regulation of macroautophagy (GO:0016241),0.34665008604358444,1.3543819969635404,0.044374009508716325,0.6977002927687486,1.0,34/105,20.84%,SCOC;EXOC7;PRKACA;ATP6V0B;VPS26B;UCHL1;ATP6V0A2;LAMTOR2;GAPDH;SH3GLB1;RB1CC1;LAMTOR5;MLST8;RPTOR;CLN3;USP36;ATP6V1D;SNX5;ATG101;MTOR;PINK1;RRAGA;AKT1;ULK1;ATP6V0E2;SESN1;EXOC1;SNX32;LARP1;EXOC4;MAPK8;PIK3CA;EXOC8;VPS26A
prerank,cilium assembly (GO:0060271),0.30210077728592954,1.3542062829642931,0.009845288326300985,0.6960102538907413,1.0,71/297,17.08%,ASAP1;TUBA4A;EXOC7;SDCCAG8;RILPL1;BBS9;PRKACA;CSNK1E;KIF3B;TTLL3;PKHD1;CEP162;HYLS1;UBXN10;ODF2;TUBB;CFAP74;CEP164;EHD4;TUBG1;LRGUK;RP2;JHY;TNPO1;HAUS7;CNTRL;MKS1;CFAP52;TTC36;NME8;AVIL;CFAP221;NUDCD3;IFT52;RAB1A;INPP5E;CCDC28B;GALNT11;BBS2;CDC14B;CENPJ;ATP6V1D;TUBA1A;KIF27;KIF3A;DYNLT2B;CFAP20;CEP63;TTC21B;WDR90;HAUS2;EXOC6;CEP135;IFT20;CCDC40;HAUS6;CCDC66;TCTN1;OFD1;CEP57;MAPRE1;CFAP46;PDE6D;VANGL2;EXOC1;PTPN23;DCTN2;CPLANE2;B9D1;CEP70;TMEM17
prerank,supramolecular fiber organization (GO:0097435),0.2982351287137402,1.3540312555806213,0.008119079837618403,0.6943002431727824,1.0,52/334,10.09%,TGFBR1;ELMO1;DST;COL27A1;TSPAN14;KIF2A;HOOK2;CST3;ARHGEF2;CAPN3;GREM1;ITGA6;FGF13;CCDC88B;MYO1F;SERF1A;MYO1B;FLII;RAC1;RND1;PPP1R9B;DSP;CDC42EP2;DBN1;PPP1R9A;RHOH;ARHGAP25;SNCAIP;CAMSAP1;RHOBTB1;LOXL3;MARCKS;RND2;KLHL24;WDR73;MYO7A;RHOB;P3H2;TLE6;AVIL;ARHGAP17;CAMSAP2;ERMN;TUBGCP5;PSENEN;UBC;RPS27A;SHROOM2;P4HA1;MPRIP;MYO5B;CENPJ
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4873084334377723,1.353933859004036,0.08914728682170543,0.6922250695230827,1.0,12/19,33.98%,TGFBR2;HEYL;MDM4;EFNA1;BMP2;NOTCH1;SMAD6;BMPR1A;BMPR2;ACVR1;HEY1;SLIT3
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.4147790292107206,1.3536077899252827,0.07537688442211055,0.6911442650849163,1.0,10/39,11.34%,MAML3;TSPAN14;BMP2K;SRC;IL6ST;JAG2;NOTCH4;MAML2;DLL1;PDCD10
prerank,secondary palate development (GO:0062009),0.5335506369117277,1.3534904280206006,0.11328125,0.6893219619281695,1.0,2/14,4.71%,TGFBR2;CHD7
prerank,regulation of cellular senescence (GO:2000772),0.449503497164098,1.3530728254843984,0.09314586994727592,0.6885272514781604,1.0,6/28,8.88%,NUAK1;ABI3;MAP3K3;SLC30A10;NEK6;CGAS
prerank,translational termination (GO:0006415),0.3483867532265532,1.352953308741669,0.046511627906976744,0.6866118360066958,1.0,45/95,29.94%,MRPL50;ETF1;MRPS24;MRPL17;MRPL43;MRPS34;MRPL2;MRPL37;MRPL9;MRPL34;ABCE1;MRPL30;MRPS5;MRPS21;CHCHD1;MRPL13;MRPS18B;MRPS16;MRPS11;MRPL11;MRPS10;MRPL38;MRPL54;MRPL41;MRPS28;MRPS35;MRPS18A;MRPL36;DAP3;MRPL20;OXA1L;MRPL27;MRPL45;MRPL10;MRPL49;MRPL14;MRPL32;MRPS25;MRPL46;MRPL19;MRPL15;MRPS17;MRPL21;MRPS18C;PTCD3
prerank,negative regulation of fat cell differentiation (GO:0045599),0.42004846412715197,1.3529352444812006,0.09375,0.6843631911592323,1.0,9/34,7.94%,SMAD3;SIRT2;GPS2;CCDC85B;FLCN;ZFP36L2;GATA2;WNT10B;GPER1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4159116540907981,-1.3528269945827225,0.07674418604651163,0.543830126568015,1.0,13/31,21.79%,YWHAQ;TFDP2;YWHAE;GSK3B;ZNF205;BID;BAK1;BCL2;PPP3CC;TFDP1;BOK;E2F1;CHCHD10
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3631061688552177,-1.3527355248088306,0.07371007371007371,0.5421243743027273,1.0,16/57,14.88%,GRM7;GRM8;RGS1;GABBR1;ADCY2;ADCY5;ADCY3;ADCY8;HTR1D;CHRM3;CHRM2;OPRM1;ADRA2A;HTR4;GNAI1;PDE2A
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3434655495279928,1.3526440468865717,0.04730831973898858,0.6831275975584861,1.0,19/104,11.89%,TGFBR1;LDLRAD4;TGFBR2;GREM1;SMAD3;PMEPA1;SMAD7;SKI;TGFB1I1;SMURF1;SPRY2;PDPK1;ASPN;EID2;UBC;RPS27A;SMAD9;SKIL;MTMR4
prerank,thymus development (GO:0048538),0.5403492157390143,1.3518679943719683,0.12544802867383512,0.683999016658386,1.0,4/13,11.62%,TGFBR1;FOXE1;SHH;SOD1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.32644710239167873,1.3515522362312662,0.020061728395061727,0.6829582110663338,1.0,40/153,15.04%,TGFBR1;TGFBR2;ULK2;RPS6KA1;PRKCA;PRKACA;CSNK1E;CSNK2A2;CSNK2A1;PRKCD;CAMK1D;RPS6KA5;ATM;PDPK1;MKNK1;PKN3;NEK6;VRK3;PDGFB;ULK3;WNK1;MAP3K10;UHMK1;LATS2;GRK2;MTOR;MARK2;PINK1;MAPK14;PRKCB;ROCK2;DYRK4;AKT1;ULK1;STK39;MORC3;MAST3;AURKA;RPS6KA4;MASTL
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.394128428638106,1.351165444769027,0.08202443280977312,0.6821499817236402,1.0,17/46,20.52%,PLCL1;PCTP;DDIT3;TLR4;LAMA4;ID1;TFE3;FLCN;PLCL2;WNT10B;ABHD6;NRDC;NR1H2;IP6K1;ADAM17;NOVA2;ACVR2B
prerank,long-term memory (GO:0007616),-0.4668713924433644,-1.3510915338920877,0.1111111111111111,0.5451179140511796,1.0,6/19,9.02%,APOE;CPEB3;CAMK4;LDLR;RASGRF1;CALB1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.4749365520808764,1.3509264143974262,0.09911504424778761,0.6808261833683339,1.0,10/21,24.96%,CSF1R;MTUS1;AKIRIN1;DDT;PTK2B;THBS1;CXCL17;MIF;IL34;MDK
prerank,neuromuscular junction development (GO:0007528),-0.44620689490594034,-1.3508523820697693,0.09263657957244656,0.5438120323168234,1.0,10/24,20.19%,ANK3;GPHN;LRRK2;UNC13C;PDZRN3;UNC13B;DNAJA3;AGRN;CACNB3;DOK7
prerank,regulation of fibroblast migration (GO:0010762),0.4817387258969135,1.350726329129488,0.10909090909090909,0.6793483894528204,1.0,11/20,24.15%,GNA12;RAC1;RFFL;APPL1;CLN3;DDR2;THBS1;DMTN;ARHGEF7;APPL2;TGFB1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3023062703105703,-1.3493402315842256,0.01483679525222552,0.5462293132476518,1.0,46/161,20.21%,DAB2;CUL3;CCDC88C;LATS1;SHISA6;APOE;PSMD14;LIMD1;HECW1;RBMS3;APC2;PSMA2;PSMF1;GSK3B;PRKN;FRZB;PSMD8;IGFBP4;TLE4;LRP6;PSMD6;SIAH2;SOX13;PSME2;PSMD11;AXIN1;MLLT3;PSMD1;PSMD5;TLE1;IGFBP2;NPHP3;HDAC1;SFRP1;PSMD12;NKD1;SNAI2;ANKRD6;JADE1;MCC;SFRP2;SCYL2;TNN;GLI3;PSMB1;CTNND1
prerank,ganglioside metabolic process (GO:0001573),0.47195482613994094,1.3492645778222405,0.11272727272727273,0.6827412663870218,1.0,4/20,5.91%,HEXB;ST3GAL5;HEXA;NEU3
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4350619319712197,-1.3490163333270195,0.10981308411214953,0.5451610092246194,1.0,6/23,5.85%,CD74;SLIT2;DPP4;MCU;RIPOR2;DNM1L
prerank,regulation of nervous system process (GO:0031644),-0.47667761534021935,-1.3481779357206272,0.12189616252821671,0.5456164666534209,1.0,6/18,14.91%,APP;HTR2C;SLC8A3;DLGAP1;DLGAP2;TMEM108
prerank,negative regulation of protein localization to membrane (GO:1905476),0.45808871015869584,1.3481349861955634,0.08856088560885608,0.6850596163597938,1.0,5/24,5.15%,NUMB;MRAP;ABI3;PICALM;RHOQ
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.32707818892397006,1.3479123618433178,0.030612244897959183,0.6837168897126089,1.0,27/150,10.63%,CX3CR1;TGFBR1;IL18;P2RY12;RAC1;GAB2;SRC;PIK3R1;IGF1R;THEM4;PIK3CG;SPRY2;PDPK1;MET;PIK3AP1;FRS2;PDGFB;CCR7;RASD2;CALCR;PIK3CB;CD86;MTDH;GCNT2;PIK3CD;PTPN11;AXL
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.44085461690545713,-1.347864617725032,0.1087962962962963,0.5445934783827604,1.0,11/23,33.13%,PFKFB1;HDAC4;SIK1;TIGAR;NCOR1;CBFA2T3;CRY1;C1QTNF3;PPARA;C1QTNF12;GCK
prerank,ventricular septum development (GO:0003281),0.41774279463161107,1.347827506536417,0.07650273224043716,0.6817635463926025,1.0,5/37,1.38%,TGFBR1;SALL1;TGFBR2;SMAD7;HEYL
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.4990924668007245,-1.3477983902434778,0.11228813559322035,0.5428605082514959,1.0,6/14,25.92%,PPP2R2B;PPP2R2A;PPTC7;PPP1R15B;PPP2R2C;PPP2CA
prerank,negative regulation of hydrolase activity (GO:0051346),0.3909439653793255,1.3475952763505634,0.08153078202995008,0.6805274080695726,1.0,10/49,10.61%,F11R;CST3;LRCH1;FICD;EGLN1;ZCCHC9;RASA4;GPATCH2;WNK1;SH2D4A
prerank,negative regulation of type I interferon production (GO:0032480),0.4061133267532871,1.347558984729177,0.0730050933786078,0.6784012060910233,1.0,18/40,23.95%,SIRPA;OTUD5;RNF216;UBA7;ITCH;UFD1;PCBP2;HAVCR2;IRF3;MAVS;NLRX1;PYCARD;YY1;NPLOC4;PIN1;CYLD;PPM1B;NLRC5
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.331323904106784,1.3473989351516582,0.042105263157894736,0.6767863635631156,1.0,47/136,24.31%,SUMO1;SMAD7;HEYL;ARRB2;DDIT3;IRAK2;ITCH;PRMT2;OTULIN;PYDC1;PHB2;PKHD1;ID1;CTNNBIP1;EGLN1;MDFI;NFKBIE;WWP2;TBX6;MAP3K10;HAVCR2;ID3;PROX1;CEBPG;COMMD7;COMMD6;NLRP3;NWD1;HES6;SUFU;PTCH1;AIM2;TAF1;TCF7L2;TRIB1;PYCARD;SFRP4;RNF2;BRMS1;FZD6;KDM1A;ARRB1;CYLD;KEAP1;PAXIP1;NLRC5;ZC3H12A
prerank,genitalia development (GO:0048806),0.5493440059988096,1.3472580935493157,0.12045889101338432,0.6751920249776231,1.0,4/12,10.30%,CHD7;SHH;LHCGR;PTPN11
prerank,macrophage activation (GO:0042116),0.4252344602501603,1.347215025643575,0.10921501706484642,0.6731666926039945,1.0,10/34,7.63%,ITGAM;AIF1;AGER;TLR4;PLCG2;ITGB2;SBNO2;CLU;C1QA;EDN2
prerank,regulation of Notch signaling pathway (GO:0008593),0.3606073709997713,1.345713721469145,0.05339805825242718,0.6766411268291627,1.0,20/76,15.13%,MAML3;TSPAN14;BMP2K;SRC;RFNG;IL6ST;JAG2;ARRDC1;GATA2;NOTCH4;GALNT11;DTX1;WWP2;MAML2;DLL1;PDCD10;LLGL1;AKT1;NOTCH3;POFUT1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.31529422565581766,-1.3451349897544576,0.04885057471264368,0.5488364908020871,1.0,30/95,17.98%,GPC6;HS3ST5;B4GALT5;ST3GAL1;UST;ST3GAL4;B4GALT6;HS3ST2;CHSY3;GPC5;EXT1;SDC3;HS6ST2;DSE;CSPG4;HSPG2;GPC3;HS3ST1;B4GALT2;VCAN;PXYLP1;EXT2;B4GALT7;AGRN;NDST1;HS3ST3B1;GPC4;CHST12;SDC4;LUM
prerank,nucleotide catabolic process (GO:0009166),-0.4769992436453878,-1.3450312307318497,0.12334801762114538,0.5472235585034229,1.0,5/16,13.53%,XDH;GDA;NUDT3;SAMHD1;DERA
prerank,regulation of autophagy (GO:0010506),0.30862687784540194,1.3449101773342935,0.02849002849002849,0.6773897115285097,1.0,67/216,20.84%,EXOC7;PIM2;DDIT3;PRKACA;ATP6V0B;CSNK2A2;VPS26B;CPTP;SIRT2;UCHL1;TRIM5;ATM;EIF4G1;ATP6V0A2;FLCN;MET;LAMTOR2;TAB2;GAPDH;SH3GLB1;FOXK2;DRAM2;ACER2;PIK3CB;RB1CC1;LAMTOR5;MLST8;WDR24;RPTOR;MTDH;KDM4A;RASIP1;TPCN1;USP36;ATP6V1D;IL10RA;FBXL2;SNX5;ATG101;ABL1;MTMR4;MTOR;BMF;PINK1;RRAGA;AKT1;GPR137;ULK1;DCAF12;VDAC1;ATP6V0E2;TICAM1;EXOC1;SNX32;TMEM59;OPTN;GFAP;TRIM14;WDR6;EXOC4;MAPK8;RMC1;MAPT;TRIM65;EXOC8;HTRA2;VPS26A
prerank,regulation of axon regeneration (GO:0048679),0.5434640333567365,1.3448791186681401,0.13714285714285715,0.6753149493830101,1.0,5/12,15.21%,RTN4RL1;KLK8;CNTF;RTN4R;CERS2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.5414550846416251,1.3446716137317076,0.13090909090909092,0.6738778860654447,1.0,3/11,4.72%,TGFBR2;LRP5;CTNNBIP1
prerank,regulation of intracellular signal transduction (GO:1902531),0.29011198071166466,1.3440940446157745,0.002680965147453083,0.6739604524149101,1.0,82/420,13.36%,SRGAP2;SRGAP3;CHN2;ARHGAP5;FGD2;NUAK1;ARHGAP45;GNA12;ARHGAP39;OPHN1;ARHGAP22;ARHGEF2;CAPN3;PREX1;VAV2;PJA2;RAC1;MAP4K4;RHNO1;CHEK2;AGER;CRNN;ARAP3;ITGAV;TRAF5;CSNK2A2;CSNK2A1;TBCK;RNF41;LYN;RHOH;ARHGAP25;PLCG2;PKHD1;RFC2;RFFL;ATM;ARHGAP28;SLC15A4;NEK8;PDPK1;RHOQ;FLCN;RAD17;NBN;AKAP13;CHD3;EHMT2;AKAP12;RHOB;PIP4P1;ARHGAP8;RASD2;FSHR;GRM2;POU4F1;ARHGAP17;PRDM1;BRCA1;MLST8;FGD3;AKAP5;CEACAM1;TAF6;TAF12;ARAF;BOP1;XIAP;FBXL2;MDM4;RAD1;BLM;ARHGAP30;EXO1;MTOR;PRDM11;MAPK14;AKAP7;PHF20;ARHGAP36;ARHGAP4;AKT1
prerank,regulation of protein localization to membrane (GO:1905475),-0.41216958175198143,-1.3440051962788884,0.08333333333333333,0.5483034462521703,1.0,7/28,8.88%,GPC6;SPTBN1;GSN;GPC5;ACTB;PRKN;GPC3
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4029500097037646,1.3433354270877658,0.0994671403197158,0.6747403396576953,1.0,8/43,9.48%,TMEM119;LRP5;NPNT;MEF2C;IL6R;CTNNBIP1;IL6ST;WNT7B
prerank,Golgi to lysosome transport (GO:0090160),0.5654891267595357,1.3428687016543228,0.11588785046728972,0.6743107893883814,1.0,9/11,29.92%,SORT1;CLN3;RBSN;AP4M1;ANKFY1;CCDC91;EHD3;GAK;LAPTM5
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.4737632348849385,-1.3424039927567788,0.10884353741496598,0.5510687957674494,1.0,6/18,14.90%,AOAH;NAGA;SAMHD1;DERA;OGA;FUCA1
prerank,striated muscle cell differentiation (GO:0051146),0.5078422889380332,1.342319711352437,0.12570356472795496,0.6743205636046296,1.0,5/16,6.53%,MEF2C;SKI;MTLN;AKAP13;SORT1
prerank,serine family amino acid catabolic process (GO:0009071),-0.5664591366777062,-1.3418693140140763,0.15169660678642716,0.5508327614288756,1.0,6/10,21.20%,GCSH;SHMT1;DAO;GLDC;AMT;SHMT2
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5123256033579784,1.3414128011810138,0.12093862815884476,0.6756582833951823,1.0,6/16,10.54%,VSIR;AGER;TNFRSF21;PDCD1LG2;IL12B;DLL1
prerank,sulfation (GO:0051923),-0.541773472882488,-1.3413148167327977,0.12896405919661733,0.5504461678297519,1.0,2/11,1.83%,HS3ST5;UST
prerank,microtubule anchoring (GO:0034453),-0.518839269116772,-1.3412909754710964,0.1301518438177874,0.5485799458526698,1.0,4/12,21.18%,BICD1;SAXO2;DAG1;PEX14
prerank,regulation of TOR signaling (GO:0032006),0.3728221609587102,1.3412893844656193,0.07590759075907591,0.6740017979250443,1.0,17/67,13.89%,GNA12;TBCK;TBC1D7;PKHD1;RFFL;FLCN;LAMTOR2;SEC13;TNFAIP8L1;LAMTOR5;MLST8;WDR24;RPTOR;ARAF;PDCD6;RRAGA;SEH1L
prerank,phagosome acidification (GO:0090383),0.4534111270277505,1.3404996648163772,0.11804384485666104,0.6751285743569502,1.0,8/26,15.01%,ATP6V0B;ATP6V0A2;TCIRG1;RAB39A;ATP6V0A4;ATP6V1D;RAB20;ATP6V0E2
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4267267218044118,-1.3401431839748883,0.10657596371882086,0.5499077639210405,1.0,6/24,5.08%,NLGN1;GPM6A;TENM2;PALM;CDC42;RIPOR2
prerank,sensory perception of sound (GO:0007605),-0.3274874406768124,-1.3400899748954889,0.049738219895287955,0.5481898327568355,1.0,44/88,31.45%,GRM7;PCDH15;ROR1;RIPOR2;USP53;BIRC5;COL1A1;NDUFB9;DCDC2;SPTBN4;MARVELD2;MYO3B;TPRN;PAX3;CLRN1;KIT;KCNQ1;LHFPL4;LHFPL3;CCDC50;TIMM10;SNAI2;TSPEAR;EPS8L2;TIMM9;TMC1;LOXHD1;SLC26A4;PDZD7;TMIE;LHFPL5;LRP2;MKKS;COL4A3;CHRNB2;TBX1;TFAP2A;COL2A1;ESPNL;PJVK;ATP6V1B1;MYO1A;OTOS;GRXCR1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5146614711547994,-1.3398555631895253,0.1346153846153846,0.5470978374106118,1.0,4/13,9.88%,RBPJ;ZFPM2;ERBB4;PIM1
prerank,regulation of mitochondrial fission (GO:0090140),-0.426903701367385,-1.339800382029919,0.10329670329670329,0.545397969561911,1.0,8/24,11.56%,LRRK2;MCU;DNM1L;PRKN;DDHD1;MFF;RALBP1;FIS1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.5021104876640939,-1.3396534964545848,0.12708333333333333,0.5440180738439211,1.0,4/14,4.44%,HTT;RAPGEF2;PKIA;SIRT1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5484444593931,-1.3386940754856231,0.15711252653927812,0.544855938757975,1.0,4/10,12.40%,PARP14;PTPN2;INPP5F;PPP2R1A
prerank,positive regulation of metabolic process (GO:0009893),-0.3219356350183508,-1.3385150975571511,0.029023746701846966,0.543554577403192,1.0,26/103,17.33%,ESRRG;KSR2;CCR2;CD36;FABP4;CEBPB;ZBTB7B;ADIPOR2;PLAC8;IRF4;JAK2;G0S2;PER2;KDM6B;GRB10;THRA;ACLY;PRDM16;DISP3;EBF2;ALMS1;JCHAIN;ACHE;TSHR;FFAR4;AGPAT1
prerank,peptidyl-arginine modification (GO:0018195),0.5002251617753981,1.3373895829546392,0.13099630996309963,0.6848987289581462,1.0,6/15,19.67%,ART4;PADI2;PRMT8;PRMT1;NDUFAF5;PARK7
prerank,dendritic spine morphogenesis (GO:0060997),-0.4906097585040362,-1.3367408198311648,0.12128146453089245,0.5468298822439379,1.0,4/15,6.02%,CTNND2;CDC42;SHANK3;PAK3
prerank,cellular response to hydrogen peroxide (GO:0070301),0.4210937001458853,1.3365816056017032,0.10172413793103448,0.6858452460207267,1.0,11/33,17.01%,SIRPA;NFE2L2;PRKCD;IMPACT;TRPM2;RHOB;ABL1;PAX2;ANKZF1;MAPK7;ECT2
prerank,negative regulation of cartilage development (GO:0061037),0.5271351342674844,1.3360953288652881,0.1520912547528517,0.6855604903088375,1.0,4/13,10.30%,TGFBR1;GREM1;EFEMP1;PTPN11
prerank,nervous system development (GO:0007399),-0.26655906523426137,-1.3356372827460665,0.0,0.5483817516134057,1.0,112/429,19.43%,LSAMP;RBFOX1;NRXN1;NLGN1;DNM3;ZBTB16;ROBO1;KIRREL3;NRCAM;ADGRL3;GPM6A;SPOCK1;BDNF;TRPC5;FGF12;GDA;DPYSL5;NAV1;ADGRG6;SLITRK1;GSN;SCN2A;WWP1;JARID2;RBFOX2;ST8SIA4;GSS;ADAM22;NINJ1;MSI1;APC2;POU6F2;PLXND1;IL1RAPL2;ACVR1C;APBA2;FN1;CNTN6;SEMA5A;SHANK3;DCLK1;FAT4;CDK5RAP2;RAPGEFL1;HDAC4;EDNRB;RBFOX3;PRKN;CLN5;MYT1L;GFRA2;NAB1;SDHA;PKD2;JAG1;CHRM3;ECRG4;LIG4;SH3GL2;ERBB4;MAB21L2;LGI1;CHRM2;FGF11;ST8SIA2;GRIK1;ERCC6;ZEB2;POU3F2;ERBB3;VCAN;PRX;CRIM1;UNC119;SERPINI1;MAL;NDP;LY6H;INTU;SRRM4;HMGCR;OBSL1;CDH1;ACHE;TMEM223;SDK1;GDF11;DPF3;RELN;ZIC5;EFNA5;AHI1;CYP26C1;SEMA6A;FBXL17;POU3F1;PTS;ALDH3A2;PCDHB16;NR2C2;SCRG1;FKTN;CNTN4;GSTP1;BTD;NRXN2;NHLH2;DSCAM;ACTL6B;FGF5;PCDHB13;PCDHB6
prerank,long-chain fatty acid metabolic process (GO:0001676),0.36362451098597054,1.3353059553556996,0.06310679611650485,0.6865116093268652,1.0,25/64,29.77%,DAGLB;ACAD9;ACSL4;HPGD;SLC27A4;ALOXE3;PLA2G4B;PLA2G4A;FADS1;CPT1A;ABCD1;GPX4;ACOT8;HACL1;ACOT1;DAGLA;ACOT4;SCP2;EPHX1;FADS2;ASAH2;ACOX1;SLC27A3;HSD17B4;LTC4S
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.536835480547113,-1.335137261160289,0.1343612334801762,0.5481010086542972,1.0,4/11,18.10%,ZFPM2;JAG1;HEY2;BMP4
prerank,vasodilation (GO:0042311),0.5324040777127177,1.3349396251379524,0.13051470588235295,0.6857507240109152,1.0,6/13,23.15%,KCNMA1;AGTR2;GPER1;SOD1;NOS1;ADRB1
prerank,organelle assembly (GO:0070925),0.2907463025432472,1.334878136212476,0.005326231691078562,0.6838180231731378,1.0,125/385,24.90%,HPS4;ASAP1;ULK2;CAPN3;BIN2;EXOC7;RILPL1;BBS9;FLII;ATG14;ATG9A;KIF3B;TTLL3;STARD9;GOLGA8B;PKHD1;CEP162;HYLS1;UBXN10;ATXN2L;CEP164;EHD4;EIF2S1;EIF2A;STX12;RP2;CD34;HAUS7;NEK6;RBM14;MKS1;CFAP52;TTC36;NME8;AVIL;CFAP221;NUDCD3;IFT52;RAB1A;RB1CC1;INPP5E;TUBGCP5;G3BP1;CCDC28B;GALNT11;BBS2;CDS1;CDC14B;CENPJ;AUP1;PIK3C3;ATP6V1D;KIF27;KIF3A;DYNLT2B;CFAP20;CEP63;ATG101;WDR90;HAUS2;EXOC6;VPS37A;ATG5;BSCL2;VPS36;VPS37D;UBXN2A;IFT20;HAUS6;CCDC66;TCTN1;OFD1;ULK1;KASH5;MIS12;ATG9B;MAPRE1;PDE6D;CHMP1A;POGZ;TSG101;EXOC1;NUP62;PTPN23;CPLANE2;B9D1;TMEM17;CHMP2A;PACS2;RAB32;EXOC4;TP53INP2;WDR45B;DHX29;MAPT;IFT140;TRAPPC6A;SH3PXD2B;EXOC8;ATAT1;DBNL;PLA2G3;ARL3;DDX3X;CC2D2A;HGS;KLHL41;ARF4;IST1;ANLN;HPS1;PGM5;TCTN2;ATG2A;ACTR2;SSX2IP;DYNLL1;RAB23;GABARAPL1;HAUS5;TTBK2;IFT122;YTHDF3;CSNK1D;ATG12
prerank,platelet aggregation (GO:0070527),0.41238269949065054,1.3348451072895002,0.08117443868739206,0.6818474745235645,1.0,8/33,12.08%,P2RY12;FERMT3;STXBP1;PIK3CG;UBASH3B;PIK3CB;PLEK;MYH9
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3832924384862473,-1.3330957577193723,0.07058823529411765,0.5521049673090652,1.0,12/40,12.83%,RIMS2;SYT1;SNPH;SYT10;UNC13C;PCLO;CPLX2;RIMS1;SNAP25;UNC13B;RAB3A;SNCA
prerank,superoxide anion generation (GO:0042554),-0.514178539980585,-1.3327046478477351,0.13232104121475055,0.5513934184595725,1.0,3/13,8.26%,CYBB;NCF2;CYBA
prerank,peptide biosynthetic process (GO:0043043),-0.29636879340516,-1.3326033985403016,0.018469656992084433,0.5499215050880842,1.0,62/153,26.62%,DMD;PCSK5;RPL30;RPL36A;MRPL18;RPS29;RPL35A;RPS3;RPL4;RPS7;RPS2;RPL41;RPL7A;RPLP2;IGHMBP2;RPL38;RPL18A;RPS14;RPS27;MRPS7;RPL13A;RPL26;RPL22;RPS25;RPS15A;RPS15;EEF1A2;GGT7;RPS6KB2;RPL8;RPL23A;RPLP1;RPL37;HBS1L;RPS12;MRPS33;RPL24;RPL19;RPS11;RPLP0;RHD;RPS6;RPS9;RPSA;RPS10;RPS19;PABPC4;RPL23;RPL17;MRPL23;YARS2;EEF1A1;AGO2;ZAR1;RPS5;CARNS1;RPL29;GGTA1;RPL18;RPS21;MRPS6;MRPL55
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.3793395890172044,-1.3324687939603532,0.07951807228915662,0.548485667261314,1.0,13/41,15.11%,NEDD9;DOCK3;BDNF;GRM5;STAP1;NTRK2;DLG3;ERBB3;SRCIN1;UNC119;ADRA2A;LILRA5;RELN
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.526719764456938,-1.332375867291355,0.1320754716981132,0.5469151925420245,1.0,6/12,21.48%,CD74;FOXP1;KLF4;OAS3;HMGB1;MAP2K5
prerank,regulation of interferon-gamma production (GO:0032649),0.36561497556006806,1.3323671948801181,0.07628524046434494,0.6893363927803426,1.0,17/71,11.00%,IL18;TLR7;SIRPA;VSIR;LGALS9;DDIT3;TLR4;CYRIB;EBI3;INHA;IL12RB2;CCR7;PDCD1LG2;SLC7A5;IL12B;AXL;HAVCR2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4621973820228308,1.3319917255792844,0.09814814814814815,0.6884896013158954,1.0,6/21,12.96%,GREM1;BCOR;ASPN;TRPM4;PTK2B;ROCK2
prerank,neuron projection extension (GO:1990138),-0.39776186634810773,-1.331833799656789,0.09280742459396751,0.5467428058127519,1.0,11/32,19.02%,AUTS2;IQGAP1;ALCAM;MAP1B;SEMA5A;SH3GL2;HSP90AB1;TMEM108;CTNNB1;TNN;EIF2AK4
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.38057964667656885,1.3312125362622556,0.08600337268128162,0.6893557419388364,1.0,8/49,8.12%,IL18;CSF1R;LYN;IL6R;IL6ST;CNTF;IL12B;CTF1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5169105251016937,1.3311402140365098,0.11610486891385768,0.6875244881824242,1.0,7/14,21.35%,TGFBR1;GREM1;EFEMP1;PTPN11;CHADL;RFLNA;PTHLH
prerank,peptide metabolic process (GO:0006518),-0.33356588325955566,-1.330907568793029,0.07062146892655367,0.5476292614594028,1.0,26/75,27.06%,DMD;CPQ;NPEPPS;PCSK5;MME;SPCS2;PARL;CLN5;TRHDE;MGAT3;ENPEP;AEBP1;CPXM1;ANPEP;GSTT1;GSTP1;RHD;ACE;GSTZ1;GSR;ABCB9;TPP1;CPXM2;GSTK1;LNPEP;SPCS1
prerank,regulation of histone modification (GO:0031056),0.5354802435093318,1.3308762497118485,0.12126865671641791,0.6863876046372054,1.0,5/13,11.64%,AKAP8;CDK9;AKAP8L;FLCN;HPF1
prerank,DNA damage checkpoint signaling (GO:0000077),0.43645330955280615,1.3308713774473402,0.12142857142857143,0.6843320787029978,1.0,8/28,11.18%,RHNO1;CHEK2;ATM;USP28;RAD17;NBN;RAD1;CEP63
prerank,response to axon injury (GO:0048678),0.4839169143514447,1.3306979173418645,0.11764705882352941,0.6828614957931488,1.0,4/18,11.62%,RTN4RL1;P2RY12;NREP;SOD1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.41784098504609934,-1.3306463465156362,0.1084070796460177,0.5465798334750879,1.0,8/26,16.42%,YWHAE;GPR35;CBARP;CALM1;PKD2;ADRA2A;UBQLN1;GNB5
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5333164903348812,1.3303419790649211,0.12430426716141002,0.6821314868654508,1.0,3/12,1.99%,DOCK8;AIF1;JAM2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.38496084522839646,1.3299997710692928,0.09105960264900662,0.6814936466640873,1.0,12/50,11.26%,TLR7;LGALS9;AGER;TLR4;PHB2;CD27;TRADD;LRRC19;TRIM44;IL12B;CD86;LIMS1
prerank,mitochondrial translational elongation (GO:0070125),0.34400053437527695,1.3279797066945018,0.06785137318255251,0.6871943688613501,1.0,44/88,29.94%,MRPL50;MRPS24;MRPL17;MRPL43;MRPS34;MRPL2;MRPL37;MRPL9;MRPL34;MRPL30;MRPS5;MRPS21;CHCHD1;MRPL13;MRPS18B;MRPS16;MRPS11;MRPL11;MRPS10;MRPL38;MRPL54;MRPL41;MRPS28;MRPS35;TUFM;MRPS18A;MRPL36;DAP3;MRPL20;OXA1L;MRPL27;MRPL45;MRPL10;MRPL49;MRPL14;MRPL32;MRPS25;MRPL46;MRPL19;MRPL15;MRPS17;MRPL21;MRPS18C;PTCD3
prerank,negative regulation of neuron projection development (GO:0010977),-0.3538231542619037,-1.3276691346717198,0.06788511749347259,0.5532484841205423,1.0,8/56,4.22%,NLGN1;DCC;BCL11A;SPOCK1;LINGO1;APOE;RTN4;ARHGDIA
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3017304700525941,1.3265584211011199,0.0226628895184136,0.6907908838037409,1.0,73/241,22.78%,SRRM1;SNRNP70;POLR2H;SRRT;NCBP1;DDX5;RBM19;SNRPA;CSTF2;HNRNPA3;SF3B2;SF3B1;HNRNPC;SNRPC;ZMAT2;POLR2D;SNRPF;SRSF5;FUS;DHX38;SRRM2;PABPN1;RBM14;POLR2J;SART3;CPSF1;CWC25;U2AF2;HNRNPH1;SNRNP48;GEMIN6;RBM17;PCBP2;DHX9;HNRNPR;SNRPA1;TRA2B;SNRPN;U2AF1L4;ALYREF;RBM8A;METTL14;SLU7;CCAR1;DDX39B;TRA2A;SRSF9;PCF11;SF3A1;BUD13;RBMX;PRPF3;LSM7;FIP1L1;DDX46;SNIP1;PNN;WBP4;POLR2E;PRPF4;POLR2I;NOVA2;SYF2;SNRNP25;HNRNPH3;RBM4;HNRNPUL1;SNRNP40;LSM8;CD2BP2;HNRNPA2B1;MAGOHB;MAGOH
prerank,receptor-mediated endocytosis (GO:0006898),-0.3039083313045,-1.3260370938393031,0.013623978201634877,0.5562739526174239,1.0,36/132,16.93%,MRC1;DAB2;CD163;LRP1B;DNM3;DNAJC6;STAB1;CD36;LILRB1;MSR1;APOE;SNAP91;CTTN;SGIP1;AP2A2;LDLR;WASF1;CLEC9A;LRP6;DNM1;HSPG2;INPP5F;SCARF1;EPS15;TFR2;SNX9;SNCA;CTSL;HPX;JCHAIN;AP2B1;TMEM108;FCGR2B;TFRC;HP;HPR
prerank,pre-miRNA processing (GO:0031054),-0.4936646679731591,-1.3259888084452525,0.15789473684210525,0.5546124182947099,1.0,6/14,24.01%,AGO4;TUT4;DROSHA;TARBP2;ADAR;AGO2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3440625024046113,1.3257070112882672,0.05194805194805195,0.6920199774352102,1.0,30/87,20.36%,F11R;ABI3;TWF2;CSF1R;RAC1;RND1;PRKCD;RHOH;FSCN1;RHOBTB1;RND2;RHOQ;TRPM2;RHOB;ARHGAP17;PTK2B;MLST8;RAPGEF3;HIP1R;ABL1;MTOR;ROCK2;LRP1;TAOK2;NEB;CELSR1;DMTN;RAC3;ARHGEF5;PIK3CA
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5081697962026623,1.3250024191713559,0.13043478260869565,0.6925298913452059,1.0,2/15,0.62%,TGFBR1;TGFBR2
prerank,positive regulation of interleukin-12 production (GO:0032735),0.41916379347020855,1.3249321016566105,0.10350877192982456,0.6907046562658384,1.0,7/31,7.73%,LGALS9;AGER;TLR4;RIPK2;PLCG2;CCR7;IL12B
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4823545532614091,1.3248680796272614,0.11808118081180811,0.6888842425981865,1.0,7/17,25.27%,BIN1;SERPINE2;BMP2;IL34;TGFB1;MDK;NOTCH1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.4435230446724713,-1.3245266194110121,0.1282608695652174,0.5574153772742745,1.0,9/21,13.64%,MCU;SLC8A3;PDZD8;LETM1;SLC8B1;MCUB;MICU2;FIS1;MICU3
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.32621870491421123,-1.32435006840905,0.05194805194805195,0.5560672642115428,1.0,42/85,31.45%,GRM7;PCDH15;ROR1;RIPOR2;USP53;BIRC5;COL1A1;NDUFB9;DCDC2;SPTBN4;MARVELD2;MYO3B;TPRN;PAX3;CLRN1;KCNQ1;LHFPL4;LHFPL3;CCDC50;TIMM10;SNAI2;TSPEAR;EPS8L2;TIMM9;LOXHD1;SLC26A4;PDZD7;TMIE;PIEZO2;LHFPL5;LRP2;COL4A3;CHRNB2;TBX1;TFAP2A;COL2A1;ESPNL;PJVK;ATP6V1B1;MYO1A;OTOS;GRXCR1
prerank,regulation of bone mineralization (GO:0030500),0.3766083618913091,1.3240417400193656,0.07704918032786885,0.6898910240224247,1.0,10/55,9.95%,TMEM119;GREM1;NBR1;MEF2C;BMP2K;SLC8A1;BCOR;TRPM4;PTK2B;PKDCC
prerank,lipoprotein localization (GO:0044872),-0.5410044382732544,-1.3235154086201173,0.14046121593291405,0.556814710724157,1.0,5/11,11.55%,PPARG;CD36;VMP1;UNC119;ZDHHC17
prerank,actin filament organization (GO:0007015),0.3196581989533602,1.323056832119174,0.04328358208955224,0.6916161276067224,1.0,32/151,11.69%,ELMO1;ARHGEF2;MYO1F;MYO1B;FLII;BAIAP2L2;RAC1;RND1;AIF1;PPP1R9B;CDC42EP2;DBN1;PPP1R9A;RHOH;ARHGAP25;RHOBTB1;MARCKS;RND2;FHOD1;MYO7A;RHOB;TLE6;AVIL;ARHGAP17;ERMN;SPIRE1;SHROOM2;MPRIP;MYO5B;HIP1R;TRPV4;MYO1E
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.44399273940896555,1.3230511607967101,0.10357142857142858,0.6896174373106463,1.0,6/24,9.59%,IRAK2;RIPK2;ITCH;TAB2;UBC;RPS27A
prerank,negative regulation of viral life cycle (GO:1903901),-0.4922902594511685,-1.322977533964254,0.11597374179431072,0.5566472778495408,1.0,8/15,16.91%,CIITA;GSN;IFITM3;MID2;PPIA;LY6E;IFITM2;IFITM1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4551191341369566,1.3224999487306701,0.11926605504587157,0.6896375963953628,1.0,9/23,19.05%,SMAD3;SMAD7;BCL9;EID2;NREP;LATS2;DKK3;ENG;LTBP4
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4853036509044818,1.322310893806019,0.12177121771217712,0.6883917705353151,1.0,6/19,12.50%,POLR3G;CHD8;BRF2;RPTOR;MTOR;TENM1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.48401900706828793,1.3221024922947255,0.12293577981651377,0.6871268710508552,1.0,8/19,24.96%,CSF1R;CAMK1D;AKIRIN1;THBS1;CXCL17;MPP1;IL34;MDK
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.40812667917993534,-1.3219652327394045,0.09024390243902439,0.5578685531974995,1.0,11/32,13.16%,RIMS2;LRRK2;SYN1;MCTP2;GSK3B;CPLX2;RIMS1;RIMS4;MCTP1;DTNBP1;KCNMB4
prerank,tRNA transport (GO:0051031),0.406965491167127,1.3219081357102134,0.12307692307692308,0.6858284967625189,1.0,15/35,23.14%,TOMM20L;XPOT;RANBP2;SSB;NUP42;SEC13;NUP35;NUP50;SEH1L;NUP62;NUP107;NUP88;NUP188;NUP214;TOMM20
prerank,synaptic vesicle localization (GO:0097479),-0.5123141515749985,-1.3219040079883424,0.13404255319148936,0.5562494437967344,1.0,5/13,8.46%,NLGN1;KIF5C;TOR1A;SYNDIG1;KIF5B
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.44596753623817703,-1.3215738635277996,0.1394335511982571,0.5554415281919168,1.0,4/20,3.02%,B2M;PRKCZ;DENND1B;RSAD2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4370211761745927,-1.321284529435022,0.11894273127753303,0.5545917624947021,1.0,5/21,9.03%,PPARG;APOE;PLTP;SIRT1;NFKBIA
prerank,amyloid precursor protein catabolic process (GO:0042987),0.5146303250732851,1.321222657428509,0.1298932384341637,0.6864838995066891,1.0,9/14,28.37%,PSEN2;PSENEN;CLN3;APH1B;DYRK1A;ADAM10;ADAM17;APH1A;ABCG1
prerank,regulation of protein processing (GO:0070613),-0.438623667707833,-1.321219309899751,0.12072892938496584,0.5530014337971932,1.0,3/21,1.54%,LRRK2;NLRC4;CCBE1
prerank,actin filament polymerization (GO:0030041),-0.4121724235088604,-1.3211313247832408,0.0997624703087886,0.5515206658112053,1.0,8/29,9.87%,ARHGAP6;PSTPIP1;PSTPIP2;GSN;DIAPH3;WASF1;JAK2;MSRB1
prerank,negative regulation of phosphorylation (GO:0042326),-0.31613146204397263,-1.3208710990414803,0.04568527918781726,0.5504740809214269,1.0,30/85,22.32%,PID1;XDH;LRRK2;STAP1;SLIT2;NTRK3;PFKFB1;SIRT1;PPIA;CORO1C;HDAC4;CADM4;PRKN;LRP6;SH3GL2;MYADM;TIGAR;PAQR3;PLPP3;CDKN2A;CDKN1A;PTPN13;NCOR1;BMP4;CBFA2T3;CDKN1C;PRR5L;CDK5RAP3;PPP1R15B;TRAF3IP1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5648060927217239,1.320616680985885,0.14003944773175542,0.6867444988381506,1.0,3/10,9.59%,DIS3L2;UBC;RPS27A
prerank,ribosomal small subunit assembly (GO:0000028),-0.4746338216277094,-1.3204818880722924,0.15605749486652978,0.5497926816470496,1.0,9/16,24.43%,RPS14;RPS27;MRPS7;XRCC5;RPS15;ABT1;RPSA;RPS19;RPS5
prerank,acylglycerol metabolic process (GO:0006639),0.4079098153371218,1.3203658780394718,0.1013745704467354,0.685709660363911,1.0,10/37,11.96%,ABHD12;DGAT1;DGKK;SEL1L;LMF1;GK5;ABHD6;APOH;DGKD;PGS1
prerank,calcium ion transport into cytosol (GO:0060402),-0.4377398312088677,-1.319940116402333,0.11374407582938388,0.5496025045372758,1.0,9/21,20.07%,GRIN2A;ADRA1A;RYR2;GRIN2B;CACNA1C;GRIN2D;CACNB3;CACNA2D1;MS4A1
prerank,positive regulation of biosynthetic process (GO:0009891),-0.3775075568288171,-1.3188493559659953,0.09523809523809523,0.5507715797697926,1.0,17/40,18.98%,SORBS1;CD36;APOE;VIM;CREBL2;ZBTB20;WNT4;CYBA;CREB3L1;MMP8;RGCC;CCL5;MTPN;SCX;SERPINF2;BMP4;CREB1
prerank,phospholipid translocation (GO:0045332),-0.41329967449120103,-1.3183065692153701,0.11678832116788321,0.5507510801882444,1.0,12/28,18.39%,ATP8B4;ATP11A;ANO6;ATP11C;MFSD2A;PLSCR2;ATP8B2;PLSCR4;ABCC1;ABCA4;ATP10B;ATP9B
prerank,positive regulation of chemotaxis (GO:0050921),0.3944188528351288,1.3178701166833797,0.08561643835616438,0.6933611051434393,1.0,9/43,7.63%,P2RY12;SMOC2;AIF1;LGMN;IL6R;MET;EDN3;PDGFB;EDN2
prerank,epiboly involved in wound healing (GO:0090505),-0.48407714936864554,-1.3176003136691385,0.12153518123667377,0.5511734780853972,1.0,6/16,16.59%,CD44;ARHGAP35;TMEFF2;TOR1A;CD151;FLNA
prerank,mitochondrial translational termination (GO:0070126),0.3409937284158839,1.3173635389588456,0.07234726688102894,0.6933328054936054,1.0,43/88,29.94%,MRPL50;MRPS24;MRPL17;MRPL43;MRPS34;MRPL2;MRPL37;MRPL9;MRPL34;MRPL30;MRPS5;MRPS21;CHCHD1;MRPL13;MRPS18B;MRPS16;MRPS11;MRPL11;MRPS10;MRPL38;MRPL54;MRPL41;MRPS28;MRPS35;MRPS18A;MRPL36;DAP3;MRPL20;OXA1L;MRPL27;MRPL45;MRPL10;MRPL49;MRPL14;MRPL32;MRPS25;MRPL46;MRPL19;MRPL15;MRPS17;MRPL21;MRPS18C;PTCD3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5108884895612729,-1.317121260571885,0.14838709677419354,0.5508383157532385,1.0,7/12,30.16%,NFIB;SPTBN4;EPHA4;EPHB2;PAFAH1B1;CHRNB2;TSKU
prerank,regulation of platelet activation (GO:0010543),0.4585865862900193,1.316644284034201,0.11481481481481481,0.6941322623029939,1.0,6/21,9.89%,PRKCA;TLR4;LYN;PDGFB;PLA2G4A;PLEK
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.4199574006344217,1.3148318895606737,0.12784588441331,0.6993018776454023,1.0,12/30,25.29%,ARHGEF2;CFLAR;RFFL;TRADD;BRCA1;PARK7;FAIM;SERPINE1;DDX3X;FADD;TMBIM1;RNF34
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4821197167496156,-1.3141523128756567,0.14623655913978495,0.5576553373861654,1.0,4/14,4.44%,CD74;LILRB1;CAMK4;SIRT1
prerank,adherens junction organization (GO:0034332),-0.36296671468147695,-1.3139442280550766,0.08808290155440414,0.5565248292142123,1.0,17/48,14.99%,CADM2;CTNNA1;CDH8;AFDN;CDH22;CDH4;ACTB;CDH13;NECTIN1;CDH7;CDH20;CDH11;CDHR3;CDH5;CDH10;CDH1;CTNNB1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.4889538907005222,1.3137754529656842,0.14690265486725665,0.7014182687407093,1.0,7/16,13.89%,FLCN;PIP4P1;LAMTOR5;GPR137C;RRAGA;GPR137;SEH1L
prerank,cilium-dependent cell motility (GO:0060285),-0.4362245103770012,-1.3135833600043811,0.11738148984198646,0.5558958963983438,1.0,11/22,24.70%,RFX3;DNAH8;DNAH2;DNAI3;CFAP44;DNAH3;EFHC1;DNAH17;CCDC65;TEKT5;CCDC39
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.4756955947348763,1.3135162981477215,0.14535901926444833,0.7004618062369259,1.0,9/19,25.19%,RHOH;CD27;NCKAP1L;AXL;GATA3;XRCC6;MDK;ZMIZ1;ZBTB1
prerank,microtubule-based transport (GO:0099111),-0.5025109196286897,-1.3133832891674846,0.1434878587196468,0.554714457566092,1.0,7/13,32.88%,HTT;DYNC1I2;SPEF2;SPA17;DYNC1I1;DNAAF4;ROPN1L
prerank,axoneme assembly (GO:0035082),0.419939231466764,1.3132853273375173,0.12966252220248667,0.6994399301942884,1.0,8/31,14.37%,DRC1;TTLL3;CFAP74;LRGUK;JHY;TTC12;CCDC40;CFAP46
prerank,cellular transition metal ion homeostasis (GO:0046916),0.33933712561386303,1.3128601653593472,0.07022900763358779,0.6991748420877274,1.0,22/91,11.62%,SLC30A5;FRRS1;SLC30A10;SLC40A1;ATP6V0A2;ISCU;SLC30A8;HAMP;ANKRD9;TMEM199;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;MT2A;TMPRSS6;CYB561A3;SOD1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5227144771776279,1.3125392505854687,0.1577981651376147,0.6984184946580811,1.0,7/12,27.88%,GINS4;MCM2;MCM3;MCMDC2;CDC7;MCM6;MCM7
prerank,smooth muscle tissue development (GO:0048745),0.5625983942429027,1.312259699819752,0.15613382899628253,0.6974473512478208,1.0,5/10,17.51%,SHH;PROX1;SMO;ENG;PTCH1
prerank,regulation of transport (GO:0051049),-0.37837531764853,-1.3119874838977952,0.09069767441860466,0.5570569183747661,1.0,12/36,16.27%,LRRK2;ACTB;PRKN;ICA1;POFUT2;SCFD1;DISP3;SNCA;EPB41;ACTG1;MYO6;WWC1
prerank,positive regulation of telomerase activity (GO:0051973),-0.38821164196124874,-1.3118397410016713,0.10638297872340426,0.5558013961315847,1.0,11/33,14.99%,PARM1;CCT2;MYC;MAPKAPK5;XRCC5;AURKB;HSP90AB1;KLF4;WRAP53;PRKCQ;CTNNB1
prerank,N-terminal protein amino acid modification (GO:0031365),0.5049689333042438,1.311704329116873,0.1487758945386064,0.6975876094355804,1.0,5/14,17.82%,NAA11;NAA40;METAP1D;NAA50;METAP2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.3676515685443962,-1.3116938062757897,0.09879518072289156,0.554520657141981,1.0,11/43,13.91%,PID1;SORBS1;PRKCZ;IRS1;ZBTB7B;SIRT1;TNS2;PTPN2;GRB10;KANK1;PRKCQ
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.38984246931210337,1.31160902956759,0.08950086058519793,0.6960014740033621,1.0,9/39,10.39%,SALL1;TGFBR2;LRP5;NPNT;PKHD1;MET;SHH;NOTCH4;RASIP1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.5063743551407066,-1.3115254971693513,0.14222222222222222,0.5533337711096337,1.0,3/13,7.60%,MDFIC;BARD1;SP100
prerank,dendrite self-avoidance (GO:0070593),-0.47757360559873613,-1.3110970433274116,0.13852813852813853,0.5528974962835083,1.0,7/16,19.27%,NPTN;PALLD;EMB;CNTN6;CNTN4;TNN;DSCAM
prerank,heart looping (GO:0001947),0.39397997200385243,1.3107651308106822,0.10344827586206896,0.6972615545228821,1.0,11/40,17.06%,TGFBR2;MEF2C;SHH;SOX17;TBX6;NDRG4;DLL1;CCDC40;VANGL2;SMO;ENG
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5634695267788197,1.3104178040379608,0.1551094890510949,0.6947735317230024,1.0,3/10,6.93%,PRKCD;PLA2G6;SMPD2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5634695267788197,1.3104178040379608,0.1551094890510949,0.6947735317230024,1.0,3/10,6.93%,PRKCD;PLA2G6;SMPD2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.38787953281362925,-1.310112456415623,0.07711442786069651,0.5539788820411966,1.0,8/33,12.82%,PTPN22;RPS3;CD226;PTPN2;TESPA1;THY1;UBASH3A;RELA
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.29017251701112257,-1.310099940956236,0.037940379403794036,0.5523743034053811,1.0,61/168,21.90%,SAMD4A;PPP2R2A;RPL30;RPL36A;RPS29;SMG7;RPL35A;RPS3;RPL4;RPS7;RPS2;RPL41;EIF4A3;SMG6;RPL7A;RPLP2;XRN2;RPL38;RPL18A;ZFP36;PABPC1;RPS14;RPS27;EIF3E;RPL13A;RPL26;MRTO4;RPL22;RPS25;RPS15A;TUT4;CNOT10;RPS15;TUT1;LSM1;PPP2R1A;RPL8;RPL23A;SMG5;EXOSC7;RPLP1;PATL1;RPL37;ERI1;POLR2G;RPS12;CNOT4;HELZ2;UPF1;RPL24;RPL19;RPS11;RPLP0;PNLDC1;TENT2;RPS6;SMG1;RPS9;RPSA;RPS10;RPS19
prerank,lipoprotein transport (GO:0042953),-0.5483607738493588,-1.3097061623659827,0.16216216216216217,0.5519271446267919,1.0,5/10,11.55%,PPARG;CD36;VMP1;UNC119;ZDHHC17
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5391203717341273,1.3096651557698056,0.15828677839851024,0.6956399872825761,1.0,2/11,3.33%,RAC1;SIRT2
prerank,gland development (GO:0048732),0.3643524478531996,1.309595925358227,0.09584664536741214,0.6939927100851101,1.0,11/59,13.55%,TGFBR1;SALL1;PRKCSH;TG;FOXE1;MET;SHH;NOTCH4;SOD1;PROX1;CEBPG
prerank,positive regulation of type 2 immune response (GO:0002830),-0.49471965659094475,-1.30926817975386,0.1407563025210084,0.5515909349208702,1.0,4/14,3.02%,CD74;PRKCZ;DENND1B;RSAD2
prerank,peptide catabolic process (GO:0043171),-0.4218361250133397,-1.3092436950777158,0.10046728971962617,0.5500513773571342,1.0,6/23,12.69%,CPQ;NPEPPS;TRHDE;ENPEP;GGT7;ANPEP
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3386596693662352,1.3089201364601384,0.06570512820512821,0.6945516977085276,1.0,31/95,22.71%,CX3CR1;SIRPA;MEF2C;TLR4;SIRT2;CASP1;CYRIB;SBNO2;CTR9;PABPN1;PDCD1LG2;CXCL1;CD86;TICAM2;AXL;MAPK14;NLRP3;HMGB2;TNIP2;TICAM1;CCR5;NOD2;MAPK8;PYCARD;SHPK;MYD88;CXCL10;SERPINE1;PDCD4;IL36G;TRAF6
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5085008192506968,1.3084726661065722,0.1553030303030303,0.6942722077713723,1.0,3/15,6.17%,SMOC2;LGMN;MET
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.542847246798448,1.3069642049243233,0.15879017013232513,0.6983595260673494,1.0,2/11,2.98%,PJA2;LYN
prerank,negative regulation of bone mineralization (GO:0030502),0.5155876546367487,1.3067363222565407,0.14638783269961977,0.6973493053632078,1.0,4/13,8.98%,GREM1;BCOR;TRPM4;PTK2B
prerank,cell chemotaxis (GO:0060326),0.36396994877353417,1.306654974728273,0.09195402298850575,0.695741357314678,1.0,7/60,7.55%,CX3CR1;DOCK4;BIN2;ARRB2;PRKCD;PDGFB;CCR7
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5541690096934863,1.306190851995188,0.15384615384615385,0.6955944495926523,1.0,2/10,0.85%,MLXIPL;ABCD2
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.39318454367015887,-1.3058656114020186,0.12195121951219512,0.556565137721977,1.0,11/29,24.29%,CENPP;KNL1;CENPT;MIS18BP1;NASP;CENPW;NPM1;CENPS;RBBP7;OIP5;CENPC
prerank,CENP-A containing chromatin organization (GO:0061641),-0.39318454367015887,-1.3058656114020186,0.12195121951219512,0.556565137721977,1.0,11/29,24.29%,CENPP;KNL1;CENPT;MIS18BP1;NASP;CENPW;NPM1;CENPS;RBBP7;OIP5;CENPC
prerank,negative regulation of cell differentiation (GO:0045596),0.3059390014594522,1.3055282403640276,0.0364963503649635,0.6962239265306895,1.0,32/181,10.54%,TGFBR1;LDLRAD4;LRP5;GREM1;SMAD3;NBR1;SMAD7;SOX8;NELFB;SKI;ITGAV;SIRT2;GPS2;EFEMP1;CCDC85B;SPRY2;TRPM4;CTR9;SHH;HOXB8;ZFP36L2;OVOL2;GATA2;WNT10B;GPER1;ANKRD2;TWIST2;NOTCH4;PTK2B;DTX1;PTPN11;DLL1
prerank,filopodium assembly (GO:0046847),0.49196648197365295,1.3053947082117512,0.16322701688555347,0.6948717585319121,1.0,5/16,9.87%,SRGAP2;FGD2;PPP1R9B;FGD3;SPATA13
prerank,phosphatidic acid metabolic process (GO:0046473),0.3754480376751721,1.3046974352300098,0.10887772194304858,0.695733662779887,1.0,10/48,11.18%,LIPH;PLD1;LPCAT4;PLD2;PLA2G6;PLA2G5;PLA2G4B;PLA2G4A;DGKD;GPD1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.46576314438389904,1.30469652237995,0.15045871559633028,0.6938859881602426,1.0,10/21,25.58%,RASAL3;ARHGAP25;CYRIB;SPRY2;LZTR1;SYNGAP1;MFN2;CD2AP;STAMBP;CGNL1
prerank,neuronal action potential (GO:0019228),-0.4267477982588702,-1.303769637956716,0.12557077625570776,0.5609289031093901,1.0,6/22,13.16%,ANK3;KCNMB2;SCN2A;SCN3A;CACNA1G;KCNMB4
prerank,regulation of phagocytosis (GO:0050764),0.371405100756987,1.3029959170731529,0.08737864077669903,0.6982271643051026,1.0,11/53,16.60%,MERTK;SIRPA;TGM2;ITGAV;CAMK1D;PLA2G5;GATA2;RAB27A;SCARB1;SYT11;SNX3
prerank,regulation of osteoblast differentiation (GO:0045667),0.3385189742525644,1.3024270813895387,0.07345575959933222,0.6984626811317854,1.0,15/82,9.48%,TMEM119;LRP5;GREM1;NBR1;NPNT;MEF2C;PRKACA;SKI;DDX5;IL6R;CTNNBIP1;TRPM4;IL6ST;TWIST2;WNT7B
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.30131725831866957,1.3024228280988,0.02608695652173913,0.6966330699123557,1.0,63/234,19.67%,CX3CR1;IL18;ARHGEF2;CAPN3;SMAD3;LGALS9;CFLAR;ANXA3;DDIT3;AGER;CRNN;TLR4;TRAF5;IRAK2;RIPK2;PHB2;PLCG2;CAMK1D;TRIM5;RPS6KA5;TRADD;CLU;FZD2;SHH;TAB2;ABRA;EDA2R;TSSK4;MBTPS2;LAMTOR5;UBC;RPS27A;TAF12;MTDH;CRTC1;DHX9;TRIM62;PRKCB;RNF31;CIB1;AKT1;CEBPG;RNF25;EIF2AK2;NLRP3;FLOT2;RPS6KA4;MAVS;TICAM1;DDR2;FZD1;FANK1;SMO;TRIM14;PIDD1;AIM2;TAF1;NOD2;HDAC5;TCF3;PYCARD;PARK7;ARHGEF5
prerank,"wound healing, spreading of cells (GO:0044319)",-0.4224581093934904,-1.3019725466782996,0.1159090909090909,0.5644307352645966,1.0,9/24,17.52%,CD44;ARHGAP35;TMEFF2;TOR1A;MMP12;CD151;COL5A1;FLNA;ACVRL1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.5028307642874349,-1.301906939899527,0.1574279379157428,0.5629912723187697,1.0,7/13,21.22%,KCNT2;KCND3;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNK5
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.5379491268654581,-1.3017660746246917,0.17959183673469387,0.5617752332220082,1.0,3/10,10.06%,SEMA5A;CARMIL1;ACTN2
prerank,protein ubiquitination (GO:0016567),0.27866379156350385,1.3011071013438762,0.01038961038961039,0.6996886530904293,1.0,112/471,17.92%,FBXL18;NFE2L2;HERC2;PJA2;ARRB2;RNF38;KLHL7;FBXL20;VHL;FBXO22;TRIM11;RNF41;ITCH;SPSB1;OTULIN;FBXL15;UBE2H;FBXO24;RNF138;TRIM5;PEX10;SMURF1;PCNA;RNF141;HLTF;UNKL;DTX4;TRIM44;KLHL24;ZSWIM8;SPSB2;ENC1;TRIM36;TRIM72;CTR9;CDC34;CUL4B;PSMD3;TRIM69;ASB4;ARRDC1;ANKRD9;ASB11;OS9;MIB2;ASB5;RNF103;RNF8;AKTIP;KBTBD8;CRBN;BRCA1;KLHL18;DTX1;WWP2;FBXW4;UBC;RPS27A;RNF166;FBXO11;BFAR;WSB1;PSMA7;MSL2;DDB2;TRIM62;FBXL2;UHRF2;AREL1;FBXO21;RNF11;UBE2U;UBE2V2;PINK1;DTX3L;RNF31;RRAGA;ANAPC11;PELI2;MYLIP;PSMB3;DET1;PSMB9;RNF25;TRIM47;FBXL22;LZTR1;PSMC2;MKRN3;RNF187;TNFAIP1;FBH1;MGRN1;RNF144B;FBXL8;CCDC22;TRIM3;PSME4;PSMC1;PSMB7;ZNRF3;TOPORS;TRIM14;TRAF7;FBXL7;USP5;UBE2A;TAF1;KLHL3;RNF4;SYVN1;PSMB5
prerank,C4-dicarboxylate transport (GO:0015740),-0.48739396986553923,-1.300919441448701,0.14065934065934066,0.5624477305647116,1.0,6/14,18.78%,SLC25A30;SLC1A6;SLC1A1;SLC25A18;SLC13A5;SLC25A12
prerank,translational elongation (GO:0006414),0.32911277289687557,1.3006957440823128,0.072,0.699368177149838,1.0,49/101,29.94%,MRPL50;MRPS24;MRPL17;MRPL43;MRPS34;MRPL2;MRPL37;MRPL9;MRPL34;MRPL30;MRPS5;MRPS21;CHCHD1;EEF2K;MRPL13;MRPS18B;MRPS16;MRPS11;NEMF;MRPL11;MRPS10;MRPL38;MRPL54;MRPL41;MRPS28;MRPS35;GTPBP1;TUFM;MRPS18A;MRPL36;DAP3;MRPL20;OXA1L;MRPL27;MRPL45;EEFSEC;LTN1;MRPL10;MRPL49;MRPL14;MRPL32;MRPS25;MRPL46;MRPL19;MRPL15;MRPS17;MRPL21;MRPS18C;PTCD3
prerank,regulation of cell development (GO:0060284),0.40166144068770604,1.3006719230121284,0.12433392539964476,0.6976138944034092,1.0,7/36,15.43%,CX3CR1;HEYL;FBXO22;DLL1;AKT1;HMGB2;HES6
prerank,mitochondrial translation (GO:0032543),0.3270723204630348,1.300392239968972,0.0766721044045677,0.6968109814731602,1.0,48/104,29.94%,MRPL50;MRPS24;MRPL17;MRPL43;MRPS34;MRPL2;MRPL37;MRPL9;MRPL34;MRPL30;MRPS5;MRPS21;CHCHD1;MRPL13;MRPS18B;MRPS16;MRPS11;MTIF2;MRPL11;MRPS10;MRPL38;MRPL54;MRPL41;MRPS28;MRPS35;TUFM;MRPS18A;MRPL36;FASTKD2;DAP3;MRPL20;OXA1L;MRPL27;NOA1;GATC;MRPL45;MRPL10;MRPL49;MRPL14;MRPL32;MRPS25;MRPL46;MRPL19;MRPL15;MRPS17;MRPL21;MRPS18C;PTCD3
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.3231814408226403,-1.3001892675373092,0.06166219839142091,0.562891107582257,1.0,19/90,12.90%,ESRRG;KSR2;CCR2;CD36;FABP4;CEBPB;ZBTB7B;ADIPOR2;PLAC8;IRF4;JAK2;G0S2;PER2;KDM6B;GRB10;THRA;PRDM16;EBF2;ALMS1
prerank,negative regulation of autophagy (GO:0010507),0.3706002261296736,1.2999612556986826,0.09747899159663866,0.69655037847402,1.0,16/54,13.36%,SNRNP70;CPTP;SIRT2;EIF4G1;MET;TAB2;FOXK2;KDM4A;RASIP1;USP36;IL10RA;MTOR;BMF;PINK1;RRAGA;AKT1
prerank,endothelial cell proliferation (GO:0001935),-0.45512658113681886,-1.2999194096228028,0.12633832976445397,0.5620923884220141,1.0,7/17,18.10%,ERN1;SEMA5A;ITGB1BP1;HMOX1;TEK;ACVRL1;BMP4
prerank,atrioventricular valve development (GO:0003171),0.5024568068400171,1.2998635302273425,0.15134099616858238,0.6950579585325913,1.0,8/14,29.74%,TGFBR2;HEYL;MDM4;BMP2;NOTCH1;BMPR1A;BMPR2;ACVR1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5058640377800641,1.2990463450718932,0.16165413533834586,0.696338758734404,1.0,5/13,17.38%,ALG12;ALG6;ALG2;ALG8;ALG11
prerank,hemopoiesis (GO:0030097),0.33999761194656847,1.298596346654791,0.0698051948051948,0.6962194434324118,1.0,17/87,10.54%,SELPLG;TGFBR2;CSF1R;LYL1;FLCN;ARMC6;CD34;WNT2B;ZFP36L2;TNFRSF13B;PLD4;WNT10B;PDGFB;NOTCH4;PLEK;MFAP5;DLL1
prerank,chloride transport (GO:0006821),-0.32695743288395096,-1.2982338270099107,0.07989690721649484,0.5651621523772988,1.0,23/74,17.10%,GABRB1;GABRA3;SLC4A10;GLRA1;SLC12A8;GABRG1;GABRA2;GABRG3;ANO3;SLC12A4;ANO10;GABRB3;SLC12A5;ANO6;SLC26A7;GABRG2;SLC1A1;ANO5;GLRA2;SLC4A8;GABRA5;GABRQ;CFTR
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4591026361561029,-1.2980388164104586,0.14945054945054945,0.5641071007344344,1.0,6/17,17.92%,ANK2;RYR2;NEDD4L;KCNH2;KCNQ1;KCNE3
prerank,cell cycle G2/M phase transition (GO:0044839),0.3179499818137233,1.2972273714455516,0.05,0.6994469067199652,1.0,47/130,24.20%,TUBA4A;DNM2;SDCCAG8;AKAP8;CHEK2;PRKACA;CSNK1E;FBXL15;AKAP8L;ODF2;TUBB;CEP164;TUBG1;HAUS7;CNTRL;CENPJ;TUBA1A;KHDRBS1;CEP63;HAUS2;CEP135;HAUS6;OFD1;FBXL22;CEP57;MAPRE1;AURKA;FBXL8;MASTL;PLK3;KDM8;DCTN2;OPTN;CEP70;FBXL7;CCNY;ACTR1A;CEP43;CCP110;NDE1;PPP1CB;CUL1;AJUBA;DYNLL1;CDC25A;HAUS5;FBXL12
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.33337734861075263,-1.2972144980070484,0.07785888077858881,0.5648620293783461,1.0,28/66,27.13%,MTSS1;NFIB;ROBO1;XDH;APOE;B2M;KLF9;ALOX5;CDC73;CASK;DUSP10;AQP11;NLRC3;RGCC;SFRP1;SNAI2;MCC;SFRP2;CDKN1C;CDK6;PTPRK;MED1;GHRL;MARVELD3;CAV2;TNMD;CNMD;FBXW7
prerank,ncRNA 3'-end processing (GO:0043628),0.5117194808713814,1.296782631427056,0.13857677902621723,0.6992450678051306,1.0,3/14,3.68%,INTS6L;TRNT1;SSB
prerank,glycogen metabolic process (GO:0005977),-0.40730382890862665,-1.2962159646712401,0.11990407673860912,0.5660455154168389,1.0,12/27,18.29%,PRKAG2;GBE1;GSK3B;CALM1;PER2;PHKG1;PGM1;GYG1;PYGM;PGM2L1;UGP2;STBD1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5322354576465849,-1.295481005407438,0.17286652078774617,0.5664038987131127,1.0,5/10,25.36%,RIC1;ANXA2;RGP1;CDK5RAP3;EPHA4
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.4049091501405092,1.29451796759303,0.1413427561837456,0.7060408580212423,1.0,11/37,13.49%,GTF2H2;RFC2;PCNA;CUL4B;UBC;RPS27A;ERCC2;POLD2;DDB2;ERCC4;RFC1
prerank,membrane organization (GO:0061024),-0.27493906517339006,-1.2939792999309028,0.0189873417721519,0.569021261476527,1.0,58/227,18.41%,SGCZ;DAB2;HIP1;ANK3;DNM3;MYOF;DNAJC6;ANK2;SPTBN1;EGFR;TMCC1;SYT1;ACTR3;REEP3;ITSN1;CTTN;SGIP1;AP2A2;LDLR;VAPA;PLEKHA3;SAR1B;CORO1C;NAPA;DNM1L;TOR1A;ACTB;PIK3C2A;CCDC88A;HSPA8;RIMS1;DNM1;ARPC5;SH3GL2;CHRM2;DMPK;REPS1;EPS15;MYADM;KIF20A;SNX9;DYSF;OCRL;ACTG1;REEP4;REPS2;AP2B1;COX18;ARPC2;CTDNEP1;TOR1AIP2;TFRC;CFTR;SYP;CERT1;NUP155;ATP10B;SLC18A3
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.29116456571341603,-1.2937060088445174,0.0449438202247191,0.5682795494283899,1.0,53/125,28.57%,CENPP;KNL1;CENPF;DYNC1I2;NUP98;CENPT;CDCA8;NDC80;SPDL1;ZW10;RAN;DLGAP5;EML1;BIRC5;RPS27;PLK2;CENPE;NUSAP1;SPC25;KNTC1;BUB1B;AURKB;KIF11;TTK;BUB1;MAD1L1;EFHC1;ERCC6L;RCC2;GPSM2;NUP43;TBCE;CENPS;CEP126;CCNB1;SPC24;KIF4A;DCTN6;MAD2L1;KIF2C;CENPC;PLK1;NUF2;PAFAH1B1;DYNC1I1;SKA1;AHCTF1;MECP2;NEK9;PCNT;CENPN;DYNC1H1;STIL
prerank,Golgi to endosome transport (GO:0006895),0.48850845976792023,1.2935336737609124,0.15495495495495495,0.7078856031509035,1.0,8/16,22.56%,AP2A1;SORT1;MON2;DOP1B;AP4M1;VPS13C;KIF16B;SYS1
prerank,amide transport (GO:0042886),-0.4089093563267912,-1.2934789941589637,0.1352549889135255,0.5674641891536689,1.0,13/26,24.50%,DISP1;PLTP;PLEKHA3;TAP1;SLC14A1;AQP11;SLC46A1;CERT1;SLC14A2;SLC5A6;ABCB9;FOLR2;FOLR1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3686619705489779,-1.293421867755017,0.1188118811881188,0.566065875228513,1.0,12/41,11.29%,ITPR1;GRIN2A;HTR2C;SLC8A3;RYR2;RYR3;GRIN2B;SLC24A2;HTR2B;PKD2;GRIN2D;ERO1A
prerank,sodium ion import across plasma membrane (GO:0098719),0.4796516687000041,1.2932418130114445,0.15949820788530467,0.707105778427664,1.0,3/17,6.14%,SLC9A9;SLC8A1;TRPM4
prerank,regulation of microtubule polymerization (GO:0031113),0.3930643090860956,1.2930510889706095,0.11837455830388692,0.7060862567554571,1.0,12/40,19.94%,NAV3;RAC1;NUMA1;CAMSAP1;MET;CAMSAP2;ABL1;MAPRE1;FES;DYRK1A;CLIP3;MAPT
prerank,positive regulation of calcium ion transport (GO:0051928),-0.37553675377031087,-1.2930007189544763,0.11697247706422019,0.5656260469267876,1.0,10/36,15.19%,ANK2;ATP2B1;CCR1;CCL4;TRPC3;STIM2;CCL2;FFAR1;LILRA5;CCL5
prerank,regulation of viral entry into host cell (GO:0046596),-0.3934815006913803,-1.2928641426455363,0.12095032397408208,0.5644528466511229,1.0,6/30,4.26%,CD74;HS3ST5;CIITA;GSN;IFITM3;MID2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.34976058176727354,1.2927756932891878,0.081377151799687,0.7053661252091562,1.0,11/77,5.85%,CX3CR1;TGFBR1;ITGA6;CFLAR;ITGAV;CSNK2A2;CSNK2A1;SRC;CLU;NDUFS3;ZMYND11
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3777306810264866,-1.2924051696734373,0.09176470588235294,0.5641546059119281,1.0,11/39,10.63%,LTV1;SNU13;RIOK1;RPS7;NOB1;RIOK3;RPS14;RPS27;MRPS7;RPS25;RPS15
prerank,embryonic appendage morphogenesis (GO:0035113),0.52061838150832,1.2923748029513602,0.17523809523809525,0.7051880936262458,1.0,5/12,23.09%,SKI;SHH;FBXW4;PTCH1;MBNL1
prerank,triglyceride biosynthetic process (GO:0019432),0.4699350296732983,1.2921864666364358,0.16058394160583941,0.7040895013511322,1.0,5/18,7.57%,AGMO;LPIN2;DGAT1;MOGAT2;MOGAT1
prerank,nuclear pore complex assembly (GO:0051292),-0.5461986138850055,-1.291671263298312,0.17364016736401675,0.5644856195873998,1.0,3/10,10.08%,RTN4;NUP98;NUP205
prerank,homotypic cell-cell adhesion (GO:0034109),0.3872112720351611,1.2915562714694084,0.11205432937181664,0.7047610884490488,1.0,11/39,16.37%,P2RY12;FERMT3;STXBP1;PIK3CG;UBASH3B;PIK3CB;PLEK;TJP2;MYH9;DSC2;MEGF10
prerank,synaptic vesicle cycle (GO:0099504),-0.39706874493407185,-1.2912517577186589,0.13513513513513514,0.5641452072573425,1.0,9/30,12.83%,NLGN1;SYT10;SYNDIG1;PCLO;CPLX2;RIMS1;SNAP25;RAB3A;SNCA
prerank,DNA double-strand break processing (GO:0000729),0.4625152985742773,1.290852942277928,0.15425531914893617,0.705702829947748,1.0,7/18,12.24%,RNF138;ATM;NBN;SLX4;BRCA1;BLM;UBE2V2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.4102751839878096,-1.290724689767119,0.11737089201877934,0.5640029079703005,1.0,9/26,11.29%,ITPR1;HTR2C;RYR2;RYR3;LETM1;HTR2B;SLC8B1;PKD2;ERO1A
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4534044956465783,-1.2904956750071812,0.14412416851441243,0.5631383937584056,1.0,11/19,33.59%,RFX3;AQP4;CFAP53;SPEF2;NPHP3;SPA17;DNAAF1;CCDC39;DNAAF4;ROPN1L;ODAD4
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5512598138937658,1.2900304452970721,0.18018018018018017,0.7071552223208689,1.0,3/10,12.21%,CX3CR1;SMARCD3;DRD2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.48027755995703986,1.2894052440558847,0.1684981684981685,0.7079224688359373,1.0,5/17,16.29%,LIPC;LMF1;SORT1;APOH;NR1H2
prerank,lysosome organization (GO:0007040),0.39705418911021095,1.2889972507213745,0.10956521739130434,0.7077608359867413,1.0,15/36,24.24%,HPS4;HOOK2;ARSB;MYO7A;AKTIP;CLN3;MTOR;MBTPS1;ACP2;ACP4;ABCA1;GAA;HPS1;HOOK3;TMEM106B
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3841920289048808,1.2887396270581393,0.13245033112582782,0.706877853876713,1.0,14/42,19.99%,AARS2;CARS2;KARS1;NARS1;RARS1;DARS2;EPRS1;QARS1;FARSA;SARS2;SARS1;WARS2;MARS2;AIMP1
prerank,cellular response to amino acid starvation (GO:0034198),0.3512329620805663,1.2886318653467221,0.09020217729393468,0.705531519113631,1.0,20/71,15.66%,ATP6V0B;EIF2S1;FLCN;IMPACT;TCIRG1;LAMTOR2;SEC13;SH3GLB1;LAMTOR5;MLST8;WDR24;RPTOR;ATP6V1D;MTOR;RRAGA;GCN1;SEH1L;EIF2AK2;ATP6V0E2;SESN1
prerank,cellular response to alcohol (GO:0097306),-0.3629603820682341,-1.2883888535331265,0.11650485436893204,0.5676103400117652,1.0,16/42,17.10%,CTNNA1;ADCY2;ADCY5;GLRA1;KLF9;ADCY3;ADCY8;GOLPH3;LRP6;AHR;GNAI1;CDH1;GLRA2;CTNNB1;SFRP1;CFTR
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5061310267480077,1.2879350980854383,0.17765567765567766,0.7063525746643414,1.0,3/13,13.63%,NELFB;RNF8;NELFE
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.30510394831124127,1.2872439281287473,0.04817518248175182,0.707109841943083,1.0,34/172,12.86%,INPP5D;LIPH;PLD1;LPCAT2;PCTP;PI4KB;LPIN2;CSNK2A2;CSNK2A1;LPCAT4;PIK3R1;PLCG2;PLD2;PIK3CG;INPP4B;RAB4A;PLA2G5;PLA2G4B;PIK3CB;INPP5E;CHKB;PLA2G4A;CDS1;CLN3;PIK3CD;PIK3C3;PLEKHA4;DGKD;GPD1;IMPA1;MTMR4;PGS1;PITPNM1;BMX
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.46037260032006305,1.2871943218373691,0.15837937384898712,0.7055618483715478,1.0,3/19,3.05%,CX3CR1;CPTP;PYDC1
prerank,negative regulation of receptor binding (GO:1900121),-0.5338265565311816,-1.2868494417942982,0.1462882096069869,0.5705494747360168,1.0,3/10,11.08%,B2M;ATP2A2;ATP2A3
prerank,positive regulation of T cell proliferation (GO:0042102),0.3595102690299751,1.2866556203009574,0.08623548922056384,0.7058096193457438,1.0,11/55,9.16%,IL18;CCDC88B;AIF1;AGER;EBI3;NCKAP1L;TNFRSF13C;IL6ST;PDCD1LG2;IL12B;CD86
prerank,regulation of interleukin-10 production (GO:0032653),0.3846646413752224,1.2863396644652072,0.1152542372881356,0.7053174656281976,1.0,10/44,10.54%,VSIR;LGALS9;AGER;TLR4;PLCG2;TNFRSF21;CD34;PDCD1LG2;IL12B;DLL1
prerank,muscle cell differentiation (GO:0042692),-0.39095274654085466,-1.285929522747529,0.1310344827586207,0.5718092746531921,1.0,5/32,6.20%,SGCZ;DMD;NINJ1;NEBL;SYNE1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.37959831212939865,-1.2855895417957772,0.09615384615384616,0.5712797594893037,1.0,10/39,8.63%,ANK2;UTRN;FGF12;YWHAE;NEDD4L;FXYD5;HOMER1;PTPN3;CHRM3;TCAF1
prerank,mRNA processing (GO:0006397),0.28609897747032753,1.285113705930544,0.03337969401947149,0.7080513654203007,1.0,84/287,23.30%,SRRM1;SNRNP70;SON;POLR2H;SRRT;PRKACA;NCBP1;DDX5;RBM19;GTF2H2;SNRPA;CSTF2;AKAP8L;HNRNPA3;SF3B2;SF3B1;HNRNPC;SNRPC;ZMAT2;POLR2D;SNRPF;SRSF5;FUS;RNMT;DHX38;SRRM2;PABPN1;RBM14;POLR2J;SART3;CPSF1;CWC25;U2AF2;HNRNPH1;SNRNP48;GEMIN6;RBM17;ERCC2;PCBP2;DHX9;HNRNPR;SNRPA1;TRA2B;SNRPN;U2AF1L4;ALYREF;RBM8A;METTL14;SLU7;CCAR1;DDX39B;TRA2A;SRSF9;PCF11;SF3A1;GEMIN2;BUD13;ALKBH5;RBMX;PRPF3;THOC6;LSM7;FIP1L1;DDX46;SNIP1;PNN;WBP4;POLR2E;PRPF4;POLR2I;NOVA2;SYF2;SNRNP25;HNRNPH3;RBM4;HNRNPUL1;SNRNP40;LSM8;CD2BP2;HNRNPA2B1;MAGOHB;MAGOH;ZC3H11A;THOC3
prerank,regulation of chromosome organization (GO:0033044),-0.4218499099658484,-1.2848719126866752,0.15631691648822268,0.5718577700964491,1.0,10/22,20.91%,MYC;SMG6;LIG4;XRCC5;BUB1;SMG5;UPF1;PIF1;SETMAR;SMG1
prerank,generation of neurons (GO:0048699),-0.28024856932073483,-1.28486980379712,0.024464831804281346,0.5703229043829684,1.0,47/190,17.11%,AUTS2;PTPRD;CDKL5;NRCAM;ADGRL3;GPM6A;SPOCK1;NAV1;MAP1B;TAFA1;IL1RAPL1;SNPH;ASTN2;NTRK2;FUT9;RAPGEF2;ACSL3;SOX11;RACGAP1;NR4A2;SH3RF1;EML1;MYT1L;RUNX2;WNT4;DCDC2;PER2;ERCC6;POU3F2;TUBB2A;DDIT4;EN2;IRX5;PLXNB2;DTNB;LRP12;CTNNB1;RELN;MTPN;MDGA1;SMARCA1;CX3CL1;HEY2;WNT9A;BRSK1;POMGNT2;ASTN1
prerank,response to chemokine (GO:1990868),0.5087731888334736,1.2848452958452374,0.1377952755905512,0.7072734114468963,1.0,4/13,13.94%,DOCK8;LRCH1;WNK1;STK39
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.38427768784266875,1.2848114676167508,0.10385259631490787,0.705682537713595,1.0,17/41,27.73%,DAGLB;PTGS1;ALOXE3;PLA2G4B;PLA2G4A;FADS1;PTGR1;SCD;ABCD1;GPX4;ACOT8;DAGLA;SCP2;SCD5;EPHX1;FADS2;ACOX1
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.33145671859213066,-1.2847544215557267,0.08,0.5691109893073045,1.0,23/65,20.32%,KCND2;NPEPPS;SUV39H1;SLC8A3;SCN2A;LMNA;SIRT1;MYC;HIPK2;OPRD1;TIGAR;EGLN3;RGCC;AK4;SFRP1;UBQLN1;HMOX1;CARD16;MDM2;SUV39H2;CPEB4;TSC1;TERT
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5268210298392308,-1.2842588849496925,0.1731958762886598,0.569089103323659,1.0,6/10,24.28%,DSE;PXYLP1;B3GAT2;CSGALNACT2;CSGALNACT1;XYLT1
prerank,endothelial cell development (GO:0001885),-0.4176112392672358,-1.2839627406940934,0.13272311212814644,0.5684652284333256,1.0,12/25,26.66%,PDE4D;RAPGEF2;MARVELD2;MYADM;MSN;PDE2A;PECAM1;ICAM1;EZR;PPP1R16B;TNMD;CNMD
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5446826588614307,1.2839477073288155,0.1712707182320442,0.7071209574330758,1.0,3/10,6.23%,TGFBR2;LRP5;SHH
prerank,double-strand break repair (GO:0006302),0.3054480452219348,1.2838748858607851,0.05822416302765648,0.7056845983464951,1.0,47/158,21.46%,SUMO1;ZFYVE26;HERC2;IFFO1;CHEK2;MTA1;RNF138;SPIDR;ATM;RAD54B;POLN;NBN;SLX4;SWSAP1;RAD51B;EYA3;RNF8;BRCA1;TNKS1BP1;DCLRE1B;DCLRE1C;KDM4A;ABRAXAS1;SMARCA5;ERCC4;BLM;HPF1;UBE2V2;AP5Z1;DTX3L;MORF4L1;CIB1;FBH1;HMGB2;BABAM1;DCLRE1A;PALB2;BAZ1B;APTX;MAPK8;RPA3;XRCC6;CDCA5;NABP1;YY1;RAD51C;KDM2A
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.41117864832361084,1.283759741488449,0.1408199643493761,0.7044256139549007,1.0,10/29,25.73%,BAG6;STAG3;KASH5;TEX12;PRDM9;MAJIN;ZCWPW1;SYCP2;SYCE2;HORMAD1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5089701195864725,1.2834575951108789,0.18484288354898337,0.7037799293637396,1.0,4/13,15.65%,IL18;IL12B;AXL;TICAM1
prerank,positive regulation of cell division (GO:0051781),-0.3689380801347374,-1.2830799223932916,0.11138613861386139,0.5694319047891624,1.0,9/38,9.91%,CUL3;KIF23;CDC42;RACGAP1;PKP4;HTR2B;GIPC1;KIF14;AURKB
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5199867481504267,1.2829516480589171,0.16448598130841122,0.7038715455529607,1.0,6/12,26.87%,SOX8;PAX2;NOG;SMO;AGT;SOX9
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4321603346425339,-1.282522051851565,0.14977973568281938,0.5694964021531566,1.0,4/20,3.38%,PDE4D;ADRA1A;ZDHHC21;RAPGEF2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.31646507614107683,-1.2820757730673646,0.06036745406824147,0.5692290142454799,1.0,14/80,7.52%,NLGN1;EPS8;AUTS2;GPM6A;HTT;ARHGAP35;ACTR3;TENM2;ABI2;PALM;CDC42;RIPOR2;FAM98A;CCDC88A
prerank,response to calcium ion (GO:0051592),-0.30130033330637473,-1.281476801939372,0.05929919137466307,0.5693120777739454,1.0,39/102,25.45%,NLGN1;IQGAP1;SYT1;KCNMB2;RYR2;RYR3;CPNE8;KCNH1;CARF;SYT10;HOMER1;ALOX5AP;TRPC3;RASGRP2;CPNE4;CALM1;ADCY8;PKD2;SLC25A24;KCNMB4;CHP2;KCNIP2;CRHBP;SYT3;TRPV6;HPCA;SLC25A12;PRKAA1;ALOX15;CPNE6;KCNMB3;NEUROD2;CPNE2;PEF1;ITPR3;CASQ2;KCNMB1;PPIF;SYT5
prerank,melanocyte differentiation (GO:0030318),0.5334014313474646,1.281472281784917,0.19593345656192238,0.7076539090189891,1.0,2/11,1.94%,LRMDA;MEF2C
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.5169556666505242,-1.2811590791857002,0.16228070175438597,0.5686775437614199,1.0,6/11,20.68%,STK26;PRKN;UBQLN1;LANCL1;FYN;REST
prerank,brain morphogenesis (GO:0048854),-0.4975213539984802,-1.2806735511396425,0.17473684210526316,0.5685475663748492,1.0,8/12,27.11%,CTNNA2;SHANK3;VPS51;SPEF2;BBS4;FBXW11;PAFAH1B1;MKKS
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4687908133286782,1.2803909540577414,0.15771230502599654,0.7100219182232498,1.0,4/18,6.10%,SMAD3;LGALS9;ITGAV;CD34
prerank,inositol lipid-mediated signaling (GO:0048017),0.36931865890047677,1.2799965849674697,0.11896551724137931,0.7097852346735846,1.0,12/50,10.36%,ADAP2;CSF1R;PLCL1;PI4KB;GAB2;PIK3R1;IGF1R;PIK3CG;PLCL2;PIK3CB;PIK3CD;PIK3C3
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.4735070562453764,-1.2797841802340122,0.1728395061728395,0.5696315458078118,1.0,4/14,8.84%,IRS1;SIRT1;SLC45A3;PTPN2
prerank,protein sumoylation (GO:0016925),0.3730560240248773,1.279777578488852,0.12794612794612795,0.7089040744777874,1.0,15/49,16.94%,SUMO1;UBA2;RANBP2;STX1A;NUP42;TRPM4;NUP35;NUP50;PIAS2;PIAS3;SEH1L;NUP62;NUP107;TOPORS;NUP88
prerank,determination of heart left/right asymmetry (GO:0061371),0.37859502483826735,1.2783099304819812,0.1353637901861252,0.7126960107615284,1.0,11/43,17.06%,TGFBR2;MEF2C;SHH;SOX17;TBX6;NDRG4;DLL1;CCDC40;VANGL2;SMO;ENG
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3088198886254114,-1.2779940672506875,0.049315068493150684,0.5732416721373635,1.0,25/93,16.17%,DMD;CD44;PDE4D;BDNF;EGFR;APP;LATS1;NCK2;CREBL2;NTRK3;NLRP2B;SPTBN4;RAF1;INPP5J;OPRD1;IRGM;AXIN1;HSP90AB1;DDIT4;SNCA;PAK1;NSD1;PAQR3;CAPRIN2;TFRC
prerank,positive regulation of embryonic development (GO:0040019),-0.4446726350559521,-1.277939214078177,0.14479638009049775,0.5719042068535227,1.0,8/19,24.16%,PLCB1;B4GALT5;WNT4;TENM4;SCX;NR2C2;NIBAN2;RACK1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.30938356328077093,1.2779213207229625,0.0593607305936073,0.7123710707079182,1.0,37/149,17.78%,CX3CR1;IL18;ARHGEF2;CAPN3;LGALS9;CFLAR;AGER;CRNN;TLR4;TRAF5;IRAK2;RIPK2;TRIM5;RPS6KA5;TRADD;CLU;TAB2;EDA2R;LAMTOR5;UBC;RPS27A;MTDH;DHX9;TRIM62;PRKCB;RNF31;CIB1;RNF25;EIF2AK2;NLRP3;FLOT2;RPS6KA4;TICAM1;TRIM14;PIDD1;AIM2;NOD2
prerank,cell-matrix adhesion (GO:0007160),-0.3029953292161384,-1.2768884873020039,0.07588075880758807,0.5734591555354485,1.0,39/95,25.27%,SORBS1;ITGA4;LYVE1;CD44;MKLN1;PPFIA2;ITGAL;CTTN;SIGLEC1;ADAMTS12;ITGB7;FN1;TRIP6;THSD1;COL13A1;ACTN2;VCAM1;THY1;ITGB1BP1;TIAM1;ITGA8;ITGB6;RCC2;PEAK1;ITGA11;ANGPTL3;TNN;ITGBL1;CD96;TSC1;ITGB1;ITGA10;CD63;PTPRK;PKD1;PARVG;DDR1;OTOA;WHAMM
prerank,response to growth factor (GO:0070848),0.3834821684577243,1.2768076789860543,0.1232876712328767,0.714900108940432,1.0,13/41,22.16%,TGFBR1;TGFBR2;TWF2;TBC1D7;PDGFB;PLK5;CIB1;AKT1;MAPK7;NOS1;ACVR2B;HTRA2;STAT5B
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.46675840451888956,-1.2767392598724152,0.17073170731707318,0.5724011955486049,1.0,4/15,6.80%,NLGN1;SYN3;ADRA1A;CNTNAP4
prerank,lipid droplet organization (GO:0034389),0.44249221550673457,1.2766381808142067,0.1494661921708185,0.7138178763051267,1.0,5/22,12.54%,PPID;RAB3GAP1;CDS1;AUP1;BSCL2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.4122141569566612,1.2763777409328991,0.15732368896925858,0.7130775290532566,1.0,6/29,7.73%,ITGAM;CADM1;CYRIB;RAET1E;NOS2;IL12B
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.48240637212629095,1.2758688463336483,0.1564748201438849,0.7133912551977626,1.0,6/15,16.10%,FAM98B;CSTF2;CPSF1;TSEN2;TSEN54;RTCB
prerank,heterochromatin assembly (GO:0031507),-0.42590781117772925,-1.2755803692444387,0.16263736263736264,0.5740829738600884,1.0,8/20,18.19%,SUV39H1;SIRT1;HELLS;CDKN2A;BAHD1;HDAC1;H3-3A;BAZ2A
prerank,cellular response to lipopolysaccharide (GO:0071222),0.32630407376764475,1.2747684026712651,0.08229813664596274,0.7155873260050163,1.0,32/101,22.71%,CX3CR1;IL18;SIRPA;MEF2C;TLR4;LYN;CASP1;SBNO2;CTR9;PABPN1;PDCD1LG2;CXCL1;CD86;MTDH;TICAM2;AXL;MAPK14;NLRP3;HMGB2;TNIP2;TICAM1;CCR5;NOD2;MAPK8;PYCARD;SHPK;MYD88;CXCL10;SERPINE1;PDCD4;IL36G;TRAF6
prerank,negative regulation of lyase activity (GO:0051350),-0.4595461198789968,-1.2744543914257747,0.16339869281045752,0.5759046992103061,1.0,4/16,6.07%,CCR2;GABBR2;PALM;EDNRB
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.49013226568960316,-1.274202897850931,0.17124735729386892,0.5750966013602035,1.0,3/13,6.92%,ANK3;PDE4D;CALM1
prerank,regulation of protein ubiquitination (GO:0031396),0.3266157512943955,1.2737591257117686,0.07644305772230889,0.7176035637310717,1.0,20/108,14.20%,IVNS1ABP;TGFBR1;SENP2;SMAD7;ARRB2;RIPK2;TBC1D7;SPRY2;NDFIP2;KLHL40;BRCA1;U2AF2;XIAP;USP4;PINK1;HDAC8;AKT1;PTTG1IP;PHF23;FANCI
prerank,cellular response to nitrogen compound (GO:1901699),0.44684044362248665,1.2736708876721443,0.1592128801431127,0.7162950260487287,1.0,11/20,32.05%,EPG5;SPIDR;BLM;ROCK2;RTF2;NSMCE3;DDX11;ATP2B4;ATRX;DDI2;PDE12
prerank,regulation of hemopoiesis (GO:1903706),0.5432529855934897,1.2735239699198433,0.1875,0.7151097845641624,1.0,3/10,14.11%,MYSM1;PRKCB;RUNX1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.44810142016241417,-1.2730628314999721,0.15402298850574714,0.5768706252295436,1.0,5/19,11.72%,DLG2;LRRC7;DLG3;PATJ;MTCL1
prerank,histone H3-K4 trimethylation (GO:0080182),0.5410145750260333,1.272902120142737,0.170873786407767,0.7157753251076916,1.0,3/11,8.64%,KMT2D;CTR9;TET3
prerank,positive regulation of endopeptidase activity (GO:0010950),0.42190315892592833,1.2728593299897353,0.12681159420289856,0.7142724386661847,1.0,14/26,24.85%,VSIR;AGER;LYN;PICALM;PSENEN;ROCK2;APH1B;USP50;AIM2;PYCARD;EFNA1;EFNA3;MEFV;APH1A
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.544421217909613,1.272631169098308,0.1894353369763206,0.7134353060640959,1.0,3/10,5.42%,VHL;SIRT2;IMPACT
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4382822026177532,1.272367661598903,0.14207650273224043,0.7127599676075557,1.0,10/21,21.34%,FOXJ2;MEF2D;MMP2;PDGFB;LDLRAP1;GJA1;ADAMTS1;JUN;P2RY6;MFN2
prerank,negative regulation of metabolic process (GO:0009892),0.3584427828104394,1.2723515407356483,0.11993243243243243,0.7111793703138365,1.0,18/54,20.52%,PLCL1;PCTP;DDIT3;TLR4;LAMA4;ID1;TFE3;FLCN;PLCL2;WNT10B;ABHD6;NRDC;NR1H2;IP6K1;ZDHHC7;ADAM17;NOVA2;ACVR2B
prerank,positive regulation of ruffle assembly (GO:1900029),-0.4974341007921701,-1.2722603978239522,0.16186252771618626,0.5777682450346288,1.0,3/13,7.18%,NLGN1;EPS8;FAM98A
prerank,tryptophan metabolic process (GO:0006568),-0.5178720497618892,-1.2721764705982739,0.18398268398268397,0.5765252500949287,1.0,4/11,24.16%,ATP7A;KMO;IDO2;KYAT1
prerank,modulation by symbiont of host process (GO:0044003),-0.5373925119071349,-1.2720566876740964,0.1853448275862069,0.5753847662112669,1.0,2/10,2.63%,MRC1;B2M
prerank,neuron projection regeneration (GO:0031102),0.5317387326168537,1.27164807039187,0.1945945945945946,0.7121214140705983,1.0,2/10,6.38%,RTN4RL1;NREP
prerank,embryonic skeletal system development (GO:0048706),-0.3720856621186038,-1.2713721879060287,0.13875598086124402,0.575890628208757,1.0,18/35,33.81%,SULF2;HOXC4;PCSK5;HOXC9;SOX11;COL1A1;HOXB3;RBP4;WNT9A;HOXB4;XYLT1;KIAA1217;HOXD4;FUZ;WNT11;HOXA4;ALX1;MEGF8
prerank,negative regulation of interleukin-1 production (GO:0032692),0.43067557100546106,1.2707022478298693,0.15586690017513136,0.7138664737089204,1.0,6/23,16.32%,CX3CR1;CPTP;PYDC1;CEACAM1;NLRP3;CD33
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4231506629848078,1.270348633881104,0.16129032258064516,0.7136404852622971,1.0,9/26,22.46%,SPTLC3;ACER3;ACER2;ASAH1;NOS2;AKT1;NQO1;NOS1;SPR
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3433008130566759,1.26945731723017,0.09317803660565724,0.7152891772358558,1.0,11/74,9.84%,TGFBR1;LDLRAD4;TGFBR2;GREM1;SMAD3;SMAD7;TGFB1I1;SPRY2;OVOL2;PHLDB1;GCNT2
prerank,lymphocyte differentiation (GO:0030098),0.3503649951454367,1.2690048045952504,0.09136212624584718,0.7152992385071855,1.0,20/68,20.00%,IKZF1;BLNK;LYL1;DNAJB9;RHOH;PLCG2;GPS2;CHD7;JAG2;PIK3CD;AXL;CEBPG;GATA3;GPR89A;GPR89B;PTPRJ;HDAC5;TCF3;CD79A;ADAM17
prerank,regulation of neurogenesis (GO:0050767),0.3585299147529504,1.2687232151388272,0.1284246575342466,0.7147263936562765,1.0,11/55,15.43%,CX3CR1;NUMB;HEYL;TGM2;PAX6;GPER1;RGS14;DLL1;SERPINF1;HMGB2;HES6
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.30898091014953916,1.267762494133306,0.06584992343032159,0.7166784359035772,1.0,33/148,15.45%,NUAK1;RHNO1;CHEK2;CSNK2A2;CSNK2A1;RFC2;RFFL;ATM;PDPK1;RAD17;NBN;CHD3;EHMT2;PIP4P1;POU4F1;PRDM1;BRCA1;MLST8;TAF6;TAF12;BOP1;MDM4;RAD1;BLM;EXO1;MTOR;MAPK14;PHF20;AKT1;TAF4;TOP3A;AURKA;PLK3
prerank,T cell activation (GO:0042110),-0.32497175353039337,-1.2671699505518874,0.08808290155440414,0.5864814009766667,1.0,31/69,27.73%,CD74;CD44;DPP4;NCK2;PTPN22;IRF4;JAML;LFNG;PTPN2;CD2;ICOSLG;MSN;KIT;NLRC3;CTPS1;TNFRSF4;ITK;CD3E;FOXP3;EIF2AK4;CRTAM;DLL4;IL2;CD8B;LCK;CD4;CCL19;RASGRP1;CD8A;CD276;SLA2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.36803908268512175,1.267004614629184,0.12436974789915967,0.7177388069716312,1.0,10/46,10.63%,SIRPA;CNKSR3;TLR4;LYN;SPRY2;FLCN;GPER1;RGS14;PTPN1;DUSP29
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.3436284996232736,-1.2668211899946222,0.10628019323671498,0.5859897667578847,1.0,19/53,24.43%,HTR2C;CCR1;HRH1;HTR2B;HTR1D;CHRM3;CHRM2;OPRM1;OPRD1;CCL2;HTR4;HTR6;TSHR;CNR2;HTR1F;LPAR3;XCR1;HRH3;PTGIR
prerank,response to glucose (GO:0009749),0.3730858120439261,1.2667803134827513,0.13541666666666666,0.716930498988625,1.0,15/46,19.31%,PRKACA;IGF1R;PFKL;EIF2B3;SLC30A8;GPER1;EIF2B4;TRA2B;PAX2;KHK;SELENOT;THBS1;PCK2;TCF7L2;KCNB1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.43800275228976615,1.2667611029503345,0.16258741258741258,0.7154054961148444,1.0,7/22,13.27%,SSH2;TWF2;PRKCD;CYRIB;SSH1;HIP1R;PFN4
prerank,purine nucleotide catabolic process (GO:0006195),-0.4798338524040174,-1.2664835562614811,0.15973741794310722,0.5854530321642213,1.0,3/13,8.19%,XDH;GDA;HINT1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.35299207669029603,-1.266362178646612,0.1111111111111111,0.584309400213396,1.0,13/48,18.73%,ROBO1;PPARG;STAP1;SLIT2;PELI3;PARP14;NLRP2B;PTPN2;TTLL12;SAMHD1;OAS3;CARD16;GSTP1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3399378602795047,1.265993333185441,0.11185308848080133,0.7167305409856372,1.0,18/66,17.78%,CX3CR1;SIRPA;LGALS9;AGER;TLR4;RIPK2;CPTP;PYDC1;CASP1;CCR7;ORM2;GBP5;NLRP3;USP50;CD33;EGR1;AIM2;NOD2
prerank,positive regulation of nuclear division (GO:0051785),0.4203158769372002,1.2659806941562237,0.16308243727598568,0.7151677077939121,1.0,6/25,15.95%,LRP5;SIRT2;EDN3;PDGFB;AURKA;NUP62
prerank,protein localization to cell-cell junction (GO:0150105),0.48897320337210026,1.2658538875946383,0.1846435100548446,0.7140416040061124,1.0,4/15,10.12%,F11R;DSP;TJP1;TJP2
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5413892163575204,1.265135536239205,0.17723880597014927,0.7150397979392957,1.0,7/10,34.30%,IMPACT;ERRFI1;ENG;TESK1;MVP;CHP1;ENPP1
prerank,calcium import into the mitochondrion (GO:0036444),-0.524354957375485,-1.264692168563698,0.19654427645788336,0.5876024848977481,1.0,4/10,13.64%,MCU;MCUB;MICU2;MICU3
prerank,rRNA metabolic process (GO:0016072),-0.28223666252095775,-1.264233512876741,0.06267029972752043,0.5874908225007754,1.0,39/160,14.38%,DEDD2;RPL30;RPL36A;UTP20;RPL35A;DDX10;SNU13;LAS1L;RPL4;WDR18;RPS7;RPS2;RPL41;RPL7A;RPLP2;XRN2;NOB1;POP4;RPL38;RPL18A;EXOSC1;RPS14;RPS27;RPL13A;RPL26;MRTO4;RPL22;ESF1;RPS25;RPS15;NOC4L;DCAF13;RPL8;RPL23A;EXOSC7;RPLP1;RPL37;UTP15;UTP14A
prerank,regulation of chemotaxis (GO:0050920),0.4124039356058977,1.2642138630321027,0.1559633027522936,0.7167189993946373,1.0,8/30,17.48%,P2RY12;AIF1;CYRIB;ZSWIM8;PDGFB;STX4;THBS1;ZSWIM4
prerank,negative regulation of cyclase activity (GO:0031280),-0.47417383603094054,-1.2640859319498086,0.183585313174946,0.5863853965697395,1.0,4/14,6.07%,CCR2;GABBR2;PALM;EDNRB
prerank,regulation of ion transport (GO:0043269),-0.31471209171311154,-1.2639949847604846,0.08174386920980926,0.5850950451931334,1.0,17/76,12.83%,NKAIN2;ANK3;SYT1;B2M;KCNJ3;SYT10;NEDD4L;TOR1A;PRKN;KCNJ6;SPTBN4;CHRNA4;SIK1;PER1;ATP1A1;DTNBP1;SNCA
prerank,cellular response to calcium ion (GO:0071277),-0.3229626226255424,-1.2637089912973192,0.09278350515463918,0.584366258925906,1.0,14/67,9.15%,NLGN1;IQGAP1;SYT1;RYR3;CPNE8;KCNH1;CARF;SYT10;ALOX5AP;RASGRP2;CPNE4;ADCY8;PKD2;SLC25A24
prerank,response to amino acid starvation (GO:1990928),0.34314381421097845,1.2634194167050865,0.0998439937597504,0.717959390381968,1.0,20/72,15.66%,ATP6V0B;EIF2S1;FLCN;IMPACT;TCIRG1;LAMTOR2;SEC13;SH3GLB1;LAMTOR5;MLST8;WDR24;RPTOR;ATP6V1D;MTOR;RRAGA;GCN1;SEH1L;EIF2AK2;ATP6V0E2;SESN1
prerank,heme biosynthetic process (GO:0006783),0.43520621932302117,1.263068132132608,0.16404886561954624,0.7175975403733191,1.0,12/22,31.38%,PPOX;HMBS;FECH;NFE2L1;TSPO;UROD;ATP5IF1;PGRMC1;CPOX;ALAS2;ABCG2;ALAD
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.39251361022206566,1.2624932206254036,0.14311270125223613,0.7181740880227658,1.0,6/34,11.91%,SASH3;DNAJB9;PHB2;SLC7A5;CD86;STX4
prerank,positive regulation of lipid transport (GO:0032370),-0.4974814478355921,-1.2621583165014754,0.17872340425531916,0.5873770551605205,1.0,3/12,9.54%,APOE;SPP1;PRELID1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.4213233322674421,-1.2621543094612149,0.15570175438596492,0.5859342738429084,1.0,7/20,8.20%,MCU;SLC8A3;PARL;LETM1;SLC8B1;MCUB;MICU2
prerank,cellular response to ketone (GO:1901655),-0.3723599674915036,-1.261890062831296,0.14153132250580047,0.5852578004734406,1.0,13/35,17.10%,ADCY2;ADCY5;SPP1;KLF9;ADCY3;ADCY8;GOLPH3;MSN;AHR;GNAI1;NR3C1;SFRP1;CFTR
prerank,rRNA processing (GO:0006364),-0.2807849647169889,-1.2618424447429815,0.05763688760806916,0.5839299774433899,1.0,42/172,14.38%,RPL30;RPL36A;UTP20;RPL35A;DDX10;SNU13;RIOK1;NSA2;LAS1L;RPL4;WDR18;RPS7;RPS2;RPL41;RPL7A;RPLP2;XRN2;NOB1;RIOK3;POP4;RPL38;RPL18A;EXOSC1;RPS14;RPS27;RPL13A;RPL26;MRTO4;RPL22;ESF1;RPS25;RPS15;NOC4L;DCAF13;RPL8;RPL23A;EXOSC7;RPLP1;RPL37;ERI1;UTP15;UTP14A
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5141657210017861,-1.2612206062535842,0.20382165605095542,0.5843218060319182,1.0,5/10,9.70%,RAPGEF2;GIPC1;MFSD12;ATP7A;ZEB2
prerank,amino acid import (GO:0043090),0.4431288151445275,1.2608895961377184,0.14835164835164835,0.7223538257900228,1.0,5/21,7.99%,SLC7A8;SLC1A3;SLC36A1;SLC7A5;SLC22A2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3452193961705526,1.2607889978615934,0.1218274111675127,0.7211627910894999,1.0,13/63,9.62%,SASH3;IL18;CCDC88B;AIF1;MEF2C;NCKAP1L;TNFRSF13C;CD320;IL6ST;PDCD1LG2;IL12B;CD86;TNFSF13B
prerank,sphingolipid metabolic process (GO:0006665),0.31774192742106244,1.2604406184465142,0.0784,0.7207550899607829,1.0,26/108,17.14%,HEXB;CPTP;CERS3;DEGS2;HEXA;SPTLC3;PLA2G15;HACD3;PPM1L;NEU3;ACER3;SMPD2;ACER2;ALOXE3;ASAH1;FUT7;CERK;PLPP2;PPT1;PLPP1;VAPB;PRKD3;CERS2;ORMDL2;NEU4;SUMF2
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4822760411066107,-1.260417387417397,0.2119205298013245,0.5851492657450387,1.0,3/13,4.44%,CD74;LILRB1;SIRT1
prerank,mesonephros development (GO:0001823),-0.5024155492653875,-1.2601515283330316,0.2091346153846154,0.5845419713026647,1.0,2/11,2.01%,ZBTB16;FGF10
prerank,fluid transport (GO:0042044),-0.49416201671239524,-1.2595023022852467,0.18789144050104384,0.5848616980027213,1.0,4/12,32.18%,AQP4;AQP11;AQP1;SLC4A11
prerank,growth hormone receptor signaling pathway (GO:0060396),0.4893393927271671,1.2571207059059022,0.1881918819188192,0.7310732959889059,1.0,7/14,22.93%,LYN;PIK3R1;PTPN1;GHR;PXN;STAT5B;STAT6
prerank,regulation of autophagosome maturation (GO:1901096),-0.4882071867511179,-1.2567614618679792,0.16379310344827586,0.5914635331742056,1.0,5/13,11.29%,RUBCN;TBC1D25;UVRAG;IRGM;SMCR8
prerank,cellular modified amino acid catabolic process (GO:0042219),0.4818483994392636,1.256702566395436,0.1900369003690037,0.7310286907235996,1.0,4/15,17.27%,ABHD12;DPEP1;ALDH4A1;GGT5
prerank,regulation of cartilage development (GO:0061035),-0.44658150923829887,-1.2562562793301781,0.16856492027334852,0.5914254463874032,1.0,3/18,3.40%,TRPS1;ZBTB16;SOX5
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3958781719987215,1.2561302987012752,0.15761821366024517,0.7315398908533,1.0,5/36,2.58%,CX3CR1;TGFBR1;CRADD;CSNK2A2;CSNK2A1
prerank,potassium ion transmembrane transport (GO:0071805),-0.2820720233076253,-1.2546865760006336,0.07297297297297298,0.5945333378751966,1.0,27/135,12.08%,KCND2;KCNT2;KCNB2;KCNK10;HCN1;KCNN2;KCNQ5;KCNC2;KCNJ3;KCNQ3;KCNH1;SLC24A2;NALCN;SLC12A8;KCNA6;SLC12A4;KCND3;KCNAB2;PKD2;KCNH7;KCNH2;KCNJ6;KCNH5;SLC12A5;ATP1B3;ATP1A1;KCNK4
prerank,intracellular sterol transport (GO:0032366),0.49321329732471286,1.254435240959019,0.17938931297709923,0.7362737274390344,1.0,5/13,21.08%,NPC2;NPC1;SERAC1;ABCA1;OSBP
prerank,regulation of actin filament-based process (GO:0032970),0.33593597505081596,1.2540570102992499,0.12231404958677686,0.7360956841257997,1.0,23/70,19.67%,F11R;TWF2;RAC1;RND1;PRKCD;RHOH;FSCN1;RHOBTB1;RND2;RHOQ;RHOB;ARHGAP17;MLST8;HIP1R;ABL1;MTOR;ROCK2;LRP1;TAOK2;CELSR1;DMTN;RAC3;ARHGEF5
prerank,P-body assembly (GO:0033962),-0.4853278037379515,-1.2537259080256695,0.2079646017699115,0.5959421041957782,1.0,9/12,39.06%,LIMD1;PATL1;ATXN2;LSM3;EDC3;DYNC1H1;LSM4;EIF4ENIF1;PATL2
prerank,cAMP metabolic process (GO:0046058),-0.4711464888728101,-1.2534132555683293,0.19954648526077098,0.5954298605685716,1.0,5/13,7.35%,PDE4D;ADCY2;ADCY5;ADCY3;ADCY8
prerank,mRNA export from nucleus (GO:0006406),0.32078666376128134,1.2526251887981437,0.09328968903436989,0.7398675251697475,1.0,34/102,23.30%,SRRM1;NCBP1;RANBP2;NUP42;POLR2D;SRSF5;DHX38;SEC13;PABPN1;NUP35;CPSF1;U2AF2;NUP50;U2AF1L4;ALYREF;RBM8A;SEH1L;SLU7;DDX39B;NUP62;NUP107;SRSF9;NUP88;ALKBH5;THOC6;FIP1L1;DDX19B;NUP188;HNRNPA2B1;NUP214;MAGOHB;MAGOH;ZC3H11A;THOC3
prerank,actin polymerization or depolymerization (GO:0008154),-0.3415461483195865,-1.2524445218600206,0.12953367875647667,0.5968821255717139,1.0,13/50,10.64%,ARHGAP6;PSTPIP1;PSTPIP2;GSN;DIAPH3;ABI2;WASF1;MICAL3;DSTN;JAK2;MSRB1;ENAH;VILL
prerank,adipose tissue development (GO:0060612),0.5330349131148194,1.2522241185642704,0.20499108734402852,0.7397216770901635,1.0,2/11,1.62%,LRP5;SOX8
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.3827322594084081,1.2521418602205288,0.14076782449725778,0.7384446235745891,1.0,15/38,23.98%,NDUFB2;NDUFB8;NDUFS3;NDUFS4;NDUFB10;NDUFAF1;NDUFB3;NDUFS5;NDUFV3;NDUFA13;NDUFC2;NDUFV1;NDUFA9;NDUFB11;NDUFV2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.5239101796498613,1.251352518219148,0.1926070038910506,0.7398177231239759,1.0,5/11,10.22%,LGALS9;MEF2C;LYN;PIK3CB;PIK3CD
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.49070396168369146,1.2511507963545776,0.18281535648994515,0.7389807280322388,1.0,5/14,18.25%,ENTPD1;NUDT15;ENTPD7;NUDT16;ENTPD6
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.41318534578641486,-1.2506610164569913,0.18493150684931506,0.6004773726674828,1.0,5/22,12.62%,MDFIC;LRRK2;BARD1;SP100;ITGB1BP1
prerank,cellular response to metal ion (GO:0071248),-0.2887675671962892,-1.2506370261998414,0.07807807807807808,0.5991038110849709,1.0,20/123,7.98%,DLG2;NLGN1;ANK3;IQGAP1;LRRK2;EGFR;SYT1;B2M;RYR3;CPNE8;KCNH1;CARF;SYT10;ALOX5AP;GLRA1;RASGRP2;CPNE4;PRKN;ADCY8;PKD2
prerank,regulation of immune response (GO:0050776),-0.28517797174159987,-1.2506019093740277,0.06775067750677506,0.5977794257600039,1.0,45/135,23.40%,ITGA4;CLEC2D;LILRB1;FOXP1;ITGAL;B2M;DENND1B;PTPN22;RSAD2;CD40;ITGB7;CD226;IRF4;CD300LF;SLAMF7;JAML;COL1A1;CD300LD;CD200R1;VCAM1;SPN;AHR;KLRD1;SAMHD1;FCGR2B;CD300E;CD300LG;IFITM1;CD3E;ICAM1;KLRK1;TREML4;FOXP3;CD96;NPDC1;FCRLB;CD300C;IRF7;ITGB1;SELL;CRTAM;CD3D;CD247;CD19;RIPK3
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.40167555116984954,-1.2505696637154693,0.16778523489932887,0.5964637233340272,1.0,7/25,11.08%,RBPJ;HIP1;RTN4;DOK1;CCDC88A;PLAUR;PDE6H
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.4915802457287869,-1.2503027222005743,0.19047619047619047,0.5958020840326145,1.0,2/12,8.12%,GSS;GGCT
prerank,organelle disassembly (GO:1903008),0.3905027357150762,1.2501735239906306,0.15073529411764705,0.7410893129979799,1.0,14/33,23.42%,ULK2;PLK5;PELO;RB1CC1;UBA5;ULK1;RETREG1;MTIF2;EIF2D;PLK3;KLC1;STX5;UFC1;ATG2A
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.42408322175728064,1.2498889793362173,0.1663716814159292,0.7404814867404944,1.0,2/24,1.85%,ITGAM;DDIT3
prerank,keratan sulfate metabolic process (GO:0042339),0.4014653173981635,1.24972437778418,0.15716753022452504,0.7395409669834682,1.0,6/31,4.08%,HEXB;ST3GAL6;B3GNT2;PRELP;CHST1;HEXA
prerank,DNA integrity checkpoint signaling (GO:0031570),0.38369058710215537,1.249494214892688,0.15760869565217392,0.738855378539982,1.0,8/36,11.18%,RHNO1;CHEK2;ATM;USP28;RAD17;NBN;RAD1;CEP63
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4921236829379052,-1.2493650120730757,0.19907407407407407,0.5971387661983013,1.0,6/12,16.46%,DAB2;FOXP1;SIRT1;HDAC1;SFRP1;NCOR1
prerank,RNA splicing (GO:0008380),0.3194173755590249,1.249289380703066,0.10305958132045089,0.7380271718012156,1.0,31/95,23.09%,IVNS1ABP;SRRM1;PPP1R9B;NCBP1;SF3B2;SF3B1;HNRNPC;SNRPF;FUS;SNRNP48;LUC7L3;SNRPA1;TRA2B;SNRPN;RBM8A;SLU7;SCNM1;DDX39B;GEMIN2;PRPF3;WBP4;MPHOSPH10;PRPF4;TARDBP;SNRNP25;HNRNPH3;SNRNP40;DDX47;MAGOHB;MAGOH;MBNL1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.2820723538436983,1.2487329180131725,0.04727793696275072,0.7383791930407199,1.0,60/260,17.08%,SRGAP2;FGD2;OPHN1;P2RY12;ASAP1;EXOC7;RILPL1;BBS9;RAC1;AIF1;MAP4K4;PPP1R9B;KIF3B;TTLL3;PKHD1;CEP162;HYLS1;UBXN10;FSCN1;ARFIP2;CEP164;EHD4;RP2;MKS1;CFAP52;TTC36;NME8;AVIL;CFAP221;NUDCD3;IFT52;RAB1A;INPP5E;CCDC28B;GALNT11;BBS2;FGD3;SPATA13;CDC14B;CENPJ;ATP6V1D;KIF27;KIF3A;DYNLT2B;CFAP20;WDR90;EXOC6;IFT20;CCDC66;TCTN1;OFD1;PDE6D;CYFIP1;VSTM5;EXOC1;PTPN23;PMP22;CPLANE2;B9D1;TMEM17
prerank,proteasomal protein catabolic process (GO:0010498),0.28775616246486574,1.248589320219687,0.06484149855907781,0.7373359926491784,1.0,53/201,17.92%,NFE2L2;BAG6;ARRB2;DDIT3;MTA1;RNF216;RNF41;ITCH;SPSB1;SIRT2;UCHL1;SEL1L;SMURF1;RFFL;ZSWIM8;SPSB2;ENC1;TRIM72;CDC34;MAEA;CUL4B;PSMD3;ANKRD9;CRBN;WWP2;BFAR;PSMA7;PCBP2;AREL1;DCAF11;UBE2U;SOCS6;UBXN2A;ERLEC1;PSMB3;PSMB9;FBXL22;KCTD2;PSMC2;RNF187;TNFAIP1;TRIM3;PSME4;PSMC1;PSMB7;TOPORS;ZFAND2A;SPOPL;UBE2A;RNF4;SYVN1;GID8;PSMB5
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.39069431693633605,1.2484448282722276,0.14056939501779359,0.7363120801085612,1.0,16/35,25.44%,PMEPA1;DDX5;SRC;CALCOCO1;PADI2;GPER1;KDM3A;DDX17;PLPP1;ARID1A;SAFB;DDX54;UBE3A;WBP2;ZMIZ1;AR
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4837348549018189,-1.2474463303312988,0.17697228144989338,0.6011746254326942,1.0,4/12,12.41%,MAGI2;IQGAP1;JAG1;PODXL
prerank,cell cycle checkpoint signaling (GO:0000075),-0.48843685164893413,-1.2472699699607244,0.19690265486725664,0.6002773273633036,1.0,4/12,11.48%,ZW10;PLK2;BUB1B;BUB1
prerank,response to hydrogen peroxide (GO:0042542),0.3662046462679071,1.2466317802053557,0.13504273504273503,0.7413978107115865,1.0,14/45,17.61%,SIRPA;NFE2L2;PRKCD;IMPACT;TRPM2;RHOB;PDCD10;SOD1;ABL1;PAX2;ANKZF1;MAPK7;ECT2;APTX
prerank,endodermal cell differentiation (GO:0035987),0.4037768917922926,1.2452837436178859,0.14130434782608695,0.7448612223205834,1.0,8/31,12.92%,ITGB5;ITGAV;ITGB2;MMP2;CTR9;SETD2;COL11A1;ITGA7
prerank,retina homeostasis (GO:0001895),-0.4122709393595335,-1.2450042888361113,0.17482517482517482,0.6053904481665779,1.0,9/23,21.00%,B2M;PRDX1;ACTB;POTEF;SLC28A2;ACTG1;JCHAIN;BBS4;LTF
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3768681577627099,1.2445864727079878,0.14893617021276595,0.7458482113452058,1.0,15/38,25.29%,ARHGEF2;CFLAR;RFFL;TRADD;BRCA1;STX4;THBS1;PMAIP1;FAIM;SERPINE1;MADD;DDX3X;FADD;TMBIM1;RNF34
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3412243641945348,1.244062716880039,0.13410596026490065,0.7461752343031869,1.0,21/72,20.06%,POLR2H;COPS4;GTF2H2;RFC2;PCNA;POLR2D;CUL4B;POLR2J;UBC;RPS27A;ERCC2;POLD2;ERCC4;GPS1;RFC1;LIG1;COPS6;HMGN1;POLR2E;RPA3;POLR2I
prerank,regulation of dendrite extension (GO:1903859),-0.4339985593812341,-1.2437031335111677,0.16666666666666666,0.607683680879952,1.0,6/18,16.58%,RIMS2;SYT1;NEDD4L;RIMS1;PLAA;SYT3
prerank,DNA repair (GO:0006281),0.2813833480053561,1.2431250177527153,0.05329593267882188,0.7479003153129824,1.0,68/284,17.80%,SUMO1;HERC2;RHNO1;CHEK2;MTA1;CSNK1E;EID3;PRIMPOL;GTF2H2;WDR48;RFC2;MPG;ATM;PCNA;REXO4;FAM111A;POLN;RAD17;NBN;MGMT;FANCM;SLX4;RAD51B;FAAP24;CUL4B;KMT5C;EYA3;MMS19;RNF8;INTS3;BRCA1;TNKS1BP1;UBC;RPS27A;FANCG;DCLRE1B;ERCC2;DCLRE1C;KDM4A;POLD2;ABRAXAS1;DDB2;SMARCA5;ERCC4;RAD1;BLM;EXO1;HPF1;ABL1;UBE2U;SETD2;UBE2V2;PRMT6;DTX3L;CIB1;FANCI;FBH1;BABAM1;LIG1;DCLRE1A;PSME4;FANCA;RAD9A;BAZ1B;ALKBH5;UBE2A;APTX;FAAP100
prerank,translesion synthesis (GO:0019985),0.3711544768146753,1.2424584841952764,0.15254237288135594,0.7488013037900179,1.0,13/42,20.05%,PRIMPOL;RFC2;PCNA;POLN;UFD1;UBC;RPS27A;POLD2;PCLAF;RFC1;SPRTN;RPA3;POLDIP2
prerank,neuron projection development (GO:0031175),-0.2745884656579282,-1.2422919347202066,0.06997084548104957,0.610305225054679,1.0,25/168,6.52%,CNTNAP2;GRM7;NLGN1;CTNND2;FRY;NYAP2;LRRK2;GPM6A;BDNF;APP;APOE;CTTN;RAPGEF2;MAP2;EHD1;VAPA;RASGRF1;CDC42;SHANK3;DCLK1;STMN4;CNTNAP1;TOR1A;PAK3;GSK3B
prerank,mRNA metabolic process (GO:0016071),0.3238049417869207,1.2419893024069013,0.12145110410094637,0.7489210612350893,1.0,23/90,17.93%,SON;PRKACA;NCBP1;DDX5;AKAP8L;DXO;SSB;SF3B2;SNRPF;SRSF5;DIS3L2;ZFP36L2;NANOS2;U2AF2;PCBP2;HNRNPR;SRSF9;PCF11;SF3A1;GEMIN2;ALKBH5;NUDT16;PRPF3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.4254356666548576,-1.2417538402845505,0.18526315789473685,0.6104376047484521,1.0,9/19,15.30%,PTPRD;CDKL5;IL1RAPL1;CUL7;SS18L1;OBSL1;SS18L2;RELN;CAPRIN2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.36936802953100506,1.241690668020366,0.14762741652021089,0.7485007667929501,1.0,14/44,19.34%,BIN1;BAIAP2L2;CDC42EP2;NCKAP1L;CCR7;PTK2B;FCHSD2;SPIRE1;TENM1;VASP;CCL24;FCHSD1;EVL;PYCARD
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.32821841002353785,1.2416254726048097,0.10841423948220065,0.7471806423012349,1.0,25/83,19.74%,TUBA4A;SDCCAG8;PRKACA;CSNK1E;ODF2;TUBB;CEP164;TUBG1;HAUS7;CNTRL;CENPJ;TUBA1A;CEP63;HAUS2;CEP135;HAUS6;OFD1;CEP57;MAPRE1;AURKA;DCTN2;CEP70;ACTR1A;CEP43;CCP110
prerank,regulation of cell projection organization (GO:0031344),0.489812121382075,1.24155034284368,0.20106761565836298,0.7459034606881727,1.0,5/13,12.41%,MOV10;SPRY2;MACF1;ERMN;SEMA4D
prerank,regulation of neuron differentiation (GO:0045664),0.3315772982497117,1.2413599299094045,0.14748784440842788,0.7450867071823716,1.0,15/76,11.12%,BIN1;ZFHX3;ARHGEF2;YWHAH;HEYL;MMD;MEF2C;IMPACT;NREP;CDK5RAP1;SIN3A;DTX1;MOSMO;DLL1;ZEB1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.45294704171387923,1.241220246345922,0.20593692022263452,0.7425070027260006,1.0,7/19,20.75%,POLR2H;POLR2D;POLR2J;TERF1;POLR2E;POLR2I;ACD
prerank,regulation of DNA recombination at telomere (GO:0072695),0.45294704171387923,1.241220246345922,0.20593692022263452,0.7425070027260006,1.0,7/19,20.75%,POLR2H;POLR2D;POLR2J;TERF1;POLR2E;POLR2I;ACD
prerank,reverse cholesterol transport (GO:0043691),0.5005813478259674,1.240993377481408,0.2045028142589118,0.741877804980311,1.0,6/13,19.23%,LIPC;CLU;APOM;SCARB1;ABCA1;LCAT
prerank,regulation of protein kinase B signaling (GO:0051896),0.2908016734288265,1.2399703065152998,0.07988587731811697,0.7440958595672204,1.0,39/193,13.36%,CX3CR1;TGFBR1;IL18;P2RY12;ARRB2;RAC1;DDIT3;GAB2;RNF41;SRC;PIK3R1;IGF1R;PKHD1;THEM4;PIK3CG;SPRY2;PDPK1;FLCN;MET;PIK3AP1;FRS2;PDGFB;CCR7;RASD2;GPER1;CALCR;GRM2;PIK3CB;CD86;MTDH;GCNT2;PIK3CD;PTPN11;AXL;DRD2;PDCD6;PINK1;CIB1;AKT1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.415642266780778,-1.2390713422621875,0.16397228637413394,0.616970181245442,1.0,7/22,12.16%,SORBS1;PPARG;APOE;CREBL2;ZBTB20;EEF1A2;DISP3
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3623399832806209,1.2389348621562704,0.14795918367346939,0.74635217542776,1.0,9/46,11.18%,LIPH;PLD1;LPCAT4;PLD2;PLA2G5;PLA2G4B;PLA2G4A;DGKD;GPD1
prerank,heart contraction (GO:0060047),-0.3529574957195746,-1.238815598136576,0.1431924882629108,0.6162377225299663,1.0,8/41,14.72%,SGCZ;DMD;RYR2;SGCD;KCNH2;TNNI1;KCNQ1;MYBPC3
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.33419389310807335,1.2380837637533388,0.1345514950166113,0.747971093315675,1.0,18/72,16.84%,RNASE1;GTF2H2;DXO;RFC2;PCNA;REXO4;CUL4B;UBC;RPS27A;ERCC2;POLD2;DDB2;RNASE6;ERCC4;RFC1;FBH1;ISG20;DCP1B
prerank,protein localization to chromatin (GO:0071168),-0.4260733742032028,-1.2380528621908213,0.1943231441048035,0.617004220872805,1.0,9/18,29.36%,MCM9;SGF29;PIH1D1;PPHLN1;FAM47E;MSH2;PLK1;LEMD2;MCM8
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4255388135222574,1.237372959621903,0.18772563176895307,0.7490712321707191,1.0,11/23,29.58%,COPS4;CUL4B;UBC;RPS27A;DDB2;GPS1;COPS6;CUL4A;RAD23B;RBX1;COPS7A
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.44732182074784804,-1.2369261314087079,0.19310344827586207,0.6187955500450526,1.0,2/16,1.83%,DPYD;DPYSL5
prerank,negative regulation by host of viral process (GO:0044793),-0.5077083020910038,-1.2361344235059462,0.21350762527233116,0.6197564061985745,1.0,6/10,30.37%,VAPA;PRKN;EIF2AK4;LTF;CCL8;CRP
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.40060582900899033,1.235025731869431,0.17962962962962964,0.7561106662879266,1.0,12/30,19.49%,SMAD3;SMAD7;BCL9;EID2;NREP;XIAP;LATS2;FST;DKK3;ENG;LTBP4;SFRP4
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.322833610137334,-1.2348161574100687,0.12564102564102564,0.6222071523323406,1.0,20/59,19.43%,ROBO1;KIRREL3;TENM3;PTPRT;NPTN;PALLD;EMB;CNTN6;CDH4;CDH13;NECTIN1;PLXNB2;OBSL1;CDH1;SDK1;PECAM1;CADM3;CNTN4;DSCAM;PCDHB6
prerank,endoderm formation (GO:0001706),0.3833688224340274,1.23400370820217,0.16267123287671234,0.7583223504157607,1.0,8/35,12.92%,ITGB5;ITGAV;ITGB2;MMP2;SOX17;SETD2;COL11A1;ITGA7
prerank,positive regulation of viral transcription (GO:0050434),0.41751018003635293,1.2337710489858802,0.16696914700544466,0.7575906815803339,1.0,9/25,20.06%,NELFB;POLR2H;CDK9;POLR2D;POLR2J;DHX9;NELFE;POLR2E;POLR2I
prerank,nucleotide metabolic process (GO:0009117),0.42199716090391953,1.2336533437020958,0.21061946902654868,0.7564961544683454,1.0,6/23,13.09%,FHIT;GUK1;REXO2;CMPK1;DCTD;PNP
prerank,regulation of cellular protein localization (GO:1903827),-0.34555553640678816,-1.2333581316876883,0.13559322033898305,0.6250934142657679,1.0,11/45,10.97%,GPC6;BDNF;GPC5;MAP2;TOR1A;KCNAB2;GPC3;VCPIP1;TRIM67;HSP90AB1;TRIM46
prerank,positive regulation of immune response (GO:0050778),0.3445094239319772,1.2331982596631135,0.1461038961038961,0.756631053017424,1.0,15/64,14.78%,SASH3;ITGAM;POLR3G;LGALS9;ITGB2;KARS1;SLC15A4;IL6ST;CCR7;IL12B;AKIRIN2;DHX9;STX4;GBP5;NLRP3
prerank,"transcription, DNA-templated (GO:0006351)",0.2856802150654811,1.2330834635295436,0.07202216066481995,0.755528679805499,1.0,55/207,21.49%,IVNS1ABP;POLR3G;RREB1;ARRB2;NELFB;POLR2H;NCBP1;GTF3C2;DDX5;GTF2H2;DEAF1;CDK9;POLR2D;BRF1;TTF2;CTR9;RNMT;BRF2;POLR2J;PKNOX1;PAX1;POLR3H;SMN1;MMS19;DTX1;TAF6;TAF12;ERCC2;GTF3C6;SMARCA5;HSF2BP;MEF2A;MBD1;NELFE;TAF4;MED4;GTF3A;POLR1C;UBTF;TOPORS;RPAP1;EPC1;TAF1;RBMX;THAP1;TAF10;CEBPD;POLR2E;POLR2I;DEK;NFYA;IRF9;NFIX;MNT;TAF5
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.4146883161842892,1.2327918294864217,0.22638146167557932,0.7550630011022245,1.0,8/24,19.84%,RFC2;PCNA;UBC;RPS27A;POLD2;RFC1;LIG1;RPA3
prerank,sensory perception of taste (GO:0050909),-0.5231252376395952,-1.232583176445245,0.1887966804979253,0.6260195195759698,1.0,5/10,37.88%,CD36;ASIC3;TAS1R3;TAS1R1;PKD2L1
prerank,positive regulation of cellular respiration (GO:1901857),0.5062130158136646,1.2321743810107775,0.22122302158273383,0.7558087920660671,1.0,4/11,19.67%,ISCU;PINK1;IL10RB;PARK7
prerank,negative regulation of protein modification process (GO:0031400),-0.30437405364409753,-1.2321532218239715,0.10695187165775401,0.6258272075743632,1.0,17/79,11.11%,DMD;PID1;XDH;LRRK2;SLIT2;TPPP;NTRK3;SIRT1;PPIA;CORO1C;CADM4;GSK3B;PRKN;LRP6;SH3GL2;MYADM;P3H1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4717639288988935,1.2321135954463402,0.2037037037037037,0.7545335822456877,1.0,7/14,18.11%,SEC13;RAB1A;MIA3;SAR1A;SEC31B;SCAP;SEC31A
prerank,protein alkylation (GO:0008213),0.43174952273171124,1.2314341231728436,0.1960431654676259,0.755474238557539,1.0,6/22,10.31%,FAM98B;PRMT2;ETF1;EEF2KMT;PRMT8;PRMT1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.4993062732621566,-1.2312248202103404,0.2094017094017094,0.6272386812826463,1.0,3/10,8.02%,SOX11;BMP5;LRP6
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.38755059381297013,1.231108449799359,0.1649659863945578,0.7552067581008628,1.0,15/33,26.64%,KLK2;DDX5;PRMT2;UBA5;KCTD6;CARM1;RUNX1;SAFB2;PARK7;NCOA2;KDM1A;KLK3;PKN1;AR;EP300
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.4271342567625032,-1.2306575261465391,0.21286031042128603,0.6275165577375916,1.0,6/17,14.32%,SLIT2;FSTL1;DOK5;CASK;ZDHHC17;TFAP2B
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.41893851465841325,1.2305914143668246,0.2231833910034602,0.7555463425576194,1.0,4/21,5.90%,SNTA1;KCNA5;SCN4B;NOS1AP
prerank,mitotic spindle organization (GO:0007052),-0.2722342931999882,-1.2303610247677859,0.05202312138728324,0.6269322637796003,1.0,43/153,19.25%,CENPP;KNL1;CENPF;DYNC1I2;NUP98;CENPT;KIF23;CDCA8;NDC80;SPDL1;ZW10;RAN;TOGARAM2;DLGAP5;EML1;TPX2;BIRC5;RPS27;PLK2;CENPE;SPC25;KNTC1;BUB1B;AURKB;KIF11;PRC1;MAP9;TTK;BUB1;MAD1L1;EFHC1;ERCC6L;RCC2;GPSM2;NUP43;TBCE;FLNA;CCDC61;CENPS;CEP126;CCNB1;SPC24;KIF4A
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4470166461466239,1.2301388666477349,0.20553359683794467,0.7558027440313055,1.0,6/16,15.94%,ULBP1;TUBB;RAET1E;CEBPG;VAMP7;PLEKHM2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.34475537569921216,1.2299878127079313,0.1423841059602649,0.7547772077021783,1.0,16/59,20.94%,TLR7;TLR4;IRAK2;RIPK2;TRADD;TAB2;UBC;RPS27A;TICAM2;ROCK2;RNF31;AKT1;TICAM1;TBKBP1;MAP3K14;FAIM
prerank,monocyte differentiation (GO:0030224),0.5222839968686813,1.2293090922996632,0.24055666003976142,0.7558055274792562,1.0,4/10,12.08%,CSF1R;PDE1B;MT1G;MYH9
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.48129640390224004,-1.229217973374349,0.20625,0.6287903074519914,1.0,7/12,16.91%,CIITA;GSN;IFITM3;MID2;LY6E;IFITM2;IFITM1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.4987401354969083,1.2284231092961735,0.232421875,0.7574865899298049,1.0,4/12,6.14%,BIN1;DSP;DSG2;TRPM4
prerank,response to nutrient levels (GO:0031667),0.451033693689991,1.2283311878067822,0.2126126126126126,0.7563588305280425,1.0,7/17,27.39%,EIF4G1;RPTOR;MTOR;ULK1;KCNB1;CD68;SCTR
prerank,regulation of coagulation (GO:0050818),-0.4934470455706443,-1.2280192033912787,0.22505307855626328,0.631005607925017,1.0,1/11,0.51%,HS3ST5
prerank,zinc ion transport (GO:0006829),0.43556742373833135,1.2279723327717977,0.19137931034482758,0.7561960639389992,1.0,5/21,11.98%,SLC30A5;SLC30A10;TRPM2;SLC30A8;SLC39A2
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.44632072403894774,-1.2274655024761858,0.19271948608137046,0.6312590169215349,1.0,6/15,11.99%,RBPJ;EGFR;PTPN12;CDH13;RHBDF2;MVB12A
prerank,bone development (GO:0060348),0.36938159131855464,1.2268820206193674,0.17010309278350516,0.7585726887188876,1.0,16/39,25.39%,LRP5;TGM2;SKI;DYM;AKAP13;MBTPS2;GJA1;SBDS;SFRP4;FGFR2;SH3PXD2B;STC1;TP53;GNAS;SULF1;SLC10A7
prerank,placenta development (GO:0001890),-0.4857543951723825,-1.2268746408261337,0.20869565217391303,0.6317122813231316,1.0,8/12,36.62%,PPARG;CUL7;E2F7;ADAM19;PLAC1;CITED1;E2F8;PTK2
prerank,Rac protein signal transduction (GO:0016601),0.4409393800829566,1.2268631315498697,0.21082089552238806,0.7571580393209639,1.0,5/18,5.23%,ELMO1;RAC1;AIF1;RHOH;HACD3
prerank,mitochondrial transport (GO:0006839),-0.3307181549700491,-1.2267288618055054,0.14482758620689656,0.6307485351705837,1.0,20/53,20.83%,TOMM22;TIMM23;TIMM17B;MFF;TOMM5;SLC25A24;FLVCR1;FBXO7;TIMM17A;BAK1;SLC25A16;FIS1;COX18;TIMM10;BCL2;MTX2;AIP;DNAJC19;TIMM9;SPG7
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.4802640196124536,-1.226661009045396,0.22245322245322247,0.6295556750168108,1.0,4/12,8.24%,LRRK2;ATP6AP2;CLN5;TMEM165
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4320794910203459,1.2263577156463545,0.18604651162790697,0.7575841437437143,1.0,5/21,6.73%,LGALS9;ITGAV;KARS1;ZFP36L1;ZFP36L2
prerank,postreplication repair (GO:0006301),0.3616809757555278,1.2260782738753182,0.16155088852988692,0.7571084449211304,1.0,14/45,19.84%,PRIMPOL;RFC2;PCNA;POLN;BRCA1;UBC;RPS27A;POLD2;UBE2V2;PCLAF;RFC1;UBE2A;SPRTN;RPA3
prerank,7-methylguanosine RNA capping (GO:0009452),0.3883819072710688,1.2259575177045536,0.18620689655172415,0.7545685229840419,1.0,7/31,10.11%,POLR2H;NCBP1;GTF2H2;POLR2D;RNMT;POLR2J;ERCC2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3883819072710688,1.2259575177045536,0.18620689655172415,0.7545685229840419,1.0,7/31,10.11%,POLR2H;NCBP1;GTF2H2;POLR2D;RNMT;POLR2J;ERCC2
prerank,RNA 3'-end processing (GO:0031123),0.3350335342331387,1.225783675251133,0.13804713804713806,0.7537270709793666,1.0,22/69,24.01%,SRRM1;NCBP1;CSTF2;SRSF5;DHX38;PABPN1;CPSF1;U2AF2;U2AF1L4;ALYREF;RBM8A;SLU7;DDX39B;SRSF9;PCF11;THOC6;FIP1L1;MAGOHB;MAGOH;ZC3H11A;THOC3;CSTF1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.40735126859044046,1.2256454046575054,0.2015065913370998,0.75280519166752,1.0,4/28,6.17%,NAV3;RAC1;NUMA1;MET
prerank,regulation of B cell differentiation (GO:0045577),0.4480446741239675,1.2253755565909272,0.2222222222222222,0.7522908440776186,1.0,5/17,7.21%,CD27;NCKAP1L;ZFP36L1;ZFP36L2;INHA
prerank,regulation of cell cycle (GO:0051726),0.2737164847907488,1.2251090915624245,0.05730659025787966,0.7517765362749986,1.0,99/271,28.08%,BIN1;TGFBR1;TTC28;MLXIPL;SON;SMAD3;PIM2;PPP1R9B;PRKACA;CSNK2A2;CSNK2A1;SIRT2;CDK9;SIPA1;HBP1;ATM;AFAP1L2;HPGD;NBN;APBB2;NEK6;MAEA;RHOB;INHA;IL12B;CKS1B;GPER1;POU4F1;BRCA1;TAF6;E4F1;CDK11B;LIN9;CDC14B;BOP1;XIAP;UHRF2;UHMK1;ABL1;PRDM11;PCLAF;PROX1;PES1;FBXL22;FBXL8;MASTL;CHMP1A;RPRM;THBS1;GATA3;ADAM10;TCF7L2;RNF20;CDKN1B;THAP1;WDR6;MED25;JUN;FGFR2;HTRA2;TFAP4;TSPYL2;LIN37;WDR12;MFN2;BMP2;TARDBP;MADD;PDCD4;TP53;RRP8;KIF20B;CYLD;MIF;PUM1;GMNN;CDC25A;LIN54;TGFB1;FBXL12;SND1;MAP2K1;FZD9;NOTCH1;TRNP1;KAT2B;FAP;EP300;BIRC2;NEK7;SOX9;SRA1;EIF4G2;RPRD1B;ASAH2;TXLNG;NF2;HMGA2;BIRC3
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.45419363561163834,-1.2250777197000788,0.20758928571428573,0.63272047840915,1.0,3/15,8.33%,IQGAP2;ACTR3;ARPC5
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.27824984281873677,-1.2244221662845278,0.08547008547008547,0.6332527376160368,1.0,23/151,7.01%,CD74;CD44;EGFR;CD36;APP;GAREM1;HTR2C;ADRA1A;FGF10;DSTYK;APOE;CCR1;ROR1;PRKCZ;PTPN22;NTRK2;CCL4;RAPGEF2;NTRK3;PDGFD;P2RY1;HTR2B;PDE8A
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.5048338580671201,-1.2239456959415838,0.22624434389140272,0.6332658546337147,1.0,4/10,16.42%,GPR35;CBARP;CALM1;GNB5
prerank,RNA export from nucleus (GO:0006405),0.31365922051707645,1.2238725855327326,0.11707317073170732,0.7547912556841132,1.0,34/100,23.30%,SRRM1;NCBP1;RANBP2;NUP42;SRSF5;DHX38;SEC13;NUP35;NUP62CL;CPSF1;U2AF2;NUP50;U2AF1L4;ALYREF;RBM8A;SEH1L;SLU7;DDX39B;NUP62;NUP107;SRSF9;NUP88;ALKBH5;THOC6;FIP1L1;DDX19B;NUP188;XPO5;HNRNPA2B1;NUP214;MAGOHB;MAGOH;ZC3H11A;THOC3
prerank,regulation of protein secretion (GO:0050708),-0.28596090858892476,-1.2237695622513942,0.08356545961002786,0.6324041303310985,1.0,29/119,15.19%,STXBP5L;CACNA1E;ITPR1;DPP4;KCNC2;DISP1;APOE;RSAD2;STXBP5;RFX3;PPIA;DNM1L;CACNA1C;ALOX5;SLC8B1;GOLPH3;PER2;SNAP25;UNC13B;P3H1;ADRA2A;RHBDF2;FFAR1;HMGCR;CLOCK;TFAP2B;ACHE;SERGEF;CCL5
prerank,cell-cell junction organization (GO:0045216),0.32479498313400923,1.2236743160659733,0.1421647819063005,0.7540385407879706,1.0,23/79,14.85%,CSF1R;SMAD3;CADM1;DSP;TLN2;PKHD1;NECTIN4;FSCN1;CSK;FLCN;DSG2;CXADR;CDH18;CDH24;PKP3;GJA4;TJP1;TJP2;TRPV4;LIMS1;CDH15;CDH3;NECTIN2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.3849760496848595,1.2229216086508767,0.1909722222222222,0.753884455143205,1.0,12/32,19.38%,XPOT;RANBP2;SSB;NUP42;SEC13;NUP35;NUP50;SEH1L;NUP62;NUP107;NUP88;NUP188
prerank,tRNA export from nucleus (GO:0006409),0.3849760496848595,1.2229216086508767,0.1909722222222222,0.753884455143205,1.0,12/32,19.38%,XPOT;RANBP2;SSB;NUP42;SEC13;NUP35;NUP50;SEH1L;NUP62;NUP107;NUP88;NUP188
prerank,protein destabilization (GO:0031648),-0.36780041701005595,-1.222517282831653,0.1497584541062802,0.6347385838418598,1.0,10/32,12.83%,CUL3;CCDC88C;HTT;GSN;SIRT1;PRKN;CDC73;BTRC;IRGM;SNCA
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.417016381936452,1.222394680912288,0.19384057971014493,0.754314735478868,1.0,9/23,26.87%,SOX8;PIK3CD;PAX2;GJA1;NOG;SMO;AGT;MDK;SOX9
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3812126662813736,-1.2218016332388808,0.18863636363636363,0.6354283697090631,1.0,9/29,10.87%,GRIK2;SHISA9;APP;SHISA6;APOE;SLC4A10;NETO1;RAB3A;MCTP1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.3973354055282106,-1.220995179534592,0.19362186788154898,0.6365857079968457,1.0,12/26,23.87%,IQGAP1;EGFR;PTPN12;GAREM1;PDE8A;ZFP36;SYAP1;SNAI2;FOXC1;MED1;KNSTRN;EEF1A1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.46658946158074555,-1.2208722640053666,0.20556745182012848,0.6355539100733246,1.0,4/13,8.17%,PPARG;CD36;LDLR;CDH13
prerank,regulation of defense response to virus (GO:0050688),0.47159947128668506,1.2202241238109166,0.19926873857404023,0.7609581379208624,1.0,5/14,17.40%,RNF216;ITCH;PCBP2;DHX9;C1QBP
prerank,glutathione biosynthetic process (GO:0006750),-0.49158533737507026,-1.2201404185935583,0.20430107526881722,0.636276567897919,1.0,2/11,8.12%,GSS;GGCT
prerank,response to lipopolysaccharide (GO:0032496),0.2990022821540861,1.2195396373765721,0.11388455538221529,0.7619739582484366,1.0,43/138,23.38%,CX3CR1;SIRPA;LGALS9;MEF2C;OTUD5;TLR4;CASP1;SLPI;SBNO2;CTR9;TAB2;PABPN1;SELE;NOS2;PDCD1LG2;CXCL1;CD86;TICAM2;AXL;MAPK14;SCARB1;NLRP3;HMGB2;TNIP2;TICAM1;GGT5;CCR5;NOD2;TRIB1;NOS1;MAPK8;PYCARD;SHPK;ADAM17;MYD88;CXCL10;SLC11A1;SERPINE1;PDCD4;IL36G;TRAF6;S100A9;S100A8
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.39225835409521187,-1.2193666315726384,0.1774580335731415,0.6372482826708644,1.0,10/25,21.68%,B3GALT1;NDST4;FUT9;EXT1;EXT2;NDST1;B3GALT2;CSGALNACT2;CSGALNACT1;NDST3
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.5049527171577581,-1.21901360089199,0.20944558521560575,0.6368401723939064,1.0,3/10,10.41%,PTPN22;NINJ1;LBP
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.3209979085871965,-1.218700929302485,0.15328467153284672,0.6364273534265166,1.0,14/57,11.56%,HTT;MCU;DNM1L;GSK3B;PRKN;DDHD1;MFF;ZNF205;FBXO7;RALBP1;PLAUR;BID;BAK1;FIS1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.31455948433114017,1.2185941813485737,0.11889250814332247,0.7640015729728536,1.0,32/96,23.30%,SRRM1;NCBP1;RANBP2;NUP42;SRSF5;DHX38;SEC13;NUP35;CPSF1;U2AF2;NUP50;U2AF1L4;ALYREF;RBM8A;SEH1L;SLU7;DDX39B;NUP62;NUP107;SRSF9;NUP88;ALKBH5;THOC6;FIP1L1;DDX19B;NUP188;HNRNPA2B1;NUP214;MAGOHB;MAGOH;ZC3H11A;THOC3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.40183105803490515,1.2180347176937907,0.19389587073608616,0.7646057405628969,1.0,6/26,9.59%,IRAK2;RIPK2;ITCH;TAB2;UBC;RPS27A
prerank,steroid metabolic process (GO:0008202),0.33034096960059456,1.2178449036745653,0.14748784440842788,0.7638877112549604,1.0,14/72,14.31%,FDXR;HSD3B2;LGMN;CYP46A1;SHH;AKR1D1;SULT2A1;HSD17B1;CYP7B1;NPC1;TSPO;DHRS4;CYP2R1;HSD17B10
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3782122258287136,1.2177967682791078,0.17907801418439717,0.7626047899062205,1.0,8/38,7.82%,BIN1;KCNA5;CACNB2;DSP;SCN4B;DSG2;TRPM4;KCNH6
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.4476643086037242,-1.217562534141157,0.2198581560283688,0.6385351110826764,1.0,7/15,19.75%,UST;DSE;CSPG4;VCAN;CHST12;CSGALNACT2;CSGALNACT1
prerank,positive regulation of cell killing (GO:0031343),0.4780808000817195,1.217466212183105,0.22977941176470587,0.7623460658500505,1.0,6/13,29.35%,RAC1;NOS2;MAPK8;NOXO1;WNT5A;FZD7
prerank,base conversion or substitution editing (GO:0016553),-0.49031541697400766,-1.2162492816227062,0.20833333333333334,0.6410130485938801,1.0,7/11,37.58%,ADARB2;ADAR;AICDA;APOBEC2;ADAD1;ADARB1;APOBEC1
prerank,regulation of actomyosin structure organization (GO:0110020),0.48612316017035956,1.2162326665721361,0.2122905027932961,0.7652503870752861,1.0,5/13,12.96%,RAC1;ASAP3;AKAP13;FHOD1;ROCK2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.31171091159575276,-1.21600065223866,0.1358974358974359,0.6403314539077739,1.0,25/66,21.80%,PLCB1;EGFR;FGF10;ANKRD17;KMT2E;CCND2;UBE2E2;CDC73;KIF14;PKD2;PSME2;CCL2;E2F7;KLF4;DCUN1D3;CDKN2A;RGCC;CDKN1A;JADE1;TFDP1;E2F1;CDK4;MYO16;CDK6;RBL1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.3523880125464941,1.2158037837006537,0.15780445969125215,0.7653727585862228,1.0,15/49,23.09%,TLR7;LGALS9;DDIT3;TLR4;AFAP1L2;NOS2;RAB1A;LAMTOR5;MAVS;NOD2;PYCARD;PARK7;MYD88;SERPINE1;FADD
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.42603165109017377,1.2156628483942618,0.21621621621621623,0.7644471002574285,1.0,8/21,20.29%,PSEN2;PSENEN;SPPL2B;MYH9;RBMX;ADAM10;ADAM17;ERAP1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4402744530983554,1.2152358654322568,0.2075134168157424,0.7645140955929702,1.0,5/18,10.30%,SRC;IL6R;CTR9;IL6ST;PTPN11
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.43853399812822025,-1.2151634196726888,0.19148936170212766,0.641436246848413,1.0,6/16,17.35%,FGF10;PTPN22;SOX11;IKZF3;AHR;TNFSF9
prerank,female gonad development (GO:0008585),0.4401226378789191,1.2151519447798456,0.21507352941176472,0.7633926334648036,1.0,6/19,16.37%,INHA;FSHR;LHCGR;EIF2B4;SOD1;NUP107
prerank,calcium ion transport (GO:0006816),-0.28537942175322145,-1.2148052741622217,0.09943181818181818,0.6410843333035858,1.0,36/113,20.48%,ANK2;CACNA1E;ITPR1;TRPC5;TRPC4;SLC8A3;RYR2;CCR1;RYR3;TRPM3;SLC24A2;NALCN;ATP2A2;TRPC3;TPT1;CACNA1C;PKD2;TMEM165;STIM2;ANO6;GRIN3A;CHRNA4;ATP2A3;MCOLN3;CACNA1G;SELENOK;PANX1;CCL5;SLC3A2;CACNB3;TRPV6;TRPV3;CACNA2D1;TRPM7;MS4A1;FYN
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.49648881108424936,-1.2147311985407345,0.23060344827586207,0.6399518508454853,1.0,5/10,27.85%,DNAJB2;HSPA2;HSPA1B;SORL1;SACS
prerank,protein kinase B signaling (GO:0043491),0.4113609522763483,1.2146820184593154,0.19285714285714287,0.7636393333105913,1.0,11/23,29.01%,SIRT2;THEM4;ZFP36L1;PAX2;AKT1;PLK3;TGFB1;TYRO3;PIK3R3;PTEN;MT3
prerank,histone H2A monoubiquitination (GO:0035518),0.44862889768473757,1.2141064949857883,0.22491349480968859,0.7643152501004111,1.0,9/17,25.66%,BCOR;CUL4B;DDB2;PCGF2;RNF2;RING1;PCGF3;KDM2B;PCGF1
prerank,positive regulation of ion transport (GO:0043270),-0.3364782362098033,-1.214060108681254,0.16341463414634147,0.640655852577544,1.0,13/48,15.19%,ANK3;ANK2;ATP2B1;CCR1;CCL4;KIF5B;STIM2;ANO6;ACTN2;ADRA2A;FFAR1;LILRA5;CCL5
prerank,anterior/posterior pattern specification (GO:0009952),0.3487337415173576,1.2138916138023006,0.16638078902229847,0.7637174561883566,1.0,6/53,2.13%,TGFBR1;LRP5;HEYL;BASP1;DDIT3;SKI
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.38948231306564185,-1.2135764821449484,0.17937219730941703,0.6407185269728118,1.0,8/27,13.91%,PID1;PRKCZ;IRS1;TNS2;PTPN2;GRB10;KANK1;PRKCQ
prerank,cell-cell junction maintenance (GO:0045217),0.4883492931600652,1.2130923422455209,0.23277467411545624,0.7652440877600716,1.0,2/11,10.09%,CSF1R;TJP1
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.2949405864490845,-1.2130492268302202,0.13164556962025317,0.6408127788608193,1.0,19/85,18.10%,MTSS1;EGFR;FGF10;B2M;MYC;BMP5;CDC73;ZFP36;FGF9;FGF7;DUSP10;AQP11;NLRC3;SFRP1;MCC;ACVRL1;NME2;SFRP2;BMP4
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3851664063020923,-1.2129336834447664,0.17045454545454544,0.6397541345292491,1.0,6/26,12.05%,CUL3;HECW2;CDK5RAP2;DLGAP5;CENPE;UBE2C
prerank,glycine metabolic process (GO:0006544),-0.4869086683270981,-1.2129103399777248,0.19607843137254902,0.6384357611063752,1.0,7/12,24.26%,GCSH;SHMT1;GLDC;AMT;SHMT2;GLYAT;GCAT
prerank,autophagy of nucleus (GO:0044804),0.4555061512116389,1.2124800312473787,0.20772058823529413,0.766117879333057,1.0,9/16,24.90%,ULK2;ATG9A;RB1CC1;ATG5;ULK1;ATG9B;WDR45B;ATG2A;ATG12
prerank,protein localization to plasma membrane (GO:0072659),-0.2783249276165257,-1.2121961686262315,0.09016393442622951,0.6391165044265672,1.0,30/129,14.07%,KCNIP4;DPP6;ANK3;KCNB2;DPP10;ANK2;SPTBN1;RAB3C;MYO5A;RAPGEF2;EHD1;AFDN;P2RY1;CCDC88A;RAB3D;LRP6;RAB40B;SPTBN4;PIGW;ACTN2;RAB3A;ATP1B3;MYADM;RAB8A;ZDHHC23;TMED2;ITGB1BP1;TESC;EFR3A;CDH1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.462195002242618,-1.2119198429109885,0.22863741339491916,0.6385671185670443,1.0,5/12,21.81%,ATF7IP;TET1;SETDB2;PPHLN1;DNMT1
prerank,negative regulation of secretion (GO:0051048),-0.5119487285197437,-1.2113892728437434,0.23382045929018788,0.6388392841773848,1.0,8/10,40.14%,CD74;ERBB3;SPX;NRG1;VAMP8;PTGER3;VAMP3;EGF
prerank,substrate-dependent cell migration (GO:0006929),0.46697307372321684,1.2113888983588594,0.20658135283363802,0.7685422294071215,1.0,3/14,7.48%,OPHN1;P2RY12;EPHA8
prerank,sphingoid metabolic process (GO:0046519),0.48882045137666347,1.2112779270015914,0.23392857142857143,0.7675519409724352,1.0,4/12,12.08%,DEGS2;SPTLC3;PLPP2;PLPP1
prerank,sterol homeostasis (GO:0055092),0.32945770685552417,1.211259133866853,0.1474036850921273,0.7662009248965247,1.0,16/65,19.33%,LIPC;IL18;LRP5;APOM;NPC2;CYP7B1;LDLRAP1;NPC1;CNBP;SCARB1;TTC39B;NR1H2;ABCD1;ABCA1;LCAT;FGFR4
prerank,ventricular septum morphogenesis (GO:0060412),0.39865549686022905,1.2111134100745151,0.20708955223880596,0.7652794754225861,1.0,4/27,1.38%,TGFBR1;TGFBR2;SMAD7;HEYL
prerank,positive regulation of dendrite extension (GO:1903861),-0.43400895543081097,-1.2110188444280732,0.20045558086560364,0.6385778845459549,1.0,6/17,16.58%,RIMS2;SYT1;NEDD4L;RIMS1;PLAA;SYT3
prerank,transferrin transport (GO:0033572),0.3809881469674791,1.2108582602479028,0.20238095238095238,0.7647391668748509,1.0,7/33,10.73%,DNM2;ATP6V0B;MCOLN1;ATP6V0A2;TCIRG1;ATP6V0A4;ATP6V1D
prerank,positive regulation of macrophage migration (GO:1905523),0.44153068760101144,1.2102660318710725,0.21532846715328466,0.7656502984410606,1.0,3/19,6.01%,P2RY12;CSF1R;AKIRIN1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4988465663413553,1.2102403447350798,0.22796934865900384,0.7643309504248419,1.0,9/12,33.32%,ZCCHC3;CGAS;DHX9;MAVS;IFIT1;MUL1;RALB;COLEC12;FLOT1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.37371179465821536,1.2091227597184302,0.19680851063829788,0.7668449893155961,1.0,11/39,13.49%,GTF2H2;RFC2;PCNA;CUL4B;UBC;RPS27A;ERCC2;POLD2;DDB2;ERCC4;RFC1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.42225689782375786,1.2090933471601524,0.20466786355475763,0.7655776561116912,1.0,8/22,17.76%,GREM1;NBN;PDGFB;TNKS1BP1;GPNMB;TAOK2;CALM2;RASSF2
prerank,extracellular transport (GO:0006858),0.4676660506734068,1.2083810678555662,0.2230347349177331,0.766561014560901,1.0,4/13,15.26%,ARRDC1;WWP2;CCDC40;TSG101
prerank,signal transduction in response to DNA damage (GO:0042770),0.3535947362071105,1.2081382495760145,0.19022687609075042,0.7660370104484335,1.0,12/49,12.55%,RHNO1;CHEK2;ATM;USP28;RAD17;NBN;ACER2;MDM4;RAD1;CEP63;ABL1;MAPK14
prerank,response to cAMP (GO:0051591),-0.3548094907892298,-1.2080709398168585,0.1686746987951807,0.6458078916385611,1.0,16/37,24.60%,AKAP6;HCN1;RAPGEF2;PKD2;AHR;KCNQ1;PDE2A;CRHBP;CFTR;HCN2;EZR;SLC26A3;AQP1;SLC5A5;HCN4;WT1
prerank,regulation of T cell migration (GO:2000404),0.4339219501200569,1.2078886852733333,0.21223709369024857,0.7655148980475639,1.0,3/18,2.04%,DOCK8;AIF1;LRCH1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.42319108251934706,-1.207704765675055,0.21017699115044247,0.6455120205968575,1.0,3/16,4.42%,AMPD3;PPAT;ADSS2
prerank,cellular response to unfolded protein (GO:0034620),-0.37837372261981495,-1.2076912103075903,0.18478260869565216,0.6441863738680943,1.0,8/26,15.07%,ERN1;BAG3;PRKN;HSPA8;HSPA5;BAK1;HSPA2;HSPA1B
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.4793299689732479,-1.2069316011263653,0.21379310344827587,0.6451339360617527,1.0,3/13,4.44%,CD74;CD44;SIRT1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2960108465663138,1.2069148896278319,0.11076443057722309,0.7677625965552125,1.0,45/129,24.20%,TUBA4A;DNM2;SDCCAG8;CHEK2;PRKACA;CSNK1E;FBXL15;ODF2;TUBB;CEP164;TUBG1;HAUS7;CNTRL;CENPJ;TUBA1A;KHDRBS1;CEP63;HAUS2;CEP135;HAUS6;OFD1;FBXL22;CEP57;MAPRE1;AURKA;FBXL8;MASTL;PLK3;KDM8;DCTN2;OPTN;CEP70;FBXL7;CCNY;ACTR1A;CEP43;CCP110;NDE1;PPP1CB;CUL1;AJUBA;DYNLL1;CDC25A;HAUS5;FBXL12
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.32597311133561474,1.2069107584439862,0.1630971993410214,0.7664034840965216,1.0,14/72,12.41%,IL18;SRC;LYN;PIK3R1;IGF1R;PIK3CG;PIK3AP1;PDGFB;GPER1;FSHR;PIK3CB;PIK3CD;HCST;SEMA4D
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.45727358809512053,-1.2068364920919457,0.2505592841163311,0.6440220540724174,1.0,5/13,22.14%,NDC80;CDK5RAP2;GEN1;CCNB1;MAD2L1
prerank,leukocyte tethering or rolling (GO:0050901),0.4472457739285806,1.206783961115239,0.22122302158273383,0.7655071071687011,1.0,3/17,1.99%,CX3CR1;SELPLG;JAM2
prerank,mRNA splice site selection (GO:0006376),0.39127798455994967,1.2067073601519605,0.2024866785079929,0.7644224580898688,1.0,10/30,16.89%,CELF2;SNRPC;SFSWAP;PRPF39;SRSF5;LUC7L3;LUC7L;SLU7;SRSF9;SF3A1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.36973572425317175,1.2064923973538586,0.20242214532871972,0.7638357748171194,1.0,6/36,7.52%,OPHN1;FHIT;BAG6;UCHL5;USP25;KLHL40
prerank,tRNA aminoacylation (GO:0043039),0.3716706674722935,1.2064445912906456,0.19931856899488926,0.762646383365621,1.0,15/37,25.15%,KARS1;NARS1;RARS1;DARS2;EPRS1;QARS1;FARSA;SARS2;SARS1;WARS2;MARS2;AIMP1;IARS1;GATC;TARS1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3975935762910865,-1.2061299319746843,0.20601851851851852,0.6447362476225513,1.0,9/23,17.45%,PPARG;PARP14;JAK2;PTPN2;IRGM;HSP90AB1;IFNGR1;TXK;PIAS1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3403536479725844,1.205602335580599,0.1546572934973638,0.7629653247005388,1.0,23/56,25.95%,NDUFB2;NDUFB8;ACAD9;NDUFAF6;NDUFS3;NDUFS4;NDUFB10;NDUFAF1;NDUFB3;NDUFS5;BCS1L;NDUFAF5;NDUFV3;NDUFA13;NDUFC2;NDUFV1;NDUFA9;NDUFB11;TMEM126A;NDUFV2;OXA1L;NDUFAF3;NDUFAF7
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3403536479725844,1.205602335580599,0.1546572934973638,0.7629653247005388,1.0,23/56,25.95%,NDUFB2;NDUFB8;ACAD9;NDUFAF6;NDUFS3;NDUFS4;NDUFB10;NDUFAF1;NDUFB3;NDUFS5;BCS1L;NDUFAF5;NDUFV3;NDUFA13;NDUFC2;NDUFV1;NDUFA9;NDUFB11;TMEM126A;NDUFV2;OXA1L;NDUFAF3;NDUFAF7
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.36827105573940744,-1.205558835041422,0.2039911308203991,0.6449104348383261,1.0,9/31,15.07%,ERN1;BAG3;PRKN;UBE2W;HSPA8;HSPA5;BAK1;HSPA2;HSPA1B
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3434600552112643,1.2053841248201533,0.19732441471571907,0.762333475705705,1.0,23/52,27.04%,EXTL3;PREB;HYOU1;PDIA5;DNAJB9;GFPT1;CXXC1;KLHDC3;PLA2G4B;VAPB;PPP2R5B;SYVN1;SEC31A;EDEM1;TSPYL2;DNAJB11;SERP1;CTDSP2;SRPRB;FKBP14;DDX11;MYDGF;ACADVL
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.32283336539284835,-1.2052741383370202,0.16252821670428894,0.6443212615031109,1.0,9/51,5.65%,CNTNAP2;NYAP2;LRRK2;GPM6A;BDNF;CTTN;DCLK1;CNTNAP1;WASF1
prerank,keratinocyte differentiation (GO:0030216),0.39023701719103787,1.2046922526756607,0.2026266416510319,0.7635608141532932,1.0,4/29,7.26%,DSP;ST14;CERS3;ASAH1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.30178469840776534,1.204608106180597,0.1337579617834395,0.7624787753226354,1.0,23/109,12.86%,INPP5D;CSF1R;PI4KB;MTMR10;PIK3R1;PLCG2;PIK3CG;INPP4B;RAB4A;PIP4P1;PLA2G5;PIK3CB;INPP5E;PLA2G4A;CDS1;PLEK;PIK3CD;PIK3C3;PLEKHA4;IMPA1;MTMR4;PITPNM1;BMX
prerank,regulation of pH (GO:0006885),0.4955182311170163,1.2045524871514641,0.24214417744916822,0.7613364465080416,1.0,3/11,10.66%,ATP1A4;PDK2;ATP6V0A4
prerank,protein import into nucleus (GO:0006606),0.32877895884102215,1.204499567666286,0.1508828250401284,0.7601750358280377,1.0,26/66,23.24%,FAM53A;PHB2;RANBP2;TNPO1;SEC13;NUP35;SPRN;NUP62CL;APPL1;NUP50;IPO4;TNPO3;AKT1;PTTG1IP;CSE1L;NUP62;NUP107;KPNA3;NUP88;E2F3;NUP188;IPO7;RPAIN;NUP214;HIKESHI;APPL2
prerank,zinc ion transmembrane transport (GO:0071577),0.42897455328691225,1.2044551130609862,0.21196581196581196,0.7589804468024257,1.0,5/22,11.98%,SLC30A5;SLC30A10;TRPM2;SLC30A8;SLC39A2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.4861798110770871,-1.2044157189584725,0.2224622030237581,0.6455322596988629,1.0,5/11,33.13%,SIK1;CRY1;C1QTNF3;C1QTNF12;GCK
prerank,hematopoietic stem cell proliferation (GO:0071425),0.5007014918674987,1.2041432236572087,0.22659176029962547,0.7587307439884938,1.0,4/11,14.11%,CD34;WNT2B;WNT10B;RUNX1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3523900445121183,1.2036139454495502,0.1896551724137931,0.759214047848549,1.0,10/51,7.63%,CSF1R;LGALS9;AIF1;LGMN;IL6R;VEGFB;AKIRIN1;EDN3;CCR7;EDN2
prerank,sensory perception of chemical stimulus (GO:0007606),-0.4353383095110473,-1.2034722827460091,0.21199143468950749,0.6469763372115387,1.0,3/15,7.35%,CD36;SYT10;ADCY3
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3762003842555626,1.2034195349795498,0.19099099099099098,0.7586594077356522,1.0,9/35,11.79%,F11R;ABI3;CSF1R;BAIAP2L2;TRPM2;PTK2B;RAPGEF3;TJP1;ABL1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.27512047223522484,-1.2033790716157493,0.11140583554376658,0.6459010817711457,1.0,31/129,16.48%,LRRK2;EGFR;CSNK1G1;FGF10;GPC5;PSMD14;PPM1A;UBR5;ATP6AP2;PSMA2;SEMA5A;PSMF1;PSMD8;COL1A1;PSMD6;GPC3;PSME2;PSMD11;ZEB2;LGR4;AXIN1;CCAR2;TNKS2;LGR5;PSMD1;PSMD5;KANK1;CAPRIN2;SFRP1;PSMD12;BAMBI
prerank,response to interleukin-6 (GO:0070741),0.5160528471202568,1.202991008504001,0.24765478424015008,0.7588856204916212,1.0,3/10,4.34%,SELPLG;ST3GAL6;SBNO2
prerank,regulation of viral transcription (GO:0046782),0.365395964589476,1.201674401423607,0.19655172413793104,0.7620858042274211,1.0,13/39,20.06%,NELFB;UBP1;POLR2H;TRIM11;CDK9;POLR2D;POLR2J;DHX9;TRIM62;NELFE;TRIM14;POLR2E;POLR2I
prerank,aminoglycan catabolic process (GO:0006026),-0.37279576974792555,-1.2012123128937462,0.2091346153846154,0.6510117505641559,1.0,10/28,17.97%,GPC6;GPC5;SDC3;HGSNAT;HSPG2;GPC3;AGRN;FUCA1;GPC4;SDC4
prerank,calcium ion import (GO:0070509),-0.3748778740712552,-1.2009033449161726,0.1963470319634703,0.6506302633604882,1.0,9/28,13.64%,CACNA1E;TRPC4;MCU;ATP2A2;CACNA1C;MCUB;MICU2;CACNA1G;MICU3
prerank,multivesicular body organization (GO:0036257),0.38694503486895176,1.2008373542277164,0.21996615905245348,0.7637417555150107,1.0,18/31,34.14%,RAB27A;VPS37A;VPS36;VPS37D;CHMP1A;TSG101;CHMP2A;HGS;IST1;STAM2;CHMP7;VPS37B;VTA1;CHMP3;RAB11A;PDCD6IP;CHMP6;CHMP5
prerank,clathrin-dependent endocytosis (GO:0072583),-0.38106914618436444,-1.2006474751121277,0.18372093023255814,0.6500569518601713,1.0,6/26,3.93%,DNAJC6;ITSN1;SNAP91;SGIP1;SIGLEC1;AP2A2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.32127025692009487,1.2006394271211605,0.16887417218543047,0.763121742619522,1.0,21/76,19.34%,BIN1;BAIAP2L2;CDC42EP2;NUMA1;NCKAP1L;CCR7;PTK2B;FCHSD2;PLEK;ABL1;SORBS3;TENM1;PROX1;VASP;NUP62;FES;CCL24;KATNBL1;FCHSD1;EVL;PYCARD
prerank,neutrophil activation (GO:0042119),0.4964533818878063,1.200258445685841,0.2413793103448276,0.7631531362782201,1.0,2/12,2.84%,PREX1;PRKCD
prerank,exit from mitosis (GO:0010458),-0.4725034724439001,-1.200218569000036,0.23076923076923078,0.650028418220734,1.0,2/12,12.05%,EPS8;UBE2C
prerank,regulation of interferon-beta production (GO:0032648),0.34801476034153733,1.2001666879159996,0.18739352640545145,0.7621571985782591,1.0,6/46,2.82%,POLR3G;TLR7;SIRPA;RNF216;TLR4;RIPK2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4074317195898149,-1.1997067725447175,0.2111111111111111,0.6501662471171672,1.0,4/20,5.07%,NLGN1;APOE;CPEB3;SHANK3
prerank,Notch signaling pathway (GO:0007219),0.3348117397667783,1.199639626191663,0.17160686427457097,0.7628389035032864,1.0,21/59,20.00%,MAML3;HEYL;ITCH;DTX4;JAG2;PSEN2;NOTCH4;PSENEN;GALNT11;DTX1;NLE1;MAML2;DLL1;DTX3L;NOTCH3;POFUT1;APH1B;TRAF7;ADAM10;DTX3;ADAM17
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.4950282954142975,-1.1994334970125202,0.2533039647577093,0.6496540524747324,1.0,6/10,16.36%,GABRA3;GABRG1;GABRA2;GABRG3;GABRG2;GABRA5
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3559378270427118,-1.1991374545452103,0.18588235294117647,0.6492388466048705,1.0,7/34,6.92%,PDE4B;ANK2;PDE4D;ADRA1A;RYR2;ATP2A2;CALM1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.45188206001071957,1.198882039642536,0.22988505747126436,0.7641954803520702,1.0,11/17,37.11%,COX8A;COX7A2L;COX5A;COX6B1;COX6A2;COX6A1;AFG1L;COX4I1;COX10;COX15;COX7C
prerank,nucleoside phosphate catabolic process (GO:1901292),0.47917468795176177,1.1987640274074023,0.2518939393939394,0.7632672007269173,1.0,4/13,18.25%,ENTPD1;NUDT15;ENTPD7;ENTPD6
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.34084904786944964,1.1981846659728352,0.17903225806451614,0.7639157159624073,1.0,13/55,13.04%,TGFBR2;RAC1;COQ7;BCO2;RNF41;SIRT2;AATF;PDGFB;BRCA1;PINK1;MAPK14;DHRS4;PAX2
prerank,regulation of TORC1 signaling (GO:1903432),0.382133746647606,1.1979331505047741,0.18835616438356165,0.7635210894239854,1.0,11/33,21.28%,ATM;FLCN;PIP4P1;LAMTOR5;GPR137C;RRAGA;GPR137;SEH1L;SESN1;TELO2;DEPDC5
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.38119873043226654,-1.197691744222256,0.19545454545454546,0.652045298835044,1.0,13/28,25.04%,ITPR1;ERN1;TMEM117;CEBPB;ATP2A3;BAK1;ERO1A;SELENOK;BCL2;BRSK2;TRIB3;ATP2A1;CASP4
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.46928802269803327,-1.1975817727597986,0.2170212765957447,0.6510598460337279,1.0,3/12,4.94%,TMEFF2;PF4;TAF7
prerank,striated muscle cell development (GO:0055002),0.4660730303372469,1.1974876872950675,0.24675324675324675,0.7637433399277485,1.0,2/14,1.56%,CAPN3;FLII
prerank,immunoglobulin mediated immune response (GO:0016064),-0.49440414136194943,-1.1973167471209925,0.2572614107883817,0.6505821037322413,1.0,5/10,23.35%,CD74;FCGR2B;TLR8;GAPT;CD19
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3726493885918485,-1.1966687814567312,0.21149425287356322,0.6511096789655779,1.0,10/30,18.91%,CD74;CD44;SIRT1;RPS3;TPT1;CCAR2;SNAI2;SFRP2;MDM2;DDIAS
prerank,regulation of cytokine production (GO:0001817),0.29508543658651515,1.1962294364152366,0.13782051282051283,0.766710954672246,1.0,29/126,16.45%,SIRPA;CADM1;CCDC88B;LGALS9;LYN;RPS6KA5;PIK3CG;LRRC19;DTX4;AFAP1L2;GAPDH;PLD4;CCR7;BCL6B;NOS2;IL12B;IL33;SCAMP5;PIK3CD;SOD1;IGF2BP2;MAPK14;IRF8;IRF3;EIF2AK2;GPNMB;RPS6KA4;SYT11;GATA3
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4496135261533974,1.1960009256746569,0.24632352941176472,0.7662153577247147,1.0,3/16,6.23%,SALL1;NPNT;SHH
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.43657610242196254,1.1955373641159213,0.2365988909426987,0.7665333613377091,1.0,3/18,1.99%,CX3CR1;SELPLG;JAM2
prerank,cellular lipid catabolic process (GO:0044242),0.39323153272447436,1.1951577059852978,0.22841726618705036,0.7665806785506709,1.0,6/27,5.78%,ABHD12;LPIN2;PPARD;SIRT2;PLA2G15;NUDT19
prerank,excitatory postsynaptic potential (GO:0060079),-0.40696383391070423,-1.1949880829410577,0.2315035799522673,0.6548710425008966,1.0,6/19,9.95%,GRID2;LRRK2;GRIN2A;GRIN2B;GSK3B;GRIN2D
prerank,amide biosynthetic process (GO:0043604),-0.3259922840798067,-1.1949843945593543,0.18925233644859812,0.6535706848351113,1.0,6/47,2.89%,DMD;SGMS1;PAM;PCSK5;SPTSSA;SGMS2
prerank,protein stabilization (GO:0050821),0.2876425051129656,1.1947313346082526,0.11213517665130568,0.766824978810974,1.0,48/168,22.11%,HPS4;SUMO1;SMAD7;PIM2;BAG6;CHEK2;COA8;VHL;PRKCD;PIK3R1;PHB2;SEL1L;TRIM44;CLU;STX12;SWSAP1;GAPDH;WNT10B;SOX17;PEX6;USP36;HIP1R;MDM4;PDCD10;BAG4;CCT3;PINK1;USP19;NAPG;MORC3;FLOT2;TNIP2;HYPK;WDR81;TAF1;RASSF2;SYVN1;MFSD1;STXBP4;PARK7;TELO2;COG7;EFNA1;LAMP2;TRIM39;GLMP;CRYAB;CCT5
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.32506654017098124,1.194679818093855,0.17704918032786884,0.7657250122656976,1.0,10/70,5.52%,SRGAP2;OPHN1;RILPL1;RAC1;MEF2C;ITGAV;FERMT3;PIK3R1;PKHD1;LPXN
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.48888404860957024,-1.1943434599109206,0.24897119341563786,0.6541905865444672,1.0,5/10,22.65%,MLLT3;SFRP1;HOXB4;ACE;SP7
prerank,B cell activation (GO:0042113),0.3249615177421313,1.1942739777980877,0.16887417218543047,0.7658076286537524,1.0,9/68,3.60%,BLNK;LYL1;MEF2C;LAT2;FCRL1;DNAJB9;PHB2;PLCG2;GPS2
prerank,glycerolipid catabolic process (GO:0046503),0.4375995035157247,1.1942434094292511,0.2302158273381295,0.7646056535099175,1.0,4/19,10.21%,ABHD12;PLA2G4B;PLA2G4A;ABHD6
prerank,T cell proliferation (GO:0042098),0.4758941996007686,1.1940177905679055,0.23782771535580524,0.7640292291514655,1.0,3/13,4.33%,DOCK8;CADM1;PIK3CG
prerank,B cell differentiation (GO:0030183),0.34950382807724767,1.1939874175595497,0.1890547263681592,0.7628632041733656,1.0,13/46,20.00%,BLNK;LYL1;DNAJB9;PLCG2;GPS2;IRF2BP2;CEBPG;SYVN1;PTPRJ;HDAC5;TCF3;CD79A;ADAM17
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.39415323889519516,1.1938115707908346,0.21493624772313297,0.7621983201842846,1.0,4/25,3.36%,ABI3;PRKCD;TBC1D7;CAPZB
prerank,regulation of MAPK cascade (GO:0043408),-0.26578265853795585,-1.1935827370563226,0.08163265306122448,0.6550444129843681,1.0,35/157,17.53%,CD74;IQGAP1;RIT2;LBH;TMEM106A;EGFR;ADRA1A;FGF10;PHLPP1;ROR1;PAK5;NTRK2;IAPP;ATP6AP2;NTRK3;FN1;PAK3;STYX;RET;ADRA2A;FGFR3;ZDHHC17;DAG1;PAK1;FAM83D;MMP8;KIT;LILRA5;CX3CL1;TNIK;WWC1;TEK;HMGB1;WDR54;PDGFA
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2628130064718909,1.1933134144991948,0.06657420249653259,0.7627097013766047,1.0,83/341,17.99%,MVB12B;NFE2L2;BAG6;ARRB2;DDIT3;MTA1;FBXO22;TGFB1I1;RNF216;ITCH;SPSB1;SIRT2;UCHL1;UBE2H;SMURF1;RFFL;ZRANB1;ZSWIM8;SPSB2;NDFIP2;UFD1;TRIM72;CDC34;MAEA;PSMD3;ARRDC1;ANKRD9;OS9;RNF8;CRBN;WWP2;FBXW4;RNF166;FBXO11;BFAR;PSMA7;PCBP2;AREL1;FBXO21;ANAPC15;DCAF11;RNF11;UBE2U;VPS37A;PINK1;VPS37D;KCTD6;UBXN2A;NTAN1;DTX3L;ANAPC11;MYLIP;PSMB3;PSMB9;FBXL22;KCTD2;PSMC2;RNF187;TNFAIP1;RNF144B;AURKA;TSG101;UBQLN4;PTPN23;TRIM3;PSME4;PSMC1;PSMB7;ZNRF3;TOPORS;ANAPC1;ZFAND2A;FBXL7;SPOPL;WDR81;UBE2A;TAF1;KLHL3;RNF4;SYVN1;GID8;PSMB5;FBXO8
prerank,endothelial tube morphogenesis (GO:0061154),-0.4903835835223943,-1.192976412155358,0.22857142857142856,0.6555438805351219,1.0,5/10,19.47%,RBPJ;CTNNB1;ACVRL1;BMP4;STARD13
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4605682283702407,1.1928580051658673,0.2514395393474088,0.7630739160242382,1.0,3/14,7.73%,IL18;CD84;IL12B
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.46932522686656836,1.1928126957309002,0.25,0.7619156153463831,1.0,6/14,24.96%,CSF1R;AKIRIN1;THBS1;CXCL17;IL34;MDK
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2818379307985113,-1.1926522309720435,0.14444444444444443,0.6551311353106993,1.0,24/110,11.22%,CD36;NAPB;LATS1;APOE;GSN;TPPP;PRKCZ;IAPP;ATF7IP;TRABD2B;RPS3;CDC42;SAR1B;NAPA;FAF1;GSK3B;RIOK3;HSPA8;RAF1;HSPA5;OPRD1;IRGM;BID;BAK1
prerank,sphingolipid biosynthetic process (GO:0030148),0.32417705513664663,1.1925821431391548,0.17609046849757673,0.761467466890716,1.0,17/71,13.52%,LARGE1;ST3GAL5;CERS3;DEGS2;SPTLC3;HACD3;PPM1L;ACER3;SMPD2;ACER2;ALOXE3;ASAH1;PNPLA1;PLPP2;PLPP1;VAPB;PRKD3
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.36492693578621455,1.1923337664386813,0.20270270270270271,0.7610729820018477,1.0,16/40,26.27%,GNA12;CSNK2A2;CSNK2A1;SMURF1;CLU;PTK2B;ARAF;UBQLN4;CCDC22;TAF1;TRIM39;UBE3A;SGTA;XPO1;RAD23B;GLMN
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.35465944574344316,-1.192197292604123,0.2,0.6551979341681488,1.0,15/35,21.52%,NLGN1;CDH8;CDH22;CDH13;CDH7;CDH20;CDH11;CDHR3;CDH5;CDH10;PCDHB16;PCDHB13;PCDHB6;PCDHB14;SELL
prerank,epithelial structure maintenance (GO:0010669),0.4825053138736267,1.1921370022359958,0.2505091649694501,0.7605084510776994,1.0,4/11,25.23%,CXADR;MUC6;NOD2;TLR9
prerank,regulation of protein sumoylation (GO:0033233),0.4389057352762641,1.1914137853917914,0.2560747663551402,0.7617001649487922,1.0,10/17,26.43%,CAPN3;UBA2;RASD2;PIAS3;EGR1;GNL3L;PARK7;SAE1;ZMIZ1;PIAS4
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.49089271199363693,-1.191246490817382,0.25162689804772237,0.6567485129354096,1.0,2/10,3.40%,ZBTB16;SOX5
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.41433772732745033,-1.1912087947709409,0.23042505592841164,0.6555549646980574,1.0,6/17,17.46%,PRKG1;PPARG;SOD2;CDKN1A;TAFA5;APLN
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.2603755954643762,-1.1905288842381092,0.08860759493670886,0.6562977682448032,1.0,46/186,18.33%,DAB2;CUL3;CCDC88C;LATS1;SHISA6;APOE;PSMD14;LIMD1;HECW1;RBMS3;APC2;TRABD2B;PSMA2;PSMF1;GSK3B;PRKN;FRZB;PSMD8;IGFBP4;TLE4;LRP6;PSMD6;SIAH2;SOX13;PSME2;PSMD11;GRB10;AXIN1;MLLT3;NXN;PSMD1;PSMD5;TLE1;IGFBP2;NPHP3;HDAC1;SFRP1;PSMD12;NKD1;SNAI2;ANKRD6;JADE1;MCC;SFRP2;SCYL2;NLK
prerank,glycine transport (GO:0015816),0.5024958603707768,1.1905060848699829,0.26597938144329897,0.7636296913428364,1.0,2/10,3.11%,SLC7A8;SLC36A1
prerank,ganglion development (GO:0061548),-0.4757135454493111,-1.1899643963360373,0.23060796645702306,0.6566399252477788,1.0,1/11,0.44%,UNC5C
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.34817504145275674,1.1896894245269258,0.19448946515397084,0.7652017711872269,1.0,20/47,24.31%,ITGAM;TGFBR2;TLR4;RNF41;PRKCD;PLCG2;ITGB2;PDGFB;RAB27A;SOD1;MAPK14;DHRS4;THBS1;CBR1;SLC5A3;MAPT;TP53;AGT;TGFB1;ZC3H12A
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.3829627516670472,1.1887854672758298,0.21660649819494585,0.7670123024987942,1.0,10/29,25.27%,SMAD7;MYL3;PROX1;NOG;ENG;FGFR2;BMP2;TPM1;TGFB1;NOTCH1
prerank,cilium organization (GO:0044782),0.2752118458253845,1.1882993863376967,0.11176470588235295,0.7674906128610751,1.0,64/210,24.33%,ASAP1;EXOC7;RILPL1;BBS9;KIF3B;TTLL3;PKHD1;CEP162;HYLS1;UBXN10;ODF2;CEP164;EHD4;RP2;MKS1;CFAP52;TTC36;NME8;AVIL;CFAP221;NUDCD3;IFT52;RAB1A;INPP5E;CCDC28B;GALNT11;BBS2;CDC14B;CENPJ;ATP6V1D;KIF27;KIF3A;DYNLT2B;CFAP20;WDR90;EXOC6;MNS1;IFT20;CCDC66;TCTN1;OFD1;PDE6D;EXOC1;PTPN23;CPLANE2;B9D1;TMEM17;MARK4;EXOC4;CCP110;IFT140;EXOC8;ATAT1;PLA2G3;ARL3;CC2D2A;ARF4;TCTN2;ACTR2;SSX2IP;DYNLL1;RAB23;TTBK2;IFT122
prerank,establishment of mitotic spindle localization (GO:0040001),-0.3675877614959845,-1.1882655480639503,0.20935412026726058,0.660306635405236,1.0,13/28,26.05%,HTT;NDC80;SPDL1;CDK5RAP2;ZW10;NUSAP1;GPSM2;ITGB1;MAD2L1;NSFL1C;PLK1;FBXW11;PAFAH1B1
prerank,response to interferon-gamma (GO:0034341),-0.3067007259426875,-1.1876619640909538,0.16995073891625614,0.6608171137993434,1.0,23/67,19.77%,CD74;CD47;CIITA;IFITM3;CCL4;CD40;AQP4;GBP3;DAPK1;SP100;RPL13A;GBP4;CCL2;SNCA;GBP2;IFITM2;CCL5;CX3CL1;IFITM1;CCL14;NUB1;CCL7;SYNCRIP
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3834958501774117,-1.1875602800604659,0.20042643923240938,0.6598181655914853,1.0,6/25,10.69%,DMD;ANK3;ANK2;TCAF1;ACTN2;ATP1B3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.32785566125219834,1.187517350497779,0.1742671009771987,0.7689736870589923,1.0,20/67,18.96%,ELMO1;VAV2;RAC1;ITGAV;SRC;PIK3R1;SHB;NCKAP1L;VEGFB;PIK3CB;PTK2B;AXL;PDCD6;MAPK14;ROCK2;CYFIP1;CLEC14A;SH2D2A;PXN;VAV1
prerank,negative regulation of B cell activation (GO:0050869),0.41603676677572676,1.1874903581524852,0.23434704830053668,0.7677682875982077,1.0,5/21,7.21%,LYN;ATM;TNFRSF21;TNFRSF13B;INHA
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.48557677263613785,-1.186982202343287,0.25386313465783666,0.6602304108061591,1.0,6/10,24.58%,JARID2;SIRT1;DNMT3B;RIF1;DNMT1;MYB
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.42441106168220943,-1.1863796523103705,0.23076923076923078,0.6607031171158119,1.0,6/17,15.77%,NLGN1;SYT10;RAB3D;RAB3A;CACNA1G;SLC4A8
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.48569720825748164,1.1863723456543824,0.2504638218923933,0.7705640604519938,1.0,5/11,15.65%,ITGAM;ITGB2;STX4;MAVS;TICAM1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.2956304568231836,-1.1858478540532,0.1625,0.6610287633185075,1.0,27/83,21.71%,CUL3;POLA1;CDK14;LATS1;TFDP2;CDK7;MYC;NASP;PLK2;PPP6C;BCAT1;NPAT;USP29;CACUL1;CDK15;CDKN2A;CDKN1A;GPR132;DBF4;EIF4EBP1;TFDP1;CDK2;E2F1;SPDYA;USP26;CDK4;CDK6
prerank,negative regulation of potassium ion transport (GO:0043267),0.46522543863707955,1.1856114298938405,0.2593283582089552,0.771902367599547,1.0,5/13,18.66%,BIN1;PTK2B;STK39;VIP;NOS1
prerank,mRNA destabilization (GO:0061157),0.36003400785265605,1.185248568970247,0.2289156626506024,0.7718961348898971,1.0,10/38,13.66%,CNOT1;MOV10;POLR2D;ZFP36L1;DIS3L2;ZFP36L2;RBM24;DCPS;ROCK2;METTL14
prerank,myeloid leukocyte differentiation (GO:0002573),0.32608747944848204,1.1851320625112967,0.18152350081037277,0.7710072988510333,1.0,14/65,14.11%,TGFBR2;CSF1R;LGALS9;GAB2;SBNO2;CCR7;PDE1B;MT1G;PIK3CD;OSTM1;MYH9;MAPK14;OSCAR;RUNX1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.42908669505223307,-1.1850638598131877,0.24,0.6621821163087807,1.0,4/16,4.44%,CD36;KCNC2;APOE;GUCY1B1
prerank,regulation of lamellipodium assembly (GO:0010591),0.37617109129127946,1.1847713480515658,0.2129783693843594,0.7710684317719574,1.0,8/34,7.84%,ABI3;TWF2;RAC1;PIK3R1;CAPZB;FSCN1;AKIRIN1;AVIL
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.45194332620760425,1.184100447784477,0.24548736462093862,0.7721965687617165,1.0,6/15,26.87%,SOX8;PAX2;NOG;SMO;AGT;SOX9
prerank,bile acid metabolic process (GO:0008206),0.3879043450635634,1.1840951008076133,0.23476702508960573,0.7709520532529004,1.0,10/27,23.19%,CH25H;CYP46A1;OSBPL3;AKR1D1;CYP7B1;NPC1;HSD17B10;ACOT8;OSBP;SCP2
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3853282980025628,1.1839104686569473,0.22361359570661896,0.7703196664927647,1.0,5/30,7.73%,LGALS9;TLR4;PLCG2;CD34;IL12B
prerank,rRNA methylation (GO:0031167),0.41609360808491824,1.1830268272764652,0.22183098591549297,0.7721471652447838,1.0,8/22,20.65%,EMG1;BUD23;METTL5;NSUN5;FTSJ3;NSUN3;FBL;TFB1M
prerank,activation of protein kinase activity (GO:0032147),0.2985201905086111,1.1828528292268332,0.15673981191222572,0.7714495425523706,1.0,23/106,13.44%,IL18;TGFBR2;MAP4K4;PRKACA;PRKCD;ADCY9;PHB2;PDPK1;STRADA;PDGFB;ADCY4;PTK2B;CD86;MLST8;ZFP91;ADCY6;ABL1;MTOR;MARK2;PINK1;CHRNA3;AKT1;PRRC1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4854627538215256,-1.182611062922275,0.2542016806722689,0.6683703650046081,1.0,4/11,10.91%,AGBL4;TTL;AGBL1;ATG7
prerank,regulation of hippo signaling (GO:0035330),-0.4077344531077059,-1.182465623009316,0.22857142857142856,0.6674992712556755,1.0,4/17,5.11%,MOB3B;LIMD1;SOX11;MARK3
prerank,cellular protein localization (GO:0034613),0.26283201677161266,1.181996302352275,0.08608321377331421,0.7731371815263249,1.0,91/285,21.40%,TBC1D16;UNC93B1;ARHGEF2;CAPN3;HERC2;YWHAH;TBC1D9B;ARFIP1;TBC1D8;COPA;ATG9A;TBC1D17;AP3D1;TBCK;VPS26B;FAM91A1;ARL5C;SMURF1;STX1A;STXBP1;VIPAS39;ID1;AP2A1;TBC1D15;TMED9;ARFIP2;RAB3GAP2;PIGK;STX12;LAMTOR2;SEC13;MYO7A;CPE;STX19;MESD;TBC1D10B;TM9SF1;RAB1A;ARFGAP3;TBC1D9;BBS2;TRAPPC8;SAR1A;TICAM2;SNX31;SEC31B;SGSM2;STX4;PDCD6;USP4;SCG5;RUNDC1;RRAGA;SGSM3;ADPRH;TMED4;NAPG;ATG9B;GGA3;SLU7;GJA1;RAB20;EIF2D;ARL11;AP4M1;CPLANE2;RAB6B;PICK1;CEP68;GRTP1;STX16;TBC1D30;SEC31A;PACS2;RAB32;CELSR1;KIF13A;PIGU;WDR45B;CROCC;TBC1D13;COG7;SH3PXD2B;ACD;VPS26A;AXIN2;WLS;ARF1;GRIN3B;MFN2;STX5
prerank,cartilage development (GO:0051216),-0.3174854687187668,-1.1819742494932524,0.1731266149870801,0.6677477167053238,1.0,9/49,11.50%,ZBTB16;NFIB;CD44;SULF2;SNX19;SOX5;RUNX2;ATP7A;FGFR3
prerank,dendrite morphogenesis (GO:0048813),-0.3545711029651597,-1.1819019875034702,0.1938534278959811,0.6666626255469005,1.0,7/35,8.25%,CTNND2;CTNNA2;MAP2;CDC42;SHANK3;PAK3;DCDC2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3759764926826996,-1.18110477577452,0.2026726057906459,0.6677824450529518,1.0,8/28,13.91%,PID1;PRKCZ;IRS1;TNS2;PTPN2;GRB10;KANK1;PRKCQ
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.40484354629712777,-1.1805446326523377,0.24036281179138322,0.668216081939886,1.0,6/20,14.65%,ITGA4;GSN;CD40;ANO6;CCL2;RGCC
prerank,negative regulation of protein polymerization (GO:0032272),0.38504901021686205,1.1805426103002494,0.2218370883882149,0.7770096226237463,1.0,9/27,18.43%,SSH2;TWF2;PRKCD;CYRIB;SSH1;HIP1R;MAPRE1;DYRK1A;CLIP3
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.2529339313142566,1.180315385292598,0.06513409961685823,0.7765741666423759,1.0,111/509,17.96%,CX3CR1;TGFBR1;IL18;TLR7;P2RY12;PIM2;LGALS9;RAC1;CFLAR;DDIT3;TGM2;AGER;TMEM101;ATP2C1;TLR4;MAP3K3;ITGAV;GAB2;TRAF5;SRC;RIPK2;LYN;PIK3R1;PHB2;PLCG2;IGF1R;ZCCHC3;TRIM5;CASP1;CD27;KSR1;THEM4;PIK3CG;TRADD;LRRC19;SPRY2;TRIM44;PDPK1;FLCN;NDFIP2;NOS1AP;AKAP13;MET;LAMTOR2;TAB2;SEC13;NEK6;GAPDH;ZDHHC13;PIK3AP1;RYK;FRS2;EPHA8;PDGFB;CCR7;IL12B;EDA2R;RASD2;GPER1;CALCR;FSHR;PIK3CB;MIB2;CGAS;LAMTOR5;CXXC5;CD86;MLST8;WDR24;RPTOR;MTDH;GCNT2;TICAM2;PIK3CD;PTPN11;AXL;HCST;TRIM62;LIMS1;BMF;SEMA4D;PINK1;PRKCB;ROCK2;RNF31;RRAGA;GPR61;PELI2;TNFRSF19;TMED4;SEH1L;EIF2AK2;GJA1;MAVS;TNIP2;TICAM1;CCDC22;NUP62;GPR62;THBS1;GATA3;TRIM14;ECT2;TRAF7;ENG;C1QBP;BCL2L11;P2RX5;GPR89A;NOD2;PTPRJ
prerank,regulation of signal transduction (GO:0009966),-0.2570016514087507,-1.180240951737028,0.08417508417508418,0.6678493126589055,1.0,53/190,21.52%,MDFIC;PLCB1;LRRK2;GRK5;CD36;APP;NCK2;SLC8A3;SHARPIN;FRMPD1;SIRT1;RASGRP4;SEMA5A;PPIA;HOMER1;KCTD8;NCAM1;LFNG;IGFBP4;SP100;DOK5;DCDC2;PTPN2;RGS20;ERBB3;AXIN1;IFT81;CDC42SE2;ZDHHC17;DTNBP1;PPP2R1A;ITGB1BP1;LIFR;RGS6;INTU;YJEFN3;IGFBP2;UGCG;TMEM108;CX3CL1;FBXL17;CD80;TSPEAR;CD3E;VEPH1;FOXP3;CD46;RGS3;FYN;IGFBP7;NUCKS1;ALOX15;CD63
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.2753042795399387,-1.1801729629556983,0.1440443213296399,0.66675715199368,1.0,48/110,32.55%,ADGRE5;ADGRB3;ADGRL3;ADRA1A;ADGRG6;IAPP;ADCY2;RAPGEF2;ADCY5;PF4;ADCY3;ADCY8;S1PR5;LGR4;GPR161;ADRA2A;LGR5;ADGRG5;TSHR;LPAR2;RXFP2;ADM;CNR2;ADGRL4;GPR65;GNA13;ADGRL2;S1PR2;MC4R;LPAR3;PTGIR;CALCA;ADRA1B;GNAQ;PTH1R;PTGER1;PTGFR;S1PR4;ADGRG4;MC2R;CXCL9;ADGRD1;DRD1;GPR12;GPR3;ADRA2C;GHRH;CALCB
prerank,histone H3-K4 methylation (GO:0051568),0.3994725393466298,1.1801529335504704,0.23175182481751824,0.7759258509946759,1.0,12/26,27.86%,KMT2D;CXXC1;CTR9;TET3;SETD4;PRDM9;WDR5;DPY30;PAXIP1;KMT2C;KMT2B;DYDC2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.328750392270985,-1.1801129146391498,0.17475728155339806,0.6656786787400978,1.0,13/45,14.64%,CD44;OAS2;CIITA;B2M;IRF4;NCAM1;SP100;JAK2;PTAFR;VCAM1;IFNGR1;GBP2;OAS3
prerank,histone H2A acetylation (GO:0043968),0.45851040097925033,1.1793188102220986,0.2613430127041742,0.7774495874191752,1.0,5/16,17.13%,BRD8;MORF4L1;NAA40;ACTL6A;EPC1
prerank,pancreas development (GO:0031016),0.46854117035501053,1.1793185636163208,0.26436781609195403,0.7762016747587912,1.0,5/12,18.28%,MET;CCDC40;PROX1;SELENOT;TCF7L2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.44835864429730776,1.1788861590646378,0.25045045045045045,0.7765085399624523,1.0,7/15,26.79%,PRKCD;PLA2G6;SMPD2;ORMDL2;SIRT3;ORMDL3;SMPD3
prerank,cellular response to organic cyclic compound (GO:0071407),-0.26185618547204376,-1.1786495078925507,0.10324483775811209,0.6687191063475096,1.0,41/141,18.51%,AKAP6;LRRK2;CTNNA1;HCN1;EGFR;GABRB1;HRH1;RYR3;ADCY2;RAPGEF2;ADCY5;SPP1;P2RY1;ACTB;ADCY3;ADCY8;RIOK3;GOLPH3;PKD2;GABRB3;CCL2;GABRG2;MSN;ATP1A1;SLC1A1;AHR;GNAI1;CDH1;KCNQ1;PDE2A;CTNNB1;LCOR;NR3C1;CCL5;CRHBP;SFRP1;CFTR;HCN2;NR1H4;DIAPH1;ADTRP
prerank,RNA processing (GO:0006396),0.27623783057713375,1.1786322008639438,0.13602391629297458,0.776138656113441,1.0,52/176,23.09%,IVNS1ABP;SRRM1;SON;PPP1R9B;PRKACA;NCBP1;CELF2;AKAP8L;SF3B2;SF3B1;HNRNPC;SNRPF;SRSF5;FUS;PABPN1;U2AF2;HNRNPH1;SNRNP48;TSEN2;DDX17;HNRNPR;LUC7L3;RBM39;SNRPA1;DUSP11;TSEN54;SNRPN;RBM8A;SLU7;SCNM1;DDX39B;SRSF9;SF3A1;GEMIN2;ALKBH5;PRPF3;WBP4;MPHOSPH10;PRPF4;DDX54;TARDBP;SNRNP25;HNRNPH3;RBM4;HNRNPUL1;FASTKD2;SNRNP40;DDX47;HNRNPA2B1;MAGOHB;MAGOH;MBNL1
prerank,positive regulation of protein acetylation (GO:1901985),0.48079218096085613,1.1777949708238689,0.27075812274368233,0.7778487646721268,1.0,5/12,22.21%,DIP2B;CEP295;RAPGEF3;CAMK1;DDX3X
prerank,apoptotic mitochondrial changes (GO:0008637),-0.3583937366745888,-1.1773225385008925,0.20594965675057209,0.671407399384939,1.0,13/32,18.87%,NDUFS1;DNM1L;MFF;GGCT;ERBB4;BID;SOD2;BAK1;FIS1;CCAR2;BCL2;ATG3;BOK
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4229095519441648,1.177264097529252,0.26666666666666666,0.7783991150539187,1.0,8/20,23.60%,DIP2B;RPS6KA5;BRCA1;RPS6KA4;NOS1;GLYR1;ARRB1;PAXIP1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.43626948431400014,1.1770720839495905,0.2624113475177305,0.7777952475048843,1.0,3/18,4.45%,PLCG2;SBNO2;KARS1
prerank,thyroid hormone generation (GO:0006590),0.4989366066216442,1.1770076036947241,0.2653846153846154,0.7767542005403575,1.0,3/10,7.41%,TG;FOXE1;DUOX1
prerank,negative regulation of cell development (GO:0010721),-0.38091308124535067,-1.176906606716181,0.20842572062084258,0.6714194355666362,1.0,11/25,27.13%,LILRB1;B2M;GSK3B;FBN1;REST;LTF;WNT7A;SORL1;RFLNB;IGF1;FBXW7
prerank,regulation of B cell proliferation (GO:0030888),0.34872452925427916,1.1760431562369065,0.2206148282097649,0.7788124762814171,1.0,10/44,9.62%,SASH3;MEF2C;LYN;ATM;TNFRSF21;NCKAP1L;TNFRSF13C;CD320;TNFRSF13B;TNFSF13B
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3668290160000814,1.1760118270206916,0.23050259965337955,0.7776804634359465,1.0,7/34,8.98%,P2RY12;ATG14;PIK3R1;EPHA8;PDGFB;CCR7;PTK2B
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4666804246820121,-1.1757623576085952,0.2557077625570776,0.6734911875755832,1.0,2/12,2.83%,SORBS1;IRS1
prerank,interstrand cross-link repair (GO:0036297),0.33395317696148175,1.1757223636745453,0.19412724306688417,0.7774452026001272,1.0,16/53,17.80%,WDR48;POLN;FANCM;SLX4;FAAP24;RNF8;UBC;RPS27A;FANCG;DCLRE1B;DCLRE1C;ERCC4;FANCI;DCLRE1A;FANCA;FAAP100
prerank,carbohydrate catabolic process (GO:0016052),0.3569198696156862,1.1754159303132197,0.20517560073937152,0.7772871215427657,1.0,10/38,18.16%,HK2;MAN2B1;PFKL;NEU3;GAPDH;PFKFB2;PGAM1;PGAM4;NEU4;LDHA
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.371490373469901,-1.175354007910742,0.22298850574712645,0.6734427888117132,1.0,3/26,1.65%,CCR2;CCBE1;SULF2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.25794923948319015,1.1752780021511142,0.09651474530831099,0.7765333212259714,1.0,87/327,23.66%,TGFBR1;ZFHX3;MLXIPL;ZSCAN26;RREB1;DENND4A;DNM2;LYL1;DDIT3;CHEK2;MEF2C;SRRT;VHL;HDAC10;RHOH;KMT2D;GTF2IRD1;EFEMP1;RPS6KA5;REXO4;SBNO2;MLX;CHD7;FOXN3;TAF6L;CXXC1;FUS;CTR9;APBB2;CHD3;FOXK2;ZSCAN21;NUP35;SOX17;CDK11B;PATZ1;SMARCA2;FADS1;HP1BP3;ABL1;TRAPPC2;CNBP;PRDM2;SPTY2D1;CARM1;MLLT6;CCAR1;RPS6KA4;POFUT1;HES6;WTIP;EZH2;NUP107;BNC2;DMTF1;ENG;SUFU;SAP30L;GZF1;RNF20;THAP1;TCF7L1;TCF3;NFIA;ZFPL1;IRF2;CRABP2;NFYA;ACVR2B;HIF1A;NCOA2;TAF5;BMP2;TGIF2;ZFP37;SCRT1;TP53;MSC;TAF5L;ZNF628;MITF;BTG1;NFX1;AJUBA;RPL6;KAT6B;ATXN1L
prerank,protein phosphorylation (GO:0006468),0.2517443586770944,1.1749972075431865,0.06275033377837116,0.7762930413283402,1.0,107/479,17.97%,TGFBR1;MERTK;NUAK1;ABI3;TLR7;TGFBR2;CSF1R;ULK2;SMAD7;PIM2;MAP4K4;RPS6KA1;CHEK2;IGFBP3;BMP2K;PRKCA;PRKACA;TLR4;CSNK1E;MAP3K3;CSNK2A2;CSNK2A1;TBCK;SRC;PRKCD;LYN;CDKL3;CAMK1D;IGF1R;CDK9;EFEMP1;RPS6KA5;NEK3;ATM;NRBP1;PDPK1;PDK1;CSK;MKNK1;MAP4K3;STRADA;PKN3;NEK6;RYK;VRK3;EPHA8;PDGFB;TSSK6;TSSK4;PTK2B;PDK2;CAMKK2;ULK3;CDK11B;PKDCC;PIK3CD;WNK1;MAP3K10;MUSK;HCST;NUAK2;EEF2K;UHMK1;LATS2;GRK2;ABL1;STK19;MTOR;MARK2;PINK1;CDC42BPB;MAPK14;PRKCB;BMX;CCNE1;ROCK2;PXK;DYRK4;AKT1;MAP3K11;TYK2;ULK1;STK39;PASK;EIF2AK2;MORC3;MAST3;AURKA;RPS6KA4;MASTL;FES;DDR2;WNK2;MAP4K2;TAOK2;WNK3;DYRK1A;PICK1;LIPE;BAZ1B;CAMK1G;CLK3;MARK4;TAF1;ADAM10;TEC;MINK1
prerank,cellular response to pH (GO:0071467),0.430649269586019,1.1739106807866522,0.24772313296903462,0.7788762502328682,1.0,7/17,33.27%,MCOLN1;IMPACT;HVCN1;GPLD1;ASIC1;GPR68;CHP1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.38496841880229077,-1.1733555207036608,0.21330275229357798,0.6782625451140949,1.0,12/24,29.41%,RPS3;DACH1;ZRANB3;XRCC5;CDKN1A;ACVRL1;MSH6;NIBAN2;MSH2;DFFA;TERF2IP;H1-0
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3748110606151782,1.1725220394217715,0.2344582593250444,0.7825954430792393,1.0,17/32,29.87%,ATM;FOXN3;NBN;BRCA1;CDC14B;ABRAXAS1;BLM;BABAM1;TAOK2;DONSON;TRIM39;TOPBP1;RINT1;HMGA2;TAOK3;MRNIP;TICRR
prerank,regulation of nervous system development (GO:0051960),0.3583711803003736,1.1723616168143847,0.21575342465753425,0.7819028263318303,1.0,7/37,15.43%,CX3CR1;HEYL;SIRT2;NSUN5;DLL1;HMGB2;HES6
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.46089678793976546,-1.1717103091604717,0.25690021231422505,0.6818273397298849,1.0,5/13,10.29%,GRIK2;SHISA9;SHISA6;SLC4A10;RAB3A
prerank,positive regulation of MAPK cascade (GO:0043410),-0.24645557135597312,-1.1715211843516837,0.11079545454545454,0.6811088684416983,1.0,26/245,3.91%,CD74;IQGAP1;ROBO1;RIT2;LRRK2;CD44;TMEM106A;EGFR;CD36;APP;GAREM1;HTR2C;ADRA1A;FGF10;DSTYK;APOE;CCR1;ROR1;PRKCZ;PTPN22;NTRK2;CCL4;IAPP;RAPGEF2;CD40;NTRK3
prerank,regulation of cytoskeleton organization (GO:0051493),0.2953057660863392,1.1714581011576333,0.15664556962025317,0.7839272099040732,1.0,36/108,23.38%,F11R;TWF2;RAC1;RND1;PRKCD;RHOH;FSCN1;RHOBTB1;RND2;RHOQ;TRIM36;RHOB;ARHGAP17;MLST8;PHLDB1;CLN3;TJP1;HIP1R;ABL1;MTOR;SORBS3;MARK2;ROCK2;LRP1;TAOK2;CELSR1;KATNBL1;DMTN;RAC3;ARHGEF5;MAPT;RHOC;PFDN2;CYLD;S100A9;S100A8
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.473900393658671,1.1714029994043271,0.2830188679245283,0.7828976247611055,1.0,2/12,12.20%,FDXR;TSPO
prerank,rRNA transcription (GO:0009303),0.4354552465140141,1.1713699218415168,0.2340823970037453,0.7817973421110977,1.0,7/17,25.90%,GTF3C2;BRF1;GTF3C6;GTF3A;POLR1G;POLR1E;SPIN1
prerank,cellular response to amyloid-beta (GO:1904646),-0.3422948023116967,-1.1713318837233437,0.21809744779582366,0.6804024419888177,1.0,17/35,26.74%,ITGA4;GRIN2A;GRM5;CD36;APP;GSK3B;VCAM1;ABCC1;FCGR2B;ICAM1;CACNA2D1;FYN;FPR2;NGFR;CASP4;EPHA4;IGF1
prerank,Ras protein signal transduction (GO:0007265),0.2880315598416259,1.1711628438254909,0.16863905325443787,0.7813206776133748,1.0,18/137,6.83%,ELMO1;ARHGAP5;GNA12;RASGRP3;RREB1;PLD1;RAC1;AIF1;CDC42EP2;USP8;RHOH;RGL2;KSR1;USP28;HACD3;TAX1BP3;RRAS2;RHOB
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4562080927554075,-1.17022209574772,0.2384937238493724,0.6823146218391711,1.0,3/12,3.97%,APOE;IAPP;LDLR
prerank,cholesterol homeostasis (GO:0042632),0.32054378353244734,1.1692784963282572,0.1875,0.7867979032046784,1.0,15/64,19.33%,LIPC;IL18;LRP5;APOM;NPC2;CYP7B1;LDLRAP1;NPC1;CNBP;SCARB1;TTC39B;NR1H2;ABCA1;LCAT;FGFR4
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.37973779819793557,-1.1690883004367425,0.23423423423423423,0.6844799719979825,1.0,6/23,8.46%,KIF5C;CCDC88C;KIF1B;DYNC1I2;CCDC88A;KIF5B
prerank,potassium ion transport (GO:0006813),-0.2676034681268876,-1.168646787240586,0.11873350923482849,0.684543383464604,1.0,21/120,9.01%,KCND2;KCNB2;KCNK10;HCN1;KCNN2;KCNMB2;KCNQ5;KCNC2;KCNJ3;KCNQ3;KCNH1;SLC24A2;NALCN;KCNA6;KCND3;KCNAB2;PKD2;KCNH7;KCNH2;KCNJ6;KCNH5
prerank,sphingolipid catabolic process (GO:0030149),0.4513861166225184,1.1682069711816971,0.2617702448210923,0.789398450168551,1.0,5/15,10.71%,ACER3;SMPD2;ACER2;ASAH1;PPT1
prerank,mitotic metaphase plate congression (GO:0007080),-0.31322323785105416,-1.1681372718054257,0.18401937046004843,0.6848251809467122,1.0,18/51,27.69%,CUL3;CDCA8;NDC80;SPDL1;ZW10;KIF22;KIF14;CENPE;MAD1L1;BECN1;CCNB1;RRS1;KIFC1;KIF2C;CENPC;NUF2;BOD1;CHMP1B
prerank,ovarian follicle development (GO:0001541),0.4636865130548712,1.1678870644405075,0.2660377358490566,0.7893107319697433,1.0,4/13,11.62%,INHA;LHCGR;EIF2B4;SOD1
prerank,histone H3 deacetylation (GO:0070932),-0.4236829715727215,-1.1678013700892471,0.2686230248306998,0.6845418950208886,1.0,5/15,15.17%,SIRT1;HDAC4;PER2;PER1;HDAC1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.49876172832851806,1.1676520928628973,0.27850467289719627,0.7888862431594539,1.0,6/10,24.48%,NDFIP2;WWP2;TERF1;SNX3;MAPT;PPM1F
prerank,ureteric bud morphogenesis (GO:0060675),0.4388167097486234,1.1675664072886858,0.26865671641791045,0.7879645165186743,1.0,5/16,16.45%,SALL1;NPNT;SHH;PAX2;GATA3
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2882382094933032,1.1671158075632841,0.17307692307692307,0.7882807529232487,1.0,36/132,20.76%,DAGLB;MLXIPL;ABCD2;PIM2;CNOT1;ITCH;PRKCD;TRIM5;DXO;MOV10;MTLN;FLCN;ZSWIM8;SH3GLB1;PIK3CB;PTPN1;MTDH;TPCN1;ARNT;PHKG2;DTX3L;ULK1;PTTG1IP;NRDC;PFKFB2;TICAM1;TMEM59;OPTN;TRIM14;ABCD1;VGLL4;SLC4A4;GTPBP1;HIF1A;TRIM65;TWIST1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.35388051533093,-1.1662691860782124,0.21768707482993196,0.6879365563225361,1.0,6/35,3.15%,HIP1;MKLN1;BICD1;B2M;SNAP91;SGIP1
prerank,mesenchyme development (GO:0060485),0.45271101937881536,1.1662380213010022,0.27011494252873564,0.7902594573280115,1.0,1/15,0.08%,TGFBR1
prerank,negative regulation of GTPase activity (GO:0034260),0.4039513551724083,1.1661267873447012,0.25830258302583026,0.7894220634146377,1.0,5/22,10.32%,F11R;LRCH1;FICD;RASA4;WNK1
prerank,presynapse organization (GO:0099172),-0.4866877135277591,-1.1650824731670606,0.28199566160520606,0.690152340991435,1.0,2/10,7.72%,NLGN1;LRRTM3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.4881244899894413,1.164946141983183,0.283609576427256,0.7923916511029068,1.0,3/11,10.63%,MERTK;CCR7;AXL
prerank,regulation of mitochondrion organization (GO:0010821),-0.3154634801944186,-1.1646772835404662,0.19194312796208532,0.6900703751340636,1.0,11/47,11.56%,PID1;LRRK2;IAPP;PARL;DNM1L;GSK3B;PRKN;GOLPH3;MFF;RHOT2;FIS1
prerank,organic substance transport (GO:0071702),0.29084335579221765,1.164036486023656,0.16873065015479877,0.794367314150238,1.0,27/121,18.35%,SLCO2B1;ABCA9;ABCD2;PCTP;TAP2;NME4;CD320;SCAMP2;ARRDC1;RD3;SLC22A2;SLC22A6;SLC29A4;MIA3;SCAMP5;PPT1;KIF3A;MYH9;SLC19A1;MFSD2B;CHMP1A;PICK1;CHMP2A;ARL6IP5;ABCD1;TOM1;ABCA1
prerank,defense response to protozoan (GO:0042832),-0.45483007180868296,-1.1639878947345828,0.2645739910313901,0.6908385752809277,1.0,5/12,13.07%,CD40;PF4;IRF4;GBP4;GBP2
prerank,organophosphate ester transport (GO:0015748),0.39478971363415716,1.1637364501623677,0.2482394366197183,0.7942668866994155,1.0,12/24,25.11%,PITPNC1;PCTP;EPG5;NPC2;OSBPL5;PITPNM1;SCARB1;PRELID2;MTTP;PITPNB;SCP2;PRELID3A
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.440772116419445,1.1635722374637758,0.25794392523364484,0.7923864291078596,1.0,8/15,20.85%,CNOT1;ZFP36L1;ZFP36L2;NANOS2;TNRC6B;NANOS1;TOB1;TNRC6C
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.440772116419445,1.1635722374637758,0.25794392523364484,0.7923864291078596,1.0,8/15,20.85%,CNOT1;ZFP36L1;ZFP36L2;NANOS2;TNRC6B;NANOS1;TOB1;TNRC6C
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3137643034946146,1.1632616595589587,0.20797227036395147,0.792201894701489,1.0,19/68,20.76%,TLR7;ARHGEF2;LGALS9;AIF1;AGER;TLR4;PLCG2;IL6R;NOS2;IL33;PTPN11;DHX9;MAVS;SETD4;NOD2;POU2F2;PYCARD;MYD88;TWIST1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4313401329691646,-1.1625759251859025,0.24375,0.6938941247493426,1.0,3/14,5.14%,USP15;ANKRD17;DDX60
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4402881922249964,-1.1619283454006182,0.2803738317757009,0.6945408621317616,1.0,6/14,24.68%,RPS3;CD226;TESPA1;RELA;TRAT1;LCK
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.31918399027802663,1.1616698022006542,0.20330578512396694,0.7965086875807212,1.0,19/69,21.49%,POLR2H;SRRT;NCBP1;CDK9;INTS11;POLR2D;POLR2J;INTS3;TAF6;RPAP2;TAF8;ELL2;POU2F1;POU2F2;POLR2E;POLR2I;INTS8;NABP1;TAF5
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.40363195145413067,-1.1616601448829165,0.2657952069716776,0.6940844999143035,1.0,5/18,15.01%,ELOVL7;ACSL3;HACD1;ELOVL5;ACSF3
prerank,maintenance of protein localization in organelle (GO:0072595),0.41381821155085985,1.1613178641354247,0.25844594594594594,0.7964823650744322,1.0,6/19,16.77%,HK2;TAF8;PINK1;AKT1;MORC3;TOPORS
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3777599264888169,1.1608942190344322,0.25486725663716814,0.7967436870813552,1.0,6/27,8.98%,P2RY12;ATG14;EPHA8;PDGFB;CCR7;PTK2B
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4779625228790754,1.1608827439726725,0.29357798165137616,0.7955731544328171,1.0,9/12,32.68%,KHDRBS1;UHMK1;RBM4;NUP214;TGFB1;PTPN14;NEDD4;SIRT7;TPR
prerank,limb development (GO:0060173),0.3796075329970505,1.1603401227813361,0.2422145328719723,0.79630627728217,1.0,8/28,18.18%,SALL1;GREM1;CHD7;IQCE;NOG;ZNRF3;PTCH1;LRP4
prerank,lipid modification (GO:0030258),-0.3347866204908243,-1.1601512511709768,0.23444976076555024,0.6973832069792646,1.0,9/37,11.19%,DGKB;PLA2G7;PLPPR4;PLPP5;DGKI;PLPP4;ALOX5;DGKH;PLPPR1
prerank,canonical glycolysis (GO:0061621),0.3916938355474958,1.159918858232073,0.2596685082872928,0.7954260378324203,1.0,4/24,6.92%,HK2;PFKL;GAPDH;FOXK2
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3916938355474958,1.159918858232073,0.2596685082872928,0.7954260378324203,1.0,4/24,6.92%,HK2;PFKL;GAPDH;FOXK2
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.3300167031489564,-1.1595911449093455,0.22760290556900725,0.697798084608579,1.0,8/40,6.57%,ARHGAP6;BDNF;EGFR;ADRA1A;NTRK2;NTRK3;RASGRP4;HTR2B
prerank,vascular transport (GO:0010232),0.2991985359799974,1.1593063217667652,0.20098039215686275,0.7964536138197179,1.0,22/81,21.05%,SLCO2B1;SLC7A8;SLC1A3;AGER;SLC24A3;ABCC9;SLC27A4;SLC7A5;SLC22A2;SLC29A4;ATP1A4;SLC19A1;SLC15A2;SLC6A9;LRP1;SLC16A7;SLC5A3;SLC4A4;SLC38A1;SLC8A2;SLC29A1;SLC4A3
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.38787849875474734,-1.1586849933729906,0.24528301886792453,0.6991590508010328,1.0,6/22,14.50%,APOE;PTPN3;ADRA2A;SNX9;SH3D19;TIMP3
prerank,regulation of gene silencing by RNA (GO:0060966),0.3309198202370199,1.1586531098445052,0.22780569514237856,0.7962988470558767,1.0,19/50,23.46%,POLR2H;RANBP2;EIF4G1;NUP42;POLR2D;SEC13;POLR2J;NUP35;NUP50;SEH1L;NUP62;NUP107;NUP88;NUP188;POLR2E;POLR2I;AGO1;NUP214;PUM1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3309198202370199,1.1586531098445052,0.22780569514237856,0.7962988470558767,1.0,19/50,23.46%,POLR2H;RANBP2;EIF4G1;NUP42;POLR2D;SEC13;POLR2J;NUP35;NUP50;SEH1L;NUP62;NUP107;NUP88;NUP188;POLR2E;POLR2I;AGO1;NUP214;PUM1
prerank,negative regulation of JNK cascade (GO:0046329),0.3744230973278361,1.158616083495822,0.23407917383820998,0.795207760919307,1.0,7/31,12.46%,SIRPA;ITCH;GPS2;ZMYND11;KLHL31;MAPK8IP1;PINK1
prerank,regulation of protein localization (GO:0032880),0.3231367305565593,1.1583712517514893,0.21608040201005024,0.7948668919086334,1.0,15/58,19.26%,SUMO1;MMD;CTSD;CSNK1E;USP8;TRIM5;PICALM;VIP;PLEKHM2;TRIM14;ATCAY;RAB9A;ZDHHC7;MAPK8;CAMK1
prerank,positive regulation of cilium assembly (GO:0045724),-0.41242206402239945,-1.1583009678593086,0.2708333333333333,0.6990690381912037,1.0,4/18,7.52%,HTT;ARHGAP35;SEPTIN9;CCDC88A
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3125708419079226,1.1581384081406334,0.22129783693843594,0.7945616968460522,1.0,30/76,27.18%,SENP2;SMAD7;RIPK2;UBA2;TBC1D7;WDR48;NDFIP2;KLHL40;RASD2;BRCA1;XIAP;PIAS3;PINK1;PTTG1IP;PHF23;FANCI;SPRTN;SAE1;DCUN1D4;UBE3A;STUB1;NSMCE3;TRAF6;PAXIP1;ZC3H12A;TNIP1;TSPYL5;PIAS4;BIRC2;DCUN1D5
prerank,B cell mediated immunity (GO:0019724),-0.47182625844140297,-1.1580977592672204,0.2940038684719536,0.6983915241488288,1.0,6/10,27.73%,CD74;FCGR2B;TLR8;CD19;MSH2;SLA2
prerank,cellular response to type I interferon (GO:0071357),-0.3300024994108061,-1.1580881942425123,0.23514851485148514,0.6958833351365249,1.0,13/41,17.93%,OAS2;IFITM3;RSAD2;IRF4;SP100;GBP2;SAMHD1;IFIT3;OAS3;IFITM2;RNASEL;IFITM1;IP6K2
prerank,type I interferon signaling pathway (GO:0060337),-0.3300024994108061,-1.1580881942425123,0.23514851485148514,0.6958833351365249,1.0,13/41,17.93%,OAS2;IFITM3;RSAD2;IRF4;SP100;GBP2;SAMHD1;IFIT3;OAS3;IFITM2;RNASEL;IFITM1;IP6K2
prerank,regulation of protein transport (GO:0051223),-0.3646650993084977,-1.156814603518017,0.24439461883408073,0.6984640205090693,1.0,8/27,11.87%,STXBP5L;DISP1;STXBP5;HSPA8;P3H1;RHBDF2;NDFIP1;SCFD1
prerank,regulation of lamellipodium organization (GO:1902743),0.44568746409041515,1.1565243828225058,0.3023255813953488,0.7989288426479663,1.0,3/14,3.36%,TWF2;RAC1;CAPZB
prerank,regulation of store-operated calcium entry (GO:2001256),0.4957015346630231,1.156515038906399,0.2857142857142857,0.7977637267848411,1.0,2/10,2.70%,SARAF;CD84
prerank,response to UV-B (GO:0010224),-0.45127773489703527,-1.1564326388107655,0.26963906581740976,0.6984209755834865,1.0,7/12,29.87%,MME;CRIP1;RELA;CDKN1A;MFAP4;MSH2;IL12A
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.4271499835520314,1.1563687882500087,0.272572402044293,0.7971060814252448,1.0,4/16,9.13%,SNRPC;SFSWAP;PRPF39;DCPS
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3771785075157077,1.1561781034315886,0.2486865148861646,0.7965552350199876,1.0,4/29,7.31%,LDLRAD4;SMAD7;SPRY2;OVOL2
prerank,vesicle transport along actin filament (GO:0030050),0.4160052342100388,1.1561114487894661,0.26811594202898553,0.7956067093060106,1.0,7/19,17.65%,MYO1F;MYO1B;MYO7A;MYO5B;MYO1E;MYO15A;WASL
prerank,positive regulation of T cell migration (GO:2000406),0.40525011779944875,1.1554758326192007,0.26159554730983303,0.7966127919233608,1.0,9/20,20.81%,DOCK8;AIF1;WNK1;STK39;ADAM10;TNFRSF14;PYCARD;ADAM17;CXCL10
prerank,negative regulation of immune effector process (GO:0002698),-0.44225284339076976,-1.1551991213277597,0.2629310344827586,0.7010181830163015,1.0,2/13,1.87%,CD47;LILRB1
prerank,histone monoubiquitination (GO:0010390),0.3916293101029969,1.1550306468058449,0.25309734513274335,0.797007515769974,1.0,11/24,25.66%,BCOR;CTR9;CUL4B;DDB2;DTX3L;RNF20;RNF2;RING1;ATXN7L3;KDM2B;PCGF1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.30113169752766883,1.1544737214178389,0.20270270270270271,0.7976750366894481,1.0,32/87,25.95%,NDUFB2;NDUFB8;ACAD9;COA8;UQCC1;NDUFAF6;NDUFS3;NDUFS4;NDUFB10;NDUFAF1;NDUFB3;NDUFS5;COX19;COX16;BCS1L;NDUFAF5;UQCC2;FASTKD3;NDUFV3;NDUFA13;LYRM7;NDUFC2;COX17;NDUFV1;SAMM50;NDUFA9;NDUFB11;TMEM126A;NDUFV2;OXA1L;NDUFAF3;NDUFAF7
prerank,regulation of ruffle assembly (GO:1900027),-0.3814408841300267,-1.1544648701198892,0.2560706401766004,0.7019976098428438,1.0,3/23,1.64%,NLGN1;EPS8;STAP1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4889571453249422,1.1543469891844178,0.2746858168761221,0.7969698195801228,1.0,6/10,28.23%,DCLRE1B;DCLRE1C;DCLRE1A;ACD;RTEL1;TFIP11
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3226161970997097,1.1541942303121964,0.23166666666666666,0.7963052778534957,1.0,8/57,8.12%,IL18;CSF1R;LYN;IL6R;IL6ST;CNTF;IL12B;CTF1
prerank,regulation of GTPase activity (GO:0043087),0.27200385783354,1.153966449087973,0.17257318952234207,0.7959376805921288,1.0,32/177,11.66%,SRGAP2;CHN2;DOCK8;FGD2;F11R;ITGA6;VAV2;ARHGAP27;MAP4K4;RAP1GDS1;RGS10;TGM2;LRCH1;SNX18;ASAP3;TBC1D7;FICD;TBC1D15;PICALM;FLCN;RAB3GAP2;RASA4;TBC1D10B;RAB3GAP1;FGD3;RAPGEF3;WNK1;RASIP1;LIMS1;DOCK10;SOD1;SGSM2
prerank,positive regulation of interferon-beta production (GO:0032728),0.3588435298168876,1.1534728894333541,0.26444833625218916,0.7965318027941399,1.0,8/33,15.10%,POLR3G;TLR7;TLR4;RIPK2;PTPN11;DHX9;IRF3;MAVS
prerank,embryonic digit morphogenesis (GO:0042733),0.42955868077493986,1.1533897022446369,0.2610294117647059,0.7956299101842448,1.0,2/18,6.23%,SALL1;SHH
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.4069916686891223,-1.153326001690225,0.25792811839323465,0.7042343149176011,1.0,4/18,11.17%,APOE;CTSC;FAF1;MSN
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.27840157097849927,1.1531178749648918,0.17921686746987953,0.7954361150187921,1.0,41/158,17.78%,PIM2;LGALS9;CFLAR;TMEM101;ATP2C1;MAP3K3;TRAF5;RIPK2;TRIM5;CASP1;TRADD;NDFIP2;AKAP13;TAB2;NEK6;GAPDH;ZDHHC13;CCR7;EDA2R;MIB2;LAMTOR5;CXXC5;MTDH;TICAM2;TRIM62;PINK1;PRKCB;RNF31;PELI2;TNFRSF19;TMED4;GJA1;MAVS;TNIP2;TICAM1;CCDC22;NUP62;TRIM14;ECT2;GPR89A;NOD2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2545331283693865,1.1525843534674947,0.14560439560439561,0.7960976282606655,1.0,74/314,17.92%,FBXL18;NFE2L2;BAG6;ARRB2;DDIT3;MTA1;FBXL20;RNF216;DNAJB9;ITCH;SPSB1;FBXL15;SIRT2;UCHL1;SEL1L;SMURF1;RFFL;ZSWIM8;SPSB2;UFD1;TRIM72;CDC34;MAEA;CUL4B;PSMD3;ANKRD9;OS9;RNF103;CRBN;WWP2;FBXW4;UBC;RPS27A;AUP1;BFAR;PSMA7;PCBP2;FBXL2;AREL1;FBXO38;ANAPC15;DCAF11;UBE2U;USP19;UBXN2A;ANAPC11;PSMB3;PSMB9;FBXL22;KCTD2;PSMC2;RNF187;DCAF12;TNFAIP1;ANKZF1;AURKA;FBXL8;TRIM3;PSME4;PSMC1;PSMB7;TOPORS;ANAPC1;NEMF;RNF121;ZFAND2A;FBXL7;SPOPL;UBE2A;TAF1;RNF4;SYVN1;GID8;PSMB5
prerank,cardiac muscle cell differentiation (GO:0055007),0.4022902301246276,1.1524922632379018,0.2513562386980108,0.7952444656159833,1.0,4/21,6.12%,MEF2C;SLC8A1;AKAP13;CXADR
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.4379534878875093,1.152221116219586,0.2849462365591398,0.7950256306921925,1.0,4/16,12.40%,ETF1;IGF1R;CLN3;SHFL
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.47367054349025595,1.1521832155256573,0.29124236252545826,0.7940136466206829,1.0,4/11,17.37%,PRKCD;PDK1;PDCD10;ARL6IP5
prerank,negative regulation of cellular component organization (GO:0051129),-0.2896786771768038,-1.1520106914834898,0.20954907161803712,0.7071171878983273,1.0,22/74,18.59%,LILRB1;PRKCZ;TMEFF2;IAPP;RUBCN;CDC42;MTMR2;GSK3B;RIOK3;HSPA8;CARMIL1;RAF1;XRCC5;HSPA5;OPRD1;MCTP1;DNAJB2;HSPA2;HSPA1B;TMC8;NR1H4;EPHA3
prerank,cellular response to osmotic stress (GO:0071470),0.4032364115532361,1.152002638934003,0.2732142857142857,0.7934822350155283,1.0,7/21,16.41%,ARHGEF2;CAPN3;ZFP36L1;RCSD1;TRPV4;STK39;WNK3
prerank,positive regulation of heart rate (GO:0010460),-0.4086618587978018,-1.1517919154535798,0.28118393234672306,0.7064646366277305,1.0,4/17,5.28%,PDE4D;ADRA1A;RYR2;ATP2A2
prerank,protein polymerization (GO:0051258),-0.3044926057387086,-1.1516774763294602,0.21265822784810126,0.7055479928947807,1.0,12/56,12.67%,ARHGAP6;PSTPIP1;PSTPIP2;GSN;TPPP;DIAPH3;WASF1;PRKN;JAK2;MSRB1;UBE2C;UBE2K
prerank,regulation of synapse organization (GO:0050807),-0.35972241941045996,-1.151665852476859,0.23660714285714285,0.7043225771523118,1.0,4/26,2.42%,PDLIM5;CTNNA2;CDKL5;IL1RAPL1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3428416090641529,-1.1514303065287854,0.22489082969432314,0.703763481584507,1.0,7/32,12.91%,MAGI2;PPIA;CALM1;HSP90AB1;DUSP26;CNEP1R1;CDH5
prerank,anion transport (GO:0006820),0.36359084960961213,1.1512446829494911,0.2679509632224168,0.7949449695846486,1.0,7/33,14.42%,SLCO2B1;SLC22A6;SLC17A8;TSPO;LRRC8A;SLC19A1;VDAC1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.3648189527188739,-1.1510833684907347,0.25235849056603776,0.7035844611826747,1.0,6/24,11.91%,PID1;MYC;NDUFS1;SDHAF4;COQ10B;GFPT2
prerank,protein import (GO:0017038),0.3010129373116291,1.1501252102223583,0.20336391437308868,0.7975970016381487,1.0,30/84,23.24%,ABCD2;FAM53A;PHB2;CLU;TNPO1;SEC13;SPRN;NUP62CL;APPL1;NUP50;IPO4;TNPO3;AKT1;PTTG1IP;CSE1L;NUP62;NUP107;NUP88;E2F3;PXMP2;ABCD1;NUP188;IPO7;RPAIN;LAMP2;HSPA4;SAMM50;NUP214;HIKESHI;APPL2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.45862499580483806,1.150048359083424,0.28771929824561404,0.7966921854139304,1.0,3/13,8.67%,NCBP1;CSTF2;CPSF1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3172402013303002,1.1499201287517615,0.2391681109185442,0.7959749795484318,1.0,15/59,23.44%,LIPC;LIPH;CH25H;CYP46A1;OSBPL3;AKR1D1;CYP7B1;HSD17B10;GAMT;SDS;PARK7;ACOT8;OSBP;SCP2;ELOVL4
prerank,protein K63-linked deubiquitination (GO:0070536),0.3611806156281314,1.1498740364906959,0.259391771019678,0.7950009329621142,1.0,9/31,15.43%,OTUD5;USP8;ZRANB1;USP25;STAMBPL1;ABRAXAS1;OTUB2;BABAM1;USP50
prerank,positive regulation of apoptotic process (GO:0043065),0.25667990280717934,1.1497267003455105,0.13005780346820808,0.7943913554475198,1.0,80/293,22.71%,BIN1;TGFBR1;FGD2;ARHGEF2;PREX1;ITGA6;VAV2;DNM2;CALHM2;CRADD;DDIT3;CTSD;IGFBP3;TGM2;QRICH1;KCNMA1;PRMT2;SIRT2;SUDS3;ATM;TRADD;FLCN;CLU;KLF11;AKAP13;PPID;RHOB;SLC27A4;WNT10B;PIP5KL1;GPER1;PSEN2;PSENEN;FGD3;UBC;RPS27A;MAP3K10;HIP1R;SOD1;APAF1;LATS2;ABL1;PRDM11;BMF;MAP3K11;TRIO;CCAR1;TNFRSF12A;APH1B;DUSP6;FANK1;ECT2;TRAF7;ARL6IP5;C1QBP;BCL2L11;PIDD1;RASSF2;SHQ1;CLIP3;VAV1;PMAIP1;MAPK8;PYCARD;JUN;IRF5;SFRP4;ARHGEF5;HTRA2;TFAP4;TRIM39;BMP2;GPLD1;BRMS1;ARHGEF7;TP53;DDX3X;STPG1;BTG1;TRAF6
prerank,bile acid biosynthetic process (GO:0006699),0.3899275336487513,1.1497259583937953,0.26691042047531993,0.7932497966710392,1.0,9/24,23.19%,CH25H;CYP46A1;OSBPL3;AKR1D1;CYP7B1;HSD17B10;ACOT8;OSBP;SCP2
prerank,positive regulation of vacuole organization (GO:0044090),0.4895772705328236,1.149593086432203,0.31309297912713474,0.7925720726070781,1.0,3/10,9.12%,RAB3GAP2;SH3GLB1;RAB3GAP1
prerank,protein autoubiquitination (GO:0051865),0.3275236986172564,1.1490959983177702,0.23825503355704697,0.7931848630484453,1.0,23/61,25.24%,RNF41;ITCH;RNF141;KLHL24;ASB4;RNF8;BRCA1;WWP2;BFAR;DDB2;UHRF2;RNF11;DTX3L;RNF187;UBE2A;RNF4;OBI1;UBE3A;STUB1;TRAF6;NFX1;RNF13;RNF157
prerank,negative regulation of growth (GO:0045926),0.2856360942981198,1.1488232918871333,0.17364341085271318,0.7929539673027868,1.0,32/121,19.46%,SMAD3;PPP1R9B;OSGIN2;SIPA1;AGTR2;CCDC85B;FLCN;NDUFS3;APBB2;SOX17;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;SMARCA2;MT2A;PPT1;OSGIN1;NME6;PRDM11;DACT3;GJA1;EI24;NDUFA13;PTPRJ;CDKN1B;ADAM15;VGLL4
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.4583558000962799,-1.1487272847454868,0.28775510204081634,0.7096403068713258,1.0,4/12,18.61%,BICD1;CEP19;CCDC120;BBS4
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3713800504276148,1.148650986165991,0.2696245733788396,0.7924050350923338,1.0,8/32,7.84%,TWF2;RREB1;RAC1;SRC;PIK3R1;FSCN1;AKIRIN1;AVIL
prerank,nucleoside catabolic process (GO:0009164),-0.46188220553952974,-1.1478774651031067,0.27232142857142855,0.7108686161089395,1.0,3/11,13.53%,DPYD;UPP2;DERA
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4426158112277751,1.1477084953151955,0.2742230347349177,0.794599447018181,1.0,6/14,22.36%,SFSWAP;U2AF2;SRSF9;C1QBP;RBMX;PCBP4
prerank,positive regulation of cell differentiation (GO:0045597),0.2618242767504149,1.1472244173482253,0.1621212121212121,0.7950936882611509,1.0,51/237,16.05%,TGFBR1;TMEM119;IL18;TGFBR2;ARHGEF2;LRP5;SMAD3;HEYL;MMD;RPS6KA1;IGFBP3;NPNT;MEF2C;VHL;TGFB1I1;PPARD;IL6R;CTNNBIP1;ZFP36L1;IMPACT;AKIRIN1;CD34;TRPM4;IL6ST;ASB4;PLA2G5;EDN3;RBM24;NEUROD4;SIN3A;WNT7B;CEACAM1;CDS1;GCNT2;PKDCC;ZEB1;ABL1;MEF2A;MTOR;LRRC8A;MAPK14;BNIP2;PAX2;AKT1;CARM1;GJA1;CDH15;MEDAG;EZH2;FES;DDR2
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4129542468503635,1.1471221031347187,0.2862453531598513,0.7943042576292507,1.0,3/18,11.00%,NAV3;CD34;HAVCR2
prerank,vasculogenesis (GO:0001570),0.37115199014617944,1.1467854109320534,0.2589928057553957,0.7943315071566976,1.0,12/32,27.88%,TGFBR2;SHH;SOX17;WNT7B;RASIP1;AGGF1;ENG;CCM2;TGFB1;NOTCH1;GLMN;RASA1
prerank,regulation of protein phosphorylation (GO:0001932),-0.24055839539864965,-1.1465357908519183,0.10652920962199312,0.7136794104229948,1.0,56/256,16.67%,PID1;DAB2;CD74;XDH;LRRK2;CCDC88C;EGFR;GRM5;APP;SLIT2;FGF10;KDM4D;NTRK2;NPTN;CD40;NTRK3;CEBPB;SIRT1;FN1;MOB1B;PPIA;CCND2;CORO1C;CADM4;SLCO3A1;P2RY1;LIMCH1;PRKN;PDE8A;VEGFD;CCDC88A;LRP6;SH3GL2;FGF9;ERBB4;SPTBN4;FGF7;IRGM;AXIN1;RALBP1;PLAUR;MYADM;CDH5;PAK1;NSD1;PLXNB2;PAQR3;PLPP3;EFNA5;VEGFC;NPM1;TNIK;TFRC;PECAM1;PTPN13;TEK
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3336249186539439,1.1463981192273154,0.24482758620689654,0.7945032937382601,1.0,9/48,7.73%,IL18;TLR7;LGALS9;TLR4;CYRIB;EBI3;IL12RB2;SLC7A5;IL12B
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3680263676749369,-1.146364898368544,0.2585034013605442,0.7129788710724941,1.0,6/26,10.69%,ANK2;YWHAE;NEDD4L;NETO1;ACTN2;ATP1B3
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3234803443223773,-1.1463555619578514,0.24056603773584906,0.711748481128098,1.0,14/41,17.36%,ANK3;CD44;CD47;AFDN;SKAP1;PLAUR;THY1;PODXL;PLPP3;CCL5;CX3CL1;ADAM19;SERPINF2;CD3E
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.4398512715858721,1.1457808073108289,0.29074074074074074,0.7955753641166972,1.0,3/15,6.17%,SMOC2;LGMN;MET
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.33961053516005457,1.1454193420956942,0.22742474916387959,0.7957077801872735,1.0,15/43,21.34%,IL18;AIF1;FOXJ2;MEF2D;IL6R;MMP2;PDGFB;LDLRAP1;AKT1;GJA1;THBS1;ADAMTS1;JUN;P2RY6;MFN2
prerank,positive regulation of phospholipid transport (GO:2001140),-0.47980610776636357,-1.1453875407821485,0.30376940133037694,0.7133419515294147,1.0,2/10,9.54%,APOE;PRELID1
prerank,protein localization to cell periphery (GO:1990778),-0.2634747119481397,-1.1453060728884255,0.16619718309859155,0.7123037115221676,1.0,29/133,14.07%,KCNIP4;DPP6;ANK3;KCNB2;DPP10;ANK2;SPTBN1;RAB3C;MYO5A;RAPGEF2;EHD1;P2RY1;WDR19;RAB3D;LRP6;RAB40B;SPTBN4;PIGW;ACTN2;RAB3A;ATP1B3;MYADM;RAB8A;ZDHHC23;TMED2;ITGB1BP1;TESC;EFR3A;CDH1
prerank,mesonephric tubule development (GO:0072164),0.4362621743799342,1.1448900971819427,0.27153558052434457,0.7963716267088633,1.0,2/15,1.94%,SALL1;NPNT
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3688375512306913,1.1441382152800785,0.26102292768959434,0.7978066871469423,1.0,6/29,8.98%,P2RY12;ATG14;EPHA8;PDGFB;CCR7;PTK2B
prerank,negative regulation of cell adhesion (GO:0007162),-0.29114372514657394,-1.1439343508087056,0.17557251908396945,0.7151900047985785,1.0,26/72,19.58%,SPOCK1;PLXNC1;ADAM22;PLXND1;ARHGDIA;PLXNA2;SEMA5A;RIPOR2;JAG1;CDH13;PLXNA1;ERBB3;SPN;PODXL;ITGB1BP1;PLXNB2;CDH1;CBLL1;DACT2;PLXNB1;CX3CL1;SEMA6A;SNAI2;ACVRL1;DSCAM;JAM3
prerank,wound healing (GO:0042060),0.31947147017059346,1.1437513369931422,0.24054982817869416,0.7979894214811495,1.0,15/62,17.35%,TGFBR1;DST;SMAD3;CFLAR;DSP;TRIM72;MACF1;MIA3;MYH9;SCARB1;NOG;PRCP;SYT11;PPL;CLDN1
prerank,regulation of postsynapse organization (GO:0099175),0.36811475544401323,1.1430434610917914,0.2867256637168142,0.799257731820181,1.0,4/28,1.06%,TANC2;ARHGAP22;ABI3;ABHD17C
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3149146515848941,1.1427692882962555,0.22647527910685805,0.7991118334597797,1.0,23/71,20.36%,ELMO1;VAV2;RAC1;SRC;PRKCD;LYN;PIK3R1;PLCG2;PLD2;NCKAP1L;PLA2G6;PIK3CB;ABL1;WIPF2;ARPC1A;CYFIP1;ARPC1B;WASL;NCKIPSD;VAV1;ARPC3;PLCG1;PIK3CA
prerank,sodium ion transport (GO:0006814),-0.28306307701406913,-1.142628339004679,0.17647058823529413,0.7180609366011158,1.0,37/85,32.97%,HCN1;SLC8A3;SCN2A;NEDD4L;SLC24A2;NALCN;SCN3A;PKD2;ANO6;ATP1B3;SLC6A15;SLC6A6;SLC4A8;HCN2;ASIC3;SLC12A1;SLC6A16;SLC5A6;SCN9A;SLC6A17;SLC6A7;SLC5A5;SLC12A3;HCN4;SLC6A1;HCN3;SLC6A11;SLC6A12;SLC5A1;SLC6A13;CATSPER4;SLC6A19;SLC6A14;SLC5A10;SLC4A11;SLC5A12;SCN4A
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.4895291863700515,1.1425756279724673,0.30275229357798167,0.797548886915603,1.0,2/10,7.55%,CDC42EP2;CCR7
prerank,regulation of pseudopodium assembly (GO:0031272),0.4895291863700515,1.1425756279724673,0.30275229357798167,0.797548886915603,1.0,2/10,7.55%,CDC42EP2;CCR7
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.458431151526996,-1.1424666008628985,0.2853982300884956,0.717252469426478,1.0,2/12,6.92%,PDE4D;CALM1
prerank,cell proliferation in forebrain (GO:0021846),0.4874419530052994,1.142121336608815,0.3019230769230769,0.7980412926827924,1.0,1/10,0.22%,NUMB
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3456494416044981,-1.1412491153924318,0.2408256880733945,0.7198480977328123,1.0,6/32,7.32%,SORBS1;APOE;PRKAG2;CREBL2;ADIPOR2;ZBTB20
prerank,apoptotic cell clearance (GO:0043277),0.3699340758585904,1.1411875727421892,0.2766726943942134,0.8002550946293225,1.0,9/30,16.42%,RAC1;TGM2;ITGAV;RHOH;RHOBTB1;SCARB1;LRP1;MEGF10;THBS1
prerank,nucleocytoplasmic transport (GO:0006913),0.33736634652513936,1.141118178215012,0.24155405405405406,0.7993598569488161,1.0,10/40,16.99%,BACH2;NCBP1;SNRPF;ANP32A;SMN1;RGS14;GEMIN6;SNUPN;GEMIN2;NEMF
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.44673858166517477,-1.1411054007491577,0.28991596638655465,0.7190151177554431,1.0,2/12,0.41%,DMD;ANK3
prerank,protein K48-linked deubiquitination (GO:0071108),0.38604661884022023,1.14090184806038,0.2851919561243144,0.7989957219932043,1.0,7/23,17.44%,OTUD5;USP8;USP25;MINDY2;OTUB2;USP50;USP5
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.31576701128095735,1.140872014986158,0.2310177705977383,0.7979797842185028,1.0,23/70,20.36%,ELMO1;VAV2;RAC1;SRC;PRKCD;LYN;PIK3R1;PLCG2;PLD2;NCKAP1L;PLA2G6;PIK3CB;ABL1;WIPF2;ARPC1A;CYFIP1;ARPC1B;WASL;NCKIPSD;VAV1;ARPC3;PLCG1;PIK3CA
prerank,embryonic heart tube morphogenesis (GO:0003143),0.33698356035832444,1.1404681962622698,0.2427843803056027,0.7982200203728916,1.0,11/44,17.06%,TGFBR2;MEF2C;SHH;SOX17;TBX6;NDRG4;DLL1;CCDC40;VANGL2;SMO;ENG
prerank,sulfur compound transport (GO:0072348),-0.3615626549736247,-1.140264394029847,0.26096491228070173,0.7203070842864786,1.0,7/27,12.82%,SLC25A30;SLC35F3;SLC25A19;RACGAP1;MGST1;SLC26A7;SLC6A6
prerank,positive regulation of exocytosis (GO:0045921),-0.3368182076095333,-1.1401189953992763,0.2535885167464115,0.7195537704321455,1.0,14/35,31.86%,CADPS;SDCBP;STXBP5;RAB3D;RAB3A;SNCA;CFTR;SDC4;RAB27B;STAM;RAB5A;CADPS2;SYTL4;EXPH5
prerank,negative regulation of telomere maintenance (GO:0032205),0.4450739170152858,1.1400811670824964,0.29906542056074764,0.7984455891241627,1.0,5/15,13.15%,ATM;NBN;SLX4;ERCC4;TERF1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4328856371502105,1.1400754742532813,0.3094812164579606,0.797356349853972,1.0,7/15,24.84%,SEL1L;UFD1;OS9;AUP1;SYVN1;NPLOC4;FAF2
prerank,positive regulation of signal transduction (GO:0009967),-0.24116760417850483,-1.1400556642166064,0.12408759124087591,0.7185329374046764,1.0,36/238,8.51%,NRXN1;NLGN1;RBPJ;RIMS2;CD74;SORBS1;ROBO1;LRRK2;BDNF;CCBE1;HTT;SULF2;DSTYK;ERN1;PRKCZ;IRS1;NPTN;ATP6AP2;NTRK3;ZBTB7B;SIRT1;RPS3;CD226;LMO3;SHANK3;HOMER1;VWF;KLF2;CDC73;JAK2;PKD2;RIMS1;JAG1;TPD52L1;DCDC2;F7
prerank,regulation of cardiac conduction (GO:1903779),-0.3095219363595281,-1.1397214888462144,0.21601941747572814,0.718309201333103,1.0,12/54,11.72%,ANK2;ITPR1;SLC8A3;RYR2;ATP2B1;RYR3;ATP2A2;TMEM65;DMPK;ATP1B3;ATP2A3;ATP1A1
prerank,regulation of mitochondrial translation (GO:0070129),0.397403393395499,1.1396150634896887,0.2643884892086331,0.7978365856238708,1.0,12/21,29.65%,MPV17L2;RMND1;NSUN3;UQCC2;FASTKD3;C1QBP;NGRN;FASTKD2;MTG1;MTG2;ALKBH1;RCC1L
prerank,regulation of cellular biosynthetic process (GO:0031326),0.37583150807296306,1.1395274737784733,0.26714801444043323,0.7970049459891896,1.0,5/28,7.84%,CX3CR1;SIRPA;RAC1;NOS1AP;AVIL
prerank,epidermis development (GO:0008544),0.32121223103146623,1.1393988508399533,0.23737373737373738,0.7963231846602952,1.0,15/56,21.35%,DSP;ATP2C1;CERS3;OVOL2;EDA2R;DLL1;FLOT2;LAMC2;KRTDAP;SPINK5;SVEP1;TGM5;FGFR2;CRABP2;PTHLH
prerank,atrial septum development (GO:0003283),-0.43615027169166226,-1.1391816522201192,0.27385892116182575,0.7187601057031434,1.0,5/13,22.48%,ANK2;NPHP3;HEY2;NOTCH2;GJA5
prerank,regulation of interleukin-2 production (GO:0032663),-0.31973202000815815,-1.1387622247984672,0.2457831325301205,0.7188619742492208,1.0,8/43,7.89%,PDE4B;SPTBN1;CCR2;PDE4D;RPS3;IRF4;VSIG4;ZFP36
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.24834740339530711,1.1383332143214888,0.12598425196850394,0.798715983781724,1.0,98/366,23.66%,TGFBR1;ZFHX3;MLXIPL;ZSCAN26;RREB1;DENND4A;DNM2;LYL1;DDIT3;CHEK2;MEF2C;SRRT;VHL;HDAC10;RHOH;KMT2D;GTF2IRD1;EFEMP1;RPS6KA5;REXO4;SBNO2;MLX;CHD7;EIF2A;FOXN3;TAF6L;CXXC1;FUS;CTR9;APBB2;CHD3;EHMT2;FOXK2;ZSCAN21;NUP35;PKP3;SOX17;EIF2B4;CDK11B;PATZ1;SMARCA2;FADS1;HP1BP3;ABL1;TRAPPC2;CNBP;PRDM2;SPTY2D1;CARM1;MLLT6;CCAR1;CYFIP1;RPS6KA4;POFUT1;HES6;WTIP;EZH2;PCIF1;NUP107;BNC2;ORC3;DMTF1;ENG;SUFU;SAP30L;GZF1;RNF20;THAP1;RPL10;DSCC1;TCF7L1;TCF3;NFIA;ZFPL1;IRF2;CRABP2;NFYA;ACVR2B;HIF1A;NCOA2;TAF5;BMP2;TGIF2;ZFP37;SCRT1;OBI1;TP53;MSC;TAF5L;ZNF628;MITF;BTG1;NFX1;AJUBA;RPL6;GMNN;KAT6B;ATXN1L
prerank,epidermal cell differentiation (GO:0009913),0.339525273591675,1.1381639027089425,0.281786941580756,0.7981850834946562,1.0,6/41,10.11%,DSP;ST14;CERS3;ASAH1;OVOL2;ERCC2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.334699013543344,1.1379948033782514,0.2580071174377224,0.7976598033148168,1.0,13/48,20.56%,ETS1;PRKCA;MAP3K3;PDPK1;GATA2;PDGFB;MAPK14;CIB1;AKT1;THBS1;ADAM17;PLCG1;HIF1A
prerank,regulation of endocytosis (GO:0030100),-0.29754336842809526,-1.1379414370516918,0.22332506203473945,0.7201049333532271,1.0,15/61,12.83%,DAB2;HIP1;RIT2;LILRB1;APOE;NEDD4L;RUBCN;MTMR2;RAB5C;CDH13;GPC3;MCTP1;CD151;TFR2;SNCA
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.28904293242298323,-1.137723202544065,0.2178477690288714,0.719549104742122,1.0,15/67,12.77%,CYBB;CD36;B2M;PSMD14;NCF2;PSMA2;PSMF1;TAP1;PSMD8;CYBA;PSMD6;PSME2;PSMD11;PSMD1;PSMD5
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.28801115656767823,1.1377087650669497,0.2336874051593323,0.7975499685919032,1.0,17/102,10.12%,PDE3B;PRKACA;LPIN2;SRC;PRKCD;SLC30A10;ADCY9;PIK3R1;PDPK1;ZFP36L1;RHOQ;TRARG1;GPER1;LHCGR;ADCY4;CEACAM1;ADCY6
prerank,regulation of translation (GO:0006417),0.270856462144183,1.1374575471774113,0.18262150220913106,0.7973533235870277,1.0,44/173,18.91%,PLD1;RPS6KA1;NCBP1;CTIF;CNOT1;EIF4A2;ETF1;EIF4G1;EIF2A;METTL5;IMPACT;ENC1;GAPDH;NSUN5;NANOS2;PKP3;EIF2B4;EIF4H;DHX9;RPS27L;MRPL13;MTOR;IGF2BP2;SHFL;MIF4GD;METTL14;PASK;EIF2AK2;EPRS1;MTIF2;CYFIP1;EIF3D;NSUN3;EIF1B;CAPRIN1;PCIF1;THBS1;TYMS;NEMF;LARP1;EIF5;RPL10;NANOS1;TOB1
prerank,muscle tissue development (GO:0060537),0.4548406426721091,1.1368016044922244,0.33147113594040967,0.7986167544915098,1.0,7/13,26.41%,SHH;SMO;ENG;PTCH1;PGM5;POGLUT1;CSRP2
prerank,nuclear membrane organization (GO:0071763),0.4121888626348946,1.1366922193533737,0.2980251346499102,0.797922769429752,1.0,7/19,21.57%,AKAP8L;GPER1;TOR1AIP1;UBXN2A;NEMP1;CHMP2A;TARDBP
prerank,regulation of synapse maturation (GO:0090128),-0.47803332780906155,-1.136085941594738,0.3176229508196721,0.723482236318193,1.0,4/10,24.82%,NRXN1;RELN;NEUROD2;ARHGEF15
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3823290055082884,-1.1360135204728832,0.26218097447795824,0.7212022532077192,1.0,8/23,20.03%,YWHAQ;TFDP2;YWHAE;BID;BCL2;PPP3CC;TFDP1;E2F1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3823290055082884,-1.1360135204728832,0.26218097447795824,0.7212022532077192,1.0,8/23,20.03%,YWHAQ;TFDP2;YWHAE;BID;BCL2;PPP3CC;TFDP1;E2F1
prerank,endodermal cell fate commitment (GO:0001711),0.48540752343586,1.1358557062875076,0.3053435114503817,0.7995950875342671,1.0,2/10,8.19%,CTR9;SOX17
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2671172891832421,1.1358365113588873,0.18590704647676162,0.798556491535116,1.0,53/185,20.90%,TUBA4A;SDCCAG8;PPP1R9B;PRKACA;CSNK1E;SIRT2;ODF2;TUBB;CEP164;ZFP36L1;TUBG1;HAUS7;CNTRL;NEK6;ZFP36L2;PSMD3;PLK5;APPL1;KLHL18;UBC;RPS27A;CDC14B;CENPJ;ERCC2;PSMA7;TUBA1A;CEP63;ANAPC15;HAUS2;CEP135;HAUS6;ANAPC11;PSMB3;OFD1;PSMB9;CEP57;PSMC2;MAPRE1;AURKA;DCTN2;PSME4;PSMC1;PSMB7;CEP70;ANAPC1;PSMB5;ACTR1A;ANAPC2;CEP43;CCP110;PSMB8;TFAP4;NDE1
prerank,positive regulation of neuron differentiation (GO:0045666),0.3525892285677394,1.1357965012075133,0.2621184919210054,0.7976058704013604,1.0,14/40,21.50%,ARHGEF2;HEYL;MMD;MEF2C;IMPACT;SIN3A;ZEB1;PROX1;ECT2;PCP4;TCF4;TCF3;FGF20;BMP2
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4164253679472395,-1.135661497944635,0.2841880341880342,0.7210176700632367,1.0,9/17,29.14%,ANXA4;PTPN22;KLF4;MAP2K5;SSC5D;ANXA1;MAPKBP1;OTUD7B;TMSB4X
prerank,snRNA transcription (GO:0009301),0.31151482678694686,1.135448378149361,0.24342105263157895,0.7976795561499038,1.0,19/70,21.49%,POLR2H;SRRT;NCBP1;CDK9;INTS11;POLR2D;POLR2J;INTS3;TAF6;RPAP2;TAF8;ELL2;POU2F1;POU2F2;POLR2E;POLR2I;INTS8;NABP1;TAF5
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.40563476505283924,1.1349900879252122,0.29135338345864664,0.7981652831652578,1.0,5/18,14.95%,CAMK1D;RPS6KA5;TSSK4;CRTC1;RPS6KA4
prerank,regulation of fibroblast proliferation (GO:0048145),-0.3093791161969307,-1.1343960380987348,0.23929471032745592,0.7237375436724238,1.0,17/45,23.03%,CD74;FN1;MYC;CDC73;LIG4;B4GALT7;NLRC3;PARP10;CTNNB1;CDKN1A;SFRP1;PDGFA;GSTP1;E2F1;CDK4;CDK6;AQP1
prerank,regulation of cell aging (GO:0090342),0.4690777235958875,1.1342849847137264,0.31238095238095237,0.7996111955522002,1.0,2/11,6.42%,NUAK1;NEK6
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.3282524673518638,1.133624681380538,0.25535714285714284,0.8007472364993902,1.0,15/45,20.44%,LGALS9;AGER;TLR4;RIPK2;PYDC1;CASP1;ORM2;GBP5;NLRP3;USP50;EGR1;AIM2;NOD2;PYCARD;MYD88
prerank,microtubule polymerization (GO:0046785),0.3643650313896165,1.1331076599530907,0.26055045871559634,0.8014519027495833,1.0,12/29,28.66%,FGF13;TUBG1;TUBGCP5;CENPJ;TRPV4;MAPT;NDE1;PIN1;TPPP3;CSNK1D;TUBGCP3;CLASP1
prerank,regulation of lymphocyte activation (GO:0051249),0.4583743881325897,1.1323236862392179,0.3104693140794224,0.8031013726403742,1.0,1/12,0.06%,PAG1
prerank,aerobic electron transport chain (GO:0019646),0.30870657320206735,1.132257239500371,0.25806451612903225,0.802267866153707,1.0,22/68,23.98%,NDUFB2;NDUFB8;COX8A;NDUFS3;NDUFS4;COX7A2L;NDUFB10;UQCRC2;UQCRB;NDUFAF1;NDUFB3;NDUFS5;NDUFV3;NDUFA13;COX5A;NDUFC2;COX6B1;NDUFV1;NDUFA9;NDUFB11;COX6A2;NDUFV2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.3176817273013478,-1.1312865023998253,0.26044226044226043,0.7322627585141521,1.0,11/38,18.78%,CENPP;KNL1;CENPT;MIS18BP1;ASF1A;NASP;CENPW;NPM1;H3-3A;CENPS;RBBP7
prerank,negative regulation of locomotion (GO:0040013),-0.44220857893052434,-1.1311864350818797,0.29555555555555557,0.7313119328076162,1.0,3/12,8.84%,FRMD5;SPOCK3;PTPN2
prerank,mRNA transport (GO:0051028),0.28965565379057867,1.130891299413243,0.22006472491909385,0.8057838011123913,1.0,33/101,23.30%,SRRM1;NCBP1;RANBP2;NUP42;ZFP36L1;SRSF5;DHX38;SEC13;NUP35;CPSF1;U2AF2;NUP50;U2AF1L4;ALYREF;RBM8A;SEH1L;SLU7;DDX39B;NUP62;NUP107;SRSF9;NUP88;ALKBH5;THOC6;FIP1L1;DDX19B;NUP188;HNRNPA2B1;NUP214;MAGOHB;MAGOH;ZC3H11A;THOC3
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3519360682330046,-1.1307559348092184,0.27400468384074944,0.731434469639647,1.0,3/26,2.71%,APP;NCK2;CBLB
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.4614321776133995,1.1303169770356472,0.30467289719626167,0.8067912858130618,1.0,3/11,15.65%,UNC93B1;TNIP2;TICAM1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4225561462322346,1.1299431893121468,0.3129370629370629,0.8069059280731575,1.0,7/16,16.86%,DDX5;RBM17;DDX17;DHX9;SLU7;SCNM1;SRSF9
prerank,selective autophagy (GO:0061912),0.3208479829525873,1.1298664349989946,0.23166666666666666,0.8060826142265743,1.0,15/56,17.70%,ULK2;NBR1;ATG14;PHB2;ATM;RB1CC1;UBC;RPS27A;AUP1;UBA5;ATG5;ULK1;RETREG1;WDR81;KLHL3
prerank,cellular response to reactive oxygen species (GO:0034614),0.3156146018079526,1.129520123990878,0.24719101123595505,0.8062330306658919,1.0,19/59,19.94%,SIRPA;NFE2L2;PRKCD;IMPACT;TRPM2;RHOB;PDK2;CAMKK2;ABL1;PAX2;AKT1;ANKZF1;MAPK7;ECT2;PXN;MAPK8;JUN;PARK7;MAPT
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.467059060621402,1.1294683155503635,0.31496062992125984,0.8053224117817318,1.0,4/11,10.12%,F11R;RAB1A;TJP1;TJP2
prerank,cellular response to leucine (GO:0071233),0.4886760781367633,1.1294669406854263,0.3333333333333333,0.8031774013673272,1.0,3/10,15.66%,RPTOR;MTOR;SESN1
prerank,response to leucine (GO:0043201),0.4886760781367633,1.1294669406854263,0.3333333333333333,0.8031774013673272,1.0,3/10,15.66%,RPTOR;MTOR;SESN1
prerank,negative regulation of chemokine production (GO:0032682),0.4465665077680986,1.1291513940831437,0.30091743119266057,0.8030647756732737,1.0,2/14,1.59%,SIRPA;LGALS9
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.28911769406675064,-1.1290146585241247,0.20572916666666666,0.7355778764331734,1.0,16/65,12.53%,HIP1;EGFR;PTPN12;CDC42;DOK1;PTPN3;CCDC88A;CDH13;SH3GL2;PTPN2;PLAUR;EPS15;PDE6H;RHBDF2;MVB12A;RNF126
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.446110530821317,-1.128985667735844,0.30158730158730157,0.7319288333250253,1.0,2/12,6.03%,CUL3;DLGAP5
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.446110530821317,-1.128985667735844,0.30158730158730157,0.7319288333250253,1.0,2/12,6.03%,CUL3;DLGAP5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.446110530821317,-1.128985667735844,0.30158730158730157,0.7319288333250253,1.0,2/12,6.03%,CUL3;DLGAP5
prerank,respiratory system development (GO:0060541),0.3529896735838559,1.1289128027744535,0.28520499108734404,0.8027927259605138,1.0,8/32,13.07%,BAG6;BASP1;LOXL3;CHD7;SHH;WNT7B;CCDC40;PROX1
prerank,proteoglycan metabolic process (GO:0006029),-0.3537485806145636,-1.1288306192516173,0.26291079812206575,0.7311550317030472,1.0,13/26,27.88%,SULF2;HS3ST4;ADAMTS12;B4GALT7;CHST10;CHST12;CSGALNACT2;CSGALNACT1;XYLT1;BMPR1B;CNMD;IGF1;CHST14
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.4534666867474872,-1.1282027798611114,0.29004329004329005,0.7319295085666491,1.0,5/11,20.02%,PARP14;PARP10;PARP3;PARP12;TIPARP
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.4452728536139896,-1.1274090754944652,0.3018867924528302,0.7331470116580622,1.0,5/12,17.86%,UST;DSE;CSPG4;VCAN;CHST12
prerank,actin crosslink formation (GO:0051764),-0.444527818915641,-1.1273113642598571,0.3134020618556701,0.7321957803575626,1.0,3/12,4.57%,EPS8;GAS2;GAS2L3
prerank,positive regulation of cytokine production (GO:0001819),0.25168058733425885,1.1272077012658142,0.16736401673640167,0.807348299867609,1.0,76/292,20.85%,IL18;POLR3G;TLR7;ARHGEF2;CSF1R;CADM1;CCDC88B;LGALS9;AIF1;DDIT3;POLR2H;AGER;TLR4;RIPK2;PLCG2;CYRIB;PIK3CG;IL6R;EBI3;AFAP1L2;CD34;GAPDH;IL6ST;IL12RB2;CCR7;NOS2;SLC7A5;IL12B;ORM2;POLR3H;RAB1A;CGAS;LAMTOR5;G3BP1;CD86;APPL1;BRCA1;IL33;SCAMP5;PIK3CD;PTPN11;DHX9;ARNT;HAVCR2;SOD1;DRD2;MAPK14;ROCK2;PNP;IRF3;CEBPG;LY9;EIF2AK2;RUNX1;GBP5;NLRP3;MAVS;POLR1C;SETD4;TICAM1;GATA3;EGR1;NOD2;POU2F2;STOML2;TNFRSF14;PYCARD;IRF5;POLR2E;PARK7;XRCC6;ADAM17;MYD88;HIF1A;TWIST1;SLC11A1
prerank,lamellipodium assembly (GO:0030032),0.3694560057454347,1.127200457412188,0.2672413793103448,0.8062962039672587,1.0,4/26,4.81%,SRGAP2;P2RY12;RAC1;ARFIP2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3435059588861486,1.1271484153353903,0.3003412969283277,0.8054099978528743,1.0,12/40,19.70%,SLC7A8;SLC36A1;SLC7A5;SLC38A10;SLC25A11;SLC19A1;SLC16A7;SLC25A10;SLC38A7;SLC25A14;SLC38A1;SLC7A7
prerank,cytosolic transport (GO:0016482),0.2852231045966742,1.12713094403011,0.24646781789638933,0.8044019743522981,1.0,42/108,27.82%,HOOK2;PHETA1;TBC1D17;VPS26B;AP2A1;YKT6;SORT1;TBC1D10B;VPS54;AKTIP;CLN3;PIK3C3;SNX5;RBSN;MON2;DOP1B;AP4M1;PTPN23;SNX32;VPS13C;RAB6B;WDR81;STX16;DENND5A;RAB9A;VPS26A;KIF16B;STX5;SYS1;ANKFY1;CCDC91;VPS29;HOOK3;VPS35;STX8;STX6;PREPL;TBC1D5;VTI1A;EHD3;GAK;RAB29
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.37354377504005365,-1.1270871579891706,0.2786516853932584,0.7316985012814926,1.0,12/23,26.05%,HTT;NDC80;SPDL1;CDK5RAP2;ZW10;GPSM2;ITGB1;MAD2L1;NSFL1C;PLK1;FBXW11;PAFAH1B1
prerank,nucleic acid metabolic process (GO:0090304),0.307498011111289,1.1264528855758804,0.24013157894736842,0.8056752973441039,1.0,20/69,22.59%,POLR2H;NCBP1;DXO;HNRNPA3;HNRNPC;POLR2D;POLR2J;MMS19;HNRNPH1;PCBP2;HNRNPR;DUSP11;METTL14;DNASE2;RBMX;POLR2E;DDX54;POLR2I;LSM8;HNRNPA2B1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.464959653629369,1.1262216199636126,0.31053604436229204,0.8053939659164748,1.0,3/11,3.01%,ABCD2;COA8;SLC30A10
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3823958580896611,1.1261193008195836,0.3005464480874317,0.8046771948616148,1.0,6/24,16.45%,NFE2L2;PDPK1;GATA2;MAPK7;TNIP2;GATA3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3811598156640179,-1.1261031108250699,0.28211009174311924,0.733431436089564,1.0,8/20,25.46%,DCC;GSK3B;ERBB3;BAK1;BCL2;BOK;CASP9;MCL1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4217977888562893,1.1256004354006428,0.30656934306569344,0.8053103044689421,1.0,5/16,18.10%,MLXIPL;COX7A2L;PINK1;UQCC2;ABCD1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3067817809626268,1.1253118152354133,0.2577854671280277,0.8052401229130827,1.0,11/70,9.23%,SMAD3;CRADD;ITGAV;RNF41;CD27;IL6R;TRADD;PDPK1;SORT1;SIVA1;APPL1
prerank,multivesicular body assembly (GO:0036258),0.36604493093741736,1.1252118593334797,0.30256410256410254,0.8045051863700104,1.0,17/30,34.14%,VPS37A;VPS36;VPS37D;CHMP1A;TSG101;CHMP2A;HGS;IST1;STAM2;CHMP7;VPS37B;VTA1;CHMP3;RAB11A;PDCD6IP;CHMP6;CHMP5
prerank,basement membrane organization (GO:0071711),-0.4211404871468212,-1.1248837700353864,0.298876404494382,0.7359662626165961,1.0,6/14,14.93%,FLRT2;COL4A1;LAMB2;NID1;NTNG1;NTNG2
prerank,cardiac ventricle development (GO:0003231),0.4024679726828888,1.124726847665095,0.3016759776536313,0.8050751784093122,1.0,5/20,17.06%,SALL1;HEYL;MDM4;GATA3;ENG
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.4410008888112962,1.1247067069024723,0.31261101243339257,0.8040966583013421,1.0,3/14,4.06%,PYDC1;GPS2;RFFL
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3018771482786154,1.1241885497309192,0.25555555555555554,0.8047646463858129,1.0,11/74,9.23%,TGFBR1;ARHGEF2;ITGA6;CFLAR;ITGAV;SRC;RFFL;TRADD;ZMYND11;EYA3;BRCA1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3062767901954061,1.1241297758709865,0.25709779179810727,0.803932714779464,1.0,23/73,20.36%,ELMO1;VAV2;RAC1;SRC;PRKCD;LYN;PIK3R1;PLCG2;PLD2;NCKAP1L;PLA2G6;PIK3CB;ABL1;WIPF2;ARPC1A;CYFIP1;ARPC1B;WASL;NCKIPSD;VAV1;ARPC3;PLCG1;PIK3CA
prerank,positive regulation of T cell differentiation (GO:0045582),0.35688016241241316,1.124090171620438,0.28055077452667815,0.8030147877097242,1.0,9/36,17.36%,VSIR;RHOH;NCKAP1L;SHH;IL12B;VNN1;PNP;GATA3;IL4I1
prerank,T cell differentiation in thymus (GO:0033077),0.4399371147353087,1.1238542154407278,0.2981132075471698,0.8027576777934735,1.0,3/14,6.73%,ZFP36L1;SHH;ZFP36L2
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.3587661671484031,-1.123793286624682,0.27790432801822323,0.7380622663700638,1.0,7/24,15.35%,CTNNA2;OLFM2;CTNNA1;CDC42;BOC;CTNNB1;SPAG9
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3774744641469174,1.123667778814726,0.31351351351351353,0.8022925487348432,1.0,10/26,20.13%,KMT2D;EEF2KMT;CTR9;KMT5C;TET3;ANTKMT;SETD2;SETD4;SETD3;PRDM9
prerank,import into cell (GO:0098657),0.3335536695239075,1.1233730049406987,0.26548672566371684,0.8021694375753672,1.0,10/41,13.48%,SLC7A8;SLC1A3;SLC36A1;SLC12A6;NEURL1B;SLC7A5;SLC22A2;IL10RA;LRRC8A;SLC19A1
prerank,diacylglycerol metabolic process (GO:0046339),0.3852065639546642,1.123181680642355,0.2879581151832461,0.8017808992031912,1.0,7/23,11.96%,DGAT1;DGKK;PLA2G15;MOGAT2;MOGAT1;DGKD;PGS1
prerank,cytoskeleton organization (GO:0007010),0.28088879610560197,1.1230652398887284,0.21879815100154082,0.8011135850034103,1.0,17/114,7.06%,BIN1;FGD2;DST;RAC1;RND1;ARAP3;RHOH;CAPZB;CAMSAP1;PLD2;SIPA1;ZRANB1;RHOBTB1;RND2;RANBP10;RHOB;FMNL3
prerank,regulation of phospholipase C activity (GO:1900274),-0.4171560858828418,-1.1229138418919937,0.2943820224719101,0.7395537257818333,1.0,4/15,16.11%,BICD1;NTRK3;KIT;ABL2
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.4578733458666685,-1.1229045782307598,0.32409381663113007,0.7383498831483206,1.0,6/10,33.55%,PRKN;SNCA;HP;GZMA;AOC3;ETFBKMT
prerank,cell projection organization (GO:0030030),0.3542836785235904,1.1227858907244073,0.28452579034941766,0.8010055364801335,1.0,8/30,14.93%,P2RY12;RAC1;RHOH;NCKAP1L;RHOQ;PLEK;CSPG5;CYFIP1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3012006607609493,-1.1226382394378296,0.25609756097560976,0.7379933718501636,1.0,8/52,6.54%,RBFOX1;RBFOX2;KHDRBS2;NOVA1;MBNL3;PUF60;CELF6;RBFOX3
prerank,fatty acid metabolic process (GO:0006631),0.27959202296953656,1.1225230620743134,0.23208722741433022,0.8008390867102012,1.0,15/115,8.51%,LIPC;LIPH;ABCD2;ACAD9;ACSL4;LPIN2;PPARD;THEM4;PLA2G15;HPGD;NUDT19;ACADM;SLC27A4;ALOXE3;CROT
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.2837517440298653,-1.1225222655074771,0.24111675126903553,0.7371400829995965,1.0,11/72,5.27%,ARHGEF3;EPS8;ROBO1;RIT2;CUL3;ARHGAP35;APOE;STARD8;ARHGDIA;RIPOR2;GPR35
prerank,modification-dependent protein catabolic process (GO:0019941),0.2623756190453795,1.1224668801925863,0.2062314540059347,0.7999802258515757,1.0,47/193,18.37%,BAG6;PCYOX1;FBXO22;ITCH;SPSB1;UBE2H;SMURF1;RFFL;SPSB2;NDFIP2;UFD1;CDC34;PSMD3;ARRDC1;OS9;RNF8;FBXW4;UBC;RPS27A;RNF166;FBXO11;BFAR;AREL1;FBXO21;ANAPC15;RNF11;PINK1;KCTD6;NTAN1;DTX3L;ANAPC11;MYLIP;PSMC2;RNF144B;AURKA;UBQLN4;ZNRF3;TOPORS;ANAPC1;FBXL7;WDR81;UBE2A;TAF1;KLHL3;SYVN1;FBXO8;RNF20
prerank,histone ubiquitination (GO:0016574),0.39324764263585854,1.1215130336694716,0.30017761989342806,0.8020045269987721,1.0,8/21,21.80%,CTR9;RNF8;UBE2U;DTX3L;UBE2A;RNF20;PHC1;ATXN7L3
prerank,nuclear membrane disassembly (GO:0051081),0.42898686201344793,1.1211133570323377,0.33516483516483514,0.802240116088122,1.0,5/14,17.57%,PRKCA;AKAP8L;NEK6;PRKCB;LPIN1
prerank,proteasome assembly (GO:0043248),0.467410071704919,1.121097559880793,0.32633587786259544,0.8012556323021175,1.0,2/11,4.00%,OTUD6B;PSMG1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3683062626696317,1.120895898175594,0.28415300546448086,0.8009046546717027,1.0,10/25,24.68%,SRRM1;SF3B1;TRA2B;SLU7;GEMIN2;PRPF3;MPHOSPH10;PRPF4;SNRNP40;SF3B3
prerank,negative regulation of histone modification (GO:0031057),-0.40612907054567304,-1.120207055180113,0.2995391705069124,0.7432020806291004,1.0,8/14,27.66%,JARID2;TAF7;SNCA;AASS;FOXP3;THAP7;SPHK2;NOC2L
prerank,purine nucleotide metabolic process (GO:0006163),0.37990153650089953,1.1197910820480197,0.2915951972555746,0.8036368243526928,1.0,9/24,18.09%,FHIT;GUK1;NUDT15;MTHFD1;PRPS1L1;PRPS1;PNP;GART;PRPSAP2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.40476296024371666,-1.119729407136012,0.2866666666666667,0.7434335987736735,1.0,5/15,15.87%,LDLR;SIK1;CNEP1R1;MFSD2A;CTDNEP1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.2804224633486482,-1.1195677143204081,0.25526315789473686,0.7427092184731132,1.0,15/70,12.77%,CYBB;CD36;B2M;PSMD14;NCF2;PSMA2;PSMF1;TAP1;PSMD8;CYBA;PSMD6;PSME2;PSMD11;PSMD1;PSMD5
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.38054078454195994,1.1195093301674854,0.29896907216494845,0.8035860955926749,1.0,5/25,5.90%,SMAD3;TLR4;AGTR2;CLU;NOS1AP
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.28370961581465626,-1.1193663178373519,0.24054054054054055,0.7421369274013331,1.0,22/67,21.71%,NEDD9;DOCK5;UTRN;CD36;VIT;FN1;CDC42;GSK3B;SKAP1;JAK2;CDH13;CARMIL1;MYADM;CX3CL1;SFRP1;FLNA;CD3E;EPHA1;OLFM4;S100A10;ALOX15;CDK6
prerank,positive regulation of binding (GO:0051099),-0.27501173270279045,-1.1193020339542656,0.23116883116883116,0.7411343797629243,1.0,22/84,16.92%,LRRK2;PPARG;APP;APOE;KDM4D;B2M;RAPGEF2;MARK3;RAN;GSK3B;PRKN;CLN5;HIPK2;PLAUR;RARA;TIAM1;EPB41;MMP8;CAPRIN2;BAMBI;ADD2;HMGB1
prerank,cellular response to drug (GO:0035690),-0.3520464989111762,-1.1192433363453125,0.26987951807228916,0.7400978152764046,1.0,8/25,16.17%,PDE4B;PPM1E;MYC;KCNH2;CERS1;KCNQ1;CRHBP;TFRC
prerank,protein deacetylation (GO:0006476),0.34013985001997993,1.1192293947639715,0.2864493996569468,0.8034425691890996,1.0,11/41,15.18%,MTA1;HDAC10;SIRT2;SUDS3;RBM14;SIN3A;MIDEAS;BRMS1L;MORF4L1;SIN3B;MIER3
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.39319312474484713,1.1190365019487931,0.3165217391304348,0.8030493419272783,1.0,6/22,10.75%,GTF2H2;CUL4B;UBC;RPS27A;ERCC2;DDB2
prerank,central nervous system development (GO:0007417),-0.23566797537525622,-1.11901199788342,0.13214285714285715,0.739650813648804,1.0,82/250,25.53%,CNTNAP2;ZBTB16;NFIB;NRCAM;ADGRL3;GRIN2A;SPOCK1;POMK;SLC8A3;GSN;WWP1;JARID2;TPPP;GRIN2B;ADAM22;ATP6AP2;MYRF;POU6F2;IL1RAPL2;VIT;SOX11;CNTN6;DCLK1;CDK5RAP2;NR4A2;COL4A1;EML1;PRKN;CLN5;PKD2;AFF2;HSPG2;ECRG4;LIG4;SH3GL2;GRIK1;ZFHX2;GRIN2D;VCAN;DDIT4;SERPINI1;MAL;MFSD2A;PBX1;PLXNB2;RELN;ZIC5;MDGA1;AHI1;SMARCA1;CYP26C1;UGP2;PTS;ALDH3A2;SCYL2;NKX2-2;CNTN4;GSTP1;BTD;PBX3;NHLH2;SOX10;ADGRL2;CDK5RAP3;ADAM23;ARNT2;APOD;EPHA7;PPP1R17;SOX12;SLC6A17;GRHL2;ACAN;PKD1;TPP1;HAPLN2;RAB18;NPTX1;HAPLN4;NES;NCKAP1;ATXN1
prerank,positive regulation of protein processing (GO:0010954),-0.3845267793829691,-1.1189414562585611,0.2988505747126437,0.7386863416789512,1.0,3/19,2.41%,NLRC4;CCBE1;GSN
prerank,embryonic organ morphogenesis (GO:0048562),-0.31211715623413866,-1.1181713453295337,0.27053140096618356,0.7400007150960708,1.0,10/42,14.89%,HOXC4;RYR2;HOXC9;SOX11;RARG;FBN2;FBN1;HOXB3;RBP4;RBPMS2
prerank,lipid translocation (GO:0034204),-0.37956173370906676,-1.1180850949840944,0.3130841121495327,0.7390484829090443,1.0,8/21,18.39%,ATP8B4;ATP11A;ATP11C;ATP8B2;ABCC1;ABCA4;ATP10B;ATP9B
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.42382044983048317,1.1178128099809008,0.3192307692307692,0.8061767714907307,1.0,9/15,23.68%,TLR4;CPTP;PYDC1;EIF2AK2;GBP5;USP50;MYD88;DDX3X;MEFV
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.2918260043778155,-1.116944346928695,0.2630272952853598,0.7413875751705679,1.0,9/56,6.03%,PLCB1;CUL3;EGFR;FGF10;ANKRD17;KMT2E;CCND2;UBE2E2;DLGAP5
prerank,negative regulation of cell growth (GO:0030308),0.2773475905274934,1.1163158944543345,0.2353823088455772,0.8100007983957122,1.0,30/121,19.46%,ULK2;SMAD3;FGF13;PPP1R9B;DIP2B;OSGIN2;CDKL3;SIPA1;AGTR2;CCDC85B;FLCN;NDUFS3;APBB2;SOX17;SMARCA2;PPT1;OSGIN1;NME6;PRDM11;DACT3;RTN4R;ULK1;GJA1;EI24;NDUFA13;PTPRJ;CDKN1B;ADAM15;MAG;VGLL4
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.40789559237836603,1.1152297790678984,0.3208955223880597,0.8126157482751906,1.0,3/17,3.58%,LY86;PRKCA;TRIM5
prerank,regulation of mononuclear cell migration (GO:0071675),0.3907214091590749,1.114158715955399,0.3159851301115242,0.8150509135721077,1.0,4/23,6.01%,CSF1R;AIF1;LYN;AKIRIN1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.30318447365464835,1.1136966656551708,0.2832764505119454,0.8155881184017804,1.0,22/69,23.98%,NDUFB2;NDUFB8;COX8A;NDUFS3;NDUFS4;COX7A2L;NDUFB10;UQCRC2;UQCRB;NDUFAF1;NDUFB3;NDUFS5;NDUFV3;NDUFA13;COX5A;NDUFC2;COX6B1;NDUFV1;NDUFA9;NDUFB11;COX6A2;NDUFV2
prerank,myotube differentiation (GO:0014902),0.41047131543211246,1.1136230948996109,0.3176895306859206,0.8148038303524672,1.0,5/17,7.52%,MEF2C;JAM2;SKI;SORT1;KLHL40
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.361091220428293,1.1134548021960806,0.289198606271777,0.8143703080290701,1.0,8/29,14.40%,CNOT1;KMT2D;BRCA1;UBA5;KCTD6;CARM1;RUNX1;KANK2
prerank,cell junction maintenance (GO:0034331),0.4293070336648488,1.113022567828637,0.3126177024482109,0.8148246731375585,1.0,4/14,17.35%,CSF1R;CBLN1;CBLN2;CLDN1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.42108850410551135,1.1129410313606145,0.3123877917414722,0.8140532452019841,1.0,8/16,29.10%,BLM;MCM2;MCMDC2;SSBP1;MCM6;RECQL;MCM7;RPA1
prerank,amino acid import across plasma membrane (GO:0089718),0.36889720065634485,1.1129135857698629,0.30337078651685395,0.8131323099007961,1.0,5/24,7.99%,SLC7A8;SLC1A3;SLC36A1;SLC7A5;SLC22A2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.42911559532139404,1.1128640044642741,0.2987012987012987,0.8122721692239556,1.0,8/15,28.66%,CST3;FSCN1;LRP1;DDR2;FGFR4;TGFB1;FAP;CLASP1
prerank,response to progesterone (GO:0032570),0.4033408286584718,1.1128472181177989,0.3183453237410072,0.8113253281388061,1.0,8/18,31.62%,SRC;THBS1;CATSPER2;UBE3A;TGFB1;WBP2;NR1H3;CATSPER3
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.4271571822582269,1.1128329182226282,0.30825688073394497,0.8103618500665704,1.0,9/15,33.54%,ENTPD1;CMPK1;ENTPD7;ENTPD6;AK1;ENTPD3;AK7;CMPK2;AK8
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.31975943708297133,-1.1124679237134276,0.26555023923444976,0.7543948890293476,1.0,6/38,4.44%,MAGI2;BANK1;XDH;PHLPP1;PLEKHA1;SIRT1
prerank,regulation of cilium assembly (GO:1902017),0.31052537250744555,1.1120976697618994,0.270223752151463,0.811733389114851,1.0,19/62,20.46%,TBC1D16;SDCCAG8;TBC1D9B;TBC1D8;TBC1D17;TBC1D7;TBC1D15;TBC1D10B;DYNLT2B;ENTR1;ATG5;IFT20;SGSM3;MARK4;TBC1D30;CCP110;CROCC;TBC1D13;IFT140
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3805393824267552,1.1120154372483946,0.3078231292517007,0.8110057955683144,1.0,4/22,12.54%,PDE3B;GPER1;CEACAM1;BSCL2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3653196438673134,1.1119451424749212,0.29484902309058614,0.8102396042795447,1.0,6/29,7.55%,LGALS9;AIF1;JAM2;AGER;LGMN;CCR7
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.42210388160105866,-1.111744048391939,0.3333333333333333,0.7554956890071493,1.0,5/14,14.65%,ITGA4;CD40;ANO6;CCL2;RGCC
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.3996210124527556,-1.1116351419305233,0.33021077283372363,0.7546302075978389,1.0,7/17,19.20%,PID1;PFKFB1;HDAC4;FIS1;TIGAR;NCOR1;CBFA2T3
prerank,regulation of execution phase of apoptosis (GO:1900117),0.470187041668799,1.111544238368967,0.3441441441441441,0.8105956176557093,1.0,5/11,26.28%,SIRT2;TP53;ZC3H12A;FZD3;FAP
prerank,positive regulation of developmental process (GO:0051094),-0.24660846319627552,-1.1115029248694799,0.21621621621621623,0.7538314556294081,1.0,40/164,18.10%,NRXN1;NLGN1;PLCB1;ZBTB16;B4GALT5;MCU;APOE;RTN4;CPEB3;SOX5;LMNA;CEBPB;SIRT1;SHANK3;CORO1C;DNM1L;BMP5;PRKN;ALK;GRIP1;DDHD1;MFF;RALBP1;HSP90AB1;FIS1;MAP3K13;ENPP2;DAG1;KMT5B;SLC6A6;ZDHHC15;RELN;ESRRB;SCX;TFRC;SHLD3;SERPINF2;SRF;NR2C2;BMP4
prerank,regulation of peptide hormone secretion (GO:0090276),-0.2855764404987957,-1.1113224769792904,0.2638190954773869,0.753131025186083,1.0,18/67,15.67%,CACNA1E;ITPR1;DPP4;HTR2C;KCNC2;RFX3;CACNA1C;ALOX5;SLC8B1;PER2;SNAP25;ADRA2A;TFR2;FFAR1;CLOCK;TFAP2B;CCL5;CRHBP
prerank,actin filament-based transport (GO:0099515),0.39109976663916424,1.1112574579905532,0.31793960923623443,0.8105298985796113,1.0,8/21,17.65%,MYO1F;MYO1B;MYO7A;MYO5B;MYO1E;SUN2;MYO15A;WASL
prerank,neuromuscular process controlling balance (GO:0050885),-0.43807633667811774,-1.1111083287041474,0.3257261410788382,0.75256986393313,1.0,2/12,1.05%,NRXN1;PCDH15
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.39262879345439594,-1.1110567964945466,0.30180180180180183,0.7515031001043677,1.0,6/18,21.54%,RIC1;FAF1;MSN;RGP1;EZR;CDK5RAP3
prerank,manganese ion transport (GO:0006828),-0.4269404566595705,-1.1108066883851053,0.3225108225108225,0.7510400491647201,1.0,4/14,8.24%,TRPC5;TRPC4;TRPC3;TMEM165
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.3663392769900129,-1.1104755842750176,0.31910112359550563,0.7509146124488448,1.0,7/21,18.59%,SLK;CORO1C;LIMCH1;ACTG1;EFNA5;PEAK1;EPHA3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.27569601809594046,1.1103458570383458,0.24572317262830481,0.8126489853659584,1.0,23/119,12.86%,INPP5D;PI4KB;TMEM150A;PIGV;PIK3R1;PLCG2;PGAP2;PIK3CG;INPP4B;RAB4A;DPM3;PIK3CB;INPP5E;CDS1;PIK3CD;PIK3C3;PIGO;PLEKHA4;IMPA1;MTMR4;SOCS6;PITPNM1;BMX
prerank,monocyte chemotaxis (GO:0002548),-0.33353321894057364,-1.1101249879356305,0.289237668161435,0.7507737473060263,1.0,16/32,36.28%,CCL4;CCL2;CCL5;CX3CL1;CCL14;CCL7;RPS19;FOLR2;CALCA;ANXA1;CCL19;CCL8;MSMP;PTPRO;TNFRSF11A;CCL3
prerank,positive regulation of telomere capping (GO:1904355),-0.39513206532102496,-1.1100018975964892,0.3042505592841163,0.7499284498535892,1.0,10/17,36.31%,MAPKAPK5;AURKB;TNKS2;PRKCQ;MAPK15;MAPK1;NABP2;NEK2;PNKP;HNRNPD
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4100721503398275,1.1099087607083362,0.30275229357798167,0.8131125237975024,1.0,6/16,12.55%,IGFBP3;MEF2C;AKIRIN1;RBM24;LRRC8A;MAPK14
prerank,endochondral bone morphogenesis (GO:0060350),0.4658595740341366,1.1098837630620244,0.3357142857142857,0.8121928225583095,1.0,2/11,1.94%,TMEM119;MEF2C
prerank,myofibril assembly (GO:0030239),0.33314527041421194,1.109371529831235,0.28842832469775476,0.8128751795219707,1.0,3/42,1.67%,CAPN3;FLII;CFLAR
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.3956298715327447,-1.1089469477550766,0.31555555555555553,0.7520129145467004,1.0,13/16,39.50%,DPM2;PIGX;PIGW;PIGP;PIGC;PIGA;PIGB;PIGN;PIGZ;PIGQ;PIGF;PIGL;PIGH
prerank,histone deacetylation (GO:0016575),0.33216971458044214,1.1088850438614042,0.28264462809917357,0.8134206056289431,1.0,12/43,15.18%,MTA1;HDAC10;SIRT2;SUDS3;RBM14;SIN3A;MIDEAS;BRMS1L;HDAC8;MORF4L1;SIN3B;MIER3
prerank,negative regulation of lymphocyte migration (GO:2000402),0.4635990041530274,1.1087782784830116,0.31800766283524906,0.8127728302799575,1.0,5/10,17.65%,LRCH1;PADI2;MIA3;AKT1;WASL
prerank,actomyosin structure organization (GO:0031032),0.29702122016952365,1.1085906511782297,0.2603448275862069,0.8123852194290766,1.0,6/75,2.80%,EPB41L2;ITGB5;F11R;CAPN3;FLII;SRC
prerank,lipid transport (GO:0006869),0.28421371330119466,1.1085718461080651,0.2717219589257504,0.8114421687734457,1.0,15/97,13.16%,SLCO2B1;ABCA9;ABCD2;PITPNC1;PCTP;PPARD;CPTP;NME4;SLC27A4;NPC2;CEACAM1;CLN3;OSBPL5;PITPNM1;SCARB1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.4334605718072893,-1.108443633620956,0.3157894736842105,0.7524081918029057,1.0,5/12,20.02%,TNKS2;PARP10;PARP3;PARP12;TIPARP
prerank,activation of phospholipase C activity (GO:0007202),-0.3382730742671447,-1.108372792171004,0.28672985781990523,0.7514227650745027,1.0,7/29,6.57%,ARHGAP6;BDNF;EGFR;ADRA1A;NTRK2;RASGRP4;HTR2B
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4635610371691121,-1.1082164430953039,0.33403805496828753,0.7506760295485261,1.0,4/10,5.73%,APP;NPTN;SHANK3;NETO1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.4348798028429254,1.1080665398227116,0.34014869888475835,0.8120863486131839,1.0,7/14,22.21%,MPV17L2;RMND1;UQCC2;FASTKD3;C1QBP;NGRN;FASTKD2
prerank,dendritic spine organization (GO:0097061),-0.34756475158722255,-1.1079744418511337,0.29205607476635514,0.7502374072655688,1.0,5/26,6.47%,CTNND2;CDC42;SHANK3;PAK3;MTMR2
prerank,cellular glucan metabolic process (GO:0006073),-0.44247070140356126,-1.1075895314722568,0.32882882882882886,0.7502275407167514,1.0,5/11,16.60%,PRKAG2;GBE1;GSK3B;PYGM;UGP2
prerank,regulation of striated muscle contraction (GO:0006942),-0.34021081223283967,-1.107405546625973,0.27828054298642535,0.7496269002830002,1.0,4/27,2.33%,DMD;ANK2;SLC8A3;RYR2
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.3842227720356966,-1.1070695662568197,0.3097949886104784,0.749493186917004,1.0,10/19,29.43%,ALDH1L1;MTHFD1L;SLC46A1;SHMT1;MTHFD2;FPGS;SHMT2;FOLR2;MTHFD2L;DHFR
prerank,DNA methylation or demethylation (GO:0044728),-0.38633887926199373,-1.106943906010335,0.3159041394335512,0.7475251910568659,1.0,10/19,26.95%,KMT2E;ATF7IP;GATAD2A;DNMT3B;HELLS;SPOCD1;BAZ2A;DNMT1;EHMT1;FOS
prerank,DNA alkylation (GO:0006305),-0.38633887926199373,-1.106943906010335,0.3159041394335512,0.7475251910568659,1.0,10/19,26.95%,KMT2E;ATF7IP;GATAD2A;DNMT3B;HELLS;SPOCD1;BAZ2A;DNMT1;EHMT1;FOS
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.38073163679813216,1.1068341944518725,0.315884476534296,0.8150809514037854,1.0,5/22,15.04%,NCKAP1L;CRY2;ROCK2;MGAT5;MASTL
prerank,positive regulation of response to external stimulus (GO:0032103),0.271728734874796,1.106734093213908,0.2576219512195122,0.8143965920244285,1.0,27/128,16.54%,IL18;POLR3G;TLR7;P2RY12;LY86;ETS1;AIF1;PRKCA;TLR4;ZCCHC3;TRADD;SLC15A4;CNTF;PDGFB;IL12B;DDT;AKIRIN2;IL33;APOH;DHX9;STX4;GBP5;PLG;SETD4;GPR4;THBS1;OPTN
prerank,chordate embryonic development (GO:0043009),0.31305074862236726,1.1066783985197628,0.29391304347826086,0.8135997107063386,1.0,21/55,27.44%,TGFBR1;SOX8;ZNF568;DEAF1;CHD7;FLCN;BRCA1;WNT7B;PROX1;NOG;GATA3;PTCH1;ADAM10;FGFR2;BMP2;MBNL1;TGFB1;SULF1;PTPRR;WNT5A;DVL1
prerank,response to laminar fluid shear stress (GO:0034616),0.47360525492195826,1.1066049172983758,0.33460076045627374,0.8128692624311793,1.0,2/10,1.05%,NFE2L2;SMAD7
prerank,regulation of dendritic spine development (GO:0060998),-0.3818989311886232,-1.1064811050836307,0.30184331797235026,0.7478132073182264,1.0,5/19,5.07%,NLGN1;APOE;PPFIA2;CPEB3;SHANK3
prerank,autophagosome assembly (GO:0000045),0.31740334080982546,1.1063818937502605,0.2908777969018933,0.8126062233389918,1.0,22/52,24.90%,ULK2;ATG14;ATG9A;SMURF1;STX12;RAB1A;RB1CC1;TRAPPC8;PIK3C3;ATG101;ATG5;UBXN2A;ULK1;ATG9B;PACS2;TP53INP2;WDR45B;MFN2;ATG2A;RAB23;GABARAPL1;ATG12
prerank,regulation of interleukin-6 production (GO:0032675),0.28315296335125867,1.106286585443741,0.2639593908629442,0.8119022860994103,1.0,15/96,10.68%,TLR7;SIRPA;ARHGEF2;LGALS9;AIF1;AGER;TLR4;PLCG2;IL6R;NCKAP1L;AFAP1L2;NOS2;IL33;PTPN11;DHX9
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.28267170059160357,-1.1062153835789263,0.28211586901763225,0.7474815805084997,1.0,21/64,20.13%,UTRN;CD36;SLK;CORO1C;GSK3B;LIMCH1;SKAP1;JAG1;CDH13;CASK;THY1;ACTG1;CDKN2A;EFNA5;CX3CL1;SFRP1;PEAK1;CD3E;EPHA3;EPHA1;TSC1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.4213793834056815,-1.1061352877354873,0.3031674208144796,0.7465626374598127,1.0,4/13,10.67%,UST;DSE;CSPG4;VCAN
prerank,regulation of DNA metabolic process (GO:0051052),-0.309109680931535,-1.1057122909827786,0.28028503562945367,0.7466606642359763,1.0,19/44,27.37%,WDR18;MYC;UBE2N;SMG6;KDM1B;XRCC5;SMG5;UPF1;PDGFA;USP1;PIF1;WDR70;SMG1;STOX1;NUCKS1;GRHL2;KPNA2;POLH;TERF2IP
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2218622754172278,1.1056810504263839,0.09317443120260022,0.8128899662619192,1.0,397/1645,22.72%,TGFBR1;SALL1;ZFHX3;IKZF1;ARID3B;ETV5;POLR3G;MLXIPL;ZSCAN26;SUMO1;RREB1;LRP5;DENND4A;CAPN3;BICRAL;SMAD3;NFE2L2;SMAD7;DNM2;SALL3;YWHAH;BACH2;LYL1;ETS1;HEYL;PBXIP1;PIM2;FLI1;SOX8;UBP1;RPS6KA1;BASP1;DDIT3;CHEK2;QRICH1;MEF2C;SRRT;VHL;TGFB1I1;TRAK1;FOXJ2;MLXIP;ZFP90;PPARD;CHD8;DDX5;HIVEP3;PRMT2;EPOP;HDAC10;RHOH;ERF;PHB2;MEF2D;GTF2H2;SIRT2;ZNF568;SUDS3;DEAF1;KMT2D;ELK1;AATF;PHF14;GTF2IRD1;PAX6;ZBTB21;ZXDB;EFEMP1;CALCOCO1;RPS6KA5;CREB3L2;HBP1;KLF3;ID1;ZBTB18;PCNA;REXO4;SBNO2;KARS1;ZIM3;LOXL3;MLX;PICALM;MYCL;CHD7;CCDC85B;ELK3;NFATC1;ATMIN;ZBTB24;CRY2;TFE3;MEIS3;TRIM44;BCOR;FOXN3;AFAP1L2;SAMD1;TAF6L;JMJD6;BCL7A;KLF11;FOXE1;CUX1;BICRA;ZMYND11;KDM5B;CXXC1;EID2;ZNF569;FUS;CTR9;SLTM;FZD2;KLF12;APBB2;SHH;HOXB8;CHD3;TRIM45;RXRB;BRF2;ILF2;FOXK2;ZSCAN21;NUP35;PKNOX1;TIAL1;TAL2;OVOL2;SAMD11;GATA2;HOXA6;PDGFB;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;SAMD13;PAX1;FOXO6;DMRTB1;ANKRD2;SOX17;NEUROD6;NEUROD4;TWIST2;POU4F1;HMX2;SRCAP;HOXD9;MMS19;MYNN;NR2F1;NPAS1;KDM3A;PITHD1;NOTCH4;RGS14;CD86;PRDM1;BRCA1;SMARCD3;SIN3A;MIDEAS;WWP2;CAMKK2;ZFP91;E4F1;LBX1;TBX6;MTDH;CDK11B;LIN9;ZNF367;DDX17;KDM4A;PATZ1;SMARCA2;TMPRSS6;MAP3K2;EED;MAP3K10;FADS1;DHX9;ARNT;KHDRBS1;ETV3;SMARCA5;MDM4;SMAD9;SNX5;DPF1;ZEB1;BLM;E2F2;LIMS1;MRGBP;HP1BP3;NFE2L1;NRF1;TTC21B;ZNF83;ABL1;MEF2A;PIAS2;BRD9;PIAS3;TRAPPC2;CNBP;PRDM11;CCNL1;PRDM2;MBD1;PRMT6;TENM1;MAPK14;PRKCB;SCMH1;ID3;PHF20;MXD1;OLIG2;CCNE1;ZMIZ2;SP9;DTX3L;IRF8;PAX2;PROX1;ARID1A;SPTY2D1;AKT1;IRF3;CARM1;TSC22D4;IRF2BP2;SP140;CEBPG;MXI1;MLLT6;ZBTB39;ZBTB8B;RUNX1;RLF;TEF;MED4;RNF187;QARS1;COMMD7;GCLC;ZNF3;CCAR1;DPF2;RPS6KA4;CUX2;KDM5A;CHMP1A;POFUT1;BRD3;HMGB2;MED18;PROX2;ZFP62;HES6;DKK3;KDM7A;WTIP;EID2B;NUP62;EZH2;SAFB;SP110;FZD1;KDM8;POU2F1;FANK1;NR1H2;TAL1;ZSCAN22;NUP107;GATA3;ZKSCAN1;ACTL6A;ATAD2;EDRF1;PLAGL2;BNC2;ZNF692;DYRK1A;DMTF1;TYMS;EGR1;ENG;SUFU;EPC1;ZNF292;BAZ1B;SAP30L;SAFB2;E2F3;KTI12;NDUFA13;ZNF585B;ZNF585A;RNF4;ZSCAN12;MGA;ZNF394;INPP5K;TCF7L2;TCF4;GZF1;RNF20;POU2F2;CDKN1B;THAP1;NOS1;PHC2;BHLHA9;CEBPD;TP53INP2;HDAC5;MED12;ZNF260;TCF7L1;TCF3;NFIA;JUN;IRF5;VGLL4;ZFPL1;DBX2;IRF2;BATF3;SETD3;HR;FOXP4;ZNF740;XRCC6;TOX2;RFXANK;ZBTB45;PHF8;CRABP2;RING1;PHC1;DEK;NFYA;TNNI2;IRF9;ACVR2B;HIF1A;IRX1;NFIX;TWIST1;YEATS2;TFAP4;EID1;WDR77;MED7;NCOA2;MNT;YY1;KDM2A;PCGF3;TAF5;BMP2;TGIF2;TEAD3;ZFP37;BRMS1;SCRT1;ZNF76;ATXN7L3;CRYAB;PDCD4;EPC2;TP53;ZBTB48;STAT5B;ZBTB2;RRP8;MSC;KDM1A;ARRB1;TAF5L;ZBTB14;CSRNP2;ZNF628;MITF;BTG1;HOXB5;ZHX1;TRAF6;SCML2
prerank,regulation of type I interferon production (GO:0032479),0.2898842089647889,1.1052313493546826,0.27182866556836904,0.8133767777574341,1.0,27/84,23.07%,POLR3G;POLR2H;OTUD5;RNF216;UBA7;ITCH;DTX4;UFD1;GAPDH;POLR3H;CGAS;G3BP1;PCBP2;DHX9;IRF8;IRF3;MAVS;POLR1C;NLRX1;IRF5;POLR2E;XRCC6;MYD88;NPLOC4;STAT6;PIN1;CYLD
prerank,somite development (GO:0061053),0.4645118991813827,1.1051147439006561,0.34980988593155893,0.8127915468842232,1.0,5/11,17.51%,LOXL3;SHH;MTHFD1;SMO;PTCH1
prerank,iron ion homeostasis (GO:0055072),-0.2875127661153945,-1.1049871922632137,0.22074468085106383,0.7477616404100993,1.0,16/58,16.49%,ABCB7;NEO1;FTL;B2M;MYC;ATP6V1A;ATP6V0D1;FBXL5;FLVCR1;SCARA5;NDFIP1;TFR2;SLC46A1;CYBRD1;TFRC;HMOX1
prerank,regulation of dephosphorylation (GO:0035303),-0.4168265737629295,-1.104981467925251,0.3264840182648402,0.7466200186343939,1.0,9/15,22.14%,SMG7;MTMR2;SMG6;SMG5;MTMR3;MTMR1;CDK5RAP3;PPP1R16B;PPP1R17
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.3791147034573464,-1.1047958725086366,0.30406852248394006,0.7459881698112265,1.0,7/18,16.39%,CUL3;ARHGAP35;RIPOR2;HEG1;KANK1;ABL2;SCAI
prerank,cellular response to organic substance (GO:0071310),0.27750436893177405,1.1046468603500132,0.2572741194486983,0.813444675332503,1.0,33/116,21.24%,TGFBR1;IL18;TGFBR2;TWF2;CSF1R;SMAD3;IL1RL2;CRNN;CDK9;CASP1;PDGFB;CCR7;PLK5;POU4F1;DCPS;PTPN11;LDLRAP1;IL18BP;CIB1;GHR;MAPK7;PTPN23;PTPN5;ARL6IP5;INPP5K;NCOA3;NOS1;MAPK8;PARK7;ACVR2B;PTPN18;HTRA2;NCOA2
prerank,protein heterotetramerization (GO:0051290),-0.4140613825492261,-1.1046440897788432,0.3147751605995717,0.7452906869514943,1.0,5/13,23.98%,GRIN2B;PKD2;CBR4;KRT10;PKD1
prerank,receptor metabolic process (GO:0043112),0.31430774271815676,1.104392532778652,0.2981574539363484,0.8133352893379452,1.0,11/53,11.78%,DNM2;PHETA1;ARRB2;ITGB2;SMURF1;LGMN;PICALM;SH3GLB1;CD9;LDLRAP1;GRK2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.4792772857159912,1.1043686027456343,0.3320235756385069,0.81243548073793,1.0,5/10,22.93%,LYN;PTPN1;GHR;STAT5B;STAT6
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.41277007371068875,1.104115694834769,0.33393501805054154,0.8123140994913702,1.0,8/17,20.63%,SMAD7;SIRT2;EIF4G1;SPRY2;CALM2;INPP5K;DMTN;SPRED2
prerank,dendritic cell migration (GO:0036336),-0.40111890267223377,-1.104044796090165,0.3227176220806794,0.7459329256381025,1.0,4/16,7.16%,EPS8;CCR2;CCR1;ALOX5
prerank,regulation of activated T cell proliferation (GO:0046006),0.3568776802184235,1.103948734151968,0.30973451327433627,0.8118892642055439,1.0,5/30,7.73%,IL18;LGALS9;AGER;PDCD1LG2;IL12B
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.36417978882755964,1.102781348519214,0.3172043010752688,0.8147084495864287,1.0,9/27,16.92%,GUK1;NME4;DUT;CMPK1;DCTD;AK2;NME1;NUDT13;TYMS
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.32814522803039,1.1025043014008424,0.2972508591065292,0.8146275184946165,1.0,20/43,29.87%,ATM;FOXN3;RAD17;NBN;INTS3;BRCA1;CDC14B;ABRAXAS1;BLM;BABAM1;TAOK2;DONSON;NABP1;TRIM39;TOPBP1;RINT1;HMGA2;TAOK3;MRNIP;TICRR
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.31562799998556884,1.1022876852249062,0.2791095890410959,0.8143747145762762,1.0,11/53,15.58%,GNA12;OPHN1;PRKACA;UCHL5;ECSCR;NUDT15;ARAF;PINK1;USP19;PSMC2;UBQLN4
prerank,regulation of feeding behavior (GO:0060259),-0.44355300957266464,-1.1020583242116087,0.3202614379084967,0.7507327931487862,1.0,7/11,36.18%,SGIP1;AGRP;EIF2AK4;GNB3;NR4A3;LEPR;STAT3
prerank,protein modification process (GO:0036211),0.29159462752718773,1.1017843516068655,0.2620232172470978,0.8150305804572817,1.0,16/76,11.79%,ST3GAL6;MAN2B1;FBXO22;UBA7;CDKL3;USP25;CDC34;CPE;RABGGTA;WWP2;FBXO11;ARAF;SLC35A1;FBXL2;PPP4R2;ABL1
prerank,nuclear pore organization (GO:0006999),-0.41001475861967723,-1.1016050894944904,0.35135135135135137,0.7509777587558919,1.0,4/14,10.49%,RTN4;NUP98;NUP205;NUP54
prerank,cellular response to mechanical stimulus (GO:0071260),0.3243728623061065,1.1013733048944965,0.29545454545454547,0.8154304258761835,1.0,5/46,3.71%,F11R;TLR7;CRADD;TLR4;CASP1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.35574577863253665,-1.1013303561042151,0.3150684931506849,0.7507364470607656,1.0,7/24,11.29%,ITPR1;HTR2C;RYR2;RYR3;HTR2B;PKD2;ERO1A
prerank,endothelial cell differentiation (GO:0045446),-0.4369354584853429,-1.1012276949249316,0.319910514541387,0.7498921992618504,1.0,5/12,22.26%,FSTL1;JAG1;KDM6B;ACVRL1;TIE1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.33465415635394125,-1.1007091201164543,0.28607594936708863,0.7503945621268839,1.0,13/31,21.80%,CDC73;PKD2;CCL2;E2F7;KLF4;DCUN1D3;CDKN2A;CDKN1A;JADE1;CDK4;MYO16;CDK6;RBL1
prerank,negative regulation of protein kinase activity (GO:0006469),-0.26805833227889464,-1.100626415979874,0.25,0.7494728858903236,1.0,30/88,21.79%,SH3BP5;PTPRT;SLC8A3;PRKAG2;PPM1E;TAF7;PPIA;CORO1C;DBNDD1;LRP6;SRCIN1;DUSP10;DUSP26;SMCR8;DTNBP1;THY1;ITGB1BP1;SNCA;CDKN1A;NPM1;SH3BP5L;TARBP2;TAB1;GSTP1;EPHA1;CDKN1C;CAMK2N2;TRIB2;CDK5RAP3;DEPTOR
prerank,positive regulation of transferase activity (GO:0051347),-0.2516775338968431,-1.1004752767714263,0.2346368715083799,0.7487907558818425,1.0,53/142,25.91%,CD74;DCUN1D2;EGFR;DSTYK;ROR1;NTRK2;PARM1;NTRK3;CCT2;MYC;UBE2N;RPS2;LMO4;RET;ALK;MAPKAPK5;ARRDC3;ERBB4;XRCC5;AURKB;ERBB3;AXIN1;HSP90AB1;FGFR3;KLF4;EPHA5;WRAP53;PRKCQ;KIT;DCUN1D3;CTNNB1;MAGEC2;TEK;SERINC5;EPHA3;EPHA1;LMTK2;EPHA7;TIE1;LTK;TRIB3;EPHA6;GRHL2;DDR1;MAPK15;SORL1;TCP1;PLK1;EPHA4;MRE11;MAPK1;CD4;EPHB2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3326452899183538,1.1003871916162173,0.3159722222222222,0.8177699305902923,1.0,6/37,7.52%,FHIT;BAG6;CSNK2A2;CSNK2A1;UCHL5;KLHL40
prerank,regulation of lipid kinase activity (GO:0043550),0.4525746576645168,1.0999996994573185,0.35304990757855825,0.8180647115250516,1.0,6/11,29.25%,RBL2;PIK3R1;WDR81;PPP2R5A;PIK3R3;RB1
prerank,ncRNA export from nucleus (GO:0097064),0.3401567972225726,1.0995695938939105,0.33043478260869563,0.8184691663049934,1.0,12/36,19.38%,XPOT;RANBP2;SSB;NUP42;SEC13;NUP35;NUP50;SEH1L;NUP62;NUP107;NUP88;NUP188
prerank,protein deacylation (GO:0035601),0.373951497548012,1.0993082143695025,0.3153153153153153,0.8183880306678746,1.0,5/23,10.71%,ABHD17C;HDAC10;SIRT2;SIN3A;PPT1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.3532992316687215,1.0992908823913206,0.32616487455197135,0.8174503454142069,1.0,6/30,9.89%,CSF1R;ARMC6;SHH;TNFRSF13B;PLD4;PLEK
prerank,vesicle organization (GO:0016050),0.3243037599121941,1.0988920043846986,0.30782608695652175,0.8178045277292014,1.0,14/46,21.97%,HOOK2;PHETA1;USP8;CD34;SORT1;LAPTM4B;AKTIP;SAR1A;USP50;WASHC4;WASL;EXOC8;ZFYVE16;DNAJC13
prerank,regulation of cellular localization (GO:0060341),-0.3005358596789029,-1.0987180367572318,0.30423940149625933,0.7531757134733043,1.0,18/46,20.31%,LRRK2;GSN;ADCY5;TTL;MAP2;PRKN;TRIM67;HSP90AB1;TRIM46;SPAG5;MAD1L1;EPHA5;EFNA5;BRSK1;WWC1;NR1H4;BRSK2;BLK
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.27561915974681483,-1.0980284561758396,0.2679900744416873,0.7541646651322291,1.0,17/73,17.63%,CD44;BDNF;EGFR;APP;LATS1;CREBL2;NTRK3;RAF1;OPRD1;IRGM;AXIN1;HSP90AB1;SNCA;PAK1;CAPRIN2;TFRC;SFRP2
prerank,transport across blood-brain barrier (GO:0150104),0.2822890390050924,1.0980157659084735,0.27450980392156865,0.8197622206250903,1.0,22/83,21.05%,SLCO2B1;SLC7A8;SLC1A3;AGER;SLC24A3;ABCC9;SLC27A4;SLC7A5;SLC22A2;SLC29A4;ATP1A4;SLC19A1;SLC15A2;SLC6A9;LRP1;SLC16A7;SLC5A3;SLC4A4;SLC38A1;SLC8A2;SLC29A1;SLC4A3
prerank,establishment of skin barrier (GO:0061436),0.42154003279384017,1.0976283642416442,0.3472949389179756,0.8190342128351208,1.0,4/15,17.43%,MET;ALOXE3;CLDN1;LSR
prerank,regulation of water loss via skin (GO:0033561),0.42154003279384017,1.0976283642416442,0.3472949389179756,0.8190342128351208,1.0,4/15,17.43%,MET;ALOXE3;CLDN1;LSR
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2643284637968959,-1.0974998734481167,0.2737430167597765,0.7546038035374983,1.0,16/91,11.87%,RIMS2;HIP1;STXBP5L;RIT2;LRRK2;SYT1;RAB3C;STXBP5;CPLX2;RAB5C;RAB3D;CDH13;INPP5F;RAB3A;RAB8A;SCFD1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.38059656053023433,1.097461526164821,0.3492647058823529,0.8186354259304431,1.0,8/22,24.15%,IL18;SLC7A5;IL12B;LY9;NOD2;MYD88;SLAMF6;TGFB1
prerank,regulation of myelination (GO:0031641),0.3712987864355016,1.0974086605131808,0.34385964912280703,0.8178447196924,1.0,5/25,7.28%,JAM2;SIRT2;TNFRSF21;KLK8;NSUN5
prerank,membrane depolarization (GO:0051899),-0.3366675958194719,-1.097358111732413,0.29550827423167847,0.753869749677673,1.0,10/32,21.86%,CACNA1E;SCN2A;CACNG2;SCN3A;KCNH2;CHRNA4;CACNA1G;CACNB3;SCN9A;CACNA1B
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.4602139310569282,-1.097314504706461,0.3318872017353579,0.7528397658792553,1.0,5/10,27.66%,SIRT1;TAF7;SNCA;THAP7;NOC2L
prerank,protein secretion (GO:0009306),-0.29150527043681934,-1.0970975633148004,0.2628992628992629,0.7523752564178425,1.0,12/56,11.69%,RIMS2;OLFM2;RAB3C;PCSK5;SNX19;RCN3;GOLPH3;RAB3D;RAB3A;RAB8A;COPG2;ARL4D
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.30172121227763515,-1.0969713889724892,0.2965686274509804,0.7516284088954165,1.0,23/46,25.25%,ATRNL1;ITGA4;TMEFF2;ITGB7;FN1;KIF14;LAMB2;SRCIN1;MEGF9;NTNG1;ITGA8;NTNG2;LAMA5;TEK;PEAK1;LAMC3;EPHA1;RADIL;PARVB;MICALL2;FER;PARVG;NTN4
prerank,myelination (GO:0042552),-0.3000709192437321,-1.0968754606065416,0.31565656565656564,0.7507668997077293,1.0,9/46,5.48%,B4GALT5;ADGRG6;SLC8A3;B4GALT6;SCN2A;TPPP;MYRF;PLLP;CNTNAP1
prerank,gluconeogenesis (GO:0006094),-0.31630365595275295,-1.0967437194878231,0.3140877598152425,0.7500636611360758,1.0,11/39,20.11%,PFKFB1;SLC37A4;PER2;PGM1;G6PC3;RBP4;ALDOC;GPI;SLC25A12;CRY1;GOT1
prerank,respiratory electron transport chain (GO:0022904),-0.41353646041524805,-1.0967060236755566,0.33260869565217394,0.7490412280195693,1.0,6/14,25.05%,GPD2;SDHA;ETFRF1;SLC25A18;SLC25A12;UQCRFS1
prerank,aggrephagy (GO:0035973),-0.33904467318798287,-1.0965125184206146,0.308252427184466,0.7485158150527128,1.0,5/27,6.69%,DYNC1I2;VIM;ACBD5;UBE2N;PRKN
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.25618879460069177,1.0963374042111007,0.25449101796407186,0.8205251160278514,1.0,49/208,17.78%,CAPN3;PIM2;LGALS9;CFLAR;TMEM101;ATP2C1;MAP3K3;TRAF5;RIPK2;RHOH;PLCG2;TRIM5;CASP1;TRADD;PDPK1;NDFIP2;ZMYND11;AKAP13;TAB2;NEK6;GAPDH;ZDHHC13;CCR7;EDA2R;MIB2;LAMTOR5;CXXC5;MTDH;TICAM2;TRIM62;PINK1;PRKCB;RNF31;PELI2;TNFRSF19;TMED4;GJA1;MAVS;TNIP2;TICAM1;CCDC22;NUP62;NLRX1;OPTN;TRIM14;ECT2;PIDD1;GPR89A;NOD2
prerank,regulation of lipase activity (GO:0060191),0.43861549117137355,1.0960440546957357,0.36622390891840606,0.8205179145595876,1.0,2/13,3.78%,LIPC;LMF1
prerank,sensory perception of light stimulus (GO:0050953),0.28735780370058744,1.0955805668965555,0.2956081081081081,0.8209979729024003,1.0,16/87,13.44%,CDH23;CRYBB1;WHRN;PAX6;EFEMP1;RP2;MYO7A;DRAM2;RABGGTA;RD3;EYA3;TULP2;BBS2;COL11A1;PAX2;ATXN7
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.35771807744830875,-1.0954035437143312,0.30697674418604654,0.7507172057478771,1.0,5/23,15.98%,SH3BP5;CBLB;SRCIN1;THY1;SH3BP5L
prerank,regulation of JNK cascade (GO:0046328),0.2806439437057605,1.095115205924583,0.29523809523809524,0.8215845085936556,1.0,25/101,17.97%,SIRPA;PJA2;MAP4K4;AGER;TRAF5;ITCH;IGF1R;GPS2;CD27;ZMYND11;KLHL31;CCR7;EDA2R;PTK2B;WNT7B;MAP3K10;MAPK8IP1;PINK1;TNFRSF19;MAP3K11;MAP4K2;TAOK2;RASSF2;NOD2;MINK1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.4008958705188804,-1.094887550968294,0.31919642857142855,0.7511861677920965,1.0,3/14,4.99%,PPAT;ADSS2;ADK
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.27798789172388827,1.0947102780097053,0.272,0.8219009324662622,1.0,17/100,12.41%,IL18;CRNN;SRC;LYN;PIK3R1;IGF1R;PIK3CG;PIK3AP1;PDGFB;GPER1;FSHR;PIK3CB;CEACAM1;PIK3CD;HCST;FBXL2;SEMA4D
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.3936575546559016,-1.094496682849086,0.3372365339578454,0.7501337287551791,1.0,7/16,22.82%,ARHGAP6;CORO1C;ITGB1BP1;RCC2;ACVRL1;APOD;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.3936575546559016,-1.094496682849086,0.3372365339578454,0.7501337287551791,1.0,7/16,22.82%,ARHGAP6;CORO1C;ITGB1BP1;RCC2;ACVRL1;APOD;BCAS3
prerank,positive regulation of behavior (GO:0048520),-0.4487599692854195,-1.0944211652452556,0.33406113537117904,0.7492492285749622,1.0,2/10,3.15%,NLGN1;SGIP1
prerank,positive regulation of hydrolase activity (GO:0051345),0.2683893355170163,1.0942341113662168,0.2611464968152866,0.8225279559416865,1.0,40/137,23.15%,SRGAP2;DOCK8;F11R;ITGA6;ARHGAP27;MAP4K4;RAP1GDS1;RGS10;TGM2;SNX18;ASAP3;TBC1D7;PICALM;FLCN;RAB3GAP1;RAPGEF3;LIMS1;DOCK10;SGSM2;SEMA4D;PINK1;RTN4R;SGSM3;HMGB2;EZH2;ECT2;CALM2;NDUFA13;TBC1D30;CCL24;MAPK8;MMUT;RGS8;RAB11FIP2;BMP2;RHOC;ARHGEF7;SNX13;PIN1;ADRB1
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.3147790491692553,-1.0942172307214175,0.31685393258426964,0.7487577943192996,1.0,11/42,20.05%,CCR2;CCR1;CCL4;PF4;GPR35;CCL2;CCL5;CX3CL1;CCL14;CCL7;FOXC1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2973840313014564,-1.0940864135744937,0.2978723404255319,0.7480596175870456,1.0,14/48,16.59%,NEDD9;PTPRD;CDKL5;DOCK5;IL1RAPL1;CDC42;CUL7;CARMIL1;MYADM;SS18L1;OBSL1;SS18L2;CAPRIN2;FLNA
prerank,positive regulation of programmed cell death (GO:0043068),0.24591004150254775,1.0940344578750498,0.25178826895565093,0.8221645552378817,1.0,65/272,19.67%,BIN1;FGD2;ARHGEF2;PREX1;ITGA6;VAV2;DNM2;CALHM2;CRADD;CTSD;IGFBP3;TGM2;QRICH1;KCNMA1;PRMT2;SUDS3;ATM;TRADD;FLCN;CLU;KLF11;AKAP13;PPID;RHOB;SLC27A4;WNT10B;NOS2;PIP5KL1;GPER1;PSEN2;PSENEN;FGD3;UBC;RPS27A;MAP3K10;HIP1R;SOD1;APAF1;LATS2;ABL1;BMF;MAP3K11;TRIO;CCAR1;TNFRSF12A;APH1B;DUSP6;FANK1;ECT2;ARL6IP5;C1QBP;BCL2L11;PIDD1;MARK4;RASSF2;SHQ1;CLIP3;VAV1;PMAIP1;MAPK8;PYCARD;JUN;IRF5;SFRP4;ARHGEF5
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.2981029373382326,1.0938234425891094,0.2825342465753425,0.8218793684396148,1.0,18/67,19.80%,ABI3;CSF1R;SRC;LYN;IGF1R;EFEMP1;PDGFB;PTK2B;PKDCC;ABL1;BMX;GHR;FES;DDR2;DYRK1A;TEC;FGFR4;FGFR2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.2487071786989319,-1.0934877406556613,0.24166666666666667,0.7487775309524021,1.0,52/138,26.83%,MTSS1;NEDD9;PTPRD;PTPRG;BDNF;EGFR;PTPRT;STAP1;ROR1;SHC3;NTRK2;NTRK3;RASGRP4;RET;ALK;GFRA2;JAK2;BCAR1;ERBB4;FRK;ERBB3;FGFR3;CLNK;LIFR;EPHA5;KIT;AHI1;TEK;CD3E;STYK1;EPHA3;GUCY2F;GUCY2D;EPHA1;LMTK2;BLK;FYN;EFS;EPHA7;TIE1;LTK;MPZL1;EPHA6;FER;CD8B;DDR1;LCK;EPHA4;CD4;EPHB2;FLT3;ABI1
prerank,neutrophil mediated immunity (GO:0002446),-0.21714968302522594,-1.0932922330420554,0.1693548387096774,0.7481991841889027,1.0,81/432,14.03%,IQGAP2;ATP8B4;IQGAP1;CYBB;PTPRN2;ADGRE5;ARMC8;LRRC7;CD44;AMPD3;CYSTM1;CD47;CD36;ACTR10;LILRB3;CD93;FTL;GSN;ITGAL;B2M;KMT2E;CTSC;CLEC12A;PSMD14;MME;HGSNAT;SDCBP;ATP6AP2;AP2A2;PSMA2;RAB6A;VAPA;CCT2;STOM;PLAC8;UBR4;PPIA;S100A11;MGST1;CTSB;ATP11A;RAB5C;ALOX5;AP1M1;HSPA8;KCNAB2;CNN2;RAB3D;CFP;CYBA;ARPC5;PSMD6;SNAP25;TBC1D10C;CAMP;FRK;PTAFR;RNASE3;XRCC5;PSMD11;ANO6;SLC44A2;ANXA2;RAB3A;PLAUR;HSP90AB1;OLR1;ATG7;LAMP1;PGM1;TRAPPC1;ACLY;DNAJC3;PSMD1;ANPEP;GYG1;APRT;GLIPR1;DERA;MMP8;MCEMP1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.4450701796556921,1.0932189563564638,0.36968576709796674,0.8228655596684008,1.0,7/12,29.19%,FADS1;ABCD1;ACOT8;SCP2;FADS2;ACOX1;HSD17B4
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.4678630461885531,-1.0931424290525835,0.34210526315789475,0.7475123001170692,1.0,3/10,5.65%,ZBTB7B;IRF4;SH3RF1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.44788414537485016,-1.0927369003958496,0.3269230769230769,0.7476465420026398,1.0,3/10,3.56%,BTLA;LILRB1;CD40
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.3843165851367738,-1.0925295620001394,0.3347732181425486,0.7471926306161274,1.0,3/17,4.27%,PPARG;PRKAG2;ADIPOR2
prerank,membrane protein proteolysis (GO:0033619),0.33805037332127724,1.0923214886790926,0.33275862068965517,0.8247671997734941,1.0,17/37,25.89%,PSEN2;MBTPS2;PSENEN;TMPRSS6;SPPL2B;MYH9;MBTPS1;APH1B;RBMX;ADAM10;ADAM17;ERAP1;AFG3L2;TRAF6;TGFB1;APH1A;CTSH
prerank,negative regulation of cation channel activity (GO:2001258),-0.3498778403025136,-1.0923069523368125,0.3370288248337029,0.7467781146252934,1.0,11/26,27.65%,GPR35;CBARP;CALM1;PKD2;UBQLN1;GNB5;KCNE3;CASQ2;EPHB2;FMR1;MMP9
prerank,regulation of defense response to virus by host (GO:0050691),0.3514606456817816,1.092242165180063,0.3321917808219178,0.8240660822621656,1.0,9/30,17.61%,RNF216;TRIM44;IL12B;CGAS;SIN3A;DHX9;DTX3L;MAVS;AIM2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.3616395480343266,-1.091952008555065,0.30701754385964913,0.7467506313303945,1.0,7/23,24.04%,CALM1;CAMKMT;GUCY2F;GUCY2D;FNTA;PDE6A;NMT2
prerank,external encapsulating structure organization (GO:0045229),-0.2376716479402159,-1.0919410898597937,0.21649484536082475,0.7456871694327181,1.0,60/205,17.98%,ITGA4;CD44;CD47;APP;MMP16;ITGAL;ADAMTS12;ADAMTS17;ITGB7;THSD4;SPP1;VIT;FN1;TNR;COL4A1;VWF;ADAMTS19;ADAM12;COL1A1;COL13A1;FBN2;ST7;FBN1;POSTN;HSPG2;ATP7A;TNC;LAMB2;NID1;MMP15;VCAN;MMP12;COL14A1;VCAM1;LOX;DAG1;ADAMTSL5;ADAMTSL4;ITGA8;MMP14;ITGA2B;ITGB6;MMP8;CDH1;AGRN;MMP19;ADAMTS10;ADAMTSL1;ADAM19;LAMA5;SMOC1;COL5A1;PECAM1;ELN;ICAM1;PDGFA;COL23A1;LAMC3;ITGA11;LUM
prerank,positive regulation of B cell proliferation (GO:0030890),-0.34141387824622427,-1.0917525746606669,0.32,0.745174705764794,1.0,4/29,3.56%,VAV3;CD38;CD74;CD40
prerank,myeloid cell differentiation (GO:0030099),-0.3088070563171016,-1.0917191457595363,0.2976190476190476,0.7441938014300582,1.0,11/47,15.13%,ZBTB16;KMT2E;RASGRP4;HIPK2;JAK2;RPS14;PTPN2;FLVCR1;CEBPA;KIT;KAT6A
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.25622007453441387,-1.0914724813462493,0.24736842105263157,0.7438709954578948,1.0,20/107,11.08%,ANK2;CCR2;HTR2C;SLC8A3;RYR2;ATP2B1;CCR1;NPTN;CD40;ATP13A3;SLC24A2;ATP2A2;TPT1;HTR2B;RMDN3;SLC8B1;TMEM165;STIM2;DMPK;ATP2A3
prerank,regulation of protein localization to centrosome (GO:1904779),-0.45187637895171356,-1.091294896997742,0.3580508474576271,0.7432880136603038,1.0,2/10,6.52%,BICD1;GSK3B
prerank,regulation of interleukin-13 production (GO:0032656),0.4428152414712975,1.0907676225714698,0.3654545454545455,0.8279458726627393,1.0,3/13,4.54%,IL18;LGALS9;TNFRSF21
prerank,positive regulation of lymphocyte activation (GO:0051251),0.35404368465856717,1.0904391532339572,0.3383742911153119,0.8280720270099056,1.0,10/28,19.93%,SIRPA;CCDC88B;CYRIB;NCKAP1L;IL12B;TNIP2;TICAM1;NOD2;PYCARD;XRCC6
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2962391718169235,1.0903474422550035,0.2859504132231405,0.8274120428325354,1.0,22/75,20.83%,LRP5;PKIG;PRKCD;LYN;UCHL1;SLC8A1;INCA1;SPRY2;PIK3CB;RGS14;CDK5RAP1;PTPN1;RASIP1;LATS2;ABL1;AKT1;PTPRJ;INPP5K;CDKN1B;PYCARD;IPO7;TFAP4
prerank,negative regulation of T cell activation (GO:0050868),0.3424980731113364,1.0901837321891834,0.3338926174496644,0.8270144582438511,1.0,9/35,14.40%,PAG1;TNFRSF21;NCKAP1L;PDCD1LG2;CD86;CEACAM1;HAVCR2;TNFAIP8L2;GPNMB
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2987797075428711,1.0901788661180478,0.31333333333333335,0.8260625162755151,1.0,27/69,27.41%,BAG6;DNAJB9;SEL1L;UFD1;OS9;RNF103;AUP1;USP19;ANKZF1;RNF121;SYVN1;MAN1B1;EDEM1;UBE4A;STUB1;NPLOC4;SGTA;UBE2G2;RHBDD2;ERLIN2;FAF2;FBXO2;DNAJB14;ECPAS;EDEM2;FBXO17;RNF5
prerank,RNA methylation (GO:0001510),0.3049760855721928,1.089976889223088,0.30477759472817134,0.8257639984751584,1.0,23/60,26.07%,TRMT6;BUD23;METTL5;NSUN5;NSUN6;BCDIN3D;METTL14;FTSJ3;NSUN3;PCIF1;FBL;METTL6;TRMT61A;WDR6;TRDMT1;MTO1;TFB1M;FTSJ1;METTL8;TGS1;ALKBH8;METTL2A;METTL2B
prerank,actin nucleation (GO:0045010),-0.3648456163238174,-1.0897873950548131,0.30669546436285094,0.7468727872150759,1.0,3/21,8.33%,IQGAP2;ACTR3;ARPC5
prerank,protein autophosphorylation (GO:0046777),0.2585732842802202,1.0897533897003842,0.27633587786259545,0.8255026396190277,1.0,42/157,18.49%,CSF1R;ULK2;PIM2;CHEK2;MAP3K3;SRC;LYN;IGF1R;ATM;PDPK1;MKNK1;NEK6;EPHA8;PTK2B;CAMKK2;ULK3;MAP3K10;MUSK;EEF2K;UHMK1;ABL1;MTOR;MARK2;PINK1;BMX;AKT1;MAP3K11;ULK1;STK39;PASK;EIF2AK2;AURKA;FES;DDR2;WNK2;TAOK2;WNK3;DYRK1A;TAF1;TEC;MINK1;VRK2
prerank,blood circulation (GO:0008015),-0.29975269209982236,-1.0897149893177638,0.3012658227848101,0.7459833693445865,1.0,14/49,22.28%,SGCZ;MYOF;SGCD;GUCY1B1;SERPING1;OLR1;MEOX2;ITGB1BP1;ELN;ACVRL1;SCPEP1;ACE;ACE2;DLL4
prerank,regulation of gene expression (GO:0010468),0.224457176822589,1.0895431543642249,0.1623529411764706,0.8252266171759456,1.0,244/903,23.68%,TGFBR1;ZFHX3;TMEM119;SNRNP70;MLXIPL;SIRPA;ZSCAN26;SON;RREB1;DENND4A;SMAD3;NFE2L2;DNM2;LYL1;ETS1;VSIR;LGALS9;FAM98B;AIF1;DDIT3;CHEK2;MEF2C;SRRT;COQ7;CLK1;MTA1;CRNN;VHL;TLR4;ATG14;TRIM11;SLC24A3;LYN;HDAC10;RHOH;RBL2;HNRNPDL;PLCG2;KMT2D;TRIM5;GTF2IRD1;PAX6;EFEMP1;SLC8A1;CALCOCO1;RPS6KA5;CIAO3;LGMN;ATM;MOV10;REXO4;SBNO2;MLX;LRRC19;PICALM;CHD7;SPRY2;TRIM44;ZFP36L1;FOXN3;ADNP;FLCN;TAF6L;CLU;NDFIP2;CXXC1;NOS1AP;CD34;FUS;CTR9;APBB2;SHH;PABPN1;CHD3;SORT1;FOXK2;ZSCAN21;NUP35;OVOL2;GATA2;EDN3;CNTF;PDGFB;BCL6B;NOS2;PKP3;SLC7A5;IL12B;GPER1;CALCR;SLC22A2;SOX17;UTY;POU4F1;PIK3CB;SART3;LAMTOR5;PRDM1;BRCA1;IL33;HNRNPH1;WWP2;ESRP1;ANKRA2;GCNT2;CDK11B;PIK3CD;KDM4A;PATZ1;SMARCA2;PCBP2;FADS1;MUSK;USP36;TCEAL1;HAVCR2;CLK4;LIMS1;PDCD10;HP1BP3;RAB27A;ABL1;MTOR;TRAPPC2;CNBP;TRA2B;PRDM11;IGF2BP2;PRDM2;PINK1;MAPK14;ROCK2;PROX1;SPTY2D1;AKT1;CARM1;MLLT6;RUNX1;RNF187;C1D;GJA1;CDH3;NOG;AURKA;CCAR1;FLOT2;RPS6KA4;CUX2;POFUT1;POGZ;NWD1;ZUP1;LGALS7;HES6;TICAM1;WTIP;EZH2;TNRC6B;NUP107;GATA3;SMO;BNC2;DMTF1;TRIM14;EGR1;ENG;SUFU;TDRD7;SAP30L;LARP1;CLK3;TAF1;ADAM10;GZF1;RNF20;CRKL;THAP1;NANOS1;HPN;TOB1;HDAC5;MAPK8;TCF7L1;TCF3;NFIA;FGFR4;ANXA7;ZFPL1;SFRP4;IRF2;PARK7;SLC8A2;MAPT;PRDM9;RFXANK;FGF20;NOVA2;CRABP2;MYD88;NFYA;ACVR2B;AGO1;HIF1A;TWIST1;SLC11A1;TNRC6C;NFKBID;NCOA2;PTHLH;YY1;TRIM39;TAF5;BMP2;TGIF2;TARDBP;ZFP37;SCRT1;PLA2G3;MYOM1;TP53;HNRNPH3;IL36G;MBIP;DDX3X;HGS;MSC;PCBP4;TAF5L;ZNF628;MITF;BTG1;TAPBP;PIN1;NFX1;MBNL1;AJUBA;RPL6;AMH;MIF;PUM1;KAT6B;RNF207;ATXN1L;MEFV
prerank,negative regulation of cellular catabolic process (GO:0031330),0.3012195541558187,1.089049284866989,0.30258899676375406,0.8259181719375219,1.0,14/63,13.36%,CST3;CPTP;SIRT2;EIF4G1;MET;TAB2;FOXK2;KDM4A;RASIP1;IL10RA;MTOR;BMF;RRAGA;AKT1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3126317277908172,1.0890187983275752,0.3197969543147208,0.8250515699509515,1.0,15/54,18.47%,CRADD;CHEK2;CNOT1;RBL2;ATM;PCNA;TNKS1BP1;PRMT1;CNOT3;MDM4;CARM1;AURKA;PLK3;PIDD1;CDKN1B
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.38742634165491263,1.088820898400009,0.3280141843971631,0.8247337158268413,1.0,6/20,14.74%,MRAP;MET;RGS14;PLEK;GRK2;MGRN1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.24550104005920173,-1.088798258742052,0.23397435897435898,0.7476703391122187,1.0,39/166,15.88%,SORBS1;SAMD4A;EGFR;CD36;EIF3C;IRS1;CPEB3;VIM;LDLR;SIRT1;MYC;FAF1;KLF2;EIF4A3;GIPC1;SLC45A3;PKD2;EIF3E;ZNF205;PTPN2;ATP7A;RPL26;ZEB2;PRR16;HSP90AB1;ELOVL5;DDAH2;CNEP1R1;MFSD2A;KLF4;SNCA;PLXNB2;MMP8;RGCC;ATAD5;NPM2;CCL5;CTDNEP1;NPM1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.40425718588899495,-1.0885578849973652,0.3598233995584989,0.747274149254995,1.0,4/15,14.64%,PTPN2;TTLL12;SAMHD1;OAS3
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.40490703668136535,1.0884570567221357,0.3634651600753296,0.8249837486147237,1.0,6/16,28.44%,KLK2;DRD2;PRCP;KLK3;DDAH1;BMPR2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.394419600461561,-1.088026648578269,0.3472222222222222,0.7477878299666838,1.0,4/17,6.69%,CD74;CD44;SIRT1;PRKN
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.34517227433793995,1.087541554776072,0.3194444444444444,0.8270167765141136,1.0,7/32,11.30%,FHIT;BAG6;DDX5;USP28;POU4F1;PDK2;RPS27L
prerank,cholesterol transport (GO:0030301),0.3207163734991673,1.0872247067089262,0.3175438596491228,0.8271457540804508,1.0,13/45,21.08%,LIPC;CLU;STX12;APOM;NPC2;LDLRAP1;NPC1;OSBPL5;SCARB1;SERAC1;ABCA1;LCAT;OSBP
prerank,regulation of cellular pH (GO:0030641),0.36033191666719755,1.0871834228488868,0.32922535211267606,0.8263351817915696,1.0,9/29,23.59%,SLC9A9;SLC9A8;ATP1A4;CLN3;SLC4A4;SLC4A5;SLC4A3;SLC26A6;SLC9A3
prerank,positive regulation of ERAD pathway (GO:1904294),0.42748976506362757,1.0867500934815006,0.3539651837524178,0.8267800868517308,1.0,2/13,1.52%,NFE2L2;BAG6
prerank,regulation of cellular metabolic process (GO:0031323),0.3222701868569581,1.0866403590572449,0.32318104906937395,0.8261927070802523,1.0,10/45,13.12%,TBC1D16;COQ7;BCO2;RNF41;SSH1;NPC2;PDK2;PANK2;PINK1;PM20D2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3739725901255011,-1.0864593869658872,0.3416289592760181,0.7513313827827305,1.0,4/17,12.74%,PTPN22;PTPN2;THY1;UBASH3A
prerank,ribosome biogenesis (GO:0042254),-0.23637679613006027,-1.086447647962527,0.2554945054945055,0.7502868664780658,1.0,41/187,14.38%,RPL30;RPL36A;UTP20;RPL35A;LTV1;DDX10;SNU13;RIOK1;LAS1L;RPL4;WDR18;RPS7;RAN;RPS2;RPL41;RPL7A;RPLP2;XRN2;NOB1;POP4;RPL38;RPL18A;EXOSC1;RPS14;RPS27;RPL13A;RPL26;MRTO4;RPL22;ESF1;RPS25;RPS15;NOC4L;DCAF13;RPL8;RPL23A;EXOSC7;RPLP1;RPL37;UTP15;UTP14A
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.41004780811951863,1.086384314249126,0.32727272727272727,0.8261153288031675,1.0,3/17,7.53%,DOCK4;AIF1;PDGFB
prerank,male meiosis I (GO:0007141),0.4058591914340214,1.0863000825676323,0.34690265486725663,0.825438428962527,1.0,3/16,11.10%,FOXJ2;ZSCAN21;HSF2BP
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.23381970563214538,1.086282655523042,0.2245430809399478,0.824555690918012,1.0,60/476,9.62%,TGFBR1;SALL1;ZFHX3;MLXIPL;RREB1;LRP5;CAPN3;BICRAL;SMAD3;DNM2;YWHAH;LYL1;ETS1;PIM2;FLI1;SOX8;RPS6KA1;DDIT3;CHEK2;QRICH1;MEF2C;VHL;TGFB1I1;ZFP90;PPARD;CHD8;HIVEP3;PRMT2;DEAF1;ELK1;PAX6;CALCOCO1;CREB3L2;KARS1;PICALM;NFATC1;ATMIN;TFE3;TRIM44;AFAP1L2;JMJD6;FOXE1;BICRA;CXXC1;FZD2;SHH;TRIM45;RXRB;ILF2;FOXK2;PDGFB;SOX17;MMS19;KDM3A;PITHD1;NOTCH4;CD86;BRCA1;SMARCD3;CAMKK2
prerank,regulation of cell migration (GO:0030334),0.23691298696312488,1.0862639538168553,0.22085048010973937,0.823663406855303,1.0,66/382,14.84%,TGFBR1;SRGAP2;SRGAP3;LDLRAD4;NAV3;NUMB;GNA12;ABI3;KIF2A;CSF1R;SLURP1;ARSB;ITGA6;SMAD7;SEMA3B;VSIR;RAC1;AIF1;MAP4K4;PRKCA;FERMT3;RNF41;SRC;IGF1R;RFFL;CYRIB;ATM;TRADD;SEMA4C;SPRY2;FLCN;MACF1;SHH;RHOB;PDGFB;PIP5KL1;GPER1;TWIST2;MIA3;PTK2B;APPL1;CEACAM1;GCNT2;SPATA13;CLN3;TJP1;PIK3CD;PDCD10;OSGIN1;DOCK10;SUN2;STX4;DRD2;DPEP1;SEMA4D;ROCK2;SEMA4G;ARHGAP4;CIB1;AKT1;MAPRE1;MGAT5;SERPINE2;GPNMB;NOG;CCAR1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3320253273421243,-1.0862169289320498,0.3225806451612903,0.7499020860531713,1.0,6/31,5.07%,NLGN1;PDLIM5;LRRK2;PPFIA2;ABI2;SHANK3
prerank,receptor internalization (GO:0031623),0.3217556038044133,1.0855239519631177,0.2976588628762542,0.8251197883076243,1.0,10/44,14.38%,DNM2;ARRB2;GTF2H2;ITGB2;PICALM;CD9;CEACAM1;LDLRAP1;GRK2;LRP1
prerank,protein neddylation (GO:0045116),-0.41695211578707436,-1.085432175686575,0.3700440528634361,0.7512551755642782,1.0,5/13,25.84%,DCUN1D2;UBA3;DCUN1D3;UBE2M;UBE2F
prerank,small GTPase mediated signal transduction (GO:0007264),0.27652186859483097,1.0851475800214556,0.2983257229832572,0.825347754055593,1.0,19/103,12.62%,RAPGEF5;RASGRP3;RREB1;PLD1;RAC1;USP8;RGL2;PLD2;KSR1;ARFIP2;USP28;HACD3;RGS19;RRAS2;G3BP1;RRAD;ARHGAP30;MAPK14;MRAS
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3961977612251166,1.0848479653546832,0.3778966131907308,0.825386052890925,1.0,7/17,24.84%,SEL1L;UFD1;OS9;AUP1;SYVN1;NPLOC4;FAF2
prerank,negative regulation of cell population proliferation (GO:0008285),-0.22088426378997403,-1.0847469026372063,0.18846153846153846,0.7522712303971377,1.0,101/351,22.28%,MAGI2;MTSS1;PPARG;APP;ADRA1A;NCK2;B2M;ST18;RAPGEF2;ZBTB7C;UTP20;LMNA;ACVR1C;SOX11;DLG3;MYC;S100A11;BMP5;RARG;FRZB;CDC73;JAK2;TNS2;PKD2;CDH13;PER2;ERBB4;CTCF;PTPN2;FRK;RAF1;OPRM1;CEBPA;DUSP10;DNAJA3;SOD2;P3H1;KLF10;SLC16A2;MN1;E2F7;AQP11;ITGB1BP1;TESC;KLF4;RERG;PAK1;B4GALT7;PBRM1;BTG2;RBP4;IFIT3;TFAP2B;NLRC3;CDKN2A;RGCC;DNAJB2;PARP10;SULT2B1;CTNNB1;HSPA1B;PLXNB1;SMYD2;CDKN1A;CGREF1;WNT9A;MINAR1;NPM1;SFRP1;HMOX1;ING4;IFITM1;MCC;CCN3;ACVRL1;SFRP2;RPS6KA2;BNIPL;BMP4;FKTN;TNN;TNFRSF8;GSTP1;TFDP1;FOXP3;CBFA2T3;E2F1;TSC1;TPTE;REST;CDKN1C;AVPR2;IGFBP7;COPS8;TBRG1;MYO16;CDK6;APOD;PTPRK;POU1F1;DLL4
prerank,sterol transport (GO:0015918),-0.3824844773620824,-1.0845913608353055,0.35881104033970274,0.7516568276533581,1.0,3/19,3.97%,CD36;MSR1;LDLR
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3668652762580444,1.0845871749062341,0.34806629834254144,0.8253309516497415,1.0,5/26,3.27%,ABCD2;COA8;TLR4;SLC30A10;PLCG2
prerank,positive regulation of cell motility (GO:2000147),0.25120822603665083,1.084404976857796,0.2530487804878049,0.8249629881101868,1.0,40/205,16.55%,TGFBR1;NUMB;CSF1R;ITGA6;SEMA3B;VSIR;AIF1;MAP4K4;PRKCA;FERMT3;IGF1R;ATM;TRADD;SEMA4C;SPRY2;DUOX1;PDGFB;CCR7;GPER1;TWIST2;PTK2B;GCNT2;TJP1;PIK3CD;CFAP20;PDCD10;SUN2;STX4;SEMA4D;ROCK2;SEMA4G;CIB1;MAPRE1;MGAT5;GPNMB;CCAR1;LAMC2;THBS1;MIEN1;SMO
prerank,neutrophil degranulation (GO:0043312),-0.21604787571526443,-1.0842337902918415,0.18072289156626506,0.7517085235293726,1.0,80/425,14.03%,IQGAP2;ATP8B4;IQGAP1;CYBB;PTPRN2;ADGRE5;ARMC8;LRRC7;CD44;AMPD3;CYSTM1;CD47;CD36;ACTR10;LILRB3;CD93;FTL;GSN;ITGAL;B2M;CTSC;CLEC12A;PSMD14;MME;HGSNAT;SDCBP;ATP6AP2;AP2A2;PSMA2;RAB6A;VAPA;CCT2;STOM;PLAC8;UBR4;PPIA;S100A11;MGST1;CTSB;ATP11A;RAB5C;ALOX5;AP1M1;HSPA8;KCNAB2;CNN2;RAB3D;CFP;CYBA;ARPC5;PSMD6;SNAP25;TBC1D10C;CAMP;FRK;PTAFR;RNASE3;XRCC5;PSMD11;ANO6;SLC44A2;ANXA2;RAB3A;PLAUR;HSP90AB1;OLR1;ATG7;LAMP1;PGM1;TRAPPC1;ACLY;DNAJC3;PSMD1;ANPEP;GYG1;APRT;GLIPR1;DERA;MMP8;MCEMP1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2175243547701218,1.0836593752419503,0.15128755364806867,0.8264946385935332,1.0,404/1667,23.10%,SALL1;ZFHX3;MAML3;IKZF1;ARID3B;ETV5;IL18;MLXIPL;ZSCAN26;ARHGEF2;SUMO1;RREB1;LRP5;CSF1R;GREM1;SMAD3;ITGA6;NFE2L2;SMAD7;BRD8;SALL3;DNMT3A;BACH2;LYL1;ETS1;HEYL;PHF21A;FLI1;SOX8;UBP1;RPS6KA1;CEBPZ;DDIT3;MEF2C;MTA1;SKI;VHL;TLR4;TRAK1;LPIN2;FOXJ2;MLXIP;ZFP90;PPARD;CHD8;DDX5;CNOT1;RIPK2;HIVEP3;EPOP;HDAC10;PIK3R1;ERF;MEF2D;GTF2H2;SIRT2;ZNF568;SUDS3;DEAF1;KMT2D;CDK9;ELK1;GPS2;AKAP8L;AATF;PHF14;GTF2IRD1;PAX6;ZBTB21;ZXDB;CALCOCO1;RPS6KA5;CREB3L2;HBP1;KLF3;ID1;ZBTB18;ATM;MOV10;SBNO2;ZIM3;MLX;MYCL;ELK3;NFATC1;ATMIN;ZBTB24;CRY2;TFE3;MEIS3;BCOR;RHOQ;FLCN;TAF6L;JMJD6;IMPACT;KLF11;FOXE1;CUX1;KDM5B;FIZ1;BCL9;ZNF569;AKIRIN1;FUS;CTR9;MET;SLTM;KLF12;SHH;MYSM1;HOXB8;MOSPD1;CHD3;FHOD1;RBM14;RXRB;EHMT2;PPID;MDFI;FOXK2;ZSCAN21;PKNOX1;TIAL1;TAL2;OVOL2;GATA2;ABRA;HOXA6;BCL6B;BARHL1;LEFTY1;SPAG8;BHLHE22;CRYM;ALX4;TLE6;GPER1;ZBTB32;PAX1;FOXO6;HAMP;DMRTB1;CITED4;ANKRD2;SOX17;NEUROD6;NEUROD4;TWIST2;POU4F1;HMX2;SRCAP;HOXD9;TET3;MYNN;NR2F1;AKIRIN2;NPAS1;KDM3A;CXXC5;NOTCH4;PRDM1;BRCA1;IL33;SMARCD3;SIN3A;MIDEAS;WWP2;UBC;RPS27A;TAF6;ZFP91;E4F1;LBX1;TBX6;MTDH;CRTC1;MAML2;BRMS1L;LIN9;ZNF367;DDX17;PATZ1;SMARCA2;TMPRSS6;EED;DLL1;DHX9;CCDC62;RPAP2;ARNT;ETV3;SMARCA5;MDM4;SMAD9;DPF1;ZEB1;E2F2;MRGBP;NFE2L1;NRF1;TTC21B;ZNF83;SKIL;ABL1;MEF2A;PIAS2;BRD9;PIAS3;CNBP;CCNL1;PRDM2;SEMA4D;MAPK14;PRKCB;HDAC8;ID3;PHF20;MED10;MXD1;OLIG2;ZMIZ2;SP9;IRF8;PAX2;PROX1;ARID1A;IRF3;IRF2BP2;SIN3B;SP140;CEBPG;MXI1;MLLT6;ZBTB39;ZBTB8B;RUNX1;RLF;TEF;MED4;KANK2;NOG;ZNF3;NLRP3;SARS1;DPF2;RPS6KA4;CUX2;FST;MAPK7;PCGF2;TCF25;MAVS;BRD3;POGZ;MIER3;HMGB2;MED18;PROX2;TNIP2;ZFP62;HES6;PLK3;MED19;KDM7A;EZH2;SAFB;SP110;KCNIP3;POU2F1;NR1H2;TNRC6B;TAL1;ZSCAN22;NRIP1;GATA3;ZKSCAN1;ACTL6A;ATAD2;PLAGL2;ZNF692;SSBP4;DMTF1;EGR1;ENG;SUFU;LMO1;EPC1;THAP3;ZNF292;BAZ1B;IL4I1;C1QBP;SAFB2;PTCH1;LPIN1;E2F3;KTI12;WASL;TAF1;ZNF585B;ZNF585A;NOD2;RNF4;RBMX;ZSCAN12;MGA;ZNF394;TCF7L2;TCF4;GZF1;NCOA3;POU2F2;THAP1;RPL10;NOS1;BHLHA9;CEBPD;AKNA;MED25;HDAC5;MED12;ZNF260;TCF7L1;TCF3;CAMK1;NFIA;JUN;IRF5;DBX2;RNF2;IRF2;BATF3;PARK7;SETD3;CBX8;FGFR2;HR;FOXP4;ZNF740;XRCC6;TOX2;RFXANK;ZBTB45;PHF8;DEK;NFYA;IRF9;ACVR2B;AGO1;HIF1A;IRX1;NFIX;TWIST1;YEATS2;CXCL10;TFAP4;SLC11A1;TNRC6C;EFNA1;EID1;LIN37;WDR77;MED7;NCOA2;GLYR1;MNT;YY1;SERPINE1;KDM2A;GLMP;PCGF3;BMP2;TGIF2;TEAD3;ZFP37;BRMS1;SCRT1;ZNF76;ATXN7L3;EPC2;TP53;ZBTB48;STAT5B;DDX3X;ZBTB2;MSC;KDM1A;ARRB1;ZBTB14;CSRNP2;ARF4;MITF;HOXB5;ZHX1;TRAF6;TBL1XR1;STAT6;PIN1;NFX1;ZFP14;FADD;OTP;POU3F4
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4406872159199112,-1.083436341090526,0.35294117647058826,0.7530156376502644,1.0,3/11,9.00%,RTN4;ATL2;VCPIP1
prerank,cellular response to interleukin-12 (GO:0071349),-0.2939619785690752,-1.0834131590444733,0.30935251798561153,0.7520147441328752,1.0,11/48,11.17%,PLCB1;CD47;CDC42;PPIA;CNN2;JAK2;STAT4;PSME2;ANXA2;SOD2;MSN
prerank,negative regulation of stress fiber assembly (GO:0051497),0.36889592339742866,1.0826610975302173,0.35583941605839414,0.8288585953602102,1.0,5/24,10.09%,F11R;PIK3R1;ARHGAP28;MET;TJP1
prerank,organelle transport along microtubule (GO:0072384),-0.32591724931108595,-1.0826042005276584,0.3512304250559284,0.7533971580194411,1.0,8/31,11.47%,HTT;BORCS5;BICD1;RAB6A;CDC42;KIF5B;COPG2;RHOT2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.397179996849256,1.0825041311790735,0.32620320855614976,0.828415628273343,1.0,4/18,12.96%,GSAP;PICALM;CLU;ROCK2
prerank,cellular protein modification process (GO:0006464),0.2206400608782111,1.082214689369315,0.16786570743405277,0.8284524706818085,1.0,200/983,17.97%,TGFBR1;MERTK;GOLM1;ST3GAL6;PTPRM;NUAK1;SSH2;LARGE1;TGFBR2;CST3;PPM1H;PRKCSH;CTTNBP2NL;FBXL18;B3GNT2;DAPP1;MGAT4A;PIM2;ST3GAL5;MACROD1;MAN2B1;MAP4K4;CHEK2;IGFBP3;TGM2;DSP;BMP2K;PRKCA;PRKACA;ASB8;FBXL20;VHL;FBXO22;CSNK1E;CSNK2A1;UBA7;TBCK;PRKCD;ART4;SPSB1;LYN;COPS4;CDKL3;FBXL15;SIRT2;CDK9;RPS6KA5;NEK3;ATM;MPI;USP25;GAD1;NRBP1;DCAF8;PDPK1;PDK1;CSK;PORCN;MKNK1;PPM1L;MAP4K3;PIGK;SPSB2;SSH1;STRADA;CDC34;PKN3;NEK6;CUL4B;PSMD3;CPE;ASB4;RCE1;RYK;RABGGTA;PDGFB;AMBN;B3GNT4;TSSK6;TSSK4;ASB15;FUT7;ANKRD9;PP2D1;ASB11;RAB1A;MIA3;ASB5;ILKAP;PTK2B;KBTBD8;PTPN1;PDK2;WWP2;FBXW4;CAMKK2;GCNT2;CDK11B;ASB3;CDC14B;FBXO11;PIK3CD;WNK1;PIK3C3;WSB1;PSMA7;ARAF;DUSP29;PTPRE;DDB2;MSLN;SLC35A1;HCST;FBXL2;NUAK2;JMJD7;FBXO21;DUSP11;PTPN21;MGAT1;PPP4R2;LATS2;NPC1;GRK2;ABL1;DCAF11;MTMR4;STK19;MTOR;SOCS6;MARK2;GPS1;TIMM50;PINK1;ATG5;CDC42BPB;KCTD6;PRKCB;ST3GAL3;BMX;CCNE1;ROCK2;DCAF10;PXK;PTPRH;AKT1;MAP3K11;TYK2;PSMB3;ADPRH;MBTPS1;ULK1;KCTD7;PSMB9;STK39;PASK;FBXL22;EIF2AK2;PSMC2;MAN2A2;MORC3;AURKA;FBXL8;ALG5;RPS6KA4;PARP8;PTPRA;UBXN7;DUSP6;METAP1D;CCDC22;RAB13;PSME4;WNK2;PSMC1;MAP4K2;COPS6;TAOK2;PSMB7;WNK3;THBS1;DYRK1A;PTPN5;PICK1;LIPE;SUMF2;FBXL7;WSB2;DUSP12;PPP2R5B;CLK3;MARK4;TAF1;KLHL3;METAP2;ADAM10;PSMB5;TEC;PTPRJ;MINK1
prerank,positive regulation of histone acetylation (GO:0035066),0.377720662979982,1.0820814478080047,0.34774436090225563,0.8279205814623177,1.0,10/23,28.60%,RPS6KA5;BRCA1;RPS6KA4;NOS1;GLYR1;ARRB1;PAXIP1;WBP2;BRD7;MUC1
prerank,sodium-independent organic anion transport (GO:0043252),0.46576725302798694,1.0819699049756044,0.37857142857142856,0.8273213265181375,1.0,1/10,0.03%,SLCO2B1
prerank,neutrophil activation involved in immune response (GO:0002283),-0.215065377928171,-1.0818235917074626,0.17269076305220885,0.7546480424071302,1.0,80/428,14.03%,IQGAP2;ATP8B4;IQGAP1;CYBB;PTPRN2;ADGRE5;ARMC8;LRRC7;CD44;AMPD3;CYSTM1;CD47;CD36;ACTR10;LILRB3;CD93;FTL;GSN;ITGAL;B2M;CTSC;CLEC12A;PSMD14;MME;HGSNAT;SDCBP;ATP6AP2;AP2A2;PSMA2;RAB6A;VAPA;CCT2;STOM;PLAC8;UBR4;PPIA;S100A11;MGST1;CTSB;ATP11A;RAB5C;ALOX5;AP1M1;HSPA8;KCNAB2;CNN2;RAB3D;CFP;CYBA;ARPC5;PSMD6;SNAP25;TBC1D10C;CAMP;FRK;PTAFR;RNASE3;XRCC5;PSMD11;ANO6;SLC44A2;ANXA2;RAB3A;PLAUR;HSP90AB1;OLR1;ATG7;LAMP1;PGM1;TRAPPC1;ACLY;DNAJC3;PSMD1;ANPEP;GYG1;APRT;GLIPR1;DERA;MMP8;MCEMP1
prerank,pharyngeal system development (GO:0060037),0.4109768743632361,1.0817427120977439,0.34843205574912894,0.8271321107404265,1.0,4/15,17.51%,TGFBR1;NOG;GATA3;PTCH1
prerank,MAPK cascade (GO:0000165),-0.2228298607018144,-1.081666847266237,0.23465703971119134,0.7540213592115353,1.0,63/295,16.67%,DLG2;RIT2;LRRC7;LRRK2;CUL3;RASAL2;SPTBN1;EGFR;FGF10;RGL1;SHC3;GRIN2B;IRS1;PSMD14;RAPGEF2;YWHAE;PSMA2;RASGRP4;RASGRF1;SHANK3;MARK3;DLG3;MYC;NCAM1;PSMF1;HTR2B;CALM1;PTPN3;PSMD8;RET;GFRA2;ZFP36;JAK2;IL3RA;PSMD6;FGF9;ERBB4;SPTBN2;SPTBN4;PSME2;RAF1;BTRC;PSMD11;ACTN2;ERBB3;FGF7;CCL2;FGFR3;IL2RB;PSMD1;PSMD5;PAK1;PRKCQ;PAQR3;KIT;NRG2;CCL5;MAPKAPK2;KITLG;TNIK;PSMD12;LAMTOR3;TEK
prerank,blood vessel morphogenesis (GO:0048514),0.31301837149184575,1.081640629246234,0.3223684210526316,0.8265031757265512,1.0,8/54,10.39%,TGFBR1;TGFBR2;LRP5;SMAD7;ID1;SHH;SOX17;RASIP1
prerank,protein complex oligomerization (GO:0051259),-0.2627002942264375,-1.0816203690914552,0.29365079365079366,0.7530954171996682,1.0,14/85,7.98%,LRRC8C;NLRC4;KCNC2;MCU;HGSNAT;NINJ1;EHD1;HOMER1;DNM1L;LETM1;ATL2;ADCY8;TRMT61B;PKD2
prerank,positive regulation of cellular process (GO:0048522),0.22791072215111122,1.0815822993176163,0.2335858585858586,0.8257708749917922,1.0,71/565,10.54%,TGFBR1;MERTK;ZFHX3;TGFBR2;MLXIPL;SIRPA;LRP5;CSF1R;GREM1;ETS1;FAM98B;RAC1;AIF1;RPS6KA1;TGM2;PRKCA;TBC1D8;VHL;TLR4;NCBP1;ITGAV;GAB2;CSNK2A1;RIPK2;PRKCD;LYN;NUMA1;SIRT2;CAMK1D;IGF1R;KMT2D;PKHD1;LGMN;ATM;IL6R;EIF4G1;MTLN;TFE3;MEIS3;ZFP36L1;FLCN;TRPM4;TCIRG1;SHH;ACER3;IL6ST;ACER2;S1PR3;PLA2G5;IL12RB2;GATA2;EDN3;CNTF;PDGFB;CCR7;EDN2;IL12B;GPER1;CALCR;CTF1;FUT7;NEUROD4;PTK2B;CD86;TBX6;RPTOR;GCNT2;DHPS;TJP1;PRMT1;DLL1
prerank,phospholipid metabolic process (GO:0006644),0.2904834560472527,1.0811938372723824,0.3322734499205087,0.8260948789659773,1.0,22/71,22.84%,ABHD12;LPCAT4;PLA2G15;SMPD2;PIP4P1;PLA2G5;PLA2G4B;PLA2G4A;PLPP2;MBOAT1;PLBD2;FADS1;PLPP1;PLPPR2;ACP6;GPX4;LCAT;GNPAT;PLA2G3;PLCB2;PIP4K2B;GDE1
prerank,artery development (GO:0060840),0.37018383729983084,1.0810114986013748,0.3473684210526316,0.8257669829089632,1.0,2/23,1.05%,TGFBR1;SMAD7
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.3822690945682869,1.0809927747660544,0.3482758620689655,0.8248870113684328,1.0,8/21,24.96%,CX3CR1;SMARCD3;DRD2;PROX1;KDM1A;FZD9;FZD3;MDK
prerank,axonemal dynein complex assembly (GO:0070286),-0.33990237771237963,-1.0808881131573884,0.3568281938325991,0.7541861290405252,1.0,16/28,30.40%,ODAD2;DNAH8;DNAI4;DNAAF5;DNAI3;ODAD3;DNAH17;DNAAF1;DNAAF3;CCDC65;SPAG1;CFAP100;CCDC39;DNAL1;DNAAF4;CCDC63
prerank,second-messenger-mediated signaling (GO:0019932),0.2876232864160287,1.080033908666097,0.30658105939004815,0.8271033365138178,1.0,18/82,11.74%,CX3CR1;P2RY12;PPP1R9B;LAT2;PPP1R9A;PLCG2;AGTR2;PDPK1;TRPM4;SELE;PLA2G4B;EDN3;CCR7;NOS2;EDN2;CAMKK2;DGKD;NMUR2
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4123657706754512,1.0800136858469913,0.3594890510948905,0.8262408297782087,1.0,8/16,29.25%,MAU2;POGZ;NAA50;DSCC1;CDCA5;PDS5B;SMC1A;RB1
prerank,RNA biosynthetic process (GO:0032774),0.3444296991628547,1.0799723989359977,0.343804537521815,0.8254311684681693,1.0,8/31,13.71%,BRF1;TTF2;BRF2;SMN1;TAF6;TAF12;SMARCA5;TAF4
prerank,negative regulation of proteolysis (GO:0045861),0.3410665389352955,1.0797455108369154,0.3573825503355705,0.82527988236967,1.0,10/34,21.38%,CST3;BAG6;CLN3;AKT1;ACP4;SERPINE2;TMEM59;GAS1;EFNA1;DNAJC1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4152347165929472,-1.07967366481592,0.3393258426966292,0.7568141534995982,1.0,2/13,2.83%,SORBS1;IRS1
prerank,cardiac muscle cell contraction (GO:0086003),-0.3767046175226929,-1.079460529107164,0.32867132867132864,0.7564300182902892,1.0,5/19,12.68%,FGF12;GSN;CACNA1C;ATP1A1;CACNA1G
prerank,response to ionizing radiation (GO:0010212),0.29668266208602023,1.0789278783218383,0.3157894736842105,0.8269519242989866,1.0,18/70,17.13%,RHNO1;MTA1;SPIDR;ATM;USP28;RHOB;EYA3;RNF8;INTS3;BRCA1;TNKS1BP1;ABRAXAS1;RAD1;BLM;MAPK14;BABAM1;ECT2;RAD9A
prerank,anterograde axonal transport (GO:0008089),-0.31113516729857116,-1.0787967737968416,0.3156626506024096,0.7573370825800394,1.0,7/37,11.94%,DLG2;KIF5C;KIF1B;AP3M1;KIF5B;AP3S2;DTNBP1
prerank,negative regulation of biosynthetic process (GO:0009890),0.41180074704699765,1.0786366372571732,0.35555555555555557,0.827016887567969,1.0,5/16,9.60%,ABCD2;COA8;SLC30A10;GPER1;CEACAM1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.4125197227573624,1.078610589061239,0.3464285714285714,0.826191957536983,1.0,5/15,13.09%,EBI3;HSPH1;SHH;IL12B;PNP
prerank,neurotransmitter uptake (GO:0001504),0.43550262009852836,1.0786093745727798,0.37109375,0.8252743683245247,1.0,5/12,20.45%,SLC1A3;SLC22A2;SLC29A4;SLC38A1;SLC29A1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.33423696264463465,-1.078460809404621,0.3446601941747573,0.7573111504462766,1.0,9/30,14.22%,ANK2;FGF12;RYR2;NEDD4L;CACNA1C;KCNH2;ATP1A1;CACNA1G;KCNQ1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.33408096069059784,-1.078184364040957,0.3394495412844037,0.7570638760291974,1.0,6/31,11.72%,DLG2;LRRC7;CDC42;DLG3;MSN;MTCL1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.384110207818928,-1.078116127317238,0.3419354838709677,0.7561931761421431,1.0,8/17,22.78%,PLA2G7;CCR2;CCR1;ANO6;CCL5;HMGB1;CREB3;FPR2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.4501918462560526,-1.07810136490477,0.3630434782608696,0.7551642340752193,1.0,2/10,9.70%,PID1;GRB10
prerank,sensory perception of smell (GO:0007608),-0.4334735843732562,-1.0780376066902835,0.3771551724137931,0.7542833198544969,1.0,4/11,27.11%,SYT10;ADCY3;BBS4;MKKS
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.30237858464734557,1.0780206621391644,0.31666666666666665,0.8262489763509046,1.0,11/62,13.63%,NELFB;POLR2H;NCBP1;GTF2H2;CDK9;POLR2D;CTR9;POLR2J;ERCC2;SETD2;NELFE
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.22291459762196633,1.0779288688176931,0.2130952380952381,0.8256319525067147,1.0,207/807,22.72%,SALL1;ZFHX3;IKZF1;ETV5;MLXIPL;SUMO1;RREB1;CAPN3;SMAD3;SMAD7;DNMT3A;HEYL;PBXIP1;PHF21A;SOX8;BASP1;DDIT3;MEF2C;MTA1;SKI;VHL;ZFP90;PPARD;CHD8;DDX5;CNOT1;PRMT2;HDAC10;ERF;PHB2;SIRT2;ZNF568;SUDS3;DEAF1;GPS2;GTF2IRD1;PAX6;ZBTB21;RPS6KA5;ID1;ZBTB18;SBNO2;LOXL3;MLX;CCDC85B;ELK3;CRY2;BCOR;FOXN3;SAMD1;FLCN;IMPACT;BCL7A;KLF11;FOXE1;CUX1;ZMYND11;EID2;CTR9;KLF12;SHH;MOSPD1;CHD3;EHMT2;PPID;MDFI;FOXK2;SAMD11;PDGFB;BCL6B;LEFTY1;CRYM;TLE6;ZBTB32;SAMD13;HAMP;ANKRD2;TWIST2;POU4F1;HOXD9;NR2F1;NPAS1;CXXC5;NOTCH4;PRDM1;BRCA1;IL33;SIN3A;MIDEAS;WWP2;UBC;RPS27A;E4F1;TBX6;MTDH;BRMS1L;KDM4A;PATZ1;SMARCA2;TMPRSS6;EED;MAP3K10;KHDRBS1;MDM4;DPF1;ZEB1;LIMS1;SKIL;MEF2A;CNBP;PRDM11;PRDM2;MBD1;PRMT6;SEMA4D;SCMH1;HDAC8;ID3;MXD1;IRF8;PAX2;PROX1;TSC22D4;IRF2BP2;SIN3B;MXI1;RUNX1;QARS1;COMMD7;GCLC;KANK2;NOG;ZNF3;SARS1;DPF2;CUX2;FST;PCGF2;TCF25;CHMP1A;MIER3;HMGB2;PLK3;DKK3;EID2B;EZH2;KDM8;KCNIP3;POU2F1;NR1H2;NRIP1;GATA3;ZNF692;SUFU;EPC1;C1QBP;PTCH1;TAF1;NDUFA13;INPP5K;TCF7L2;GZF1;CDKN1B;THAP1;RPL10;PHC2;MED25;HDAC5;TCF3;JUN;VGLL4;RNF2;IRF2;BATF3;CBX8;FGFR2;FOXP4;XRCC6;RING1;PHC1;ACVR2B;IRX1;NFIX;TWIST1;YEATS2;TFAP4;EFNA1;EID1;LIN37;MNT;YY1;KDM2A;BMP2;TGIF2;ZFP37;BRMS1;SCRT1;CRYAB;PDCD4;TP53;ZBTB2;KDM1A;ZBTB14;MITF;ZHX1;TRAF6;SCML2
prerank,regulation of cell morphogenesis (GO:0022604),0.3437357048194169,1.0774907824538509,0.3310696095076401,0.8261095223181815,1.0,6/30,6.39%,CAPZB;CAMSAP1;MOV10;ZRANB1;MACF1;SPARC
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.4125350949402992,-1.0774860949148442,0.368763557483731,0.7549307372368244,1.0,6/13,20.68%,NFIB;PPARG;RELA;SRF;BMP4;REST
prerank,negative regulation of ossification (GO:0030279),0.3683309411417245,1.077271507692289,0.37265917602996257,0.8259319471040066,1.0,6/23,11.32%,GREM1;MEF2C;BCOR;TRPM4;PTK2B;CHSY1
prerank,positive regulation of wound healing (GO:0090303),0.33735126007409616,1.0771853317849724,0.3182608695652174,0.8252848854493456,1.0,10/36,18.77%,RREB1;SMOC2;F12;DUOX1;APOH;MTOR;INSL3;THBS1;CLDN1;DMTN
prerank,bicarbonate transport (GO:0015701),-0.34285118898494754,-1.0767784259152324,0.30472103004291845,0.7560369234774079,1.0,15/25,34.63%,SLC4A10;SLC26A7;SLC4A8;CFTR;CYB5R2;CA4;SLC4A1;AQP1;SLC39A8;RHAG;CYB5R4;CA1;SLC4A11;CA3;CYB5RL
prerank,cellular response to insulin stimulus (GO:0032869),0.26715894566279075,1.0767036794026592,0.2844175491679274,0.8260071067377659,1.0,27/124,19.13%,PDE3B;ATP6V0B;LPIN2;PIK3R1;IRS4;IGF1R;ATP6V0A2;PDPK1;ZFP36L1;RHOQ;TCIRG1;SLC27A4;TRARG1;APPL1;PDK2;CEACAM1;ATP6V0A4;ATP6V1D;AKT1;EPRS1;ATP6V0E2;RAB13;PCK2;LPIN1;INPP5K;ZDHHC7;HDAC5
prerank,skin development (GO:0043588),0.30134591528389315,1.0766633299991029,0.3277027027027027,0.8252229755872807,1.0,12/65,17.45%,ITGA6;DSP;ST14;CERS3;MET;ALOXE3;ASAH1;DLL1;ERRFI1;CLDN1;LSR;ITGB4
prerank,protein catabolic process (GO:0030163),0.2965743162915516,1.0765205826229587,0.3283333333333333,0.8247628288799898,1.0,15/59,21.16%,CAPN3;BAG6;CHEK2;CTSD;RNF41;CUL4B;CEACAM1;PPT1;MTOR;SOCS6;NEU4;ATE1;PMAIP1;HTRA2;LAMP2
prerank,cation transmembrane transport (GO:0098655),0.3186419213708404,1.0765090796224357,0.3572649572649573,0.8238971552983954,1.0,7/44,8.20%,SLC7A8;TRPM6;ABCC9;TRPM2;TRPM4;SLC7A5;SLC29A4
prerank,chemical homeostasis (GO:0048878),-0.28225877924164616,-1.076429960199568,0.29528535980148884,0.7560158514729898,1.0,23/61,27.13%,PPARG;TLCD3A;NEDD4L;USF1;AQP4;SLC4A10;ZBTB20;CEBPA;AQP11;SLC4A8;ADCK1;ANGPTL3;ABHD5;RBP1;PNPLA3;TLCD3B;SLC4A1;TM6SF2;EIF5A2;ABCB11;WNK4;TLCD2;FBXW7
prerank,global genome nucleotide-excision repair (GO:0070911),0.3640062802709548,1.0763968557454953,0.36203866432337434,0.8233571561462678,1.0,7/26,11.08%,GTF2H2;CUL4B;UBC;RPS27A;ERCC2;DDB2;ERCC4
prerank,ureteric bud development (GO:0001657),0.39945313219503814,1.0763754552854383,0.3761467889908257,0.8225238366666912,1.0,2/17,1.94%,SALL1;NPNT
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4520450778286069,1.0762090303777145,0.3588235294117647,0.8221686021258897,1.0,4/10,25.27%,NOTCH4;PLG;PPM1F;NOTCH1
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.2473947386111971,-1.07614868110371,0.28350515463917525,0.7558200000528471,1.0,35/124,19.67%,CNTNAP2;NLGN1;FRY;GPM6A;APP;APOE;CTTN;PLEKHA1;RAPGEF2;MAP2;EHD1;VAPA;RASGRF1;STMN4;TOR1A;GSK3B;PKD2;SH3GL2;CARMIL1;LGI1;ERCC6;CFAP61;DTNBP1;BTG2;PLP1;LRP12;TMEM108;STMN2;HMGB1;FAM161B;CNTN4;SAMD14;BICDL1;CORO1B;BLOC1S3
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.41002709217426425,-1.075880704344292,0.36009174311926606,0.7556039122775688,1.0,6/13,27.92%,LRRK2;SMCR8;SCFD1;MTM1;SEC22B;FEZ2
prerank,RNA transport (GO:0050658),0.2892300067457104,1.0754875071730092,0.3333333333333333,0.8235030301733327,1.0,24/71,23.30%,SRRM1;TGFBR2;NCBP1;ZFP36L1;SRSF5;DHX38;NUP62CL;U2AF2;U2AF1L4;ALYREF;RBM8A;SLU7;DDX39B;NUP62;SRSF9;THOC6;NUP188;XPO5;HNRNPA2B1;NUP214;MAGOHB;MAGOH;ZC3H11A;THOC3
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4197147552904008,-1.075190296075398,0.3470319634703196,0.7565728983243698,1.0,7/12,27.59%,NDC80;CENPE;MAD1L1;KIF2C;CENPC;NUF2;BOD1
prerank,cytoplasmic microtubule organization (GO:0031122),0.3062590801675145,1.0751033649451156,0.33163265306122447,0.8237556269031401,1.0,11/54,15.45%,DST;HOOK2;CCDC88B;NUMA1;CAMSAP1;WDR73;CAMSAP2;TUBGCP5;TRPV4;CIB1;PLK3
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.4274003172394677,1.074488746096184,0.3670212765957447,0.8248242533609469,1.0,10/13,37.13%,SART3;USP4;PRPF3;CD2BP2;PRPF31;PRPF8;LSM2;SRSF10;PRPF19;DDX20
prerank,positive regulation of interleukin-13 production (GO:0032736),0.4634847136421361,1.0743441463331562,0.39568345323741005,0.8244072646565728,1.0,2/10,1.59%,IL18;LGALS9
prerank,mitochondrion localization (GO:0051646),0.38494705779005145,1.074216192247951,0.33935018050541516,0.8239326742767864,1.0,7/19,21.34%,TRAK1;TLE6;MEF2A;MARK2;NECTIN2;ATCAY;MFN2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3889714164245092,1.0739144533388585,0.36203866432337434,0.8240292963434376,1.0,3/17,5.90%,SNTA1;SCN4B;NOS1AP
prerank,sulfate transport (GO:0008272),-0.4070266088395787,-1.0738999588911793,0.3530701754385965,0.7595013242405175,1.0,6/14,23.85%,SLC25A30;RACGAP1;SLC26A7;SLC26A2;SLC26A4;SLC26A8
prerank,glucose transmembrane transport (GO:1904659),0.38335001022655685,1.073203111185446,0.3435114503816794,0.825447682025576,1.0,4/18,19.43%,PPARD;SORT1;RAB4B;SLC5A3
prerank,epithelial to mesenchymal transition (GO:0001837),0.31079795022449896,1.073085931542385,0.3327702702702703,0.8249019813588759,1.0,19/47,28.00%,TGFBR1;HEYL;DDX5;LOXL3;NOTCH4;DDX17;LIMS1;ROCK2;NOG;ENG;AKNA;HIF1A;TASOR;BMP2;TGFB1;NOTCH1;WNT5A;SOX9;HMGA2
prerank,phosphorylation (GO:0016310),0.23473556749544752,1.0729714115089162,0.2540983606557377,0.8244190284847326,1.0,86/385,17.97%,TGFBR1;MERTK;NUAK1;TGFBR2;PIM2;MAP4K4;CHEK2;IGFBP3;BMP2K;PRKCA;PRKACA;CSNK1E;CSNK2A1;TBCK;PRKCD;LYN;CDKL3;DGKK;CDK9;RPS6KA5;NEK3;ATM;PIK3CG;NRBP1;PDPK1;PDK1;CSK;MKNK1;MAP4K3;STRADA;PKN3;NEK6;RYK;PDGFB;TSSK6;TSSK4;PIK3CB;CERK;PTK2B;GK5;PDK2;CAMKK2;CDK11B;PIK3CD;WNK1;DGKD;HCST;NUAK2;PANK2;LATS2;GRK2;ABL1;STK19;MTOR;MARK2;PINK1;CDC42BPB;PRKCB;BMX;CCNE1;ROCK2;PXK;AKT1;MAP3K11;TYK2;ULK1;STK39;PASK;EIF2AK2;MORC3;AURKA;RPS6KA4;WNK2;MAP4K2;TAOK2;WNK3;DYRK1A;PICK1;LIPE;TNK2;CLK3;MARK4;TAF1;ADAM10;TEC;MINK1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.31708984745567353,-1.072910755746724,0.3325842696629214,0.7614653343649723,1.0,9/32,20.03%,POLA1;CDK14;TFDP2;E2F7;NPAT;CDK15;ESRRB;TFDP1;E2F1
prerank,catecholamine biosynthetic process (GO:0042423),-0.435941500659437,-1.0724975639518095,0.38276553106212424,0.7616697505802288,1.0,5/11,31.94%,SNCA;DAO;MOXD1;GCH1;TH
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3224370516669248,-1.0723766159675017,0.3462414578587699,0.760964043771322,1.0,8/33,7.39%,PLCB1;EGFR;FGF10;ANKRD17;KMT2E;CCND2;UBE2E2;CDC73
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.2283186367189299,1.07224903442323,0.2399497487437186,0.8258356485113078,1.0,141/572,21.69%,SALL1;ZFHX3;ETV5;SUMO1;RREB1;SMAD3;SMAD7;DNMT3A;PHF21A;SOX8;DDIT3;MEF2C;MTA1;SKI;VHL;ZFP90;PPARD;CHD8;DDX5;CNOT1;HDAC10;ERF;SIRT2;ZNF568;SUDS3;DEAF1;GPS2;GTF2IRD1;PAX6;ZBTB21;ID1;ZBTB18;MLX;CRY2;BCOR;FLCN;IMPACT;KLF11;FOXE1;CUX1;CTR9;KLF12;SHH;MOSPD1;CHD3;EHMT2;PPID;MDFI;PDGFB;BCL6B;LEFTY1;CRYM;TLE6;ZBTB32;HAMP;ANKRD2;POU4F1;HOXD9;NR2F1;CXXC5;NOTCH4;PRDM1;IL33;SIN3A;WWP2;UBC;RPS27A;E4F1;TBX6;MTDH;BRMS1L;SMARCA2;TMPRSS6;EED;MDM4;ZEB1;SKIL;MEF2A;CNBP;PRDM2;SEMA4D;HDAC8;ID3;MXD1;IRF8;PROX1;IRF2BP2;SIN3B;MXI1;RUNX1;KANK2;NOG;ZNF3;SARS1;DPF2;CUX2;FST;PCGF2;TCF25;MIER3;PLK3;EZH2;KCNIP3;NR1H2;NRIP1;GATA3;ZNF692;SUFU;EPC1;C1QBP;PTCH1;TAF1;TCF7L2;GZF1;THAP1;RPL10;MED25;HDAC5;TCF3;JUN;RNF2;IRF2;BATF3;CBX8;FGFR2;FOXP4;ACVR2B;IRX1;NFIX;TWIST1;YEATS2;EFNA1;EID1;LIN37;MNT;YY1;BMP2;TGIF2;ZFP37;BRMS1;SCRT1
prerank,positive regulation of developmental growth (GO:0048639),-0.2893620927723287,-1.0715443224073407,0.3036144578313253,0.7623297170158849,1.0,6/49,4.03%,RIMS2;PLCB1;CDKL5;BDNF;SYT1;NEDD4L
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.35990559366419483,1.0714525466726574,0.35977859778597787,0.8274751368223506,1.0,4/25,6.92%,HK2;PFKL;GAPDH;FOXK2
prerank,negative regulation of ion transport (GO:0043271),0.36414729307497096,1.0712919775641432,0.3456140350877193,0.8271531193401743,1.0,12/24,21.26%,PTK2B;WNK1;PXK;VIP;WNK2;CD33;WNK3;SYT11;INPP5K;NOS1;PLN;STC1
prerank,calcium-mediated signaling (GO:0019722),0.2773863001332777,1.0711862868879678,0.31259720062208396,0.8265943013995356,1.0,17/93,9.62%,CX3CR1;P2RY12;PPP1R9B;PRKACA;LAT2;PPP1R9A;PLCG2;SLC8A1;PDPK1;TRPM2;TRPM4;SELE;PLA2G4B;CCR7;EDN2;STIMATE;CAMKK2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.39340293220186673,-1.0710928727835365,0.35990888382687924,0.7626843992168784,1.0,4/15,12.05%,HECW2;CENPE;PTTG1;UBE2C
prerank,negative regulation of protein binding (GO:0032091),-0.27041020634344154,-1.0707661260749541,0.3168831168831169,0.7626201542811943,1.0,17/71,17.08%,DAB2;ITGA4;LRRK2;B2M;MAP2;ATP2A2;STYX;ACTB;GSK3B;AURKB;ATP2A3;ITGB1BP1;TTBK1;DNAJB2;CDKN1A;TMC8;CARD16
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.36691951920430416,-1.0702617681979454,0.3598233995584989,0.7630637690190124,1.0,7/19,21.48%,TMEM106A;APP;KLF2;KLF4;MTPN;SLCO1C1;MAP2K5
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.43451986211984406,1.0700950026632512,0.3988439306358382,0.8293034215794155,1.0,3/12,7.53%,DOCK4;MEF2C;PDGFB
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.39780726931003585,-1.0694868135722535,0.368763557483731,0.764429929133729,1.0,4/15,11.44%,BDNF;NTRK2;BCAR1;DDIT4
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.46147142518362416,1.069466182734468,0.3984375,0.8304548012684543,1.0,6/10,18.70%,CHRM1;DGKD;PLPP1;PRKD3;PICK1;GAP43
prerank,regulation of protein autophosphorylation (GO:0031952),0.3278888827313926,1.0694277468143203,0.33895446880269814,0.829647677551347,1.0,11/36,17.76%,IMPACT;NBN;PDGFB;TNKS1BP1;GPNMB;TAOK2;ERRFI1;ENG;CALM2;PPP2R5B;RASSF2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.40913980937553934,-1.06934491139937,0.3556910569105691,0.7637658300752873,1.0,2/13,2.33%,RBPJ;RYR2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.42692312607598865,1.0691729120499083,0.3686200378071834,0.8295549863060667,1.0,3/13,8.97%,TGFBR2;SHH;NOTCH4
prerank,protein-containing complex assembly (GO:0065003),-0.2245417723515497,-1.0691554519049964,0.28104575163398693,0.7633188766289748,1.0,64/259,19.13%,DMD;CD74;LRRK2;CUL3;MCU;GRIA1;CTSC;HGSNAT;CD40;ST13;CDC123;GOSR2;FN1;MYC;SAR1B;NAPA;ZW10;WASF1;DNM1L;AFDN;RAB1B;GSK3B;SEC23A;TLE4;ADCY8;WDR19;CDC73;RIMS1;TCF7;ANO6;KNTC1;GEMIN5;AXIN1;PPP6C;TRAPPC1;SCFD1;PPIH;TMED2;IL2RB;SNX9;PPP2R1A;BCL9L;ITGB1BP1;TIAM1;TLE1;SEC24C;JCHAIN;REPS2;SEC24B;SEC24D;CTNNB1;HDAC1;CX3CL1;PYGO2;GPAA1;PARD3;ADD2;CD3E;MDM2;TRAF1;CARD10;BOK;LMAN1;TRAPPC4
prerank,positive regulation of cholesterol transport (GO:0032376),-0.33662603057481666,-1.0688931298233773,0.37122969837587005,0.7629847454070343,1.0,7/27,17.22%,PPARG;APOE;PLTP;SIRT1;NFKBIA;ABCA5;EEPD1
prerank,aorta morphogenesis (GO:0035909),-0.3777053996367288,-1.0688420089012594,0.36343115124153497,0.762113361585773,1.0,6/17,22.28%,RBPJ;JAG1;TFAP2B;HEY2;ACVRL1;DLL4
prerank,skeletal system development (GO:0001501),-0.23880824789378519,-1.0684017936959658,0.2824207492795389,0.7623993050000987,1.0,53/148,27.02%,TRPS1;ZBTB16;CD44;SULF2;MMP16;PCSK5;EXT1;SOX5;PRDX1;SOX11;PAPSS2;BMP5;TLL1;FRZB;COL1A1;COL13A1;FBN1;ATP7A;VCAN;P3H1;FGFR3;CDH11;EBP;MMP14;RBP4;TEAD4;SPEF2;GDF11;PHEX;EXTL1;GDF10;CHRD;TNFRSF11B;BGLAP;ALPL;COL19A1;NOTUM;EVC;GHRL;ACAN;PKD1;XYLT1;SHOX2;HAPLN2;HAPLN4;NPR3;RFLNB;BMPR1B;KIAA1217;PTH1R;CNMD;IGF1;HES5
prerank,heart morphogenesis (GO:0003007),0.30398219005800325,1.0677234741009518,0.34974533106960953,0.8332136701657433,1.0,6/50,10.97%,TGFBR1;HEYL;CHD7;LEFTY1;SOX17;MDM4
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2809510806207916,-1.0669096579011108,0.31683168316831684,0.7659019310358128,1.0,21/61,21.71%,CUL3;LATS1;CDK7;MYC;NASP;PLK2;PPP6C;BCAT1;USP29;CACUL1;CDKN2A;CDKN1A;GPR132;DBF4;EIF4EBP1;CDK2;E2F1;SPDYA;USP26;CDK4;CDK6
prerank,regulation of keratinocyte migration (GO:0051547),-0.4100053377278221,-1.0668775640456027,0.3720430107526882,0.7649475728782714,1.0,3/12,10.33%,IQSEC1;FGF10;FGF7
prerank,carbohydrate biosynthetic process (GO:0016051),-0.35223402857420066,-1.066597850193536,0.35214446952595935,0.7647391968672391,1.0,3/21,3.11%,B3GALT1;ST3GAL4;FUT9
prerank,positive regulation of vasculature development (GO:1904018),0.2754116674011318,1.066379991768951,0.32558139534883723,0.8365752160439602,1.0,16/94,12.60%,HK2;SMOC2;ETS1;ANXA3;PRKCA;PDPK1;VEGFB;CD34;RHOB;GATA2;BRCA1;RAPGEF3;MTDH;PIK3CD;PDCD6;PRKCB
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3202929337377962,-1.0656811380378213,0.3480278422273782,0.7664574773620161,1.0,4/32,7.32%,PID1;APP;PFKFB1;ZBTB20
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.25451701174772307,-1.0656592333570847,0.2789473684210526,0.7654752611057307,1.0,17/98,12.62%,ANK3;SORBS1;DPP10;SPTBN1;YWHAQ;EGFR;TFDP2;YWHAE;PRKN;MFF;PLS1;KIF5B;TCAF1;BID;FIS1;MTCL1;ITGB1BP1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.21351552468398843,-1.0655964588472062,0.24899598393574296,0.7646114798682851,1.0,58/390,10.33%,VAV3;MTSS1;NEDD9;SORBS1;PLCB1;CYBB;PTPRG;BDNF;EGFR;PTPRT;STAP1;SULF2;ACTR3;FGF10;ITSN1;NCK2;ROR1;SHC3;FLRT2;RBFOX2;GRIN2B;IRS1;NTRK2;CYFIP2;RAPGEF2;SDCBP;NCF2;NTRK3;AP2A2;RASGRP4;CDC42;ATP6V0D2;HNRNPM;PDGFD;ATP6V1A;PAK3;ACTB;GSK3B;PIK3C2A;VEGFD;RET;ALK;COL1A1;GFRA2;JAK2;DNM1;CYBA;BCAR1;ARPC5;FGF9;ERBB4;PTPN2;CHN1;FRK;ATP6V0D1;GRB10;ERBB3;FGF7
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.424180447748965,-1.0655740157547808,0.3646788990825688,0.7636384735604886,1.0,4/11,21.81%,ATF7IP;SETDB2;PPHLN1;DNMT1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.38932329182650544,1.0653789734185533,0.3724770642201835,0.8387553208072808,1.0,7/18,19.75%,GINS4;PCNA;POLD2;LIG1;MCM3;MCMDC2;GINS3
prerank,positive regulation of vascular permeability (GO:0043117),0.42650909451489794,1.0652562625868136,0.36397748592870544,0.8382756296756246,1.0,3/12,11.15%,TJP1;TJP2;TRPV4
prerank,autophagosome organization (GO:1905037),0.3068676915349584,1.0650400371424276,0.3564189189189189,0.8380300037352423,1.0,16/50,19.29%,ULK2;ATG14;ATG9A;STX12;RAB1A;RB1CC1;ULK3;PIK3C3;ATG101;ATG5;UBXN2A;ULK1;ATG9B;PACS2;TP53INP2;WDR45B
prerank,positive regulation of reproductive process (GO:2000243),0.33721529689701923,1.0650073219949145,0.3595505617977528,0.837237052682428,1.0,9/31,24.28%,LHFPL2;SIRT2;TAC4;VIP;PGAM4;C1QBP;PRDM9;TACR1;TACR3
prerank,regulation of cellular component size (GO:0032535),-0.327491513589023,-1.0648614666386462,0.3441108545034642,0.764826720126864,1.0,6/30,6.99%,VAV3;EPS8;PEX11A;RAB22A;RARG;RAP1GAP2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.290701922215687,-1.06480111134406,0.34660421545667447,0.7639659883754132,1.0,10/46,11.17%,PLCB1;CDC42;PPIA;CNN2;JAK2;STAT4;PSME2;ANXA2;SOD2;MSN
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.29458770138778095,1.064431582159584,0.3504983388704319,0.8382098133800916,1.0,9/63,7.94%,TGFBR1;ITGA6;CFLAR;ITGAV;SRC;AGTR2;TRADD;ZMYND11;GPER1
prerank,vacuolar acidification (GO:0007035),-0.35023114309643616,-1.0642827083827113,0.3620309050772627,0.7645735584821849,1.0,6/21,9.36%,DMXL2;ATP6AP2;DMXL1;ATP6V0D2;CLN5;ATP6V0D1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.44907559750617143,1.0639753907616396,0.3861209964412811,0.8388412457384397,1.0,4/10,10.63%,LGALS9;LYN;CCR7;AXL
prerank,autophagy of mitochondrion (GO:0000422),0.3230194570619772,1.0637251373249064,0.3677536231884058,0.8387083066184337,1.0,10/38,13.92%,ULK2;ATG14;ATG9A;PHB2;RB1CC1;MARK2;PINK1;ATG5;ULK1;ATG9B
prerank,extracellular structure organization (GO:0043062),-0.2312062216762117,-1.0635338220126014,0.310580204778157,0.7657116039167812,1.0,61/204,17.98%,ITGA4;CD44;CD47;APP;MMP16;ITGAL;ADAMTS12;ADAMTS17;ITGB7;THSD4;SPP1;VIT;FN1;TNR;COL4A1;VWF;ADAMTS19;ADAM12;COL1A1;COL13A1;FBN2;ST7;FBN1;POSTN;HSPG2;ATP7A;TNC;LAMB2;NID1;MMP15;VCAN;MMP12;COL14A1;VCAM1;LOX;DAG1;ADAMTSL5;ADAMTSL4;ITGA8;MMP14;ITGA2B;ITGB6;MMP8;CDH1;AGRN;MMP19;ADAMTS10;ADAMTSL1;ADAM19;LAMA5;SMOC1;COL5A1;PECAM1;TEX14;ELN;ICAM1;PDGFA;COL23A1;LAMC3;ITGA11;LUM
prerank,metal ion transport (GO:0030001),-0.25895249292745354,-1.0633498526371743,0.3228346456692913,0.7652069838774189,1.0,27/86,20.48%,CACNA1E;ITPR1;TRPC5;TRPC4;SLC8A3;RYR2;CCR1;RYR3;TRPC3;TPT1;CACNA1C;PKD2;GRIN3A;CHRNA4;ATP2A3;MMGT1;NDFIP1;SELENOK;PANX1;CCL5;SLC3A2;CACNB3;TRPV6;MAGT1;CACNA2D1;TRPM7;FYN
prerank,cellular glucose homeostasis (GO:0001678),0.32088649696744853,1.0632332498681363,0.3350877192982456,0.8393842126571766,1.0,13/41,20.56%,HK2;PRKACA;PIK3R1;IGF1R;FOXK2;GPER1;TRA2B;LRRC8A;PAX2;CARTPT;PCK2;KCNB1;HIF1A
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3368841869947589,1.0629631322405726,0.3634651600753296,0.8394082091751888,1.0,10/31,17.51%,LRP5;GREM1;NBR1;SKI;TRPM4;TWIST2;SEMA4D;NOG;SUFU;PTCH1
prerank,negative regulation of viral release from host cell (GO:1902187),0.42692054125151757,1.0623293893870975,0.3834296724470135,0.8404788883443471,1.0,2/13,3.58%,TRIM11;TRIM5
prerank,artery morphogenesis (GO:0048844),0.33812444185704205,1.0620912565412202,0.3858407079646018,0.8403544419386444,1.0,6/30,17.06%,TGFBR1;SMAD7;HPGD;LRP1;NOG;ENG
prerank,cellular response to hypoxia (GO:0071456),-0.24563673358874855,-1.0620418878428532,0.30029154518950435,0.7681171632310082,1.0,29/126,17.08%,KCND2;NPEPPS;SUV39H1;SLC8A3;SCN2A;PSMD14;LIMD1;LMNA;PSMA2;SIRT1;MYC;PSMF1;PSMD8;HIPK2;PSMD6;PSME2;PSMD11;OPRD1;PSMD1;PSMD5;TIGAR;EGLN3;RGCC;AK4;SFRP1;PSMD12;UBQLN1;HMOX1;CARD16
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.3958413010128029,1.0619332001997657,0.38803088803088803,0.8400016075231201,1.0,4/16,9.60%,AGER;CYRIB;IL12B;CEACAM1
prerank,glycolytic process (GO:0006096),0.3438456123086174,1.0614035074086503,0.39776951672862454,0.8407690536579527,1.0,7/28,18.16%,HK2;PFKL;GAPDH;PFKFB2;PGAM1;PGAM4;LDHA
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.3594704893804921,-1.0613054129957806,0.35374149659863946,0.7693297338239591,1.0,3/20,3.11%,B3GALT1;ST3GAL4;FUT9
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.3643044145410619,1.061116298776883,0.36524822695035464,0.8407646708258794,1.0,4/23,7.19%,CADM1;LGALS9;ARRB2;RAET1E
prerank,cellular response to glucose stimulus (GO:0071333),0.3381886181075563,1.060955529206818,0.35753176043557167,0.8403707918757579,1.0,11/30,21.44%,MLXIPL;AGER;PRKACA;IGF1R;GPER1;TRA2B;PAX2;SELENOT;PCK2;KCNB1;RAB11FIP2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.29522959051163256,-1.0608434612480564,0.36018957345971564,0.7697278726995118,1.0,4/48,1.33%,DMD;AKAP6;ANK2;PDE4D
prerank,B cell activation involved in immune response (GO:0002312),-0.4014005545679389,-1.0608089713591637,0.3611111111111111,0.76878631329706,1.0,6/13,24.87%,LIG4;FCGR2B;MSH6;GAPT;CD19;MSH2
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3449330072650909,-1.0603229991410976,0.37360178970917224,0.7692610342856826,1.0,5/24,6.22%,AGBL4;TTLL11;GGCX;TTLL7;TTLL5
prerank,regulation of nuclear division (GO:0051783),-0.3617478735129302,-1.0601932923929902,0.37142857142857144,0.7686418131533257,1.0,9/20,33.05%,MKI67;CUL7;OBSL1;CDC25C;PKMYT1;CAV2;BORA;CCDC8;NEK2
prerank,regulation of neuron migration (GO:2001222),-0.3329028566590553,-1.059885457539084,0.3493150684931507,0.7685374472145474,1.0,11/26,19.23%,CTNNA2;RAPGEF2;PHACTR1;NTNG1;PLXNB2;NTNG2;CX3CL1;SEMA6A;PLAA;TNN;IGSF10
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3153743788618174,1.059771373091688,0.3158813263525305,0.843255103297892,1.0,10/42,13.26%,CHD8;HNRNPC;CHD3;SRCAP;RNF8;SMARCA2;SMARCA5;INO80B;ARID1A;SPTY2D1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.4309486490571366,-1.0593794375027088,0.37849462365591396,0.7690581519255918,1.0,3/10,10.33%,IQSEC1;FGF10;FGF7
prerank,positive regulation of interleukin-1 production (GO:0032732),0.30051625794460607,1.0593721838006467,0.3649122807017544,0.8436079503930379,1.0,15/51,20.44%,LGALS9;AGER;TLR4;RIPK2;PYDC1;CASP1;ORM2;GBP5;NLRP3;USP50;EGR1;AIM2;NOD2;PYCARD;MYD88
prerank,detection of mechanical stimulus (GO:0050982),-0.36133862192999655,-1.0592063002185867,0.3902439024390244,0.768540614590292,1.0,9/19,37.88%,PKD2;CTNNB1;PKD1;PIEZO2;LHFPL5;TTN;PKD1L1;PTK2;PKD2L1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3897195774117843,1.0591448575899076,0.39219330855018586,0.8434341810327041,1.0,5/17,18.37%,NCBP1;CDK9;CTR9;NELFE;RNF20
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.31700173618383987,1.0590851629757743,0.3587521663778163,0.8427375963384055,1.0,4/40,2.23%,TGFBR1;TGFBR2;SMAD3;TGFB1I1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.344645219577744,-1.058962246066055,0.3841059602649007,0.7682971563872022,1.0,6/25,7.13%,CTNNA3;ANK2;RYR2;ATP2A2;CALM1;CACNA1C
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.34991985224964006,-1.0587026656696314,0.37044967880085655,0.7680332953808835,1.0,10/20,23.98%,EGFR;CCND2;CCNYL1;PKD2;HSP90AB1;TTBK1;RGCC;SPDYA;STOX1;PKD1
prerank,response to ATP (GO:0033198),0.3874771284327967,1.0585135625830875,0.3752212389380531,0.8437391683541026,1.0,3/18,5.74%,P2RY12;ABCC9;SSH1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4017733047327243,-1.0584916097368184,0.378076062639821,0.7666600216500793,1.0,2/13,12.23%,PLCB1;IL2RB
prerank,cellular response to interleukin-15 (GO:0071350),-0.4017733047327243,-1.0584916097368184,0.378076062639821,0.7666600216500793,1.0,2/13,12.23%,PLCB1;IL2RB
prerank,respiratory tube development (GO:0030323),0.3439339016194702,1.0584328921242325,0.3771106941838649,0.843119225635977,1.0,7/28,13.07%,BAG6;HECA;LOXL3;SHH;WNT7B;CCDC40;PROX1
prerank,positive regulation of kinase activity (GO:0033674),-0.25109893372514175,-1.0581201227210284,0.30845771144278605,0.7667702251966587,1.0,41/107,26.59%,CD74;IQGAP1;EGFR;DSTYK;ROR1;NTRK2;PRKAG2;RAPGEF2;NTRK3;LMO4;RET;ALK;CENPE;ERBB4;XRCC5;ERBB3;EEF1A2;FGFR3;SNX9;TIGAR;EPHA5;KIT;CACUL1;RELN;CDKN1A;TEK;EPHA3;EPHA1;LMTK2;SPDYA;EPHA7;TIE1;LTK;EPHA6;DDR1;EPHA4;MRE11;CD4;EPHB2;CCL19;FLT3
prerank,melanosome organization (GO:0032438),0.3589371702173417,1.0580685660133053,0.37454545454545457,0.8434119371394885,1.0,10/26,29.40%,HPS4;AP3D1;SHROOM2;RAB32;KIF13A;TRAPPC6A;HPS1;RAB29;BLOC1S5;LYST
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2748232092558698,1.0580561727624955,0.3280757097791798,0.8425729438019784,1.0,29/95,23.47%,ZFYVE26;GINS4;RNF138;SPIDR;RAD54B;POLN;NBN;FANCM;SLX4;SWSAP1;RAD51B;BRCA1;ERCC4;BLM;MCM2;AP5Z1;MORF4L1;FBH1;MCM3;PALB2;MCMDC2;RPA3;NABP1;YY1;RAD51C;CDC7;RAD51AP2;MCM6;HELQ
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.23461930699474565,-1.0575496319616553,0.28488372093023256,0.7675043787880198,1.0,41/152,22.78%,GRM8;ADGRE5;ADGRB3;ADGRL3;GRK5;ADGRG6;GNAO1;RGS1;IAPP;GABBR1;ADCY2;ADCY5;PF4;ADCY3;ADCY8;HTR1D;S1PR5;CHRM2;LGR4;GPR161;ADRA2A;LGR5;GNAI1;ADGRG5;PDE2A;TSHR;LPAR2;RXFP2;ADM;CNR2;ADCYAP1R1;ADGRL4;GPR65;GNA13;AVPR2;ADGRL2;S1PR2;HTR1F;MC4R;LPAR3;FPR2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3514922436433944,1.057463649988543,0.35986159169550175,0.8435153592069575,1.0,6/27,8.19%,SIRPA;CCDC88B;ETS1;ITGB2;CYRIB;FUT7
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2816917867995527,1.0574629408465135,0.357487922705314,0.8426324901504174,1.0,30/80,27.31%,SENP2;SMAD7;MTA1;RIPK2;TBC1D7;NDFIP2;FANCM;KLHL40;BRCA1;XIAP;PDCD6;PINK1;PTTG1IP;PHF23;FANCI;TOPORS;SPRTN;DCUN1D4;UBE3A;STUB1;NSMCE3;KDM1A;TRAF6;PIN1;PAXIP1;TSPYL5;ARRDC4;BIRC2;DCUN1D5;RBX1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.31860906293422636,1.0571138356275218,0.342512908777969,0.8428409240377465,1.0,8/39,12.26%,PI4KB;TMEM150A;PIK3R1;PIK3CG;PIK3CB;PIK3CD;PIK3C3;SOCS6
prerank,endothelial cell migration (GO:0043542),-0.3075205218502315,-1.0570391832664658,0.33410138248847926,0.7679451420422131,1.0,11/37,19.47%,DPP4;PLXND1;FSTL1;GIPC1;CDH13;CDH5;PLEKHG5;CCN3;TNFSF12;CORO1B;STARD13
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.41067468537057233,-1.056778673499867,0.3707093821510298,0.7676903601922513,1.0,6/13,15.83%,CPEB3;TNRC6A;ZFP36;PABPC1;BTG2;POLR2G
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.21615474527605633,1.0564834986668006,0.2546728971962617,0.8439576054247715,1.0,234/1082,20.85%,TGFBR1;SALL1;ZFHX3;MAML3;ETV5;IL18;MLXIPL;ARHGEF2;RREB1;LRP5;CAPN3;GREM1;BICRAL;SMAD3;ITGA6;NFE2L2;SMAD7;DNM2;BRD8;YWHAH;LYL1;ETS1;HEYL;PIM2;FLI1;SOX8;UBP1;RPS6KA1;CEBPZ;DDIT3;CHEK2;QRICH1;MEF2C;SKI;VHL;TGFB1I1;TLR4;LPIN2;FOXJ2;MLXIP;ZFP90;PPARD;CHD8;RIPK2;HIVEP3;PRMT2;PIK3R1;MEF2D;SIRT2;DEAF1;KMT2D;CDK9;ELK1;GPS2;AKAP8L;AATF;PAX6;CALCOCO1;RPS6KA5;CREB3L2;ZBTB18;ATM;SBNO2;KARS1;MLX;PICALM;ELK3;NFATC1;ATMIN;TFE3;MEIS3;TRIM44;RHOQ;AFAP1L2;FLCN;TAF6L;PADI2;JMJD6;FOXE1;BICRA;CXXC1;FIZ1;BCL9;AKIRIN1;MET;FZD2;SHH;MYSM1;MOSPD1;TRIM45;FHOD1;RBM14;RXRB;ILF2;FOXK2;ZSCAN21;GATA2;ABRA;PDGFB;SPAG8;GPER1;CITED4;SOX17;POU4F1;TET3;MMS19;NR2F1;AKIRIN2;KDM3A;PITHD1;NOTCH4;CD86;BRCA1;IL33;SMARCD3;SIN3A;UBC;RPS27A;CAMKK2;TAF6;E4F1;RPTOR;CRTC1;MAML2;DDX17;SMARCA2;TMPRSS6;MAP3K2;DLL1;DHX9;CCDC62;ARNT;SMARCA5;SNX5;DPF1;BLM;E2F2;NRF1;ABL1;MEF2A;MTOR;CNBP;PRDM11;PRDM2;HDAC8;MED10;ZMIZ2;DTX3L;IRF8;PAX2;PROX1;ARID1A;AKT1;IRF3;ALYREF;CEBPG;MLLT6;RUNX1;RLF;MED4;RNF187;NLRP3;DPF2;RPS6KA4;MAPK7;KDM5A;MAVS;POGZ;HMGB2;TNIP2;DDX39B;MED19;UBTF;NUP62;FZD1;KDM8;POU2F1;FANK1;NR1H2;TAL1;NRIP1;GATA3;ATAD2;EDRF1;SSBP4;DYRK1A;EGR1;ENG;LMO1;EPC1;THAP3;IL4I1;LPIN1;E2F3;WASL;NOD2;RNF4;RBMX;HMGN1;INPP5K;TCF7L2;TCF4;NCOA3;RNF20;POU2F2;NOS1;ELOF1;AKNA;TP53INP2;MED25;HDAC5;MED12;TCF3;CAMK1;NFIA;JUN;IRF5;IRF2;PARK7;SETD3;FGFR2;XRCC6;TOX2;RFXANK;PHF8;NFYA;TNNI2;AGO1;HIF1A;NFIX;TWIST1;CXCL10;TFAP4;SLC11A1
prerank,positive regulation of angiogenesis (GO:0045766),0.2668274105214561,1.0564545879315281,0.33548387096774196,0.8431667644869818,1.0,18/108,12.60%,HK2;SMOC2;ETS1;ANXA3;PRKCA;PDPK1;VEGFB;CD34;RHOB;GATA2;BRCA1;RAPGEF3;MTDH;TJP1;PIK3CD;DLL1;PDCD6;PRKCB
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.27906304687948863,-1.0562312559698066,0.33496332518337407,0.7684190961817722,1.0,13/56,12.63%,ANK3;SPTBN1;SEPTIN9;KIF23;RACGAP1;CUL7;NUSAP1;AURKB;UNC119;KIF20A;SNX9;EFHC1;ALKBH4
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.3472647224094013,1.0561878248043723,0.37681159420289856,0.8431420175682569,1.0,4/27,4.86%,SNTA1;YWHAH;FXYD1;SCN4B
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3604490721949334,-1.0559298211110144,0.3767123287671233,0.7683322927121552,1.0,4/19,5.85%,CD74;MCU;RIPOR2;DNM1L
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.3913490198758878,-1.0558314073724973,0.38789237668161436,0.7676281774081697,1.0,6/15,15.83%,CPEB3;TNRC6A;ZFP36;PABPC1;BTG2;POLR2G
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.34080133237497684,1.0550871978106595,0.3687821612349914,0.845666302534921,1.0,10/30,22.01%,SRC;CTC1;HNRNPC;ERCC4;TEN1;TERF1;EXOSC10;GNL3L;ACD;TP53
prerank,response to amyloid-beta (GO:1904645),-0.29401527092915053,-1.054943511043395,0.36596736596736595,0.7692655873109073,1.0,20/44,27.65%,ITGA4;GRIN2A;GRM5;CD36;APP;GSK3B;MMP12;VCAM1;ABCC1;FCGR2B;ICAM1;CACNA2D1;FYN;CACNA1B;FPR2;NGFR;CASP4;EPHA4;IGF1;MMP9
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.32433108150398093,1.0544333743170176,0.36713286713286714,0.8468332430186079,1.0,7/38,10.68%,POLR3G;LY86;PRKCA;ZCCHC3;SLC15A4;AKIRIN2;DHX9
prerank,regulation of protein kinase C signaling (GO:0090036),-0.39673650683490747,-1.0543842281593603,0.38611713665943603,0.7699106378316138,1.0,7/14,32.39%,ADRA1A;CD40;MYADM;DGKG;SPHK2;WNT11;FLT4
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3306983115670405,1.0543455813445795,0.37609841827768015,0.8462392579823386,1.0,9/33,21.44%,NFE2L2;PKHD1;PDPK1;GATA2;MAPK7;TNIP2;GATA3;TCF7L2;SERPINE1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.3579902411853322,-1.0542983132021684,0.33653846153846156,0.7691903867533344,1.0,8/19,21.13%,AMPD3;POLL;ADK;APRT;POLD3;CDA;TERT;POLD1
prerank,nucleus organization (GO:0006997),0.30786321537452055,1.0539394015022416,0.37416107382550334,0.8466870663955661,1.0,11/47,17.25%,BIN1;NUMA1;IRAG2;WDR73;NUP35;USP36;SUN2;ATXN7;SEH1L;CHMP1A;CHMP2A
prerank,regulation of monocyte differentiation (GO:0045655),-0.3960633614773525,-1.0538734015405171,0.3801295896328294,0.7695208738818146,1.0,3/14,5.28%,CD74;FOXP1;MYC
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3320761910418237,-1.0534868652499523,0.3690205011389522,0.7695986365200205,1.0,8/25,19.89%,ANK3;PRKN;SNCA;TFAP2B;TMC8;TRPV6;TMTC2;TRPM7
prerank,phospholipid dephosphorylation (GO:0046839),-0.3049545205589118,-1.0533733061282675,0.35083532219570407,0.7689370756734408,1.0,14/37,21.00%,PLPPR4;PLPP5;PLPP4;MTMR2;INPP5F;INPP5J;PLPPR1;OCRL;MTMR3;PLPP3;MTMR1;PLPPR3;TPTE;MTM1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3742480534374296,-1.0529855497040266,0.3778280542986425,0.7690978429609556,1.0,3/17,4.74%,STAP1;NTRK3;CDC42
prerank,T-helper cell differentiation (GO:0042093),-0.39679496547917076,-1.052985174742881,0.37389380530973454,0.7680990022861393,1.0,6/14,28.67%,FOXP1;ATP7A;HMGB1;LEF1;RORC;ZFPM1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3592501062073951,1.0529352783978536,0.37132987910189985,0.8490146446017951,1.0,6/22,16.02%,MVB12B;VPS37A;VPS36;VPS37D;TSG101;PTPN23
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.317191726365603,1.0528594443555175,0.3811881188118812,0.8483783314176903,1.0,9/42,13.49%,PRIMPOL;RFC2;PCNA;POLN;UBC;RPS27A;POLD2;PCLAF;RFC1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.25047570234214356,1.0528138377875602,0.335832083958021,0.8476480868723721,1.0,42/163,20.36%,PAG1;INPP5D;BLNK;FYB1;MEF2C;LAT2;RIPK2;FYB2;PIK3R1;PLCG2;LCP2;TNFRSF21;NCKAP1L;PDPK1;CSK;EIF2B3;TAB2;PSMD3;PIK3CB;EIF2B4;PIK3CD;WNK1;PSMA7;KHDRBS1;PRKCB;BMX;RNF31;PSMB3;PSMB9;PSMC2;PSME4;PSMC1;PSMB7;GATA3;PSMB5;TEC;PTPRJ;STOML2;CD79A;PSMB8;PLCG1;PIK3CA
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.42681559317419565,1.052396765984578,0.39105058365758755,0.8481584516159453,1.0,1/11,0.08%,BIN1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3424296436724858,1.0520079115786285,0.3785211267605634,0.8484275085232362,1.0,12/27,25.46%,RNASE1;POP1;RNASE6;KHNYN;ZC3H12B;ZC3H12C;NHP2;PCF11;NUDT16;RNASEH1;ZC3H12A;PARN
prerank,visual system development (GO:0150063),0.3211590265548316,1.051791748281246,0.3830935251798561,0.8482024403226793,1.0,5/37,6.50%,ITGAM;PAX6;MEIS3;FREM2;C1QA
prerank,bone morphogenesis (GO:0060349),0.4072884053943836,1.0517631831676053,0.38404452690166974,0.8474337021243447,1.0,2/14,2.13%,LRP5;SKI
prerank,indolalkylamine catabolic process (GO:0046218),-0.4409256813581502,-1.0514372885246677,0.42436974789915966,0.771760476260349,1.0,3/10,24.16%,KMO;IDO2;KYAT1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.39449589095280463,1.051406535643879,0.39748201438848924,0.8476693513801635,1.0,11/16,35.38%,NAA11;NAA25;NAA40;NAA20;NAA50;KAT2B;EP300;NAA10;NAA80;NAA60;AANAT
prerank,endoplasmic reticulum organization (GO:0007029),-0.26355443786299293,-1.0514032355994394,0.33249370277078083,0.7708762630959001,1.0,11/72,9.00%,LRRK2;TMCC1;APP;REEP3;RTN4;VAPA;UBE2J2;DNM1L;ATL2;REEP2;VCPIP1
prerank,early endosome to late endosome transport (GO:0045022),0.3707907136666925,1.0512828899553421,0.39191564147627417,0.8472283493827903,1.0,8/20,24.89%,HOOK2;AKTIP;PIK3C3;PTPN23;WDR81;KIF16B;HOOK3;STX8
prerank,positive regulation of actin nucleation (GO:0051127),-0.4288463003612565,-1.051048163019372,0.3938053097345133,0.7709747337489313,1.0,3/11,5.65%,GSN;ABI2;WASF1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.36851888818288553,1.050735859752998,0.3880070546737213,0.84805917531279,1.0,2/20,1.38%,TGFBR1;HEYL
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.3955692363443201,1.0506950298938293,0.37800687285223367,0.8473062087800846,1.0,4/16,8.19%,ETS1;ITGB2;SELE;FUT7
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4323826100133765,-1.0505780686068382,0.4194915254237288,0.7713570878078103,1.0,3/10,7.01%,LRRK2;STK26;PDE8A
prerank,UV protection (GO:0009650),-0.4352751972068851,-1.0502006958616594,0.39019189765458423,0.7714725782675109,1.0,5/10,23.55%,XPA;CAT;MFAP4;FEN1;SCARA3
prerank,cGMP metabolic process (GO:0046068),-0.4152423499474108,-1.0501327610833198,0.38934426229508196,0.7706864919735552,1.0,5/12,19.42%,PDE9A;GUCY1B1;PDE2A;GUCY2F;GUCY2D
prerank,regulation of epithelial cell differentiation (GO:0030856),0.39450707357875264,1.0498544462505852,0.3897058823529412,0.8491214729800877,1.0,9/17,28.48%,DSPP;CEACAM1;DLL1;AJAP1;GATA3;MAFG;SOX9;CD24;OSR1
prerank,positive regulation of organelle assembly (GO:1902117),0.3138521397774332,1.0496161326528095,0.3798319327731092,0.8490288798553095,1.0,14/44,20.04%,ASAP1;CNOT1;NUMA1;FSCN1;RAB3GAP2;SH3GLB1;RAB3GAP1;G3BP1;ENTR1;NUP62;MARK4;STX18;CCP110;CROCC
prerank,protein mannosylation (GO:0035268),-0.33955445265123785,-1.0494320478604204,0.39740820734341253,0.7717880881135367,1.0,13/22,25.64%,DPM2;DPY19L1;CRPPA;TMTC1;POMT2;TMTC4;POMGNT2;DPY19L3;FKTN;TMTC2;TMTC3;DPY19L2;FKRP
prerank,regulation of cellular response to stress (GO:0080135),0.2609368618090933,1.049410273571131,0.34202453987730064,0.8487802049147385,1.0,37/115,23.78%,NUAK1;RANBP2;ATM;EIF4G1;NUP42;HSPH1;SEC13;NEK6;NUP35;MBTPS2;MLST8;RPTOR;CLN3;NUP50;HSPB8;BAG4;ABL1;MTOR;ARMT1;PINK1;USP19;ROCK2;SEH1L;DNAJC7;NUP62;NUP107;NUP88;ABCD1;NUP188;RPA3;MAPT;CHORDC1;CRYAB;NUP214;AJUBA;HIKESHI;BAG5
prerank,peptide cross-linking (GO:0018149),-0.33452920859355995,-1.0492741177109146,0.3812785388127854,0.7712621016397254,1.0,15/25,33.98%,F13A1;FN1;TGM4;EVPL;TGM1;CD247;KRT10;ANXA1;ABCA7;TGM6;EPB42;TGM7;CD3G;SPRR1A;NDNF
prerank,peptidyl-tyrosine modification (GO:0018212),0.29218687121612497,1.049244982538354,0.38030560271646857,0.8483841992268837,1.0,16/56,19.80%,ABI3;CSF1R;TPST2;SRC;LYN;EFEMP1;PDGFB;PTK2B;PKDCC;ABL1;FES;DDR2;DYRK1A;TEC;FGFR4;FGFR2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.2496702207068777,-1.049188155205496,0.3463541666666667,0.7705467158971171,1.0,21/108,13.11%,HIP1;ROBO1;XDH;NLRC4;PPARG;GSN;ST18;DAP;SIRT1;RPS3;ACVR1C;DAPK1;MYC;DIABLO;JAK2;BEX3;BID;ATP2A3;FIS1;SNCA;SENP1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.35074283156744857,-1.0487584217067463,0.38461538461538464,0.7707984000288546,1.0,7/21,14.18%,DMD;PDE4D;NCK2;NLRP2B;INPP5J;DDIT4;PAQR3
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.42665678876032953,1.0485744145450977,0.38747553816046965,0.8497127362448402,1.0,3/11,6.93%,PICALM;TAX1BP3;LEPROT
prerank,positive regulation of cartilage development (GO:0061036),-0.3718054057883726,-1.048315691612812,0.38724373576309795,0.7710874912792471,1.0,9/17,32.83%,ZBTB16;SOX5;SCX;ACVRL1;BMP4;BMPR1B;SOX6;GDF6;BMP1
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.3248138775725812,-1.0482237387427875,0.3858447488584475,0.7703763438613705,1.0,10/27,23.03%,CD74;FN1;MYC;LIG4;CDKN1A;PDGFA;E2F1;CDK4;CDK6;AQP1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.4370055552316571,-1.0478984348294236,0.3787878787878788,0.7702996009299494,1.0,3/10,10.61%,LILRB1;FN1;HSP90AB1
prerank,response to organophosphorus (GO:0046683),0.38999093890255554,1.0477981827595626,0.3925399644760213,0.8512944240947043,1.0,3/16,7.41%,ABCC9;NDUFS4;DUOX1
prerank,myelin assembly (GO:0032288),-0.4354897816596807,-1.047794823532655,0.3678646934460888,0.7695938033374103,1.0,3/10,10.09%,TPPP;CNTNAP1;TENM4
prerank,macromolecule catabolic process (GO:0009057),0.34430319945431964,1.0477560717294685,0.4056437389770723,0.8505631218023111,1.0,6/26,12.07%,CAPN3;SMURF1;LGMN;SH3GLB1;PPT1;MTOR
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.290965517818202,-1.0474134431572304,0.3492063492063492,0.7697378325579155,1.0,12/47,9.88%,ZBTB16;PPARG;CREBL2;CEBPB;ZBTB7B;LMO3;FRZB;ZFP36;NAPEPLD;SOX13;FNDC5;PIM1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.37739195317247504,-1.0473496834442622,0.3872340425531915,0.7689677509782661,1.0,6/16,13.16%,SYN1;MCTP2;CPLX2;RIMS1;MCTP1;KCNMB4
prerank,negative regulation of centrosome duplication (GO:0010826),-0.41868529083948725,-1.0473356922324597,0.4013605442176871,0.768039769820642,1.0,5/11,15.88%,CDK5RAP2;CCNF;TRIM37;MDM1;NPM1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.33861716323624413,-1.047186607447202,0.3590308370044053,0.7675214581765,1.0,9/26,21.00%,PTPN22;RSAD2;RTN4;NINJ1;CYBA;LBP;HMGB1;TREML4;LTF
prerank,positive regulation of innate immune response (GO:0045089),0.3400335027658551,1.0470535952538507,0.39145299145299145,0.8519080138701447,1.0,8/30,15.10%,POLR3G;SLC15A4;PLA2G5;AKIRIN2;DHX9;TRIM62;GBP5;MAVS
prerank,cellular response to interferon-gamma (GO:0071346),-0.2563592705352195,-1.0461727264880842,0.3324742268041237,0.769621003456036,1.0,23/88,15.69%,CD44;OAS2;CD47;CIITA;B2M;CCL4;AQP4;GBP3;DAPK1;IRF4;NCAM1;SP100;JAK2;RPL13A;PTAFR;GBP4;CCL2;VCAM1;IFNGR1;GBP2;OAS3;CCL5;CX3CL1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4458128695802153,-1.045992161625212,0.38193018480492813,0.7691609370576844,1.0,2/10,4.42%,CD36;ACSL3
prerank,metal ion export (GO:0070839),-0.324090363423556,-1.0457629161450361,0.39429928741092635,0.7688535708872836,1.0,9/31,17.92%,KCNT2;KCND3;KCNH2;ATP7A;ATP1B3;ATP1A1;KCNQ1;KCNIP2;KCNE3
prerank,regulation of response to oxidative stress (GO:1902882),-0.42894771786827546,-1.0457019480862413,0.40997830802603036,0.7680516744736356,1.0,8/11,33.10%,PRKN;ALOX5;MCTP1;GGT7;STOX1;AIFM2;HEBP2;ACOX2
prerank,heart development (GO:0007507),-0.23473159611521527,-1.0455099080359318,0.3480825958702065,0.7676265621521224,1.0,25/150,10.41%,SGCZ;PDLIM5;ZFPM2;FGF12;PCSK5;FLRT2;CACYBP;NTRK3;SGCD;FN1;ZDHHC16;BMP5;PDLIM1;RBM20;HTR2B;CACNA1C;CRIP1;PKD2;FBN1;KDM6B;HEG1;ERBB4;GPC3;ERBB3;LDB3
prerank,vesicle transport along microtubule (GO:0047496),0.3638530156265696,1.0454716933053458,0.41304347826086957,0.8561240063493513,1.0,9/23,20.90%,TRAK1;KIF3B;BICDL2;RAB1A;CLN3;KIF3A;KIF13A;FYCO1;NDE1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.21601249219052904,1.0452175921815514,0.3005988023952096,0.8560568835520247,1.0,224/834,25.47%,SALL1;ZFHX3;MAML3;ETV5;IL18;MLXIPL;ARHGEF2;RREB1;LRP5;GREM1;SMAD3;ITGA6;NFE2L2;SMAD7;BRD8;ETS1;HEYL;SOX8;UBP1;RPS6KA1;CEBPZ;DDIT3;MEF2C;SKI;TLR4;LPIN2;FOXJ2;MLXIP;PPARD;CHD8;RIPK2;PIK3R1;MEF2D;SIRT2;KMT2D;CDK9;ELK1;GPS2;AKAP8L;AATF;PAX6;CALCOCO1;RPS6KA5;ZBTB18;ATM;SBNO2;MLX;ELK3;NFATC1;ATMIN;TFE3;MEIS3;RHOQ;FLCN;TAF6L;JMJD6;FIZ1;BCL9;AKIRIN1;MET;SHH;MYSM1;MOSPD1;FHOD1;RBM14;RXRB;FOXK2;ZSCAN21;GATA2;ABRA;PDGFB;SPAG8;GPER1;CITED4;SOX17;POU4F1;TET3;NR2F1;AKIRIN2;NOTCH4;BRCA1;IL33;SMARCD3;SIN3A;UBC;RPS27A;TAF6;E4F1;CRTC1;MAML2;DDX17;SMARCA2;TMPRSS6;DLL1;DHX9;CCDC62;ARNT;SMARCA5;SMAD9;DPF1;E2F2;NRF1;ABL1;MEF2A;CNBP;PRDM2;HDAC8;MED10;ZMIZ2;IRF8;PAX2;PROX1;IRF3;GCN1;CEBPG;NOTCH3;MLLT6;RUNX1;RLF;MED4;NLRP3;DPF2;RPS6KA4;MAPK7;MAVS;POGZ;HMGB2;TNIP2;MED19;POU2F1;NR1H2;TAL1;NRIP1;GATA3;ATAD2;SSBP4;EGR1;ENG;LMO1;EPC1;THAP3;IL4I1;LPIN1;E2F3;WASL;NOD2;RNF4;RBMX;TCF7L2;TCF4;NCOA3;POU2F2;NOS1;AKNA;MED25;HDAC5;MED12;TCF3;CAMK1;NFIA;JUN;IRF5;IRF2;PARK7;SETD3;FGFR2;XRCC6;TOX2;RFXANK;AGO1;HIF1A;NFIX;TWIST1;CXCL10;SLC11A1;NCOA2;GLYR1;YY1;SERPINE1;GLMP;BMP2;ZNF76;TP53;STAT5B;DDX3X;KDM1A;ARRB1;CSRNP2;ARF4;MITF;TRAF6;TBL1XR1;STAT6;PIN1;FADD;KAT6B;PPRC1;PAXIP1;ACTR2;RXRG;TOX3;PRDM4;NLRC5;TGFB1;WBP2;KLF5;ZC3H12A;MCRS1;FGF1;RNF111;GRHL3;TNIP1;NFIC;LMO2;SMARCA4;PPP3CB;TFAP2C;ZMIZ1;TLR9;CDK8;NOTCH1;BPTF;AR;NR2F2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3721035309233558,-1.0451712949809797,0.38675213675213677,0.7676778658696827,1.0,2/17,0.41%,AKAP6;ANK3
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.4128235494263729,1.0446418783189206,0.4049429657794677,0.8569937973246803,1.0,2/13,4.21%,CNOT1;MOV10
prerank,positive regulation of protein catabolic process (GO:0045732),-0.26310564025740313,-1.0446346148662757,0.36828644501278773,0.7682897630441451,1.0,26/84,20.66%,APOE;WWP1;HECW2;HECW1;APC2;NEDD4L;FAF1;BARD1;GSK3B;PRKN;PLK2;GPC3;AXIN1;ATG7;MSN;ADRA2A;SNX9;SH3D19;FOXO1;RILP;NKD1;TNFSF12;OAZ1;TIPARP;EZR;DTL
prerank,connective tissue development (GO:0061448),-0.3080774671398356,-1.0445994011635884,0.3710843373493976,0.7674204305046144,1.0,6/35,8.98%,ZBTB16;CD44;SULF2;SOX5;PGRMC2;ATP7A
prerank,positive regulation of insulin secretion (GO:0032024),0.32482445168546514,1.0444586759593828,0.3739130434782609,0.8567249403656817,1.0,9/36,12.25%,ACSL4;C2CD2L;PLA2G6;TRPM4;SLC30A8;GPER1;TM7SF3;STX4;LRRC8A
prerank,negative regulation of phosphatase activity (GO:0010923),0.349505695855099,1.044381755105734,0.3719298245614035,0.8560950180294287,1.0,6/25,15.04%,ZCCHC9;CRY2;GPATCH2;SH2D4A;SEMA4D;MASTL
prerank,sensory perception (GO:0007600),-0.28921395920758447,-1.0443692595743186,0.3644859813084112,0.7671138389717691,1.0,10/45,12.31%,PCDH15;CCR2;TMEM150C;MME;OPRM1;NIPSNAP1;CCL2;CHRNA4;KCNK4;CLRN1
prerank,histone H3-K36 demethylation (GO:0070544),0.44528790910449056,1.0441760064045007,0.43087971274685816,0.8558736704652775,1.0,7/10,27.63%,KDM4A;KDM7A;KDM8;PHF8;KDM2A;KDM2B;KDM4B
prerank,epithelial cell migration (GO:0010631),-0.30322225362517585,-1.0438231963863918,0.3952380952380952,0.7677415196239659,1.0,11/37,19.47%,DPP4;PLXND1;FSTL1;GIPC1;CDH13;ZEB2;KANK1;PLEKHG5;KIT;TNFSF12;STARD13
prerank,positive regulation of cell death (GO:0010942),0.28756279955488134,1.0437535966965434,0.375609756097561,0.8563050109248955,1.0,10/59,7.96%,ITGAM;RIPK2;ITGB2;PICALM;EIF4G1;EIF2S1;CLU;C1QA;ACER2;CALCR
prerank,regulation of T cell activation (GO:0050863),0.31145765487692073,1.0432747064484473,0.3831932773109244,0.8569233933147067,1.0,10/42,17.36%,PAG1;SIRPA;CCDC88B;CYRIB;TNFSF8;ABL1;TNFAIP8L2;GPNMB;SPINK5;IL4I1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3836485122486153,-1.0429751348986471,0.3773987206823028,0.7692962407461218,1.0,4/15,13.20%,APOE;ADRA2A;SNX9;SH3D19
prerank,regulation of cholesterol efflux (GO:0010874),-0.32296006295355084,-1.0427514708191121,0.37668161434977576,0.7689525433403975,1.0,7/30,13.58%,PPARG;APOE;PLTP;SIRT1;NFKBIA;ABCA5;YJEFN3
prerank,tRNA wobble uridine modification (GO:0002098),0.4056779766260973,1.042499372724884,0.4072727272727273,0.8584577275705655,1.0,8/14,26.12%,TRMU;CTU2;KTI12;ELP1;MTO1;MOCS3;ALKBH8;TRMT9B
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.3744925336510573,-1.0423650392045423,0.3787878787878788,0.7691822996088978,1.0,6/16,9.88%,ZBTB7B;SIRT1;NAPEPLD;SOX13;FNDC5;PIM1
prerank,pyruvate metabolic process (GO:0006090),0.2909525415021917,1.0423333554500092,0.3723404255319149,0.8581013688049538,1.0,12/52,18.72%,HK2;PFKL;GAPDH;PFKFB2;VDAC1;PGAM1;PGAM4;PCK2;LDHAL6B;SDS;LDHA;ME2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.3147098989538543,-1.042006602502709,0.36507936507936506,0.7692953770620564,1.0,10/30,21.04%,UBR5;TRIP12;RNF169;PARPBP;OGG1;ERCC6;CYREN;SHLD3;RIF1;FANCB
prerank,T cell receptor signaling pathway (GO:0050852),0.2536535045945616,1.0417496460966398,0.3577981651376147,0.8590978831821847,1.0,35/138,20.36%,PAG1;INPP5D;FYB1;RIPK2;FYB2;PIK3R1;PLCG2;LCP2;TNFRSF21;PDPK1;CSK;EIF2B3;TAB2;PSMD3;PIK3CB;EIF2B4;PIK3CD;WNK1;PSMA7;KHDRBS1;RNF31;PSMB3;PSMB9;PSMC2;PSME4;PSMC1;PSMB7;GATA3;PSMB5;TEC;PTPRJ;STOML2;PSMB8;PLCG1;PIK3CA
prerank,Golgi to plasma membrane transport (GO:0006893),0.30007914334622887,1.041685568448283,0.3787878787878788,0.8584313637655898,1.0,23/47,27.03%,CCDC93;MACF1;RAB34;BBS2;LLGL1;GOLGA4;EXOC6;OSBPL5;GGA3;EXOC1;CCDC22;OPTN;KIF13A;EXOC4;EXOC8;ARL3;VPS35L;SYS1;GOLPH3L;PREPL;GOPC;RAB26;VAMP5
prerank,histone mRNA metabolic process (GO:0008334),0.3484216994614433,1.0416103341382899,0.36247723132969034,0.8578068335330439,1.0,4/27,5.34%,NCBP1;SSB;ATM;SNRPF
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.27538140730383515,1.0413619294112253,0.37799043062200954,0.8577276609700121,1.0,23/88,23.12%,SUMO1;SMAD3;PRKCA;CDC42EP2;SPIDR;MTLN;CLU;SLX4;SH3GLB1;PLEK;BMF;TSG101;TAL1;CHMP2A;BCL2L11;GNL3L;STX18;PARK7;SLF2;RHOC;HGS;CHGA;AJUBA
prerank,UV-damage excision repair (GO:0070914),-0.4078186175181866,-1.0413272998937557,0.4022222222222222,0.7702667727296624,1.0,5/12,21.92%,POLA1;SIRT1;XPA;POLD3;DDB1
prerank,B cell proliferation (GO:0042100),-0.36910276318534574,-1.0413043015437844,0.39065817409766457,0.7693740689746638,1.0,9/17,28.98%,CD40;CR2;CTPS1;BCL2;MS4A1;GAPT;CD19;RASGRP1;HSPD1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3034612141997532,1.0410079503439713,0.37435008665511266,0.8579650438926194,1.0,21/48,30.14%,POLR2H;SF3B1;PADI2;SMARCA5;ZMIZ2;ARID1A;POLR1C;ATAD2;BAZ1B;ELOF1;POLR2E;DEK;POLR1G;POLR1E;WBP2;ZMIZ1;KAT2B;EP300;POLR1A;TBP;POLR1B
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3755615692230849,1.040926212887819,0.39201451905626133,0.8573631267519752,1.0,4/20,9.82%,IL18;TLR4;LYN;MTDH
prerank,regulation of T cell proliferation (GO:0042129),0.28742594653728687,1.0406086365810108,0.3741830065359477,0.8574981815452858,1.0,12/61,14.40%,CCDC88B;AIF1;TNFRSF21;NCKAP1L;TNFRSF13C;IL6ST;PDCD1LG2;IL12B;CD86;TNFSF8;PNP;GPNMB
prerank,positive regulation of vasculogenesis (GO:2001214),0.4450019867212826,1.040498373660448,0.4169811320754717,0.8569949998638322,1.0,3/10,9.60%,CD34;ASB4;CEACAM1
prerank,protein polyglutamylation (GO:0018095),-0.41655837861470346,-1.040453327588847,0.41294642857142855,0.7709631487049975,1.0,3/11,6.22%,TTLL11;TTLL7;TTLL5
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.34187947835269966,1.0402346140306287,0.39590443686006827,0.8569685487356274,1.0,8/30,15.49%,HPS4;CSNK2A2;SH3GLB1;LEPROT;USP36;PINK1;RNF31;TOMM7
prerank,positive regulation of proteolysis (GO:0045862),-0.2837437972393573,-1.0400400474026383,0.38190954773869346,0.7712221639076913,1.0,11/55,13.20%,NLRC4;CCBE1;APOE;CTSC;CYFIP2;RCN3;BTRC;BAK1;ADRA2A;SNX9;SH3D19
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3800841100040682,1.0398331841706472,0.4040590405904059,0.8573911621523701,1.0,4/19,11.79%,RAC1;MAP4K4;LIMS1;ABL1
prerank,zymogen activation (GO:0031638),0.31328468750814986,1.0397913600242772,0.41308089500860584,0.8566547316854483,1.0,6/39,4.68%,KLK2;VSIR;RIPK2;ASPH;LGMN;F12
prerank,modified amino acid transport (GO:0072337),-0.37639488127691867,-1.0396902136301733,0.41200828157349895,0.7712755440943322,1.0,8/15,33.77%,MGST1;SLC46A1;SLC1A4;SLC5A6;FOLR2;FOLR1;SLC6A13;SLC25A32
prerank,regulation of RNA splicing (GO:0043484),0.2799246260503075,1.039410015733623,0.3873015873015873,0.8570174012943936,1.0,14/69,12.16%,SNRNP70;SON;CLK1;QKI;PIK3R1;JMJD6;FUS;U2AF2;HNRNPH1;ESRP1;KHDRBS1;CLK4;RBM39;TRA2B
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.2751497440131986,1.0393832400002516,0.3853503184713376,0.8562395560297348,1.0,19/78,16.41%,NUMB;MRAP;ABI3;PIK3R1;PICALM;PDPK1;RHOQ;GPER1;APPL1;AKAP5;CLN3;ZDHHC5;LDLRAP1;STX4;CIB1;AKT1;LRP1;TMEM59;WNK3
prerank,coenzyme A metabolic process (GO:0015936),0.4066607317619726,1.0389953793507916,0.4278169014084507,0.8566089513385736,1.0,4/14,11.48%,PPCDC;PANK4;CROT;PANK2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3741186713846306,-1.0387017060342782,0.39655172413793105,0.7732290574677161,1.0,3/16,5.88%,AUTS2;RASGRF1;CADM4
prerank,transepithelial transport (GO:0070633),0.3945723648136233,1.03843512512106,0.3889908256880734,0.8575147453615071,1.0,8/15,31.60%,SLC1A3;CXADR;GPLD1;SLC26A6;BEST1;ABCG2;SLC23A2;SLC23A1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.4394965382688398,1.0384123861599286,0.4046692607003891,0.8567437421074897,1.0,1/10,1.21%,DNMT3A
prerank,retrograde axonal transport (GO:0008090),-0.3663250606932544,-1.0382753601908539,0.41509433962264153,0.7735271627528099,1.0,2/16,1.63%,DLG2;ACTR10
prerank,ether lipid metabolic process (GO:0046485),0.39485579633737644,1.0382090467998986,0.4066147859922179,0.8565403981774133,1.0,3/14,5.84%,AGMO;TMEM86B;PLA2G6
prerank,positive regulation of cell migration (GO:0030335),0.23394167162729057,1.038142323165145,0.32305433186490456,0.8559180396101446,1.0,52/253,18.77%,TGFBR1;NUMB;ARHGEF2;RREB1;CSF1R;ITGA6;SEMA3B;VSIR;AIF1;MAP4K4;PRKCA;FERMT3;SRC;PLCG2;IGF1R;ATM;TRADD;NCKAP1L;SEMA4C;SPRY2;PDGFB;GPER1;TWIST2;MIA3;PTK2B;GCNT2;TJP1;PIK3CD;PDCD10;SUN2;STX4;MTOR;SEMA4D;ROCK2;SEMA4G;CIB1;MAPRE1;INSL3;MGAT5;GPNMB;CCAR1;LAMC2;DDR2;THBS1;MIEN1;SMO;CLDN1;C1QBP;ADAM10;CRKL;CCL24;DMTN
prerank,cardiac ventricle morphogenesis (GO:0003208),0.30844888401826837,1.038038223614923,0.4098939929328622,0.8553509161916737,1.0,6/41,7.87%,TGFBR2;SMAD7;HEYL;MEF2C;CPE;MYL3
prerank,intermediate filament organization (GO:0045109),0.3793853882353715,1.0380184690268475,0.4278169014084507,0.8545691297359601,1.0,4/17,16.80%,DSP;KLHL24;BFSP2;GFAP
prerank,ncRNA transcription (GO:0098781),0.41636581819881674,1.0378855519737835,0.4111111111111111,0.8541362042595333,1.0,6/13,25.90%,BRF1;RPAP2;GTF3A;POLR1G;SNAPC2;SPIN1
prerank,positive regulation of phagocytosis (GO:0050766),0.30064966863454623,1.0374610668179887,0.36689419795221845,0.8546931972778551,1.0,6/47,7.35%,MERTK;SIRPA;CAMK1D;NCKAP1L;PLA2G5;GATA2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.2954541762392327,1.037391055001944,0.40134907251264756,0.8540717546894022,1.0,18/55,24.10%,TGFBR1;CRADD;DDIT3;AGTR2;GPER1;BMF;TNFRSF12A;TRAF7;BCL2L11;PMAIP1;PYCARD;TRIM39;TP53;CYLD;FADD;S100A9;S100A8;AGT
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.39126348897294616,-1.037352282936886,0.41561181434599154,0.7751771103165839,1.0,4/14,15.53%,ANK2;ACTN2;ATP1B3;KCNIP2
prerank,cellular response to ATP (GO:0071318),0.40511201590266344,1.0369557800388887,0.42342342342342343,0.8546446278281825,1.0,4/14,19.19%,P2RY12;SSH1;TAF1;CIB2
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3815788228768453,1.0367903055375807,0.3927272727272727,0.8542829218876181,1.0,10/18,28.37%,PSEN2;PSENEN;CLN3;LDLRAP1;APH1B;ADAM10;ADAM17;APH1A;TMCC2;ABCG1
prerank,inflammatory response (GO:0006954),0.2417753534438165,1.0364458039745506,0.3748148148148148,0.8545118355069274,1.0,24/195,8.27%,BLNK;F11R;IL18;CSF1R;PJA2;LGALS9;RAC1;AIF1;TLR4;RIPK2;ITCH;ITGB2;AGTR2;PIK3CG;LOXL3;AFAP1L2;TAC4;SELE;PLA2G4B;CCR7;NOS2;VNN1;FUT7;CXCL1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.3117727621265049,-1.036294710114209,0.4009111617312073,0.77732133026054,1.0,9/31,16.29%,DCUN1D2;UBE2N;RPS2;ARRDC3;BTRC;AXIN1;UBE2C;DCUN1D3;MAGEC2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.29296098246876356,-1.0362914191777142,0.4043062200956938,0.7763738369756866,1.0,11/39,15.69%,SPOCK1;CORO1C;JAG1;CASK;SPRY4;ITGB1BP1;KANK1;CDKN2A;RCC2;EFNA5;CX3CL1
prerank,response to alcohol (GO:0097305),0.3421137051830928,1.0361843430041684,0.38986013986013984,0.8544753993485532,1.0,5/27,11.62%,TGFBR1;TGFBR2;HSD3B2;CCR7;SOD1
prerank,regulation of interleukin-4 production (GO:0032673),0.36476312622545787,1.0360449351240664,0.40574506283662476,0.8540703247605848,1.0,7/21,16.45%,LGALS9;DDIT3;SLC7A5;CD86;HAVCR2;NLRP3;GATA3
prerank,transcription by RNA polymerase II (GO:0006366),0.23033714972164537,1.0360000785766923,0.37101063829787234,0.8533610697843561,1.0,74/305,21.60%,MAML3;RREB1;ARRB2;NELFB;POLR2H;SRRT;NCBP1;PPARD;DDX5;HDAC10;GTF2H2;DEAF1;CSTF2;CDK9;INTS11;NRBP1;POLR2D;SNRPF;TTF2;CTR9;RNMT;PABPN1;RXRB;POLR2J;PKNOX1;PAX1;CPSF1;NR2F1;NOTCH4;INTS3;DTX1;TAF6;TAF12;MAML2;ERCC2;RPAP2;HSF2BP;E2F2;TAF8;ELL2;GTF2I;SETD2;MBD1;NELFE;NOTCH3;TAF4;MED4;MED18;C5AR1;POU2F1;NR1H2;PCF11;RPAP1;E2F3;TAF1;RBMX;FIP1L1;POU2F2;TAF10;ELOF1;CEBPD;HDAC5;POLR2E;POLR2I;INTS8;NABP1;DEK;NFYA;IRF9;NFIX;MED7;MNT;TAF5;TEAD3
prerank,actin filament capping (GO:0051693),-0.3597180924044159,-1.0358894324607235,0.38222222222222224,0.7756686988611996,1.0,3/18,2.41%,EPS8;ADD3;GSN
prerank,barbed-end actin filament capping (GO:0051016),-0.3597180924044159,-1.0358894324607235,0.38222222222222224,0.7756686988611996,1.0,3/18,2.41%,EPS8;ADD3;GSN
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.3062201037505756,-1.035796378964136,0.4069264069264069,0.7750038469884382,1.0,5/32,9.39%,RPL30;PF4;ROMO1;CAMP;RNASE3
prerank,regulation of transferase activity (GO:0051338),0.3842019091342583,1.0357165427890402,0.41530054644808745,0.8534673273479453,1.0,9/17,31.90%,ATM;PPP1R3F;JMJD8;BAG5;NLRC5;PARP4;FEM1A;EMP2;HMBOX1
prerank,renal filtration (GO:0097205),-0.43394348782033904,-1.0354920989110328,0.4095634095634096,0.7749767330960073,1.0,4/10,13.84%,SULF2;TMEM63C;XPNPEP3;JCHAIN
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3099227880973708,-1.0353829626015443,0.4110576923076923,0.7743446701573016,1.0,7/34,10.06%,CTNNA1;LATS1;NEDD4L;ILRUN;RIPOR2;GSK3B;ACTN2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.278910686687554,1.0351394009215968,0.39344262295081966,0.8544301814879192,1.0,14/72,14.11%,SUMO1;CFLAR;IRAK2;OTULIN;TRADD;TRIM44;ABCE1;PTPN1;IFNGR2;PTPN11;AXL;SPPL2B;RNF31;RUNX1
prerank,glycerol metabolic process (GO:0006071),-0.4201146524491964,-1.034972911137107,0.42403628117913833,0.7746151175760904,1.0,5/10,24.72%,COQ2;GK;ANGPTL3;GOT1;TKFC
prerank,cardiac conduction system development (GO:0003161),-0.3332849251194966,-1.0348732577911655,0.37727272727272726,0.7739838326048296,1.0,9/24,24.57%,CACNA1G;HEY2;BMP4;NOTCH2;SMAD1;GJA5;MSX1;HCN4;SHOX2
prerank,nuclear envelope organization (GO:0006998),-0.3481845306136268,-1.034124448961113,0.4376417233560091,0.7752506722887096,1.0,8/20,26.01%,REEP3;TOR1A;DMPK;REEP4;CTDNEP1;NUP155;LEMD2;EMD
prerank,myoblast fusion (GO:0007520),-0.40588417919960673,-1.033433273509504,0.41739130434782606,0.7763382670612101,1.0,3/12,7.49%,ADGRB3;KCNH1;ADAM12
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2810327384927474,1.0331715575294624,0.3782894736842105,0.859722316439044,1.0,14/69,10.36%,CSF1R;NYAP1;PLCL1;PI4KB;GAB2;PIK3R1;SIRT2;IGF1R;PIK3CG;ZFP36L1;PLCL2;PIK3CB;PIK3CD;PIK3C3
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.3604563924831975,-1.033085883791214,0.3797752808988764,0.7763735947725804,1.0,4/17,5.85%,CD74;MCU;RIPOR2;DNM1L
prerank,outflow tract septum morphogenesis (GO:0003148),-0.33523290728013494,-1.0326798709570102,0.4052132701421801,0.7766652045792778,1.0,2/24,0.85%,ZFPM2;ROBO1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2181934773991845,1.0326198451667719,0.36036036036036034,0.8606061518759754,1.0,126/532,20.81%,INPP5D;ITGAM;IL18;CSF3R;CSF1R;IL1RL2;PRKACA;MAP3K3;GAB2;TRAF5;IRAK2;SRC;RIPK2;PRKCD;PYDC1;HNRNPDL;PIK3R1;TRIM5;CASP1;ITGB2;STX1A;RPS6KA5;CD27;FSCN1;IL6R;TRADD;EBI3;MMP2;TNFRSF25;CSK;TNFRSF13C;MAP3K8;CTR9;TAB2;IL6ST;PSMD3;TNFRSF13B;IL12RB2;DUOX1;CNTF;PDGFB;NOS2;EDN2;IL12B;EDA2R;CTF1;CXCL1;PIK3CB;PTK2B;CD86;APPL1;IL33;IFNGR2;UBC;RPS27A;CEACAM1;TNFSF13B;TNFSF8;TNFRSF17;PIK3CD;PTPN11;PSMA7;MT2A;MID1;TRIM62;IL10RA;ZEB1;LIMS1;SNRPA1;SOD1;BAG4;STX4;IL18BP;SOCS6;TXLNA;IRF8;IL1RL1;PELI2;AKT1;IRF3;TYK2;PSMB3;PSMB9;IL10RB;PSMC2;COMMD7;IL1R2;GHR;RPS6KA4;IL7R;TNFRSF12A;TNIP2;ISG20;POU2F1;PSME4;PSMC1;IL20RA;PSMB7;GATA3;EGR1;CCR5;BCL2L11;IL4R;AIM2;NOD2;PSMB5;TEC;PTPRJ;CRKL;CDKN1B;CCL24;CEBPD;VAV1;TNFRSF14;PYCARD;IRF5;MAP3K14;IRF2;ADAM17;PSMB8;PIK3CA;MYD88;IRF9;HIF1A;TWIST1;CXCL10
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.2715127753037475,-1.03171464526093,0.3712737127371274,0.7785525521848028,1.0,16/55,17.98%,GPC6;LYVE1;CD44;GPC5;SDC3;HGSNAT;HMMR;CSPG4;HSPG2;GPC3;VCAN;AGRN;FUCA1;GPC4;SDC4;LUM
prerank,cellular response to tumor necrosis factor (GO:0071356),0.245034125086215,1.0315714523086887,0.3821752265861027,0.8629721858019274,1.0,46/175,20.14%,ARHGEF2;NFE2L2;NPNT;TRAF5;PYDC1;CD27;TRADD;TNFRSF21;TNFRSF25;ZFP36L1;TNFRSF13C;ZFP36L2;PSMD3;TNFRSF13B;ASAH1;EDA2R;GPER1;PTK2B;BRCA1;TNFSF13B;TNFSF8;TNFRSF17;PSMA7;DHX9;LIMS1;BAG4;CIB1;AKT1;PSMB3;PSMB9;PSMC2;COMMD7;TNFRSF12A;PSME4;PSMC1;PSMB7;GATA3;AIM2;PSMB5;INPP5K;CCL24;TNFRSF14;PYCARD;MAP3K14;ADAM17;PSMB8
prerank,negative regulation of synaptic transmission (GO:0050805),-0.34455169840105054,-1.0315340182551591,0.41284403669724773,0.778164824462,1.0,5/23,8.56%,LRRK2;SLC24A2;ATAD1;MTMR2;PLK2
prerank,visual perception (GO:0007601),0.2719583724580189,1.0312415687026841,0.40268456375838924,0.8631325234170278,1.0,15/84,13.44%,CRYBB1;PAX6;EFEMP1;RP2;MYO7A;DRAM2;RABGGTA;RD3;EYA3;TULP2;BBS2;REEP6;COL11A1;PAX2;ATXN7
prerank,purine nucleotide biosynthetic process (GO:0006164),0.4224929679216374,1.031190383329508,0.43853211009174314,0.8624841767028031,1.0,8/12,30.61%,MTHFD1;PRPS1L1;PRPS1;GART;PRPSAP2;PRPSAP1;ADSL;AMPD2
prerank,protein O-linked mannosylation (GO:0035269),-0.35656216752011394,-1.0309956886773162,0.43544857768052514,0.7788213660229084,1.0,9/18,21.10%,DPM2;CRPPA;TMTC1;POMT2;TMTC4;POMGNT2;FKTN;TMTC2;TMTC3
prerank,copper ion transport (GO:0006825),-0.4281702778140853,-1.0309057190046256,0.42298850574712643,0.7781240273540729,1.0,4/11,17.57%,ATP7A;SLC31A2;CUTC;STEAP4
prerank,positive regulation of double-strand break repair (GO:2000781),0.31069032273552266,1.0307415230813555,0.39327731092436974,0.8629983636547067,1.0,9/39,13.04%,WDR48;SPIDR;MGMT;FUS;KMT5C;MMS19;SPIRE1;DTX3L;SHLD2
prerank,response to exogenous dsRNA (GO:0043330),0.37997173133077256,1.030701035524225,0.42987249544626593,0.8622758342794153,1.0,5/18,15.65%,ZCCHC3;CGAS;DHX9;MAVS;TICAM1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.36898892249017706,-1.0306436963972943,0.3934065934065934,0.7779571525030555,1.0,7/17,18.10%,VIM;WNT4;CREB3L1;RGCC;SCX;SERPINF2;BMP4
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.28761404321618117,1.030334871134487,0.39072847682119205,0.8626127244664105,1.0,11/64,13.63%,NELFB;POLR2H;NCBP1;GTF2H2;CDK9;POLR2D;CTR9;POLR2J;ERCC2;SETD2;NELFE
prerank,ESCRT complex disassembly (GO:1904896),0.4451270406557554,1.030046618761653,0.4306569343065693,0.861832231113406,1.0,7/10,37.12%,CHMP1A;CHMP2A;IST1;CHMP7;VTA1;CHMP5;VPS4A
prerank,ESCRT III complex disassembly (GO:1904903),0.4451270406557554,1.030046618761653,0.4306569343065693,0.861832231113406,1.0,7/10,37.12%,CHMP1A;CHMP2A;IST1;CHMP7;VTA1;CHMP5;VPS4A
prerank,spermatid development (GO:0007286),0.329866743996428,1.0300163873867552,0.420863309352518,0.8610686619549307,1.0,7/32,14.85%,JAM2;PIWIL1;RIMBP3;RNF8;CIB1;CEP57;NECTIN2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.44279136932227847,1.0298182442799904,0.4316546762589928,0.8607881102330399,1.0,2/10,7.68%,LGALS9;PDCD1LG2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.35580701725275565,1.0296332869224898,0.4059233449477352,0.8605344484045381,1.0,6/24,7.84%,TWF2;RAC1;PIK3R1;FSCN1;AKIRIN1;AVIL
prerank,regulation of ERAD pathway (GO:1904292),0.42784572173338303,1.0295667321685493,0.4446529080675422,0.8599215536803141,1.0,4/11,18.01%,BAG6;USP25;USP19;TMEM259
prerank,peptidyl-lysine modification (GO:0018205),0.26482292938557456,1.0292387612952467,0.3934169278996865,0.8601250131963611,1.0,20/99,16.94%,SUMO1;SENP2;HDAC10;UBA2;RANBP2;SIRT2;STX1A;VIPAS39;LOXL3;NUP42;TRPM4;NUP35;NUP50;PIAS2;PIAS3;SEH1L;NUP62;NUP107;TOPORS;NUP88
prerank,bile acid and bile salt transport (GO:0015721),0.3467082118894924,1.0289987128609481,0.4181184668989547,0.8600809433778493,1.0,1/24,0.03%,SLCO2B1
prerank,apoptotic process (GO:0006915),-0.21973938605527854,-1.028737809511792,0.3385093167701863,0.7825427347603204,1.0,50/203,17.92%,HIP1;ZBTB16;DCC;TRPC5;APP;PAEP;ADRA1A;SCN2A;PAK5;CYFIP2;RTN4;DAP;IAPP;DAPK1;PPIA;MYC;NDUFS1;DIABLO;PAWR;JAK2;LIG4;CD2;NFKBIA;RAF1;DMPK;ERBB3;BID;BAK1;AKAP1;DDIT4;MAL;CDIP1;PAX3;PPP2R1A;AHR;CSRNP1;PLAGL1;EGLN3;FOXO1;CHEK1;MELK;EFNA5;BCL2;SEMA6A;ING4;JADE1;YARS1;TNFSF12;BNIPL;MDM2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.30680647965542973,-1.0283798326076303,0.3744186046511628,0.7827146438443013,1.0,7/34,10.62%,PTPN12;PTPRT;PTPN22;DUSP16;TNS2;PTPN2;DUSP10
prerank,negative regulation of developmental growth (GO:0048640),0.33328944879577266,1.0282329879112053,0.41589648798521256,0.8616058316022361,1.0,10/30,19.20%,ULK2;FGF13;DIP2B;CDKL3;BBS2;RTN4R;ULK1;PTCH1;CDKN1B;MAG
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.31017747876570617,1.0281209723205718,0.4087719298245614,0.8610845792041227,1.0,10/42,15.58%,WDR48;SPIDR;FUS;MMS19;CGAS;PPP4R2;SETD2;SHLD2;FBH1;UBQLN4
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.29803415790129134,1.027709180892486,0.40695652173913044,0.8615878586799556,1.0,7/49,5.50%,LDLRAD4;PMEPA1;SRC;CPTP;PYDC1;IMPACT;CLU
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.39979707238548234,-1.0276498024169627,0.42691415313225056,0.7838874227651907,1.0,7/12,26.68%,EXTL2;GMDS;GFPT2;UGP2;CSGALNACT1;SLC35A3;FUT8
prerank,regulation of cytokinesis (GO:0032465),-0.26115818973953525,-1.0274638164620116,0.40310077519379844,0.783503684702607,1.0,17/78,12.90%,CUL3;KIF23;CDC42;RACGAP1;PKP4;UVRAG;CALM1;GIPC1;KIF14;PLK2;KLHL13;AURKB;PRC1;MAP9;E2F7;KIF20A;PRPF40A
prerank,intracellular pH reduction (GO:0051452),0.32867120240082237,1.0272824286360311,0.4297520661157025,0.8620678778748231,1.0,10/33,17.63%,ATP6V0B;ATP6V0A2;TCIRG1;RAB39A;ATP6V0A4;ATP6V1D;RAB20;ATP6V0E2;GPR89A;GPR89B
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3331892999155891,-1.0269791543298523,0.4095860566448802,0.7840103454001549,1.0,7/23,16.52%,ELOVL7;ACSL3;HACD1;ELOVL5;ACSF3;FAR2;FAR1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.36321565719816284,1.0269468595214917,0.4058721934369603,0.8622855324177614,1.0,4/20,10.98%,TMEM35A;PSMG1;CLU;NDUFAF1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.28559726517788137,1.0267181300745418,0.39864864864864863,0.8621999805091848,1.0,24/62,24.79%,POLR2H;RANBP2;EIF4G1;NUP42;POLR2D;SEC13;POLR2J;NUP35;NUP50;DHX9;SEH1L;WTIP;NUP62;NUP107;NUP88;NUP188;POLR2E;POLR2I;AGO1;NUP214;AJUBA;PUM1;TGFB1;ELAVL1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.22066800970025927,-1.0266659476774482,0.37267080745341613,0.783895804004588,1.0,49/214,17.85%,CD74;CD44;EGFR;CD36;APP;GAREM1;HTR2C;ADRA1A;FGF10;DSTYK;APOE;CCR1;ROR1;PRKCZ;PTPN22;NTRK2;CCL4;RAPGEF2;NTRK3;FN1;LMO3;PDGFD;STYX;P2RY1;HTR2B;PDE8A;ERBB4;PTPN2;OPRM1;CCL2;DUSP10;DUSP26;FGFR3;ZDHHC17;GLIPR2;ITGB1BP1;FAM83D;TIMP3;CCL5;CX3CL1;SEMA6A;TEK;HMGB1;FFAR4;SERPINF2;SEMA7A;ICAM1;PDGFA;CCL14
prerank,protein glycosylation (GO:0006486),0.25568562481283796,1.0262298813605555,0.37681159420289856,0.8628258987519957,1.0,30/125,15.64%,ST3GAL6;LARGE1;B3GNT2;MGAT4A;ST3GAL5;TRAK1;ALG12;MPI;GFPT1;ALG6;POMGNT1;DPM3;MGAT2;GALNT10;POMT1;B3GNT4;FUT7;TET3;EOGT;GCNT2;GALNT1;MGAT1;NPC1;ALG2;ST3GAL3;MAN1C1;MGAT5;ALG5;POFUT1;GALNT7
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.36881358838011097,-1.0260044573383014,0.4118942731277533,0.784853941461935,1.0,7/16,20.83%,KDM4D;KMT5B;WRAP53;PARP3;SHLD3;SETMAR;RIF1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.4102331666863735,1.0258271531730014,0.442,0.8632729617242071,1.0,3/13,10.36%,DNAJB9;PTPN1;BFAR
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.39999899553910057,1.0258269918821326,0.4208566108007449,0.8624487923939326,1.0,6/14,23.02%,ABCD2;MTLN;AKT1;ABCD1;TWIST1;TYSND1
prerank,amino sugar metabolic process (GO:0006040),-0.43046513353230526,-1.0258065503078662,0.4190064794816415,0.784517093974935,1.0,5/10,24.92%,ST3GAL1;EXTL2;GFPT2;CSGALNACT1;SLC35A3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3907337659409281,1.0256139771579509,0.41025641025641024,0.8622805353700689,1.0,7/15,24.31%,POP1;KHNYN;ZC3H12B;ZC3H12C;NUDT16;RNASEH1;ZC3H12A
prerank,lipid phosphorylation (GO:0046834),-0.41746212267542293,-1.0255955385143705,0.4251101321585903,0.7841692178452344,1.0,3/10,10.11%,DGKB;DGKI;DGKH
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.34314623078032835,1.0253723577523974,0.425414364640884,0.862258938704059,1.0,3/25,2.58%,OPHN1;CSNK2A2;CSNK2A1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.3404281538533137,-1.0252220582854037,0.3983402489626556,0.7842441597680431,1.0,7/21,22.63%,GSK3B;LRP6;AXIN1;CTNNB1;WNT8B;FRAT1;CSNK1A1
prerank,establishment of endothelial barrier (GO:0061028),-0.3217064726622548,-1.0247375509397967,0.41797752808988764,0.7847699217081832,1.0,12/29,21.71%,PDE4D;RAPGEF2;AFDN;RAB1B;MARVELD2;MYADM;MSN;PDE2A;PECAM1;ICAM1;EZR;PPP1R16B
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.2938130643508433,1.0246690134930236,0.4073455759599332,0.8635627954511164,1.0,14/54,20.56%,ETS1;MEF2C;PRKCA;AGTR2;PDPK1;GATA2;PDGFB;MAPK14;AKT1;PRCP;THBS1;ADAM17;PLCG1;HIF1A
prerank,protein hydroxylation (GO:0018126),0.3964804360778807,1.0245821113711047,0.4110898661567878,0.8630028629363324,1.0,4/15,11.03%,ASPH;VIPAS39;P3H2;JMJD7
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.29580629015616206,1.0244011949957017,0.40301003344481606,0.8627118384991106,1.0,7/54,4.52%,CFLAR;OTULIN;PYDC1;GPS2;CASP1;RFFL;TRADD
prerank,cellular response to leucine starvation (GO:1990253),0.43455034130798487,1.0243737483798883,0.44814814814814813,0.8619744309496746,1.0,4/10,15.66%,IMPACT;MTOR;GCN1;SESN1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.33365390089944275,-1.0237244765064624,0.40842105263157896,0.7867590192834054,1.0,7/25,11.16%,CTNNA3;ITGA4;NINJ1;ITGB7;CD2;CD200R1;VCAM1
prerank,N-glycan processing (GO:0006491),0.3719824827729048,1.0235170423516693,0.41798941798941797,0.8638264706089619,1.0,7/18,20.33%,PRKCSH;MGAT4A;GANAB;MAN1C1;MAN2A2;MAN1B1;MGAT4B
prerank,macroautophagy (GO:0016236),0.25369922596871336,1.0234311525877573,0.4176829268292683,0.8632712865009036,1.0,43/118,26.38%,NBR1;ATG14;CSNK2A2;CSNK2A1;SRC;HDAC10;EPG5;VIPAS39;TCIRG1;RB1CC1;ULK3;CLN3;PIK3C3;ATG101;VPS37A;PINK1;ATG5;VPS36;VPS37D;ULK1;VDAC1;VAMP7;TSG101;TOMM7;EI24;CHMP2A;KLHL3;MTMR14;LAMP2;MFN2;PIP4K2B;HGS;TOMM20;DYNLL1;GABARAPL1;TOMM70;ATG12;RUBCNL;PRKAB2;STAM2;TBC1D5;LIX1;ATG10
prerank,COPII vesicle coating (GO:0048208),-0.2664493720216582,-1.0232669601240256,0.3891625615763547,0.785287133754789,1.0,15/61,14.75%,CUL3;GRIA1;CTSC;GOSR2;SAR1B;NAPA;RAB1B;SEC23A;PPP6C;TRAPPC1;SCFD1;TMED2;SEC24C;SEC24B;SEC24D
prerank,vesicle coating (GO:0006901),-0.2664493720216582,-1.0232669601240256,0.3891625615763547,0.785287133754789,1.0,15/61,14.75%,CUL3;GRIA1;CTSC;GOSR2;SAR1B;NAPA;RAB1B;SEC23A;PPP6C;TRAPPC1;SCFD1;TMED2;SEC24C;SEC24B;SEC24D
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2664493720216582,-1.0232669601240256,0.3891625615763547,0.785287133754789,1.0,15/61,14.75%,CUL3;GRIA1;CTSC;GOSR2;SAR1B;NAPA;RAB1B;SEC23A;PPP6C;TRAPPC1;SCFD1;TMED2;SEC24C;SEC24B;SEC24D
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3090287080576433,1.0232451395647062,0.41594454072790293,0.8630432753945806,1.0,5/41,6.10%,SIRPA;VSIR;LGALS9;TLR4;CD34
prerank,lung epithelium development (GO:0060428),-0.4197289369773391,-1.0230851209387481,0.4225663716814159,0.7848649473420086,1.0,5/10,23.98%,FGF10;RCN3;BMP4;GRHL2;PKD1
prerank,histone exchange (GO:0043486),-0.29002568003520424,-1.022457897030433,0.3883495145631068,0.7857496281082154,1.0,10/37,18.78%,CENPP;KNL1;CENPT;MIS18BP1;NASP;ACTR6;CENPW;NPM1;CENPS;RBBP7
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3774034472726502,-1.0222795425963738,0.4037122969837587,0.7853524813676741,1.0,3/15,3.91%,CD36;MSR1;PF4
prerank,positive regulation of transport (GO:0051050),-0.25215702632771175,-1.0220830645685224,0.412532637075718,0.7849597818913913,1.0,21/85,15.02%,DAB2;CD47;APOE;NEDD4L;ACSL3;SGK2;ACTB;GSK3B;CYBA;ZNF205;GPC3;ANXA2;BID;SPAG5;BAK1;CD151;TFR2;IL2RB;SNCA;CBLL1;FCGR2B
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3206092837330287,1.0219891909401326,0.4214162348877375,0.866090998774161,1.0,11/33,22.14%,PPP6R3;CTC1;TNKS1BP1;DCLRE1B;TERF1;RFC1;NHP2;SHQ1;TELO2;ACD;ZBTB48
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3847241607999424,-1.0218618891098565,0.42946058091286304,0.7847245324488629,1.0,3/14,15.69%,LDLR;CD200R1;CX3CL1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2761042170234006,1.021789276506683,0.39344262295081966,0.8659189769323723,1.0,31/72,29.05%,CRADD;CHEK2;CNOT1;RBL2;ATM;PCNA;NBN;ACER2;TNKS1BP1;PRMT1;CNOT3;MDM4;RPS27L;CARM1;AURKA;PLK3;PIDD1;CDKN1B;TFAP4;TP53;PCBP4;PAXIP1;CASP2;CNOT2;EP300;CNOT11;KAT5;BATF;MUC1;FOXM1;CNOT6L
prerank,regulation of protein metabolic process (GO:0051246),-0.29045430350410134,-1.0213847010211092,0.41876430205949655,0.7851723590143118,1.0,13/44,15.45%,APP;APOE;LDLR;NEDD4L;PARL;FAF1;KLF2;SPOP;PLAUR;HSP90AB1;KLF4;FAM83D;MTPN
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.246110447293836,1.0210447563135,0.39907550077041604,0.8673904158531507,1.0,44/146,24.02%,TUBA4A;SDCCAG8;PRKACA;CSNK1E;ODF2;TUBB;CEP164;TUBG1;HAUS7;CNTRL;RAD51B;PSMD3;CENPJ;PSMA7;TUBA1A;CEP63;HAUS2;CEP135;HAUS6;PSMB3;OFD1;PSMB9;CEP57;PSMC2;MAPRE1;AURKA;DCTN2;PSME4;PSMC1;PSMB7;CEP70;FBXL7;PSMB5;ACTR1A;CEP43;CCP110;PSMB8;NDE1;RAD51C;CDC7;CUL1;DYNLL1;CDC25A;HAUS5
prerank,DNA duplex unwinding (GO:0032508),0.29442299257067894,1.020726452026523,0.42356687898089174,0.8675538105252947,1.0,22/50,29.48%,GTF2H2;NBN;CUL4B;UBC;RPS27A;ERCC2;DHX9;DDB2;BLM;MCM2;MCMDC2;SSBP1;CUL4A;MCM6;RECQL;RTEL1;DDX11;RAD23B;RBX1;MCM7;RPA1;DDX1
prerank,iron ion transport (GO:0006826),0.30181281373124214,1.020551064593983,0.4153094462540717,0.8672590582889783,1.0,8/47,10.73%,DNM2;ATP6V0B;SLC40A1;MCOLN1;ATP6V0A2;TCIRG1;ATP6V0A4;ATP6V1D
prerank,histone acetylation (GO:0016573),0.27639217926924886,1.0203825679918255,0.4224683544303797,0.8670076548877412,1.0,27/69,27.89%,BRD8;TAF6L;CPA4;TAF6;TAF12;MRGBP;PHF20;JADE2;MORF4L1;NAA40;ACTL6A;EPC1;NAA50;BRD1;TAF10;WDR5;YEATS2;TAF5;MBIP;TAF5L;KAT6B;MORF4L2;KAT2B;EP300;KAT14;SUPT7L;KAT5
prerank,cardiac cell development (GO:0055006),0.42010396562562813,1.0203601035271186,0.4362549800796813,0.8662721985666864,1.0,2/11,6.12%,SLC8A1;CXADR
prerank,response to muramyl dipeptide (GO:0032495),0.4130471910385151,1.0202134670129612,0.46285714285714286,0.8659225362748638,1.0,2/12,2.82%,ARHGEF2;RIPK2
prerank,protein autoprocessing (GO:0016540),0.38073663084814163,1.0201748732653477,0.4200743494423792,0.8652188807166086,1.0,7/17,22.10%,CASP1;FAM111A;F12;PIDD1;SPRTN;HTRA2;AFG3L2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.42812630891264536,1.0201399037711054,0.4444444444444444,0.8644985477157203,1.0,3/11,10.28%,BAG6;UFD1;AUP1
prerank,mesenchymal cell development (GO:0014031),0.3630247081366087,1.0199736192042854,0.43830570902394106,0.8641543752408998,1.0,4/18,12.31%,HEYL;SOX8;KBTBD8;PDCD6
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4037480051362816,1.0199268278606315,0.40409683426443205,0.8634997472678236,1.0,2/13,8.07%,TPST2;SULT2A1
prerank,regulation of cell junction assembly (GO:1901888),0.33358034688767435,1.019490901131753,0.4119718309859155,0.8640366812027752,1.0,6/27,14.11%,F11R;MEF2C;PRKACA;TJP1;ROCK2;RUNX1
prerank,defense response to virus (GO:0051607),0.26002400042504903,1.0193305426453523,0.40664556962025317,0.8637344924667764,1.0,27/100,20.81%,TLR7;RNASE1;SERINC3;PHB2;TRIM5;MOV10;ATAD3A;ABCC9;ZMYND11;ABCE1;CGAS;G3BP1;RNASE6;SETD2;EXOSC5;SHFL;IRF3;EIF2AK2;MAVS;ISG20;TTC4;PMAIP1;PYCARD;MAP3K14;IRF2;MYD88;CXCL10
prerank,cAMP biosynthetic process (GO:0006171),-0.41942106972530635,-1.0191408061736047,0.4310722100656455,0.7908432989844254,1.0,4/10,7.35%,ADCY2;ADCY5;ADCY3;ADCY8
prerank,regulation of telomerase activity (GO:0051972),-0.2785451517093973,-1.0191225958522716,0.4176904176904177,0.789960617368106,1.0,13/45,14.99%,PARM1;CCT2;MYC;SMG6;MAPKAPK5;XRCC5;AURKB;HSP90AB1;KLF4;WRAP53;PRKCQ;CERS1;CTNNB1
prerank,positive regulation of RNA splicing (GO:0033120),0.33051422844050116,1.0190460537331014,0.4427083333333333,0.8637449831462586,1.0,8/29,17.83%,NCBP1;PIK3R1;U2AF2;TRA2B;DAZAP1;TRA2A;DYRK1A;RBMX
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.3659456478543232,1.0187393839138823,0.4226618705035971,0.8638835745795435,1.0,5/19,14.90%,BIN1;PICALM;CLU;GGA3;FLOT2
prerank,ether lipid biosynthetic process (GO:0008611),0.42053556104694967,1.0186602610325646,0.46096654275092935,0.8633169619771018,1.0,2/10,9.38%,LPCAT2;PLA2G4A
prerank,ceramide biosynthetic process (GO:0046513),0.31409611115166625,1.0186251565534739,0.44194107452339687,0.8626291669791738,1.0,8/40,7.55%,ST3GAL5;CERS3;DEGS2;SPTLC3;SMPD2;ALOXE3;ASAH1;PNPLA1
prerank,regulation of angiogenesis (GO:0045765),0.23670327893067805,1.0181882563880211,0.42484662576687116,0.8631507578531457,1.0,57/192,26.47%,PDE3B;PTPRM;HK2;SMOC2;ETS1;ANXA3;PRKCA;FOXJ2;EGLN1;SPRY2;PDPK1;VEGFB;CD34;SPARC;RHOB;ECSCR;GATA2;BRCA1;CEACAM1;RAPGEF3;MTDH;PIK3CD;APOH;GTF2I;PDCD6;PRKCB;ROCK2;RUNX1;SERPINF1;GPNMB;SARS1;SPINK5;THBS1;AGGF1;ADAMTS1;NAXE;TSPAN12;PLCG1;AGO1;HIF1A;TWIST1;CXCL10;EFNA3;SERPINE1;HGS;BTG1;KLK3;ZC3H12A;FGF1;SYNJ2BP;SULF1;ATP2B4;CTSH;NPR1;RRAS;WNT5A;PGK1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3196544480843271,1.0181009524594364,0.4045936395759717,0.8625864102921693,1.0,7/33,11.24%,EPN1;PDPK1;PIK3CB;CEACAM1;TJP1;DLL1;E2F2
prerank,cation transport (GO:0006812),0.24237300230490932,1.018079068972043,0.42790697674418604,0.8618402651175862,1.0,22/167,8.35%,SLC7A8;KCNA5;FGF13;KCNMA1;KCNK6;SLC36A1;KCNH4;SLC8A1;KCNN1;TRPM6;MCOLN1;CNGB3;SCN4B;ABCC9;TRPM2;NDFIP2;TRPM4;KCNG2;SLC22A2;SLC29A4;ATP1A4;KCNS2
prerank,tryptophan catabolic process (GO:0006569),-0.41777362193494383,-1.017712644580044,0.4199134199134199,0.7932141799865223,1.0,3/11,24.16%,KMO;IDO2;KYAT1
prerank,negative regulation of apoptotic process (GO:0043066),0.2189328004048716,1.0175993810771433,0.39556135770234985,0.8624829200086638,1.0,90/444,19.20%,CX3CR1;MERTK;SON;CAPN3;GREM1;PIM2;SOX8;CFLAR;MAP4K4;RPS6KA1;MEF2C;PRKCA;VHL;CSNK2A2;CSNK2A1;SRC;RIPK2;ITCH;PRKCD;SLC30A10;PIK3R1;PHB2;IGF1R;AATF;PKHD1;CD27;LGMN;ATAD3A;NCKAP1L;SPRY2;MGMT;WDR73;CIAPIN1;SHH;MAEA;IL6ST;YME1L1;CNTF;POU4F1;PSEN2;LAMTOR5;PTK2B;UBC;RPS27A;MTDH;CLN3;TJP1;BFAR;ARAF;APOH;DLL1;AXL;PPT1;XIAP;NUAK2;AREL1;PDCD10;SOD1;BAG4;DPEP1;SEMA4D;PINK1;BNIP2;PAX2;CIB1;AKT1;RETREG1;VIP;QARS1;GCLC;VDAC1;RNF144B;PLK3;NUP62;FANK1;WNK3;THBS1;MIEN1;TOPORS;HYPK;PIDD1;ADAM10;TMBIM6;THOC6;API5;RPL10;HPN;OPA1;MAPK8;MAG
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.4106545518727436,1.0175921944875437,0.447265625,0.8617026908605209,1.0,2/12,5.36%,CHEK2;RAD17
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.32547922787020617,1.0175659222046152,0.43010752688172044,0.8609884291131702,1.0,8/30,15.90%,F11R;RAC1;AKAP13;ABRA;GPR55;GPR18;RTN4R;GPR4
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4127187343196905,1.017506279298727,0.42314990512333966,0.86035956963173,1.0,4/12,11.91%,C2CD2L;PLA2G6;TRPM4;STX4
prerank,xenobiotic transport (GO:0042908),0.37423819982632067,1.0174994405794782,0.4186471663619744,0.8595778738197537,1.0,5/17,14.55%,SLC7A5;SLC22A2;SLC29A4;SLC15A2;GJA1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3887661633228405,-1.0169090041064073,0.42795698924731185,0.7947043323534363,1.0,5/13,9.88%,ZBTB7B;NAPEPLD;SOX13;FNDC5;PIM1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2623744944548132,1.0166756628122202,0.41080196399345337,0.8612071404150411,1.0,36/88,23.46%,CCDC93;DNM2;MYO1B;AP2A1;RP2;SCAMP2;SORT1;AP1M2;AP1S2;LLGL1;EXOC6;OSBPL5;STX4;CLTA;MON2;DOP1B;ACBD3;AP1S1;VAMP7;EXOC1;AP4M1;CCDC22;VPS13C;CHMP2A;EXOC4;AP1B1;EXOC8;KIF16B;ARF1;ARL3;HGS;ARRB1;VPS35L;SYS1;CLINT1;PUM1
prerank,phospholipid biosynthetic process (GO:0008654),-0.30248575164253705,-1.016584757323312,0.4318766066838046,0.7947179634786062,1.0,14/36,28.54%,SGMS1;SGMS2;AGPAT4;MVD;HDHD5;FAR1;DPAGT1;SRD5A3;CPNE6;GPAT2;SPHK2;AGPAT3;FDPS;SAMD8
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.3806096781359987,1.0162400001896372,0.4352517985611511,0.8617331598981136,1.0,4/16,8.04%,MOV10;ZFP36L1;ZFP36L2;RBM24
prerank,regulation of protein export from nucleus (GO:0046825),-0.3295522659637661,-1.0159650317538103,0.43123543123543123,0.7956398312958499,1.0,5/23,7.60%,YWHAE;BAG3;BARD1;GSK3B;SP100
prerank,tRNA modification (GO:0006400),0.28325788396053386,1.0159334453811297,0.4226475279106858,0.8618840451540505,1.0,24/62,26.12%,QTRT1;TRMT6;ANKRD16;AARS2;SSB;THUMPD1;NSUN6;BCDIN3D;QTRT2;CTU2;METTL6;TRMT61A;WDR6;CDKAL1;TYW5;TRDMT1;MTO1;FTSJ1;OSGEP;MOCS3;ALKBH8;METTL2A;METTL2B;TRMT9B
prerank,establishment of apical/basal cell polarity (GO:0035089),0.39429475879962034,1.015766000758936,0.44765342960288806,0.8616208489075354,1.0,2/14,4.26%,OPHN1;FSCN1
prerank,regulation of insulin secretion (GO:0050796),-0.24152488716818973,-1.0155073345268588,0.41160949868073876,0.7960712250135736,1.0,26/101,17.43%,CACNA1E;ITPR1;DPP4;KCNC2;MCU;IRS1;ADCY5;RFX3;MYRIP;PRKN;CACNA1C;ALOX5;SLC8B1;PER2;SNAP25;ADRA2A;FFAR1;EPHA5;RBP4;CLOCK;TFAP2B;CCL5;EFNA5;SFRP1;CCN3;NR1H4
prerank,response to endoplasmic reticulum stress (GO:0034976),0.2589056750813592,1.0155064990263907,0.42225859247135844,0.8615913262524332,1.0,23/107,18.01%,HYOU1;BAG6;DDIT3;QRICH1;DNAJB9;PIK3R1;SEL1L;CREB3L2;FICD;EIF2S1;OS9;MBTPS2;SCAMP5;UBA5;PDIA3;USP19;ERLEC1;MBTPS1;PDIA4;THBS1;BCL2L11;SYVN1;TMEM259
prerank,integrin-mediated signaling pathway (GO:0007229),0.27452183486608434,1.0149938341077382,0.4440944881889764,0.8623768018773307,1.0,19/73,18.92%,ITGB5;DST;FYB1;ITGAV;FERMT3;SRC;FYB2;ITGB2;PTK2B;CEACAM1;PLEK;ABL1;MYH9;PTPRA;ITGB4;ADAM10;TEC;ADAMTS1;ADAM15
prerank,mesenchymal cell differentiation (GO:0048762),0.2891000920714831,1.01486464621956,0.4280821917808219,0.8619590148897734,1.0,15/51,21.50%,TGFBR1;HEYL;MEF2C;DDX5;LOXL3;NOTCH4;DDX17;LIMS1;ROCK2;NOG;ENG;AKNA;FGFR2;HIF1A;BMP2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.2270849296284404,-1.0148018520128608,0.4016393442622951,0.7972124272467865,1.0,29/152,12.99%,LRRK2;EGFR;CSNK1G1;SULF2;FGF10;GPC5;PSMD14;PPM1A;UBR5;ATP6AP2;PSMA2;SEMA5A;PSMF1;PSMD8;CDC73;COL1A1;PSMD6;GPC3;PSME2;PSMD11;ZEB2;LGR4;AXIN1;CCAR2;TNKS2;LGR5;PSMD1;PSMD5;KANK1
prerank,epithelial cell differentiation (GO:0030855),-0.24716899590370206,-1.0147466714468074,0.3887468030690537,0.7964334240499477,1.0,34/88,33.09%,DAB2;PPARG;LATS1;ANXA4;CTSB;FSTL1;JAG1;KDM6B;ERBB4;TST;E2F7;TAGLN;HDAC1;DHRS9;ALDOC;PIH1D1;BMP4;CNN3;GRHL2;DEUP1;TPP1;WT1;GSTK1;ANXA1;CASP6;TBX1;CITED1;AKR1C1;CDHR2;IRF6;OVOL1;GLI1;GSTA2;CCNO
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3313108638112014,-1.0143547760274971,0.4230769230769231,0.7967009497750054,1.0,10/23,30.82%,PPM1A;TSPAN6;RELA;NLRC3;CCN3;C1QTNF3;UACA;TMSB4X;NMI;NLRP12
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.3409844428604059,1.0142880224838082,0.436426116838488,0.8628853859671756,1.0,5/26,5.90%,SMAD3;TLR4;AGTR2;CLU;NOS1AP
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.384264272815673,-1.0139180396234388,0.43735763097949887,0.7970761183022765,1.0,9/14,36.20%,XRCC5;TNKS2;TERT;TPP1;NABP2;TERF2IP;BRCA2;TINF2;ATR
prerank,regulation of stem cell population maintenance (GO:2000036),0.3699006576051281,1.0138456117255537,0.42805755395683454,0.8633583506447383,1.0,8/18,28.00%,CNOT1;TAF6L;CNOT3;NCOA3;TAF5L;ELAVL1;CNOT2;HMGA2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.28098255350774615,-1.0132120782311382,0.4386792452830189,0.7982649140320641,1.0,14/50,21.54%,CDK7;CCND2;CCNF;ACTB;CCNJ;HSP90AB1;TTBK1;CDKN1A;CDC25C;CCNB1;PKMYT1;CDKN1C;STOX1;CDK5RAP3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4033685273563913,-1.0132093626517855,0.44175824175824174,0.7973458206919456,1.0,4/11,15.87%,LDLR;CNEP1R1;MFSD2A;CTDNEP1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3720226418851126,1.013041771909013,0.417910447761194,0.8649605237171707,1.0,4/17,16.54%,ALG12;ALG6;ALG2;ALG8
prerank,regulation of cholesterol storage (GO:0010885),-0.3710688753635148,-1.012980310231371,0.42637362637362636,0.7971175122740627,1.0,3/15,4.37%,PPARG;MSR1;EHD1
prerank,regulation of cell division (GO:0051302),0.2760894099115283,1.0128891145099235,0.44122383252818037,0.8646148906102766,1.0,22/72,21.01%,ZFYVE26;SIRT2;FLCN;SHH;SH3GLB1;TLE6;PLK5;PIK3C3;DLL1;ENTR1;BLM;SETD2;CIB1;AURKA;PLK3;TAL1;CALM2;NCOA3;KIF13A;CCP110;FGFR2;KLHL9
prerank,regulation of Golgi organization (GO:1903358),0.3701367029652318,1.0128594903059955,0.4296028880866426,0.8639172731197415,1.0,9/17,26.94%,ARMH3;CAMSAP2;PDCD10;RBSN;STX18;STX5;MAP2K1;MAP2K2;EHD3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.3468993434847468,1.0127475076596497,0.43409490333919154,0.8634736252746079,1.0,5/24,11.79%,RAC1;MAP4K4;PIK3R1;LIMS1;ABL1
prerank,heterochromatin organization (GO:0070828),-0.3701284222893695,-1.0125497481092145,0.4126984126984127,0.7974996305992588,1.0,4/14,15.11%,SIRT1;PRDM16;SETDB2;BAHD1
prerank,regulation of neuron death (GO:1901214),0.27014527806621885,1.0122285849206745,0.42628205128205127,0.8642516364534161,1.0,11/82,6.64%,ITGAM;RILPL1;MEF2C;ITGB2;PICALM;EIF4G1;EIF2S1;CLU;CD34;C1QA;RRAS2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.28131050953403564,1.0120932840898809,0.41721854304635764,0.8638830583814672,1.0,16/63,18.47%,CRADD;CHEK2;CNOT1;RBL2;ATM;PCNA;TNKS1BP1;PRMT1;CNOT3;MDM4;RPS27L;CARM1;AURKA;PLK3;PIDD1;CDKN1B
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.40714250080602943,1.011363706890177,0.46126126126126127,0.8652460533566658,1.0,2/12,7.73%,IL18;IL12B
prerank,regulation of monooxygenase activity (GO:0032768),-0.3310382126260375,-1.0112341868817685,0.44493392070484583,0.8002947294019677,1.0,6/23,12.83%,NOSTRIN;EGFR;ZDHHC21;CALM1;DDAH2;SNCA
prerank,regulation of histone acetylation (GO:0035065),0.31627092403053003,1.0109583076553867,0.43859649122807015,0.8657354699524018,1.0,12/33,23.60%,RPS6KA5;FLCN;BRCA1;RAPGEF3;RPS6KA4;NOS1;HDAC5;CAMK1;PARK7;GLYR1;ARRB1;PAXIP1
prerank,epithelial cell morphogenesis (GO:0003382),0.3718004196824616,1.0102250268789308,0.4293381037567084,0.867176918588713,1.0,3/17,6.17%,RILPL1;PKHD1;MET
prerank,inorganic anion transport (GO:0015698),-0.2718229496687641,-1.0099828863422495,0.4289405684754522,0.8031142474314136,1.0,9/53,13.36%,SLC25A30;SLC4A10;RACGAP1;GLRA1;ANO10;ANO6;SLC26A7;ANO5;XPR1
prerank,regulation of dopamine secretion (GO:0014059),-0.31937246506042616,-1.0099743160163266,0.4606205250596659,0.8022119977329906,1.0,7/25,16.58%,SYT1;SYT10;PRKN;CHRNA4;DTNBP1;SNCA;SYT3
prerank,regulation of amyloid-beta formation (GO:1902003),0.31831653176792535,1.0096952519387938,0.4392361111111111,0.8679993837941209,1.0,4/34,5.50%,BIN1;GSAP;PICALM;CLU
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3036009221496487,1.0096498272365422,0.42586206896551726,0.8673431669361897,1.0,8/44,11.69%,PRKCD;LYN;UCHL1;SPRY2;PIK3CB;RGS14;PTPN1;MAPK8IP1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.35078608065312866,-1.0094587835742659,0.41950113378684806,0.8028021516318553,1.0,4/18,5.85%,CD74;MCU;RIPOR2;DNM1L
prerank,regulation of fat cell differentiation (GO:0045598),0.27133154426631184,1.0093009498385708,0.43915343915343913,0.8675991010304248,1.0,20/74,17.04%,LRP5;SMAD3;PPARD;SIRT2;GPS2;CCDC85B;ZFP36L1;TRPM4;ZFP36L2;GATA2;WNT10B;GPER1;CDS1;TAF8;AKT1;CARM1;TRIO;MEDAG;GATA3;ANKRD26
prerank,protein acylation (GO:0043543),-0.2945882887685641,-1.0087080150955121,0.44907407407407407,0.8041261298276215,1.0,13/38,21.96%,ZDHHC21;ZDHHC16;GTF2B;ZDHHC17;ZDHHC23;CLOCK;SELENOK;FOXO1;ZDHHC15;KAT6A;ING4;ZDHHC18;NAT9
prerank,embryonic eye morphogenesis (GO:0048048),-0.41033541391290396,-1.0081553076679415,0.44420600858369097,0.8048026649902974,1.0,4/11,8.09%,RARG;FBN2;LRP6;FBN1
prerank,protein localization to organelle (GO:0033365),-0.22998667986059446,-1.0079104964423296,0.4405797101449275,0.8045929032754513,1.0,28/133,18.61%,ANK2;CNTLN;LRRK2;APP;BICD1;YWHAE;WDR35;LMNA;RAB6A;EHD1;VAPA;UBE2J2;TOR1A;MTCH2;COL1A1;XPA;LAMP1;CNEP1R1;GBP2;OBSL1;PAQR3;CTDNEP1;HMOX1;FAM83H;ALDH3A2;MDM2;BMP4;BBS4
prerank,hippo signaling (GO:0035329),-0.3209490937955039,-1.0076381021200735,0.4503311258278146,0.8045017562359815,1.0,4/26,5.20%,LATS1;YWHAE;MOB1B;FAT4
prerank,response to reactive oxygen species (GO:0000302),-0.2708991938505928,-1.007352102665961,0.44547563805104406,0.8044142220246774,1.0,22/54,27.65%,EGFR;APOE;SIRT1;RPS3;ROMO1;STK26;PKD2;ERCC6L2;SOD2;AGAP3;HMOX1;HP;CAT;GSTP1;FYN;APOD;PTPRK;FER;MAPK1;FOS;PTPRN;MMP9
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.3669863773370657,1.007280601820695,0.44507575757575757,0.8728397172542959,1.0,3/18,13.94%,BIN1;HAMP;STK39
prerank,mesoderm development (GO:0007498),0.37285745707713325,1.007269856662866,0.43280632411067194,0.8720812843361768,1.0,4/18,12.86%,IKZF1;MESD;TBX6;BMX
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.421886229141064,1.0072275997069233,0.45387453874538747,0.8714328781891386,1.0,7/10,26.70%,TLR4;MIA3;AKT1;TICAM1;MYD88;CD68;TLR6
prerank,response to interleukin-1 (GO:0070555),-0.25538442077985496,-1.0068191497575127,0.432,0.8050238630082378,1.0,19/73,18.94%,CD47;APP;CCL4;CD40;ADAMTS12;GBP3;HDAC4;USP10;CCL2;RELA;SNCA;GBP2;CCL5;CX3CL1;SFRP1;IL1R1;UPF1;CCL14;CCL7
prerank,response to purine-containing compound (GO:0014074),0.37044085221147616,1.0066545705865548,0.4267399267399267,0.8723510193308686,1.0,4/17,7.41%,ABCC9;TRPM2;NDUFS4;DUOX1
prerank,mitotic chromosome condensation (GO:0007076),0.3311211367639378,1.0066401454977811,0.45051194539249145,0.871607845072594,1.0,8/26,20.32%,CSNK2A2;CSNK2A1;AKAP8L;NCAPH2;CHMP1A;NCAPH;CDCA5;PHF8
prerank,pinocytosis (GO:0006907),0.42209208709569795,1.006317675407366,0.4426877470355731,0.8717875147272612,1.0,6/10,29.78%,RAB34;PPT1;SNX5;PYCARD;SNX33;DOCK2
prerank,positive regulation of catalytic activity (GO:0043085),0.3109211463929348,1.0059776205234638,0.462738301559792,0.8719823258613342,1.0,14/37,24.85%,PSEN2;PSENEN;SOD1;ABL1;STX4;MAPK14;CIB1;NOD2;MAPK8;FGFR4;SLC5A3;SSBP1;XRCC4;APH1A
prerank,cellular response to superoxide (GO:0071451),-0.42690320373445184,-1.005849276105841,0.4424778761061947,0.8068331561094568,1.0,3/10,11.06%,PRDX1;ATP7A;SOD2
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.2769735905629209,-1.0055981981288569,0.4064039408866995,0.8066561935240614,1.0,16/45,22.14%,BRINP3;ZW10;PTPN3;BRINP2;PLK2;BUB1B;BUB1;BTG2;RGCC;CTNNB1;CHEK1;TRIM35;BMP4;FOXC1;CDKN1C;MAD2L1
prerank,sodium ion transmembrane transport (GO:0035725),-0.24720496942494716,-1.0055954412107735,0.45169082125603865,0.8057421295864344,1.0,30/84,30.04%,HCN1;SLC8A3;SCN2A;SLC24A2;NALCN;SCN3A;PKD2;ANO6;ATP1B3;SLC6A15;ATP1A1;SLC6A6;SLC4A8;SLC9A4;HCN2;ASIC3;SLC12A1;SLC6A16;SCN9A;SLC6A17;SLC6A7;SLC12A3;SLC9A2;HCN4;SLC6A1;HCN3;SLC6A11;SLC6A12;SLC5A1;SLC6A13
prerank,striated muscle tissue development (GO:0014706),-0.31121227269696505,-1.0051976194782304,0.4666666666666667,0.8060191920028396,1.0,3/29,5.98%,SGCZ;SGCD;BMP5
prerank,negative regulation of T cell differentiation (GO:0045581),-0.41238438485634404,-1.0051883807613808,0.44349680170575695,0.8051270919807684,1.0,5/10,33.21%,ZC3H8;BMP4;GLI3;CTLA4;IRF1
prerank,ncRNA processing (GO:0034470),-0.21759692724193425,-1.00506401512456,0.4411764705882353,0.804593823126671,1.0,57/200,21.01%,RPL30;RPL36A;UTP20;RPL35A;DDX10;SNU13;LAS1L;AGO4;RPL4;WDR18;RPS7;RPS2;RPL41;INTS9;RPL7A;RPLP2;XRN2;NOB1;POP4;RPL38;RPL18A;EXOSC1;RPS14;RPS27;RPL13A;RPL26;MRTO4;RPL22;ESF1;RPS25;TUT4;RPS15;DROSHA;NOC4L;DCAF13;TUT1;RPL8;RPL23A;EXOSC7;RPLP1;RPL37;UTP15;UTP14A;POP7;PIH1D1;TARBP2;INTS7;RPL24;AARS1;RPP30;RPL19;INTS10;RPLP0;SMAD1;RPS6;RRP9;RPS9
prerank,negative regulation of receptor internalization (GO:0002091),-0.3888673548145989,-1.0050470430242973,0.44779582366589327,0.8037244830561701,1.0,5/12,17.46%,SDCBP;MTMR2;ATXN2;UBQLN2;WDR54
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.4196434928145214,1.0049919598995354,0.43761996161228406,0.8741855257975337,1.0,3/11,7.26%,EBI3;IL6ST;IL12RB2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3737074480228706,1.004941035024444,0.45387453874538747,0.8735505343088175,1.0,4/17,6.14%,CACNB2;SLC8A1;SCN4B;TRPM4
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.21894814478010283,-1.0047672858540204,0.4114114114114114,0.8036319873203696,1.0,62/182,24.47%,ROBO1;XDH;APP;MSR1;APOE;FOXP1;CCR1;PTPN22;SDCBP;RBMS3;LDLR;SIRT1;SOX11;AGO4;TET1;MTMR2;PARP14;PRKN;TNRC6A;PTRH2;WNT4;SH3GL2;CREB3L1;REL;OPRD1;HSP90AB1;MYADM;SMCR8;NDFIP1;SETDB2;KLF4;MMP8;ATXN2;TTBK1;PARP10;HDAC1;HEY2;SFRP1;CD3E;WDR54;APLN;ACVRL1;SFRP2;APLNR;BMP4;PRKAA1;ABCC2;TIPARP;CD46;TERT;NOTCH2;REST;STOX1;RBL1;DNMT1;DLL4;NR0B2;SNX12;TRAT1;AGO2;RACK1;ANKRD13A
prerank,peripheral nervous system development (GO:0007422),-0.3294116567472998,-1.0047416621530154,0.4410480349344978,0.8027959957132248,1.0,8/23,22.57%,BDNF;ADGRG6;ERBB3;SERPINI1;ALDH3A2;SOX10;GFRA3;GPC1
prerank,regulation of hydrolase activity (GO:0051336),-0.25407628333538856,-1.0044940841485457,0.43103448275862066,0.8026543404050493,1.0,18/71,15.53%,VAV3;ARHGAP15;PRKG1;PLXNC1;NTRK2;PLXND1;FGD6;PLXNA2;FGD5;CHN1;PLXNA1;RALBP1;ITGB1BP1;OCRL;EPHA5;PLXNB2;EFNA5;PLXNB1
prerank,positive regulation of glucose import (GO:0046326),-0.3404656511948196,-1.0042649972734499,0.48095238095238096,0.8024592844603505,1.0,4/21,7.61%,SORBS1;IRS1;CREBL2;OSBPL8
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3450483616870855,-1.0039593532203237,0.4282608695652174,0.8024290043618435,1.0,6/18,21.79%,GSK3B;ZNF205;BID;BAK1;BOK;CHCHD10
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.38562794880717843,1.0035828764913666,0.4500907441016334,0.8768988078165275,1.0,8/15,24.74%,RAB3GAP2;RAB3GAP1;SEC61A1;SRP14;ZFAND2A;EDEM1;SRPRB;SEC61G
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.25158263576305423,1.002686294147569,0.43709677419354837,0.8787725616006529,1.0,31/114,20.14%,TRAF5;PYDC1;CD27;TRADD;TNFRSF25;TNFRSF13C;PSMD3;TNFRSF13B;EDA2R;PTK2B;TNFSF13B;TNFSF8;TNFRSF17;PSMA7;LIMS1;BAG4;PSMB3;PSMB9;PSMC2;COMMD7;TNFRSF12A;PSME4;PSMC1;PSMB7;AIM2;PSMB5;TNFRSF14;PYCARD;MAP3K14;ADAM17;PSMB8
prerank,activation of protein kinase B activity (GO:0032148),0.32827893509715955,1.0026362301777656,0.4472271914132379,0.8781387830156542,1.0,7/29,13.36%,IL18;PDPK1;PDGFB;MLST8;MTOR;PINK1;AKT1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3901630729178901,1.00225895272711,0.45660377358490567,0.8785358645296424,1.0,5/14,22.88%,BOP1;PES1;FTSJ3;WDR12;RPL7
prerank,negative regulation of protein phosphorylation (GO:0001933),0.2433834047930919,1.0022412056341345,0.4474885844748858,0.8778048945749036,1.0,19/150,5.42%,LDLRAD4;MLXIPL;SIRPA;GREM1;PMEPA1;SMAD7;IGFBP3;CNKSR3;ATG14;PRKCD;LYN;PYDC1;SIRT2;PRKRIP1;EIF4G1;SPRY2;UBASH3B;PDPK1;IMPACT
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.23433407354850722,-1.0021850680527187,0.4233983286908078,0.8066733812115399,1.0,25/122,15.88%,SORBS1;SAMD4A;TMEM106A;EGFR;EIF3C;CIITA;IRS1;CPEB3;VIM;SIRT1;MYC;FAF1;EIF4A3;JAK2;EIF3E;RPL26;PRR16;CCL2;KLF4;PLXNB2;RGCC;ATAD5;NPM2;MTPN;NPM1
prerank,sulfur amino acid catabolic process (GO:0000098),0.4268376295795967,1.001901562060501,0.44692737430167595,0.8780714983927774,1.0,4/10,26.10%,MPST;GADL1;TXN2;ADO
prerank,superoxide metabolic process (GO:0006801),-0.3113373475934009,-1.0018952641867638,0.47115384615384615,0.8065558784810566,1.0,7/29,11.06%,CYBB;NCF2;PRDX1;NRROS;CYBA;ATP7A;SOD2
prerank,ephrin receptor signaling pathway (GO:0048013),-0.24596708795331934,-1.001771096791721,0.4296675191815857,0.8059996658167511,1.0,20/82,15.41%,VAV3;ACTR3;ITSN1;NCK2;GRIN2B;SDCBP;AP2A2;CDC42;PAK3;ACTB;DNM1;ARPC5;CHN1;TIAM1;PAK1;ACTG1;EPHA5;AP2B1;EFNA5;ARPC2
prerank,regulation of apoptotic process (GO:0042981),0.20908565166197682,1.0016257452221253,0.4700122399020808,0.8781499209996381,1.0,145/676,19.69%,BIN1;FGD2;ARHGEF2;SON;CAPN3;GREM1;PREX1;ITGA6;VAV2;DNM2;CALHM2;PIM2;CRADD;SOX8;CFLAR;MAP4K4;RPS6KA1;CTSD;IGFBP3;TGM2;QRICH1;MEF2C;VHL;KCNMA1;SRC;RIPK2;ITCH;PRMT2;PIK3R1;PHB2;SUDS3;IGF1R;AATF;CASP1;PKHD1;CD27;ATM;PLSCR3;ATAD3A;TRADD;NCKAP1L;TNFRSF25;SPRY2;FLCN;CLU;KLF11;MGMT;WDR73;AKAP13;CIAPIN1;SHH;IL6ST;PPID;RHOB;SLC27A4;ACER2;YME1L1;RABGGTA;WNT10B;PIP5KL1;GPER1;PLK5;ANP32A;PSEN2;PTK2B;PSENEN;FGD3;UBC;RPS27A;MTDH;CLN3;TJP1;FBXO11;BFAR;ARAF;MAP3K10;AXL;USP36;PPT1;HIP1R;XIAP;NUAK2;AREL1;PDCD10;OSGIN1;SOD1;APAF1;BAG4;LATS2;ABL1;BMF;DPEP1;SEMA4D;PINK1;BNIP2;PAX2;CIB1;AKT1;IRF3;MAP3K11;TRIO;VIP;GCLC;VDAC1;RNF144B;CCAR1;TNFRSF12A;APH1B;BCL2L14;PLK3;DUSP6;NME1;NUP62;FANK1;WNK3;THBS1;MIEN1;GAS1;TOPORS;ECT2;HYPK;ARL6IP5;C1QBP;BCL2L11;PIDD1;RASSF2;ADAM10;TMBIM6;THOC6;SHQ1;API5;CLIP3;RPL10;HPN;VAV1;PMAIP1;OPA1;MAPK8;PYCARD;JUN;IRF5;SFRP4;PARK7;ARHGEF5;IER3IP1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.2508421158372472,1.0014241729160176,0.44499178981937604,0.8779414896820136,1.0,17/112,11.00%,CX3CR1;SIRPA;ARHGEF2;VSIR;LGALS9;AGER;TLR4;PLCG2;CLU;CD34;IL12B;ORM2;DDT;IL33;PTPN11;DHX9;HAVCR2
prerank,protein O-linked glycosylation (GO:0006493),0.256283172047263,1.0010844901998501,0.45,0.8782117607227714,1.0,23/96,15.64%,LARGE1;B3GNT2;XXYLT1;GALNT12;TRAK1;GALNT5;POMGNT1;DPM3;GALNT10;POMT1;MUC6;B3GNT4;TET3;GALNT11;EOGT;GALNT3;GXYLT2;GALNT1;ST3GAL3;POFUT1;GCNT1;GALNT15;GALNT7
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.325275917219509,-1.0010843240022773,0.44222222222222224,0.8070906767986503,1.0,9/23,21.54%,ZW10;PLK2;PABIR1;BUB1B;AURKB;BUB1;CHEK1;SETMAR;CDK5RAP3
prerank,glial cell development (GO:0021782),-0.3164153029361565,-1.0004650131845358,0.431924882629108,0.80797135846028,1.0,5/25,6.18%,APP;TPPP;MYRF;SOX11;NRROS
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3541382448250767,-1.0003107630608226,0.4406779661016949,0.8075364632336544,1.0,3/17,10.61%,MAGI2;CALM1;HSP90AB1
prerank,natural killer cell mediated immunity (GO:0002228),0.3699431276622134,1.000221401950153,0.4339250493096647,0.8800430581115575,1.0,5/15,15.94%,ULBP1;TUBB;RAET1E;CEBPG;PLEKHM2
prerank,positive regulation of lipid storage (GO:0010884),-0.3304044480425735,-0.9999930889300345,0.45739910313901344,0.8075395491921723,1.0,4/21,10.28%,MSR1;EHD1;PLIN2;IKBKE
prerank,cellular senescence (GO:0090398),-0.31288513989399724,-0.9995490166392297,0.4576659038901602,0.8079669579395811,1.0,8/27,17.36%,SIRT1;MAPKAPK5;ECRG4;SMC5;CDKN2A;KAT6A;CDKN1A;SRF
prerank,Rho protein signal transduction (GO:0007266),-0.2690126914633899,-0.9994181442138558,0.4496124031007752,0.8074283932539192,1.0,7/53,8.17%,ARHGEF3;EPS8;ARHGAP6;ARHGDIA;CDC42;RHOU;CDH13
prerank,protein methylation (GO:0006479),0.307547871573366,0.9993641978447615,0.4421416234887737,0.8818333217464553,1.0,10/40,15.95%,FAM98B;PRMT2;ETF1;EEF2KMT;EHMT2;PRMT8;PRMT1;PRMT6;CARM1;EZH2
prerank,regulation of chromosome segregation (GO:0051983),0.3799924861851588,0.9992589615961447,0.4769503546099291,0.8813573223498787,1.0,3/16,3.21%,CSNK2A2;CSNK2A1;NUMA1
prerank,histone H2B ubiquitination (GO:0033523),0.42631883925748004,0.9990888322275473,0.458955223880597,0.8811020828982904,1.0,4/10,18.37%,CTR9;RNF8;DTX3L;RNF20
prerank,regulation of axon extension (GO:0030516),0.3039912728710446,0.999027138507922,0.4548736462093863,0.8805181711625888,1.0,10/37,13.39%,TWF2;DNM2;DIP2B;DBN1;CDKL3;MACF1;SIN3A;GOLGA4;ABL1;RTN4R
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.41462429950961843,-0.9989233653603745,0.4489795918367347,0.8079721471692843,1.0,2/10,13.04%,DPYD;UPP2
prerank,lipoprotein catabolic process (GO:0042159),0.41902200076144513,0.9988559895885608,0.47173489278752434,0.880246211279195,1.0,3/11,10.71%,ABHD17C;CTSD;PPT1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.3739121619777892,0.9987624491482937,0.45072992700729925,0.8797097524658412,1.0,3/17,13.36%,PDE3B;BSCL2;AKT1
prerank,positive regulation of histone deacetylation (GO:0031065),0.40192829306496636,0.998690582271997,0.46828358208955223,0.8791518852876132,1.0,2/12,3.61%,AKAP8;AKAP8L
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.3468982216824198,-0.9981634271180692,0.4792626728110599,0.8092633355741288,1.0,7/18,18.73%,MYC;CDC73;B4GALT7;NLRC3;PARP10;SFRP1;GSTP1
prerank,regulation of leukocyte activation (GO:0002694),0.386841244365587,0.9980829232324214,0.47601476014760147,0.8802321230280089,1.0,7/14,23.37%,PJA2;LYN;GPER1;CD33;SHPK;MYO18A;MIF
prerank,glycogen catabolic process (GO:0005980),0.3847720160495404,0.9980551579785563,0.45719489981785066,0.8795149647308638,1.0,8/15,22.45%,PYGB;RB1CC1;PHKB;AGL;PHKG2;GAA;PHKA2;PYGL
prerank,protein monoubiquitination (GO:0006513),-0.29068331401172137,-0.998007572393274,0.45652173913043476,0.8088354238640932,1.0,8/36,13.79%,CUL3;PRKN;UBE2W;WAC;CDC73;PEX12;RNF126;UBE3D
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2612768302842286,0.9977749959756471,0.4472843450479233,0.8795858554837518,1.0,19/86,16.40%,NFE2L2;DDIT3;VHL;EGLN1;IMPACT;PSMD3;ANKRD2;UBC;RPS27A;PSMA7;ARNT;PSMB3;GCN1;PSMB9;PSMC2;MAPK7;PSME4;PSMC1;PSMB7
prerank,myeloid cell development (GO:0061515),-0.3469098050065678,-0.9976903136621836,0.4166666666666667,0.8088348392163354,1.0,5/18,14.19%,APP;FOXP1;NRROS;ANXA2;KIT
prerank,recombinational repair (GO:0000725),0.2682227581657516,0.9975707495675992,0.433489827856025,0.879398157853222,1.0,16/77,14.65%,ZFYVE26;RHNO1;RNF138;SPIDR;RAD54B;POLN;NBN;SLX4;SWSAP1;RAD51B;BRCA1;ERCC4;BLM;AP5Z1;MORF4L1;FBH1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.3146813193577668,-0.997427865733492,0.46228710462287104,0.8086977918654956,1.0,9/29,23.98%,CCR2;JAK2;STAT4;PKD2;CCL2;PIAS1;SOCS2;FER;PKD1
prerank,regulation of neuroinflammatory response (GO:0150077),0.35328695342281713,0.9973636364137757,0.46285714285714286,0.8792027776636098,1.0,2/19,9.26%,IL18;IL33
prerank,negative regulation of blood pressure (GO:0045776),0.3985880056875255,0.9972440079213225,0.47093023255813954,0.8788057853338693,1.0,4/13,18.66%,NOS2;DRD2;PRCP;NOS1
prerank,cardiac muscle contraction (GO:0060048),-0.2949835058535277,-0.996780156990161,0.4236111111111111,0.8096427537340032,1.0,7/34,14.72%,DMD;RYR2;GSN;KCNH2;TNNI1;KCNQ1;MYBPC3
prerank,regulation of humoral immune response (GO:0002920),0.29261527941985693,0.996339600269633,0.4612794612794613,0.8806548394055926,1.0,6/44,7.55%,C1QB;PHB2;PROS1;CLU;C1QA;CCR7
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.26729342277205215,0.9960813346330738,0.46935201401050786,0.8806729031413293,1.0,19/73,17.96%,ARHGEF2;LGALS9;AGER;TLR4;PLCG2;CLU;IL12B;ORM2;DDT;CD86;IL33;PTPN11;DHX9;HAVCR2;MAVS;SETD4;THBS1;NOD2;PTPRJ
prerank,negative regulation of cell division (GO:0051782),-0.40908868355113814,-0.9960032515320504,0.4751131221719457,0.8110083762314936,1.0,3/11,11.77%,MYC;AURKB;E2F7
prerank,peptidyl-proline hydroxylation (GO:0019511),0.4091607361057803,0.9959875274720735,0.47784200385356457,0.8801682982680039,1.0,3/11,9.85%,EGLN1;P3H2;P4HA1
prerank,regulation of ATP metabolic process (GO:1903578),0.27795267870819446,0.9959150240656437,0.4426229508196721,0.8796051822439104,1.0,19/54,23.15%,RANBP2;NUP42;COX7A2L;SEC13;NUP35;NUP50;PINK1;SEH1L;NUP62;UQCC2;NUP107;PGAM1;NUP88;ABCD1;NUP188;HIF1A;NUP214;ATP5IF1;JMJD8
prerank,oligodendrocyte differentiation (GO:0048709),0.3637638619675662,0.995529156506669,0.47593582887700536,0.8800218312760221,1.0,5/19,8.59%,SOX8;EIF2B3;SHH;NSUN5;EIF2B4
prerank,positive regulation of heart contraction (GO:0045823),-0.3353797409441262,-0.9954769511577921,0.46122448979591835,0.8115571036589879,1.0,6/19,19.20%,ADRA1A;RYR2;ATP2A2;KCNQ1;APLN;ADM
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3643100484447763,0.9950676354639311,0.4675572519083969,0.8805952772644059,1.0,3/18,3.22%,BAG6;DDIT3;PIK3R1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.22600003961232804,-0.995049274766821,0.45664739884393063,0.8118383749254067,1.0,36/151,16.94%,MAGI2;IQGAP1;CD44;EGFR;PTPN12;GAREM1;DSTYK;KIDINS220;ERN1;NTRK2;RAPGEF2;SOX5;ADAMTS12;NTRK3;EHD1;ACVR1C;PDE8A;RUNX2;ZFP36;WNT4;BCAR1;CCL2;ITGB1BP1;KLF4;RELA;SYAP1;PDE2A;CTNNB1;NR3C1;CCL5;SEMA6A;MAPKAPK2;SFRP1;STMN2;AMHR2;SNAI2
prerank,primary neural tube formation (GO:0014020),0.324230452789056,0.9950345800365258,0.47739602169981915,0.879916552121297,1.0,11/30,24.51%,SKI;DEAF1;SEMA4C;MTHFD1;PAX2;VANGL2;VASP;CELSR1;TGFB1;IFT122;GRHL3
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.3874660694539299,-0.9950120742696277,0.4661016949152542,0.8110475776906,1.0,4/13,7.13%,ANK2;KCNN2;KCNJ3;CACNA1C
prerank,circulatory system development (GO:0072359),0.24664525185398428,0.9949704974412927,0.4530046224961479,0.8793423792377287,1.0,18/118,11.85%,TGFBR1;ADAP2;SALL1;TGFBR2;MEF2C;BCOR;AKAP13;CXADR;SHH;TAB2;PDGFB;SOX17;UTY;POU4F1;NOTCH4;PTPN11;MEF2A;MTHFD1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.2966155384019825,0.994852744703551,0.4880546075085324,0.8789307399846276,1.0,5/43,6.10%,SIRPA;VSIR;LGALS9;TLR4;CD34
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.4071502146176114,0.9946953842215832,0.4616822429906542,0.8786327035487488,1.0,5/11,25.17%,PADI2;ZMIZ2;ARID1A;ELOF1;ZMIZ1
prerank,male gonad development (GO:0008584),0.3070973229168504,0.994561515157896,0.4547038327526132,0.8782840829667546,1.0,5/34,8.09%,SOX8;WNT2B;ADAM29;FSHR;LHCGR
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.2856210708539235,-0.9944121197850443,0.45652173913043476,0.8119497392894541,1.0,13/37,26.60%,BICD1;TPPP;STMN4;GSK3B;SKA3;EFNA5;STMN2;EPHA3;PRKAA1;TRAF3IP1;STMN3;SKA1;GAS2L1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3536803335936752,-0.9943839246919973,0.47494033412887826,0.8111409085862334,1.0,4/19,5.88%,ROBO1;XDH;CCBE1;CADM4
prerank,snRNA processing (GO:0016180),0.375169509901324,0.9943601704756079,0.45454545454545453,0.878113022564389,1.0,3/16,9.07%,INTS6L;INTS11;INTS3
prerank,organelle organization (GO:0006996),0.21773618834741473,0.9943460625973176,0.4789687924016282,0.8773907601447686,1.0,97/388,20.66%,BIN1;FGD2;DST;ABCD2;DYM;ARAP3;TMEM135;NUMA1;PHB2;CAPZB;GOLGA8B;GOLGA5;CAMSAP1;IRAG2;PEX10;PLD2;SIPA1;ZRANB1;ATAD3A;MCOLN1;ODF2;TMED9;RANBP10;WDR73;CXADR;SORT1;PPID;FMNL3;YME1L1;RAB34;LMAN1L;RAB1A;MIA3;PEX6;RAB3GAP1;FGD3;FANCG;TRAPPC8;SAR1A;TICAM2;AUP1;SEC31B;KIF3A;NRF1;MNS1;STX4;MIEF2;FMNL2;VAPB;PINK1;CSPG5;CDC42BPB;BSCL2;REEP6;UBXN2A;POLG2;ARHGAP4;SEC61A1;ATXN7;DOP1B;TMED4;COG2;LYSMD3;HSD17B10;MAST3;TRAPPC11;NECTIN2;CHMP1A;BCS1L;GORASP1;WTIP;PLEKHM2;SPRYD3;OPTN;VPS13C;CHMP2A;TJAP1;WDR81;MARK4;WASL;ABCD1;SEC31A;RAB32;CCL24;STOML2;DMTN;NCKIPSD;OPA1;PEX1;TMEM11;PARK7;VPS13D;REEP5;AGTPBP1;COG7;TFB1M;SSBP1
prerank,secondary alcohol metabolic process (GO:1902652),0.2997594749099181,0.9943122546119609,0.489010989010989,0.8767189710026374,1.0,10/42,19.23%,PPARD;CH25H;PIP4P1;SULT2A1;LDLRAP1;OSBPL5;SCAP;ABCA1;NSDHL;LCAT
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.33508777452463884,-0.9940626130455769,0.46731234866828086,0.8111781478040897,1.0,4/20,9.63%,AMPD3;PPAT;ADSS2;AK3
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.41413779095402664,0.9937306578393917,0.4686907020872865,0.8775919708530231,1.0,2/11,7.18%,LIPC;PLA2G5
prerank,regulation of organelle assembly (GO:1902115),0.27031355241779126,0.9935007581254214,0.47249190938511326,0.8775080827060925,1.0,15/73,13.59%,TBC1D16;SDCCAG8;TBC1D9B;TBC1D8;TBC1D17;TBC1D15;ATXN2L;TBC1D10B;CEP295;CENPJ;DYNLT2B;ATG5;IFT20;SGSM3;ADPRH
prerank,cell-cell junction assembly (GO:0007043),-0.2585018484910946,-0.9933241649272173,0.4714285714285714,0.8124618165028028,1.0,17/63,14.99%,CTNND2;CTNNA1;CDH8;PKP4;CNTNAP1;CDH22;ACTB;PATJ;CDH7;CDH20;CDH11;CDHR3;CDH5;ACTG1;CDH10;GJB2;CTNNB1
prerank,regulation of T cell mediated immunity (GO:0002709),0.4167326618985468,0.9932721194456225,0.4706994328922495,0.8773901559072871,1.0,3/10,8.19%,AGER;TRPM4;FUT7
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.373157096184497,0.9931606607985783,0.4665461121157324,0.8769580342984902,1.0,5/16,17.83%,NCBP1;TRA2B;DAZAP1;TRA2A;RBMX
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.42333319534589836,0.9930625728616645,0.4790528233151184,0.8764855376644495,1.0,5/10,19.48%,ATP5PO;ATP5MC1;VPS9D1;ATP5PD;ATP5F1D
prerank,sterol biosynthetic process (GO:0016126),-0.30316989210572676,-0.9929859708469754,0.44522144522144524,0.8124746640474773,1.0,9/33,16.32%,PRKAG2;LBR;HMGCS1;ACLY;MSMO1;EBP;HMGCR;LSS;MVD
prerank,negative regulation of programmed cell death (GO:0043069),0.2163503459201727,0.9928402513938528,0.4847277556440903,0.8764037744017946,1.0,76/355,19.23%,SON;CAPN3;GREM1;PIM2;SOX8;CFLAR;MAP4K4;RPS6KA1;VHL;SRC;RIPK2;ITCH;PIK3R1;PHB2;IGF1R;AATF;PKHD1;CD27;ATAD3A;NCKAP1L;SPRY2;MGMT;WDR73;CIAPIN1;MET;SHH;IL6ST;YME1L1;POU4F1;PSEN2;TM7SF3;PTK2B;DCPS;UBC;RPS27A;MTDH;CLN3;TJP1;BFAR;ARAF;AXL;PPT1;XIAP;NUAK2;AREL1;PDCD10;BAG4;DPEP1;SEMA4D;BNIP2;PAX2;CIB1;AKT1;VIP;GCLC;KANK2;VDAC1;RNF144B;PLK3;NUP62;FANK1;WNK3;THBS1;MIEN1;TOPORS;HYPK;PIDD1;ADAM10;TMBIM6;THOC6;API5;RPL10;HPN;OPA1;MAPK8;GPX4
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.37850259898468197,-0.9928205812530732,0.45905172413793105,0.8120949993845816,1.0,3/13,3.18%,GRIN2A;NLRC4;CYFIP2
prerank,cellular potassium ion homeostasis (GO:0030007),0.38658514118512427,0.9928201296138174,0.45623836126629425,0.8757089638769449,1.0,2/13,8.21%,KCNMA1;ATP1A4
prerank,cholesterol efflux (GO:0033344),0.3557492716600858,0.9927320534491202,0.4430604982206406,0.8752073575907438,1.0,6/20,18.35%,STX12;APOM;NPC2;NPC1;SCARB1;ABCA1
prerank,inorganic ion transmembrane transport (GO:0098660),0.3975878605764293,0.9923682761717838,0.5053763440860215,0.8755280217804344,1.0,2/12,6.14%,ABCC9;TRPM4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.41919568566775073,-0.9918387165678538,0.45217391304347826,0.8140065839671026,1.0,6/10,23.54%,CDC42;RACGAP1;SPAG5;RCC2;CCNB1;KNSTRN
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.3926948452628304,-0.9918289030211163,0.4731610337972167,0.8131433232705737,1.0,2/12,2.33%,ANK2;RYR2
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.3107263449168074,-0.9912597679477457,0.4925,0.8139052474963411,1.0,11/29,20.71%,MYC;TLE4;CDC73;TCF7;BCL9L;TLE1;CTNNB1;HDAC1;PYGO2;TERT;LEF1
prerank,cholesterol biosynthetic process (GO:0006695),-0.3044544372911762,-0.991051503816162,0.44419134396355353,0.8136025335130187,1.0,9/31,20.21%,LBR;HMGCS1;ACLY;MSMO1;EBP;HMGCR;LSS;MVD;DHCR7
prerank,regulation of embryonic development (GO:0045995),-0.2964691504317875,-0.9905533416478751,0.4595238095238095,0.8141676614725782,1.0,7/34,14.94%,PLCB1;B4GALT5;TRIP12;RACGAP1;CCSAP;DAG1;NPHP3
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.39484059837331176,0.9902591077131273,0.47438330170777987,0.8809195246875743,1.0,2/12,4.84%,ABCD2;MTLN
prerank,organic cation transport (GO:0015695),-0.34106244805445907,-0.9899102763373675,0.46205357142857145,0.8150815052496878,1.0,9/20,19.35%,SLC25A19;SLC44A1;SLC5A7;SLC44A2;RALBP1;SLC47A1;SLC22A4;SLC22A18;SLC22A5
prerank,negative regulation of neurogenesis (GO:0050768),-0.29778539263484033,-0.9898932288944304,0.46099290780141844,0.8142444365125594,1.0,5/34,4.22%,LINGO1;B2M;RTN4;RAPGEF2;ARHGDIA
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.24362237048971602,-0.989667326276137,0.45910290237467016,0.8139954812484606,1.0,16/84,12.77%,CUL3;PSMD14;PSMA2;PSMF1;PSMD8;ANAPC10;ECRG4;PSMD6;PSME2;PSMD11;BUB1B;AURKB;PTTG1;UBE2C;PSMD1;PSMD5
prerank,protein targeting (GO:0006605),-0.22803792328963451,-0.9896374073432023,0.49025069637883006,0.8131775644393874,1.0,33/118,21.54%,NLGN1;AKAP6;CHM;ZDHHC21;SDCBP;SPCS2;TOMM22;AP4S1;TIMM23;TIMM17B;GIPC1;PEX12;MFF;TOMM5;ZFAND6;FBXO7;TIMM17A;FIS1;ZDHHC23;AQP11;ZDHHC15;TIMM10;PARD3;RASSF9;ATG3;AP1S3;AIP;DNAJC19;TIMM9;ZDHHC18;ZDHHC24;AP4E1;NACA
prerank,monosaccharide transmembrane transport (GO:0015749),-0.3585648525385896,-0.9895772384701164,0.452431289640592,0.8124420803864598,1.0,8/16,37.99%,SLC45A3;SLC2A12;SLC2A2;SLC2A8;SLC5A1;SLC5A10;SLC50A1;SLC2A6
prerank,macrophage chemotaxis (GO:0048246),-0.40653146980637495,-0.9895734623300407,0.5,0.8115749891986135,1.0,4/10,16.78%,EDNRB;CCL2;CCL5;TAFA4
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.26756564679436107,0.9892819393044741,0.4944,0.8830409302643256,1.0,27/76,27.14%,TLR7;LGALS9;AGER;TLR4;PHB2;CD27;TRADD;LRRC19;TRIM44;IL12B;CD86;LIMS1;EIF2AK2;NLRP3;RASSF2;NOD2;PDCD4;DDX3X;TRAF6;CYLD;PPM1B;ZC3H12A;PTP4A3;TLR9;EP300;ACTN4;C1QTNF4
prerank,regulation of G0 to G1 transition (GO:0070316),0.30729910553489437,0.9886839477867362,0.47322970639032813,0.8840123837728278,1.0,14/38,22.38%,RHNO1;EHMT2;BRCA1;EED;APAF1;PCGF2;EZH2;EPC1;MGA;RNF2;RING1;PHC1;CDC7;SUZ12
prerank,regulation of cholesterol transport (GO:0032374),0.3504510956156335,0.9885746525922694,0.47735849056603774,0.8835640024863725,1.0,6/20,18.85%,TSPO;ABCB4;TTC39B;LRP1;NR1H2;NAXE
prerank,positive regulation of hemostasis (GO:1900048),0.42297278552464307,0.9884222969190445,0.4680073126142596,0.8824613611675568,1.0,5/10,21.44%,F12;APOH;THBS1;DMTN;SERPINE1
prerank,positive regulation of coagulation (GO:0050820),0.42297278552464307,0.9884222969190445,0.4680073126142596,0.8824613611675568,1.0,5/10,21.44%,F12;APOH;THBS1;DMTN;SERPINE1
prerank,positive regulation of viral process (GO:0048524),0.2805847966416169,0.98829509206929,0.474036850921273,0.882085675182688,1.0,11/60,13.63%,NELFB;POLR2H;CDK9;POLR2D;HACD3;PPID;POLR2J;AXL;DHX9;VAPB;NELFE
prerank,glutathione metabolic process (GO:0006749),0.3029836898139175,0.9879236310821973,0.46459412780656306,0.882444123458247,1.0,9/38,21.17%,HPGDS;SOD1;DPEP1;GSTA3;GCLC;CTNS;GGT5;PARK7;GSTM5
prerank,actin filament depolymerization (GO:0030042),-0.3960427443241943,-0.987733263553819,0.48775055679287305,0.816002125303885,1.0,3/11,7.01%,GSN;MICAL3;DSTN
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3336238175537612,0.9873607078583105,0.4673913043478261,0.8833323491200012,1.0,5/25,7.96%,CAPN3;CACNB2;PDPK1;GPER1;CALCR
prerank,positive regulation of autophagy (GO:0010508),0.26182668998994496,0.9870745779157113,0.48776508972267535,0.883430628182206,1.0,19/81,17.55%,SCOC;PIM2;PHB2;TRIM5;FLCN;SH3GLB1;PIK3CB;CAMKK2;MTDH;TPCN1;PINK1;ULK1;PLK3;TICAM1;SESN1;TMEM59;OPTN;TRIM14;LARP1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.19919304266559615,-0.986967093160721,0.5518672199170125,0.8172318368274237,1.0,91/348,22.45%,MAGI2;RBPJ;PID1;RIMS2;CD74;ANK3;ROBO1;ANK2;ATF2;CD36;STAP1;APP;LILRB1;FGF10;GSN;PTPN22;NTRK2;UBR5;RBMS3;NTRK3;PF4;ATF7IP;ZBTB7B;ATAD1;RPS3;FN1;SOX11;AGO4;RPS7;MYC;AFDN;KLF2;GSK3B;PRKN;FAM98A;TNRC6A;RIMS1;FGF9;CTCF;INPP5F;ANXA2;FGF7;DNMT3B;MSN;IFNGR1;DTNBP1;SETDB2;SRPK2;TESC;KLF4;SNCA;TLE1;CDH5;ACTG1;MMP8;TTBK1;RGCC;PDE2A;HSPA1B;MTPN;SCX;AHI1;HEY2;ADAM19;TFRC;POU3F1;HMGN5;PPHLN1;CD3E;SCYL2;BMP4;ADTRP;PRKAA1;FGF5;E2F1;EZR;CD46;ACTA1;LEF1;SMAD1;AVPR2;STOX1;MAP2K5;CD63;DNMT1;VSTM2A;FGF22;MED1;DLL4;WNT6;TADA3
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.27770446406991145,0.9869518196808209,0.47068403908794787,0.8830553993326629,1.0,15/58,16.20%,SUMO1;HERC2;IFFO1;ATM;NBN;RNF8;BRCA1;DCLRE1B;DCLRE1C;ABRAXAS1;ERCC4;UBE2V2;HMGB2;BABAM1;DCLRE1A
prerank,DNA strand elongation (GO:0022616),0.35557829778278305,0.9867943240740149,0.473967684021544,0.8827653888268445,1.0,7/18,19.75%,GINS4;NBN;DCLRE1B;POLD2;MCM3;MCMDC2;GINS3
prerank,telomere organization (GO:0032200),0.29201319965413575,0.9865931576865413,0.4533106960950764,0.8826233244388318,1.0,9/43,13.15%,CTC1;ATM;PCNA;NBN;DCLRE1B;POLD2;ERCC4;BLM;TERF1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.2887498424984119,-0.9864440512703717,0.45647058823529413,0.8178003813599002,1.0,11/38,18.86%,OTUD7A;PPM1A;SIRT1;RIOK3;USP10;PER1;TLE1;NLRC3;NR1H4;GSTP1;TRIM59
prerank,regulation of DNA repair (GO:0006282),-0.2782889488035059,-0.9863411969030579,0.47341772151898737,0.8172125472562886,1.0,14/44,19.31%,EGFR;FGF10;UBR5;SIRT1;RPS3;TRIP12;UBE2N;EYA2;ERCC6;TIGAR;WRAP53;BABAM2;USP1;RAD52
prerank,positive regulation of type I interferon production (GO:0032481),0.2666823091540827,0.9862118106168304,0.4768211920529801,0.8830010135741603,1.0,15/73,15.24%,POLR3G;TLR7;POLR2H;TLR4;RIPK2;GAPDH;POLR3H;CGAS;G3BP1;PTPN11;DHX9;SETD2;IRF3;MAVS;POLR1C
prerank,regulation of mRNA catabolic process (GO:0061013),0.24445115318301458,0.9859444502792796,0.5015337423312883,0.8830371777969941,1.0,37/121,25.46%,PRKCA;CNOT1;PRKCD;MOV10;EIF4G1;ZFP36L1;TNPO1;ZFP36L2;PSMD3;PKP3;RBM24;ANP32A;UBC;RPS27A;PSMA7;CSDC2;EXOSC5;IGF2BP2;AKT1;PSMB3;PSMB9;PSMC2;PSME4;PSMC1;PSMB7;PSMB5;GTPBP1;PSMB8;PCBP4;NUP214;PUM1;ZC3H12A;EXOSC8;YTHDF3;ELAVL1;XPO1;PARN
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.3582780109614757,0.985868392928175,0.47330960854092524,0.8825013316263288,1.0,5/17,13.64%,MAML3;HEYL;NOTCH4;MAML2;NOTCH3
prerank,modulation by symbiont of entry into host (GO:0052372),0.36757815060754573,0.9858330649416326,0.47126436781609193,0.8818340607328411,1.0,5/16,16.91%,EXOC7;TRIM5;TRIM62;NECTIN2;TRIM14
prerank,regulation of receptor internalization (GO:0002090),-0.2927195814535577,-0.9856993301244129,0.491183879093199,0.8181452869267669,1.0,5/35,6.47%,MAGI2;MKLN1;SDCBP;ATAD1;MTMR2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2516128900658977,0.9856409483510994,0.46266233766233766,0.8816496056758004,1.0,23/93,17.97%,PJA2;AGER;TRAF5;CD27;SEMA4C;CCR7;EDA2R;PTK2B;WNT7B;PRMT1;MID1;MAP3K10;PDCD10;MAPK8IP1;TNFRSF19;MAP3K11;EIF2AK2;MAP4K2;TAOK2;ARL6IP5;RASSF2;NOD2;MINK1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.2768700941039831,-0.9856373281513189,0.45524296675191817,0.8174569578717654,1.0,8/43,12.53%,EGFR;CBLB;CDC42;PTPN3;SH3GL2;PTPN2;EPS15;RNF126
prerank,cellular response to purine-containing compound (GO:0071415),-0.4128657563527067,-0.9848714108592549,0.47468354430379744,0.8187669644643422,1.0,3/10,6.24%,RYR2;RYR3;P2RY1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.35023036776127314,0.9847526633050169,0.4772313296903461,0.8834831919265301,1.0,10/20,29.25%,PAX6;POU4F1;LAMTOR5;GATA3;PARK7;TWIST1;TRAF6;TGFB1;EP300;RB1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.31653736767412616,0.9847084895055285,0.48257839721254353,0.8828622171720222,1.0,8/30,16.54%,DPM3;MGAT2;NUDT14;OSTC;MGAT1;MGAT5;ALG5;ALG8
prerank,regulation of macromolecule metabolic process (GO:0060255),0.23432562718378047,0.9844446851452417,0.4947994056463596,0.8829205818720848,1.0,50/170,23.84%,TBC1D16;SIRPA;AIF1;COQ7;CRNN;TRIM11;HNRNPDL;TRIM5;SLC8A1;CIAO3;TRIM44;ZFP36L1;ADNP;SHH;SORT1;EDN3;UTY;SART3;PRDM1;ANKRA2;PCBP2;MTMR4;PRDM11;IGF2BP2;PRDM2;ROCK2;PROX1;RNF187;C1D;POGZ;ZUP1;TRIM14;RSPO1;TOB1;SLC8A2;PRDM9;RFXANK;NOVA2;HIF1A;KIF16B;NFKBID;ARF1;PTHLH;TRIM39;TARDBP;PCBP4;TAPBP;PIN1;MEFV;PRDM4
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3264582061487609,0.9840120361998849,0.47586206896551725,0.883491407303012,1.0,5/26,7.76%,ST3GAL6;B3GNT2;PRELP;CHST1;B3GNT4
prerank,positive regulation of protein phosphorylation (GO:0001934),0.21603480772670844,0.9839691802042745,0.495225102319236,0.882866020901627,1.0,76/348,20.27%,CX3CR1;TGFBR1;TMEM119;ARHGEF2;CSF1R;RAC1;MMD;AGER;ATG14;SRC;RIPK2;LYN;PLCG2;CDK9;RPS6KA5;CAMKK1;IL6R;LCP2;EIF4G1;SPRY2;FLCN;VEGFB;NBN;TAB2;INHA;PDGFB;CCR7;LEFTY1;GPER1;CALCR;CCND3;RB1CC1;PTK2B;AKTIP;TNKS1BP1;CAMKK2;RAPGEF3;RPTOR;PTPN11;ARAF;MUSK;PDCD10;ABL1;SEMA4D;PINK1;TENM1;ROCK2;PELI2;CIB1;AKT1;GPNMB;FBH1;GHR;RPS6KA4;MAVS;CDK2AP1;DDR2;TAOK2;WNK3;ENG;CALM2;TNK2;RASSF2;TEC;PTPRJ;RSPO1;CRKL;CLIP3;NOS1;TNFRSF14;CAMK1;JTB;PARK7;XRCC6;ADAM17;FGF20
prerank,protein K63-linked ubiquitination (GO:0070534),0.29781280383063136,0.9839033275998715,0.4496527777777778,0.8823330983923745,1.0,8/41,12.24%,TRAF5;ITCH;TRIM5;RNF8;WWP2;ZFP91;BFAR;UBE2V2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.21216056547938794,0.9838743231567695,0.5195681511470985,0.8816611012809803,1.0,78/417,16.45%,SALL1;IKZF1;MLXIPL;SUMO1;CAPN3;HEYL;PBXIP1;SOX8;BASP1;DDIT3;PPARD;CHD8;PRMT2;HDAC10;EIF4A2;PHB2;SIRT2;ZNF568;SUDS3;DEAF1;ZBTB21;RPS6KA5;ID1;ZBTB18;SBNO2;LOXL3;MLX;CCDC85B;ELK3;CRY2;BCOR;FOXN3;SAMD1;BCL7A;FOXE1;ZMYND11;EID2;FOXK2;SAMD11;PDGFB;SAMD13;TWIST2;NPAS1;BRCA1;SIN3A;MIDEAS;WWP2;KDM4A;PATZ1;SMARCA2;TMPRSS6;EED;MAP3K10;KHDRBS1;DPF1;ZEB1;LIMS1;PRDM11;MBD1;PRMT6;SCMH1;ID3;PAX2;PROX1;TSC22D4;QARS1;COMMD7;GCLC;DPF2;CHMP1A;HMGB2;DKK3;EID2B;EZH2;KDM8;POU2F1;NR1H2;GATA3
prerank,potassium ion import across plasma membrane (GO:1990573),-0.271770809708191,-0.9837719574666579,0.4528301886792453,0.8210273056006321,1.0,8/41,11.72%,KCNJ3;SLC12A8;SLC12A4;KCNH2;KCNJ6;SLC12A5;ATP1B3;ATP1A1
prerank,protein K48-linked ubiquitination (GO:0070936),0.2800301721825888,0.9836478673446635,0.4847972972972973,0.8816059604954678,1.0,19/54,23.51%,RNF216;ITCH;UBE2H;RFFL;CDC34;RNF8;BFAR;FBXO38;DTX3L;RNF187;TOPORS;UBE2A;KLHL3;RNF4;SYVN1;UBE2R2;UBE3A;UBE2G2;ZNRF1
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.2203959488896465,-0.9835322103436178,0.5,0.8208529928441567,1.0,33/151,17.42%,DMD;GPHN;B4GALT5;SGMS1;PAM;ST3GAL4;PCSK5;APOE;SPTSSA;SGMS2;ELOVL7;SLC44A5;VAPA;SLC44A1;MGST1;CHAT;SGPL1;HACD1;GOLPH3;ASL;SLC44A2;ELOVL5;MFSD2A;CHKA;ESD;CERS1;ACHE;PLPP3;NMRAL1;CEPT1;GSTT1;ALDH3A2;CERT1
prerank,response to molecule of bacterial origin (GO:0002237),0.2679357400526712,0.9831959952445606,0.49666666666666665,0.8821746324931137,1.0,9/69,7.61%,LGALS9;OTUD5;TLR4;SIRT2;CYRIB;SLPI;TAB2;SELE;NOS2
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.20209945063016316,-0.982735579479765,0.5051194539249146,0.8222103902795491,1.0,107/306,27.75%,B4GALT5;THRB;POLA1;ST3GAL4;APOE;RPL30;RPL36A;MRPL18;FUT9;EXT1;RPS29;CREBL2;RPL35A;MCM9;POLL;RPS3;RBMS1;RPL4;RPS7;NR4A2;RPS2;RPL41;BARD1;POLE2;RPL7A;RPLP2;IGHMBP2;GOLPH3;RPL38;RPL18A;RPS14;RPS27;MRPS7;RBBP8;RPL13A;RPL26;RPL22;RPS25;RPS15A;RPS15;EEF1A2;RPS6KB2;RPL8;RPL23A;HUS1;EXT2;RPLP1;RPL37;POLR2K;CHEK1;SCX;POLD3;HBS1L;POLR2G;RPS12;MRPS33;ING4;UPF1;RPL24;DBF4;BAZ2A;PIF1;MCM5;RPL19;RPS11;CDK2;E2F1;RPLP0;TERT;POLR2F;RPS6;RPS9;POLD1;TBRG1;RPSA;RPS10;RPS19;PABPC4;FEN1;RPL23;RPL17;MRPL23;BRIP1;CLSPN;YARS2;EEF1A1;AGO2;ZAR1;RPS5;PTMA;RNPS1;RPL29;TOP1;MRE11;RPL18;EEF1G;PTMS;PAX8;RPS21;MRPS6;MRPL55;FUBP3;KIN;RPS23;TIPIN;RFC4;RECQL4
prerank,myotube cell development (GO:0014904),0.4233298612865194,0.9827286014689883,0.4678030303030303,0.8828181146019372,1.0,2/10,7.52%,SKI;KLHL40
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.3078720707396829,0.982545368626622,0.484629294755877,0.8826022171243075,1.0,17/34,35.61%,TLR4;LYN;GPS2;TICAM2;GPR108;TICAM1;GRAMD4;TLR9;TYRO3;TLR6;OTUD4;CD14;TREM2;CD300A;TNFAIP3;RAB7B;ACOD1
prerank,protein localization to phagophore assembly site (GO:0034497),0.4021632192260379,0.982492593408892,0.4701348747591522,0.8820084690706317,1.0,6/11,21.34%,ATG9A;TRAPPC8;ATG9B;PACS2;WDR45B;MFN2
prerank,cellular biogenic amine catabolic process (GO:0042402),0.41791086749447187,0.9823982020156741,0.4581673306772908,0.881569427457349,1.0,4/10,20.06%,CHDH;COMT;SMOX;HNMT
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.30509361949204317,-0.9818747680819425,0.4502262443438914,0.8237718769750514,1.0,9/30,20.21%,LBR;HMGCS1;ACLY;MSMO1;EBP;HMGCR;LSS;MVD;DHCR7
prerank,cellular response to lipid (GO:0071396),-0.2141847597335519,-0.9816467913470407,0.5158227848101266,0.8235273167042758,1.0,49/191,18.98%,PID1;BRINP3;PDE4B;EGFR;STAP1;LILRB1;IRS1;ADCY2;ADCY5;VIM;PF4;SPP1;RORB;MGST1;ADCY3;ADCY8;CDC73;BRINP2;RET;ZFP36;IRGM;LBP;CCL2;MSN;ATP1A1;KCNK4;TESC;RELA;AHR;PDK3;GNAI1;ZNF35;LCOR;NR3C1;CRHBP;WNT9A;SFRP1;ABL2;PLAA;CD80;HMGB1;CARD16;CFTR;UPF1;NR1H4;ADTRP;EPHA3;GSTP1;CREB1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.415061536516703,0.9813718853177884,0.4912959381044487,0.8831097216583712,1.0,3/10,13.25%,AP2A1;CLTA;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.415061536516703,0.9813718853177884,0.4912959381044487,0.8831097216583712,1.0,3/10,13.25%,AP2A1;CLTA;MYLIP
prerank,positive regulation of immune effector process (GO:0002699),-0.31452634684506153,-0.9812322082284898,0.4880382775119617,0.8237927919983804,1.0,4/27,5.14%,CCR2;LILRB1;ANKRD17;DDX60
prerank,regulation of chondrocyte differentiation (GO:0032330),0.3350175832167603,0.9809294499103589,0.4577205882352941,0.88363058461348,1.0,6/24,10.30%,TGFBR1;GREM1;MBOAT2;EFEMP1;PKDCC;PTPN11
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4042012493206322,0.98070051464384,0.5090252707581228,0.8820650596744829,1.0,6/11,27.55%,PPCDC;PANK4;PANK2;DCAKD;PANK1;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),0.4042012493206322,0.98070051464384,0.5090252707581228,0.8820650596744829,1.0,6/11,27.55%,PPCDC;PANK4;PANK2;DCAKD;PANK1;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4042012493206322,0.98070051464384,0.5090252707581228,0.8820650596744829,1.0,6/11,27.55%,PPCDC;PANK4;PANK2;DCAKD;PANK1;ACOT7
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4103103325208347,0.9806065848518452,0.48194945848375453,0.8816125043179933,1.0,1/11,1.05%,SMAD7
prerank,positive regulation of DNA repair (GO:0045739),0.2918436070285844,0.9803962271097593,0.5016501650165016,0.88144412892582,1.0,13/46,15.33%,HDAC10;SPIDR;PCNA;MGMT;EYA3;RNF8;BRCA1;SPIRE1;ABRAXAS1;DHX9;CEBPG;TMEM161A;BABAM1
prerank,spinal cord development (GO:0021510),-0.379150304636411,-0.9801068910648019,0.49344978165938863,0.8262216025704778,1.0,6/12,23.98%,VIT;SOX11;PKD2;RELN;SOX12;PKD1
prerank,mitotic recombination (GO:0006312),-0.35669440434215943,-0.9800901234442697,0.49176470588235294,0.8253832817227957,1.0,6/15,19.31%,TPRKB;SMC5;GEN1;RAD51D;DMC1;RAD52
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.32415355677180296,-0.9791777414842463,0.4725274725274725,0.8270977678455276,1.0,5/22,17.73%,SCAF8;CDC73;ERCC6;ELL;CDK12
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.2669219607782497,-0.9791501366499099,0.4838709677419355,0.8262908883978535,1.0,14/47,20.08%,NEDD9;DOCK5;CDC42;CORO1C;CARMIL1;MYADM;SPRY4;ITGB1BP1;KANK1;RCC2;EFNA5;FLNA;OLFM4;S100A10
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3236449316177948,0.9790790587120921,0.4954954954954955,0.884524241058118,1.0,3/27,4.59%,SIRPA;TLR4;NCKAP1L
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4025358366018129,-0.9789312242062936,0.460446247464503,0.8260841926842728,1.0,4/10,24.01%,DROSHA;TARBP2;TERT;AGO2
prerank,positive regulation of cell cycle (GO:0045787),-0.2532020133899715,-0.9784871270005228,0.5,0.8264389272024958,1.0,19/62,22.42%,EGFR;APP;ANKRD17;TTL;CCND2;CCNYL1;PKD2;LRP6;RPS15A;RARA;SRPK2;RGCC;CHEK1;MDM2;CCNB1;EIF4EBP1;SPDYA;CDK4;TGM1
prerank,lipid homeostasis (GO:0055088),-0.2568659257897057,-0.9784025735097343,0.494949494949495,0.8257951325700312,1.0,16/57,21.13%,PPARG;APOE;TLCD3A;SIRT1;USF1;RCN3;ZBTB20;CEBPA;ADCK1;ANGPTL3;PRKAA1;ABHD5;RBP1;PNPLA3;TLCD3B;POLD1
prerank,lymphocyte proliferation (GO:0046651),-0.32206906682964936,-0.9783796402276054,0.48148148148148145,0.8249899113611946,1.0,11/22,28.98%,CD40;MSN;CR2;HELLS;CTPS1;BCL2;TNFRSF4;MS4A1;FLT3;RASGRP1;HSPD1
prerank,neural tube closure (GO:0001843),0.3077120733091457,0.9781002333699013,0.48849557522123893,0.8866181485339473,1.0,14/34,27.44%,SKI;DEAF1;SEMA4C;MTHFD1;PAX2;VANGL2;VASP;CELSR1;TGFB1;IFT122;GRHL3;KDM2B;DVL3;DVL1
prerank,positive regulation of cell growth (GO:0030307),-0.23280006819326,-0.9780472376752063,0.4842105263157895,0.8250907794777201,1.0,24/96,17.63%,RIMS2;AKAP6;CDKL5;BDNF;EGFR;SYT1;SDCBP;NEDD4L;CDC42;RIMS1;DERL2;LGI1;PABIR1;MAP3K13;MFSD2A;MMP14;MTPN;BCL2;SFRP1;PLAA;SYT3;H3-3A;SEMA7A;SFRP2
prerank,regulation of cell motility (GO:2000145),-0.22595910129151578,-0.9779623998140697,0.5261707988980716,0.8244546511458177,1.0,33/121,19.88%,FRMD5;EGFR;FGF10;SLK;PLXNC1;SPOCK3;PLXND1;LMNA;PLXNA2;CADM4;LMO4;KIF14;FGF9;ERBB4;MGAT3;RAF1;PLXNA1;INPP5F;ERBB3;FGF7;SRCIN1;ENPP2;PLXNB2;NRG2;RCC2;PLXNB1;ABL2;FLNA;DIAPH1;FGF5;ARHGAP18;CAVIN1;TMSB10
prerank,negative regulation of MAPK cascade (GO:0043409),0.2572781671265845,0.9778784907229109,0.49133858267716535,0.8865520337527526,1.0,13/87,10.63%,SIRPA;CNKSR3;TLR4;PRKCD;LYN;UCHL1;SPRY2;FLCN;GPER1;PIK3CB;RGS14;PTPN1;DUSP29
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.39362034115626865,0.977867960667614,0.4753787878787879,0.8858361639683221,1.0,2/12,7.73%,IL18;IL12B
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.28532561810525764,0.9774298882673433,0.4924114671163575,0.8863243742138791,1.0,14/46,21.34%,IL18;AIF1;IGFBP3;IL6R;PDGFB;IL12B;NDRG4;AKT1;VIP;THBS1;TCF7L2;TRIB1;XRCC6;MFN2
prerank,cellular response to interleukin-1 (GO:0071347),-0.22392688221958898,-0.9771252767358728,0.5014925373134328,0.8259587799188054,1.0,32/143,18.13%,PLCB1;CD47;ST18;PSMD14;CCL4;CD40;ADAMTS12;PSMA2;GBP3;PELI3;UBE2N;PSMF1;PSMD8;PSMD6;NFKBIA;PSME2;BTRC;PSMD11;USP10;CCL2;PSMD1;PSMD5;RELA;GBP2;CCL5;CX3CL1;SFRP1;PSMD12;IL1R1;UPF1;CCL14;TAB1
prerank,positive regulation of sodium ion transport (GO:0010765),0.39836918793281695,0.9770690878428667,0.4748201438848921,0.8865935520474261,1.0,5/12,20.72%,CNKSR3;SCN4B;WNK3;NOS1;SCN1B
prerank,apoptotic nuclear changes (GO:0030262),-0.31616400891425755,-0.9768073843279451,0.48775055679287305,0.8259840493896284,1.0,3/24,4.59%,DEDD2;TOP2A;ACVR1C
prerank,cognition (GO:0050890),-0.27189935809758387,-0.9767026846639115,0.5063291139240507,0.8253803350343875,1.0,15/42,24.17%,GRM5;APP;ST3GAL4;JAKMIP1;MGAT3;CHRNA4;MFSD2A;SETD5;PTCHD1;BBS4;MAGT1;RP9;SLC1A4;HRH3;METTL23
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.3685500655663251,0.9766082435930108,0.5080789946140036,0.8871960476431866,1.0,6/16,20.02%,DDX5;PADI2;DDX17;ARID1A;SAFB;DDX54
prerank,regulation of cellular response to heat (GO:1900034),0.25916664755531615,0.9766029776785404,0.5040783034257749,0.8864728057901923,1.0,26/77,23.78%,RANBP2;ATM;NUP42;HSPH1;CD34;SEC13;NUP35;MLST8;RPTOR;NUP50;HSPB8;BAG4;MTOR;SEH1L;DNAJC7;NUP62;NUP107;NUP88;NUP188;RPA3;MAPT;CHORDC1;CRYAB;NUP214;HIKESHI;BAG5
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3133978794868663,0.9763956535052174,0.46605504587155966,0.88632760586036,1.0,8/27,21.47%,SLC7A8;SLC1A3;SLC7A5;SLC22A2;SLC6A9;ARL6IP5;SLC38A1;PRAF2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.31408566811794714,-0.9762217207812265,0.5034965034965035,0.8259478068638931,1.0,7/26,11.06%,LRRK2;SIRT1;PPIA;PRKN;PDE8A;FBXO7;SOD2
prerank,chromatin organization (GO:0006325),-0.22152453819180268,-0.9761691215029686,0.5068119891008175,0.8252275967617277,1.0,43/132,25.96%,SUV39H1;MTF2;KDM4D;JARID2;BAZ2B;SIRT1;MYC;HDAC4;MPND;KDM6B;MCM3AP;PADI4;SMARCE1;MTA2;PRDM16;SETDB2;PAK1;PBRM1;SETD5;NPM2;HDAC1;SMARCA1;NPM1;PIH1D1;KDM4C;BAZ2A;FOXP3;ACTL6B;SUV39H2;SMARCD2;BAZ1A;NUCKS1;CBX3;HMG20A;SUPT4H1;FAM47E;SMARCC1;MYB;NUDT5;TOP1;ZBTB7A;EHMT1;KDM6A
prerank,regulation of membrane depolarization (GO:0003254),-0.34423605511310684,-0.9761531073360816,0.49551569506726456,0.8243974692588251,1.0,3/18,6.93%,LRRK2;NEDD4L;PTPN3
prerank,DNA recombination (GO:0006310),0.3011614706752536,0.9760651677374648,0.4991652754590985,0.8865774840503889,1.0,12/37,24.69%,RHNO1;HDAC10;RAD54B;RAD51B;BLM;EXO1;FBH1;RPAIN;RAD51C;TSN;RECQL;RTEL1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.36213189248978334,0.97604710582617,0.5009140767824497,0.8859033604507882,1.0,6/17,16.45%,LGALS9;SLC7A5;CD86;HAVCR2;NLRP3;GATA3
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3154529861399661,-0.976019588039079,0.5065217391304347,0.8239394488523154,1.0,4/24,2.48%,PLA2G7;CCR2;SLIT2;CCR1
prerank,regulation of vasculature development (GO:1901342),-0.31014915506370616,-0.9760096625543269,0.4749455337690632,0.8230989081882388,1.0,7/26,16.49%,PLXND1;SP100;HTATIP2;VASH2;CTNNB1;SFRP1;HMOX1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.3808200034860209,0.9760056167770239,0.49429657794676807,0.885288813199779,1.0,8/14,23.89%,AIF1;IGFBP3;MEF2C;NDRG4;LRP1;TRIB1;SERPINE1;TPM1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.2478914935028939,0.9758912128490097,0.5086614173228347,0.8848889005329259,1.0,28/109,20.36%,VAV2;RAC1;LAT2;GAB2;LYN;PIK3R1;PLCG2;LCP2;NFATC1;PDPK1;TAB2;PSMD3;PIK3CB;PSMA7;PSMB3;PSMB9;PSMC2;PSME4;PSMC1;PSMB7;PSMB5;TEC;VAV1;MAPK8;JUN;PSMB8;PLCG1;PIK3CA
prerank,brain development (GO:0007420),-0.2220932591203859,-0.9758457149517149,0.5244956772334294,0.8227055010487934,1.0,51/136,27.72%,CNTNAP2;CTNNA2;NFIB;ADGRL3;GRIN2A;POMK;GRIN2B;CENPF;RAPGEF2;SHANK3;CDK5RAP2;COL4A1;VPS51;EML1;CLN5;AFF2;HSPG2;ZFHX2;GRIN2D;DDIT4;MFSD2A;PBX1;PLXNB2;SPEF2;RELN;MDGA1;SMARCA1;UGP2;SCYL2;NKX2-2;CNTN4;BBS4;PBX3;ADGRL2;CDK5RAP3;ARNT2;APOD;EPHA7;SLC6A17;GRHL2;RAB18;NES;ATXN1;FBXW11;PAFAH1B1;AMIGO2;HES5;MKKS;ROBO2;AMIGO1;ABCB6
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.40612542171544697,-0.9753830699578219,0.4650655021834061,0.8231716119688394,1.0,6/10,29.15%,PPARG;RARG;RARA;RARB;SNW1;TBX1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.23852151914502304,0.9752492484204843,0.5168,0.8861196339800477,1.0,30/132,18.61%,NCBP1;CELF2;SF3B1;SNRPC;COIL;POLR2D;SNRPF;SRSF5;SART3;EIF4H;SMN1;NLE1;GEMIN6;DHX9;BOP1;LUC7L3;RPS27L;EIF2S2;LUC7L;SNUPN;BRIX1;MRPS11;EIF2D;DDX39B;SRSF9;GEMIN2;TRAF7;EIF5;SHQ1;RPL10
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3176224032189314,0.9750713217380872,0.47619047619047616,0.8859171315426435,1.0,5/27,9.59%,TLR4;IRAK2;TAB2;UBC;RPS27A
prerank,negative regulation of cell communication (GO:0010648),0.3387690938995985,0.9746761527320648,0.507168458781362,0.8863134409718486,1.0,3/21,9.34%,IGFBP3;UBASH3B;PTPN1
prerank,response to metal ion (GO:0010038),0.2664262884202367,0.9744984152308446,0.5,0.8861003008467931,1.0,18/67,20.56%,SLC30A5;CAPN3;KCNMA1;SLC30A8;HAMP;MT1A;MT1X;MT2A;PDCD6;ALG2;HVCN1;KHK;THBS1;CALM2;SEC31A;ATP5F1D;MAPT;HIF1A
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.2988998243028824,0.9744806815722334,0.5043177892918825,0.8854105168262151,1.0,8/35,14.44%,RASAL3;SPRY2;FLCN;MET;CCDC125;RASIP1;LZTR1;TNFAIP1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2712949048056007,0.9744739672837716,0.5109612141652614,0.8847036021965615,1.0,22/62,23.78%,ARHGEF2;NFE2L2;HYOU1;SRC;CLU;NDUFS3;VNN1;PINK1;AKT1;PTTG1IP;ARMC10;TMEM161A;MAPK7;NDUFA13;SYVN1;TMBIM6;OPA1;PARK7;HTRA2;DDX3X;TXNDC12;BAG5
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.32456600268325775,-0.9742162643982174,0.452431289640592,0.8255729994803973,1.0,10/22,22.42%,FGF10;KLF9;ZFP36;CASK;FGF7;SNAI2;NOTCH2;PTPRK;MED1;TGM1
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.2073248795054134,-0.9738493567379711,0.5555555555555556,0.8257670967986628,1.0,48/198,18.71%,PTPRD;PLCB1;LRRK2;PLBD1;PLPPR4;PLCH1;PPM1A;GPD2;LIMD1;PFKFB1;DUSP16;PPA1;ACYP2;CERKL;LGALS13;PFKM;HTR2B;CALM1;ALK;PLCB4;ITPKC;INPP5J;NUDT3;DUSP10;PLPPR1;PLCD4;GFPT2;PXYLP1;OCRL;TIGAR;PAK1;PLCH2;GK;G6PC3;PLPP3;PGM2L1;ALDOC;PLAA;AGPAT1;INPP5A;IP6K2;PLA2G2D;PFKP;ANGPTL3;GPI;DUSP28;PLCD1;PLPPR3
prerank,substantia nigra development (GO:0021762),0.29864928922051126,0.9735405980461322,0.5098039215686274,0.8866103699317344,1.0,8/37,11.09%,YWHAH;BASP1;SIRT2;SUDS3;PADI2;NDUFS3;CKB;RAD1
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.2855026203955144,-0.9734506355943973,0.48409090909090907,0.8260197161178799,1.0,8/35,16.52%,PAM;ALOX5AP;ALOX5;HMGCLL1;GGT7;ACLY;FAR2;FAR1
prerank,response to tumor necrosis factor (GO:0034612),-0.2337355958368647,-0.9734372837977918,0.5064935064935064,0.8251956939392645,1.0,23/91,18.94%,PID1;AFF3;YBX3;CCL4;CD40;ADAMTS12;SIRT1;RPS3;GBP3;ZFP36;JAK2;ZFAND6;CCL2;GGT7;RELA;GBP2;CCL5;CRHBP;CX3CL1;SFRP1;CCL14;NUB1;CCL7
prerank,regulation of programmed necrotic cell death (GO:0062098),0.34388062934011865,0.9731853874758835,0.496415770609319,0.8869008606851716,1.0,14/20,34.24%,CFLAR;ASAH1;FLOT2;STUB1;CYLD;BIRC2;BIRC3;HSP90AA1;CASP8;PELI1;CDC37;FLOT1;PDCD6IP;OGT
prerank,muscle filament sliding (GO:0030049),-0.2830754191703156,-0.9731014882407102,0.4872389791183295,0.8244174626568737,1.0,16/38,32.95%,DMD;VIM;ACTN2;TNNI1;MYBPC3;DES;TPM4;ACTA1;MYL6;TNNC1;TTN;TNNT2;MYH6;TPM2;MYH7;TNNT1
prerank,actin-myosin filament sliding (GO:0033275),-0.2830754191703156,-0.9731014882407102,0.4872389791183295,0.8244174626568737,1.0,16/38,32.95%,DMD;VIM;ACTN2;TNNI1;MYBPC3;DES;TPM4;ACTA1;MYL6;TNNC1;TTN;TNNT2;MYH6;TPM2;MYH7;TNNT1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.3822666641965462,-0.9730937752026654,0.48812095032397407,0.8235801783882849,1.0,6/12,27.66%,FOXP1;BTK;AURKB;BLK;IL2;NOC2L
prerank,regulation of defense response (GO:0031347),0.25717613388157773,0.973054627914579,0.5244299674267101,0.8865688425376309,1.0,19/76,20.44%,DAGLB;IL1RL2;CASP1;SBNO2;LRRC19;PIK3AP1;SELE;BCL6B;NLRP6;APPL1;XIAP;AREL1;NOD2;AKNA;SHPK;PARK7;CASP12;ERAP1;MYD88
prerank,protein polyubiquitination (GO:0000209),0.21592214159287373,0.9727060087741196,0.5366197183098591,0.8868423385702272,1.0,69/297,18.62%,FBXL18;FBXL20;FBXO22;RNF216;TRAF5;RNF41;ITCH;SPSB1;FBXL15;UBE2H;TRIM5;SMURF1;RFFL;UNKL;TRIM36;CDC34;PSMD3;TRIM69;MIB2;RNF8;AKTIP;BRCA1;WWP2;FBXW4;UBC;RPS27A;ZFP91;RNF166;FBXO11;BFAR;WSB1;PSMA7;DDB2;TRIM62;AREL1;FBXO38;FBXO21;UBE2U;UBE2V2;DTX3L;RNF31;ANAPC11;PELI2;MYLIP;PSMB3;PSMB9;FBXL22;ANAPC13;PSMC2;MKRN3;RNF187;RNF144B;FBXL8;TRIM3;PSME4;PSMC1;PSMB7;TOPORS;TRIM14;ANAPC1;FBXL7;UBE2A;TAF1;KLHL3;RNF4;SYVN1;PSMB5;RNF20;HECTD2
prerank,positive regulation of secretion (GO:0051047),-0.40205312629242435,-0.9726929113889277,0.5105042016806722,0.8238378718009768,1.0,6/11,36.70%,ACSL3;AQP1;ABCB11;SCIN;XBP1;TRH
prerank,carbohydrate derivative transport (GO:1901264),0.354885635244951,0.9726481971217619,0.5080213903743316,0.8863008775078701,1.0,8/18,20.45%,CPTP;SLC15A4;NPC2;CLN3;SCARB1;SLC15A2;SLC28A1;SLC29A1
prerank,stem cell development (GO:0048864),0.36651375909945627,0.9720792646338131,0.5111111111111111,0.887211171441958,1.0,4/16,12.31%,SOX8;SHH;KBTBD8;PDCD6
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.2792148269822434,-0.9718117124370257,0.4719626168224299,0.8254275379617287,1.0,8/36,15.17%,CCR2;SHANK3;JAK2;CCL2;ADRA2A;BUD31;RELN;HDAC1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.31333125751462426,-0.9716690223956402,0.4820627802690583,0.8249694940868019,1.0,3/22,8.21%,CCR2;LILRB1;BTK
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2636019374812927,0.9714753522136499,0.5035460992907801,0.8882140878761287,1.0,18/69,17.96%,ARHGEF2;LGALS9;AGER;TLR4;PLCG2;CLU;IL12B;ORM2;DDT;IL33;PTPN11;DHX9;HAVCR2;MAVS;SETD4;THBS1;NOD2;PTPRJ
prerank,positive regulation of response to stimulus (GO:0048584),-0.27706559213971865,-0.971363342594174,0.4879807692307692,0.8249573570258966,1.0,13/40,21.87%,B2M;RSAD2;SIRT1;HOMER1;MYC;NSMCE4A;IER5;CDKN2A;FCGR2B;CD80;IFIH1;NSMCE1;ARG2
prerank,regulation of protein catabolic process (GO:0042176),-0.2336654426482891,-0.9713351307934084,0.5227882037533512,0.8241893955572158,1.0,35/99,24.91%,EGFR;WWP1;HECW2;HECW1;APC2;NEDD4L;FAF1;BARD1;GSK3B;PRKN;PLK2;GPC3;AXIN1;EEF1A2;ATG7;AZIN1;HMGCR;FAM83D;FOXO1;RILP;FLNA;NKD1;TNFSF12;MDM2;OAZ1;TIPARP;DTL;DDB1;MAD2L1;SNX12;EEF1A1;SEC22B;IRAK3;SORL1;FZR1
prerank,regulation of lipid catabolic process (GO:0050994),0.3454977834030467,0.9706103339809381,0.4883720930232558,0.8899519824942635,1.0,1/19,0.11%,PDE3B
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3070905320445321,0.970307487767546,0.4848993288590604,0.8901573059413985,1.0,11/33,17.40%,NYAP1;PIK3R1;SIRT2;IGF1R;PIK3CG;ZFP36L1;PIK3CB;PIK3CD;AKT1;GATA3;C1QBP
prerank,regulation of viral release from host cell (GO:1902186),0.33813315436393543,0.9702615071995585,0.4991243432574431,0.8895568774988094,1.0,5/21,17.25%,TRIM11;TRIM5;TRIM62;TSG101;CHMP2A
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.3835110636760395,-0.970111845545621,0.5011655011655012,0.8266376881694314,1.0,3/12,5.98%,PLCB1;SLIT2;BMP5
prerank,cell-substrate junction assembly (GO:0007044),-0.2921157604174841,-0.970081228961007,0.5127020785219399,0.8258603788862354,1.0,10/33,16.99%,SORBS1;CTTN;FN1;TRIP6;THSD1;ACTN2;CD151;THY1;RCC2;PEAK1
prerank,plasma membrane repair (GO:0001778),-0.3698155365506216,-0.9698608549792606,0.5197505197505198,0.8256523585789519,1.0,4/13,14.57%,MYOF;RAB3A;DYSF;AHNAK2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.36987783627617205,0.9697310241705928,0.48523985239852396,0.8904344664083618,1.0,6/15,19.50%,CRNN;PHB2;PLCG2;KLHL18;EZH2;STXBP4
prerank,neuron differentiation (GO:0030182),0.2316217725098278,0.9696402257603545,0.5260736196319018,0.8899942963836961,1.0,22/165,10.71%,TGFBR1;OPHN1;ATP8A2;MEF2C;ACSL4;EPOP;PAX6;MET;FZD2;SHH;WNT2B;MYO7A;RYK;WNT10B;BHLHE22;CTF1;NEUROD6;NEUROD4;WNT7B;ERCC2;WNK1;PPT1
prerank,ion transport (GO:0006811),0.24300306443313874,0.9694084040446932,0.5222929936305732,0.8899343863563297,1.0,21/111,14.42%,SLC9A9;SLC1A3;SLC9A8;SLC24A3;SLC36A1;SLC12A6;SLC8A1;KCNN1;MCOLN1;SLC15A4;CNGB3;SLC20A2;ATP1A4;SLC17A8;WNK1;TSPO;LRRC8A;CHRNA3;SLC32A1;SLC15A2;VDAC1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.30908463100235684,-0.9691586720048011,0.49406175771971494,0.8267635792280736,1.0,10/26,19.22%,DAB2;FOXP1;SIRT1;STRN3;PER1;CLOCK;HDAC1;SFRP1;NCOR1;CRY1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.39963773311720696,0.969126362933406,0.478584729981378,0.890012476975036,1.0,3/11,16.42%,LGALS9;CD34;THBS1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2650568919852412,0.9689802393427897,0.49375,0.8896934715926574,1.0,19/68,21.71%,POLR2H;NCBP1;GTF2H2;CSTF2;SNRPF;TTF2;PABPN1;CPSF1;SMN1;ERCC2;POLR1C;MED18;UBTF;PCF11;FIP1L1;POLR2E;POLR1G;POLR1E;MTERF2
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.31193889447778556,-0.9689045842709106,0.518348623853211,0.8266110973984067,1.0,4/27,7.99%,RIMS2;SYT1;SYT10;RIMS1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.3843527297282403,0.968825509196614,0.4827586206896552,0.8893962923577571,1.0,3/13,11.75%,UBA7;UBA2;UBA5
prerank,negative regulation of gene expression (GO:0010629),-0.20011914384171664,-0.9685976209067084,0.5993031358885017,0.8265963409877972,1.0,77/302,20.34%,ROBO1;XDH;SAMD4A;PTBP2;APP;MSR1;ATP2B1;APOE;FOXP1;CCR1;MTF2;ERN1;JARID2;PTPN22;NPTN;CPEB3;RBMS3;SIRT1;RPS3;SOX11;DAPK1;AGO4;EIF4A3;PARP14;PRKN;TNRC6A;PTRH2;ZFP36;WNT4;SH3GL2;ZC3H12D;RPL13A;AEBP2;LGR4;CREB3L1;REL;OPRD1;CNOT10;DNMT3B;MYADM;SMCR8;NDFIP1;SETDB2;GIGYF2;HELLS;KLF4;BTG2;MMP8;SHMT1;TTBK1;RGCC;PARP10;FCGR2B;HSPA1B;HDAC1;HEY2;SFRP1;NCOR1;H3-3A;FFAR4;PPHLN1;CD3E;APLN;ACVRL1;SFRP2;APLNR;BMP4;RBBP7;FOXP3;PRKAA1;ABCC2;SYNCRIP;TIPARP;TSC1;CD46;TERT;NOTCH2
prerank,positive regulation of DNA recombination (GO:0045911),0.3208590194777225,0.9683288718000129,0.5044404973357016,0.890056832969463,1.0,10/27,23.62%,WDR48;FUS;KMT5C;MMS19;ERCC2;SHLD2;PRDM9;ZCWPW1;PAXIP1;ACTR2
prerank,DNA methylation (GO:0006306),-0.3210970680223679,-0.9682935479155476,0.48344370860927155,0.8266151699068044,1.0,10/23,26.95%,KMT2E;ATF7IP;GATAD2A;DNMT3B;HELLS;SPOCD1;BAZ2A;DNMT1;EHMT1;FOS
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2583640603475833,0.9681958526265675,0.49833333333333335,0.888996525630658,1.0,24/78,20.11%,KIF2A;DNM2;CTSD;KIF3B;CAPZB;LGMN;AP2A1;CTSS;SEC13;AP1M2;ACTR1B;AP1S2;KIF3A;CTSE;CTSF;CLTA;DCTN5;AP1S1;DCTN2;SEC31A;ACTR1A;AP1B1;DCTN4;KLC1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2583640603475833,0.9681958526265675,0.49833333333333335,0.888996525630658,1.0,24/78,20.11%,KIF2A;DNM2;CTSD;KIF3B;CAPZB;LGMN;AP2A1;CTSS;SEC13;AP1M2;ACTR1B;AP1S2;KIF3A;CTSE;CTSF;CLTA;DCTN5;AP1S1;DCTN2;SEC31A;ACTR1A;AP1B1;DCTN4;KLC1
prerank,regulation of RNA metabolic process (GO:0051252),-0.25646843469307523,-0.9681331405297736,0.5435897435897435,0.8261809248895233,1.0,14/59,14.64%,AHNAK;PTBP2;OAS2;NOVA1;MBNL3;RBM20;PCBP3;GRSF1;AFF2;PRX;FASTK;SRRM4;AHNAK2;OAS3
prerank,natural killer cell activation (GO:0030101),0.32669340229842264,0.9677205741877192,0.49183303085299457,0.8896549674896075,1.0,5/23,10.63%,BAG6;ULBP1;IL12B;PIK3CD;AXL
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.3691603599084602,0.9674206200471235,0.4830188679245283,0.8897785488848131,1.0,2/15,2.61%,MLXIPL;PPARD
prerank,protein insertion into ER membrane (GO:0045048),-0.2765913378257814,-0.9669319059240653,0.48847926267281105,0.8287237805713715,1.0,13/37,23.70%,APP;VAPA;UBE2J2;GET3;MMGT1;EMC3;EMC7;HMOX1;EMC2;ALDH3A2;EMC4;EMC10;GET4
prerank,nuclear transport (GO:0051169),-0.35000102127146926,-0.9667531126653609,0.5229759299781181,0.828390647896418,1.0,5/16,15.88%,NUP98;RSRC1;NUP205;BANF1;NPM1
prerank,odontogenesis (GO:0042476),-0.2847579137328214,-0.9659929409347157,0.5213032581453634,0.829685533908232,1.0,13/35,31.63%,TUFT1;EDA;LRP6;HDAC1;BMP4;FOXC1;WNT6;MSX1;AQP1;ANKRD11;TBX1;AMELX;PITX2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.28303044654803644,-0.965798538698797,0.506265664160401,0.829380424448793,1.0,7/38,6.69%,LRRK2;NPEPPS;ATG13;UBE2J2;PARL;RHOU;PRKN
prerank,cellular response to sterol (GO:0036315),0.3756690607494159,0.965724917237951,0.500945179584121,0.893861370543023,1.0,5/13,24.63%,GRAMD1A;SMO;PTCH1;GPLD1;INSIG2
prerank,response to iron ion (GO:0010039),-0.38403757217854617,-0.9656627035619375,0.5164835164835165,0.8289112127242817,1.0,4/12,15.70%,B2M;TFR2;SNCA;BCL2
prerank,Fc receptor signaling pathway (GO:0038093),0.24552380782192074,0.9655317442057322,0.5159744408945687,0.8936423618202205,1.0,28/110,20.36%,VAV2;RAC1;LAT2;GAB2;LYN;PIK3R1;PLCG2;LCP2;NFATC1;PDPK1;TAB2;PSMD3;PIK3CB;PSMA7;PSMB3;PSMB9;PSMC2;PSME4;PSMC1;PSMB7;PSMB5;TEC;VAV1;MAPK8;JUN;PSMB8;PLCG1;PIK3CA
prerank,regulation of response to stress (GO:0080134),-0.3999139992778237,-0.9654966969399343,0.5150862068965517,0.8285752102967143,1.0,4/10,21.02%,ADCY8;OPRM1;CRHBP;STOX1
prerank,peptidyl-asparagine modification (GO:0018196),0.30890839982123536,0.964609390471022,0.49477351916376305,0.895576507649671,1.0,8/31,16.54%,DPM3;MGAT2;NUDT14;OSTC;MGAT1;MGAT5;ALG5;ALG8
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.3536633063924797,-0.9645939303832088,0.5088105726872246,0.8302609790365818,1.0,3/15,7.77%,PPARG;OSBPL8;PLIN2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.23549745106708103,-0.9645528881363207,0.5169491525423728,0.8295283393135712,1.0,27/87,21.80%,PSMD14;PSMA2;PSMF1;PSMD8;CDC73;PKD2;PSMD6;PSME2;PSMD11;CCL2;E2F7;PSMD1;KLF4;PSMD5;DCUN1D3;CDKN2A;RGCC;CDKN1A;PSMD12;GPR132;JADE1;PSMB1;USP47;CDK4;MYO16;CDK6;RBL1
prerank,platelet degranulation (GO:0002576),0.23982340849800834,0.9644397147839109,0.5031446540880503,0.8953458918284203,1.0,18/118,11.62%,LHFPL2;TUBA4A;FERMT3;LYN;STXBP1;CYRIB;PROS1;VEGFB;CLU;SPARC;CD9;PDGFB;ORM2;F8;CYB5R1;PLEK;APOH;SOD1
prerank,regulation of transmembrane transport (GO:0034762),-0.29293865700207833,-0.9643457646142223,0.5162790697674419,0.8292621812385638,1.0,16/31,33.40%,KCNJ3;NEDD4L;ACTB;KCNJ6;PIM1;SNCA;BCL2;FFAR4;ACE2;TRIB3;KCNJ10;OCLN;KCNJ8;CLTRN;KCNJ14;KCNJ16
prerank,regulation of protein modification process (GO:0031399),-0.26339448816270916,-0.9643077062205285,0.5048780487804878,0.8285260129516113,1.0,11/50,13.71%,CCDC88C;GRM5;KDM4D;FN1;CORO1C;CADM4;CCDC88A;ATG7;CCAR2;CDH5;PLXNB2
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2155047694421891,-0.9643011893653385,0.5482954545454546,0.8277049584009427,1.0,30/160,12.83%,DMD;HIP1;NCK2;SGIP1;CENPF;RTN4;NUP98;CENPT;CCT2;STXBP6;UVRAG;DLGAP5;PIK3C2A;RPL38;GTF2B;CYBA;DNAI4;CENPE;PSMD11;TESPA1;HOPX;NUP205;AXIN1;HSP90AB1;EPS15;TBCC;CENPW;SNX9;TIAM1;SNCA
prerank,positive regulation of defense response (GO:0031349),0.25344137000029054,0.963644139992863,0.5523349436392915,0.8969585101730593,1.0,13/89,10.68%,IL18;POLR3G;TLR7;ETS1;MEF2C;TLR4;TRADD;SLC15A4;IL12B;DDT;AKIRIN2;IL33;DHX9
prerank,organophosphate catabolic process (GO:0046434),0.4027768836914112,0.9635557511761185,0.5065913370998116,0.896504595110613,1.0,3/11,10.57%,ABHD12;NUDT15;PLBD2
prerank,post-translational protein modification (GO:0043687),0.21031329877475705,0.9635540823565943,0.5629322268326418,0.8957884529571868,1.0,80/332,23.41%,GOLM1;CST3;PRKCSH;FBXL18;MGAT4A;IGFBP3;ASB8;FBXL20;VHL;FBXO22;SPSB1;COPS4;FBXL15;DCAF8;SPSB2;CUL4B;PSMD3;ASB4;RABGGTA;AMBN;ASB15;ANKRD9;ASB11;RAB1A;MIA3;ASB5;KBTBD8;FBXW4;ASB3;FBXO11;WSB1;PSMA7;DDB2;MSLN;FBXO21;DCAF11;SOCS6;GPS1;ATG5;KCTD6;DCAF10;PSMB3;MBTPS1;KCTD7;PSMB9;FBXL22;PSMC2;FBXL8;UBXN7;CCDC22;RAB13;PSME4;PSMC1;COPS6;PSMB7;SUMF2;FBXL7;WSB2;KLHL3;ADAM10;PSMB5;DMP1;DSCC1;RCN1;PSMB8;WDR5;HIF1A;EVA1A;KLHL9;WDTC1;MXRA8;CUL4A;KLHL41;TULP4;ICMT;FBXL14;CUL1;APLP2;FBXO41;KEAP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.23864278395280775,0.9635438489107867,0.528125,0.8950961695700737,1.0,20/121,12.41%,IL18;ARHGEF2;CSF1R;GREM1;SRC;RIPK2;LYN;PLCG2;IL6R;IL6ST;CNTF;PDGFB;IL12B;CTF1;PTK2B;PTPN1;PTPN11;DLG4;ABL1;SEMA4D
prerank,termination of RNA polymerase II transcription (GO:0006369),0.30898384132906315,0.9635072870475497,0.5084175084175084,0.894475494760787,1.0,9/33,18.40%,NCBP1;CSTF2;SNRPF;TTF2;PABPN1;CPSF1;MED18;PCF11;FIP1L1
prerank,cardiac muscle cell development (GO:0055013),-0.33153206136407765,-0.9633005656704098,0.5298969072164949,0.8296479619393525,1.0,8/20,30.84%,PDLIM5;OBSL1;HEY2;SORBS2;FHOD3;TTN;MYH6;ALPK3
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.31435764008837425,-0.963049927559517,0.48997772828507796,0.8294950295793546,1.0,6/24,9.38%,LATS1;APOE;CTSC;PSMD14;USP14;PSME2
prerank,pulmonary valve morphogenesis (GO:0003184),-0.3469518765234827,-0.962896016565393,0.5259593679458239,0.8290840506057096,1.0,7/17,22.48%,ROBO1;SLIT2;JAG1;HEY2;BMP4;NOTCH2;GJA5
prerank,positive regulation of cellular component organization (GO:0051130),0.24470485482810414,0.962607298019156,0.5440677966101695,0.8962515512710519,1.0,28/107,19.83%,TGFBR1;SUMO1;ASAP1;CDC42EP2;IGF1R;SPIDR;TMED9;MTLN;CLU;SH3GLB1;RAPGEF3;DLL1;BMF;ABCB4;RUNX1;LRP1;ADGRL1;PLEKHM2;PTPN23;TAL1;BCL2L11;LRP4;CLIP3;GNL3L;CAMK1;ANAPC2;PARK7;SLF2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.36596943144481586,-0.9625352699210432,0.5077951002227171,0.8292501147438773,1.0,4/13,8.09%,NRROS;FSTL1;FBN2;FBN1
prerank,cellular response to alkaloid (GO:0071312),0.35511940036257134,0.9622206477403991,0.5037037037037037,0.8966349062834015,1.0,4/17,11.23%,TGM2;SPIDR;SLC8A1;BLM
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.24410064515698604,-0.9622161701894136,0.5431472081218274,0.8293079127777945,1.0,14/73,14.21%,HIP1;ROBO1;XDH;NLRC4;PPARG;DAP;DIABLO;JAK2;BEX3;BID;ATP2A3;SNCA;SENP1;EGLN3
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.2271027954575707,-0.9621107107411149,0.5295857988165681,0.8287925417424391,1.0,21/98,18.09%,MAGI2;PID1;XDH;PPARG;APOE;ATAD1;ROMO1;RAB1B;NFKBIA;PRELID1;INPP5F;ANXA2;ACLY;KLF4;SNCA;CCL5;AHI1;CDKN1A;AGPAT1;SCYL2;CCNB1
prerank,folic acid metabolic process (GO:0046655),-0.33328569599342317,-0.9619057060926723,0.5,0.8285574657369943,1.0,10/18,29.43%,ALDH1L1;MTHFD1L;SLC46A1;SHMT1;MTHFD2;FPGS;SHMT2;FOLR2;MTHFD2L;DHFR
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.37472982235548213,-0.9617284940721978,0.48497854077253216,0.8281783941304167,1.0,1/13,0.24%,PID1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2596924074222211,0.9616785389715924,0.5238853503184714,0.8974428357443494,1.0,8/76,3.73%,ARRB2;DDIT3;IRAK2;ITCH;PRMT2;OTULIN;PYDC1;PKHD1
prerank,histone methylation (GO:0016571),0.3215742291316155,0.961613817009273,0.5245614035087719,0.8969022319339635,1.0,9/26,20.54%,PRMT2;EHMT2;PRMT8;PRMT1;PRMT6;CARM1;EZH2;FBL;SMYD1
prerank,regulation of gluconeogenesis (GO:0006111),-0.30565592566522054,-0.9613005819178146,0.5011547344110855,0.8285535546282271,1.0,12/27,35.44%,SIRT1;PTPN2;SIK1;GNMT;CRY1;DDB1;C1QTNF3;C1QTNF12;GCK;DGKQ;PPARGC1A;ARPP19
prerank,cellular component maintenance (GO:0043954),0.3833392620786323,0.9612329893251113,0.502803738317757,0.8972510561350744,1.0,3/12,17.35%,IGF1R;PICK1;CLDN1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.23583077086221696,-0.9610427331114518,0.5538847117794486,0.8284387478673935,1.0,20/86,17.63%,CD74;BANK1;CD44;EGFR;APP;FGF10;PRKCZ;CSPG4;CADM4;JAK2;FGF7;ENPP2;CLEC6A;RELN;EFNA5;SFRP1;CD80;PECAM1;PDGFA;SFRP2
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3204182312710004,-0.9609590501396497,0.5143540669856459,0.8278374363276646,1.0,8/22,25.32%,LRRK2;TAFA1;SLC16A2;DISP3;TOX;SHCBP1;DLL4;NES
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2603273431032338,0.9609133516781178,0.5225806451612903,0.8974630398341706,1.0,22/69,25.81%,CX3CR1;MEF2C;SLC30A10;LGMN;CNTF;POU4F1;PTK2B;CLN3;PPT1;SOD1;PINK1;RETREG1;MAG;PARK7;FGF20;HIF1A;PLA2G3;TOX3;FZD9;MDK;KDM2B;TYRO3
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2584111297764225,0.9608668119483753,0.5688816855753647,0.8968697303636498,1.0,17/80,16.42%,PLD1;GSAP;PRKCD;PICALM;METTL5;CLU;PLA2G6;SMPD2;NSUN5;RPS27L;MTOR;ROCK2;METTL14;PASK;EIF3D;PCIF1;THBS1
prerank,muscle cell migration (GO:0014812),-0.38961093250601786,-0.9608649429349633,0.5203426124197003,0.8272730553075515,1.0,6/10,33.87%,ITGB1BP1;PLAT;CCN3;DDR1;THBS4;ROCK1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.3859905452784646,-0.9607889682938177,0.5333333333333333,0.8266602379754976,1.0,3/12,5.88%,XDH;ADAMTS12;CADM4
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.3292832620878007,-0.9607659540902338,0.5140997830802603,0.8258921715126878,1.0,7/20,21.03%,RBPJ;CARF;RUNX2;RELA;SESN2;SMAD1;CREB3
prerank,regulation of peptidase activity (GO:0052547),0.35200322425046493,0.9607322685507576,0.521505376344086,0.8965366161682691,1.0,5/19,20.14%,CST3;PINK1;NRDC;NDUFA13;PSMB8
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.32821873862261425,0.9606649442758247,0.5142314990512334,0.8960165912613843,1.0,11/23,24.80%,TIMM29;BMF;TIMM10B;MAIP1;BCL2L11;NDUFA13;PMAIP1;HSPA4;SAMM50;TIMM13;TOMM70
prerank,protein targeting to membrane (GO:0006612),-0.23881776603600519,-0.960176598304991,0.5511363636363636,0.8266423362364171,1.0,26/83,26.33%,CHM;ZDHHC21;SDCBP;ACBD5;ATAD1;PEX12;GET3;SEC62;FIS1;ZDHHC23;AQP11;ZDHHC15;SRP19;PARD3;ALDH3A2;ATG3;SSR1;ZDHHC18;ZDHHC24;PEX14;NACA;VPS37C;ZDHHC19;SSR2;PEX19;PRKCI
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.36511299817258935,0.9601643250965941,0.5113207547169811,0.8967103787885793,1.0,6/15,17.94%,IGF1R;PTK2B;ABL1;BMX;DYRK1A;TEC
prerank,maintenance of blood-brain barrier (GO:0035633),0.3093079992718257,0.960081541025256,0.5008849557522124,0.896238432470551,1.0,10/30,17.43%,F11R;JAM2;TJP1;TJP2;GJA1;CLDN12;LAMA2;WNK3;CLDN1;LSR
prerank,mitotic cell cycle phase transition (GO:0044772),0.22444178537853807,0.9600277913401052,0.5450581395348837,0.8956773517924547,1.0,46/204,18.50%,TUBA4A;DNM2;SDCCAG8;PIM2;CHEK2;PRKACA;CSNK1E;FBXL15;CCNG2;ODF2;TUBB;CEP164;TUBG1;HAUS7;CDC34;CNTRL;CUL4B;CCND3;CENPJ;TUBA1A;KHDRBS1;CEP63;LATS2;HAUS2;CEP135;HAUS6;CCNE1;OFD1;FBXL22;CEP57;MAPRE1;AURKA;FBXL8;MASTL;PLK3;KDM8;DCTN2;OPTN;CEP70;ANAPC1;FBXL7;CHMP2A;E2F3;CCNY;CDKN1B;ACTR1A
prerank,defense response to tumor cell (GO:0002357),0.4054659791872025,0.9598879000283993,0.49616858237547895,0.8953505207939845,1.0,2/10,8.14%,ABI3;PLK5
prerank,response to glucocorticoid (GO:0051384),0.32343168585114457,0.9597586754256155,0.5171790235081374,0.8950322221642999,1.0,4/26,7.96%,HSD3B2;ZFP36L1;ZFP36L2;CALCR
prerank,glucan catabolic process (GO:0009251),0.369780964332159,0.9593746189465967,0.5177570093457944,0.8954221949554177,1.0,8/15,22.45%,PYGB;PHKB;AGL;PHKG2;MGAM;GAA;PHKA2;PYGL
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.25536672442789343,0.9593609425841833,0.5264900662251656,0.89474034258527,1.0,24/79,20.11%,KIF2A;DNM2;CTSD;KIF3B;CAPZB;LGMN;AP2A1;CTSS;SEC13;AP1M2;ACTR1B;AP1S2;KIF3A;CTSE;CTSF;CLTA;DCTN5;AP1S1;DCTN2;SEC31A;ACTR1A;AP1B1;DCTN4;KLC1
prerank,dicarboxylic acid transport (GO:0006835),-0.29485409530441303,-0.9592546411800311,0.5164319248826291,0.8283437962575692,1.0,13/28,24.50%,SLC1A6;GIPC1;SLC13A3;SLC26A7;SLC1A1;SLC46A1;SLC25A18;SLC13A5;SLC25A12;ABCC2;SLC26A8;FOLR2;FOLR1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.37023704113271216,-0.9591641535808358,0.5178571428571429,0.8277688901005477,1.0,3/13,10.87%,ELOVL7;HACD1;ELOVL5
prerank,negative regulation of response to wounding (GO:1903035),0.33814322027061416,0.959138353015865,0.5053571428571428,0.8946678923671124,1.0,5/19,15.21%,RTN4RL1;KLK8;RTN4R;AJAP1;CERS2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.37598529113862633,0.9589932397506878,0.48703703703703705,0.8943838917251322,1.0,3/14,8.71%,WDR48;FUS;MMS19
prerank,mitotic nuclear division (GO:0140014),-0.2456473650419916,-0.9588388497948087,0.5563725490196079,0.8278461574931072,1.0,14/71,13.33%,EPS8;SMC4;CDCA8;NDC80;ZW10;RAN;TOGARAM2;TPX2;NUSAP1;KIF11;MAP9;SPAG5;UBE2C;KIF18B
prerank,inner dynein arm assembly (GO:0036159),-0.38782048669171354,-0.9587325563049528,0.5122448979591837,0.827334973830895,1.0,6/11,29.72%,DNAAF5;DNAI3;DNAAF1;CFAP100;CCDC39;DNAAF4
prerank,extracellular matrix organization (GO:0030198),-0.2013066479710079,-0.9585864374368818,0.5947955390334573,0.8269173449804997,1.0,73/276,17.98%,ITGA4;CD44;CD47;APP;MMP16;GSN;ITGAL;FLRT2;ADAMTS12;ADAMTS17;ITGB7;THSD4;SPP1;VIT;FN1;TNR;COL4A1;VWF;ADAMTS19;TLL1;ADAM12;COL1A1;COL13A1;FBN2;ST7;FBN1;POSTN;HSPG2;ATP7A;PLOD3;TNC;LAMB2;CREB3L1;NID1;MMP15;VCAN;MMP12;COL14A1;P3H1;VCAM1;LOX;CD151;DAG1;ADAMTSL5;ADAMTSL4;CTSL;ITGA8;MMP14;ITGA2B;ITGB6;MMP8;CDH1;SERPINH1;AGRN;MMP19;ADAMTS10;P4HA2;ADAMTSL1;SCX;ADAM19;LAMA5;SMOC1;COL5A1;PECAM1;SERPINF2;ELN;ICAM1;PDGFA;COL23A1;LAMC3;ITGA11;COL20A1;LUM
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.30037089316046,0.9585164970085182,0.5105263157894737,0.8950325266874223,1.0,12/33,23.89%,AIF1;IGFBP3;MEF2C;IL12B;GPER1;NDRG4;VIP;CDKN1B;TRIB1;MFN2;PDCD4;TPM1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.34039266292618164,0.9579508167662913,0.5231053604436229,0.8959233645746484,1.0,6/20,13.34%,ZFP36L1;CTR9;HOXB8;PTK2B;PRMT1;CIB1
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.22693744406555763,-0.9578361238385708,0.5602240896358543,0.8281498142724734,1.0,21/108,12.99%,CTNND2;MDFIC;LRRK2;SULF2;APP;CDK14;ATP6AP2;TRABD2B;PRKN;FRZB;CDC73;DCDC2;GPC3;BTRC;GRB10;AXIN1;NXN;PPP2R1A;TIAM1;TLE1;KANK1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.37202326369892963,0.9576725552252816,0.5096322241681261,0.8960486220414603,1.0,3/14,8.67%,NCBP1;CSTF2;CPSF1
prerank,negative regulation of cellular process (GO:0048523),0.20362786688778417,0.957287164429464,0.614321608040201,0.8964348395283062,1.0,120/521,22.38%,SRGAP2;PDE3B;SIRPA;CTTNBP2NL;SLURP1;SMAD3;ATP8A2;ETS1;PIM2;RND1;PPP1R9B;IGFBP3;JAM2;SKI;VHL;TGFB1I1;OSGIN2;RNF41;LYN;SIRT2;PKHD1;SIPA1;AGTR2;INCA1;TNFRSF21;CCDC85B;FLCN;IMPACT;HPGD;CLU;LPXN;KLF11;KLK8;NDUFS3;GNRH1;DIS3L2;CD34;APBB2;SHH;RHOB;P3H2;CD9;INHA;PIWIL1;GPER1;SOX17;CXCL1;MIA3;NOTCH4;PTK2B;TAF6;SMARCA2;DLL1;PPT1;MDM4;BLM;OSGIN1;NME6;PLPP1;MYH9;PRDM11;DRD2;SEMA4D;ATG5;TENM1;DACT3;PROX1;CIB1;CLMN;EIF2AK2;KANK2;GPNMB;GJA1;PLG;CHMP1A;NME1;NUP62;WNK2;NR1H2;CD33;SYT11;GATA3;SNX3;EI24;VPS13C;CHMP2A;PLXNA4;NDUFA13;ADAM10;TMBIM6;PTPRJ;ADAMTS1;CDKN1B;NOS1;WDR6;TOB1;ADAM15;PLXNA3;CD164;TES;VGLL4;SFRP4;PARK7;LRPAP1;HTRA2;TFAP4;TSPYL2;AXIN2;ADGRG1;PTHLH;MNT;BMP2;GPLD1;CRYAB;PDCD4;TP53;DDX3X;FABP7;HGS;SUZ12
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.2730138033967888,-0.9572840426119853,0.49534883720930234,0.8288620653113293,1.0,9/39,11.69%,OLFM2;RAB3C;RCN3;GOLPH3;RAB3D;RAB3A;RAB8A;COPG2;ARL4D
prerank,regulation of viral genome replication (GO:0045069),-0.2518639399383346,-0.9570883898235247,0.5139949109414759,0.8285560567924475,1.0,23/56,27.57%,OAS2;IFITM3;RSAD2;PPIA;PABPC1;PPIH;SRPK2;OAS3;PARP10;IFITM2;CCL5;BANF1;RNASEL;TARBP2;IFITM1;IFIH1;LTF;DDB1;ADAR;NR5A2;PPARA;ZC3HAV1;OASL
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.33390013116725337,0.9570640141553953,0.5118829981718465,0.8963749199359233,1.0,8/21,27.07%,UCHL5;SHH;RAB34;ULK3;SMO;TUBD1;KIF7;TXNDC15
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.23280517638234202,-0.9568980910275416,0.5579710144927537,0.8282879153202147,1.0,19/86,19.06%,RBPJ;DAB2;SDCBP;SOX11;BMP5;GIPC1;HIPK2;JAK2;ING2;ZEB2;HSP90AB1;TTK;CDH5;GDF1;GDF11;SH2B1;ACVRL1;BMP4;GDF10
prerank,cellular iron ion homeostasis (GO:0006879),-0.25099028910016846,-0.9567554321040481,0.5158730158730159,0.8278635738862011,1.0,14/55,16.49%,ABCB7;FTL;MYC;ATP6V1A;ATP6V0D1;FBXL5;FLVCR1;SCARA5;NDFIP1;TFR2;SLC46A1;CYBRD1;TFRC;HMOX1
prerank,negative regulation of DNA recombination (GO:0045910),0.28285923062716745,0.9567138698574995,0.5380794701986755,0.8966823651036527,1.0,12/43,20.75%,POLR2H;POLR2D;POLR2J;CGAS;BLM;SHLD2;TERF1;FBH1;UBQLN4;POLR2E;POLR2I;ACD
prerank,microvillus organization (GO:0032528),-0.3603553829846281,-0.9567039916522962,0.4989384288747346,0.8271719356563719,1.0,3/13,5.15%,RAPGEF2;STK26;FXYD5
prerank,proton transmembrane transport (GO:1902600),0.29847196826245836,0.9566438909100046,0.5092436974789916,0.8961814912939091,1.0,8/36,15.01%,SLC36A1;ATP1A4;ATP5PO;ATP6V0A4;NNT;SLC25A27;HVCN1;ATP6V0E2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.2716755590584443,-0.9565431145617926,0.5160493827160494,0.8268091711672081,1.0,8/39,12.53%,EGFR;PTPN12;CDC42;PTPN3;SH3GL2;PTPN2;EPS15;RNF126
prerank,regulated exocytosis (GO:0045055),-0.211641658064522,-0.9563394931341028,0.5634218289085545,0.8265770196539459,1.0,36/173,17.53%,F13A1;RIMS2;PCDH7;CD36;APP;SYT1;PF4;SYT10;FN1;SERPING1;PHACTR2;VWF;PCLO;CPLX2;CALM1;VEGFD;RIMS1;SNAP25;ACTN2;RAB3A;CD109;LGALS3BP;SNCA;CDC37L1;ISLR;ITGA2B;TIMP3;APOOL;VEGFC;CRHBP;PECAM1;SYT3;FLNA;RAB11FIP1;SERPINF2;PDGFA
prerank,negative regulation of cell activation (GO:0050866),-0.36561152556075704,-0.9563257019470776,0.5083682008368201,0.8258057616278783,1.0,2/14,3.97%,APOE;LDLR
prerank,tube closure (GO:0060606),0.30883193343654747,0.9563124011995403,0.5276292335115864,0.8964274892901425,1.0,11/31,24.51%,SKI;DEAF1;SEMA4C;MTHFD1;PAX2;VANGL2;VASP;CELSR1;TGFB1;IFT122;GRHL3
prerank,negative chemotaxis (GO:0050919),-0.29256800969526014,-0.9558846341586916,0.4963680387409201,0.8262330075834722,1.0,5/33,7.91%,UNC5C;ROBO1;SLIT2;SEMA4A;SEMA6D
prerank,muscle organ development (GO:0007517),0.2718213565960144,0.9557062201550536,0.5373134328358209,0.8974423886426205,1.0,11/54,12.92%,LARGE1;CAPN3;MEF2C;MEF2D;SGCE;TRIM72;CTF1;ANKRD2;MEF2A;MRAS;ITGA7
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.33719717895261914,-0.9555937247858345,0.5271493212669683,0.8261510975212697,1.0,7/17,27.04%,RFX3;SULT2B1;AHI1;VEZF1;BMP4;FOXN1;KDF1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.32565106923919634,0.9553671606975481,0.5161870503597122,0.8977163295012923,1.0,4/25,13.63%,NELFB;ZMYND11;RNF8;NELFE
prerank,engulfment of apoptotic cell (GO:0043652),0.36753793791735023,0.9552855907155237,0.5241635687732342,0.8972138417979592,1.0,5/15,16.42%,RAC1;RHOH;RHOBTB1;MEGF10;THBS1
prerank,metanephric mesenchyme development (GO:0072075),0.4120671433536501,0.9552420213749622,0.5496323529411765,0.896617988542012,1.0,3/10,13.04%,BASP1;SHH;PAX2
prerank,mitotic sister chromatid segregation (GO:0000070),-0.22864479818948258,-0.9551750479814016,0.5506849315068493,0.826437076763281,1.0,16/98,11.07%,CUL3;SMC4;KIF23;CDCA8;NDC80;SPDL1;ZW10;RAN;DLGAP5;KIF22;KIF14;CENPE;PDS5A;NUSAP1;PRC1;SPAG5
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.23027767104468946,-0.9551470684487652,0.5846560846560847,0.8257098052442224,1.0,21/101,16.02%,ROBO1;LRRK2;EGFR;RAPGEF2;CD40;SIRT1;PDGFD;CCND2;CCNYL1;HTR2B;CALM1;PKD2;TPD52L1;IRGM;ADRA2A;SNCA;SYAP1;KIT;RGCC;ETAA1;PIH1D1
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.24960791843155863,-0.9549915052092706,0.5321782178217822,0.8253276656276638,1.0,11/66,14.19%,ROBO1;LRRK2;EGFR;CD40;RPS3;PDGFD;HTR2B;TPD52L1;ADRA2A;PAK1;KIT
prerank,regulation of cellular component movement (GO:0051270),0.27642612531532507,0.954948886334332,0.524390243902439,0.8967519965003387,1.0,6/49,7.12%,TGFBR1;ETS1;LYN;PKHD1;ZSWIM8;CD9
prerank,chromatin remodeling (GO:0006338),-0.22874337782056933,-0.9549399294169864,0.5408450704225352,0.8246611056731172,1.0,35/100,25.96%,KDM4D;JARID2;BAZ2B;SIRT1;MYC;HDAC4;MPND;ACTB;KDM6B;ERCC6;PADI4;SMARCE1;MTA2;PAK1;PBRM1;NPM2;BAHD1;HDAC1;SMARCA1;NPM1;PIH1D1;KDM4C;BAZ2A;FOXP3;ACTL6B;SUV39H2;SMARCD2;BAZ1A;CBX3;SMARCC1;MYB;NUDT5;TOP1;ZBTB7A;KDM6A
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.33951994640255395,0.9548820691732716,0.5122377622377622,0.8962253768259416,1.0,6/21,12.48%,CHPF2;BGN;CHST7;CHST11;CHSY1;CSPG5
prerank,L-amino acid transport (GO:0015807),0.3101041767108146,0.9548812368217889,0.5225225225225225,0.8955267132757054,1.0,4/28,7.73%,SLC7A8;SLC1A3;SLC36A1;SLC7A5
prerank,negative regulation of anoikis (GO:2000811),-0.36055670769977227,-0.9546744249280765,0.5162689804772235,0.8245733841907429,1.0,8/14,26.48%,PTRH2;TLE1;BCL2;SNAI2;ITGB1;PDK4;MCL1;ITGA5
prerank,establishment of spindle orientation (GO:0051294),-0.29708282863021845,-0.954459814423234,0.5359628770301624,0.8243512731224502,1.0,5/28,5.56%,HTT;NDC80;SPDL1;CDK5RAP2;ZW10
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.36028100697600507,-0.95424443498866,0.5102040816326531,0.824143135972551,1.0,6/13,21.32%,LTV1;RAN;NOP9;RPS15;NPM1;RRS1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.40409388069808405,0.9541993580791354,0.5223048327137546,0.8967221117221114,1.0,1/10,0.49%,OPHN1
prerank,BMP signaling pathway (GO:0030509),0.25977427859235264,0.9541224447969998,0.537828947368421,0.8962330041746153,1.0,23/62,30.02%,SMAD3;SMAD7;DDX5;SMURF1;LEFTY1;SMAD9;USP9Y;NOG;ENG;TMEM100;ACVR2B;BMP2;ZFYVE16;PDCD4;AMH;TGFB1;SMAD6;BMPR1A;BMPR2;SMAD5;HIVEP1;ACVR1;USP9X
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3323158513243588,-0.9540997071650187,0.535031847133758,0.8237315422450856,1.0,8/17,23.70%,GET3;MMGT1;EMC3;EMC7;EMC2;EMC4;EMC10;GET4
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3551950965063929,0.9538613769248983,0.5248091603053435,0.8962368511865622,1.0,8/18,19.93%,NCKAP1L;ZFP36L1;ZFP36L2;PRDM1;ABL1;SPINK5;IL4I1;XRCC6
prerank,neuromuscular process (GO:0050905),-0.3525015808101494,-0.9535362635435877,0.5496828752642706,0.8244944751951452,1.0,1/16,0.12%,NRXN1
prerank,Golgi inheritance (GO:0048313),0.38238995380638663,0.953315820931816,0.4881422924901186,0.8970212868427042,1.0,4/11,21.40%,PLK5;PDCD10;PLK3;STX5
prerank,glycoprotein biosynthetic process (GO:0009101),-0.23856923694973103,-0.9532516336048106,0.5806451612903226,0.8244459153102129,1.0,22/79,19.75%,B3GALT1;B4GALT5;TMEM106A;ST3GAL4;B3GALNT2;ST8SIA4;FUT9;SERP2;GOLPH3;ATP7A;ST8SIA2;ST8SIA1;ST6GALNAC2;B4GALT7;B3GALT4;B3GALT2;CHST10;FUT4;CHST12;ST8SIA3;CSGALNACT2;CSGALNACT1
prerank,mitochondrial protein processing (GO:0034982),0.39582806734950277,0.9531794518018593,0.5103969754253308,0.8967029260962509,1.0,7/11,29.57%,YME1L1;PMPCA;MIPEP;STOML2;AFG3L2;PMPCB;OMA1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.31561057961835565,-0.9530335969124616,0.5278396436525612,0.8242934078155807,1.0,4/22,10.62%,PPM1A;PPM1E;DUSP16;DUSP10
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.2870939262864223,-0.9529543845613728,0.530373831775701,0.8236936734166359,1.0,6/33,10.62%,PTPRG;SLIT2;APOE;CORO1C;SP100;DUSP10
prerank,regulation of phosphorylation (GO:0042325),-0.22196393722730795,-0.9527169956923687,0.5971428571428572,0.8235498852311387,1.0,28/120,18.10%,CCDC88C;EGFR;GRM5;STAP1;APP;KDM4D;PRKAG2;SDCBP;NUP98;SIRT1;FN1;CORO1C;CADM4;BARD1;CCDC88A;NUP210;NUP205;NUP54;CDH5;PLXNB2;CDKN2A;BTBD10;CCL5;NUP43;CDKN1A;NUP155;SESN2;BMP4
prerank,regulation of filopodium assembly (GO:0051489),0.29260141712238336,0.9526739407831017,0.5108514190317195,0.897429993585934,1.0,13/38,18.77%,PRKCD;PIK3R1;CAPZB;ABITRAM;FSCN1;RHOQ;TRPM2;CCR7;TENM1;MIEN1;WASL;GAP43;DMTN
prerank,negative regulation of transport (GO:0051051),0.27350532583773823,0.9525863113898275,0.5448504983388704,0.8969642207877326,1.0,12/51,17.37%,SIRPA;CTTNBP2NL;ITGAV;NDFIP2;HAMP;SCAMP5;WWP2;PXK;NR1H2;SYT11;SNX3;ARL6IP5
prerank,regulation of stress fiber assembly (GO:0051492),0.25687911255549806,0.9523161940191479,0.5498338870431894,0.8970443589406122,1.0,13/74,12.96%,TGFBR1;F11R;RAC1;ASAP3;PIK3R1;ARHGAP28;MET;FHOD1;RAPGEF3;TJP1;ABL1;SORBS3;ROCK2
prerank,sympathetic nervous system development (GO:0048485),-0.35130190326118044,-0.9518382176721235,0.5376106194690266,0.8251247959009165,1.0,8/15,38.77%,SOX11;TFAP2B;CTNNB1;NTRK1;GDNF;SOX4;NF1;NRP2
prerank,regulation of axon guidance (GO:1902667),0.4005146734758813,0.9517879774941865,0.525233644859813,0.8977741677984511,1.0,5/10,32.21%,ZSWIM8;ZSWIM4;TUBB2B;ZSWIM5;MYCBP2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.38686931483422793,-0.9515313179294159,0.5165562913907285,0.8251468717257104,1.0,7/11,42.54%,NECAB1;ITM2A;AGO2;ABCA7;SOAT1;BACE2;ITM2B
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.20165996328693955,0.951476456086044,0.6336760925449871,0.8979655527307918,1.0,124/497,22.72%,SALL1;IKZF1;MLXIPL;SUMO1;CAPN3;HEYL;PBXIP1;SOX8;BASP1;DDIT3;PPARD;CHD8;CNOT1;PRMT2;HDAC10;PHB2;SIRT2;ZNF568;SUDS3;DEAF1;ZBTB21;RPS6KA5;ID1;ZBTB18;SBNO2;LOXL3;MLX;CCDC85B;ELK3;CRY2;BCOR;FOXN3;SAMD1;RAD17;BCL7A;ENC1;FOXE1;ZMYND11;EID2;GAPDH;FOXK2;SAMD11;PDGFB;NANOS2;SAMD13;TWIST2;NPAS1;BRCA1;SIN3A;MIDEAS;WWP2;KDM4A;PATZ1;SMARCA2;TMPRSS6;EED;MAP3K10;KHDRBS1;DPF1;ZEB1;LIMS1;MRPL13;PRDM11;IGF2BP2;MBD1;PRMT6;SCMH1;ID3;PAX2;PROX1;TERF1;TSC22D4;PASK;EIF2AK2;EPRS1;QARS1;COMMD7;GCLC;DPF2;CHMP1A;HMGB2;DKK3;EID2B;EZH2;CAPRIN1;KDM8;POU2F1;PCIF1;NR1H2;GATA3;TYMS;EPC1;LARP1;NDUFA13;INPP5K;TCF7L2;GZF1;CDKN1B;NANOS1;PHC2;TOB1;HDAC5;JUN;VGLL4;XRCC6;RING1;PHC1;TWIST1;YEATS2;TFAP4;TSPYL2;EID1;BMP2;BRMS1;CRYAB;PDCD4;TP53;RBM4;DDX3X;KDM1A;ZBTB14;ZHX1;TRAF6;SCML2
prerank,insulin receptor signaling pathway (GO:0008286),0.26105559559052377,0.9511498431069131,0.529874213836478,0.8981793362641799,1.0,11/69,10.73%,ATP6V0B;PIK3R1;IRS4;IGF1R;ATP6V0A2;RHOQ;TCIRG1;APPL1;PDK2;ATP6V0A4;ATP6V1D
prerank,regulation of exit from mitosis (GO:0007096),0.29013494774953835,0.9510607360921364,0.548885077186964,0.8977351210082175,1.0,11/38,20.22%,PPP1R9B;PHB2;SIRT2;UBC;RPS27A;CDC14B;ANAPC15;ANAPC11;ANAPC1;ANAPC2;CDCA5
prerank,DNA metabolic process (GO:0006259),0.215005101739505,0.9509918529093513,0.6027397260273972,0.8972431476679988,1.0,77/270,25.79%,SUMO1;CSNK1E;EID3;PRIMPOL;CTC1;RFC2;MPG;ATM;PCNA;REXO4;RAD17;NBN;MGMT;SLX4;CDC34;RAD51B;TOP3B;NUDT15;KMT5C;MMS19;INTS3;BRCA1;UBC;RPS27A;FANCG;DCLRE1B;POLD2;TOP2B;DDB2;UHRF2;ERCC4;RAD1;BLM;EXO1;UBE2U;CNBP;MCM2;UBE2V2;TERF1;RFC1;TOP3A;HMGB2;LIG1;MCM3;PSME4;FANCA;ORC3;NTHL1;TYMS;RAD9A;DNASE2;UBE2A;TCF7L2;PARK7;RPA3;XRCC6;NABP1;RPAIN;ACD;AXIN2;PWWP3A;RAD51C;NSMCE3;CDC7;RNASEH1;PARG;MCM6;GMNN;PDS5B;TSN;TOPBP1;RECQL;RTEL1;ZBTB1;FAN1;ORC2;MNAT1
prerank,negative regulation of RNA splicing (GO:0033119),0.33966666879204976,0.9507639585336255,0.5302752293577981,0.8972321251486447,1.0,9/19,24.60%,SFSWAP;U2AF2;SRSF9;C1QBP;RBMX;TMBIM6;PCBP4;PTBP3;RPS13
prerank,negative regulation of cell cycle (GO:0045786),0.2572805725763272,0.9504656145333492,0.547077922077922,0.8973693558381299,1.0,25/73,24.15%,SMAD3;HECA;SIPA1;INCA1;HPGD;RHOB;INHA;GPER1;CDK5RAP1;TAF6;LATS2;CHMP1A;GATA3;GAS1;CDKN1B;IPO7;HTRA2;TFAP4;TSPYL2;BMP2;PDCD4;NPPC;BTG1;GMNN;TGFB1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.39947455317435215,-0.9504157755339422,0.5,0.8273700479910809,1.0,5/10,17.36%,DPP4;SKAP1;PODXL;CCL5;CD3E
prerank,regulation of protein kinase A signaling (GO:0010738),-0.323962914542621,-0.9503824077357336,0.5109649122807017,0.8266581804272216,1.0,3/20,3.27%,AKAP6;LRRK2;IAPP
prerank,regulation of inflammatory response (GO:0050727),0.22131545490676693,0.9502497712544454,0.5816901408450704,0.8972662615115257,1.0,26/190,11.29%,IL18;TLR7;DAGLB;SIRPA;IL1RL2;ETS1;TLR4;PPARD;PRKCD;OTULIN;GPS2;CASP1;SBNO2;TRADD;LRRC19;PIK3AP1;SELE;BCL6B;IL12B;GPER1;DDT;NLRP6;IL33;DHX9;XIAP;AREL1
prerank,glycoprotein metabolic process (GO:0009100),0.27371207226025496,0.9497239561498938,0.5284280936454849,0.8980427998971412,1.0,14/53,20.56%,LARGE1;PRKCSH;MGAT4A;MAN2B1;GAL3ST4;GANAB;MAN1C1;MAN2A2;GCNT1;NEU4;MAN1B1;PARK7;MGAT4B;HIF1A
prerank,axonal transport of mitochondrion (GO:0019896),-0.3797418140616927,-0.9496578609690811,0.5334728033472803,0.827740792478447,1.0,2/11,3.29%,ACTR10;SYBU
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.21442513984251613,-0.9496243259278488,0.5963060686015831,0.8270270745750312,1.0,20/142,9.02%,CCR2;CD36;TRPC5;TRPC4;ADRA1A;RYR2;ATP2B1;CCR1;NPTN;IAPP;ADCY5;YWHAE;GPR35;TRPC3;P2RY1;CACNA1C;SLC8B1;ADCY8;CD52;CALB1
prerank,clathrin coat assembly (GO:0048268),-0.34966496472406366,-0.9494069633698737,0.5343347639484979,0.8267798119969304,1.0,4/15,10.98%,HIP1;SGIP1;PIK3C2A;EPS15
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.25538822911115233,0.9491774205760176,0.537842190016103,0.8988383769498317,1.0,20/73,20.14%,ITCH;PSMD3;GATA2;PSMA7;ABL1;PSMB3;METTL14;PSMB9;EIF2AK2;RUNX1;PSMC2;PSME4;PSMC1;TAL1;PSMB7;GATA3;LMO1;PSMB5;TCF3;PSMB8
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.2925665084639124,-0.9491467702336829,0.5480349344978166,0.8266122135841231,1.0,9/28,20.83%,KDM4D;ERCC6;CYREN;KMT5B;WRAP53;PARP3;SHLD3;SETMAR;RIF1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3022597849396548,0.9486803369817983,0.5244755244755245,0.899479503157274,1.0,4/32,2.58%,PCTP;LPIN2;CSNK2A2;CSNK2A1
prerank,collagen fibril organization (GO:0030199),0.24864246556350128,0.9486323035531854,0.5307820299500832,0.8989095674734057,1.0,5/88,0.98%,TGFBR1;DST;COL27A1;GREM1;ITGA6
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2746482278425812,0.9482328545438572,0.541958041958042,0.8993135694865574,1.0,19/48,26.64%,RANBP2;NUP42;SEC13;NUP35;NOS2;NUP50;SEH1L;KHK;NUP62;NUP107;PGAM1;NUP88;NUP188;HIF1A;NUP214;JMJD8;NOA1;RUBCNL;EP300
prerank,regulation of heart contraction (GO:0008016),-0.23235390606409204,-0.9477055857123783,0.5478723404255319,0.8296351128550149,1.0,20/90,17.64%,ANK2;ITPR1;PDE4D;SLC8A3;RYR2;ATP2B1;RYR3;ATP2A2;CALM1;TMEM65;DMPK;ATP1B3;ATP2A3;ATP1A1;KCNQ1;FXYD4;KCNIP2;S100A1;APLN;DES
prerank,endocytic recycling (GO:0032456),0.27412704007943606,0.9474602267892765,0.5457685664939551,0.9007125394975117,1.0,18/50,25.17%,CCDC93;EHD4;ACAP2;TRARG1;RAB35;SNX31;ENTR1;DENND1C;CCDC22;RAB13;PTPN23;SNX3;VPS26A;VPS35L;VPS29;CMTM6;VPS35;STX6
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.26371880119430535,-0.947274982507229,0.5745721271393643,0.8300021450555638,1.0,14/42,21.71%,UTRN;CD36;GSK3B;SKAP1;CDH13;THY1;CX3CL1;SFRP1;TEK;CD3E;EPHA1;S100A10;TSC1;CDK6
prerank,protein depolymerization (GO:0051261),-0.2985773701322362,-0.9472735234914526,0.541095890410959,0.8292069200046274,1.0,12/27,25.51%,GSN;STMN4;MICAL3;DSTN;KIF14;KIF18B;STMN2;KIF24;MICAL2;KIF2C;NCKAP5;STMN3
prerank,regulation of Ras protein signal transduction (GO:0046578),0.24744163529562888,0.9469725716965783,0.5566666666666666,0.9014184855837677,1.0,15/86,14.40%,RASAL3;OPHN1;ARHGEF2;DENND4A;LYN;SPRY2;FLCN;AKAP13;ARHGAP17;RALGPS1;PDCD10;STK19;SGSM3;LZTR1;KANK2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.31200402654418974,0.9465598746706808,0.5210526315789473,0.90194127006075,1.0,5/27,10.09%,F11R;PIK3R1;ARHGAP28;MET;TJP1
prerank,defense response to symbiont (GO:0140546),0.24334501946806816,0.9465562386810351,0.5689102564102564,0.9012539542162755,1.0,24/92,20.44%,TLR7;RNASE1;SERINC3;TRIM5;MOV10;ABCC9;ZMYND11;ABCE1;CGAS;G3BP1;RNASE6;SETD2;EXOSC5;SHFL;IRF3;EIF2AK2;MAVS;ISG20;TTC4;PMAIP1;PYCARD;MAP3K14;IRF2;MYD88
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3060833629592036,-0.9465095983399889,0.5344036697247706,0.8303833972383914,1.0,6/23,14.22%,PDE4B;LRRK2;RYR2;PRKN;SNCA;KCNQ1
prerank,cellular response to peptide (GO:1901653),0.264831700644514,0.9463306229068995,0.5482233502538071,0.9011896708274669,1.0,8/56,5.10%,ARHGEF2;AGER;TLR4;SRC;RIPK2;IGF1R;LGMN;ZFP36L1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3263219720262792,-0.9460048818950149,0.5186813186813187,0.8309622888680407,1.0,5/18,10.88%,DNAJC15;ROMO1;TIMM23;TIMM17B;TIMM17A
prerank,ameboidal-type cell migration (GO:0001667),-0.25496122169659247,-0.9450604376293139,0.5820512820512821,0.8326299834544785,1.0,11/51,8.88%,ITGA4;ITGB7;SEMA5A;SEMA4A;CORO1C;PDLIM1;SGPL1;HTR2B;SEMA6D;ERBB4;GPC3
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3225242889546225,0.9450507658665099,0.5326278659611993,0.904063699239426,1.0,8/26,17.38%,LARGE1;GAL3ST4;ALG6;GK5;ALG2;GCNT1;ALG8;ALG11
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.256148452623558,0.9450334736834567,0.5464926590538336,0.9034288614886825,1.0,19/75,21.50%,TGFBR1;PRKCA;PDPK1;VEGFB;GATA2;PDGFB;PIK3CD;ARNT;PDCD6;PROX1;AKT1;VIP;HMGB2;AGGF1;CCL24;ADAM17;PLCG1;HIF1A;BMP2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3545787233404587,-0.944699100634993,0.5240174672489083,0.8328075941829054,1.0,7/14,26.28%,AUTS2;KMT2E;DNMT3B;CTNNB1;DNMT1;MYB;SNW1
prerank,steroid hormone biosynthetic process (GO:0120178),0.3052030525593501,0.9446385465795869,0.5269784172661871,0.9038346466165471,1.0,4/29,12.20%,FDXR;HSD3B2;HSD17B1;TSPO
prerank,intracellular cholesterol transport (GO:0032367),0.35818992145936035,0.9444298559591955,0.5521821631878557,0.9036968604751384,1.0,6/15,21.08%,NPC2;LDLRAP1;NPC1;SERAC1;ABCA1;OSBP
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3733800127225584,0.944226570852223,0.5097690941385435,0.9035585143692719,1.0,3/13,8.19%,ETS1;ITGB2;FUT7
prerank,negative regulation of signal transduction (GO:0009968),0.21591601582853648,0.9440803259691334,0.6083213773314203,0.9032663680598105,1.0,57/249,18.58%,CX3CR1;IGFBP3;CSNK2A2;CSNK2A1;CNOT1;PRKCD;SHISA2;LYN;GPS2;AGTR2;LGMN;CTNNBIP1;NFATC1;SPRY2;UBASH3B;TAX1BP3;MDFI;LEPROT;SLC27A4;ARRDC1;GATA2;IL12B;PIK3CB;RGS14;APPL1;PTPN1;WWP2;MOSMO;PLEK;ULK3;NDRG4;DLL1;PTPRE;GPR108;DRD2;PDCD6;KCTD6;PRKCB;DACT3;AKT1;NOTCH3;QARS1;LRP1;KANK2;NOG;MGRN1;CBLN1;DKK3;EZH2;THBS1;GATA3;SUFU;PTCH1;TMBIM6;PTPRJ;INPP5K;TRIB1
prerank,B cell receptor signaling pathway (GO:0050853),0.2956692564952407,0.9440158578377045,0.5435168738898757,0.9027522909246029,1.0,8/32,12.86%,BLNK;MEF2C;LAT2;PLCG2;NCKAP1L;PIK3CD;PRKCB;BMX
prerank,innate immune response (GO:0045087),0.2172896278470089,0.9438319632733395,0.6377840909090909,0.9025404002313147,1.0,19/217,4.68%,CX3CR1;PJA2;SERINC3;COLEC11;AGER;TLR4;TRIM11;SRC;RIPK2;OTULIN;LYN;PYDC1;PHB2;PLCG2;TRIM5;SLPI;PIK3CG;ATAD3A;F12
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.35419540603527677,0.9437636212660749,0.5417439703153989,0.902057623666266,1.0,5/15,23.78%,SMAD7;ABL1;DTX3L;PARK7;BAG5
prerank,TOR signaling (GO:0031929),0.31384974162785306,0.943742114254155,0.5502645502645502,0.9014243432259651,1.0,9/26,18.14%,FLCN;MLST8;RPTOR;MTOR;PINK1;AKT1;GATA3;LARP1;EIF4EBP2
prerank,negative regulation of angiogenesis (GO:0016525),0.2489286075336806,0.9435387906388462,0.5619694397283531,0.9012875911749623,1.0,29/84,26.47%,PDE3B;PTPRM;EPN1;FOXJ2;SPRY2;SPARC;ECSCR;PIK3CB;APOH;E2F2;GTF2I;ROCK2;SERPINF1;SARS1;SPINK5;THBS1;ADAMTS1;NAXE;AGO1;CXCL10;EFNA3;SERPINE1;HGS;KLK3;SYNJ2BP;SULF1;ATP2B4;NPR1;PGK1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.29025569675243285,0.9433009016379532,0.5622837370242214,0.9012583633180307,1.0,14/37,21.99%,MEF2C;FOXJ2;MEF2D;MMP2;PDGFB;GPER1;LDLRAP1;GJA1;ADAMTS1;CDKN1B;JUN;P2RY6;MFN2;PDCD4
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.37546287748413637,0.9430939688767703,0.5373406193078324,0.9011518177335627,1.0,4/12,17.57%,PRKCA;NEK6;PRKCB;LPIN1
prerank,urogenital system development (GO:0001655),0.39070095646039255,0.9429163416552466,0.5314814814814814,0.900934453812799,1.0,5/11,28.48%,SHH;PAX2;AMH;SOX9;OSR1
prerank,negative regulation of axon extension (GO:0030517),0.30314964829211766,0.9429120385467039,0.5381882770870338,0.9002654232029851,1.0,7/30,13.39%,SEMA3B;DIP2B;CDKL3;SEMA4C;SEMA4D;SEMA4G;RTN4R
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3045526355280041,-0.9426953275882095,0.5594405594405595,0.8373039833518859,1.0,5/25,10.60%,CCR2;JAK2;STAT4;PKD2;CCL2
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.25736123816101364,-0.9420886165695944,0.5623471882640587,0.8374101859328724,1.0,13/51,18.09%,PPP2R2A;REEP3;NUP98;LMNA;RAN;LBR;NUP205;PPP2R1A;REEP4;BANF1;NUP43;NUP155;CCNB1
prerank,mitotic nuclear membrane organization (GO:0101024),-0.25736123816101364,-0.9420886165695944,0.5623471882640587,0.8374101859328724,1.0,13/51,18.09%,PPP2R2A;REEP3;NUP98;LMNA;RAN;LBR;NUP205;PPP2R1A;REEP4;BANF1;NUP43;NUP155;CCNB1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.37227933817187625,0.9420600799453069,0.5353901996370236,0.901922163393255,1.0,1/13,0.08%,TGFBR1
prerank,regulation of receptor recycling (GO:0001919),0.3494172772132696,0.9410982218779261,0.5356489945155393,0.9038971224872565,1.0,1/16,0.29%,TBC1D16
prerank,regulation of phosphate metabolic process (GO:0019220),-0.3418149159703137,-0.9409377294871046,0.5206971677559913,0.8396792917556666,1.0,5/16,13.18%,SMG7;BARD1;SMG6;SMG5;TIGAR
prerank,epithelial cell development (GO:0002064),0.3350581754848719,0.9408850558760186,0.5357766143106457,0.9037889826323515,1.0,3/20,9.48%,RILPL1;PKHD1;WNT7B
prerank,response to gamma radiation (GO:0010332),-0.3081989000125439,-0.9407060279474774,0.548235294117647,0.8395031999484355,1.0,7/24,19.05%,MYC;LIG4;RPL26;XRCC5;DCUN1D3;MDM2;PRKAA1
prerank,myelin maintenance (GO:0043217),0.41025438105272255,0.940300641460283,0.5474308300395256,0.9047332363287777,1.0,4/10,18.10%,ABCD2;CLU;SOD1;ABCD1
prerank,digestive tract development (GO:0048565),0.2967793158451848,0.9401563078561254,0.5379061371841155,0.9044509126831931,1.0,6/33,19.80%,SALL1;CHD8;PKDCC;CCDC40;SMO;FGFR2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.3675269920408821,0.9398353522927435,0.5464895635673624,0.9045763290276839,1.0,3/13,8.75%,LARGE1;CHST1;CHST7
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.25554120506537786,0.9395093256194859,0.5629984051036683,0.9048156699279097,1.0,19/70,20.14%,ITCH;PSMD3;GATA2;PSMA7;ABL1;PSMB3;PSMB9;EIF2AK2;RUNX1;PSMC2;PSME4;PSMC1;TAL1;PSMB7;GATA3;LMO1;PSMB5;TCF3;PSMB8
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.3320201295264288,0.9394988324501437,0.5456171735241503,0.9041583912863266,1.0,3/20,8.21%,KCNMA1;SLC8A1;ATP1A4
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3031463887386656,0.9394657315776395,0.558983666061706,0.9035697087810748,1.0,12/29,30.88%,TLR4;UBC;RPS27A;TICAM2;IRF3;TICAM1;FADD;BIRC2;TLR6;BIRC3;CASP8;CD14
prerank,regulation of lipid storage (GO:0010883),-0.3114434453135093,-0.9391056730592594,0.5253456221198156,0.8429890327060611,1.0,10/22,33.74%,SIRT1;PTPN2;NFKBIA;IKBKE;VSTM2A;FBXW7;FTO;PLA2G10;CRP;ALKBH7
prerank,negative regulation of mRNA processing (GO:0050686),0.35809213938702145,0.939028237827731,0.5377532228360957,0.9041045337560383,1.0,6/15,22.36%,SFSWAP;U2AF2;SRSF9;C1QBP;RBMX;PCBP4
prerank,modulation by host of viral genome replication (GO:0044827),-0.3574309083411348,-0.9387300868902698,0.55125284738041,0.8431518386957066,1.0,7/13,30.31%,VAPA;PRKN;EIF2AK4;NUCKS1;FMR1;PPIB;CCL8
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3406090744939485,0.9386091410866495,0.5448028673835126,0.904570291634408,1.0,5/19,15.10%,IRAK2;DHX9;RUNX1;MAPK7;MAVS
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2774001096108074,0.9386090649499824,0.542314335060449,0.9038901635955852,1.0,14/41,23.15%,RANBP2;NUP42;SEC13;NUP35;NUP50;SEH1L;NUP62;NUP107;PGAM1;NUP88;NUP188;HIF1A;NUP214;JMJD8
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.35119786007351356,-0.9386036184104958,0.5418502202643172,0.8426663581580878,1.0,3/14,10.01%,LRRK2;PRKN;CREB3L1
prerank,fibrinolysis (GO:0042730),-0.3535013177384483,-0.9379519614895478,0.5374732334047109,0.8436334306907578,1.0,6/13,36.07%,PLAUR;PLAT;SERPINF2;SERPINB2;HRG;PLAU
prerank,histone lysine demethylation (GO:0070076),0.3134436249817577,0.9378722453284809,0.5421052631578948,0.9052081358826569,1.0,11/25,22.29%,KDM5B;UTY;KDM3A;KDM4A;KDM5A;KDM7A;KDM8;HR;PHF8;KDM2A;KDM1A
prerank,response to unfolded protein (GO:0006986),-0.25519496308912554,-0.9376641904386968,0.5669099756690997,0.8435802052020641,1.0,12/48,15.07%,ERN1;BAG3;PRKN;HSPA8;DNAJB4;HSPA5;HSP90AB1;BAK1;SERPINH1;DNAJB2;HSPA2;HSPA1B
prerank,regulation of phospholipase activity (GO:0010517),0.39223801057216046,0.937599239523845,0.5212355212355212,0.9052595814237396,1.0,4/10,19.80%,PDPK1;PLA2G5;LRP1;FGFR2
prerank,positive regulation of catabolic process (GO:0009896),-0.24679712990640829,-0.9375443320475112,0.5969773299748111,0.8431172682167968,1.0,24/65,24.91%,WWP1;HECW2;HECW1;APC2;NEDD4L;BARD1;GSK3B;PRKN;PLK2;GPC3;AXIN1;ATG7;FOXO1;RILP;NKD1;TNFSF12;ANGPTL3;OAZ1;TIPARP;DTL;DDB1;SEC22B;SORL1;FZR1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.2909975788042822,-0.937386402955502,0.5408653846153846,0.8427329705196198,1.0,8/32,17.68%,AKAP6;HTT;CALM1;PKD2;THY1;SNCA;CX3CL1;APLNR
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3002681382612868,0.9372756697302294,0.5499124343257443,0.9055105848331078,1.0,4/30,2.98%,TGM2;ITGAV;SRC;LYN
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3361827446708877,0.9367477167644899,0.5446428571428571,0.9063060186550378,1.0,5/19,16.20%,NFATC1;EDN3;EDN2;NMUR2;GPR62
prerank,regulation of double-strand break repair (GO:2000779),0.2856911361354241,0.9367368468711148,0.5446735395189003,0.9056565851024498,1.0,21/39,31.91%,SPIDR;MGMT;SPIRE1;OTUB2;PPP4R2;SETD2;SHLD2;SLF2;DEK;TWIST1;ZCWPW1;KDM1A;ACTR2;RTEL1;DDX11;MRNIP;FOXM1;USP51;RPA2;FMN2;SIRT7
prerank,endomembrane system organization (GO:0010256),-0.20921010957457675,-0.9365953550834228,0.6426426426426426,0.8440482606225022,1.0,39/178,18.02%,ATP8B4;ANK3;MYOF;LRRK2;SPTBN1;HTT;TMCC1;REEP3;VAPA;CDC42;ZW10;RAB22A;DNM1L;TOR1A;VPS51;SYNE1;ATL2;STX17;VMP1;GOLPH3;DNM1;CUL7;TMED1;DMPK;FAM174B;TMED2;USP6NL;DYSF;ATP8B2;REEP4;OBSL1;ALS2CL;ATL3;CTDNEP1;TOR1AIP2;SYP;ARHGAP21;NUP155;PLEKHF1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2404539178532931,0.936473569659571,0.5813953488372093,0.9057211218657631,1.0,28/94,24.48%,FHIT;BAG6;DDIT3;CHEK2;QRICH1;DDX5;PRKCD;ATM;PDK1;POU4F1;BRCA1;PDK2;APAF1;ABL1;TOPORS;ARL6IP5;C1QBP;BCL2L11;PMAIP1;PYCARD;HTRA2;CUL4A;TP53;DDX3X;RRP8;CUL1;CASP2;PPM1F
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.2568925595277021,0.9361646832658741,0.5703001579778831,0.9059137303653393,1.0,19/72,20.95%,POLR2H;NCBP1;POLR2D;POLR2J;FRS2;TIAL1;HNRNPH1;ESRP1;GALNT3;PTPN11;CEP57;NOG;FGFR4;POLR2E;FGFR2;POLR2I;FGF20;SPRED2;KIF16B
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.3714997982067355,0.9360003895344869,0.5385996409335727,0.9056758780837965,1.0,4/14,11.12%,SPRY2;NOTCH4;DLL1;ZEB1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.34434382644181377,0.9359671065794843,0.5229007633587787,0.9050890795859271,1.0,7/18,24.45%,COA8;COX19;COX16;BCS1L;FASTKD3;COX17;OXA1L
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.2713555475790794,-0.9356777070679119,0.5514018691588785,0.8456163539382434,1.0,11/35,17.21%,PLXND1;ARHGDIA;PLXNA2;SEMA5A;SEMA4A;SEMA6D;PLXNB2;PLXNB1;SEMA6A;FLNA;SEMA7A
prerank,regulation of programmed cell death (GO:0043067),-0.2079631315944072,-0.9355647532560281,0.6580645161290323,0.8451177415669265,1.0,25/161,10.88%,HIP1;CHM;LRRK2;NLRC4;PHLPP1;SLK;RTN4;SIRT1;RPS3;STK26;DAPK1;CTSB;TPT1;RARG;IKZF3;PRKN;BIRC5;ALK;JAK2;BCAR1;RAF1;PRELID1;ACTN2;DNAJA3;BID
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.27667887584974826,0.9351551915948334,0.56,0.9066455453396479,1.0,14/41,23.15%,RANBP2;NUP42;SEC13;NUP35;NUP50;SEH1L;NUP62;NUP107;PGAM1;NUP88;NUP188;HIF1A;NUP214;JMJD8
prerank,skeletal system morphogenesis (GO:0048705),0.278995899237697,0.9350342909749128,0.5697074010327022,0.9062836518843009,1.0,3/42,2.13%,TGFBR1;LRP5;SKI
prerank,protein insertion into membrane (GO:0051205),-0.2780984361115655,-0.9348511265524078,0.5667447306791569,0.8462217196628958,1.0,4/32,5.03%,EGFR;APP;VAPA;UBE2J2
prerank,regulation of stem cell differentiation (GO:2000736),0.2443820834941532,0.9341280695583045,0.567043618739903,0.9080750135640732,1.0,22/89,20.14%,NELFB;ITCH;ZFP36L2;PSMD3;GATA2;RBM24;PSMA7;ABL1;PSMB3;PSMB9;EIF2AK2;RUNX1;PSMC2;PSME4;PSMC1;TAL1;PSMB7;GATA3;LMO1;PSMB5;TCF3;PSMB8
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.23835761558135204,0.9338622198399407,0.590032154340836,0.9080766175983581,1.0,10/100,5.50%,GNA12;SUMO1;SMAD7;FHIT;BAG6;FBXO22;CSNK1E;SIRT2;UCHL5;CLU
prerank,morphogenesis of an epithelium (GO:0002009),-0.29953491485767814,-0.9336689569754693,0.5367483296213809,0.8484677728814992,1.0,11/25,27.65%,ACTB;LRP6;DAG1;ACTG1;AHI1;LAMA5;SOX10;TRAF3IP1;ARHGAP12;KDF1;VCL
prerank,regulation of cell-cell adhesion (GO:0022407),-0.267846075396438,-0.9336641673208546,0.5461165048543689,0.8476809498678188,1.0,11/39,15.51%,PTPRG;TENM3;CD47;DPP4;FUT9;AFDN;JAG1;PODXL;CDH1;EFNA5;MDGA1
prerank,chondrocyte differentiation (GO:0002062),-0.2736172099822833,-0.9332739970102272,0.5563725490196079,0.8479249925738466,1.0,9/32,18.10%,NFIB;SULF2;SNX19;SOX5;RUNX2;FGFR3;SCX;CCN3;BMP4
prerank,negative regulation of cell motility (GO:2000146),0.2337382832009438,0.933175203164765,0.5993930197268589,0.9092902262117857,1.0,18/108,14.65%,SRGAP2;SRGAP3;LDLRAD4;NAV3;SLURP1;SMAD7;RNF41;FLCN;SHH;RHOB;PIP5KL1;MIA3;CCDC125;DRD2;DPEP1;ARHGAP4;SPINT2;NOG
prerank,COPII-coated vesicle budding (GO:0090114),-0.23821214986315786,-0.9331350909568839,0.606516290726817,0.8474814148837536,1.0,16/68,14.75%,CUL3;GRIA1;CTSC;VAPA;GOSR2;SAR1B;NAPA;RAB1B;SEC23A;PPP6C;TRAPPC1;SCFD1;TMED2;SEC24C;SEC24B;SEC24D
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3902256828929654,0.9327209775578637,0.5474452554744526,0.9098859850262873,1.0,3/11,8.32%,GREM1;PADI2;DDT
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3172996667255361,-0.9326655207524502,0.577433628318584,0.8479704374515074,1.0,5/21,7.35%,ADCY2;ADCY5;GUCY1B1;ADCY3;ADCY8
prerank,lipoxygenase pathway (GO:0019372),0.3571749515593694,0.9321587511623348,0.5333333333333333,0.9107571989821001,1.0,5/14,19.23%,HPGD;ALOXE3;PON3;PON2;GPX4
prerank,regulation of myeloid cell differentiation (GO:0045637),0.2617083783195271,0.9321008670874049,0.565587734241908,0.9102434499533147,1.0,19/62,21.86%,MEF2C;LYN;KMT2D;MOV10;CTR9;HOXB8;PTK2B;SIN3A;PRMT1;PRMT6;PRKCB;RUNX1;FES;TNRC6B;THBS1;WDR5;AGO1;TNRC6C;DPY30
prerank,positive regulation of protein modification process (GO:0031401),-0.20137729980574126,-0.9318958061332118,0.6708860759493671,0.8492344415216605,1.0,29/203,10.91%,DAB2;CD74;LRRK2;EGFR;APP;FGF10;NTRK2;NPTN;CD40;NTRK3;TRABD2B;SIRT1;PPIA;CCND2;UBE2N;SLCO3A1;P2RY1;LIMCH1;CALM1;PDE8A;VEGFD;FGF9;ERBB4;FGF7;IRGM;AXIN1;RALBP1;PLAUR;ATG7
prerank,inorganic cation transmembrane transport (GO:0098662),0.21117786049972107,0.9317729016497863,0.6809728183118741,0.9104961886327567,1.0,46/268,15.05%,KCNA5;SLC9A9;SLC30A5;SLC1A3;ATP2C1;ITGAV;SLC9A8;KCNK6;SLC24A3;SLC30A10;SLC36A1;KCNH8;KCNH4;SLC40A1;SLC8A1;TRPV2;KCNN1;TRPM6;MCOLN1;SCN4B;ABCC9;TRPM2;TRPM4;LRRC55;KCNG2;SLC30A8;KCNH6;LRRC38;ATP1A4;KCNS2;ATP5PO;ATP6V0A4;TRPV4;NNT;SLC25A27;SLC39A2;KCNK13;KCNA2;HVCN1;KCNAB3;CACNA1D;KCND1;SLC6A9;SCN7A;ATP6V0E2;ORAI1
prerank,telomere maintenance (GO:0000723),0.2697742157621154,0.9317173407134277,0.5572390572390572,0.909955000232771,1.0,10/50,13.15%,CTC1;ATM;PCNA;NBN;DCLRE1B;POLD2;ERCC4;BLM;TEN1;TERF1
prerank,apical junction assembly (GO:0043297),-0.25100317845628867,-0.9316781822472087,0.568019093078759,0.848990240167049,1.0,22/53,33.78%,CTNNA1;AFDN;PATJ;MARVELD2;FRMPD2;CDH5;PECAM1;PARD3;MICALL2;GRHL2;MARVELD3;OCLN;PRKCI;PARD6G;VCL;POF1B;CLDN16;PARD6B;CLDN19;CLDN5;DLG1;CLDN18
prerank,Notch signaling involved in heart development (GO:0061314),-0.38245628094717177,-0.9315574269409052,0.5424430641821946,0.8485195352694216,1.0,6/11,22.28%,RBPJ;JAG1;HEY2;SNAI2;NOTCH2;DLL4
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3323740334529026,0.9315360328843475,0.5439252336448598,0.9098193092527289,1.0,12/19,33.44%,CEP295;CENPJ;CEP135;CCT3;CCT5;PTP4A3;CCT8;CCT7;TREM2;CHP1;CORO2B;CCT4
prerank,positive regulation of histone modification (GO:0031058),0.295217188625149,0.9315144232368285,0.5594405594405595,0.9092100340410307,1.0,12/33,23.60%,AKAP8;CDK9;AKAP8L;RPS6KA5;SART3;BRCA1;RPS6KA4;NOS1;GLYR1;KDM1A;ARRB1;PAXIP1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3432842234756798,0.9313741017250807,0.5703564727954972,0.908934928311697,1.0,3/17,12.96%,F11R;S1PR3;ROCK2
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.3717232214191664,-0.9313587543997817,0.5292887029288703,0.8482866401012086,1.0,3/11,7.93%,SIRT1;BMP5;WNT4
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.31992786054794015,0.9313075994742794,0.554954954954955,0.9084531149702726,1.0,7/23,24.15%,SMAD7;DSG2;MYL3;PROX1;FGFR2;TPM1;TGFB1
prerank,negative regulation of cell migration (GO:0030336),0.22855378390322487,0.9312186536541706,0.6324921135646687,0.9080300815982594,1.0,28/137,19.08%,SRGAP2;SRGAP3;LDLRAD4;NAV3;SLURP1;SMAD7;RAC1;IGFBP3;RNF41;FLCN;SHH;RHOB;PIP5KL1;MIA3;NDRG4;DRD2;DPEP1;ARHGAP4;LRP1;GJA1;NOG;PTPN23;ENG;PTPRJ;RNF20;TRIB1;ADAM15;EVL
prerank,antibacterial humoral response (GO:0019731),0.3457761172259208,0.9310593558932995,0.5444646098003629,0.9077884441484495,1.0,4/16,16.47%,SLPI;PLA2G6;RNASE6;RPL39
prerank,protein localization to cilium (GO:0061512),0.28935912074976977,0.9310373584522013,0.5729166666666666,0.9071962938227743,1.0,12/32,24.78%,BBS9;TULP2;ATP6V1D;TTC21B;IFT20;TCTN1;INVS;IFT140;ARL3;TCTN2;IFT122;CSNK1D
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.2665500609600629,0.9309694693063334,0.5929054054054054,0.906709010933911,1.0,11/52,14.38%,EPB41L2;NUMA1;PIK3R1;PDPK1;GPER1;AKAP5;ZDHHC5;STX4;CIB1;AKT1;LRP1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3475993004036593,-0.9309622372302166,0.5306553911205074,0.8485451637075289,1.0,4/15,16.32%,HMGCS1;PPCS;ACLY;MVD
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.29717849031997173,0.9309595450141729,0.5560975609756098,0.9060628571467831,1.0,14/30,26.64%,KLK2;HEYL;DDX5;PRMT2;PIAS2;SAFB2;PARK7;NCOA2;KDM1A;KLK3;SMARCA4;PKN1;AR;EP300
prerank,regulation of translational initiation (GO:0006446),0.2589884638213155,0.9309360225613,0.6003236245954693,0.90546734993489,1.0,25/63,27.97%,NCBP1;CTIF;EIF4A2;EIF4G1;POLR2D;IMPACT;EIF4H;KHDRBS1;UHMK1;MIF4GD;MTIF2;EIF1B;LARP1;EIF5;EIF4EBP2;BOLL;RBM4;DDX3X;YTHDF3;EIF1;EIF2AK3;EIF2B5;EIF4G2;ALKBH1;GLE1
prerank,negative regulation of cellular senescence (GO:2000773),0.376028310310833,0.930773005398978,0.5485714285714286,0.9052766619670622,1.0,2/13,3.01%,MAP3K3;SLC30A10
prerank,dendritic cell chemotaxis (GO:0002407),0.3616507917688414,0.9305398658155892,0.5521023765996343,0.9052247531758225,1.0,4/14,7.55%,PIK3CG;TRPM2;TRPM4;CCR7
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.3553998999931012,0.9302477392688576,0.5374771480804388,0.9053453621287003,1.0,4/15,12.96%,PRKCA;IL6ST;MEF2A;ROCK2
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.33658384953036363,0.9302106340503191,0.5501930501930502,0.9047817109370636,1.0,3/18,7.73%,IL18;AGER;IL12B
prerank,regulation of focal adhesion assembly (GO:0051893),-0.2484827278098556,-0.9300509501115373,0.5846560846560847,0.8502175055009137,1.0,18/54,22.82%,ARHGAP6;SLK;CORO1C;LIMCH1;THY1;ITGB1BP1;ACTG1;RCC2;EFNA5;SFRP1;TEK;PEAK1;ACVRL1;EPHA3;S100A10;TSC1;APOD;BCAS3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.26953147247401443,-0.9292775959787891,0.5648148148148148,0.8514215784946084,1.0,6/36,6.92%,NOSTRIN;EGFR;APOE;ZDHHC21;HTR2B;CALM1
prerank,fatty acid elongation (GO:0030497),-0.3585289332912341,-0.9292324519048962,0.546236559139785,0.850737806584763,1.0,3/13,10.87%,ELOVL7;HACD1;ELOVL5
prerank,gas transport (GO:0015669),-0.38253350958592836,-0.928977404714164,0.5516483516483517,0.8506071041312296,1.0,5/10,32.17%,MYC;CYGB;AQP1;RHAG;NGB
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.33198310087588273,-0.9289728879363417,0.5643340857787811,0.8498222840791914,1.0,3/16,5.48%,AKAP6;PDE9A;TRPC3
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.3371053771706713,0.9283774326264742,0.5640074211502782,0.9090800754438115,1.0,4/18,11.78%,GNA15;RGS10;CHRM1;GRK2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.33936611932872457,0.9282969203948391,0.5828779599271403,0.9085957452971289,1.0,7/18,20.13%,KMT2D;ASH1L;EHMT2;SETD2;SETD4;SETD3;PRDM9
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.29620456591070665,-0.9282804302352865,0.5480093676814989,0.8508696140440207,1.0,4/26,7.61%,SORBS1;IRS1;CREBL2;OSBPL8
prerank,negative regulation of developmental process (GO:0051093),-0.23781960306173675,-0.9281838135417244,0.6143617021276596,0.8503276072411285,1.0,17/69,18.23%,NFIB;DCC;BCL11A;PRKN;HOPX;GRIN3A;FGFR3;THY1;KANK1;HEY2;SFRP1;PARP3;TFRC;ADCK1;KLF7;BMP4;VAT1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.24984743171634205,0.9280485463349327,0.5958132045088567,0.9086308856725439,1.0,14/71,15.89%,BAG6;RNF41;LGMN;ZRANB1;CTSS;CUL4B;YME1L1;UBC;RPS27A;CTSF;SOCS6;ZYG11B;ZER1;RNF123
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.2932566869268198,-0.9279146677004135,0.5645933014354066,0.8502087836164298,1.0,4/27,3.91%,PPARG;CD36;MSR1;PF4
prerank,defense response to bacterium (GO:0042742),0.2354443750449797,0.927877890468651,0.6241935483870967,0.9084410720993158,1.0,29/105,23.38%,ANXA3;LYZL4;TLR4;PRKCD;SLPI;IL6R;PLA2G6;NOS2;IL12B;HAMP;RAB1A;GBP6;RNASE6;MAVS;HMGB2;GBP7;RPL39;OPTN;NOD2;LPO;TNFRSF14;PYCARD;ADAM17;MYD88;SLC11A1;SERPINE1;CHGA;S100A9;S100A8
prerank,negative regulation of response to external stimulus (GO:0032102),-0.22003723330643982,-0.927835975230585,0.6242937853107344,0.8496170460058576,1.0,31/105,23.14%,GRID2;CTNNA2;LRFN5;AOAH;PPARG;APOE;SHARPIN;ILRUN;TRAFD1;ALOX5;PTPN2;CASK;INPP5F;CD109;KLF4;CDH5;NLRC3;TEK;FFAR4;CARD16;CCN3;NR1H4;METRNL;FNDC4;LTF;RNF26;TRAF3IP1;FPR2;C1QTNF3;GHRL;SIGIRR
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3271404399596666,0.9270507377521207,0.5563258232235702,0.9093463981927828,1.0,5/21,11.08%,GTF2H2;CUL4B;ERCC2;DDB2;ERCC4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3271404399596666,0.9270507377521207,0.5563258232235702,0.9093463981927828,1.0,5/21,11.08%,GTF2H2;CUL4B;ERCC2;DDB2;ERCC4
prerank,regulation of complement activation (GO:0030449),0.27794730663911094,0.9266922054269059,0.5815126050420169,0.9096854970967725,1.0,5/40,6.50%,C1QB;PHB2;PROS1;CLU;C1QA
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.304087299250717,-0.9263579464559177,0.5497630331753555,0.8526531562274041,1.0,3/24,6.52%,SORBS1;IRS1;GSK3B
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.3328257158718886,-0.9260377886231008,0.5557894736842105,0.8527009134564355,1.0,6/16,18.91%,RPS3;TPT1;CCAR2;SNAI2;SFRP2;DDIAS
prerank,positive regulation of macroautophagy (GO:0016239),0.27229081574709574,0.9253250074402747,0.5602094240837696,0.9126790312471761,1.0,13/48,21.96%,SCOC;RAB3GAP2;SH3GLB1;RAB3GAP1;HSPB8;PINK1;VDAC1;SESN1;OPTN;LARP1;VPS13D;FYCO1;PIP4K2B
prerank,epithelial tube morphogenesis (GO:0060562),0.2972060701274658,0.925054553485174,0.564625850340136,0.9127558583756566,1.0,8/32,10.39%,CSF1R;MEF2C;PKHD1;MET;SHH;RHOB;SOX17;RASIP1
prerank,sprouting angiogenesis (GO:0002040),-0.2505481931368463,-0.924595230404842,0.5933147632311978,0.8556993011855956,1.0,15/51,18.51%,ROBO1;CCBE1;SLIT2;SEMA5A;VEGFD;CDH13;E2F7;ITGB1BP1;YJEFN3;VEGFC;TEK;SRF;ACVRL1;BMP4;ADTRP
prerank,smooth muscle cell differentiation (GO:0051145),-0.3599012577025301,-0.9244713514832322,0.5553097345132744,0.8552079094364641,1.0,8/12,32.86%,EDNRB;HEY2;MRTFB;APLNR;BMP4;TMEM204;MYOCD;TBX18
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.2921621837691434,0.9244509722668021,0.5747747747747748,0.9136790635272608,1.0,3/31,1.91%,TGFBR1;SMAD7;DSP
prerank,cellular response to starvation (GO:0009267),0.22234166510300843,0.9242994810823895,0.6427503736920778,0.913397773837682,1.0,28/147,15.66%,NUAK1;ATG14;ATP6V0B;EIF2S1;FLCN;IMPACT;TCIRG1;LAMTOR2;SEC13;EHMT2;SH3GLB1;LAMTOR5;MLST8;WDR24;RPTOR;PIK3C3;FADS1;ATP6V1D;NUAK2;MTOR;ATG5;RRAGA;GCN1;SEH1L;EIF2AK2;ATP6V0E2;CARTPT;SESN1
prerank,histone H4-K16 acetylation (GO:0043984),0.3398484101232602,0.9242249066645802,0.5732368896925859,0.9129482814185426,1.0,12/19,36.96%,KANSL2;MSL2;PHF20;JADE2;WDR5;MCRS1;KMT2A;KANSL1;KANSL3;OGT;MSL3;MSL1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.27589609018399663,-0.9241897224536129,0.5945945945945946,0.8551609952709959,1.0,13/33,21.80%,CDC73;PKD2;CCL2;E2F7;KLF4;DCUN1D3;CDKN2A;CDKN1A;JADE1;CDK4;MYO16;CDK6;RBL1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.39022785193234866,0.9240932783678228,0.5774134790528234,0.9126518153002054,1.0,3/10,16.96%,CLU;C5AR1;EGR1
prerank,regulation of telomere maintenance (GO:0032204),-0.2964123807523321,-0.9240724501201208,0.5903890160183066,0.854650944610174,1.0,16/26,37.31%,MYC;SMG6;PPP1R10;XRCC5;SMG5;UPF1;PIF1;SMG1;MRE11;TERF2IP;GNL3;ERCC1;DHX36;TINF2;HNRNPD;PML
prerank,cellular response to increased oxygen levels (GO:0036295),-0.3706068371110973,-0.9237897403310964,0.5753715498938429,0.8546356042661423,1.0,4/11,14.78%,ATP6V1A;ATP6V0D1;ATG7;FOXO1
prerank,regulation of cellular component organization (GO:0051128),-0.2085071488779232,-0.9234624105340941,0.6728723404255319,0.8547340644594439,1.0,28/135,16.71%,HIP1;NRG3;RIT2;SPOCK1;CD36;LATS1;APOE;PAK5;RAPGEF2;MKI67;RASGRP2;SGK2;RAB5C;KIF14;HSPA8;CDH13;BCAR1;IRGM;MLLT3;TMEM97;ALKBH4;STK38L;SETD5;PRKCQ;ABL2;TFRC;ANGPTL7;TMC8
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.29758674958459597,-0.9233794934994701,0.5558086560364465,0.8541439718136504,1.0,2/24,1.65%,CCBE1;SULF2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3118137946222056,0.9232380185829966,0.5664939550949913,0.9143293336057948,1.0,5/23,19.62%,REXO4;FBH1;HMGB2;DNASE2;EXOG
prerank,negative regulation of cell junction assembly (GO:1901889),-0.2998360309817807,-0.9231646326083979,0.5665024630541872,0.8539101891034907,1.0,8/25,22.82%,ARHGAP6;CORO1C;ITGB1BP1;RCC2;ACVRL1;ACE;APOD;BCAS3
prerank,ERBB signaling pathway (GO:0038127),-0.24049557786481646,-0.9230501666361128,0.6234096692111959,0.8534308558557753,1.0,10/64,10.16%,IQGAP1;EGFR;PTPN12;GAREM1;NCK2;SHC3;PIK3C2A;BCAR1;ERBB4;ERBB3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.25076960737303644,0.9229587681032358,0.6205733558178752,0.9144404720686413,1.0,14/76,15.90%,CX3CR1;GNA15;P2RY12;TGM2;GPR55;CHRM1;LHCGR;GPR18;NMUR2;DRD2;VIP;GPR157;C5AR1;GPR4
prerank,positive chemotaxis (GO:0050918),-0.3252729772537369,-0.922829974020475,0.5684931506849316,0.8532262674317931,1.0,4/17,15.69%,FGF10;SEMA5A;FGF7;CX3CL1
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.216512857607184,-0.9226500739317496,0.6582633053221288,0.8529160504232618,1.0,25/124,16.10%,PLCB1;CCDC88C;PRICKLE2;GNAO1;PSMD14;AP2A2;PSMA2;CDC42;AGO4;PSMF1;CALM1;FRZB;PSMD8;TNRC6A;WNT4;PSMD6;PSME2;PSMD11;PSMD1;TIAM1;PSMD5;AP2B1;CTNNB1;SFRP1;PSMD12
prerank,regulation of response to external stimulus (GO:0032101),0.22796929229279891,0.9224241174745151,0.6414790996784566,0.9151705798065005,1.0,15/121,11.29%,DAGLB;P2RY12;IL1RL2;TRIM5;CASP1;CYRIB;SBNO2;LRRC19;PIK3AP1;SELE;BCL6B;NLRP6;APPL1;XIAP;AREL1
prerank,amyloid fibril formation (GO:1990000),-0.24635245028778852,-0.9223876307583566,0.6215538847117794,0.852800110025733,1.0,11/51,12.83%,CD36;APP;GSN;B2M;IAPP;PRKN;HSPG2;SIAH2;CALB1;MFGE8;SNCA
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.3715815992014437,0.9223255820757145,0.5810055865921788,0.9147623359240041,1.0,2/12,9.26%,IL18;IL33
prerank,carbohydrate homeostasis (GO:0033500),-0.24130768084572768,-0.9222188989281086,0.6326530612244898,0.8524537711399713,1.0,21/67,24.80%,PPARG;MCU;IRS1;ADIPOR2;USF1;ALOX5;SLC8B1;ADCY8;PTPN2;CEBPA;ADRA2A;RBP4;TFAP2B;KLF7;PRKAA1;CRY1;RPS6;PDK4;NGFR;RFX6;SLC2A4
prerank,maturation of LSU-rRNA (GO:0000470),-0.28788736548191535,-0.9221900613737485,0.5520169851380042,0.8517412321471326,1.0,4/26,6.79%,SNU13;NSA2;LAS1L;RPL7A
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.27458915102958403,0.922123700361949,0.5902777777777778,0.9146320490938816,1.0,16/44,24.75%,CNOT1;MOV10;ZFP36L1;ZFP36L2;NANOS2;RBM24;ROCK2;METTL14;TNRC6B;NANOS1;TOB1;GTPBP1;TNRC6C;PUM1;ZC3H12A;YTHDF3
prerank,mRNA 3'-end processing (GO:0031124),0.24624466427294844,0.9220729668022649,0.5944625407166124,0.9141022495277059,1.0,18/78,18.40%,SRRM1;NCBP1;CSTF2;POLR2D;SRSF5;DHX38;PABPN1;CPSF1;U2AF2;U2AF1L4;ALYREF;RBM8A;SLU7;DDX39B;SRSF9;PCF11;THOC6;FIP1L1
prerank,nuclear membrane reassembly (GO:0031468),-0.24813423669734877,-0.9217948468462001,0.5841584158415841,0.8519516546047509,1.0,19/54,26.22%,PPP2R2A;REEP3;NUP98;LMNA;RAN;LBR;NUP205;PPP2R1A;REEP4;BANF1;NUP43;NUP155;CCNB1;VRK1;NSFL1C;LEMD2;PPP2CA;EMD;AHCTF1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.361965251030991,-0.9217835890020202,0.5540838852097131,0.8512020914928179,1.0,3/12,20.32%,PPARG;NCOR1;TERT
prerank,regulation of protein binding (GO:0043393),-0.21262481663148441,-0.9215724938493168,0.6264044943820225,0.8509557841999593,1.0,25/114,17.08%,DAB2;LRRK2;APP;B2M;RAPGEF2;MARK3;HDAC4;RAN;STYX;ACTB;GSK3B;PRKN;HIPK2;AURKB;ITGB1BP1;TIAM1;EPB41;TTBK1;DNAJB2;CAPRIN2;CDKN1A;BAMBI;TMC8;ADD2;CARD16
prerank,regulation of muscle contraction (GO:0006937),-0.29373562309178136,-0.9214529093390316,0.5849056603773585,0.8504506559560252,1.0,5/26,14.72%,KCNB2;CHRM2;TNNI1;MYL9;MYBPC3
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.3628904289992344,-0.9211962942274872,0.5565217391304348,0.8503376946287236,1.0,3/12,12.18%,CD44;SKAP1;THY1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.35858752823455675,-0.9210305151768038,0.5532786885245902,0.8500020844766473,1.0,3/12,14.12%,CCR2;PRKCQ;CLEC6A
prerank,neuron remodeling (GO:0016322),-0.3795137343844061,-0.9209149708709911,0.5381263616557734,0.8495252326766716,1.0,4/10,15.69%,ADGRB3;APP;SCARF1;CX3CL1
prerank,positive regulation of cell aging (GO:0090343),-0.3678606693226354,-0.9208430211399516,0.555793991416309,0.848926359872055,1.0,3/11,4.44%,B2M;LMNA;SIRT1
prerank,regulation of neuroblast proliferation (GO:1902692),0.359085723689574,0.9207102460819111,0.5635062611806798,0.9170833794633713,1.0,3/15,12.21%,CX3CR1;SMARCD3;DRD2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3442876817575612,0.9204046038827834,0.5709219858156028,0.9172175376705392,1.0,7/16,27.04%,BRCA1;CEACAM1;WDTC1;APPL2;ERLIN2;SOX9;ACADVL
prerank,lysosome localization (GO:0032418),0.2841137495288783,0.9202562828147024,0.5543859649122806,0.916936654997737,1.0,7/37,12.08%,KXD1;PIK3CG;FLCN;PIP4P1;RAB34;PIK3CD;MYH9
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3566431207899414,0.9202239249977272,0.5394495412844037,0.9163630850453749,1.0,3/15,10.54%,PDPK1;TJP1;DLL1
prerank,purine-containing compound salvage (GO:0043101),-0.3599404190727767,-0.9201920833477004,0.5566037735849056,0.8498170988379975,1.0,3/12,13.21%,AMPD3;ADK;APRT
prerank,entry into host (GO:0044409),0.3751349812782209,0.9199861300079454,0.5659340659340659,0.9162961619367339,1.0,3/13,6.17%,ITGAV;SRC;MET
prerank,axonal transport (GO:0098930),0.2872621743671235,0.9197818798406707,0.5996503496503497,0.9161588910501676,1.0,6/36,11.62%,DST;KIF3B;AP3D1;AP3B2;KIF3A;SOD1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.3516049982532232,0.9191031680438926,0.5557586837294333,0.9172910778128134,1.0,7/15,17.65%,BMP2K;NEU3;PIK3CB;DGKD;HIP1R;TNK2;WASL
prerank,cell projection assembly (GO:0030031),0.31619425080194,0.9185922543580847,0.5679862306368331,0.917977097722946,1.0,4/22,5.15%,RAC1;RHOH;NCKAP1L;RHOQ
prerank,mitotic cytokinesis (GO:0000281),-0.2550133030802133,-0.9180391781045985,0.6033653846153846,0.8547084493183347,1.0,11/47,12.43%,ANK3;SPTBN1;KIF23;RACGAP1;CUL7;NUSAP1;UNC119;CNTROB;KIF20A;SNX9;EFHC1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.2502737289569854,-0.9178498201649142,0.5945273631840796,0.8544383897649326,1.0,11/48,13.20%,AMPD3;ADCY2;ADCY5;ADSS2;GUCY1B1;PAPSS2;ADCY3;ADCY8;PPCS;SLC25A16;SLC26A2
prerank,regulation of biomineral tissue development (GO:0070167),0.3034516889528184,0.9178380204989792,0.6088495575221239,0.9192498327004965,1.0,9/26,27.60%,NBR1;BMP2K;ROCK2;DDR2;TWIST1;TGFB1;NOTCH1;SOX9;TXLNG
prerank,positive regulation of growth (GO:0045927),-0.2350181115201513,-0.9174281848641799,0.6175,0.8547032713202379,1.0,15/64,17.63%,AKAP6;PLCB1;EGFR;SDCBP;CDC42;DERL2;LGI1;PABIR1;MFSD2A;MMP14;MTPN;BCL2;SFRP1;H3-3A;SFRP2
prerank,cellular defense response (GO:0006968),0.276825330884547,0.9174129220575661,0.6036036036036037,0.9197162171704105,1.0,5/40,8.98%,CX3CR1;IL1RL2;TCIRG1;ADORA2B;PTK2B
prerank,regulation of osteoclast differentiation (GO:0045670),0.28790968763548325,0.9172351477732683,0.5757575757575758,0.9195219885371725,1.0,8/33,15.40%,TLR4;UBASH3B;GPR55;IL12B;POU4F1;MTOR;GPR137;CARTPT
prerank,cellular protein metabolic process (GO:0044267),-0.1832092139858502,-0.9169451699142134,0.8197278911564626,0.8551685835100173,1.0,80/396,16.35%,ST3GAL1;APP;MSRA;PCSK5;APOE;RPL30;RPL36A;ST8SIA4;MRPL18;RPS29;RPL35A;SPP1;RPS3;FN1;DENND3;SPCS2;RPL4;SPARCL1;PARL;RPS7;GGCX;NAPSA;RPS2;RPL41;PRKN;UBA3;FSTL1;RPL7A;RPLP2;CLN5;IGHMBP2;IGFBP4;RPN2;RPL38;RPL18A;FBN1;CHRM3;RPS14;RPS27;MRPS7;SIAH2;GPC3;RPL13A;ST8SIA2;RPL26;TNC;RPL22;LAMB2;MSRB1;PADI4;MMP15;RPS25;RPS15A;RPS15;VCAN;SHISA5;EEF1A2;FBXW2;LOX;ERO1A;L2HGDH;RPS6KB2;DNAJC3;RPL8;MFGE8;RPL23A;GNMT;B4GALT7;RPLP1;RPL37;IGFBP2;FAM20C;PHEX;HBS1L;PLAT;NUCB1;ABL2;RPS12;MAGEC2;MRPS33
prerank,phospholipid transport (GO:0015914),-0.2518877162031915,-0.9158983352836906,0.6310432569974554,0.8571104116642444,1.0,14/52,18.39%,ATP8B4;APOE;PLTP;LDLR;ATP11A;OSBPL8;PRELID1;ATP11C;MFSD2A;ATP8B2;ABCC1;ABCA4;ATP10B;ATP9B
prerank,epithelium development (GO:0060429),0.2315766529974564,0.9157502644438652,0.6333333333333333,0.922890044693371,1.0,23/107,19.80%,SALL1;SOX8;PCNA;LOXL3;CD34;SHH;SOX17;WNT7B;NDRG4;DLL1;MTHFD1;PAX2;PROX1;KANK2;VDAC1;CPT1A;SPINK5;SMO;ERRFI1;PTCH1;CBR1;ANXA7;FGFR2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.359158858840287,-0.9154707899964859,0.5588235294117647,0.8574194100005171,1.0,5/11,20.31%,ANK3;PLAUR;PRKCQ;CCL5;BLK
prerank,establishment of spindle localization (GO:0051293),0.3590141447197537,0.9153737830077844,0.558983666061706,0.9232270869600688,1.0,3/14,15.29%,TLE6;LLGL1;MAP4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.38429431148077536,0.9153706577725519,0.5783365570599613,0.9225751363786624,1.0,1/10,0.08%,BIN1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.31548697940438625,0.9152426720838045,0.5551663747810858,0.9222322211408669,1.0,6/23,15.60%,GREM1;MEF2C;RBM24;MAPK14;PROX1;PIEZO1
prerank,negative regulation of chemotaxis (GO:0050922),-0.2778413263507382,-0.9150293850212006,0.6023255813953489,0.8577251805341308,1.0,6/31,8.84%,ROBO1;SLIT2;SEMA5A;SEMA4A;SEMA6D;PTPN2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.35000069733127115,0.9150067378071625,0.5598526703499079,0.9221991201490827,1.0,3/15,7.94%,ZFP36L1;ZFP36L2;GPER1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.39244017616635807,0.914198906257479,0.5578358208955224,0.9235941347290446,1.0,5/10,19.21%,PRKCD;CD9;CEACAM1;SERPINE2;ADAMTS18
prerank,positive regulation of leukocyte activation (GO:0002696),0.32595569769158933,0.9139040896861402,0.572992700729927,0.9237365092428493,1.0,6/18,16.42%,TLR4;KARS1;IL33;NECTIN2;TNIP2;THBS1
prerank,establishment of protein localization to membrane (GO:0090150),-0.23563894708307137,-0.9138933200568565,0.6443298969072165,0.8598765615131211,1.0,19/66,24.21%,CHM;EGFR;ZDHHC21;FRMPD1;SDCBP;AFDN;BID;ZDHHC23;AQP11;COX18;ZDHHC15;PARD3;ATG3;RFTN1;ZDHHC18;ZDHHC24;NACA;VPS37C;ZDHHC19
prerank,regulation of interleukin-12 production (GO:0032655),0.26488240055420786,0.913806374617822,0.6190476190476191,0.9233426602982315,1.0,7/47,7.73%,LGALS9;AGER;TLR4;RIPK2;PLCG2;CCR7;IL12B
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.2519721209272274,0.9135349048114836,0.5898305084745763,0.9234217410998875,1.0,12/62,13.39%,F11R;RAC1;MAP4K4;LYN;PIK3CG;AKAP13;ABRA;GPR55;PIK3CB;GPR18;STK19;RTN4R
prerank,regulation of muscle cell differentiation (GO:0051147),0.29151521857528384,0.913457074397903,0.5839285714285715,0.9229747931043172,1.0,12/31,22.19%,MEF2C;CDK9;ABL1;MEF2A;MAPK14;BNIP2;CDH15;MEGF10;TCF3;CAMK1;FGFR2;RBM4
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.39518743168047554,0.9134002550822768,0.583011583011583,0.9224653019364927,1.0,4/10,19.26%,BRCA1;RAPGEF3;HDAC5;CAMK1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.2543937536306926,-0.9133561230722821,0.6,0.8605458084947168,1.0,16/45,25.71%,GLS;ASPA;ATP7A;KMO;THAP4;DDAH2;GNMT;SRR;GPT;PYCR3;SLC25A12;ALDH18A1;GOT1;RIMKLB;KYAT1;NOX4
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.31320136977401375,-0.913272744824335,0.6090712742980562,0.8599873622847053,1.0,5/18,17.46%,ITGA4;PPARG;CCL2;HMGB1;APLN
prerank,positive regulation of JNK cascade (GO:0046330),0.24694674524916366,0.9132222046082821,0.6247933884297521,0.9222499697380011,1.0,18/70,19.34%,PJA2;AGER;TRAF5;CD27;CCR7;EDA2R;PTK2B;WNT7B;MAP3K10;MAPK8IP1;TNFRSF19;MAP3K11;MAP4K2;TAOK2;RASSF2;NOD2;MINK1;PYCARD
prerank,microvillus assembly (GO:0030033),-0.33489433663439777,-0.9130866245033087,0.5829787234042553,0.8597200720650944,1.0,3/14,5.15%,RAPGEF2;STK26;FXYD5
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3861804556469305,0.9129100053745782,0.5551181102362205,0.9224242376890932,1.0,2/10,6.28%,PDE3B;CDC34
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.2932012280568128,-0.9127109854862205,0.5924170616113744,0.8598947512594235,1.0,7/24,14.75%,B2M;SAR1B;TAP1;SEC23A;SEC24C;SEC24B;SEC24D
prerank,regulation of response to biotic stimulus (GO:0002831),-0.28837783487012486,-0.9126598991550232,0.6018306636155606,0.8592604432423185,1.0,6/28,15.69%,CD36;FOXP1;PTPN22;SAMHD1;FCGR2B;CX3CL1
prerank,negative regulation of DNA binding (GO:0043392),-0.28367051321373893,-0.9126186186036913,0.6111111111111112,0.8586033765376477,1.0,6/28,9.03%,SOX11;ILRUN;SP100;JAK2;PER2;NFKBIA
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.3958985717770791,0.9124604763514103,0.6003717472118959,0.9229536032505027,1.0,3/10,17.78%,TLR4;IL33;NOD2
prerank,nucleotide-excision repair (GO:0006289),0.23537900584843968,0.9122955141628208,0.6295133437990581,0.9227054510440398,1.0,24/101,20.06%,POLR2H;COPS4;GTF2H2;RFC2;PCNA;POLR2D;SLX4;CUL4B;POLR2J;MMS19;UBC;RPS27A;ERCC2;POLD2;DDB2;ERCC4;GPS1;RFC1;LIG1;COPS6;HMGN1;POLR2E;RPA3;POLR2I
prerank,replication fork processing (GO:0031297),0.28100486616581416,0.9120870143743539,0.6169064748201439,0.9226114631740101,1.0,8/38,14.65%,PRIMPOL;CDK9;PCNA;FAM111A;FANCM;BLM;ALYREF;FBH1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.21290287781677986,0.9116101612908643,0.6940298507462687,0.9231946167665805,1.0,47/199,21.50%,LDLRAD4;SMAD7;PLCL1;PCTP;DDIT3;MEF2C;AGER;TLR4;LAMA4;RPS6KA5;ID1;SPRY2;TFE3;FLCN;SHH;PLCL2;OVOL2;WNT10B;APOM;BBS2;ABHD6;CHSY1;ROCK2;NRDC;GPNMB;GJA1;PROCR;RPS6KA4;PTPN23;NR1H2;SYT11;GATA3;IP6K1;PTCH1;LRP4;HPN;EVL;LRPAP1;ADAM17;NOVA2;ACVR2B;SPRED2;SLC11A1;EFNA1;WDR77;STC1;BMP2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3084585582249994,0.9115790885441878,0.5985130111524164,0.9226310605079122,1.0,7/24,16.20%,PDE3B;CDC34;RASD2;CGAS;GPR61;MGRN1;GPR62
prerank,negative regulation of cell cycle process (GO:0010948),0.25739534212559867,0.9111719890783367,0.6260296540362438,0.9230570333828381,1.0,21/61,24.86%,EHMT2;NANOS2;GPER1;BRCA1;EED;APAF1;NME6;TERF1;PCGF2;EZH2;EPC1;CHMP2A;MGA;RNF2;CCP110;RING1;PHC1;CDC7;SUZ12;ZFYVE19;UXT
prerank,skeletal muscle contraction (GO:0003009),0.33219873277197787,0.9111269631362782,0.5789473684210527,0.9225214806033326,1.0,4/19,20.49%,CCDC78;RCSD1;MYH14;TNNI2
prerank,organonitrogen compound catabolic process (GO:1901565),0.25454307925399283,0.9110470272693636,0.6256239600665557,0.9220536956103593,1.0,11/57,13.00%,LIPC;CAPN3;PLA2G15;PLA2G6;SMPD2;MPST;PLA2G5;PLA2G4A;PPT1;MTOR;GADL1
prerank,steroid biosynthetic process (GO:0006694),0.2535803665262407,0.9109420865486246,0.6173469387755102,0.9216620831856588,1.0,8/56,11.14%,FDXR;HSD3B2;CH25H;CYP46A1;OSBPL3;AKR1D1;HSD17B1;CYP7B1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.2885946791503411,0.9104129535906471,0.6006944444444444,0.9223188943153431,1.0,2/31,0.62%,TGFBR1;TGFBR2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.24015879340795698,-0.9098817040391546,0.6043689320388349,0.8647616294850015,1.0,8/57,5.28%,GRIN2A;NLRC4;GRIN2B;CYFIP2;SIRT1;ACVR1C;DAPK1;MYC
prerank,response to peptide (GO:1901652),0.2906592424771832,0.9095435638622811,0.6140035906642729,0.9238945747949557,1.0,10/33,22.93%,AGER;MMP2;EIF2B3;CALCR;EIF2B4;NOD2;IRF5;STAT5B;CACNA1A;STAT6
prerank,negative regulation of reproductive process (GO:2000242),-0.31968235365815584,-0.9094237351254693,0.5786026200873362,0.8651617405872661,1.0,2/17,4.59%,PAEP;ACVR1C
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.2896847980831537,0.9094000663008297,0.5817843866171004,0.9236162309774932,1.0,3/29,3.81%,UTP6;WDR46;TBL3
prerank,negative regulation of vascular permeability (GO:0043116),-0.3555296403179821,-0.9089016900198196,0.5786163522012578,0.8657005843336738,1.0,3/12,14.88%,SLIT2;SH3GL2;PDE2A
prerank,mitotic DNA replication (GO:1902969),0.38088526875117795,0.9088288801990209,0.5452865064695009,0.924476992145763,1.0,6/10,23.45%,MCM2;LIG1;MCM3;MCMDC2;GINS3;MCM6
prerank,negative regulation of coagulation (GO:0050819),-0.34228906805248194,-0.9087787377729151,0.591304347826087,0.8652438128304271,1.0,2/14,2.38%,HS3ST5;APOE
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.35733112489059593,-0.9085524220209101,0.5920177383592018,0.8650213200539834,1.0,3/12,10.93%,GET3;HSPA5;SEC62
prerank,cellular response to oxidative stress (GO:0034599),-0.20836635815876753,-0.9084893221133745,0.6888888888888889,0.8644189693823673,1.0,35/118,22.45%,CYBB;LRRK2;EGFR;MSRA;NCF2;PRDX1;RPS3;ROMO1;DAPK1;PPIA;PKD2;CYBA;MGAT3;SLC25A24;ERCC6L2;SOD2;ERO1A;AGAP3;TXNRD1;SNCA;FOXO1;HSPA1B;HMOX1;CAT;SESN2;PYROXD1;GSTP1;PRKAA1;RAD52;ZFAND1;PRR5L;PTPRK;PLA2R1;CYCS;GSR
prerank,embryonic digestive tract development (GO:0048566),0.3264746636646277,0.9083916691513276,0.5822550831792976,0.9249638627760263,1.0,1/18,0.12%,SALL1
prerank,catecholamine metabolic process (GO:0006584),0.3581578029850415,0.9080611675064597,0.5833333333333334,0.9251677214097321,1.0,3/14,12.21%,SNCAIP;COMT;DRD2
prerank,positive regulation of cell population proliferation (GO:0008284),0.19678437382976563,0.9077101560759194,0.7639257294429708,0.9254152429421263,1.0,69/423,16.42%,TGFBR1;TMEM119;IL18;TGFBR2;MLXIPL;LRP5;CSF1R;GREM1;SOX8;FAM98B;AIF1;MEF2C;TBC1D8;MAP3K3;ITGAV;GAB2;CSNK2A1;LYN;IGF1R;KMT2D;PKHD1;LGMN;IL6R;MEIS3;NDUFS4;TRPM4;TCIRG1;SHH;ACER3;IL6ST;ACER2;S1PR3;IL12RB2;EDN3;CNTF;PDGFB;EDN2;GPER1;CTF1;PTK2B;CD86;TBX6;GCNT2;DHPS;TJP1;PRMT1;DLL1;DHX9;PDCD10;STX4;CNBP;PAX2;PROX1;CIB1;AKT1;HTR1A;TSPAN31;VIP;RNF187;GJA1;CCAR1;IL7R;LAMC2;C5AR1;NME1;EZH2;DDR2;MEGF10;THBS1
prerank,protein deneddylation (GO:0000338),0.3922273576077977,0.9075899471857758,0.581573896353167,0.9250652634716685,1.0,3/10,16.33%,COPS4;GPS1;COPS6
prerank,response to ketone (GO:1901654),0.3131495187149996,0.9069705967290372,0.608286252354049,0.9260175470723815,1.0,8/24,24.20%,HSD3B2;CCR7;ABCB4;THBS1;CATSPER2;UBE3A;TGFB1;WBP2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.37851292358893807,-0.9068773140374373,0.577639751552795,0.8669473625322615,1.0,3/11,7.89%,AGO4;TNRC6A;ZFP36
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.37851292358893807,-0.9068773140374373,0.577639751552795,0.8669473625322615,1.0,3/11,7.89%,AGO4;TNRC6A;ZFP36
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.359933317895308,-0.9068707490527845,0.620253164556962,0.8661956676946488,1.0,4/12,16.14%,MAP2;SNCA;CDH5;STMN2
prerank,positive regulation of ossification (GO:0045778),-0.2588873499593401,-0.9067996056815057,0.6088992974238876,0.8656075683665195,1.0,7/39,9.69%,ZBTB16;ATP2B1;SOX11;ALOX5;FBN2;WNT4;ANO6
prerank,regulation of organelle organization (GO:0033043),0.2394534933727204,0.9067339086883093,0.6687598116169545,0.9260177855125454,1.0,24/80,23.72%,F11R;PREB;TMED9;ARMH3;CAMSAP2;SAR1A;CLN3;TJP1;PDCD10;MIEF2;MARK2;PRMT6;PINK1;RBSN;MAVS;SYT11;CPLANE2;STX18;ARHGEF5;MAPT;STX5;S100A9;S100A8;PISD
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2274895355119242,0.9064655809228099,0.6573643410852713,0.9260689187214739,1.0,27/113,20.56%,TGFBR1;RREB1;PRKCA;CRNN;PKHD1;VEGFB;PDGFB;PIK3CD;ARNT;PDCD6;PAX2;PROX1;AKT1;VIP;CDH3;HMGB2;C5AR1;NME1;AGGF1;CLDN1;NOD2;TCF7L2;CCL24;HPN;STXBP4;FGFR2;HIF1A
prerank,metal ion homeostasis (GO:0055065),0.27235870969869214,0.906315820546699,0.6196721311475409,0.9258402533594995,1.0,6/40,10.06%,SLC7A8;SLC12A6;SLC8A1;SLC12A9;CNNM2;CNNM4
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.2993677442690689,-0.9062404083637384,0.5995423340961098,0.8661842623304228,1.0,5/22,12.04%,MAP1B;APOE;MAP2;HSPA8;AEBP1
prerank,spliceosomal complex assembly (GO:0000245),0.26786015556158055,0.9058859195729703,0.6230636833046471,0.9262817944602967,1.0,10/46,16.89%,NCBP1;CELF2;SF3B1;SRSF5;SMN1;LUC7L3;LUC7L;DDX39B;SRSF9;SF3A1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.29455200527922726,-0.9055350118588161,0.6344827586206897,0.8671407969703262,1.0,5/24,10.01%,RBPJ;CEBPB;KLF2;HSPA5;CREB3L1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.20190385806059769,0.9051623850970686,0.733983286908078,0.9275600184125885,1.0,74/291,22.26%,CX3CR1;TWF2;SIRPA;P2RY12;TGM2;MEF2C;TLR4;PRKCD;LYN;CASP1;ATM;SBNO2;ZFP36L1;IMPACT;SSH1;CTR9;LAMTOR2;PABPN1;WNT10B;PDGFB;PDCD1LG2;GPER1;CXCL1;POU4F1;LAMTOR5;PTK2B;CD86;PDK2;WNT7B;CAMKK2;RAPGEF3;RPTOR;TICAM2;ADCY6;AXL;CCDC62;MTOR;ABCB4;DPEP1;MAPK14;ROCK2;PAX2;RRAGA;AKT1;NLRP3;HMGB2;TNIP2;TICAM1;FES;NRIP1;EGR1;CCR5;TAF1;NDUFA13;NOD2;PXN;INPP5K;NCOA3;DMTN;MAPK8;CIB2;PYCARD;JUN;SHPK;MAPT;MYD88;P2RY6;CXCL10;HTRA2;SERPINE1;GPLD1;PDCD4;IL36G;SLC26A6
prerank,establishment of melanosome localization (GO:0032401),0.32699000790739097,0.9051376161557784,0.5951035781544256,0.9269698816730467,1.0,4/19,11.57%,MLPH;BBS2;SHROOM2;RAB27A
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.3145431490796274,0.9050466051312531,0.5896147403685092,0.9265686462754801,1.0,8/22,31.79%,LGMN;RLBP1;CYP2R1;CBR1;PIAS4;GC;ALDH1A2;CYP1A1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3065027889984251,-0.904839245239992,0.5912087912087912,0.8681253822801175,1.0,10/21,29.25%,ATAD5;RCC2;NPM1;CDC25C;CCNB1;DTL;STOX1;CDK4;MECP2;CDC25B
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3009797817380461,-0.9046083798623427,0.5981524249422633,0.8679204668094233,1.0,10/22,32.24%,B2M;GSK3B;DISP3;CNTN4;EIF2AK4;REST;MED1;HES5;SOX3;POU4F2
prerank,neuropeptide signaling pathway (GO:0007218),-0.23710021035335918,-0.9043300234222141,0.6377171215880894,0.8678739668019722,1.0,12/58,18.95%,SORCS1;RAPGEF2;GLRA1;OPRM1;OPRD1;HCRTR2;GALR1;GLRA2;NXPH2;NTS;AGRP;NTSR1
prerank,regulation of integrin activation (GO:0033623),0.34821674019828464,0.9039059754992189,0.5996131528046421,0.9288407352278044,1.0,4/15,15.60%,SRC;PLEK;RASIP1;PIEZO1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.3139228021941185,-0.9038983325758324,0.5898004434589801,0.8681268008874011,1.0,3/18,5.14%,USP15;ANKRD17;DDX60
prerank,positive regulation of bone mineralization (GO:0030501),0.28218142974581323,0.9035528244251526,0.6030150753768844,0.9290732422189717,1.0,3/35,3.96%,TMEM119;MEF2C;SLC8A1
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.186613420156946,-0.9035151267104607,0.8014184397163121,0.868311197913545,1.0,60/308,18.10%,NLGN1;DAB2;ESRRG;PLCB1;ZBTB16;B4GALT5;KSR2;CCR2;CD36;ADRA1A;APOE;RTN4;SOX5;SDCBP;FABP4;RFX3;CEBPB;ZBTB7B;ADIPOR2;SIRT1;SOX11;PLAC8;IRF4;HTR2B;CLEC9A;COL1A1;JAK2;G0S2;PER2;KDM6B;GRB10;THRA;LBP;ADRA2A;MAP3K13;PRDM16;KMT5B;GLIPR2;BCL9L;TIAM1;EBF2;ALMS1;CLEC6A;ACHE;RGCC;CTNNB1;ESRRB;TXK;SCX;TSHR;TFRC;BAMBI;SHLD3;FFAR4;ITK;AGPAT1;SMTNL2;NME2;NR2C2;BMP4
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.31205600856923055,0.9034926485678187,0.5597920277296361,0.9285785923031997,1.0,3/20,6.89%,IL18;CASP1;ENTPD1
prerank,potassium ion homeostasis (GO:0055075),0.3041391784323782,0.90344810746645,0.5899653979238755,0.9280396754390249,1.0,4/23,8.21%,KCNMA1;SLC12A6;SLC12A9;ATP1A4
prerank,DNA conformation change (GO:0071103),0.3275725210627289,0.9031104800674821,0.6086175942549371,0.9282069728201726,1.0,5/17,15.22%,TOP3B;TOP2B;ABL1;TOP3A;HMGB2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.2793479885348998,0.9030240583583431,0.6099173553719008,0.9277890152071562,1.0,19/36,32.00%,RILPL1;MACF1;RAB34;TRARG1;BBS2;GOLGA4;GGA3;GORASP1;OPTN;KIF13A;SYS1;GOLPH3L;PREPL;RAB26;VAMP5;ARFRP1;GORASP2;VAMP2;NECTIN3
prerank,cellular response to chemokine (GO:1990869),-0.2531272417707636,-0.9030093545337264,0.6312217194570136,0.8688305741266596,1.0,6/46,5.27%,CCR2;CCR1;CCL4;PF4;RIPOR2;GPR35
prerank,ncRNA catabolic process (GO:0034661),0.29226812387762585,0.9029529183352865,0.6059479553903345,0.9273569183685213,1.0,11/28,27.93%,POP1;DIS3L2;EXOSC5;EXOSC10;NUDT16;SND1;EXOSC8;RBM7;PARN;ZCCHC8;NUDT16L1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.34366517612467457,-0.9028581707335458,0.5899122807017544,0.8684527790993295,1.0,1/13,0.56%,PLCB1
prerank,motile cilium assembly (GO:0044458),-0.35128764553443925,-0.9025456433613894,0.5899581589958159,0.8684981708094751,1.0,4/12,24.70%,SPATA6;DNAAF1;DNAAF3;CCDC39
prerank,lipid biosynthetic process (GO:0008610),0.24243473540324192,0.9025024009106313,0.6515912897822446,0.9278570744132414,1.0,8/77,10.60%,LIPC;LIPH;FDXR;HSD3B2;GGPS1;MBOAT1;HSD17B1;FADS1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3582294484864535,0.9024824959255633,0.6111111111111112,0.9272575294801694,1.0,3/13,21.28%,ATM;SESN1;DEPDC5
prerank,embryonic limb morphogenesis (GO:0030326),0.2856634353469522,0.9023773535790343,0.632688927943761,0.926863075998585,1.0,4/34,9.55%,SALL1;SKI;SHH;FBXW4
prerank,positive regulation of intracellular protein transport (GO:0090316),0.22083585047906448,0.9021986028553871,0.6749633967789166,0.9266607046906523,1.0,39/144,24.31%,HPS4;ITGAM;SMAD3;YWHAH;CSNK2A2;PRKCD;PIK3R1;ITGB2;SH3GLB1;LEPROT;AKAP5;RAPGEF3;SAR1A;USP36;PDCD10;MIEF2;PINK1;TENM1;RNF31;OAZ2;CIB1;MAVS;PLK3;TOMM7;ECT2;TCF7L2;PMAIP1;MAPK8;CAMK1;KCNB1;HTRA2;SAE1;NMT1;TP53;KIF20B;ZDHHC2;TGFB1;UBL5;ZC3H12A
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3057704098564854,0.9021868897224582,0.5863247863247864,0.9260555512619408,1.0,7/24,17.61%,TRIM44;IL12B;CGAS;SIN3A;DTX3L;MAVS;AIM2
prerank,renal system development (GO:0072001),0.25737421204548755,0.9021670659355141,0.6402027027027027,0.9254610089052291,1.0,3/52,1.52%,TGFBR1;SALL1;BAG6
prerank,protein localization to mitochondrion (GO:0070585),0.37831449388484384,0.9021323464350582,0.5769944341372912,0.9249042612833089,1.0,4/11,17.08%,HK2;PINK1;AKT1;MAIP1
prerank,cellular response to dsRNA (GO:0071359),0.3473095953732705,0.9020553795089647,0.5862068965517241,0.9244514544308868,1.0,10/15,33.32%,ZCCHC3;CGAS;DHX9;MAVS;IFIT1;MUL1;RALB;COLEC12;PDE12;FLOT1
prerank,limb morphogenesis (GO:0035108),0.3221229633447766,0.9019976866497409,0.6340579710144928,0.9239700154916469,1.0,5/20,17.51%,SKI;SHH;FBXW4;IQCE;PTCH1
prerank,Wnt signaling pathway (GO:0016055),0.23300120632138224,0.9018554205210236,0.6616666666666666,0.9236820713609029,1.0,35/92,27.44%,LRP5;CSNK1E;PLCG2;ZRANB1;PORCN;BCL9;FZD2;WNT2B;CPE;RYK;WNT10B;WNT7B;UBC;RPS27A;FZD1;SNX3;TCF7L2;RAC3;TCF7L1;SFRP4;VPS26A;WLS;FZD6;DDX3X;CUL1;VPS29;FZD9;FZD3;VPS35;CSNK1G2;FZD10;WNT5A;DVL3;RBX1;DVL1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.2806684471208783,-0.9016404054001449,0.6305309734513275,0.870092241428294,1.0,4/28,6.02%,ARHGAP35;LATS1;CTTN;PAK3
prerank,regulation of DNA replication (GO:0006275),-0.24406583331576595,-0.9013718673596992,0.6674641148325359,0.8699738249640312,1.0,12/49,17.52%,EGFR;ANKRD17;S100A11;FAF1;CCDC88A;PDS5A;PPP2R1A;ATAD5;NPM2;ESCO2;GMNC;ACVRL1
prerank,protein-containing complex disassembly (GO:0032984),-0.23877415008713493,-0.9012159899587928,0.6380510440835266,0.8696214983732122,1.0,16/54,23.98%,SNX14;MYC;UVRAG;GSK3B;STX17;HSPA8;LRP6;AXIN1;VPS16;CTNNB1;UBQLN1;WNT8B;FRAT1;CSNK1A1;RPL23;GABARAP
prerank,hexose biosynthetic process (GO:0019319),-0.2578825093330471,-0.9009165168631539,0.6474820143884892,0.8695886031441891,1.0,11/42,20.11%,PFKFB1;SLC37A4;PER2;PGM1;G6PC3;RBP4;ALDOC;GPI;SLC25A12;CRY1;GOT1
prerank,mammary gland epithelium development (GO:0061180),-0.34341624025825934,-0.9008014470030903,0.5698924731182796,0.8691047955199916,1.0,4/14,8.72%,LATS1;JAK2;WNT4;ERBB4
prerank,membrane lipid biosynthetic process (GO:0046467),-0.23875067248827364,-0.9007553885611169,0.6513513513513514,0.8684670293769038,1.0,8/58,6.52%,SGMS1;ST3GAL4;SPTSSA;SGMS2;ELOVL7;VAPA;SGPL1;HACD1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.36879289223892764,-0.9007298563892495,0.5862785862785863,0.8670100858298636,1.0,2/11,7.98%,CALM1;PKD2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.36879289223892764,-0.9007298563892495,0.5862785862785863,0.8670100858298636,1.0,2/11,7.98%,CALM1;PKD2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.27458737709797476,0.9006613942172985,0.6090750436300174,0.9259719307867496,1.0,12/39,21.99%,NFE2L2;PDPK1;ECSCR;GATA2;GPER1;MAPK7;TNIP2;THBS1;GATA3;PLCG1;SERPINE1;PDCD4
prerank,positive regulation of B cell activation (GO:0050871),0.2571735364917263,0.9003165236682061,0.6333333333333333,0.9262301070232599,1.0,8/50,9.62%,SASH3;MEF2C;CD27;NCKAP1L;TNFRSF13C;CD320;KMT5C;TNFSF13B
prerank,quinone biosynthetic process (GO:1901663),0.35355737226467643,0.9003159830722389,0.5906642728904847,0.9255917678730028,1.0,2/14,2.69%,COQ7;FDXR
prerank,regulation of acute inflammatory response (GO:0002673),0.3263656794522118,0.8996514086964066,0.6034782608695652,0.9266280696639562,1.0,3/18,14.78%,F12;IL6ST;NLRP3
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.25329270797109127,0.8992185093901176,0.6518010291595198,0.9270913023719797,1.0,25/57,31.09%,CHEK2;ATM;FOXN3;RAD17;NBN;BRCA1;CDC14B;ABRAXAS1;BLM;RPS27L;BABAM1;TAOK2;RAD9A;DONSON;TRIM39;TP53;TOPBP1;RINT1;RFWD3;HMGA2;TAOK3;MRNIP;TICRR;NEK11;RPA2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.3229214530988934,0.89891226212348,0.5932504440497336,0.9272391560595739,1.0,7/18,25.38%,EDN3;EDN2;ABL1;NOD2;PARK7;AGT;SIRT3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.36286666011743296,-0.8988279411832358,0.5927505330490405,0.871022460944273,1.0,3/12,11.29%,UVRAG;IRGM;SMCR8
prerank,regulation of lymphocyte migration (GO:2000401),0.3800349141542544,0.8988243289748234,0.5884615384615385,0.9268194135600044,1.0,4/10,17.65%,JAM2;MIA3;AKT1;WASL
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.30410808351135366,-0.8980340843172024,0.6164383561643836,0.8722157423558925,1.0,5/20,11.10%,SULF2;DSTYK;NPTN;CREB3L1;SPRY4
prerank,response to cytokine (GO:0034097),-0.20277936909938352,-0.8979128370888503,0.7275449101796407,0.8717735058194551,1.0,30/141,17.95%,PID1;AKAP6;CD74;AFF3;PTPN12;APP;CIITA;IL1RAPL1;IFITM3;MME;CD40;HDAC4;SP100;JAK2;PTPN2;REL;IKBKE;GGT7;LIFR;RELA;SNCA;TIMP3;IFITM2;BCL2;MAPKAPK2;IL1R1;PTPN13;IFITM1;SRF;NUB1
prerank,regulation of lipid metabolic process (GO:0019216),0.23323135584293386,0.8977990103714125,0.6546644844517185,0.9286994146905866,1.0,22/88,23.59%,CHD9;PPARD;GPS2;C1QTNF2;GGPS1;SMARCD3;SIN3A;NPC2;PANK2;PLPP1;IDI1;CARM1;SIN3B;CERS2;SCD;FGFR4;NFYA;NCOA2;TGS1;MVK;TBL1XR1;OPA3
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2262615508186639,-0.8975918680769516,0.6972704714640199,0.8718077934396126,1.0,26/80,24.11%,HTT;RAB6A;KIF23;RACGAP1;NAPA;ZW10;UVRAG;RAB1B;KIF22;GOLPH3;CENPE;KIF11;COPG2;SCFD1;TMED2;ARF3;PLPP3;RER1;ATP9B;KIF4A;KIF3C;KIF5A;COPE;COPZ2;KIF2C;SEC22B
prerank,dopaminergic neuron differentiation (GO:0071542),-0.30676401363477324,-0.8973745085480933,0.6018306636155606,0.8715893081673104,1.0,9/19,31.89%,NR4A2;LRP6;CTNNB1;MANF;PHOX2A;FOXA2;EN1;WNT2;CDNF
prerank,negative regulation of protein processing (GO:0010955),0.3628336711139111,0.897307429735749,0.5927342256214149,0.9293259947662162,1.0,6/12,21.44%,ACP4;SERPINE2;TMEM59;THBS1;GAS1;SERPINE1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.30628067864019015,0.896957335695713,0.6309751434034416,0.9296094911463885,1.0,4/23,8.98%,UBASH3B;NOS1AP;PSEN2;PTK2B
prerank,regulation of ossification (GO:0030278),-0.262369722183508,-0.8967521503574298,0.6425233644859814,0.872340813309237,1.0,5/36,8.02%,RBPJ;ZBTB16;SGMS2;SOX11;LRP6
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.33142257904991457,-0.896642405790384,0.576271186440678,0.8718365047321956,1.0,1/15,0.06%,MAGI2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.264167507207143,-0.8965885764783242,0.6410256410256411,0.8712096140037203,1.0,9/36,17.33%,CD74;CD300LF;PARP14;PRKN;IRGM;UBE2K;HSPA1B;TXK;AGPAT1
prerank,negative regulation of axonogenesis (GO:0050771),0.295425894526894,0.8964370689254857,0.6332737030411449,0.9302269887680521,1.0,4/27,3.15%,ULK2;FGF13;DIP2B;CDKL3
prerank,regulation of sodium ion transport (GO:0002028),-0.2697333436833726,-0.896392533737989,0.629976580796253,0.8709478604986162,1.0,7/34,11.72%,NKAIN2;ANK3;FGF12;SPTBN4;SIK1;PER1;ATP1A1
prerank,phosphate ion transport (GO:0006817),-0.32458353303881593,-0.8962719530231099,0.5959367945823928,0.8705051193925217,1.0,4/16,15.72%,SLC25A30;SLC37A4;XPR1;SLC37A3
prerank,receptor catabolic process (GO:0032801),0.30474349755046826,0.8961075624887236,0.6142595978062158,0.9304072982686266,1.0,7/24,16.61%,SMURF1;LGMN;AP2A1;SH3GLB1;CLTA;MYLIP;ZNRF3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.23350129540098644,0.8960530398695958,0.6593059936908517,0.9299008682869147,1.0,26/84,23.09%,SON;NCBP1;QKI;DDX5;CELF2;SFSWAP;JMJD6;RBM24;U2AF2;DDX17;KHDRBS1;RBM39;TRA2B;RBM8A;DAZAP1;NSRP1;TRA2A;SRSF9;C1QBP;RBMX;NOVA2;RBM25;RBM4;PCBP4;MAGOH;MBNL1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.23536043471748852,-0.8959804817626603,0.6641975308641975,0.8704718869183962,1.0,16/61,19.83%,PSMD14;PRKAG2;PSMA2;SIRT1;PSMF1;PSMD8;PSMD6;PSME2;PSMD11;PSMD1;PSMD5;AZIN1;PSMD12;NR1H4;OAZ1;PSMB1
prerank,cellular response to acid chemical (GO:0071229),-0.28192761054940485,-0.8954254959457982,0.6126126126126126,0.8710572779508342,1.0,8/27,19.74%,CPEB3;GLRA1;KLF2;RRAGB;GLRA2;LAMTOR3;SESN2;CPEB4
prerank,regulation of cellular component biogenesis (GO:0044087),-0.2602910656953037,-0.8954233630686266,0.6555555555555556,0.8703125476956715,1.0,7/39,11.17%,CD36;LATS1;APOE;RAPGEF2;HSPA8;IRGM;MSN
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.29245208093282005,-0.8951755448482801,0.6153846153846154,0.8701396915738452,1.0,6/24,12.62%,ANK3;MFF;TCAF1;FIS1;MTCL1;ITGB1BP1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2799795498685041,-0.8943861506838103,0.6040723981900452,0.871342528175581,1.0,8/26,21.48%,PF4;RET;EYA2;HSPA1B;BCL2;SNAI2;TERT;MAP2K5
prerank,presynaptic endocytosis (GO:0140238),-0.2921515686372229,-0.8943656603936498,0.6188340807174888,0.8706420467516558,1.0,2/24,1.77%,NLGN1;SYT1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.37236431328755054,-0.8940087777986891,0.5968468468468469,0.8707551883791246,1.0,5/10,26.06%,IRS1;SLC45A3;SNCA;PRKCE;PTH1R
prerank,regulation of cell-substrate adhesion (GO:0010810),0.2684655745269851,0.893694973408751,0.6427320490367776,0.9352459773095396,1.0,10/42,18.77%,RAC1;NPNT;PKHD1;PDGFB;PIK3CB;GCNT2;LIMS1;PLG;MINK1;DMTN
prerank,response to peptide hormone (GO:0043434),0.2685524343202069,0.893494605303842,0.62248322147651,0.9350855658599384,1.0,9/43,15.12%,SRC;ZFP36L1;EIF2B3;SORT1;GPER1;EIF2B4;ROCK2;AKT1;KHK
prerank,response to insulin (GO:0032868),0.23627275628656408,0.8933234455773617,0.6808510638297872,0.9348950782955701,1.0,17/80,19.13%,PDE3B;LPIN2;PIK3R1;PDPK1;ZFP36L1;RHOQ;SORT1;TRARG1;CEACAM1;AKT1;EPRS1;KHK;RAB13;PCK2;LPIN1;INPP5K;HDAC5
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.34644250991673786,0.893260855285656,0.5966542750929368,0.9344261870648034,1.0,5/13,25.17%,PADI2;ZMIZ2;ARID1A;ELOF1;ZMIZ1
prerank,hepaticobiliary system development (GO:0061008),0.3152530039757131,0.8930759581539526,0.6118299445471349,0.9342487857611506,1.0,5/20,17.43%,PRKCSH;MET;PROX1;CEBPG;LSR
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.2830252150631829,0.8928003392711219,0.6184668989547039,0.9343114313726774,1.0,12/33,24.94%,SMAD3;ETS1;GATA2;PDGFB;GATA3;EGR1;JUN;HIF1A;TP53;TGFB1;KLF5;SMARCA4
prerank,mitochondrion disassembly (GO:0061726),0.2763502525551717,0.8927393231949465,0.6224677716390423,0.9338384027265609,1.0,8/34,13.92%,ULK2;ATG9A;RB1CC1;MARK2;PINK1;ATG5;ULK1;ATG9B
prerank,negative regulation of leukocyte activation (GO:0002695),-0.33233510597464405,-0.892697565790698,0.6077586206896551,0.8732403993506712,1.0,2/15,5.62%,LRFN5;CD300LF
prerank,pulmonary valve development (GO:0003177),-0.31078999489722253,-0.8921459802919439,0.6168421052631579,0.8737706407150977,1.0,6/18,20.34%,ROBO1;SLIT2;JAG1;HEY2;BMP4;NOTCH2
prerank,receptor recycling (GO:0001881),0.3810761230620675,0.8920906617997931,0.5735294117647058,0.934802889525688,1.0,1/10,1.61%,PHETA1
prerank,hexose transmembrane transport (GO:0008645),-0.29840633279698053,-0.8920788823004561,0.615071283095723,0.873165513136967,1.0,12/21,37.99%,SLC45A3;SLC2A12;SLC2A2;SLC2A8;SLC2A4;SLC2A3;SLC5A1;SLC5A10;SLC50A1;SLC45A1;SLC2A1;SLC2A6
prerank,metallo-sulfur cluster assembly (GO:0031163),0.31681289912768934,0.8920306017611561,0.5974729241877257,0.9343109700203325,1.0,4/22,8.71%,CIAO3;ISCU;CIAPIN1;MMS19
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2851017764008455,0.8915296701368159,0.6290322580645161,0.9348763780287239,1.0,12/30,30.88%,TLR4;UBC;RPS27A;TICAM2;IRF3;TICAM1;FADD;BIRC2;TLR6;BIRC3;CASP8;CD14
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.33812874876891647,0.8913899373886797,0.6150870406189555,0.9345987303699084,1.0,5/16,13.36%,AGTR2;NOS1AP;PIK3CB;SCARB1;AKT1
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.304579042986758,-0.8912915714900935,0.6252676659528907,0.8743231179526353,1.0,4/19,14.33%,APOE;SLC5A7;CHRNA4;ACHE
prerank,regulation of anoikis (GO:2000209),-0.3118616455409271,-0.8910421639081921,0.6008869179600886,0.8741937532145277,1.0,9/19,26.48%,PTRH2;SIK1;TLE1;BCL2;SNAI2;ITGB1;PDK4;MCL1;ITGA5
prerank,sterol metabolic process (GO:0016125),0.24728561887412193,0.8905767400351797,0.6363636363636364,0.9359925731681574,1.0,13/60,19.23%,PPARD;FDXR;CH25H;CYP46A1;PIP4P1;SULT2A1;CYP7B1;LDLRAP1;OSBPL5;SCAP;ABCA1;NSDHL;LCAT
prerank,regulation of endothelial cell proliferation (GO:0001936),0.23314430002455686,0.8905489677438317,0.6773211567732116,0.9354218540171596,1.0,16/88,16.83%,TGFBR1;PTPRM;PRKCA;VEGFB;SPARC;PDGFB;PIK3CD;APOH;ARNT;PDCD6;PROX1;AKT1;VIP;HMGB2;THBS1;AGGF1
prerank,DNA catabolic process (GO:0006308),0.3632070765813321,0.8901505245264262,0.6088560885608856,0.9357560386649529,1.0,3/11,15.53%,REXO4;FBH1;ISG20
prerank,positive regulation of peptidase activity (GO:0010952),0.31625159810971964,0.8899684563755336,0.6163636363636363,0.935572791906892,1.0,5/20,17.69%,VSIR;PSENEN;PINK1;APH1B;NDUFA13
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3312490685366911,0.889864327487039,0.6153846153846154,0.9352055268206306,1.0,9/18,23.78%,NFE2L2;VNN1;PINK1;AKT1;MAPK7;PARK7;HIF1A;HTRA2;BAG5
prerank,positive regulation of protein import into nucleus (GO:0042307),0.295366815790905,0.8895316011481779,0.6350245499181669,0.9354198283556876,1.0,3/28,3.22%,SMAD3;PRKCD;PIK3R1
prerank,regulation of chromatin organization (GO:1902275),-0.33835304577835823,-0.8894773544178354,0.5896328293736501,0.8771266449175551,1.0,5/14,13.82%,MKI67;MLLT3;ALKBH4;TLK1;SETD5
prerank,glutamine family amino acid catabolic process (GO:0009065),0.34691399636184234,0.8892582735890479,0.6286764705882353,0.9354948048163957,1.0,4/13,18.66%,GAD1;NOS2;ALDH4A1;NOS1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.3462704978080028,0.8889958797518926,0.6211293260473588,0.9355165553279002,1.0,8/14,29.19%,ACOX3;CROT;ABCD1;ACOT8;SCP2;CRAT;ACOX1;HSD17B4
prerank,activation of adenylate cyclase activity (GO:0007190),0.280103246798031,0.8885433089573166,0.6414414414414414,0.9359595834121309,1.0,7/35,10.12%,ADCY9;ADORA2B;CALCR;FSHR;LHCGR;ADCY4;ADCY6
prerank,regulation of cell growth (GO:0001558),0.20583539900058798,0.8882244941268672,0.7432624113475177,0.9360755340084463,1.0,44/204,20.00%,TGFBR1;SMAD3;RPS6KA1;PPP1R9B;OSGIN2;NCBP1;CSNK2A1;ITCH;SIPA1;AGTR2;ATAD3A;EIF4G1;CCDC85B;FLCN;NDUFS3;APBB2;LAMTOR2;PAPPA2;SOX17;CEACAM1;RPTOR;CDK11B;SMARCA2;PPT1;OSGIN1;NME6;MTOR;PRDM11;DACT3;CIB1;AKT1;GJA1;TAOK2;EI24;NDUFA13;ADAM10;PTPRJ;CDKN1B;HPN;ADAM15;LTBP4;VGLL4;CEP43;ADAM17
prerank,protein heterooligomerization (GO:0051291),-0.3129065758387489,-0.8882019529188411,0.6026490066225165,0.8793552034292533,1.0,3/17,7.98%,KCNC2;GRIN2B;PKD2
prerank,polarized epithelial cell differentiation (GO:0030859),0.3490270378698366,0.8880454188764879,0.6422018348623854,0.935883420865256,1.0,1/13,0.49%,OPHN1
prerank,peptidyl-lysine acetylation (GO:0018394),0.3903591003612014,0.8878595231987619,0.6192236598890942,0.9357133026086432,1.0,1/10,1.52%,BAG6
prerank,carbohydrate transport (GO:0008643),-0.35856410788039894,-0.8876449316558085,0.6069114470842333,0.8799628397676137,1.0,5/11,33.97%,AQP11;AQP1;SLC2A2;SLC5A1;SLC50A1
prerank,negative regulation of myotube differentiation (GO:0010832),0.36080416924823644,0.8873158894562975,0.6100746268656716,0.9363919031927687,1.0,1/12,0.26%,TMEM119
prerank,regulation of T cell cytokine production (GO:0002724),-0.3251359371511969,-0.8872093271673054,0.5991561181434599,0.8802714481415892,1.0,2/15,2.63%,CCR2;B2M
prerank,glycolipid biosynthetic process (GO:0009247),0.27799592479482715,0.8870961273577528,0.6462585034013606,0.9362677984948029,1.0,5/38,6.19%,LARGE1;ST3GAL5;PIGV;PGAP2;DPM3
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.3300467139234353,-0.8867422992821898,0.6016771488469602,0.8806335109750613,1.0,2/13,7.92%,PTPRT;JAK2
prerank,ribosomal large subunit assembly (GO:0000027),0.30134560816192857,0.8866065171225133,0.6353383458646616,0.9368332634683056,1.0,9/24,24.26%,NLE1;BOP1;BRIX1;TRAF7;DHX30;RPL10;FASTKD2;RPL6;MRPL20
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2750996805235073,-0.8865936029975515,0.6295503211991434,0.8802693672045819,1.0,7/29,15.68%,NT5C3B;EXOSC1;LSM1;EXOSC7;PATL1;LSM3;HBS1L
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3382927751040971,-0.886124076997699,0.5991379310344828,0.8806535498542266,1.0,5/13,31.46%,SAR1B;BRSK2;SORL1;GCC2;SEC16B
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.2777474622389251,-0.8860211624566096,0.6674259681093394,0.8801453054340815,1.0,6/28,9.02%,APP;APOE;SHANK3;GSK3B;ADCY8;CALB1
prerank,cellular response to misfolded protein (GO:0071218),-0.308362403480005,-0.8859045290488363,0.6179775280898876,0.879679953698896,1.0,5/20,12.53%,CUL3;TOR1A;UBE2W;POMT2;RNF126
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.28790631812146755,-0.8855543049045794,0.6341463414634146,0.8797806229261373,1.0,12/24,22.76%,ITGA4;ITGAL;CERCAM;OLR1;VCAM1;MSN;CCL5;PECAM1;ICAM1;EZR;ITGB1;CD177
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.2804861459888216,0.8855336291621552,0.6327272727272727,0.9388347831180519,1.0,11/33,23.24%,CRNN;PHB2;PLCG2;PLK5;APPL1;EZH2;TAF1;CDKN1B;STXBP4;TRIM39;APPL2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3675227460959912,0.8852998046263764,0.5901328273244781,0.9388209876142504,1.0,2/11,2.80%,RREB1;SRC
prerank,translation (GO:0006412),-0.19133665337288208,-0.8852528081797209,0.8193146417445483,0.8797644788045852,1.0,69/208,26.62%,GFM2;RPL30;RPL36A;MRPL18;RPS29;RPL35A;PPA1;RPS3;RPL4;RPS7;RPS2;RPL41;RWDD1;RPL7A;RPLP2;IGHMBP2;RPL38;RPL18A;RPS14;RPS27;MRPS7;RPL13A;RPL26;RPL22;RPS25;RPS15A;RPS15;EEF1A2;RPS6KB2;MRPL16;RPL8;RPL23A;RPLP1;RPL37;AIMP2;HBS1L;RPS12;MRPS33;RPL22L1;YARS1;RPL24;AARS1;TRMT112;RPL19;RPS11;DRG2;RPLP0;GARS1;RPS6;RPS9;RPSA;RPS10;RPS19;LARS2;PABPC4;RPL23;RPL17;MRPL23;YARS2;EEF1A1;AGO2;ZAR1;RPS5;RPL29;RPL18;EEF1G;RPS21;MRPS6;MRPL55
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.26164311288637365,0.8849777262626505,0.6677631578947368,0.9390236950936404,1.0,10/45,13.36%,SRC;SLC30A10;PIK3R1;EFEMP1;RPS6KA5;PDPK1;PTK2B;PTPN11;DGKD;AKT1
prerank,androgen metabolic process (GO:0008209),0.323389683682885,0.8848538288273,0.6263537906137184,0.9387150291357998,1.0,4/18,14.31%,HSD3B2;SHH;AKR1D1;HSD17B10
prerank,negative regulation of viral genome replication (GO:0045071),-0.2484327675403614,-0.8847922403104376,0.64,0.8801550074299894,1.0,13/40,21.00%,OAS2;IFITM3;RSAD2;SRPK2;OAS3;PARP10;IFITM2;CCL5;BANF1;RNASEL;IFITM1;IFIH1;LTF
prerank,cell junction organization (GO:0034330),0.23893838124998745,0.8847250494580656,0.6893203883495146,0.938424342723904,1.0,19/71,19.94%,OPHN1;SMAD3;PPFIA4;PKHD1;CXADR;APBB2;C1QA;WNT7B;FLNC;TJP1;TJP2;LIMS1;CBLN1;VASP;CBLN2;CLDN1;LRP4;SLC8A2;MAPT
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.34727157196227,-0.8844473528877282,0.613882863340564,0.8794927245568583,1.0,1/12,0.36%,AKAP6
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.34727157196227,-0.8844473528877282,0.613882863340564,0.8794927245568583,1.0,1/12,0.36%,AKAP6
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3261060068748843,0.8843536849082665,0.6247787610619469,0.9387653152469224,1.0,2/17,5.50%,BIN1;CLU
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.2635148741057494,-0.8842950202511263,0.6477541371158393,0.8791172617059597,1.0,14/33,26.38%,PPARG;APOE;MEOX2;ITGB1BP1;KLF4;RGCC;HMGB1;ACVRL1;CARD10;STARD13;MAP2K5;DLL4;ANGPT4;MECP2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.29126420765507316,0.884281048054942,0.6203208556149733,0.9383137303758866,1.0,6/29,10.75%,GTF2H2;CUL4B;UBC;RPS27A;ERCC2;DDB2
prerank,T cell differentiation (GO:0030217),0.2701185959181697,0.884261697453747,0.671353251318102,0.937732619117948,1.0,11/40,20.00%,RHOH;CHD7;ZFP36L1;SHH;ZFP36L2;JAG2;PIK3CD;GATA3;GPR89A;GPR89B;ADAM17
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.2640216722378466,0.8840818952828899,0.6548223350253807,0.9374932278827839,1.0,6/43,7.53%,SMAD3;ETS1;PPARD;DDX5;GATA2;PDGFB
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.21630697845752678,-0.8837591029750069,0.72264631043257,0.8796791535849017,1.0,14/85,12.77%,MAGI2;PRICKLE2;PSMD14;AP2A2;PSMA2;CDC42;PSMF1;PSMD8;PSMD6;PSME2;PSMD11;PSMD1;TIAM1;PSMD5
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.29765201964433763,-0.8834310417364792,0.6341463414634146,0.8797124363086426,1.0,5/22,12.76%,CD44;SKAP1;MYADM;THY1;KLF4
prerank,sulfur amino acid metabolic process (GO:0000096),0.30238680188279676,0.8832108746662363,0.6485568760611206,0.9390324753138405,1.0,7/24,19.57%,MPST;MTHFD1;DPEP1;GADL1;GCLC;TXN2;MMUT
prerank,stem cell differentiation (GO:0048863),-0.25520368836481966,-0.8830303328395338,0.6493212669683258,0.8799275190260343,1.0,14/39,22.65%,GPM6A;MTF2;JARID2;HTR2B;LRP6;PSMD11;MLLT3;KIT;SFRP1;FBXL17;HOXB4;ACE;WNT7A;SP7
prerank,calcium ion import across plasma membrane (GO:0098703),0.34705513863230536,0.8828531598022747,0.6067615658362989,0.9392702957206799,1.0,4/14,11.15%,SLC8A1;TRPV2;TRPM2;TRPV4
prerank,regulation of cholesterol esterification (GO:0010872),-0.36939816536839465,-0.8821033646636467,0.6049107142857143,0.8813883212507108,1.0,1/10,2.38%,APOE
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.31874556987745806,0.8820692178752266,0.6548042704626335,0.9405561517455231,1.0,2/20,2.82%,TGFBR1;ITCH
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3095323978441072,0.8818934626388373,0.6151079136690647,0.9403423966863965,1.0,8/18,29.35%,CCT3;NHP2;EXOSC10;SHQ1;CCT5;PARN;CCT8;CCT7
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.20895913945474862,0.8817585528699217,0.7431059506531205,0.9400483397051435,1.0,39/166,21.61%,MAML3;POLR2H;PPARD;HDAC10;GTF2H2;CDK9;NRBP1;POLR2D;BRF1;RXRB;BRF2;POLR2J;POLR3H;NR2F1;NOTCH4;TAF6;TAF12;MAML2;ERCC2;SMARCA5;E2F2;TAF8;NOTCH3;TAF4;POLR1C;UBTF;NR1H2;E2F3;TAF1;TAF10;HDAC5;POLR2E;POLR2I;TFB1M;POLR1G;MED7;TAF5;TEAD3;POLR1E
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.2903467708557662,0.8816646130429229,0.6389380530973451,0.9396721278646035,1.0,8/27,22.92%,MAP3K8;UBC;RPS27A;TNIP2;TAOK2;MAPK8;CCM2;CUL1
prerank,negative regulation of cell aging (GO:0090344),0.337912360402787,0.8813529386034965,0.6046065259117083,0.939818192092654,1.0,2/16,3.01%,MAP3K3;SLC30A10
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.23713138258579397,-0.8811324269853077,0.6739130434782609,0.8829132880525945,1.0,7/52,8.46%,SORBS1;DPP10;SPTBN1;EGFR;ACSL3;PLS1;KIF5B
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.3115324768331456,0.8809129440235651,0.6240875912408759,0.9402797341134729,1.0,2/18,2.98%,BAG6;LYN
prerank,cholesterol metabolic process (GO:0008203),0.2395863606403744,0.8809071873107619,0.6790780141843972,0.9396676891805591,1.0,15/68,19.23%,PPARD;CH25H;CYP46A1;PIP4P1;AKR1D1;SULT2A1;GGPS1;LDLRAP1;OSBPL5;IDI1;SCAP;ABCA1;NSDHL;ACAA2;LCAT
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2269730993244434,0.8808635778107196,0.7131537242472267,0.9391595333459706,1.0,23/94,17.92%,MAP3K3;IRAK2;RIPK2;RPS6KA5;MAP3K8;TAB2;PSMD3;UBC;RPS27A;PSMA7;PELI2;PSMB3;PSMB9;PSMC2;IL1R2;RPS6KA4;TNIP2;PSME4;PSMC1;PSMB7;EGR1;NOD2;PSMB5
prerank,regulation of cell size (GO:0008361),0.30491705007860387,0.8807100478881528,0.6232638888888888,0.9389089027512009,1.0,6/23,12.07%,VAV2;RAC1;LAMTOR5;RPTOR;PLEK;MTOR
prerank,macrophage migration (GO:1905517),-0.3400860373865029,-0.8803381384022811,0.6004415011037527,0.8839414237647156,1.0,5/13,16.78%,CCR2;EDNRB;CCL2;CCL5;TAFA4
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2719054564264876,-0.8801476989918838,0.6581395348837209,0.8836251231951027,1.0,6/29,15.01%,ELOVL7;ACSL3;HACD1;ELOVL5;ACLY;ACSF3
prerank,regulation of mast cell activation (GO:0033003),0.37901434835822123,0.8799233599981977,0.5974264705882353,0.940238125572502,1.0,2/10,2.98%,CD84;LYN
prerank,amino acid transmembrane transport (GO:0003333),-0.24124827031036755,-0.879317872066222,0.664367816091954,0.8847713862601787,1.0,13/45,18.78%,SLC1A6;MFSD12;SFXN1;SLC7A1;SLC16A2;SLC47A1;SLC6A6;SLC36A2;SLC22A4;SLC25A18;SLC3A2;SLC7A11;SLC25A12
prerank,peptidyl-methionine modification (GO:0018206),0.3561852430102664,0.8790837218433443,0.620253164556962,0.9416283782804525,1.0,4/12,17.82%,NAA25;NAA20;METAP1D;METAP2
prerank,negative regulation of cell death (GO:0060548),0.2321278134647243,0.8789484213265985,0.6996805111821086,0.9413298818852185,1.0,19/88,20.83%,SRGAP2;EIF4G1;IMPACT;CLU;CD34;POU4F1;TM7SF3;DCPS;PINK1;ATG5;PAX2;AKT1;KANK2;GPNMB;NUP62;CHMP2A;PARK7;LRPAP1;HTRA2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.30617109621691874,-0.878935832669097,0.6387096774193548,0.8849454521156384,1.0,4/17,7.98%,EGFR;CCND2;CCNYL1;PKD2
prerank,protein import into peroxisome matrix (GO:0016558),0.35201262556955376,0.8784455116786016,0.6074074074074074,0.9418903533583738,1.0,3/12,19.25%,PEX10;PEX6;PEX1
prerank,regulation of cell cycle process (GO:0010564),-0.211143382632817,-0.8782846004286943,0.7452574525745257,0.8857030587451122,1.0,28/104,17.59%,TTL;MKI67;CDC42;RACGAP1;UVRAG;CALM1;CUL7;PLK2;KLHL13;AURKB;KIF11;PRC1;MAP9;SPAG5;BUB1;KIF20A;MAD1L1;PRPF40A;OBSL1;DCUN1D3;CTNNB1;CHEK1;BECN1;SFRP1;CDC25C;BIRC6;IHO1;DBF4
prerank,microtubule depolymerization (GO:0007019),-0.3159535401000107,-0.8782154679057401,0.6610526315789473,0.8851137286967452,1.0,9/17,25.51%,STMN4;KIF14;CCSAP;KIF18B;STMN2;KIF24;KIF2C;NCKAP5;STMN3
prerank,regulation of mRNA stability (GO:0043488),0.21269577784034563,0.8775861518503845,0.7492625368731564,0.9433220884790586,1.0,30/145,17.92%,PRKCA;PRKCD;EIF4G1;ZFP36L1;TNPO1;FUS;ZFP36L2;PSMD3;RBM24;ANP32A;TENT5C;UBC;RPS27A;PSMA7;CSDC2;EXOSC5;IGF2BP2;ROCK2;AKT1;PSMB3;METTL14;PSMB9;PSMC2;VIP;FASTKD3;PSME4;PSMC1;PSMB7;LARP1;PSMB5
prerank,peroxisome organization (GO:0007031),0.2881624725516838,0.8774011388052113,0.6444833625218914,0.9430943511049089,1.0,4/25,8.85%,ABCD2;TMEM135;PEX10;PEX6
prerank,proteolysis (GO:0006508),-0.18385008726366278,-0.8773591417229938,0.8553054662379421,0.8863285940552554,1.0,46/252,15.95%,CPQ;NPEPPS;PCSK2;DPP4;MMP16;PCSK5;CTSC;MME;ADAMTS12;TRABD2B;PARL;NAPSA;CTSB;RNPEPL1;CLPX;UBA3;RSPRY1;LACTB;ATG4A;RET;TRHDE;CUL7;F7;PSMD6;XPNPEP3;ENPEP;TASP1;ATG4D;MMP15;ADAM33;MMP12;OLR1;FBXW2;AEBP1;CPXM1;ANPEP;SENP1;CTSL;MMP14;VASH2;MMP8;MMP19;PHEX;PLAT;ADAM19;SDE2
prerank,negative regulation of histone acetylation (GO:0035067),-0.34818879353072363,-0.8768853590033643,0.6313559322033898,0.8867017920071859,1.0,3/11,12.83%,SIRT1;TAF7;SNCA
prerank,body fluid secretion (GO:0007589),-0.32239623041713583,-0.8764055576595362,0.6449438202247191,0.8870826317672766,1.0,4/15,17.46%,ZBTB7B;ERBB4;SLC22A4;APLN
prerank,RNA destabilization (GO:0050779),0.3188888774304556,0.8761861429236958,0.6338028169014085,0.9453636264128585,1.0,8/18,29.04%,DXO;RBM24;ROCK2;METTL14;PUM1;YTHDF3;RIDA;METTL16
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.3388256254290783,-0.8758403088415905,0.6373626373626373,0.8876329601000482,1.0,3/12,5.90%,THRB;KLF9;CTSB
prerank,inorganic cation import across plasma membrane (GO:0098659),0.2379160121083059,0.8757530648292691,0.7142857142857143,0.9457942043378895,1.0,9/75,8.21%,SLC9A9;SLC12A6;SLC8A1;TRPV2;SLC12A9;ABCC9;TRPM2;TRPM4;ATP1A4
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.35050540158645027,-0.8756165544966985,0.629399585921325,0.8874323021464642,1.0,3/11,7.39%,PAPOLA;BARD1;CDC73
prerank,cellular response to DNA damage stimulus (GO:0006974),0.19350613359881422,0.8755993522165488,0.8342245989304813,0.9455566430989293,1.0,66/336,17.67%,SUMO1;HERC2;MACROD1;DDIT3;CHEK2;CSNK1E;EID3;UBA7;LYN;WDR48;AATF;RFC2;SPIDR;ATM;REXO4;FAM111A;USP28;RAD17;NBN;MGMT;SLX4;RAD51B;CUL4B;ACER2;RBM24;PLK5;KMT5C;MMS19;CGAS;RNF8;INTS3;AKTIP;BRCA1;FANCG;DDB2;XIAP;ERCC4;RAD1;CEP63;BLM;EXO1;HPF1;ABL1;UBE2U;PCLAF;MAPK14;DTX3L;CIB1;IRF3;FBH1;MASTL;PLK3;GNL1;LIG1;UBQLN4;PSME4;FANCA;TAOK2;TOPORS;RAD9A;BAZ1B;BCL2L11;UBE2A;PIDD1;APTX;TAF1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.22028923926464242,-0.8755629766733865,0.7780548628428927,0.8868246904316281,1.0,13/72,12.82%,PSMD14;PSMA2;PSMF1;PSMD8;PSMD6;PSME2;BTRC;PSMD11;REL;NFKB2;PSMD1;PSMD5;RELA
prerank,ubiquinone metabolic process (GO:0006743),0.33475509836992406,0.8753480472914528,0.6312949640287769,0.9455459804084797,1.0,2/15,2.69%,COQ7;FDXR
prerank,Golgi organization (GO:0007030),-0.20711845068351406,-0.8752501895018363,0.753315649867374,0.8867667303949838,1.0,20/112,13.94%,ATP8B4;LRRK2;HTT;GOSR2;CDC42;ZW10;VPS51;SYNE1;ATL2;STX17;VMP1;GOLPH3;CUL7;TMED1;VCPIP1;FAM174B;TMED2;USP6NL;ATP8B2;OBSL1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.274759693953589,-0.8750444925481875,0.6481069042316259,0.8865088539369392,1.0,8/25,24.21%,SCAF8;ERCC6;CCAR2;SETD5;TCEA2;ELL;SUPT4H1;ZNF326
prerank,response to light stimulus (GO:0009416),0.2508402686789714,0.874925985606811,0.7,0.9459417214539034,1.0,10/55,12.28%,PRIMPOL;GTF2H2;FECH;CRY2;MAP4K3;ERCC2;DDB2;ERCC4;DRD2;PCLAF
prerank,nitric oxide metabolic process (GO:0046209),0.33244153093627316,0.8744277006798685,0.6307129798903108,0.9464869146568389,1.0,5/14,22.46%,NOS2;AKT1;NQO1;NOS1;SPR
prerank,regulation of cell population proliferation (GO:0042127),0.18312208175184194,0.8740911733870188,0.9164619164619164,0.9466905253832548,1.0,108/691,16.45%,TGFBR1;NUAK1;TGFBR2;MLXIPL;ARHGEF2;LRP5;CSF1R;GREM1;SLURP1;ATP8A2;ETS1;PIM2;FAM98B;AIF1;PPP1R9B;IGFBP3;SKI;TBC1D8;VHL;TGFB1I1;ITGAV;GAB2;CSNK2A1;RNF41;LYN;SIRT2;IGF1R;KMT2D;PKHD1;KSR1;LGMN;IL6R;INCA1;MEIS3;ZFP36L1;CLU;KLF11;GNRH1;EID2;DIS3L2;TRPM4;TCIRG1;SHH;ACER3;IL6ST;P3H2;ACER2;S1PR3;JAG2;INHA;IL12RB2;EDN3;CNTF;PDGFB;BCL6B;AMBN;EDN2;CHRM1;GPER1;CTF1;CXCL1;PTK2B;CD86;TBX6;GCNT2;DHPS;TJP1;PRMT1;SMARCA2;DLL1;XIAP;MDM4;LIMS1;PDCD10;OSGIN1;HP1BP3;STX4;PLPP1;CNBP;TSPO;DRD2;TENM1;PROX1;CIB1;CLMN;AKT1;HTR1A;TSPAN31;EIF2AK2;RUNX1;VIP;RNF187;KANK2;GPNMB;CCAR1;PLG;IL7R;LAMC2;HMGB2;SETD4;NME1;NUP62;EZH2;FES;WNK2;CD33;THBS1;GATA3
prerank,positive regulation of protein kinase activity (GO:0045860),0.21164456896384354,0.8735600376307363,0.767515923566879,0.9473074092153545,1.0,37/148,20.93%,TGFBR2;CSF1R;MAP4K4;MMD;SRC;PRKCD;CAMKK1;IL6R;LCP2;CLU;STRADA;TAB2;PDGFB;CCR7;IL12B;PTK2B;PTPN1;RPTOR;PDCD10;DLG4;MARK2;CIB1;EZH2;DDR2;TAOK2;EGR1;ECT2;CALM2;RASSF2;MINK1;CAMK1;JTB;SLC8A2;XRCC6;TELO2;SLC11A1;EFNA1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.316560707606841,0.8735265477891125,0.6481149012567325,0.9467671236103542,1.0,4/17,14.85%,CADM1;RAET1E;IL12B;NECTIN2
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.36307475189271554,-0.8735193502918056,0.6341991341991342,0.8892088069007812,1.0,3/10,18.73%,PTPN22;DUSP10;GSTP1
prerank,positive regulation of neuron migration (GO:2001224),0.35976456244996236,0.8733745869679062,0.6295585412667947,0.9465022175034159,1.0,1/11,0.75%,ARHGEF2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.326576801313339,0.8733704794459459,0.6236162361623616,0.945891074373101,1.0,3/15,8.75%,LARGE1;CHST1;CHST7
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.35883902310737636,-0.8732366161787476,0.6181015452538632,0.8890890247625249,1.0,4/10,24.97%,ATF7IP;THRA;HMGB1;PSMC4
prerank,positive regulation of protein deacetylation (GO:0090312),0.3393182108891101,0.8730455199565642,0.6343692870201096,0.9460276485103363,1.0,2/14,3.61%,AKAP8;AKAP8L
prerank,neural crest cell differentiation (GO:0014033),0.31724254187483336,0.8729961271250951,0.639344262295082,0.9455200032524067,1.0,4/18,12.31%,SOX8;MEF2C;KBTBD8;PDCD6
prerank,branched-chain amino acid metabolic process (GO:0009081),0.30949475944747085,0.8729368549420022,0.6531007751937985,0.9444143495562107,1.0,8/20,20.96%,ECHS1;IVD;BCKDHA;HSD17B10;ACAD8;MCCC2;DBT;BCAT2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.30949475944747085,0.8729368549420022,0.6531007751937985,0.9444143495562107,1.0,8/20,20.96%,ECHS1;IVD;BCKDHA;HSD17B10;ACAD8;MCCC2;DBT;BCAT2
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.3632303081825309,-0.8728772185556308,0.6417910447761194,0.8891623879443147,1.0,4/10,26.00%,ST3GAL1;RENBP;GNPDA2;GNPDA1
prerank,regulation of interleukin-8 production (GO:0032677),0.2388035477516262,0.8723415323530064,0.711864406779661,0.9451415683066102,1.0,17/69,23.09%,TLR7;LGALS9;DDIT3;TLR4;AFAP1L2;NOS2;RAB1A;LAMTOR5;MAVS;CD33;NOD2;PYCARD;PARK7;MYD88;SERPINE1;ARRB1;FADD
prerank,phospholipid catabolic process (GO:0009395),0.29817876300057145,0.8723100079223735,0.6414414414414414,0.9446094762705706,1.0,4/24,10.57%,ABHD12;PLA2G4B;PLA2G4A;PLBD2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.26340281306142826,0.8722433209008759,0.6633165829145728,0.9441537949793611,1.0,15/40,20.97%,BCO2;MTLN;PIP5KL1;SOD1;ABL1;PINK1;AKT1;PYCR1;ARL6IP5;ABCD1;STOML2;PMAIP1;PARK7;MAPT;SPART
prerank,membrane lipid catabolic process (GO:0046466),-0.36242481651808456,-0.8715583116195394,0.6369168356997972,0.8913628441576331,1.0,4/10,14.90%,SGPL1;NAGA;ENPP2;FUCA1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3276081500382032,0.8715069353720143,0.6446886446886447,0.9452923051990193,1.0,4/16,13.15%,ATM;SLX4;ERCC4;TERF1
prerank,regulation of necroptotic process (GO:0060544),0.2961260638745674,0.8714236768752064,0.6322463768115942,0.9448597868148086,1.0,15/23,34.24%,ARHGEF2;CFLAR;FLOT2;STUB1;CYLD;FZD9;BIRC2;BIRC3;HSP90AA1;CASP8;PELI1;CDC37;FLOT1;PDCD6IP;OGT
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.31450545238668576,0.8713681432011529,0.620754716981132,0.9443792062454893,1.0,3/18,13.34%,MAP3K3;GATA2;CIB1
prerank,chromosome condensation (GO:0030261),0.27000707786636785,0.8713634949036652,0.6599326599326599,0.9437757957556125,1.0,9/36,20.32%,CSNK2A2;CSNK2A1;AKAP8L;GPER1;NCAPH2;CHMP1A;NCAPH;CDCA5;PHF8
prerank,negative regulation of hemostasis (GO:1900047),0.3493314943426724,0.8712781825768754,0.6354961832061069,0.9433746408644408,1.0,5/12,21.44%,CD34;APOH;SERPINE2;TFPI;SERPINE1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.29073056876489195,-0.8710760915232079,0.6588785046728972,0.8909640759518223,1.0,8/21,25.46%,PF4;EYA2;HSPA1B;BCL2;SNAI2;TERT;MAP2K5;MCL1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.29073056876489195,-0.8710760915232079,0.6588785046728972,0.8909640759518223,1.0,8/21,25.46%,PF4;EYA2;HSPA1B;BCL2;SNAI2;TERT;MAP2K5;MCL1
prerank,actin filament bundle assembly (GO:0051017),0.2712269385564309,0.87099993467178,0.6684027777777778,0.9434252168098141,1.0,4/33,4.26%,MYO1B;BAIAP2L2;AIF1;FSCN1
prerank,protein import into peroxisome membrane (GO:0045046),-0.28699811241942164,-0.8708740758779886,0.6496519721577726,0.890684580844479,1.0,8/22,27.86%,ACBD5;ATAD1;PEX12;FIS1;ALDH3A2;PEX14;PEX19;PEX16
prerank,organic hydroxy compound transport (GO:0015850),0.2678324123426308,0.870861881084311,0.670774647887324,0.9431467159929824,1.0,3/36,9.60%,SLCO2B1;NPC2;CEACAM1
prerank,extracellular matrix assembly (GO:0085029),-0.2793764111873902,-0.8704055512402993,0.665903890160183,0.8909999837850279,1.0,7/23,25.25%,ATP7A;LAMB2;NTNG1;NTNG2;MFAP4;TNXB;NTN4
prerank,regulation of protein polymerization (GO:0032271),0.2698338833282371,0.8703514477734156,0.6483126110124334,0.9437658921994435,1.0,7/35,11.79%,DBN1;CAMSAP1;ABITRAM;ARHGAP28;CAMSAP2;FCHSD2;ABL1
prerank,cellular response to hexose stimulus (GO:0071331),0.2986236128439586,0.8698790249989623,0.6543438077634011,0.9442494271423386,1.0,8/23,22.26%,PRKACA;IGF1R;GPER1;TRA2B;PAX2;PCK2;KCNB1;SLC26A6
prerank,mesoderm formation (GO:0001707),-0.31177580449389564,-0.8697468586674894,0.6148796498905909,0.8918009695416542,1.0,8/17,36.52%,KDM6B;ITGA8;SCX;ITGB1;EOMES;SNAI1;SMAD2;ITGA3
prerank,homocysteine metabolic process (GO:0050667),0.36169893532000974,0.8696923123481408,0.6047794117647058,0.9441096080389126,1.0,3/11,19.57%,MPST;DPEP1;MMUT
prerank,cellular response to chemical stress (GO:0062197),-0.20573747580763524,-0.8693962689303099,0.7642045454545454,0.891870038816591,1.0,28/96,22.45%,CYBB;LRRK2;MSRA;NCF2;PRDX1;PPIA;PKD2;CYBA;MGAT3;SLC25A24;ATG7;SOD2;ERO1A;TXNRD1;SNCA;FOXO1;HSPA1B;CAT;SESN2;PYROXD1;GSTP1;PRKAA1;RAD52;ZFAND1;PRR5L;STOX1;CYCS;GSR
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.3327679138382696,0.8692122311322622,0.6257088846880907,0.9446400130448469,1.0,5/15,21.74%,LIPC;APOM;SCARB1;LCAT;PLA2G3
prerank,positive regulation of axon extension (GO:0045773),0.2995957854225967,0.8691757051449687,0.6648250460405156,0.9441140355670172,1.0,8/22,23.44%,TWF2;DBN1;MACF1;GOLGA4;MAPT;DBNL;L1CAM;ISLR2
prerank,positive regulation of isotype switching (GO:0045830),-0.3162454115148988,-0.8686028228531202,0.6595744680851063,0.892912861191166,1.0,5/15,20.83%,CD40;KMT5B;TFRC;SHLD3;RIF1
prerank,microtubule bundle formation (GO:0001578),0.2618912656508455,0.8683472222384985,0.6816666666666666,0.9454232577232121,1.0,8/42,14.37%,TTLL3;NUMA1;CFAP74;LRGUK;JHY;CCDC40;CCDC66;CFAP46
prerank,regulation of innate immune response (GO:0045088),0.2434315098726614,0.8683388942361454,0.6910299003322259,0.9448315586435215,1.0,9/57,10.90%,POLR3G;SLC15A4;ABCE1;AKIRIN2;APPL1;PTPN1;PTPN11;DHX9;XIAP
prerank,regulation of fibrinolysis (GO:0051917),0.34589310552607716,0.8682554580354298,0.6284153005464481,0.9444147114040943,1.0,7/13,27.29%,F12;APOH;PLG;THBS1;SERPINE1;FAP;THBD
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3473135341496456,0.8680375341047732,0.6451612903225806,0.9443417896641491,1.0,2/13,4.20%,DDX5;ATM
prerank,stabilization of membrane potential (GO:0030322),-0.31191891218217455,-0.8678650817065097,0.6570155902004454,0.893822756668608,1.0,7/16,29.45%,KCNK10;KCNK4;KCNK5;KCNK12;CHCHD10;KCNK2;KCNK7
prerank,negative regulation of kinase activity (GO:0033673),-0.22486785497098188,-0.8678501454904198,0.722488038277512,0.8931245574822541,1.0,20/62,22.83%,PRKAG2;PPM1E;TAF7;PPIA;DBNDD1;LRP6;SMCR8;DTNBP1;THY1;ITGB1BP1;SNCA;TARBP2;TAB1;GSTP1;EPHA1;CDKN1C;CAMK2N2;TRIB2;DEPTOR;TRIB3
prerank,lamellipodium organization (GO:0097581),-0.2687771421445482,-0.8671884821851201,0.6947608200455581,0.8939188752861382,1.0,7/29,8.75%,CTTN;ABLIM1;WASF1;GOLPH3;CCDC88A;CDH13;CARMIL1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.29004726815534937,0.867077254798139,0.6490299823633157,0.9459991116173821,1.0,5/26,12.96%,RAC1;ASAP3;FHOD1;PLEK;ROCK2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.35156653429263107,-0.8666936009622388,0.6644444444444444,0.8942761448121609,1.0,5/10,19.65%,MTMR2;MFSD2A;MTMR3;MTMR1;DNAJC19
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.21892055199566804,-0.866543103032809,0.741424802110818,0.893883900239596,1.0,20/78,21.54%,EGFR;LATS1;CDK7;CCND2;CCNF;CCNYL1;ACTB;PKD2;CEBPA;CCNJ;CDKN2A;RGCC;CDKN1A;CDC25C;HEXIM2;CCNB1;SPDYA;PKMYT1;CDKN1C;CDK5RAP3
prerank,negative regulation of viral process (GO:0048525),-0.2287277891734107,-0.8661841627945549,0.7002583979328165,0.8939508641694773,1.0,15/57,16.91%,OAS2;IFITM3;RSAD2;MID2;PPIA;ZFP36;SRPK2;OAS3;PARP10;IFITM2;CCL5;BANF1;RNASEL;TRIM35;IFITM1
prerank,respiratory chain complex IV assembly (GO:0008535),0.3050976907075283,0.8660856266426205,0.6390977443609023,0.9477447474256198,1.0,7/21,24.45%,COA8;COX19;COX16;BCS1L;FASTKD3;COX17;OXA1L
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.2986647066135684,0.8660487981545708,0.6844106463878327,0.9472347501071512,1.0,8/22,28.45%,CYRIB;IL12B;FBXO38;TRAF6;FADD;ZBTB1;STX7;IL12RB1
prerank,cellular response to fluid shear stress (GO:0071498),-0.3432766642702373,-0.8658434070259932,0.6636971046770601,0.8940347483589571,1.0,4/12,12.76%,MTSS1;KLF2;PKD2;KLF4
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.33045030271010445,-0.8655203169570771,0.6422413793103449,0.8940958070274386,1.0,5/13,19.02%,APP;SHANK3;ADCY8;RELN;EIF2AK4
prerank,embryonic hemopoiesis (GO:0035162),0.3549207565601405,0.8654856386550166,0.6556169429097606,0.9479517849789697,1.0,1/12,0.62%,TGFBR2
prerank,phospholipid homeostasis (GO:0055091),-0.3413339364144716,-0.8654245167023161,0.640625,0.8935843595711017,1.0,5/11,32.12%,RCN3;ANGPTL3;ABCB11;TLCD2;LIPG
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2659247314401809,0.865041436130216,0.7099644128113879,0.9483561414676277,1.0,8/40,14.65%,PRIMPOL;CDK9;PCNA;FAM111A;FANCM;BLM;ALYREF;FBH1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.28227852497026923,-0.8649045760880099,0.6745182012847966,0.894007293948156,1.0,6/23,12.67%,APP;PRKAG2;CALM1;IRGM;AXIN1;UBE2K
prerank,gene silencing by miRNA (GO:0035195),0.27921474588055467,0.8647739570152998,0.6660412757973734,0.9483770258821106,1.0,12/32,23.46%,CNOT1;MOV10;NOTCH4;WTIP;TNRC6B;SNIP1;AGO1;TNRC6C;XPO5;RBM4;AJUBA;PUM1
prerank,positive regulation of protein metabolic process (GO:0051247),0.21980168176067896,0.8646563834506807,0.7605177993527508,0.9480534490062312,1.0,22/110,14.99%,IL18;CSNK2A1;RNF41;ITCH;SMURF1;SLC25A37;EIF4G1;CLU;IL12B;ASB11;RAB1A;ASB5;CD86;WWP2;PRMT1;AREL1;ROCK2;OAZ2;AKT1;SLC6A9;VIP;MAPK7
prerank,negative regulation of viral transcription (GO:0032897),0.34411433948157316,0.8645592614161498,0.6439114391143912,0.9476816706636203,1.0,4/13,16.91%,UBP1;TRIM11;TRIM62;TRIM14
prerank,regulation of centriole replication (GO:0046599),-0.2982953171427395,-0.8643946006934965,0.6538461538461539,0.8944004383139922,1.0,7/18,15.88%,CDK5RAP2;TRIM37;PLK2;MDM1;ALMS1;CEP76;NPM1
prerank,protein N-linked glycosylation (GO:0006487),0.23351247563559774,0.8643852211113305,0.715702479338843,0.9474852812162238,1.0,15/66,17.38%,MGAT4A;ALG12;GFPT1;ALG6;DPM3;MGAT2;NUDT14;OSTC;MGAT1;ALG2;MAN1C1;MGAT5;ALG5;ALG8;ALG11
prerank,aromatic amino acid family catabolic process (GO:0009074),0.32306377149348575,0.8640882031151693,0.631578947368421,0.9475552264894818,1.0,3/15,17.36%,QDPR;FAH;IL4I1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.292157375072295,0.8638633145544056,0.6707964601769911,0.9474633352165632,1.0,4/25,5.91%,RAC1;ITGAV;PICALM;NEU3
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.254483160469934,-0.8635238290923243,0.6658986175115207,0.8955860473213993,1.0,5/36,7.48%,PLCB1;GNAO1;AGO4;CALM1;TNRC6A
prerank,protein dephosphorylation (GO:0006470),0.21215153531057945,0.8632512931317651,0.7767441860465116,0.9482483135001867,1.0,24/135,13.26%,PTPRM;SSH2;PPM1H;CTTNBP2NL;DAPP1;UBASH3B;PPM1L;SSH1;PP2D1;EYA3;ILKAP;PTPN1;CDC14B;PTPN11;DUSP29;PTPRE;RPAP2;DUSP11;PTPN21;DUSP18;PPP4R2;MTMR4;TIMM50;PTPRH
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.34910771785840067,-0.8632337283002632,0.6378947368421053,0.8954906504552017,1.0,4/11,16.70%,DAB2;MLLT3;SFRP1;NKD1
prerank,negative regulation of signaling (GO:0023057),0.2887890831421587,0.8628496129726582,0.6900369003690037,0.9485767443216014,1.0,3/25,9.34%,IGFBP3;UBASH3B;PTPN1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3002236528725726,0.8626227674963924,0.6635338345864662,0.9485082677638328,1.0,6/23,15.04%,CENPJ;IL10RA;IL10RB;MGAT5;GHR;IL7R
prerank,metanephros development (GO:0001656),0.29041302773744276,0.8624770521406948,0.6355633802816901,0.9482172399604357,1.0,6/26,17.51%,BASP1;SHH;SOX17;WNT7B;PAX2;PTCH1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.19647307057388408,-0.8622417887102168,0.8133704735376045,0.896980649245972,1.0,39/140,24.43%,CCR2;CD36;GRM1;HTR2C;ADRA1A;RYR2;CCR1;NPTN;IAPP;ADCY5;GPR35;TRPC3;P2RY1;CACNA1C;ADCY8;CD52;FIS1;FFAR1;GPR174;ABL2;LPAR4;LPAR2;HMGB1;CACNB3;CCKBR;FPR3;CACNA2D1;GPR65;LPAR3;P2RY10;FPR2;XCR1;GHRL;EDNRA;PTGDR;CXCR3;CD55;ITPR3;PTGIR
prerank,organic anion transport (GO:0015711),0.23306449466848356,0.8619099191537382,0.7212020033388982,0.9489687709657671,1.0,12/76,14.88%,SLCO2B1;SLC25A42;CPTP;SLC52A3;SLC22A6;CYB5R1;SLC35A1;SLC52A1;LRRC8A;SLC17A9;SLC19A1;SLC35B4
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2283462175961896,0.8616934608441864,0.7128874388254486,0.9488202564825667,1.0,26/80,26.94%,PHETA1;TBC1D17;VPS26B;TMED9;YKT6;TBC1D10B;VPS54;SNX5;SGSM2;RBSN;SNX32;SNX3;RAB6B;STX16;DENND5A;RAB9A;VPS26A;STX5;ANKFY1;VPS29;VPS35;STX6;PREPL;TBC1D5;VTI1A;EHD3
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.2676391364100046,0.8615912474205515,0.6747826086956522,0.9484683983560389,1.0,12/37,27.69%,NCBP1;ENTPD1;NUDT15;RNASE6;ISG20;ENTPD7;NUDT16;ENTPD6;RNASEH1;SND1;ADPRM;DFFB
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.253683822964095,0.8613574744479239,0.7030716723549488,0.9483937728013474,1.0,16/49,21.86%,MEF2C;KMT2D;MOV10;PITHD1;SIN3A;PRMT1;PRMT6;CIB1;RUNX1;HMGB2;TNRC6B;THBS1;WDR5;AGO1;TNRC6C;DPY30
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.26035546084327554,-0.8611460714943803,0.7107843137254902,0.8986881695203163,1.0,9/32,17.52%,ARHGAP6;CORO1C;JAG1;CASK;MMP12;ITGB1BP1;CDKN2A;RCC2;ACVRL1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.31927646503450885,0.861114605799276,0.6618444846292948,0.9483501195052402,1.0,6/17,19.48%,ATP5PO;ATP5MC1;VPS9D1;ATP5PD;STOML2;ATP5F1D
prerank,positive regulation of protein secretion (GO:0050714),0.23401561778121438,0.8610235407112135,0.7151898734177216,0.9479484484027325,1.0,18/69,22.85%,FRMD4A;TLR4;ACSL4;PPID;SLC30A8;GPER1;TM7SF3;LRRC8A;EXOC1;PTPN23;CD33;TCF7L2;IER3IP1;WLS;MYO18A;CD2AP;MYOM1;GOLPH3L
prerank,neuron projection organization (GO:0106027),0.3298512178001939,0.8609248171322759,0.6684587813620072,0.9475806967670647,1.0,5/15,21.25%,ABCD2;LGMN;PICK1;ABCD1;ARF1
prerank,protein targeting to mitochondrion (GO:0006626),-0.22998624811032847,-0.8605458110673784,0.7380952380952381,0.899293259931659,1.0,17/52,20.56%,DNAJC15;ROMO1;TOMM22;TIMM23;TIMM17B;MFF;TOMM5;FBXO7;TIMM17A;FIS1;IMMP1L;TIMM10;IMMP2L;CHCHD4;AIP;DNAJC19;TIMM9
prerank,purine ribonucleotide transport (GO:0015868),0.32493503306728405,0.860539154106861,0.6057347670250897,0.9478586657210949,1.0,4/16,13.48%,SLC25A42;LRRC8A;SLC17A9;SLC19A1
prerank,melanosome localization (GO:0032400),0.30393166263493837,0.8604157774058598,0.6817325800376648,0.9475113300405856,1.0,4/21,11.57%,MLPH;BBS2;SHROOM2;RAB27A
prerank,negative regulation of heart contraction (GO:0045822),0.36265467587211253,0.8602630375574607,0.6409774436090225,0.9472336885694075,1.0,7/11,28.02%,AGTR2;PIK3CG;GRK2;PLN;ZC3H12A;SRI;ATP1A2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.27615813334505007,0.8601450841637929,0.6943521594684385,0.9469006489919995,1.0,12/27,26.89%,DDX5;EIF4G1;DHX9;WTIP;TNRC6B;TP53;AJUBA;PUM1;TGFB1;MAP2K1;DDX6;MAP2K2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2263742986824041,0.8597764632168517,0.7346600331674958,0.9471232683105216,1.0,18/85,18.58%,SUMO1;SMAD7;BAG6;FBXO22;CSNK1E;SIRT2;CLU;ECSCR;KLHL40;DET1;ZYG11B;PSMC2;RNF144B;ZER1;USP5;TAF1;TMEM259;TRIB1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.26404042021307284,-0.8597731224157116,0.7025862068965517,0.9002794379300516,1.0,8/31,15.83%,NT5C3B;EXOSC1;LSM1;EXOSC7;PATL1;LSM3;HBS1L;POLR2G
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.28410687886548736,0.8596489345490618,0.6712564543889845,0.9468086418516114,1.0,4/27,9.18%,LPIN2;PLA2G15;PLA2G6;CHKB
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.24941715365714293,0.8594161535319635,0.7256944444444444,0.9467342637591433,1.0,11/46,15.49%,HK2;TOMM20L;PITRM1;TSPO;TIMM50;PINK1;AKT1;TIMM10B;TIMM44;GRPEL1;TOMM7
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.37051313105611394,-0.8593337509795145,0.6514522821576764,0.9005141545203832,1.0,2/10,9.69%,STAP1;ANO6
prerank,ubiquinone biosynthetic process (GO:0006744),0.33196987361866354,0.8591031981748724,0.6720720720720721,0.9468626038611913,1.0,2/15,2.69%,COQ7;FDXR
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.35807275318222503,-0.8587379909938979,0.6595289079229122,0.9011588512930934,1.0,1/10,0.41%,ANK3
prerank,regulation of myotube differentiation (GO:0010830),0.2969337216377221,0.8585827683296499,0.6932849364791288,0.9473893843529694,1.0,7/24,20.54%,TMEM119;FBXO22;RBM24;MAPK14;PIEZO1;HDAC5;SMYD1
prerank,muscle contraction (GO:0006936),-0.19820291212786714,-0.8583501933524453,0.8116710875331565,0.9012368075688996,1.0,52/126,33.87%,DMD;SORBS1;MYOF;DTNA;UTRN;ADRA1A;GNAO1;VIM;TMOD3;GLRA1;CALM1;ACTN2;MYL12B;TNNI1;DYSF;MYL9;MYBPC3;KCNIP2;SNTB1;DES;TPM4;MYOM3;ACTA1;LMOD3;ACTA2;EDNRA;HCN4;CASQ2;EMD;MYL6;VCL;TNNC1;TLN1;TTN;CHRNB2;SSPN;OXTR;LMOD1;NMUR1;TNNT2;CACNA1S;MYH6;RYR1;MYOM2;TMOD4;TPM2;MYH7;SGCA;TNNT1;SCN4A;LTB4R;ROCK1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3177130088917326,-0.8583449538363718,0.6371681415929203,0.9005200996117623,1.0,1/14,0.53%,DPYD
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.2791930231489044,-0.8583259309647291,0.6490066225165563,0.8998365964943011,1.0,9/24,23.77%,MTF2;JARID2;AEBP2;DNMT3B;H3-3A;PPHLN1;RBBP7;DNMT1;SMYD5
prerank,RNA metabolic process (GO:0016070),0.21003058588549806,0.858197301726819,0.7663551401869159,0.9476690820092135,1.0,36/127,22.80%,RNASE1;POLR2H;NCBP1;CELF2;HNRNPA3;HNRNPC;POLR2D;PABPN1;POLR2J;HNRNPH1;DDX17;PCBP2;DHX9;HNRNPR;RNASE6;RBM39;DUSP11;METTL14;ISG20;DDX39B;RBMX;MPHOSPH10;POLR2E;PRPF4;DDX54;POLR2I;AGO1;HNRNPH3;RBM4;HNRNPUL1;DDX3X;FASTKD2;SNRNP40;LSM8;HNRNPA2B1;RNASEH1
prerank,regulation of cellular respiration (GO:0043457),-0.30942718520416895,-0.8579350543820651,0.6554054054054054,0.8999770684788951,1.0,5/17,21.20%,TRAP1;PRELID1;PRDM16;CBFA2T3;SHMT2
prerank,glycoprotein catabolic process (GO:0006516),-0.30186876799989315,-0.8579078925964821,0.6651376146788991,0.899312705253079,1.0,5/17,21.43%,ADAMTS12;MMP12;CTSL;OGA;MANBA
prerank,heart trabecula morphogenesis (GO:0061384),-0.29968690087080585,-0.8577859117336374,0.6652452025586354,0.8988492061090382,1.0,3/18,5.98%,RBPJ;ADGRG6;BMP5
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.33210839807916576,-0.8577329442128205,0.6456521739130435,0.8982155722567482,1.0,4/13,15.51%,LRRK2;RAN;AK3;AK4
prerank,high-density lipoprotein particle assembly (GO:0034380),0.3698950884952231,0.8576246194053803,0.6554455445544555,0.9483669394156351,1.0,2/10,7.50%,PRKACA;APOM
prerank,iron-sulfur cluster assembly (GO:0016226),0.2960988181701708,0.8573135913824109,0.6608084358523726,0.9484333525180275,1.0,4/24,8.71%,CIAO3;ISCU;CIAPIN1;MMS19
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.34111679698855124,0.8566036543177026,0.6441281138790036,0.949490483814366,1.0,9/13,37.68%,GPRC5A;TSG101;ERRFI1;CBL;SOCS5;CHMP6;SNX6;ZGPAT;SOCS4
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.325467291099204,0.8564217155235296,0.6555555555555556,0.9492854763021797,1.0,4/16,16.42%,GATA2;IL12B;PDCD10;THBS1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3026489617216835,0.8557436713725787,0.6690140845070423,0.9502783708850407,1.0,1/21,0.06%,PAG1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.2671074773377529,0.8554485628281664,0.689119170984456,0.9504012833207691,1.0,7/36,14.33%,SIRPA;ITCH;GPS2;ZMYND11;KLHL31;PINK1;QARS1
prerank,proteoglycan biosynthetic process (GO:0030166),-0.26038235043365093,-0.8554112597704665,0.7049180327868853,0.902612759448673,1.0,15/31,26.74%,EXT1;PXYLP1;EXT2;B4GALT7;HS3ST3B1;CHST10;CHST12;B3GAT2;CSGALNACT2;CSGALNACT1;NDST3;GLCE;XYLT1;BMPR1B;IGF1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.24952379059343435,0.8552204215396758,0.7184300341296929,0.9503149399362191,1.0,15/52,22.01%,HPS4;YWHAH;CSNK2A2;SH3GLB1;LEPROT;USP36;PINK1;RNF31;TOMM7;PMAIP1;MAPK8;HTRA2;SAE1;NMT1;TP53
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.29789875786607056,0.8549458144579615,0.6721915285451197,0.950370982175193,1.0,2/21,7.31%,TGFBR1;OVOL2
prerank,histone H3-K9 demethylation (GO:0033169),0.35957075205346045,0.8548423871770137,0.6678832116788321,0.9500061050655362,1.0,6/11,22.29%,KDM3A;KDM4A;KDM7A;HR;PHF8;KDM1A
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.35923022508877095,0.8548399212332202,0.6382978723404256,0.94941585331252,1.0,4/11,16.42%,EPN1;PIK3CB;E2F2;THBS1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.30808379015343934,0.8547990538931681,0.6691729323308271,0.9489144652757395,1.0,2/20,1.89%,RAP1GDS1;TGM2
prerank,positive regulation of viral genome replication (GO:0045070),-0.2650014447803186,-0.8545244023942745,0.708029197080292,0.9038027737321823,1.0,11/29,26.78%,TOP2A;PPIA;PABPC1;PPIH;SRPK2;CCL5;TARBP2;DDB1;ADAR;NR5A2;PPARA
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.3122521263052474,0.8542793763795369,0.6551094890510949,0.949473665842821,1.0,5/17,18.89%,P2RY12;NCKAP1L;CIB1;PIEZO1;RAC3
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.35822517686839916,-0.854277452961683,0.6217948717948718,0.9035896709848422,1.0,4/10,24.60%,KLF4;MAP2K5;SIGIRR;IRAK3
prerank,positive regulation of biomineral tissue development (GO:0070169),0.25680964511055804,0.8533565090987721,0.6952861952861953,0.9508920080346237,1.0,3/40,3.96%,TMEM119;MEF2C;SLC8A1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.309796894252413,-0.8530776411238636,0.6799116997792495,0.9055514425155831,1.0,3/15,6.52%,YWHAE;BAG3;GSK3B
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.2797193734425628,0.8529574368688906,0.7117437722419929,0.9511961563347071,1.0,11/27,26.65%,MTA1;CRY2;CRTC1;FBXL22;FBXL8;PPP1CB;TP53;RBM4;PPP1CC;FBXL12;PPP1CA
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.31046834492310493,0.8528156427739365,0.6706896551724137,0.9509029609925409,1.0,2/18,7.11%,TMEM119;FRS2
prerank,response to UV-A (GO:0070141),-0.32169384681910557,-0.8527406773187364,0.6763485477178424,0.9055448522664713,1.0,2/14,3.05%,EGFR;MME
prerank,ribosome assembly (GO:0042255),0.24450393836709072,0.8525481148738103,0.6991304347826087,0.9509147469564516,1.0,16/47,24.26%,EIF2A;MPV17L2;NLE1;BOP1;RPS27L;BRIX1;MRPS11;TRAF7;C1QBP;SBDS;RPL10;DHX29;EFL1;DDX3X;RPL6;MRPL20
prerank,acute-phase response (GO:0006953),-0.3279510670259713,-0.8525208917264981,0.6533613445378151,0.9052506020998267,1.0,5/12,33.16%,CEBPB;LBP;SIGIRR;CRP;PLSCR1
prerank,inhibitory synapse assembly (GO:1904862),-0.3381636553521198,-0.8522569716446858,0.6447638603696099,0.9050838693847685,1.0,5/11,19.99%,GABRA2;GABRB3;GABRG2;PLXNB1;CBLN4
prerank,cellular response to estrogen stimulus (GO:0071391),-0.3133724473495626,-0.8521234789691935,0.6851063829787234,0.9046674845421074,1.0,4/14,22.82%,RARA;CRHBP;SFRP1;BCAS3
prerank,mRNA catabolic process (GO:0006402),-0.23843491257181437,-0.8520909536820761,0.7220902612826603,0.9040004621778762,1.0,8/44,10.58%,ERN1;AGO4;XRN2;ZFP36;ZC3H12D;MRTO4;TUT4;CNOT10
prerank,cellular response to glucose starvation (GO:0042149),0.25984809047512086,0.8520509417599907,0.7186963979416809,0.9514823108191273,1.0,11/41,22.23%,NUAK1;ATG14;IMPACT;SH3GLB1;PIK3C3;NUAK2;SESN1;PICK1;PMAIP1;TP53;RRP8
prerank,regulation of microtubule nucleation (GO:0010968),-0.351361025568318,-0.8518995283560274,0.6584362139917695,0.903706806617077,1.0,4/10,26.38%,PAK1;HSPA1B;RANGRF;MECP2
prerank,eye photoreceptor cell development (GO:0042462),-0.311772585060323,-0.8517106083876632,0.6557017543859649,0.903372463361646,1.0,4/15,18.61%,RORB;THY1;RPGRIP1;BBS4
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.2759468418889618,0.8511144923176772,0.7121771217712177,0.9529347193910557,1.0,7/29,16.94%,COPA;GOLGA5;COG6;NAPG;COG2;COG5;RAB6B
prerank,nitric oxide biosynthetic process (GO:0006809),0.33245562714374055,0.8511099755165373,0.6338289962825279,0.9523478516610886,1.0,5/13,22.46%,NOS2;AKT1;NQO1;NOS1;SPR
prerank,regulation of wound healing (GO:0061041),-0.24095104452056282,-0.8510749180017635,0.7590361445783133,0.9039955934550208,1.0,19/42,36.62%,CADM4;ALOX5;CASK;CD109;ADRA2A;KANK1;ACTG1;ITGB1;PRKCE;EPHB2;ANXA1;OCLN;HRG;FOXA2;CLDN19;CRK;VTN;PLAU;PTK2
prerank,non-motile cilium assembly (GO:1905515),-0.25581564752803776,-0.8510412542860043,0.7130801687763713,0.9033351899411729,1.0,6/30,18.61%,TBC1D32;TMEM216;TMEM107;CCDC13;RPGRIP1;BBS4
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.225342816046395,-0.8509544375783513,0.7775061124694377,0.9027840152212167,1.0,18/60,22.61%,ATF7IP;CEBPB;AGO4;MED15;TNRC6A;RUNX2;RELA;CDKN2A;CTNNB1;CDKN1A;HEY2;SRF;CCNB1;MED6;LEF1;CDK4;MED1;HNF1B
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.32085857259287265,0.8507169872070103,0.6684981684981685,0.9526524698109202,1.0,5/17,14.99%,NFE2L2;VNN1;SOD1;AKT1;MAPK7
prerank,positive regulation of inflammatory response (GO:0050729),0.22384256919156778,0.850475214282644,0.7691056910569106,0.9525850050516795,1.0,11/86,10.68%,IL18;TLR7;ETS1;TLR4;KARS1;TRADD;IL6ST;IL12B;DDT;IL33;DHX9
prerank,smoothened signaling pathway (GO:0007224),0.2677390048758383,0.8503970572421211,0.6860254083484574,0.9521555987547785,1.0,11/32,24.28%,SHH;ULK3;MAP3K10;SMO;B9D1;TMEM17;PTCH1;DISP2;CC2D2A;TCTN2;TTBK2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3230249804736553,-0.8502266362256993,0.6851441241685144,0.903593108896963,1.0,7/14,22.28%,MEOX2;ITGB1BP1;KLF4;CARD10;STARD13;MAP2K5;DLL4
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2553612300919805,-0.8499886637694786,0.710239651416122,0.9033878990171453,1.0,10/33,22.43%,BDNF;NEDD4L;TOR1A;KCNAB2;ACTN2;HSP90AB1;CTNNB1;LEPROTL1;STX3;RANGRF
prerank,autonomic nervous system development (GO:0048483),-0.30908585128161575,-0.8495473493334483,0.6935866983372921,0.9036257090441866,1.0,8/17,30.83%,FN1;SOX11;EDNRB;TFAP2B;SOX10;NTRK1;PHOX2A;GDNF
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.31544076412505817,-0.8495150758146013,0.6451612903225806,0.902982394197378,1.0,9/16,33.87%,APOE;IFNGR1;HMGCR;HDAC1;SRF;CYP51A1;ABCA7;MYOCD;ROCK1
prerank,protein processing (GO:0016485),0.2159689184547514,0.8494975471459019,0.7659235668789809,0.9536143798444906,1.0,14/102,10.05%,KLK2;VSIR;CASP1;LGMN;PITRM1;FAM111A;F12;CTSS;CPE;RCE1;YME1L1;PSEN2;PSENEN;CLN3
prerank,negative regulation of histone methylation (GO:0031061),-0.3471606538934179,-0.8493441684563376,0.6428571428571429,0.9026271592389651,1.0,5/10,21.81%,MTF2;JARID2;DNMT3B;AASS;DNMT1
prerank,autophagosome maturation (GO:0097352),-0.2551221833032629,-0.8491532373526882,0.7123595505617978,0.9023196385867837,1.0,6/32,7.13%,SNX14;ATP2A2;UVRAG;CALM1;STX17;VMP1
prerank,positive regulation of phospholipase activity (GO:0010518),-0.27796615753155146,-0.8490281155211741,0.6827586206896552,0.9018712683444581,1.0,7/22,20.72%,NTRK3;FGFR3;KIT;CCL5;ABL2;PLAA;GNA13
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.25737919318521596,0.8488551321355895,0.6930860033726813,0.954385293259229,1.0,10/39,19.99%,ACSL4;SLC30A8;GPER1;TM7SF3;DRD2;LRRC8A;RASL10B;SELENOT;TCF7L2;AIMP1
prerank,icosanoid biosynthetic process (GO:0046456),0.3582872674539796,0.8486837643230039,0.6356589147286822,0.9541893446218651,1.0,3/10,10.60%,PLA2G5;PLA2G4A;FADS1
prerank,acute inflammatory response (GO:0002526),0.290050889892088,0.8484885223351456,0.6648451730418944,0.9540087131410874,1.0,3/23,7.86%,IL6R;CTNNBIP1;VNN1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.297438179992507,0.8483778631419937,0.6767857142857143,0.9536770429720826,1.0,2/19,1.94%,TGFBR1;MEF2C
prerank,nuclear body organization (GO:0030575),-0.3298492736904025,-0.8482965015852819,0.6808988764044944,0.9026938553586212,1.0,4/12,13.83%,HIPK2;AFF2;SRPK2;WRAP53
prerank,endosome organization (GO:0007032),0.2535547092320825,0.8481676242419504,0.708041958041958,0.953543999543035,1.0,9/41,16.60%,HOOK2;PHETA1;USP8;LAPTM4B;AKTIP;RAB27A;USP50;WASHC4;SNX3
prerank,regulation of actin nucleation (GO:0051125),0.3419057395445236,0.8481335469250225,0.6586270871985158,0.9530099252551333,1.0,2/12,4.81%,ARFIP1;ARFIP2
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.2111224546747184,-0.8481309019390717,0.7746835443037975,0.9023101843032516,1.0,12/68,16.82%,LRRK2;AMPD3;PDE9A;ADSS2;RAN;HINT1;AK3;ACOT13;ACLY;SULT2B1;AK4;ACOT11
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.21494426181586485,0.8479890611313681,0.7846655791190864,0.9527509129225872,1.0,21/117,15.48%,PRKACA;SRC;LYN;ADCY9;PLCG2;KARS1;ADORA2B;CALCR;FSHR;LHCGR;NPS;ADCY4;ADCY6;MYH9;DPEP1;MAPK14;HRH2;INSL3;VIP;ADORA2A;GPR84
prerank,negative regulation of dephosphorylation (GO:0035305),0.31234429312086925,0.8479355076952905,0.6823104693140795,0.9522831080991134,1.0,7/18,28.25%,ZCCHC9;GPATCH2;SH2D4A;INPP5K;PPP1R35;ENSA;URI1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.23106561621618638,-0.8475878125058496,0.7631578947368421,0.9026893149426745,1.0,13/50,19.83%,PSMD14;PSMA2;PSMF1;PSMD8;PSMD6;PSME2;PSMD11;PSMD1;PSMD5;AZIN1;PSMD12;OAZ1;PSMB1
prerank,motor neuron axon guidance (GO:0008045),0.329592206317571,0.8475258831941159,0.662962962962963,0.9525373183530158,1.0,2/15,3.08%,RAC1;RHOH
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.3148651678791846,0.8474826761567538,0.6758747697974218,0.9520339582368552,1.0,4/16,11.08%,FANCM;SLX4;TOP2B;ERCC4
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.3683740119532546,0.8474192145040819,0.6847014925373134,0.9515849658940861,1.0,2/10,5.25%,DIP2B;FLCN
prerank,intestinal absorption (GO:0050892),-0.32824653918250885,-0.8466997915504151,0.6745182012847966,0.9038239577568944,1.0,5/13,14.48%,CD36;ADRA2A;SLC46A1;KCNQ1;UGCG
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3683066358773379,0.8463539691005785,0.6666666666666666,0.952737116792826,1.0,2/10,5.78%,MPG;MGMT
prerank,DNA dealkylation (GO:0035510),0.3683066358773379,0.8463539691005785,0.6666666666666666,0.952737116792826,1.0,2/10,5.78%,MPG;MGMT
prerank,negative regulation of cellular component movement (GO:0051271),-0.31085010270544566,-0.8461557084298972,0.701098901098901,0.9042685534331567,1.0,3/15,7.60%,FRMD5;SPOCK3;SP100
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.2474032677542205,-0.846051344776446,0.727710843373494,0.9037840387969382,1.0,13/37,24.92%,RPS3;RPS7;DNM1L;BID;FIS1;BECN1;BCL2;EIF5A;BOK;MSX1;RACK1;LCK;NACC2
prerank,regulation of protein kinase activity (GO:0045859),0.21592059175934156,0.8459475826421629,0.7908805031446541,0.9530582500489172,1.0,27/106,19.93%,MMD;PYDC1;PRKRIP1;CAMKK1;LCP2;UBASH3B;PDPK1;TAB2;SMG8;CCR7;PTK2B;CEACAM1;CAMKK2;SOD1;CEP85;AKT1;QARS1;C5AR1;DDR2;ECT2;RASSF2;INPP5K;TRIB1;JTB;CEP43;PARK7;XRCC6
prerank,purine-containing compound biosynthetic process (GO:0072522),0.28237815007187334,0.8459008203225729,0.6822742474916388,0.9525773191633484,1.0,9/25,18.09%,GMPR2;MTHFD1;PRPS1L1;PRPS1;PNP;PAICS;DGUOK;GART;PRPSAP2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.3350285678407736,0.8458305850560685,0.6929133858267716,0.952152429302131,1.0,14/14,66.53%,IL6ST;PARK7;IL6;PTGS2;C2CD4A;C2CD4B;CREB3L3;FFAR2;TNF;IL1B;PTGER3;OSM;OSMR;ADAM8
prerank,protein maturation (GO:0051604),0.22136268644935495,0.8457003167086664,0.793046357615894,0.9518476054644408,1.0,25/95,23.02%,TSPAN14;LMF1;PITRM1;F12;CTSS;CPE;NAA11;PSEN2;MMS19;PSENEN;CLN3;CCS;APH1B;NAA40;PTCH1;NAA50;METAP2;ADAM10;GALNT2;LMF2;ADAM17;DNAJB11;AFG3L2;STUB1;TYSND1
prerank,intraciliary retrograde transport (GO:0035721),-0.32759127082192474,-0.8449069971345462,0.6795698924731183,0.9054141077840456,1.0,3/12,9.51%,WDR35;WDR19;DYNC2I2
prerank,negative regulation of nuclear division (GO:0051784),0.3479019276576927,0.8445497054355143,0.680373831775701,0.9537215704730609,1.0,2/11,11.93%,NANOS2;NME6
prerank,hyaluronan metabolic process (GO:0030212),0.29153781801894835,0.8444049112633399,0.6991304347826087,0.9534323226113967,1.0,2/23,4.08%,HEXB;HEXA
prerank,positive regulation of organelle organization (GO:0010638),0.27250870396205856,0.844377778970714,0.7054263565891473,0.9528929836035595,1.0,11/32,22.90%,TMED9;SHCBP1L;RAB3GAP2;PLA2G5;RAB3GAP1;SORBS3;KATNBL1;STX18;FYCO1;HTRA2;PFDN2
prerank,cellular protein catabolic process (GO:0044257),-0.22353400500366483,-0.84435467464847,0.7929292929292929,0.9058634198161349,1.0,9/59,8.69%,CTSC;ADAMTS12;AP2A2;DENND3;CTSB;CLPX;PRKN;RSPRY1;SIAH2
prerank,blood vessel endothelial cell migration (GO:0043534),0.2925119866891212,0.844263998990931,0.6833631484794276,0.9525282103999246,1.0,5/22,13.36%,GREM1;ID1;MIA3;MYH9;AKT1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.26822970408322583,0.8442374444240197,0.708041958041958,0.9520000234135929,1.0,4/30,7.52%,FHIT;BAG6;UCHL5;KLHL40
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.24110255031703676,-0.8437769583483575,0.7373493975903614,0.9063564632315837,1.0,7/40,13.07%,ROMO1;CAMP;RNASE3;GBP4;LBP;DROSHA;GBP2
prerank,regulation of immune effector process (GO:0002697),0.253892990446415,0.8435960350149712,0.7285223367697594,0.9528266259788748,1.0,5/41,6.50%,C1QB;PHB2;PROS1;CLU;C1QA
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.2693496736110085,0.8434787961331331,0.7023809523809523,0.9525183602774898,1.0,6/31,9.16%,LYN;ATM;TNFRSF21;TNFRSF13B;PDCD1LG2;CD86
prerank,response to prostaglandin E (GO:0034695),0.3638463562470004,0.8433503328848296,0.6621880998080614,0.9522216253909097,1.0,2/10,10.12%,CCR7;ADCY6
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.3546262022046264,-0.8430228346736296,0.6485355648535565,0.907194618096813,1.0,5/10,24.43%,PTPN12;PTPN2;SNCA;APOD;PTGIR
prerank,positive regulation of cell cycle process (GO:0090068),-0.2042950310291251,-0.8427505241845076,0.8096590909090909,0.9070553230802402,1.0,20/91,18.09%,CUL3;KIF23;NDC80;CDC42;RACGAP1;PKP4;GIPC1;KIF14;NUSAP1;AURKB;SPAG5;E2F7;GEN1;RGCC;RCC2;NPM2;GPSM2;WIZ;DBF4;CCNB1
prerank,regulation of establishment of planar polarity (GO:0090175),0.21861312883599798,0.8426052306561117,0.7734627831715211,0.9533128109301284,1.0,19/88,18.71%,ARRB2;RAC1;PKHD1;SMURF1;AP2A1;FZD2;PSMD3;PSMA7;PSMB3;PSMB9;PSMC2;VANGL1;VANGL2;FZD1;PSME4;PSMC1;PSMB7;PSMB5;CELSR1
prerank,inositol phosphate metabolic process (GO:0043647),-0.23663962279718664,-0.8426033744946271,0.7530266343825666,0.9066626836589379,1.0,14/46,19.25%,PLCB1;PLCH1;CALM1;PLCB4;ITPKC;INPP5J;NUDT3;PLCD4;OCRL;PLCH2;INPP5A;IP6K2;PLCD1;ISYNA1
prerank,peptide hormone secretion (GO:0030072),-0.26477731010336747,-0.8423861080638104,0.7133182844243793,0.9063623696375145,1.0,13/26,33.17%,RIMS2;SNX19;FFAR4;GHRL;MAFA;GAL;ANXA1;PTPRN;CYB5R4;EXOC3L1;EDN1;GHRH;NEUROD1
prerank,sulfur compound biosynthetic process (GO:0044272),0.2134101143871183,0.8423843887805867,0.8073394495412844,0.9531830254501712,1.0,22/104,19.00%,ST3GAL6;HPGDS;B3GNT2;PRELP;CHST1;CHPF2;MPST;BGN;B3GNT4;CHST7;CHST11;CHSY1;PAPSS1;CSPG5;ST3GAL3;GSTA3;GCLC;CHST2;GGT5;B4GALT4;CHST15;MAT2A
prerank,negative regulation of platelet activation (GO:0010544),0.3191339750677098,0.8421838035090216,0.6903460837887068,0.9530187683423117,1.0,6/16,19.21%,PRKCD;CD9;PDGFB;CEACAM1;SERPINE2;ADAMTS18
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.34144693815970895,-0.8420568631155557,0.6875,0.9062993842317284,1.0,4/11,16.02%,GSN;ST18;PLAUR;PIH1D1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3502536233699403,0.8419948992744017,0.6785046728971963,0.9528367898035517,1.0,2/11,9.10%,UQCRC2;UQCRB
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.3427301825151068,-0.8419843289843834,0.6516129032258065,0.9057228043042496,1.0,3/11,25.83%,LMNA;FOXO1;MLIP
prerank,positive regulation of gene expression (GO:0010628),0.18224250745515078,0.8418924229938675,0.9337662337662338,0.9524691214444536,1.0,77/442,16.96%,TGFBR1;TMEM119;PLD1;SMAD3;NFE2L2;CADM1;CCDC88B;ETS1;VSIR;LGALS9;FAM98B;MEF2C;POLR2H;TLR4;DDX5;SLC24A3;PIK3R1;PLCG2;PAX6;CALCOCO1;ATM;MOV10;PIK3CG;SF3B1;SPRY2;METTL5;CLU;NOS1AP;CD34;GAPDH;NSUN5;OVOL2;GATA2;CNTF;PDGFB;PKP3;GPER1;CALCR;SLC22A2;RBM24;POU4F1;PIK3CB;LAMTOR5;BRCA1;IL33;U2AF2;SCAMP5;PIK3CD;MUSK;SMARCA5;LIMS1;RPS27L;PDCD10;RAB27A;SOD1;MTOR;MAPK14;ROCK2;AKT1;METTL14;PASK;EIF2AK2;GJA1;CDH3;NOG;CUX2;NWD1;POLR1C;EIF3D;LGALS7;TICAM1;PCIF1;TNRC6B;THBS1;SMO;DYRK1A;EGR1
prerank,V(D)J recombination (GO:0033151),0.35429552367241823,0.8418306541951854,0.67578125,0.9520191888847294,1.0,4/11,24.25%,HMGB2;LIG1;TCF3;XRCC4
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.32794276375594505,-0.8416956466934432,0.665943600867679,0.9056076941197008,1.0,2/12,4.42%,PPAT;ADSS2
prerank,histone H4-K5 acetylation (GO:0043981),0.3228427541237636,0.8416037141920292,0.6581352833638026,0.9513003814296797,1.0,5/15,24.36%,KANSL2;PHF20;JADE2;WDR5;MCRS1
prerank,histone H4-K8 acetylation (GO:0043982),0.3228427541237636,0.8416037141920292,0.6581352833638026,0.9513003814296797,1.0,5/15,24.36%,KANSL2;PHF20;JADE2;WDR5;MCRS1
prerank,T cell homeostasis (GO:0043029),0.3563031383496268,0.840988643947156,0.6420664206642066,0.9520700980090843,1.0,4/10,23.09%,NCKAP1L;AKT1;PMAIP1;FADD
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.2618253527193831,0.840932114355168,0.7367491166077739,0.9516048829797493,1.0,12/37,20.63%,SMAD7;RIPK2;SIRT2;EIF4G1;SPRY2;TNKS1BP1;RPTOR;WNK3;CALM2;INPP5K;DMTN;SPRED2
prerank,positive regulation of translational initiation (GO:0045948),0.30629081488428456,0.8404596971534167,0.6924428822495606,0.9520239333653406,1.0,9/18,27.05%,POLR2D;KHDRBS1;UHMK1;MTOR;LARP1;BOLL;DDX3X;YTHDF3;EIF2B5
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.3101625295450286,-0.8402079855996872,0.7032967032967034,0.9079797325236444,1.0,3/15,7.95%,PPARG;IRS1;SLC45A3
prerank,adenine nucleotide transport (GO:0051503),0.3135373150584789,0.8399138254835828,0.645045045045045,0.9526029907133208,1.0,4/17,13.48%,SLC25A42;LRRC8A;SLC17A9;SLC19A1
prerank,neutrophil chemotaxis (GO:0030593),0.24572589594263627,0.8398177054826791,0.7559726962457338,0.952235414505797,1.0,8/53,10.22%,ITGB2;PIK3CG;NCKAP1L;CXADR;EDN3;EDN2;CXCL1;PIK3CD
prerank,bicellular tight junction assembly (GO:0070830),-0.23339783978075504,-0.8396937096545737,0.7761904761904762,0.9083368164523685,1.0,20/46,33.78%,AFDN;PATJ;MARVELD2;FRMPD2;CDH5;PECAM1;PARD3;MICALL2;GRHL2;MARVELD3;OCLN;PRKCI;PARD6G;POF1B;CLDN16;PARD6B;CLDN19;CLDN5;DLG1;CLDN18
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3591880029861098,0.8396901804132978,0.6885553470919324,0.9519155845496574,1.0,4/10,22.68%,SEC14L1;UFD1;C1QBP;NPLOC4
prerank,positive regulation of phosphorylation (GO:0042327),0.19159627194083975,0.8395354120103672,0.8753623188405797,0.9516483247228523,1.0,52/240,20.93%,MERTK;TMEM119;MLXIPL;CSF1R;ITGA6;RAC1;AGER;ATG14;LYN;IGF1R;NCKAP1L;FLCN;VEGFB;NBN;MET;RYK;EPHA8;GPER1;CCND3;RB1CC1;AKTIP;CAMKK2;MUSK;AXL;ARNT;KCTD20;ABL1;SEMA4D;PINK1;ROCK2;PELI2;CIB1;AKT1;PFKFB2;GPNMB;FBH1;MAVS;CDK2AP1;DDR2;THBS1;ENG;RSPO1;CRKL;CLIP3;FGFR4;SLC4A4;FGFR2;ADAM17;FGF20;HIF1A;AXIN2;EFNA1
prerank,negative regulation of defense response (GO:0031348),-0.21052110674299404,-0.8395122737776195,0.7984293193717278,0.9079948308858857,1.0,23/77,23.06%,LRFN5;AOAH;PPARG;APOE;SHARPIN;ILRUN;TRAFD1;ALOX5;PTPN2;KLF4;CDH5;NLRC3;TEK;FFAR4;CCN3;NR1H4;METRNL;FNDC4;RNF26;TRAF3IP1;FPR2;C1QTNF3;GHRL
prerank,calcium ion import into cytosol (GO:1902656),0.3246299889147705,0.8394077037055462,0.6690265486725664,0.9513341495421503,1.0,4/15,11.15%,SLC8A1;TRPV2;TRPM2;TRPV4
prerank,dephosphorylation (GO:0016311),0.20488367918979203,0.839383703224972,0.826625386996904,0.9508204722091687,1.0,33/147,18.19%,PTPRM;SSH2;PPM1H;CTTNBP2NL;DAPP1;PPM1L;SSH1;PP2D1;ILKAP;PTPN1;CDC14B;PLPP2;DUSP29;PTPRE;DUSP11;PTPN21;DUSP18;PPP4R2;MTMR4;PLPP1;TIMM50;PLPPR2;PTPRH;ACP2;ACP4;PTPRA;DUSP6;PTPN5;DUSP12;ACP6;PPP2R5B;PTPRJ;INPP5K
prerank,sensory organ development (GO:0007423),0.23763103408876696,0.8391026795791455,0.7495652173913043,0.9508429799328804,1.0,11/51,21.22%,PAX6;CHD7;MEIS3;FREM2;MYO7A;SHROOM2;CPAMD8;GATA3;ADAMTS18;SH3PXD2B;SMG9
prerank,hyaluronan catabolic process (GO:0030214),0.3114379402055547,0.8381648734877949,0.7145522388059702,0.9522531523666892,1.0,2/18,4.08%,HEXB;HEXA
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2120719461445798,0.8380832668261727,0.7883096366508688,0.9518451210723665,1.0,34/104,27.28%,LRP5;CSF1R;SRC;SLC8A1;KSR1;CCNG2;CCND3;RPTOR;BLM;PDCD10;ABL1;CCNE1;CIB1;AKT1;TSG101;EZH2;CALM2;CDKN1B;TRIB1;CAMK1;PYCARD;SLC8A2;TELO2;DDX3X;HGS;CDC25A;BCCIP;MAP2K1;MNAT1;PPEF2;CCNJL;MAP2K2;CCNG1;CCNI
prerank,alanine transport (GO:0032328),-0.3496058115022916,-0.8380674819052207,0.6876310272536688,0.9102179967359655,1.0,7/10,32.14%,SLC6A6;SLC36A2;SLC1A4;SLC6A17;SLC36A3;SLC6A14;SLC38A3
prerank,cellular response to UV-A (GO:0071492),0.3447863085120901,0.8375665977218946,0.6517509727626459,0.9523997167051679,1.0,2/11,6.72%,MMP2;PPID
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.2903109043323855,0.8375534744656253,0.7097378277153558,0.9518429383426916,1.0,6/23,20.56%,MLXIPL;PDGFB;ARNT;PFKFB2;SLC4A4;HIF1A
prerank,regulation of keratinocyte differentiation (GO:0045616),0.2876508813647754,0.8374112336436307,0.7072310405643739,0.9515366981173682,1.0,6/24,18.34%,NUMA1;ZFP36L1;ROCK2;RUNX1;ERRFI1;NCOA3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.22169277595218756,0.8373919220929071,0.7725806451612903,0.9510012648587692,1.0,18/74,20.56%,NFE2L2;VHL;SIRT2;EGLN1;PSMD3;UBC;RPS27A;PSMA7;ARNT;PSMB3;PSMB9;PSMC2;PSME4;PSMC1;PSMB7;PSMB5;PSMB8;HIF1A
prerank,regulation of T cell chemotaxis (GO:0010819),0.3521363569112332,0.8371837750564886,0.6795366795366795,0.9508521091595308,1.0,7/11,28.47%,WNK1;STK39;ADAM10;ADAM17;CXCL10;WNT5A;OXSR1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.26693368319168,0.8369672192692834,0.7125220458553791,0.9507336241203517,1.0,2/29,1.99%,SMAD3;SRRT
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.31903527492654604,0.8368740754262668,0.6777777777777778,0.9503501780472355,1.0,6/15,35.38%,ASMT;SMOX;SRM;PAOX;SAT2;AANAT
prerank,response to retinoic acid (GO:0032526),-0.22545008989120277,-0.836827288954249,0.7749360613810742,0.9119727445719615,1.0,20/59,23.03%,BRINP3;RORB;RARG;BRINP2;RET;HSD17B2;RARA;TESC;RBP4;ZNF35;WNT9A;ABL2;EPHA3;CREB1;ASXL1;TRIM16;WNT6;WNT8B;LTK;AQP1
prerank,myeloid dendritic cell activation (GO:0001773),0.3348789603108825,0.8363663755535115,0.6745886654478976,0.9508503424229694,1.0,1/12,0.62%,TGFBR2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.3305023384613234,0.8362167320996815,0.680073126142596,0.9505756374157361,1.0,2/14,8.34%,IL12B;POU4F1
prerank,ear morphogenesis (GO:0042471),0.3005403263602224,0.8362033918892139,0.6962025316455697,0.9500372479761541,1.0,5/20,20.76%,CHD7;PAX2;NOG;FGFR2;TWIST1
prerank,contractile actin filament bundle assembly (GO:0030038),0.3248393861782448,0.8362000631455756,0.6930320150659134,0.948898618420866,1.0,2/15,2.80%,ITGB5;SRC
prerank,stress fiber assembly (GO:0043149),0.3248393861782448,0.8362000631455756,0.6930320150659134,0.948898618420866,1.0,2/15,2.80%,ITGB5;SRC
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.32130533236644326,-0.8361379581055496,0.6731182795698925,0.9126867715716219,1.0,3/13,12.68%,SYT1;SYT10;CACNA1G
prerank,regulation of DNA recombination (GO:0000018),0.26240745271728416,0.8360313085995464,0.7257240204429302,0.9486688645915698,1.0,7/32,15.04%,SPIDR;BLM;PPP4R2;SETD2;SHLD2;ALYREF;IL7R
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.27406981758486415,-0.8358785864788668,0.7006651884700665,0.9124966884155646,1.0,9/23,23.84%,SLC12A8;SLC12A4;KCNH2;SLC12A5;TFAP2B;SLC12A1;PDK4;SLC26A4;SLC12A3
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.26527984028562146,0.8357089221083301,0.7464539007092199,0.9487573856228986,1.0,13/36,22.38%,EHMT2;BRCA1;EED;APAF1;PCGF2;EZH2;EPC1;MGA;RNF2;RING1;PHC1;CDC7;SUZ12
prerank,regulation of microtubule-based movement (GO:0060632),0.3464178721454671,0.8356459525851588,0.6642201834862386,0.9483211761767816,1.0,3/11,11.53%,DRC1;DYNLT2B;TTC21B
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3373284865317849,-0.8356316129711981,0.7106382978723405,0.9122860969554412,1.0,2/11,2.83%,PLCB1;IRS1
prerank,mRNA methylation (GO:0080009),0.3235774620484945,0.8354081242420699,0.7,0.9482418998789034,1.0,5/15,21.58%,TRMT6;METTL14;PCIF1;TRMT61A;METTL8
prerank,glucose homeostasis (GO:0042593),0.22002972411060465,0.8354024459289549,0.7956810631229236,0.9476835526494557,1.0,23/83,23.93%,HK2;MLXIPL;PIK3R1;IGF1R;PAX6;CRY2;FOXK2;SLC30A8;PDK2;MTNR1B;LRRC8A;CARTPT;SELENOT;INPP5K;TCF7L2;KCNB1;FGFR4;PARK7;HIF1A;HECTD4;PYGL;APPL2;HK3
prerank,regulation of intracellular protein transport (GO:0033157),0.26634159643446736,0.8353370541726731,0.7240740740740741,0.9472536173821138,1.0,14/32,32.68%,PTPN1;PDCD10;UHMK1;TENM1;OAZ2;PLK3;KIF20B;TGFB1;RAB29;B3GAT3;PTPN14;VAMP2;SIRT7;TPR
prerank,L-serine metabolic process (GO:0006563),-0.3449105337825412,-0.8352498917254568,0.6783505154639176,0.9123591686431074,1.0,5/10,21.20%,PSAT1;SRR;SHMT1;SERINC5;SHMT2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.35423124749394674,0.8350348594759125,0.6958955223880597,0.9472767722733176,1.0,3/10,8.52%,SPRY2;IL12B;PIK3CB
prerank,relaxation of cardiac muscle (GO:0055119),0.3309501462923992,0.8349886651945944,0.6710526315789473,0.9468052690667791,1.0,7/13,29.07%,SLC8A1;PLN;PIK3CA;CHGA;KCNJ2;ATP1A2;CAMK2D
prerank,protein localization to cell junction (GO:1902414),-0.2805193300022914,-0.8349593998508026,0.6930455635491607,0.9122251757377117,1.0,9/22,25.31%,NLGN1;PCLO;HEG1;NECTIN1;MPP4;JAM3;BSN;ARHGEF18;MARVELD3
prerank,carboxylic acid catabolic process (GO:0046395),0.33704726304075483,0.8345188114867231,0.6952380952380952,0.9472166384412058,1.0,7/12,27.19%,PON3;IL4I1;ACOT8;NPL;ACOT4;AMDHD2;NAGK
prerank,protein palmitoylation (GO:0018345),0.2698385010850765,0.8342491523912773,0.7122557726465364,0.9471999126445072,1.0,11/30,24.03%,PORCN;ZDHHC13;ZDHHC5;ZDHHC4;ZDHHC12;CLIP3;ZDHHC7;HHAT;GOLGA7B;ZDHHC2;ZDHHC6
prerank,dopamine metabolic process (GO:0042417),-0.28531781237775616,-0.8341350032808179,0.7072649572649573,0.9131622411661342,1.0,7/18,20.90%,PRKN;ATP7A;SNCA;DAO;MAOA;MOXD1;MAOB
prerank,positive regulation of protein import (GO:1904591),0.2754769131908764,0.8336789536861521,0.7194719471947195,0.9478513879646311,1.0,3/30,3.22%,SMAD3;PRKCD;PIK3R1
prerank,leukotriene metabolic process (GO:0006691),0.29490073051741533,0.833579330795949,0.738898756660746,0.9474922680429212,1.0,6/19,17.27%,PLA2G5;PLA2G4A;DPEP1;ABCC10;PTGR1;GGT5
prerank,regulation of cell death (GO:0010941),0.21541235137537534,0.833430780563488,0.8197767145135566,0.9472420950606187,1.0,10/94,7.96%,SRGAP2;RILPL1;RIPK2;EIF4G1;IMPACT;CLU;ACER3;RRAS2;ACER2;CALCR
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.2527891299913329,0.833324181858054,0.7298657718120806,0.9469102792558634,1.0,13/40,26.22%,PLSCR3;CLU;GPER1;BMF;PINK1;AKT1;BCL2L11;PMAIP1;OPA1;PYCARD;TP53;PDCD5;GHITM
prerank,vasoconstriction (GO:0042310),0.34926080919075064,0.8332692114996675,0.6887298747763864,0.946460837702044,1.0,3/11,7.63%,SLC8A1;EDN3;EDN2
prerank,liver development (GO:0001889),0.26322127552033353,0.8324552102259027,0.7377938517179023,0.947595254133917,1.0,8/32,17.43%,PRKCSH;MET;CCDC40;PROX1;CEBPG;AURKA;PCK2;LSR
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.23277218551690368,-0.8323468197613465,0.7614457831325301,0.9159029799896917,1.0,10/47,15.45%,GRM5;APP;APOE;EDNRB;MAPKAPK5;NFKBIA;GEMIN5;KLF4;ATXN2;MTPN
prerank,RNA catabolic process (GO:0006401),-0.22754336845080542,-0.8316750254853702,0.771689497716895,0.9165233479051919,1.0,11/46,15.78%,ERN1;AGO4;XRN2;ZFP36;ZC3H12D;RNASE3;CNOT10;EXOSC7;RNASEH2C;HSPA1B;RNASEH2B
prerank,activation of protein kinase A activity (GO:0034199),0.3146606729135717,0.8315979574110401,0.6897810218978102,0.9487890618261048,1.0,5/16,13.44%,PRKACA;ADCY9;ADCY4;ADCY6;PRRC1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.21720129907540545,0.8314814719412659,0.8276972624798712,0.948455311781083,1.0,22/88,22.21%,CST3;BAG6;CNOT1;ENC1;GAPDH;NANOS2;CLN3;MRPL13;IGF2BP2;AKT1;EIF2AK2;EPRS1;SERPINE2;CAPRIN1;PCIF1;TYMS;LARP1;NANOS1;TOB1;DNAJC1;RBM4;DDX3X
prerank,carnitine metabolic process (GO:0009437),0.3387664809438115,0.8313899566467365,0.6654545454545454,0.948079909229827,1.0,5/12,25.37%,ACADM;CROT;CPT1A;CPT1C;CRAT
prerank,regulation of vasculogenesis (GO:2001212),-0.31621611722863363,-0.8312325584076936,0.6952789699570815,0.9166672457178542,1.0,2/14,3.38%,XDH;RAPGEF2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.23020386558999992,0.8312197145314376,0.7653061224489796,0.9478664509094091,1.0,22/57,25.34%,EMG1;CUL4B;SDAD1;NIP7;BOP1;PES1;GTF3A;NOM1;RPS24;SHQ1;BYSL;NVL;WDR12;MRPL36;CUL4A;TGS1;RPL7;PAK1IP1;URB2;XPO1;RBIS;NOP14
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.2987573677501314,-0.8311196829902023,0.6814988290398126,0.9161924722946284,1.0,2/17,1.74%,ROBO1;SLIT2
prerank,heterocycle biosynthetic process (GO:0018130),-0.31443671030130416,-0.8305595758596724,0.6941431670281996,0.9166166722078483,1.0,2/14,7.16%,GPHN;ALOX5
prerank,angiogenesis involved in wound healing (GO:0060055),0.3476385093687891,0.8305395397558765,0.6957364341085271,0.9487026527375769,1.0,3/11,15.15%,CD34;GATA2;PRCP
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2756102100274421,0.8303034386090625,0.727433628318584,0.9486078079330801,1.0,6/27,15.90%,GNA15;GPR55;GPR18;DRD2;GPR157;GPR4
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3215383044419927,0.8302612093810545,0.7090239410681399,0.9481271331396053,1.0,2/16,1.48%,LARGE1;ST3GAL5
prerank,regulation of MAP kinase activity (GO:0043405),0.2168776586276646,0.8300814457599544,0.8019169329073482,0.9479183466254423,1.0,20/92,18.58%,PRKCD;LYN;UCHL1;KSR1;PIK3CG;SPRY2;EDN3;PDGFB;PIK3CB;RGS14;PTPN1;PDCD10;DIRAS2;TENM1;TSG101;EZH2;NOD2;PTPRJ;INPP5K;TRIB1
prerank,cellular response to ionizing radiation (GO:0071479),0.24850075535246632,0.8300663270300671,0.7323232323232324,0.9473841815016103,1.0,14/47,22.29%,RHNO1;SPIDR;ATM;RHOB;TNKS1BP1;RAD1;BLM;MAPK14;ECT2;RAD9A;XRCC6;CRYAB;TP53;KDM1A
prerank,cellular response to heat (GO:0034605),0.25740434712280336,0.8299356246180957,0.746551724137931,0.9470923325029156,1.0,12/35,24.42%,SUMO1;PRKACA;POLR2D;TRPV4;PDCD6;SLU7;THBS1;MAPT;HTRA2;STUB1;HIKESHI;FGF1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.3483461750870569,0.8295607349045322,0.6909448818897638,0.9472880922941206,1.0,4/11,24.15%,PRKCA;FADD;IL34;TGFB1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.23840669127333702,0.8294894208545075,0.7806873977086743,0.9468639981863736,1.0,13/53,15.33%,DDX5;PRKCD;ATM;PCNA;EYA3;RNF8;BRCA1;ABRAXAS1;DHX9;CEBPG;TMEM161A;FBH1;BABAM1
prerank,regulation of kinase activity (GO:0043549),0.2169561685280534,0.8294759129669707,0.7960526315789473,0.9463353064296598,1.0,13/89,11.62%,MERTK;CSF1R;RBL2;IGF1R;NBN;MET;RYK;SMG8;EPHA8;CAMKK2;MUSK;AXL;SOD1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.23116774165211174,-0.8284570352270005,0.7927710843373494,0.9200963025345178,1.0,15/44,20.47%,CD47;PPM1E;ARHGEF10L;CDC42;LIMCH1;CCDC88A;CARMIL1;ITGB1BP1;PAK1;RGCC;SFRP1;SERPINF2;EPHA1;S100A10;GPR65
prerank,neurogenesis (GO:0022008),-0.22920291522890734,-0.8284145903576178,0.812933025404157,0.919466299663067,1.0,5/43,9.62%,SPOCK1;FAT4;CDK5RAP2;CLN5;ERCC6
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.21220832807592002,-0.827024114228719,0.8169761273209549,0.9215074066608169,1.0,18/75,20.36%,PLCB1;GRK5;FRMPD1;RASGRP4;KCTD8;CALM1;RGS20;PDE6H;RGS6;CAMKMT;CCL5;SYP;GUCY2F;CRY1;GUCY2D;FNTA;PDE6A;RGS3
prerank,gene expression (GO:0010467),0.1810769529079208,0.8268941019483421,0.93646408839779,0.9509755830305389,1.0,93/348,23.32%,SRRM1;TSPAN14;POLR2H;NCBP1;RANBP2;CELF2;LMF1;EIF4G1;NUP42;POLR2D;MRPL43;SRSF5;DHX38;SEC13;PABPN1;MRPL37;POLR2J;MRPL9;MRPL34;NUP35;RPL15;RRBP1;CPSF1;MMS19;ASMT;U2AF2;HNRNPH1;DTX1;RPS27A;DHPS;DDX17;NUP50;MRPS5;MRPS21;RBM39;DUSP11;MRPL13;MEF2A;U2AF1L4;MRPS18B;ALYREF;RBM8A;MRPS16;MRPS11;SEH1L;SLU7;ABCF1;SARS1;DDX39B;RPS24;NUP62;NUP107;RPL39;TOPORS;SRSF9;NUP88;EPC1;ALKBH5;RPL28;GALNT2;THOC6;EIF4EBP2;MRPL11;FIP1L1;THAP1;RPL10;MPHOSPH10;MRPL41;DDX19B;NUP188;POLR2E;PRPF4;LMF2;DDX54;POLR2I;RPS8;MRPS18A;DNAJB11;MRPL36;HNRNPH3;STUB1;RBM4;HNRNPUL1;FASTKD2;SNRNP40;HNRNPA2B1;NUP214;MAGOHB;MAGOH;RPL7;ZC3H11A;THOC3;RPL6
prerank,kidney development (GO:0001822),-0.21590410116722863,-0.8265952277622047,0.8556430446194225,0.9216154932306206,1.0,7/65,3.96%,ZBTB16;SULF2;FGF10;PCSK5;MME;CENPF;C1GALT1
prerank,regulation of mitotic cell cycle (GO:0007346),-0.1812396540883792,-0.8261616731838581,0.9030303030303031,0.9217272271766744,1.0,29/171,13.94%,BRINP3;IQGAP1;APP;PSMD14;SDCBP;TTL;MKI67;PSMA2;SIRT1;DLGAP5;PSMF1;PTPN3;PIM3;PSMD8;BRINP2;ANAPC10;CUL7;PSMD6;PSME2;BTRC;PSMD11;BUB1B;SIK1;UBE2C;TTLL12;PSMD1;PSMD5;BTG2;OBSL1
prerank,glycerophospholipid metabolic process (GO:0006650),0.22160211338013075,0.8261168046144537,0.8047619047619048,0.9518885006342686,1.0,10/75,10.21%,ABHD12;CSF1R;PIGV;PLA2G15;PLA2G6;PLA2G4B;PLA2G4A;PLEK;CLN3;ABHD6
prerank,peptidyl-proline modification (GO:0018208),0.28044697099890536,0.8260464641702291,0.7284172661870504,0.9514799760925209,1.0,4/25,6.94%,FKBP5;PPIL6;PPID;P3H2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.21230208969485803,-0.825972805121618,0.8395989974937343,0.921407371363671,1.0,14/65,16.52%,PSMD14;PSMA2;PSMF1;PSMD8;PSMD6;PSME2;PSMD11;PABIR1;AURKB;PSMD1;PSMD5;CHEK1;PSMD12;GPR132
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.23878835716351035,0.8254961959106442,0.765704584040747,0.9520400251108571,1.0,7/47,13.07%,SIRPA;CD34;BRCA1;CEACAM1;PLEK;ROCK2;PROX1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.25893007548613944,0.8254248951518807,0.7584459459459459,0.9516205811447318,1.0,7/33,15.97%,PRKCA;CTNNBIP1;ZFP36L1;IL12B;POU4F1;RUNX1;FES
prerank,protein localization to vacuole (GO:0072665),0.32917239573134893,0.8254148990554414,0.7129963898916968,0.9510778630834862,1.0,4/13,21.48%,SH3GLB1;LAMTOR5;MFSD1;GLMP
prerank,regulation of oxidoreductase activity (GO:0051341),-0.31277467256021196,-0.8252204331402081,0.6975717439293598,0.9221596286359786,1.0,4/13,16.92%,ATP7A;ECSIT;ABL2;HP
prerank,erythrocyte differentiation (GO:0030218),0.24541172828374522,0.8250832061078852,0.768141592920354,0.9511501039726228,1.0,8/44,18.77%,IKZF1;LYN;NCKAP1L;INHA;UBA5;CEBPG;TAL1;DMTN
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.22082598508668924,-0.8249145946242,0.8121951219512196,0.9220697691663324,1.0,16/51,20.47%,CD47;PPM1E;ARHGEF10L;CDC42;LIMCH1;CCDC88A;CARMIL1;ITGB1BP1;PAK1;RGCC;CX3CL1;SFRP1;SERPINF2;EPHA1;S100A10;GPR65
prerank,regulation of metal ion transport (GO:0010959),-0.2977664402954038,-0.8246502765789122,0.7021739130434783,0.9218697805152898,1.0,5/16,19.82%,ANK2;IL16;EPB41;BCL2;CACNA2D1
prerank,polyol metabolic process (GO:0019751),-0.23159084790494505,-0.8245658155433891,0.7799043062200957,0.9213220739325038,1.0,14/46,19.25%,PLCB1;PLCH1;CALM1;PLCB4;ITPKC;INPP5J;NUDT3;PLCD4;OCRL;PLCH2;INPP5A;IP6K2;PLCD1;ISYNA1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2626089198808551,0.8244703116530805,0.7416107382550335,0.9517809421283826,1.0,8/35,19.84%,RFC2;MPG;PCNA;POLD2;RFC1;LIG1;NTHL1;RPA3
prerank,actin filament bundle organization (GO:0061572),0.25896975242603,0.8243494681624453,0.7248201438848921,0.9514707461960108,1.0,4/33,4.26%,MYO1B;BAIAP2L2;AIF1;FSCN1
prerank,regulation of histone deacetylation (GO:0031063),0.32834835182017147,0.8243111018157601,0.7007168458781362,0.9509851973054313,1.0,3/13,12.38%,AKAP8;AKAP8L;PRMT6
prerank,positive regulation of monooxygenase activity (GO:0032770),0.27342000659457216,0.8238791564328423,0.7408759124087592,0.9512774345757581,1.0,8/26,20.56%,AGTR2;NOS1AP;PIK3CB;SCARB1;AKT1;CDH3;PARK7;HIF1A
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.3417383221771295,-0.8237662008281051,0.7248908296943232,0.9222178723878917,1.0,6/10,29.43%,MTHFD1L;SHMT1;MTHFD2;SHMT2;MTHFD2L;DHFR
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.31886708736901204,-0.8237590354536645,0.7207207207207207,0.9215197546700525,1.0,5/13,19.60%,CAMK4;TESPA1;ZC3H8;BMP4;TOX
prerank,DNA replication (GO:0006260),0.21044151635080288,0.8237038911388035,0.8434108527131783,0.9510848923120252,1.0,21/105,17.13%,RHNO1;RFC2;ATM;FAM111A;RAD17;NBN;DUT;BRCA1;POLD2;RAD1;BLM;EXO1;MCM2;PCLAF;POLG2;RFC1;TOP3A;CDK2AP1;MCM3;ORC3;RAD9A
prerank,regulation of blood coagulation (GO:0030193),0.26910047007058,0.8236949112406293,0.7426597582037997,0.950538796624281,1.0,8/27,21.44%,F12;CD34;APOH;SERPINE2;THBS1;TFPI;DMTN;SERPINE1
prerank,female gamete generation (GO:0007292),0.2639245022534205,0.8236913932822264,0.7286689419795221,0.9499868279210526,1.0,12/29,31.55%,KMT2D;NANOS2;FSHR;DIAPH2;NANOS1;PRDM9;MDK;PARN;HORMAD1;M1AP;USP9X;FMN2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2884955348444854,0.8236384173818931,0.7109515260323159,0.9495456008590534,1.0,5/20,13.27%,RGS10;CHRM1;LYPD1;GRK2;CHRNA3
prerank,monocarboxylic acid metabolic process (GO:0032787),0.20515053394478616,0.8235895947803666,0.8661538461538462,0.9490753140344045,1.0,30/117,23.19%,BCO2;ACSL4;PPARD;THEM4;SLC27A4;VNN1;CROT;CKB;PANK2;NPC1;ALDH4A1;VDAC1;ALDH8A1;CPT1A;MCCC2;PTGR1;GAMT;GGT5;LDHAL6B;LDHA;ME2;AASDHPPT;GNPAT;HACL1;AASDH;PDHB;ACOT1;CPT1C;ACOT4;SCP2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.21986854944983578,0.8235597248322025,0.8030560271646859,0.9485760185786529,1.0,25/75,26.47%,PDE3B;PTPRM;FOXJ2;SPRY2;SPARC;ECSCR;APOH;GTF2I;ROCK2;SERPINF1;SARS1;SPINK5;THBS1;ADAMTS1;NAXE;AGO1;CXCL10;EFNA3;HGS;KLK3;SYNJ2BP;SULF1;ATP2B4;NPR1;PGK1
prerank,oligosaccharide metabolic process (GO:0009311),-0.22811445559176674,-0.8235257849402808,0.7833333333333333,0.9212563591429894,1.0,11/46,17.60%,B3GALT1;ST3GAL4;ST8SIA4;FUT9;NAGA;ST8SIA2;ST8SIA1;B3GALT4;GLA;B3GALT2;FUT4
prerank,regulation of cellular amide metabolic process (GO:0034248),0.25955685638172926,0.823458950686023,0.7521514629948365,0.9482173420935879,1.0,9/32,18.61%,PRKCD;PICALM;EIF2A;PKP3;EIF2B4;CYFIP1;PCIF1;PGAM1;RPL10
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.28436171336034943,-0.8230709606828004,0.7254901960784313,0.9214547166661449,1.0,3/18,8.09%,LILRB1;LILRB3;FBN1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.21155181372586765,0.8229592531383998,0.8210180623973727,0.9486291148808178,1.0,19/88,17.92%,FBXL18;FBXL20;FBXL15;CUL4B;PSMD3;FBXW4;PSMA7;FBXL2;FBXO38;PSMB3;PSMB9;FBXL22;PSMC2;FBXL8;PSME4;PSMC1;PSMB7;FBXL7;PSMB5
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.34551790214074135,0.8229553872933912,0.6942800788954635,0.9480831540949962,1.0,3/11,12.84%,SLC19A3;DCTD;ERH
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3022270870671109,0.82253407801626,0.720292504570384,0.94833291228596,1.0,7/19,20.83%,CSNK2A2;CAMKK2;USP36;PINK1;VDAC1;PARK7;HTRA2
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3332443725458483,0.8221418213701398,0.7115384615384616,0.9485251990860701,1.0,2/12,6.73%,NELFB;ZFP36L2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.32462297020765774,-0.8218264835311896,0.7048458149779736,0.9230955616573125,1.0,4/12,15.72%,SLC25A30;SLC37A4;XPR1;SLC37A3
prerank,iron ion transmembrane transport (GO:0034755),-0.3423016579714956,-0.8218108530160563,0.7082452431289641,0.9224208432807496,1.0,3/10,11.00%,ABCB7;SLC25A28;SCARA5
prerank,sodium ion homeostasis (GO:0055078),-0.2746187133108072,-0.8212964642858367,0.7192224622030238,0.9227478570727833,1.0,6/21,23.84%,NEDD4L;ATP1B3;ATP1A1;TFAP2B;SLC12A1;SLC12A3
prerank,response to thyroid hormone (GO:0097066),-0.31579147909415295,-0.8212960753485429,0.7214611872146118,0.9220434693956284,1.0,3/13,5.90%,THRB;KLF9;CTSB
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.2751937184351932,0.8211986258090765,0.7361853832442068,0.9498059780737595,1.0,5/25,17.25%,SORT1;LEPROT;LAPTM4B;CHMP1A;CHMP2A
prerank,intracellular protein transmembrane transport (GO:0065002),-0.2308144423537491,-0.821120537561798,0.7956730769230769,0.9216940935446258,1.0,8/42,10.93%,DNAJC15;ROMO1;TIMM23;TIMM17B;PEX12;HSPA5;TIMM17A;SEC62
prerank,cellular response to UV (GO:0034644),0.22084389902150742,0.8203347042955048,0.807131280388979,0.951020494096922,1.0,12/76,12.26%,RHNO1;PRKCD;PCNA;MMP2;EIF2S1;USP28;IMPACT;CUL4B;PPID;DDB2;ERCC4;BMF
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.21638368924635396,0.8203221103355092,0.7911184210526315,0.9504835575443851,1.0,16/78,18.58%,SUMO1;NFE2L2;SMAD7;FBXO22;CSNK1E;SIRT2;CLU;KLHL40;DET1;ZYG11B;RNF144B;ZER1;PLK3;USP5;TAF1;TRIB1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.24731373876763593,-0.8200622832823069,0.7619047619047619,0.9229401473194718,1.0,7/32,14.99%,CCT2;MAPKAPK5;XRCC5;AURKB;TNKS2;PRKCQ;CTNNB1
prerank,protein-DNA complex disassembly (GO:0032986),-0.30022583270707986,-0.8200514162491798,0.7363636363636363,0.9222598280304352,1.0,6/16,24.36%,MYC;NFE2;SMARCE1;SMARCD2;RPL23;SMARCC1
prerank,regulation of actin filament depolymerization (GO:0030834),0.33546886811894266,0.8199807564074829,0.6920077972709552,0.9505459347438764,1.0,3/12,20.36%,PLEKHH2;PLEK;PIK3CA
prerank,acidic amino acid transport (GO:0015800),-0.2874585333931033,-0.8198281425742392,0.7450110864745011,0.9219750851407912,1.0,6/17,18.78%,SLC1A6;GIPC1;SLC1A1;SLC6A6;SLC25A18;SLC25A12
prerank,regulation of hormone secretion (GO:0046883),0.3110704084317859,0.8198184245636255,0.7090239410681399,0.9502937884133573,1.0,3/15,14.41%,EDN3;SCG5;NMB
prerank,hexose metabolic process (GO:0019318),0.24581193688851571,0.8195342442967872,0.7682926829268293,0.9502886506644044,1.0,9/39,22.41%,PPARD;CHST1;GALM;GDPGP1;SORD;KHK;CHST15;GAA;HECTD4
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.31776953650751133,0.8194594707434515,0.7210144927536232,0.9493437288319871,1.0,2/15,5.55%,AP3D1;AP3B2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.31776953650751133,0.8194594707434515,0.7210144927536232,0.9493437288319871,1.0,2/15,5.55%,AP3D1;AP3B2
prerank,granulocyte chemotaxis (GO:0071621),0.23671590580635443,0.8186130772187441,0.7820945945945946,0.9504392218809382,1.0,8/55,10.22%,ITGB2;PIK3CG;NCKAP1L;CXADR;EDN3;EDN2;CXCL1;PIK3CD
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.33736975489188514,0.8183148089612843,0.690978886756238,0.9504803094664163,1.0,1/11,0.75%,ARHGEF2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.19141909027342266,0.8179176674746175,0.8940677966101694,0.950701162074242,1.0,56/190,26.03%,PDE3B;ARRB2;DDIT3;SRC;LYN;RHOH;ARHGAP25;TBC1D7;PKHD1;RFFL;CYRIB;THEM4;FLCN;NDUFS3;ZMYND11;CDC34;GPER1;PIK3CB;TNFAIP8L1;PLEK;DGKD;DRD2;PDCD6;PINK1;MAPK14;CIB1;AKT1;MGRN1;NLRP3;WTIP;CCDC22;NLRX1;THBS1;PPP2R5B;NDUFA13;PTPRJ;INPP5K;PYCARD;VGLL4;TWIST1;DEPDC5;TRIM39;CD2AP;DDX3X;CYLD;AJUBA;PPM1B;PEBP1;ZC3H12A;TNIP1;STAMBP;RNF157;RNF34;CGNL1;ATP2B4;PPEF2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.3513075681942558,0.8177868664439305,0.6622137404580153,0.9504136576936538,1.0,1/10,1.05%,SMAD7
prerank,protein-containing complex subunit organization (GO:0043933),-0.19442874836106264,-0.8176827793428113,0.8624338624338624,0.9252855900134879,1.0,26/109,18.58%,CD74;CD40;NUP98;ST13;ZW10;WASF1;DNM1L;WDR19;RIMS1;KNTC1;GEMIN5;NUP205;NUP54;PPIH;IL2RB;SNX9;PPP2R1A;JCHAIN;REPS2;GPAA1;PARD3;ADD2;CD3E;MDM2;TRAF1;CARD10
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.34179782512533424,0.8175932998485282,0.6996197718631179,0.950241152816434,1.0,2/11,6.93%,VHL;LEPROT
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.2965868307132373,0.8175923726246143,0.7200704225352113,0.9496911382333544,1.0,2/17,3.96%,PRKACA;SLC8A1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.33638527096664406,0.8174232207138421,0.6905737704918032,0.9494578953392583,1.0,3/11,8.08%,NOS1AP;LRRC55;LRRC38
prerank,cellular response to radiation (GO:0071478),0.24942277497494209,0.8170412865237686,0.7424242424242424,0.9496337315536784,1.0,12/40,22.17%,RHNO1;SPIDR;RHOB;TNKS1BP1;RAD1;BLM;MAPK14;ECT2;RAD9A;GPR52;TP53;NSMCE3
prerank,positive regulation of receptor internalization (GO:0002092),-0.2693386877183652,-0.8165197496290652,0.7466367713004485,0.9267882560208055,1.0,2/22,4.37%,MAGI2;ATAD1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.24556257609918505,0.8163690890357969,0.7549194991055456,0.9503656058971426,1.0,12/42,22.34%,TLR4;IL6R;NOS2;IL12B;RNASE6;HMGB2;OPTN;TNFRSF14;PYCARD;SLC11A1;SERPINE1;CHGA
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.287719510907807,0.8163411408775182,0.7111517367458866,0.9498622927360256,1.0,6/19,18.77%,PRKACA;TRPM2;STIMATE;ADGRL1;PTPRJ;DMTN
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.3260284469803331,-0.8162874532466218,0.7182795698924731,0.9264744304126563,1.0,3/11,14.99%,NR4A2;LRP6;CTNNB1
prerank,intracellular lipid transport (GO:0032365),0.28186522032015726,0.816042494782588,0.726078799249531,0.9498854271469949,1.0,6/21,25.71%,ABCD2;NPC2;CPT1A;ABCD1;SLC25A20;PRKAB2
prerank,neural crest cell migration (GO:0001755),-0.24048637682896823,-0.8154575672049297,0.7841191066997518,0.927343363525273,1.0,7/36,8.72%,FN1;SEMA5A;SEMA4A;CORO1C;HTR2B;SEMA6D;ERBB4
prerank,regulation of glucose metabolic process (GO:0010906),-0.24241049385787933,-0.8153856505368183,0.7985436893203883,0.9267573115349086,1.0,7/34,13.35%,IRS1;SIRT1;PRKN;SLC45A3;FOXK1;GNMT;PDK3
prerank,neurotransmitter biosynthetic process (GO:0042136),0.3143698577905495,0.8152003406307787,0.6952380952380952,0.9509952000182056,1.0,2/14,7.99%,DAGLB;SLC22A2
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.21896371936191464,-0.8150873340374363,0.8273381294964028,0.9266038699866778,1.0,10/53,13.26%,PSMD14;PSMA2;PSMF1;PSMD8;PSMD6;PSME2;PSMD11;PSMD1;PSMD5;AZIN1
prerank,synaptic vesicle transport (GO:0048489),-0.333964575758665,-0.8146705413373928,0.7222222222222222,0.9266925718630225,1.0,3/11,8.46%,KIF5C;TOR1A;KIF5B
prerank,positive regulation of macrophage activation (GO:0043032),0.2955554130098122,0.8134728777159476,0.7357414448669202,0.953722556113234,1.0,5/17,16.42%,TLR4;KARS1;IL33;TNIP2;THBS1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.27235117530528186,0.813287721219953,0.7553956834532374,0.953536815395258,1.0,6/25,15.14%,BAG6;UFD1;YME1L1;AUP1;ZYG11B;ZER1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.30664883701613277,-0.8132760328120666,0.6928251121076233,0.9285989649785368,1.0,5/14,17.45%,JAK2;PTPN2;HSP90AB1;IFNGR1;PIAS1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.26087097061552594,-0.812786606178865,0.780373831775701,0.9287787542627585,1.0,8/27,17.53%,DACH1;MYC;SMG6;SMG5;RGCC;CDKN1A;ACVRL1;PDGFA
prerank,negative regulation of endocytosis (GO:0045806),-0.26503593075831766,-0.8127642813559313,0.7558139534883721,0.9281273257397645,1.0,5/24,11.13%,LILRB1;RUBCN;MTMR2;MCTP1;UNC119
prerank,negative regulation of hippo signaling (GO:0035331),-0.3141987967832329,-0.8127373664541395,0.7349137931034483,0.9274716536762846,1.0,4/12,21.13%,LIMD1;MARK3;WWC1;WWC2
prerank,positive regulation of protein sumoylation (GO:0033235),0.3430170136586585,0.8125868564125467,0.7229357798165138,0.9543243956086764,1.0,3/10,12.11%,UBA2;RASD2;PIAS3
prerank,positive regulation of JUN kinase activity (GO:0043507),0.2706241406634326,0.8122304680551992,0.753199268738574,0.9544466206995479,1.0,9/23,28.51%,MAP3K10;MAP3K11;ARHGEF5;TRAF6;FZD10;TLR9;TLR6;DVL3;TAOK3
prerank,meiosis I (GO:0007127),0.2789630737329132,0.8118938596058736,0.7495559502664298,0.9545187403446382,1.0,5/23,21.72%,FOXJ2;ZSCAN21;HSF2BP;BCL2L11;ZCWPW1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.222287776105194,-0.8116359777339129,0.8297872340425532,0.9287770454464672,1.0,12/52,16.24%,SAMD4A;NT5C3B;ZFP36;EXOSC1;TUT4;CNOT10;LSM1;EXOSC7;PATL1;LSM3;HBS1L;CNOT4
prerank,negative regulation of protein transport (GO:0051224),0.2736082509140215,0.8112705521174973,0.7584973166368515,0.9550634247804483,1.0,6/25,12.21%,CSK;NDFIP2;IL12B;WWP2;PKDCC;DRD2
prerank,mRNA stabilization (GO:0048255),0.2462082105136041,0.8111335787744502,0.7569786535303776,0.9547718295895248,1.0,13/40,21.57%,HNRNPC;FUS;RBM24;TENT5C;DHX9;MAPK14;VIP;LARP1;BOLL;MYD88;SLC11A1;AXIN2;TARDBP
prerank,negative regulation of TOR signaling (GO:0032007),0.2528714461913187,0.8109499417487931,0.7598684210526315,0.9545826464872391,1.0,6/36,15.66%,TBC1D7;ATM;FLCN;TNFAIP8L1;PDCD6;SESN1
prerank,glycerolipid metabolic process (GO:0046486),-0.31816288029512546,-0.8109318961920635,0.7236842105263158,0.9293684557325024,1.0,1/11,1.05%,DGKB
prerank,cellular response to glucagon stimulus (GO:0071377),0.3011521475533772,0.8107014662904871,0.7045045045045045,0.9545125085568282,1.0,4/17,10.12%,PRKACA;ADCY9;ADCY4;ADCY6
prerank,histone H3 acetylation (GO:0043966),0.244898445980842,0.8105370713508031,0.775206611570248,0.9542715537107581,1.0,16/40,29.21%,PHF14;TAF6L;TAF12;JADE2;BRD1;TAF10;WDR5;YEATS2;TAF5;MBIP;TAF5L;KAT6B;KAT2B;KAT14;SUPT7L;DR1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.31022951875908666,-0.8104841786503361,0.6942675159235668,0.9295164435390977,1.0,1/13,0.21%,B3GALT1
prerank,anion transmembrane transport (GO:0098656),-0.2116617673459576,-0.810404468806706,0.8442622950819673,0.9289532660924673,1.0,18/67,21.25%,LRRC8C;SLC25A30;SLC25A19;SLC1A6;MFSD12;SFXN1;LRRC8B;SLC13A3;SLC7A1;SLC1A1;ABCC1;SLC25A18;SLC3A2;SLC13A5;SLC25A12;SLC5A6;SLC35C2;SLC25A38
prerank,regulation of macrophage differentiation (GO:0045649),0.3086878672439033,0.809989774057903,0.7237354085603113,0.9547603916329883,1.0,2/15,7.21%,PRKCA;INHA
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.24702775234136184,0.8099398932970264,0.7544169611307421,0.9543187800798235,1.0,8/35,17.21%,NUAK1;PPP6R3;AGTR2;CRY2;MTOR;MASTL;PPP6R1;CALM2
prerank,determination of left/right symmetry (GO:0007368),0.2480450358429825,0.8098556746886048,0.7808695652173913,0.9539395551262114,1.0,8/37,16.55%,KIF3B;SHH;LEFTY1;GALNT11;DLL1;CCDC40;OFD1;SMO
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.3382530277992837,-0.8096056166349629,0.7166324435318275,0.9296867792399575,1.0,2/10,7.39%,CPEB3;CDC73
prerank,positive regulation of cellular senescence (GO:2000774),0.3444273382075459,0.8095127837004576,0.7111517367458866,0.9540231530423104,1.0,2/10,8.88%,ABI3;CGAS
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.19150320658334555,0.8090705715166995,0.92,0.9542793736154012,1.0,55/173,26.31%,PREB;HYOU1;COPA;CAPZB;PROS1;TMED9;NRBP1;YKT6;SEC13;LMAN1L;PROZ;RAB1A;MIA3;F8;ARFGAP3;TRAPPC8;SAR1A;TICAM2;TRAPPC2;PDCD6;VAPB;COG6;TMED4;DCTN5;COG2;COG5;TRAPPC11;ERGIC3;VAMP7;GORASP1;DCTN2;TEX261;KDELR2;SEC31A;ACTR1A;TFG;IER3IP1;ERGIC1;DCTN4;COG7;TRAPPC6A;STX5;ARF4;CAPZA2;COPB1;SPTBN5;DYNLL1;TRAPPC2L;TMED7;AREG;BET1;MPPE1;ARCN1;VTI1A;LMAN2L
prerank,transcription by RNA polymerase I (GO:0006360),0.25250137275170786,0.809043406508169,0.7530434782608696,0.9537870902081741,1.0,17/34,33.22%,POLR2H;GTF2H2;ERCC2;POLR1C;UBTF;TAF1;POLR2E;POLR1G;POLR1E;MNAT1;POLR1A;TBP;POLR1B;TAF1D;ERCC3;TCOF1;MAPK3
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.27186514490341007,0.8087827460970803,0.7662337662337663,0.9537529253820167,1.0,2/22,2.06%,PJA2;AGER
prerank,phasic smooth muscle contraction (GO:0014821),-0.3389501018553476,-0.8085911617206624,0.6802575107296137,0.9308480880428701,1.0,3/10,8.04%,EDNRB;HTR2B;HTR1D
prerank,mitochondrial transcription (GO:0006390),-0.33573029070081256,-0.8085866010026564,0.6877729257641921,0.9301574235655845,1.0,3/10,21.47%,POLRMT;MRPL12;TWNK
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.26112653838096833,-0.8084724862323001,0.7641509433962265,0.9296808092043869,1.0,3/27,4.44%,CD74;CD44;SIRT1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.21217913022738344,0.8081088006874312,0.8428805237315876,0.954467884043,1.0,18/84,18.91%,BIN1;CNOT1;CLU;ENC1;GAPDH;NANOS2;MRPL13;IGF2BP2;GGA3;EIF2AK2;EPRS1;CAPRIN1;PCIF1;ORMDL2;TYMS;LARP1;NANOS1;TOB1
prerank,secretion (GO:0046903),0.31288020296037694,0.807800935190399,0.7148014440433214,0.9545002236238603,1.0,5/14,26.25%,SLC22A2;SLC22A6;VIP;TPD52;NPR1
prerank,negative regulation of catabolic process (GO:0009895),0.23328558423238566,0.8077601330265176,0.8010204081632653,0.9540354353881335,1.0,3/47,3.33%,PDE3B;CST3;SIRT2
prerank,aspartate family amino acid metabolic process (GO:0009066),0.28999743434298775,0.8077516689862063,0.7490774907749077,0.9535084295310308,1.0,5/18,14.99%,NAALAD2;MTHFD1;GADL1;NIT2;ASPG
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.22588766997297244,0.8076289468379659,0.8092868988391376,0.953189149756922,1.0,7/60,7.53%,GREM1;SMOC2;RFC2;ATM;PCNA;CHTF18;PDGFB
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.276004389810863,-0.8074274577193131,0.7444444444444445,0.9308617604094294,1.0,3/18,11.17%,DAB2;MTMR2;MSN
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.2547988587023199,0.8072610920632971,0.7781569965870307,0.9533371485132983,1.0,10/34,18.89%,RREB1;RAC1;LIMS1;ABL1;CSPG5;CIB1;C1QBP;CRKL;DMTN;RAC3
prerank,regulation of cytoplasmic translation (GO:2000765),-0.30610056159116983,-0.8072456259143658,0.7168539325842697,0.9304787106619389,1.0,2/14,3.32%,YBX3;CPEB3
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.33101160655399064,0.8069420765531131,0.7054263565891473,0.9533746380850217,1.0,4/11,25.46%,EXOSC5;EXOSC10;FBL;PARN
prerank,synaptic vesicle recycling (GO:0036465),0.2541338334138067,0.8068290077112289,0.7688266199649737,0.9530513854245424,1.0,3/31,3.86%,OPHN1;PLD2;STX1A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.27089196467868576,0.8062169854560948,0.7675276752767528,0.9536836954894895,1.0,6/26,15.40%,TLR4;INHA;GPR55;CEACAM1;GPR137;CARTPT
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.27537239195602276,-0.8060959795454254,0.7142857142857143,0.9317676374928623,1.0,6/20,15.20%,CWC27;PPIA;PPIH;PPIL3;PPIG;PPIC
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3175453062115497,0.8058787761934718,0.6994328922495274,0.9537966533304573,1.0,5/12,29.87%,NBN;BLM;GMNN;METTL4;TICRR
prerank,sarcomere organization (GO:0045214),0.2663882047397159,0.8058185723846619,0.7791741472172352,0.9533813977177416,1.0,1/27,0.89%,CAPN3
prerank,microtubule polymerization or depolymerization (GO:0031109),0.269968072691839,0.805411678221392,0.7383177570093458,0.9535958299234361,1.0,9/25,25.54%,KIF2A;FGF13;CENPJ;TRPV4;MAPT;KATNB1;PIN1;TPPP3;NCKAP5L
prerank,regulation of protein targeting to membrane (GO:0090313),0.26633700634036395,0.8053842457944009,0.7619893428063943,0.9531009780172717,1.0,7/28,19.31%,ITGAM;ITGB2;MIEF2;CIB1;INPP5K;DMTN;KCNB1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.22692066643237202,-0.8047631843729481,0.7954545454545454,0.9334520098203565,1.0,15/44,24.42%,CD44;YWHAE;CAST;SH3RF1;BEX3;SIAH2;RAF1;KLF4;SNCA;CARD16;USP47;LTF;MAP2K5;AQP1;NGFR
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3249845426445165,0.8047616823195111,0.7164750957854407,0.9537543608186336,1.0,2/12,11.85%,SERINC3;MTHFD1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2418700670208118,-0.8044254639865169,0.795774647887324,0.9333422134016419,1.0,6/33,11.35%,HIP1;DOK1;CCDC88A;PLAUR;PDE6H;ADRA2A
prerank,fatty acid transmembrane transport (GO:1902001),-0.276274446450408,-0.8043478180148939,0.7633744855967078,0.9327744736640382,1.0,4/19,15.31%,CD36;PRKAG2;ABCD4;CPT1B
prerank,plasma membrane tubulation (GO:0097320),0.31604426876542235,0.8042528293758271,0.7222222222222222,0.9541489936889452,1.0,1/13,1.07%,BIN2
prerank,ERBB2 signaling pathway (GO:0038128),0.258996215222443,0.8041934923247523,0.7799642218246869,0.9537209937759794,1.0,3/31,3.22%,PRKCA;SRC;PIK3R1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.25198189449588626,0.8041842081850294,0.7713310580204779,0.9531934785489253,1.0,6/34,15.95%,LRP5;EDN3;PDGFB;ANAPC11;AURKA;NUP62
prerank,mitochondrial fusion (GO:0008053),0.285149891918145,0.8041758131201368,0.7205882352941176,0.9526694166133284,1.0,6/18,22.10%,MIGA2;MIEF2;STOML2;OPA1;MFN2;AFG3L2
prerank,regulation of primary metabolic process (GO:0080090),0.1988645469005574,0.8038916575352179,0.9067930489731437,0.9526470971526128,1.0,34/126,23.59%,CHD9;PPARD;GPS2;PSMD3;C1QTNF2;GGPS1;SMARCD3;SIN3A;PSMA7;PLPP1;IDI1;ROCK2;OAZ2;CARM1;SIN3B;PSMB3;PSMB9;PSMC2;CERS2;SCD;PSME4;PSMC1;PSMB7;NQO1;PSMB5;FGFR4;PSMB8;NFYA;NCOA2;TGS1;MVK;TBL1XR1;OAZ3;OPA3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.28858714250499573,-0.8036286898430521,0.7241379310344828,0.9333704531967544,1.0,7/17,22.28%,RBPJ;JAG1;HEY2;SNAI2;BMP4;NOTCH2;DLL4
prerank,vitamin transport (GO:0051180),-0.2506217903857854,-0.8033512938036365,0.7930232558139535,0.9331259493424784,1.0,10/29,25.31%,SLC35F3;TCN2;SLC46A1;SLC5A6;SLC2A2;FOLR2;FOLR1;SLC2A8;CUBN;SLC19A2
prerank,chromosome organization (GO:0051276),-0.19202019067747178,-0.8033412304471865,0.9112271540469974,0.9324534786535805,1.0,29/99,25.74%,LATS1;SUV39H1;MTF2;TOP2A;SIRT1;CENPT;CDCA8;NDC80;MYC;LIG4;XPA;PADI4;CENPW;BAHD1;HDAC1;H3-3A;NUP155;ACTL6B;NUCKS1;MSH6;COPS8;DDB1;GEM;HMG20A;SUPT4H1;MSH2;ZBTB7A;EHMT1;NUF2
prerank,microtubule anchoring at centrosome (GO:0034454),-0.3348559452414772,-0.8028963878001991,0.7237903225806451,0.9325444753581843,1.0,3/10,18.61%,CEP19;CCDC120;BBS4
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.34560864571269817,0.8028633787508909,0.7262773722627737,0.9539870654530779,1.0,2/10,11.62%,WHRN;SOD1
prerank,regulation of blood circulation (GO:1903522),0.2514296218779435,0.8023548340179696,0.7884615384615384,0.9543711052269226,1.0,4/34,6.63%,AGER;FXYD1;CELF2;KCNG2
prerank,DNA-dependent DNA replication (GO:0006261),0.19874591667065386,0.8022318441914827,0.891044776119403,0.9540618136697616,1.0,34/128,24.36%,PRIMPOL;GINS4;RFC2;CDC34;PSMD3;UBC;RPS27A;POLD2;PSMA7;BLM;MCM2;POLG2;RFC1;PSMB3;PSMB9;PSMC2;CDK2AP1;MCM3;PSME4;PSMC1;PSMB7;ORC3;PSMB5;MCMDC2;GINS3;RPA3;PSMB8;SSBP1;RPAIN;CDC7;MCM6;GMNN;TOPBP1;RECQL
prerank,steroid catabolic process (GO:0006706),0.342325349784466,0.8016132543518328,0.7245841035120147,0.9546259071208959,1.0,1/10,1.23%,YWHAH
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.20356538649095374,0.8015741401045487,0.8597063621533442,0.9536189888952541,1.0,17/104,16.40%,PRKACA;SRC;PRKCD;LYN;PLCG2;RPS6KA5;PDPK1;TAB2;PSMD3;MUC6;PSMA7;PSMB3;PSMB9;PSMC2;PSME4;PSMC1;PSMB7
prerank,cellular response to lectin (GO:1990858),0.20356538649095374,0.8015741401045487,0.8597063621533442,0.9536189888952541,1.0,17/104,16.40%,PRKACA;SRC;PRKCD;LYN;PLCG2;RPS6KA5;PDPK1;TAB2;PSMD3;MUC6;PSMA7;PSMB3;PSMB9;PSMC2;PSME4;PSMC1;PSMB7
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.27023478408513524,0.8014807400147207,0.7790893760539629,0.9532380473330063,1.0,4/26,9.30%,SMOC2;PRKCA;LGMN;KLHL18
prerank,regulation of protein neddylation (GO:2000434),-0.34311342515115395,-0.8012418263390446,0.7242798353909465,0.9347016646452189,1.0,1/10,1.01%,DCUN1D2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.20355502742168907,0.8010192071597501,0.8739770867430442,0.9535223417694175,1.0,17/105,16.40%,PRKACA;SRC;PRKCD;LYN;PLCG2;RPS6KA5;PDPK1;TAB2;PSMD3;MUC6;PSMA7;PSMB3;PSMB9;PSMC2;PSME4;PSMC1;PSMB7
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.21405053128952212,0.8009961630705157,0.8201320132013201,0.953026034206245,1.0,16/76,18.58%,SUMO1;SMAD7;FBXO22;CSNK1E;SIRT2;SMURF1;CLU;KLHL40;DET1;ZYG11B;RNF144B;ZER1;CCDC22;USP5;TAF1;TRIB1
prerank,T cell mediated immunity (GO:0002456),-0.3007611780957544,-0.8007776390092257,0.7103004291845494,0.9348202779904807,1.0,7/13,27.45%,MYO1G;JAG1;BTN3A3;CD46;CRTAM;CD55;CD8A
prerank,nitrogen compound transport (GO:0071705),0.19510041189493948,0.8004425864765572,0.9030206677265501,0.9535161560792135,1.0,19/141,12.16%,SLC7A8;SLC36A1;SEC14L1;SLC25A45;SLC15A4;CD320;SCAMP2;ARRDC1;RD3;SLC52A3;SLC7A5;SLC22A2;SLC29A4;MIA3;SCAMP5;PPT1;KIF3A;MYH9;SLC52A1
prerank,lung development (GO:0030324),-0.23927723493399922,-0.8003297501669552,0.788546255506608,0.9349247493274169,1.0,10/33,19.79%,FGF10;SOX11;RCN3;FGF9;CEBPA;FGF7;RBP4;NPHP3;BMP4;DNAAF1
prerank,regulation of B cell activation (GO:0050864),-0.25848832353529244,-0.799466063313935,0.7757847533632287,0.9357804533719221,1.0,8/25,27.15%,BANK1;IKZF3;AHR;FCGR2B;SAMSN1;CD19;THEMIS2;CD22
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.25273590044261984,0.7991748610074667,0.7727272727272727,0.9551980888325271,1.0,15/32,31.86%,POLR2H;GTF2H2;ERCC2;POLR1C;UBTF;TAF1;POLR2E;POLR1G;POLR1E;MNAT1;POLR1A;TBP;POLR1B;TAF1D;ERCC3
prerank,protein kinase A signaling (GO:0010737),0.3261830758650457,0.7989084023478361,0.7595628415300546,0.9551586237020079,1.0,4/12,28.25%,PRKACA;RAB13;MYOM1;RDX
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.26878297003663837,-0.7988800722648377,0.7517084282460137,0.9361629582491102,1.0,3/21,2.94%,STAP1;FOXP1;PTPN22
prerank,positive regulation of protein transport (GO:0051222),0.21848459829422923,0.7984970405930361,0.8294701986754967,0.955391744134713,1.0,22/67,28.37%,FRMD4A;ATP2C1;PPID;CLN3;PDCD10;TENM1;OAZ2;PLK3;EXOC1;CD33;ARHGEF5;IER3IP1;MYO18A;CD2AP;MYOM1;KIF20B;GOLPH3L;TGFB1;RAB29;IL1A;B3GAT3;ABCG1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.24346925533419736,0.7983061933980566,0.7768166089965398,0.9551806270488575,1.0,14/39,28.25%,MIA3;NOTCH4;WNK1;AKT1;SPINT2;PLG;MAPK7;AKNA;BMP2;TGFB1;PPM1F;NOTCH1;NF2;RDX
prerank,cellular macromolecule catabolic process (GO:0044265),-0.21482504323721546,-0.7982487270037983,0.8482587064676617,0.9365082257570535,1.0,10/49,16.29%,DENND3;PRKN;XRN2;SIAH2;RNASE3;EXOSC7;RNASEH2C;OGA;RNASEH2B;MAGEC2
prerank,positive regulation of viral life cycle (GO:1903902),0.278030984522307,0.7982086604821568,0.7656529516994633,0.9548124053159246,1.0,5/22,17.25%,LGALS9;TRIM11;AXL;TSG101;CHMP2A
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.2690814538762653,-0.7978701100679141,0.7412280701754386,0.9364953449833207,1.0,7/19,18.61%,NANS;GMPPB;RENBP;GFPT2;UAP1;UGP2;GNPDA2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.29699403041768235,-0.7977493502808625,0.7607758620689655,0.9360291773322708,1.0,5/14,20.83%,CD226;KMT5B;TFRC;SHLD3;RIF1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.3097363509438789,-0.7976817867927518,0.7149122807017544,0.9354619821187422,1.0,6/13,31.01%,ADRA1A;SMTNL2;AVPR2;ADRA1B;OXTR;AVPR1A
prerank,negative regulation of cellular metabolic process (GO:0031324),0.2476373619536838,0.7976490251004995,0.7706896551724138,0.9552659349049636,1.0,9/37,16.75%,ITGAV;SIRT2;AATF;BRCA1;DLG4;PINK1;PAX2;OPTN;ANKRD13B
prerank,cellular response to gamma radiation (GO:0071480),0.29577135773964536,0.7973470455554431,0.7518248175182481,0.95525424417908,1.0,7/17,26.35%,ATM;XRCC6;CRYAB;TP53;KDM1A;TSPYL5;TMEM109
prerank,negative regulation of organelle assembly (GO:1902116),-0.23930408031264624,-0.7973158090700391,0.802439024390244,0.9353797044043987,1.0,6/35,11.87%,LRRK2;CDK5RAP2;TRIM37;MDM1;SMCR8;SCFD1
prerank,positive regulation of ATPase activity (GO:0032781),-0.2251608463575048,-0.7968478081523421,0.8436018957345972,0.9355174880841461,1.0,13/41,25.17%,FGF10;RYR2;CHTOP;VMP1;ATP1B3;DNAJB2;MYBPC3;TOR1AIP2;SETMAR;MSH6;ATP2A1;MSH2;PFN1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.3270619061291868,0.7959769129674475,0.7452830188679245,0.9571749543475455,1.0,3/12,14.90%,PICALM;ROCK2;FLOT2
prerank,protein localization to nucleus (GO:0034504),0.20359390489860643,0.7959208001913706,0.8647416413373861,0.9567307694679977,1.0,28/102,23.24%,FAM53A;PHB2;TNPO1;SEC13;SPRN;NUP62CL;TOR1AIP1;APPL1;NUP50;IPO4;TNPO3;TAF8;AKT1;PTTG1IP;MORC3;CSE1L;NUP62;NUP107;TOPORS;NUP88;E2F3;NUP188;IPO7;RPAIN;BANP;NUP214;HIKESHI;APPL2
prerank,neural crest cell development (GO:0014032),0.23849141191717693,0.7955361279789702,0.8111298482293423,0.9568746150480707,1.0,8/44,13.05%,SEMA3B;SOX8;SEMA4C;SHH;KBTBD8;PDCD6;SEMA4D;SEMA4G
prerank,regulation of spindle organization (GO:0090224),-0.2765903575979892,-0.795452489213223,0.7745535714285714,0.9371219557219561,1.0,5/18,16.08%,TPX2;MAP9;GNAI1;GPSM2;PARP3
prerank,photoperiodism (GO:0009648),0.2566582785005567,0.7954055165516714,0.7744755244755245,0.9565715505667666,1.0,10/28,24.20%,MTA1;CRY2;CRTC1;FBXL22;FBXL8;PPP1CB;TP53;RBM4;PPP1CC;FBXL12
prerank,oogenesis (GO:0048477),0.30589049122843454,0.7953513262572645,0.7330960854092526,0.9561307034845308,1.0,5/15,25.73%,KMT2D;NANOS2;NANOS1;MDK;HORMAD1
prerank,positive regulation of calcium ion import (GO:0090280),0.31270693292691976,0.7952904242521825,0.7411545623836127,0.9556942933697177,1.0,2/12,7.96%,PDGFB;CALCR
prerank,telomere maintenance via telomerase (GO:0007004),0.26169166712673014,0.7952116597360889,0.7870036101083032,0.9552899062407542,1.0,8/28,20.75%,PPP6R3;TNKS1BP1;TERF1;RFC1;NHP2;SHQ1;TELO2;ACD
prerank,regulation of intracellular transport (GO:0032386),0.24366816791991647,0.7951642828359144,0.7928082191780822,0.9548274376889682,1.0,13/38,22.66%,NUMA1;PTPN1;DNAJC30;DYNLT2B;ANTKMT;TTC21B;REEP6;GAS1;REEP5;PLA2G3;CRYAB;RBM4;NUP214
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.26856283490380467,-0.7949056542043247,0.7760532150776053,0.9366266229154249,1.0,3/20,7.32%,APP;PFKFB1;ZBTB20
prerank,positive regulation of glycolytic process (GO:0045821),-0.26856283490380467,-0.7949056542043247,0.7760532150776053,0.9366266229154249,1.0,3/20,7.32%,APP;PFKFB1;ZBTB20
prerank,neutrophil migration (GO:1990266),0.22646695105531622,0.7948007372168285,0.8336106489184693,0.9549150509437879,1.0,8/58,10.22%,ITGB2;PIK3CG;NCKAP1L;CXADR;EDN3;EDN2;CXCL1;PIK3CD
prerank,macrophage differentiation (GO:0030225),0.31961677168119357,0.7942361264248936,0.7282608695652174,0.9553747359269094,1.0,1/13,0.85%,CSF1R
prerank,negative regulation of cell projection organization (GO:0031345),0.23021912856230595,0.7941223872107835,0.8165289256198347,0.9550394155799875,1.0,12/48,19.20%,RTN4RL1;YWHAH;SPRY2;ADCY6;TRPV4;MYLIP;CIB1;RTN4R;ACP4;GORASP1;DENND5A;MAG
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.3377523183228928,0.7940775450540272,0.7588235294117647,0.9546061953037152,1.0,4/10,33.42%,GNB1;PDE6B;SAG;PDE6G
prerank,inner mitochondrial membrane organization (GO:0007007),0.2320932817256335,0.7940379463085864,0.8144329896907216,0.954146517434158,1.0,22/47,30.83%,MICOS13;TIMM29;ATP5PO;DNAJC11;ATP5MC1;TIMM10B;ATP5PD;MAIP1;NDUFA13;OPA1;TMEM11;ATP5F1D;SAMM50;AFG3L2;TIMM13;TOMM70;GHITM;MICOS10;ATP5F1B;TIMM8B;CHCHD6;ATP5F1A
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.30232739641612544,-0.7937251436240944,0.7473903966597077,0.937930940087281,1.0,2/14,3.08%,CCR2;CCL4
prerank,cellular response to BMP stimulus (GO:0071773),0.21688278538468528,0.7934654910405284,0.867003367003367,0.9545882177839885,1.0,23/66,30.02%,SMAD3;SMAD7;DDX5;SMURF1;LEFTY1;SMAD9;USP9Y;ENG;TMEM100;ACVR2B;BMP2;ZFYVE16;PDCD4;AMH;TGFB1;SMAD6;SOX9;BMPR1A;BMPR2;SMAD5;HIVEP1;ACVR1;USP9X
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3177374183845746,0.7933323922303025,0.7415929203539823,0.9542933246923955,1.0,7/13,29.54%,CLU;MBTPS2;USP19;NR1H2;LPCAT3;EIF2AK3;NR1H3
prerank,regulation of smoothened signaling pathway (GO:0008589),0.22532549067256444,0.7928129585173411,0.8251273344651953,0.9546341560900247,1.0,15/50,24.77%,UCHL5;SHH;RAB34;MOSMO;ULK3;KCTD6;MGRN1;SMO;GAS1;SUFU;PTCH1;FGFR2;TUBD1;IFT122;KIF7
prerank,modulation by host of symbiont process (GO:0051851),0.2543757835280701,0.7925455580679845,0.7890222984562607,0.9545562863817626,1.0,2/31,4.63%,CX3CR1;LRRC19
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.2521432910769429,-0.7923646436645957,0.7928571428571428,0.9394517403892323,1.0,6/25,15.19%,EGFR;APP;SDCBP;SNCA;BTBD10;CCL5
prerank,protein localization to chromosome (GO:0034502),-0.23578634887857228,-0.7923365566171913,0.8457831325301205,0.9388097077785187,1.0,14/34,29.36%,MCM9;CTCF;XRCC5;TNKS2;SLF1;PARP3;FAM47E;TPP1;MSH2;PLK1;LEMD2;TERF2IP;BOD1;MCM8
prerank,embryonic organ development (GO:0048568),0.2231102522591347,0.7919770047754576,0.8473154362416108,0.9550186061961141,1.0,7/61,10.46%,SALL1;TGFBR2;FOXE1;SOX17;WNT7B;PKDCC;NDRG4
prerank,regulation of cell killing (GO:0031341),0.2953349034215429,0.7919543475016027,0.7732342007434945,0.9545182763963717,1.0,4/16,19.69%,RAC1;CFH;MAPK8;NOXO1
prerank,tRNA 5'-leader removal (GO:0001682),0.3130062163349694,0.7914413112076513,0.7373358348968105,0.9548481636001135,1.0,3/13,10.50%,POP1;SSB;RPP21
prerank,carboxylic acid transport (GO:0046942),0.22099967431825682,0.791327297679805,0.8225538971807629,0.9545228165663324,1.0,11/55,19.72%,SLC7A8;SLC16A6;SLC36A1;SLC15A4;SLC7A5;CLN3;SLC6A9;SLC16A7;SLC25A10;SLC38A1;SLC16A4
prerank,monocarboxylic acid transport (GO:0015718),0.22578728966978698,0.7912369059228905,0.8250825082508251,0.9541425432835223,1.0,6/51,14.87%,SLCO2B1;SLC16A6;SLC27A4;CEACAM1;ABCB4;SLC16A7
prerank,regulation of isotype switching (GO:0045191),0.30520673580946645,0.7912214479319319,0.7686832740213523,0.9536376671484432,1.0,3/14,13.04%,SLC15A4;KMT5C;SHLD2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.20953129117823996,0.7903477957092948,0.8569051580698835,0.9545848335297906,1.0,18/80,19.34%,RPS6KA1;CTSD;CSNK2A1;SRC;CASP1;GPER1;LAMTOR5;XIAP;PDCD6;DPEP1;PAX2;AKT1;NLRP3;THBS1;ARL6IP5;NDUFA13;PMAIP1;PYCARD
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.2933074556566618,-0.7896662628595978,0.7566371681415929,0.9425818655234395,1.0,3/14,8.08%,YBX3;ZFP36;ELAVL4
prerank,fatty acid biosynthetic process (GO:0006633),0.21648080855880641,0.7895237282396402,0.8683333333333333,0.9554133143164425,1.0,4/63,5.45%,LIPC;LIPH;HACD3;HPGD
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.2724718020611046,-0.7894740939242868,0.758985200845666,0.9422057946616809,1.0,4/20,8.76%,LIMD1;AGO4;TNRC6A;HELZ
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.31022964094241023,-0.7893464301116224,0.7489711934156379,0.9417337346041138,1.0,1/12,0.21%,B3GALT1
prerank,regulation of cell communication (GO:0010646),-0.2311305430443435,-0.7892837506150922,0.8155555555555556,0.9411564670481244,1.0,3/35,2.33%,ANK2;GRK5;RYR2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.22109902591532674,0.7890300328177159,0.8486842105263158,0.9556998213125217,1.0,13/61,15.33%,SMOC2;PCNA;NBN;PDGFB;STPG4;EYA3;RNF8;BRCA1;ABRAXAS1;DHX9;CEBPG;TMEM161A;BABAM1
prerank,positive regulation of DNA binding (GO:0043388),0.24965435181973736,0.7888150886447639,0.8047945205479452,0.955518207932576,1.0,11/31,24.15%,SKI;SIRT2;POU4F1;CEBPG;HMGB2;NME1;GATA3;PARK7;TWIST1;TRAF6;TGFB1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.19941961252815724,0.7884310991228642,0.882636655948553,0.9556167658065974,1.0,20/116,15.48%,PRKACA;SRC;LYN;ADCY9;PLCG2;ADORA2B;CALCR;FSHR;LHCGR;NPS;ADCY4;ADCY6;MYH9;DPEP1;MAPK14;HRH2;INSL3;VIP;ADORA2A;GPR84
prerank,cellular sodium ion homeostasis (GO:0006883),-0.28911071102623503,-0.7882693175969733,0.7751091703056768,0.9421833223955465,1.0,3/15,11.72%,NEDD4L;ATP1B3;ATP1A1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.2779135420596878,0.7880321020740665,0.7825278810408922,0.9557808576584856,1.0,4/20,16.19%,ACSL4;DGAT1;PPT1;SCD
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3322780664741711,0.787888385748726,0.75390625,0.9554988663166837,1.0,1/10,1.64%,QDPR
prerank,cellular response to light stimulus (GO:0071482),0.21777330809147694,0.7878609307816611,0.845514950166113,0.9550182519917395,1.0,23/66,30.45%,RHNO1;PRKCD;PCNA;EIF2S1;USP28;ERCC4;BMF;TMEM161A;TAF1;GPR52;YY1;TP53;NSMCE3;KDM1A;GNB1;CDC25A;ZBTB1;EP300;OPN3;GPR88;PDE6B;SAG;NEDD4
prerank,determination of bilateral symmetry (GO:0009855),0.2630918333108613,0.7878466601709273,0.8032490974729242,0.9545131753901773,1.0,4/25,10.54%,KIF3B;LEFTY1;GALNT11;DLL1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.27183951249958255,0.7877168696038876,0.781305114638448,0.9542012640769287,1.0,4/22,12.96%,PRKCA;IL6ST;MEF2A;ROCK2
prerank,Rap protein signal transduction (GO:0032486),-0.32779189320540053,-0.7875742747090076,0.7580993520518359,0.9426574985809245,1.0,2/10,8.56%,RAPGEF2;PLK2
prerank,Golgi localization (GO:0051645),-0.31937619389303307,-0.7874906460142641,0.7123015873015873,0.9421083245667954,1.0,2/11,5.85%,CDC42;UVRAG
prerank,regulation of viral life cycle (GO:1903900),0.28025643134855543,0.7874449626315371,0.7659176029962547,0.9541193682954201,1.0,6/21,16.91%,TRIM5;AXL;TRIM62;NECTIN2;TSG101;TRIM14
prerank,regulation of stem cell proliferation (GO:0072091),0.29382947527463243,0.7871932770091925,0.7421731123388582,0.9540054040076051,1.0,4/17,15.22%,ZFP36L1;EIF2AK2;GJA1;HMGB2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.2786536846638907,-0.7868305319171877,0.7710843373493976,0.9425225583510273,1.0,3/17,5.65%,CTNNA2;ABI2;WASF1
prerank,regulation of transposition (GO:0010528),-0.2987620863393908,-0.7866270637257929,0.7452631578947368,0.9421549579636652,1.0,7/13,30.15%,SPOCD1;SMYD5;TDRD9;PIWIL2;MYBL1;AICDA;PIWIL4
prerank,regulation of cellular catabolic process (GO:0031329),0.2157259763859071,0.7862288622614612,0.8519134775374376,0.9550769000392281,1.0,20/62,23.77%,DDIT3;ATM;DRAM2;ACER2;WDR24;RPTOR;FBXL2;ABL1;MTMR4;RRAGA;GPR137;DCAF12;ABCD1;RMC1;MAPT;DEPDC5;PIP4K2B;TYSND1;KEAP1;VPS29
prerank,mitochondrion organization (GO:0007005),0.18626874505133909,0.7860866525049752,0.9441176470588235,0.9548091186041648,1.0,48/165,24.80%,HK2;DNM2;TRAK1;PHB2;MIGA2;ATAD3A;PITRM1;COX7A2L;CXADR;YME1L1;FANCG;NRF1;MEF2A;MIEF2;TSPO;TIMM50;PINK1;POLG2;HSD17B10;TIMM10B;TIMM44;BCS1L;TOMM7;VPS13C;MYH14;ATCAY;WDR81;RAB32;STOML2;OPA1;TMEM11;ATP5F1D;PARK7;VPS13D;AGTPBP1;TFB1M;SSBP1;MFN2;SAMM50;AFG3L2;TOMM20;TIMM13;PPRC1;PISD;MTFR1L;PYROXD2;OXA1L;TOMM70
prerank,response to nitric oxide (GO:0071731),-0.30883267579962653,-0.7858464485082114,0.7566964285714286,0.942803256133194,1.0,6/13,26.28%,KCNC2;GUCY1B1;FOXO1;CDK2;AQP1;CCL19
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.2447408975175881,0.7858412259310464,0.8247787610619469,0.9547121231917788,1.0,6/35,11.34%,PTPRM;MEF2C;SPARC;IL12B;APOH;PDCD10
prerank,negative regulation by host of viral transcription (GO:0043922),-0.3081669878054212,-0.7856394320874168,0.7631578947368421,0.9424367088946428,1.0,5/12,23.71%,CCL4;HDAC1;CCL5;REST;POU2F3
prerank,calcineurin-mediated signaling (GO:0097720),0.3369419729228455,0.7854757292277738,0.7485928705440901,0.9542657589851111,1.0,1/10,4.89%,NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.3369419729228455,0.7854757292277738,0.7485928705440901,0.9542657589851111,1.0,1/10,4.89%,NFATC1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.2531698436970981,0.7849414922245131,0.8,0.9546273552112885,1.0,12/30,27.03%,MACF1;RAB34;BBS2;GOLGA4;GGA3;OPTN;KIF13A;SYS1;GOLPH3L;PREPL;RAB26;VAMP5
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.2597779419718224,0.7848191093587258,0.7909407665505227,0.9542986925724561,1.0,6/27,12.48%,CHPF2;BGN;CHST7;CHST11;CHSY1;CSPG5
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.2802077201028535,0.7840769112951023,0.7755834829443446,0.9549590746771023,1.0,4/20,13.05%,SEMA3B;SEMA4C;SEMA4D;SEMA4G
prerank,carnitine shuttle (GO:0006853),-0.30930509651772176,-0.7837001636383054,0.7459349593495935,0.9448311081505437,1.0,2/11,15.31%,PRKAG2;CPT1B
prerank,cellular component assembly (GO:0022607),0.1775307791256996,0.78352242355656,0.9539568345323741,0.9553412150311281,1.0,41/253,16.58%,OPHN1;CAPN3;MYO1B;BAG6;BAIAP2L2;RAC1;AIF1;MAGI1;TTLL3;RHOH;FSCN1;NCKAP1L;PICALM;CFAP74;RHOQ;LPXN;STAG3;LRGUK;JHY;PPID;PTK2B;SHROOM2;FLNC;LIN7A;MDM4;NDUFAF1;LIMS1;PDCD10;LLGL1;DLG4;CCDC40;DET1;NAPG;EPRS1;CFAP46;CYFIP1;TEX12;VASP;FZD1;FANCA;KPNA3
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.2597247990766484,-0.7831995756490221,0.795045045045045,0.9449291161953104,1.0,7/22,20.76%,STAP1;SIRT1;CDKN2A;CDKN1A;BMP4;CDA;CDKN1C
prerank,protein lipidation (GO:0006497),0.22052509692745326,0.7830846278912819,0.8552412645590682,0.9555222184105512,1.0,20/59,26.38%,PIGV;PGAP2;PORCN;DPM3;ZDHHC13;PIK3C3;PIGO;ZDHHC5;ATG5;ZDHHC12;ZDHHC7;PIGU;WDR45B;HHAT;GPLD1;ZDHHC2;ZDHHC6;ATG12;MPPE1;ATG10
prerank,response to UV (GO:0009411),0.20536783711028264,0.7828215581484995,0.8816,0.9553982522926466,1.0,24/95,22.29%,RHNO1;PRIMPOL;PRKCD;GTF2H2;PCNA;EIF2S1;USP28;MAP4K3;IL12B;ERCC2;DDB2;ERCC4;BMF;PCLAF;AKT1;TMEM161A;UBE2A;TAF1;MAPK8;SPRTN;YY1;TP53;NSMCE3;KDM1A
prerank,protein targeting to lysosome (GO:0006622),0.27514064303476954,0.7825275766761107,0.7619047619047619,0.955351536854162,1.0,6/20,22.28%,CLU;GGA3;AP4M1;LAMP2;ZFYVE16;HGS
prerank,negative regulation of response to stimulus (GO:0048585),0.220018165767373,0.782462186728627,0.8462837837837838,0.9549321690446331,1.0,12/60,16.66%,IGFBP3;MAP3K3;LYN;SLC30A10;UBASH3B;CLU;CD34;PTPN1;MAPK7;SPINK5;NR1H2;VPS13C
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.25020701548433444,-0.7820870462912505,0.8067226890756303,0.9460062647501407,1.0,5/25,18.10%,RBPJ;SOX11;CDH5;ACVRL1;BMP4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.25563858573257614,0.7820482466070217,0.7871287128712872,0.9550695329998071,1.0,8/29,20.91%,FUS;PKP3;RBM24;TENT5C;VIP;LARP1;SLC11A1;AXIN2
prerank,negative regulation of protein catabolic process (GO:0042177),0.2332034583353041,0.7820380385285933,0.8442906574394463,0.9545655388081002,1.0,3/40,3.33%,SNRNP70;CST3;SIRT2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.24159159549432832,0.7820377518215457,0.8251748251748252,0.954045605583992,1.0,12/36,28.89%,VHL;LEPROT;CENPJ;IL10RA;IL10RB;GHR;PIGU;HGS;SOCS3;NOTCH1;NF2;CRLF3
prerank,negative regulation of T cell proliferation (GO:0042130),-0.240967986101716,-0.7817553076732862,0.8325242718446602,0.9458420834752399,1.0,10/28,22.19%,LILRB1;CEBPB;VSIG4;SPN;CD80;SDC4;PLA2G2D;FOXP3;PRKAR1A;CRTAM
prerank,regulation of protein acetylation (GO:1901983),0.31956284938035456,0.7816850275204705,0.7631103074141049,0.9540843501542884,1.0,5/12,22.21%,CEP295;RAPGEF3;CAMK1;PARK7;DDX3X
prerank,diol metabolic process (GO:0034311),0.2795899318009481,0.7816664304428723,0.7737881508078994,0.9535943435980244,1.0,4/19,13.36%,DEGS2;PLPP2;PLPP1;AKT1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.31713467160233105,0.781394320675956,0.7543186180422264,0.9535323264409529,1.0,4/13,19.67%,NFE2L2;MET;PYCR1;PARK7
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.31587040233387376,0.7812166804943025,0.7528089887640449,0.953283363722783,1.0,2/12,9.15%,DGAT1;APOC4
prerank,plasma membrane organization (GO:0007009),0.21542021816097584,0.7810223245097477,0.8714524207011686,0.9530730406625726,1.0,8/61,12.08%,BIN1;ABCD2;BIN2;PLSCR3;TRIM72;CLN3;STX4;MYH9
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.28930016583006657,-0.7802157913721791,0.7611940298507462,0.9475734632018681,1.0,1/13,0.62%,ITGA4
prerank,mitochondrial gene expression (GO:0140053),0.2325106351562372,0.7798270828478581,0.8154657293497364,0.9544626075824671,1.0,12/42,25.00%,MRPS24;MRPS34;MRPL2;MRPS21;MRPS18B;MRPS16;MRPS11;MRPS28;MRPS18A;FASTKD2;NOA1;GATC
prerank,muscle tissue morphogenesis (GO:0060415),-0.28425627926663355,-0.7795176704311837,0.7770700636942676,0.9479515625142003,1.0,6/16,29.15%,HEY2;BMP4;TTN;TGFBR3;ZFPM1;TBX1
prerank,myelination in peripheral nervous system (GO:0022011),0.30764480250755566,0.7795100773377601,0.7638640429338104,0.9544407708889315,1.0,3/13,11.62%,SKI;SIRT2;SOD1
prerank,eye morphogenesis (GO:0048592),-0.27211884968357863,-0.7789512519977644,0.7767857142857143,0.9481374148063058,1.0,6/19,16.70%,TENM3;RARG;FBN2;FBN1;COL5A1;NKD1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.22247798495195464,0.7788998817494275,0.8390243902439024,0.9549059965350696,1.0,9/50,13.36%,RPS6KA1;CSNK2A1;SRC;RFFL;LAMTOR5;XIAP;DPEP1;PAX2;AKT1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.24695569858465025,0.7788473807280382,0.8115183246073299,0.9544742867786135,1.0,4/32,7.96%,CAPN3;PDPK1;GPER1;CALCR
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.2991397813247188,0.7784865614370197,0.7773851590106007,0.9545295556424422,1.0,1/15,1.05%,SMAD7
prerank,gastrulation (GO:0007369),0.2931116538425553,0.778304545705842,0.7773722627737226,0.9542897385082958,1.0,1/15,0.81%,LRP5
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.3119757036419486,0.7782968825169009,0.7436363636363637,0.9537886238980604,1.0,4/12,30.47%,BRCA1;PCGF3;RLIM;RBM15
prerank,mitochondrion distribution (GO:0048311),-0.30127782421389376,-0.7779320923779177,0.7658643326039387,0.9489816169695748,1.0,2/12,5.85%,LRRK2;DNM1L
prerank,camera-type eye morphogenesis (GO:0048593),-0.31676734840417553,-0.7778765399813757,0.7582644628099173,0.9483806977161798,1.0,2/10,8.02%,TENM3;LRP6
prerank,GPI anchor biosynthetic process (GO:0006506),0.2521352267947509,0.777265335090332,0.8113207547169812,0.9549056638094341,1.0,5/30,10.61%,PIGV;PGAP2;PIGK;DPM3;PIGO
prerank,innate immune response in mucosa (GO:0002227),-0.3198669895690464,-0.7769030344378894,0.7443298969072165,0.9491461286975751,1.0,3/10,21.00%,CAMP;RNASE3;LTF
prerank,positive regulation of mRNA processing (GO:0050685),0.2711711505708038,0.7767923557930184,0.8,0.9551525807180985,1.0,5/21,17.83%,NCBP1;TRA2B;DAZAP1;TRA2A;RBMX
prerank,positive regulation of DNA replication (GO:0045740),0.28965652509764256,0.7766342980488843,0.7637051039697542,0.9548982260431376,1.0,3/16,10.68%,CTC1;PCNA;DHX9
prerank,tRNA 5'-end processing (GO:0099116),0.2968675192314452,0.7752869564721717,0.7680311890838206,0.9564972424024134,1.0,4/15,14.31%,POP1;SSB;RPP21;HSD17B10
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.27565854755075825,0.7752519295481671,0.7771739130434783,0.9560207946370558,1.0,3/19,11.87%,TPST2;SULT2A1;PAPSS1
prerank,regulation of protein import into nucleus (GO:0042306),-0.22524843704387262,-0.774002149251417,0.8443271767810027,0.9529143386919496,1.0,8/36,18.10%,MDFIC;UBR5;BAG3;RAN;CDH1;CHP2;FLNA;BMP4
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3081137797531924,0.7729448086349644,0.7581818181818182,0.9590255293476796,1.0,3/13,17.67%,DDIT3;SIN3A;TAF1
prerank,GTP metabolic process (GO:0046039),-0.28542060124273505,-0.7727215924216966,0.7947598253275109,0.9542033316032756,1.0,4/15,15.51%,LRRK2;RAN;AK3;AK4
prerank,membrane raft organization (GO:0031579),0.2966962598848142,0.7717496182715649,0.8061420345489443,0.96039179946848,1.0,5/15,18.85%,CLN3;PPT1;NPC1;FLOT2;NAXE
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.27235323361718694,-0.7711065313439721,0.7714285714285715,0.9560058747152872,1.0,1/17,1.12%,PLBD1
prerank,regulation of autophagosome assembly (GO:2000785),0.24470501333471337,0.7710953840610281,0.8141135972461274,0.9608426487266801,1.0,7/33,13.97%,RAB3GAP2;SH3GLB1;RAB3GAP1;PINK1;IFT20;ADPRH;PHF23
prerank,regulation of epithelial cell migration (GO:0010632),0.2200880719342633,0.7710728281591497,0.8737373737373737,0.9603507574217558,1.0,5/51,6.20%,RREB1;ARSB;SRC;PLCG2;MACF1
prerank,regulation of neuron projection arborization (GO:0150011),-0.28271014924880233,-0.7707804818964156,0.7777777777777778,0.9558149430042829,1.0,5/15,14.93%,GRIP1;MAP3K13;MFSD2A;NTNG1;NTNG2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.3382445584225248,0.7707479160087137,0.774074074074074,0.9603476489783855,1.0,6/10,34.24%,PDK2;ZNF692;USP7;SELENOS;SIRT7;OGT
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.32662055559433834,0.7698128541615968,0.7596899224806202,0.9612635281631409,1.0,1/10,2.97%,PIH1D2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.21508763418872592,-0.7697853310541818,0.8728179551122195,0.9566372071215188,1.0,9/45,19.06%,DAB2;SDCBP;BMP5;TTK;GDF1;GDF11;ACVRL1;BMP4;GDF10
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2277656880476973,0.7694547946599097,0.868824531516184,0.9613120139083227,1.0,11/45,18.65%,ATG14;EIF2A;PKP3;EIF2B4;GCNT2;CYFIP1;PCIF1;TDRD7;LARP1;RPL10;NANOS1
prerank,eye development (GO:0001654),0.21870852127709908,0.7693882139943716,0.8703374777975134,0.9608946718169357,1.0,9/54,14.25%,SKI;PAX6;EFEMP1;MEIS3;FREM2;RAB3GAP1;SHROOM2;PAX2;CPAMD8
prerank,cell differentiation in hindbrain (GO:0021533),0.32408750109469125,0.7693111927035088,0.7538167938931297,0.9605054173490195,1.0,4/11,14.74%,OPHN1;PROX1;NOG;CBLN1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.3128954841912656,-0.7692007582846995,0.7759674134419552,0.956812024708958,1.0,3/11,14.12%,NFKBIZ;PRKCQ;CLEC6A
prerank,regulation of epidermal cell differentiation (GO:0045604),0.2727013013459325,0.7690283572213111,0.8129370629370629,0.9604085291528277,1.0,6/21,19.49%,ZFP36L1;DLL1;ROCK2;RUNX1;ERRFI1;SFRP4
prerank,positive regulation of bone resorption (GO:0045780),-0.3181013434062491,-0.7689969829342193,0.7659090909090909,0.9564377357142094,1.0,7/11,35.26%,SPP1;DEF8;MC4R;DCSTAMP;SYK;ADAM8;TNFRSF11A
prerank,copper ion homeostasis (GO:0055070),0.2866950949485481,0.7689068641948499,0.8091743119266055,0.9600713827418346,1.0,6/17,21.25%,ANKRD9;MT2A;XIAP;COX19;CCDC22;ARF1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.24712397885107396,0.7689021185920194,0.8116197183098591,0.9595652446397139,1.0,14/30,31.86%,POLR2H;GTF2H2;ERCC2;POLR1C;UBTF;POLR2E;POLR1G;POLR1E;MNAT1;POLR1A;TBP;POLR1B;TAF1D;ERCC3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2890920199199467,0.7687356227272288,0.7808471454880295,0.9593121918282633,1.0,4/16,15.58%,CGAS;SHLD2;FBH1;UBQLN4
prerank,establishment of vesicle localization (GO:0051650),-0.2710259480754066,-0.7683520183429711,0.7978723404255319,0.9567150142491946,1.0,3/18,8.46%,KIF5C;TOR1A;KIF5B
prerank,blood vessel diameter maintenance (GO:0097746),-0.23553796500236207,-0.7678046172432974,0.850356294536817,0.9568132388792278,1.0,12/34,23.63%,KCNMB2;KLF2;EDNRB;HTR2B;PER2;ITGB1BP1;KCNMB4;SERPINF2;SCPEP1;ACE;ACE2;EDNRA
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.2490378416065497,0.7674264175038495,0.8342440801457195,0.9607732904790576,1.0,11/29,24.10%,AGTR2;GPER1;TNFRSF12A;THBS1;PMAIP1;PYCARD;HTRA2;PPP2R1B;CYLD;FADD;AGT
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.33122370157293324,0.7669036128967767,0.7509803921568627,0.9610687006612125,1.0,5/10,26.28%,CST3;CHADL;TGFB1;NOTCH1;FAP
prerank,regulation of myoblast fusion (GO:1901739),-0.30703199058552877,-0.7668340393013042,0.7880085653104925,0.9575848864312209,1.0,2/11,5.08%,EHD1;RIPOR2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.25825411101028223,0.7667543310763013,0.8104693140794224,0.9607644979610718,1.0,5/24,14.87%,PTK2B;CENPJ;IL10RA;IL10RB;GHR
prerank,glutamine family amino acid metabolic process (GO:0009064),0.24264133207913435,0.76615827508697,0.8351851851851851,0.9611982783044181,1.0,8/33,20.09%,ART4;DGLUCY;ALDH4A1;NIT2;GCLC;RIMKLA;PYCR1;OAT
prerank,negative regulation of macroautophagy (GO:0016242),-0.24380216635634505,-0.7656780289717251,0.8229665071770335,0.9585985018008716,1.0,10/26,29.12%,LRRK2;RUBCN;SMCR8;SCFD1;TSC1;SMG1;MTM1;SEC22B;FEZ2;NRBP2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.18620206360237068,0.7654030033545712,0.93993993993994,0.9617879998566746,1.0,20/138,13.71%,MAML3;POLR2H;PPARD;HDAC10;GTF2H2;CDK9;NRBP1;POLR2D;RXRB;POLR2J;NR2F1;NOTCH4;TAF6;TAF12;MAML2;ERCC2;E2F2;TAF8;NOTCH3;TAF4
prerank,fat cell differentiation (GO:0045444),-0.2068457256974513,-0.764067479276017,0.8946135831381733,0.9603351064576354,1.0,15/57,18.61%,PID1;PPARG;SIRT1;NR4A2;OSBPL8;PER2;CEBPA;PRDM16;KLF4;TFAP2B;FOXO1;FFAR4;STEAP4;METRNL;BBS4
prerank,regulation of aerobic respiration (GO:1903715),0.292066932988135,0.7639001115362234,0.7907407407407407,0.9634605621586663,1.0,4/15,18.10%,COX7A2L;PINK1;UQCC2;ABCD1
prerank,SNARE complex assembly (GO:0035493),-0.3103200991183056,-0.7636726745995475,0.8008213552361396,0.9602090164770531,1.0,3/10,12.83%,STXBP6;UVRAG;SNCA
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.22669632997919734,0.7634703829942762,0.8491171749598716,0.9635985859211829,1.0,22/46,33.63%,SMAD3;PRKCD;PIK3R1;RAPGEF3;DHX9;KHDRBS1;MAVS;ECT2;TCF7L2;CAMK1;TP53;TGFB1;ZC3H12A;ANP32B;NRDE2;HYAL2;NEDD4;DMAP1;TPR;ZIC1;JUP;PIK3R2
prerank,response to interleukin-4 (GO:0070670),-0.3155993084481987,-0.7633237290744345,0.7819706498951782,0.9600703412831897,1.0,6/10,34.44%,TCF7;LEF1;DCSTAMP;CITED1;RUFY4;XBP1
prerank,canonical Wnt signaling pathway (GO:0060070),0.20775112066165002,0.7630619988789692,0.8793388429752066,0.9637073851322152,1.0,23/68,27.44%,LRP5;CSNK1E;PORCN;BCL9;FZD2;WNT2B;RYK;WNT10B;WNT7B;CDH3;FZD1;GATA3;TCF7L2;TCF7L1;SFRP4;FZD6;FZD9;FZD3;FZD10;WNT5A;PPP1CA;DVL3;DVL1
prerank,ceramide transport (GO:0035627),-0.296294487207354,-0.7630151615063988,0.777542372881356,0.9598269751683878,1.0,2/12,5.31%,PLTP;PLEKHA3
prerank,glucose metabolic process (GO:0006006),0.2153686388815366,0.7629701825849358,0.867595818815331,0.9633220215472329,1.0,10/58,18.22%,LRP5;PPARD;GALM;GAPDH;GDPGP1;SORD;SLC25A11;PGAM1;PCK2;SLC25A10
prerank,negative regulation of endothelial cell migration (GO:0010596),0.23661853219408924,0.7629252288907745,0.8704028021015762,0.9628671435406948,1.0,3/36,3.83%,PTPRM;MEF2C;AGTR2
prerank,negative regulation of calcium ion transport (GO:0051926),-0.28676970191934253,-0.7626701021917589,0.8077753779697624,0.9596377811353989,1.0,3/15,11.35%,LILRB1;CBARP;ADRA2A
prerank,protein acetylation (GO:0006473),-0.23612657658259892,-0.7626028664862134,0.8619909502262444,0.9590475920986008,1.0,7/30,16.82%,SIRT1;GTF2B;CLOCK;FOXO1;KAT6A;ESCO2;ING4
prerank,histone H4 deacetylation (GO:0070933),0.3184630675565945,0.7625300981288787,0.7532710280373832,0.9629600306828948,1.0,2/10,12.65%,SIRT2;HDAC8
prerank,mismatch repair (GO:0006298),0.25329608392917613,0.7623718742171254,0.8163636363636364,0.9626815330822095,1.0,6/27,15.55%,PCNA;POLD2;EXO1;ABL1;SETD2;LIG1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.24954739385384145,-0.7620901476141658,0.8126463700234192,0.9591152297660853,1.0,9/23,23.24%,MTMR2;INPP5F;INPP5J;OCRL;MTMR3;MTMR1;TPTE;MTM1;SACM1L
prerank,response to organic cyclic compound (GO:0014070),-0.20211833501441234,-0.7619714582493635,0.9048843187660668,0.9586025794752692,1.0,16/52,23.89%,LRRK2;SPP1;STRN3;HLCS;CCL2;GGT7;SLC1A1;CTNNB1;CCL5;SFRP1;GLDC;TIPARP;BGLAP;ALPL;WNT8B;SOCS2
prerank,regulation of cell cycle phase transition (GO:1901987),-0.1865433620711415,-0.7619333402372637,0.9497206703910615,0.9579621354996858,1.0,26/91,25.08%,PSMD14;PSMA2;PSMF1;PSMD8;ANAPC10;PSMD6;PSME2;BTRC;PSMD11;BUB1B;MN1;UBE2C;PSMD1;PSMD5;CDKN1A;PSMD12;DBF4;GTSE1;CCNB1;PSMB1;DDB1;MAD2L1;TCIM;FZR1;PSMC4;PLK1
prerank,cellular component disassembly (GO:0022411),-0.20279707905110944,-0.7619105949272936,0.900497512437811,0.9573049631270073,1.0,10/53,14.55%,CD44;MMP16;GSN;TLL1;MMP15;MMP12;CTSL;MMP14;MMP8;MMP19
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.3119391094252307,0.7616496745265063,0.7701149425287356,0.9632174700996804,1.0,3/12,11.60%,PTK2B;DLL1;DOCK10
prerank,replicative senescence (GO:0090399),-0.30541969900098587,-0.7615456646439839,0.7804878048780488,0.9571416466343855,1.0,6/12,22.09%,MME;ROMO1;CDKN2A;CHEK1;TERT;PLA2R1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.18377428411805816,-0.7613292745685583,0.970108695652174,0.9567629321650392,1.0,17/101,13.71%,SAMD4A;EIF3C;CYFIP2;CPEB3;VIM;FAF1;EIF4A3;EIF3E;NFKBIA;RPL26;BTRC;PRR16;ATG7;MSN;BAK1;KLF4;PLXNB2
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.20576818860685764,-0.7612189347351203,0.912621359223301,0.9562305427540518,1.0,14/52,21.20%,ALDH1L1;SDHA;MTHFD1L;L2HGDH;ACLY;IDH2;SLC46A1;SHMT1;MTHFD2;FPGS;ME1;ALDH18A1;GOT1;SHMT2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2224113812238297,0.7611639079808236,0.872822299651568,0.9634012688483363,1.0,12/48,22.01%,BAG6;CHEK2;ATM;USP28;BRCA1;RPS27L;ABL1;TOPORS;BCL2L11;PYCARD;HTRA2;TP53
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.2745131778879144,-0.7608992784859798,0.8058690744920993,0.9560064156892125,1.0,3/17,11.35%,ADRA1A;RAPGEF2;ADRA2A
prerank,tetrapyrrole metabolic process (GO:0033013),-0.2633172783532544,-0.760852526998042,0.834841628959276,0.9553923463493654,1.0,7/18,27.72%,TCN2;ABCD4;ABCC1;CUBN;LMBRD1;MMADHC;ABCB6
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.29916362234252797,0.7608295255853301,0.777988614800759,0.9633638510006883,1.0,6/13,32.48%,BMF;BCL2L11;PMAIP1;VDAC2;BNIP3L;RHOT1
prerank,stress granule assembly (GO:0034063),0.27179071837711816,0.7607175082223939,0.8134991119005328,0.9630326499938966,1.0,7/20,25.36%,ATXN2L;EIF2S1;G3BP1;MAPT;DDX3X;YTHDF3;DDX6
prerank,regulation of p38MAPK cascade (GO:1900744),0.2361759173916853,0.7606936741752502,0.8703703703703703,0.9625544318732173,1.0,3/35,2.06%,PJA2;LGALS9;AGER
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.254966745822673,0.7605670820406455,0.8239700374531835,0.9622363317986219,1.0,4/26,6.14%,LRP5;C2CD2L;PLA2G6;TRPM4
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.29922446702357464,0.7602638098059061,0.7773512476007678,0.962150362743024,1.0,3/13,12.08%,CALCOCO1;GPER1;PLPP1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.20372490876307725,-0.7602200299040005,0.8944723618090452,0.9556399240776522,1.0,11/55,16.52%,PSMD14;PSMA2;PSMF1;PSMD8;PSMD6;PSME2;PSMD11;PSMD1;PSMD5;PSMD12;GPR132
prerank,striated muscle contraction (GO:0006941),0.21755752407044987,0.7600212791496356,0.8823529411764706,0.9620029559336304,1.0,16/53,24.76%,CCDC78;SLC8A1;SCN4B;SMPX;MYL3;RCSD1;GRK2;MYH14;NOS1;PIK3CA;TNNI2;SCN1B;GAA;KLHL41;TPM1;MYL4
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.3055773869494224,-0.7600106917327571,0.8049792531120332,0.9552699388993975,1.0,5/12,22.32%,ACTB;ACTG1;AHI1;LAMA5;TRAF3IP1
prerank,tight junction assembly (GO:0120192),-0.2092150837579598,-0.7598891943280973,0.9004854368932039,0.9547720717022695,1.0,21/49,33.78%,AFDN;PATJ;MARVELD2;FRMPD2;CDH5;ACTG1;PECAM1;PARD3;MICALL2;GRHL2;MARVELD3;OCLN;PRKCI;PARD6G;POF1B;CLDN16;PARD6B;CLDN19;CLDN5;DLG1;CLDN18
prerank,nucleic acid-templated transcription (GO:0097659),0.2316273719591736,0.7595284325054824,0.8449744463373083,0.9622252185231689,1.0,11/42,20.06%,POLR2H;POLR2D;POLR2J;MMS19;DTX1;MEF2A;TOPORS;EPC1;THAP1;POLR2E;POLR2I
prerank,regulation of establishment of cell polarity (GO:2000114),-0.27874042381169417,-0.7590018058252278,0.8106904231625836,0.955335794517519,1.0,7/16,24.16%,GSN;RIPOR2;CDH5;KANK1;RUFY3;BCAS3;RACK1
prerank,regulation of glycolytic process (GO:0006110),0.20585086749139792,0.7585683979671459,0.9041322314049587,0.9631297604728511,1.0,18/68,23.15%,MLXIPL;RANBP2;NUP42;SEC13;NUP35;NUP50;ARNT;SEH1L;PFKFB2;NUP62;NUP107;PGAM1;NUP88;NUP188;SLC4A4;HIF1A;NUP214;JMJD8
prerank,regulation of macrophage activation (GO:0043030),0.24197744438161709,0.7584787059863036,0.8380782918149466,0.9627272630747757,1.0,12/30,26.70%,PJA2;TLR4;KARS1;IL33;TNIP2;THBS1;SHPK;MYO18A;MIF;ZC3H12A;WNT5A;TLR6
prerank,protein targeting to peroxisome (GO:0006625),0.24473811674151288,0.7580103846372017,0.8370883882149047,0.9629034072388034,1.0,7/29,21.01%,ABCD2;PEX10;PEX6;PXMP2;ABCD1;PEX1;HACL1
prerank,retinal metabolic process (GO:0042574),-0.2986030035216385,-0.7575367975201651,0.7825112107623319,0.956771769551035,1.0,4/12,15.49%,RDH13;DHRS13;RDH10;ABCA4
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.3140403091193119,0.7575225039359365,0.7711069418386491,0.9631097811762065,1.0,5/11,26.89%,DDX5;TP53;TGFB1;MAP2K1;MAP2K2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.23216052598900172,-0.7574175936465689,0.8215102974828375,0.956266894661528,1.0,7/29,16.29%,DCUN1D2;UBE2N;RPS2;ARRDC3;AXIN1;DCUN1D3;MAGEC2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.3074039850396259,-0.7572496540218949,0.7922912205567452,0.9558145110646575,1.0,3/11,10.01%,CEBPB;HSPA5;CREB3L1
prerank,cellular response to retinoic acid (GO:0071300),0.22339900000342994,0.7569967341920895,0.8626086956521739,0.9633660703499708,1.0,6/42,9.48%,TWF2;LYN;ATM;WNT10B;PTK2B;WNT7B
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.3086921857883161,0.7568938317791497,0.8044280442804428,0.9630016131873612,1.0,4/12,13.36%,FUT7;MIA3;WNK1;AKT1
prerank,peroxisomal membrane transport (GO:0015919),0.2482887642673054,0.7565339391600401,0.8368055555555556,0.9629827779426005,1.0,6/27,19.25%,ABCD2;PEX10;PEX6;PXMP2;ABCD1;PEX1
prerank,mucosal immune response (GO:0002385),-0.2771135179629213,-0.7562727483767481,0.8081896551724138,0.9564828807813416,1.0,2/15,9.39%,CAMP;RNASE3
prerank,nucleotide biosynthetic process (GO:0009165),0.27550726363860056,0.7562479449752437,0.8136200716845878,0.9628942062538509,1.0,6/18,18.09%,MTHFD1;PRPS1L1;PRPS1;PNP;GART;PRPSAP2
prerank,positive regulation of translation (GO:0045727),0.19672693411579462,0.7558870822613216,0.9382113821138212,0.9629196210398665,1.0,21/94,17.55%,PLD1;POLR2D;METTL5;NSUN5;MPV17L2;DHX9;KHDRBS1;RMND1;RPS27L;UHMK1;MTOR;CNBP;METTL14;PASK;EIF3D;UQCC2;FASTKD3;PCIF1;THBS1;C1QBP;LARP1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.2416842500493615,-0.7556808565921298,0.847926267281106,0.9566088113310266,1.0,5/24,12.55%,LRRK2;PRKN;ALOX5;CREB3L1;AQP11
prerank,response to interferon-beta (GO:0035456),-0.24629977279484527,-0.7555102197907425,0.8407079646017699,0.9561836761936848,1.0,6/22,16.91%,IFITM3;IKBKE;IRGM;UBE2K;IFITM2;IFITM1
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.24002074142840985,-0.7547665688353679,0.8473451327433629,0.9565357007407487,1.0,2/25,2.71%,PPARG;CBLB
prerank,atrial septum morphogenesis (GO:0060413),-0.31607530592424443,-0.7547531946674806,0.7913223140495868,0.9558839205773436,1.0,4/10,34.68%,HEY2;NOTCH2;ZFPM1;SOX4
prerank,cellular copper ion homeostasis (GO:0006878),-0.2856746003404526,-0.7542789854339693,0.8314855875831486,0.9558740548261214,1.0,3/14,11.63%,APP;ATP7A;SLC31A2
prerank,regulation of centrosome cycle (GO:0046605),0.2656835155496515,0.7542079361248302,0.8045375218150087,0.9648333575871808,1.0,5/21,17.65%,PKHD1;AURKA;CHMP1A;CHMP2A;MARK4
prerank,establishment of epithelial cell polarity (GO:0090162),0.2699389984881441,0.7539281741977183,0.8081936685288641,0.9647248106488809,1.0,2/19,6.59%,OPHN1;CYTH3
prerank,negative regulation of inflammatory response (GO:0050728),0.17776354492770363,0.7534326721059884,0.974739970282318,0.9649123503320385,1.0,29/182,15.48%,SIRPA;PRKACA;PPARD;SRC;PRKCD;OTULIN;LYN;ADCY9;PLCG2;GPS2;ADORA2B;GPER1;CALCR;FSHR;LHCGR;NPS;ADCY4;ADCY6;MYH9;DPEP1;MAPK14;HRH2;TNFAIP8L2;INSL3;VIP;ADORA2A;NLRP3;MAPK7;GPR84
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.27647545734406914,-0.7530584946033726,0.7733333333333333,0.9568626181716118,1.0,2/15,5.08%,EHD1;RIPOR2
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.23917572344694454,0.752701033778472,0.8301886792452831,0.9654491485677847,1.0,3/30,6.97%,ABCD2;HACD3;SLC27A4
prerank,regulation of catecholamine secretion (GO:0050433),0.24935209338406678,0.7522092859396308,0.8204225352112676,0.9656403557754621,1.0,11/29,22.34%,STX1A;GRK2;KCNA2;DRD2;SYT12;SYT11;SYT9;KCNB1;FGF20;SYT17;CHGA
prerank,mitochondrial genome maintenance (GO:0000002),0.3120889048843821,0.7521324540822029,0.7773654916512059,0.96525361523386,1.0,3/11,19.14%,MEF2A;TOP3A;OPA1
prerank,protein prenylation (GO:0018342),-0.31024737530399316,-0.7518577279570081,0.8012958963282938,0.9577878689115418,1.0,1/10,0.73%,CHM
prerank,response to lipid (GO:0033993),0.19276719022626188,0.750497008998273,0.9264705882352942,0.9670508522509498,1.0,11/105,7.61%,PAQR7;LGALS9;OTUD5;TLR4;PPARD;SLPI;TAB2;RXRB;ACER2;SELE;NOS2
prerank,photoreceptor cell development (GO:0042461),-0.28236273882591134,-0.750296780745971,0.7972350230414746,0.9591401033051904,1.0,3/14,15.61%,RORB;MFSD2A;AHI1
prerank,renal water homeostasis (GO:0003091),0.257483628764655,0.7502581636796072,0.8362989323843416,0.9668757653907578,1.0,5/23,10.12%,PRKACA;ADCY9;ADCY4;MYO5B;ADCY6
prerank,cellular response to nutrient levels (GO:0031669),0.2076879337554831,0.7501435129929325,0.8887015177065767,0.9665244747704274,1.0,11/62,15.40%,ATG14;EIF4G1;FLCN;EHMT2;PDK2;RPTOR;FADS1;MTOR;RRAGA;ULK1;CARTPT
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.29815294329116526,-0.7494136758226391,0.8155737704918032,0.9596441987565284,1.0,5/12,23.37%,PTPN22;PAX5;BLK;CD19;ELF2
prerank,histone mRNA catabolic process (GO:0071044),0.27985247059818236,0.7491026718918035,0.8213627992633518,0.9674309133207948,1.0,2/15,4.20%,SSB;ATM
prerank,camera-type eye development (GO:0043010),0.2495807520398177,0.7490831606370146,0.850828729281768,0.9669516489635942,1.0,5/25,13.04%,SKI;EFEMP1;RAB3GAP1;SHROOM2;PAX2
prerank,protein-DNA complex assembly (GO:0065004),0.1864857892990226,0.7489824248428023,0.9654654654654654,0.966583947956534,1.0,34/116,25.79%,GTF2H2;CUL4B;PSMD3;SART3;UBC;RPS27A;ERCC2;PSMA7;DDB2;SMARCA5;MCM2;SPTY2D1;PSMB3;PSMB9;PSMC2;HMGB2;MCM3;PSME4;PSMC1;PSMB7;ORC3;PSMB5;TCF4;CHAF1B;RPA3;PSMB8;CUL4A;MCM6;GMNN;KAT6B;ORC2;ANP32B;RAD23B;MNAT1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.23864181781887517,0.7484626662765287,0.8402777777777778,0.9667822152772935,1.0,11/31,26.01%,TOMM20L;PEX10;PEX6;TIMM50;TIMM44;GRPEL1;PEX1;TOMM20;DNLZ;TOMM70;PAM16
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.2960437826533805,0.7481605432384532,0.7810858143607706,0.966668574865947,1.0,5/12,27.04%,BRCA1;CEACAM1;WDTC1;ERLIN2;ACADVL
prerank,ncRNA metabolic process (GO:0034660),-0.21946409652292082,-0.7479740090779825,0.8758169934640523,0.960952963738102,1.0,13/37,30.15%,RAN;TUT4;DROSHA;DTD2;TARBP2;TDRD12;TDRD9;AGO2;MEPCE;NIFK;PIWIL2;MOV10L1;PIWIL4
prerank,2-oxoglutarate metabolic process (GO:0006103),0.2938209794012813,0.747836251159362,0.8233151183970856,0.9666115525272757,1.0,2/13,10.56%,PHYH;ADHFE1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.2324001321079892,0.7477722224763496,0.875222816399287,0.9661846359390613,1.0,6/37,12.65%,KIF3B;TNPO1;IFT52;KIF3A;TTC21B;IFT20
prerank,extracellular matrix disassembly (GO:0022617),-0.19612096591842415,-0.7459939735973797,0.9142857142857143,0.9628863978547028,1.0,10/53,14.55%,CD44;MMP16;GSN;TLL1;MMP15;MMP12;CTSL;MMP14;MMP8;MMP19
prerank,regulation of neuron apoptotic process (GO:0043523),-0.17884199167818357,-0.7458751776111132,0.9644808743169399,0.9623662449326275,1.0,16/96,15.70%,GRID2;BDNF;APOE;NTRK2;PRKN;KIF14;LIG4;ERBB3;CCL2;SOD2;SRPK2;EGLN3;TFAP2B;TRIM2;CTNNB1;BCL2
prerank,histone H4 acetylation (GO:0043967),0.2210582218615093,0.7457717249973004,0.8832236842105263,0.9683644228878896,1.0,9/47,17.13%,BRD8;KANSL2;MSL2;PHF20;JADE2;MORF4L1;NAA40;ACTL6A;EPC1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.2767650380353502,0.745343241807587,0.8128342245989305,0.968445783785882,1.0,4/16,12.46%,FLCN;DNAJC30;ANTKMT;PINK1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3003581913628649,-0.7453290499954939,0.8053691275167785,0.9623789154550142,1.0,5/10,34.04%,RPUSD1;RPUSD3;RPUSD4;RPUSD2;NOP10
prerank,positive regulation of phosphatase activity (GO:0010922),-0.2453652380079266,-0.7445343597615939,0.8640350877192983,0.9627612816033284,1.0,3/21,10.61%,MAGI2;CALM1;HSP90AB1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.2789802771149831,-0.7445014514267372,0.82,0.9621288418802502,1.0,4/14,14.16%,FAF1;PKD2;NFKBIA;G3BP2
prerank,nucleosome organization (GO:0034728),-0.19585459190176804,-0.7434961726492867,0.9328537170263789,0.9627189536005063,1.0,9/55,10.73%,NAP1L2;ASF1A;NASP;NFE2;MCM3AP;CTCF;ACTR6;PADI4;SMARCE1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.319514834712335,0.7426290647217911,0.783203125,0.9715331615843532,1.0,6/10,28.47%,WNK1;STK39;ADAM10;ADAM17;WNT5A;OXSR1
prerank,myoblast differentiation (GO:0045445),0.2858828460606262,0.742542471067105,0.8100558659217877,0.9711424845334606,1.0,4/14,23.09%,DDX5;DDX17;TCF7L2;MBNL1
prerank,snRNA 3'-end processing (GO:0034472),0.26613181875688985,0.7423032213876263,0.8298676748582231,0.9709532902853109,1.0,6/19,27.53%,INTS6L;EXOSC5;INTS8;EXOSC8;INTS5;USB1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.2996366775938956,0.7422182618676957,0.802734375,0.9705485929124875,1.0,3/12,11.57%,TLR4;PLCG2;RAB27A
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.30484544843951744,0.7419368036827796,0.8056603773584906,0.9703888262067291,1.0,6/11,32.97%,MTOR;SMARCA4;DDX11;IPPK;SIRT7;NCL
prerank,organic acid transport (GO:0015849),0.19098635584244994,0.7415738348071987,0.9465648854961832,0.97034589830159,1.0,8/94,9.60%,SLCO2B1;SLC7A8;PPARD;SLC36A1;SLC25A45;SLC27A4;SLC22A6;CEACAM1
prerank,regulation of BMP signaling pathway (GO:0030510),0.19871799625421777,0.741192595921681,0.9215686274509803,0.9703266525832782,1.0,6/73,3.80%,GREM1;SMAD7;SKI;NUMA1;FBXL15;SMURF1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.27412882205052247,0.7406129823221039,0.8233151183970856,0.9705667784032311,1.0,9/15,37.02%,CCT3;NHP2;SHQ1;CCT5;CCT8;CCT7;CCT4;DKC1;RUVBL2
prerank,organelle fusion (GO:0048284),-0.2470182926530024,-0.7405781403919306,0.8533916849015317,0.9658376138402717,1.0,5/22,15.66%,EEA1;MIGA1;MFF;FIS1;CYP26C1
prerank,chromatin assembly (GO:0031497),-0.21793111071044213,-0.7405281327779115,0.8916876574307305,0.9652223021364804,1.0,8/38,16.89%,SIRT1;NAP1L2;ASF1A;CTCF;PADI4;BAHD1;NPM1;H3-3A
prerank,response to glucagon (GO:0033762),0.26875547212454426,0.7400924628768514,0.824468085106383,0.9707373898991898,1.0,4/19,10.12%,PRKACA;ADCY9;ADCY4;ADCY6
prerank,regulation of intracellular pH (GO:0051453),0.23581491244076408,0.7400573623952822,0.875,0.9702721823291656,1.0,10/34,23.59%,SLC9A9;SLC9A8;CLN3;GPR89A;GPR89B;SLC4A4;SLC4A5;SLC4A3;SLC26A6;SLC9A3
prerank,transition metal ion transport (GO:0000041),0.22815018001887952,0.7396551695932791,0.8905723905723906,0.9702991431676302,1.0,4/35,7.42%,SLC30A5;ATP2C1;SLC30A10;SLC30A8
prerank,histone deubiquitination (GO:0016578),0.2659683785340377,0.7390907332213332,0.8302919708029197,0.970536688417397,1.0,8/18,30.95%,EPOP;USP36;ATXN7;TAF10;ATXN7L3;USP7;ENY2;USP51
prerank,regulation of protein dephosphorylation (GO:0035304),-0.21420714691186216,-0.7383644493621947,0.9020501138952164,0.967212345959802,1.0,9/37,21.71%,HTT;PPIA;CALM1;CNEP1R1;CDH5;TIPRL;PPP1R7;TSC1;PPP1R16B
prerank,aortic valve morphogenesis (GO:0003180),-0.22506387186857693,-0.7376269410672098,0.8628318584070797,0.9674870167301097,1.0,9/30,22.28%,ROBO1;SLIT2;JAG1;HEY2;SNAI2;ELN;BMP4;TIE1;DLL4
prerank,regulation of multicellular organismal development (GO:2000026),-0.2365488739332109,-0.7370534659039567,0.8738532110091743,0.9675236095541044,1.0,4/25,9.60%,OAS2;TRIP12;RACGAP1;CCSAP
prerank,negative regulation of binding (GO:0051100),0.19884012482425825,0.737002993110966,0.9265175718849841,0.9726920778912721,1.0,20/81,20.83%,SUMO1;CSNK1E;PRKCD;SLPI;ARHGAP28;CTNNBIP1;MDFI;PDGFB;AKT1;AURKA;SMO;TMBIM6;GNL3L;MAPK8;CAMK1;JUN;PARK7;PLN;LRPAP1;TFAP4
prerank,protein export from nucleus (GO:0006611),0.24377499755743312,0.73682614585247,0.8734177215189873,0.9724110469472241,1.0,18/27,37.10%,SMURF1;NUP42;STRADA;CSE1L;XPO5;NUP214;TGFB1;XPO1;XPO6;RANBP17;CALR;TPR;CHP1;STRADB;DESI1;RANBP3;NUTF2;XPO7
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.19864095355414155,-0.7366569287813769,0.9379474940334129,0.9673246869411253,1.0,14/54,21.32%,RPL35A;SNU13;NSA2;LAS1L;RPL7A;RPL26;MRTO4;RPL23A;PPAN;NPM1;RPL24;NOP16;RPLP0;RRS1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.19964201714150487,0.7366487578335787,0.9277504105090312,0.9721250767213664,1.0,22/73,26.64%,DNMT3A;POLR2H;MTA1;SF3B1;EED;SMARCA5;POLR1C;EZH2;EPC1;BAZ1B;HDAC5;POLR2E;DEK;POLR1G;TASOR;POLR1E;SUZ12;WBP2;TFAP2C;KAT2B;GLMN;EP300
prerank,negative regulation of protein metabolic process (GO:0051248),-0.2000550871787605,-0.7362922565440086,0.9189814814814815,0.9670703118657169,1.0,10/48,16.59%,EGFR;APOE;IAPP;LDLR;EDNRB;HSP90AB1;AZIN1;HMGCR;RILP;FLNA
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2398741131573444,0.7360170806878089,0.8609022556390977,0.9724406514141167,1.0,3/28,6.53%,CRADD;TRADD;SORT1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.28379216464720847,-0.7358868334262989,0.8085539714867617,0.9668994821672618,1.0,6/13,26.07%,CBLB;KPNA4;NUP54;RGPD1;KPNA2;KPNA6
prerank,cellular response to oxygen levels (GO:0071453),0.31759119105239686,0.7353785366772663,0.805607476635514,0.972744925292429,1.0,3/10,17.02%,ATP6V0A2;TMEM199;PICK1
prerank,Golgi ribbon formation (GO:0090161),0.2891869999175646,0.7352807312043157,0.811214953271028,0.9723589482893504,1.0,5/13,26.28%,OPTN;STX16;MYO18A;STX6;VTI1A
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.25825071222057827,0.7342117999361438,0.8468634686346863,0.973178175494249,1.0,4/21,10.51%,CNOT1;PAN3;TNKS1BP1;CNOT3
prerank,negative regulation of cholesterol transport (GO:0032375),0.31186598838915974,0.7340345223346051,0.8007448789571695,0.9728888960975978,1.0,1/10,6.23%,SHH
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.2583468984474078,0.734021206085927,0.8480769230769231,0.9723986277317117,1.0,6/21,23.60%,MED4;MED12;JUN;TWIST1;MITF;PAXIP1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.2739166966006391,0.7336340007233935,0.8154121863799283,0.9723774274863872,1.0,5/16,19.48%,ATP5PO;ATP5MC1;ATP5PD;STOML2;ATP5F1D
prerank,ERAD pathway (GO:0036503),0.19391329332215554,0.73343811985833,0.9295081967213115,0.9721254757340506,1.0,27/83,27.41%,BAG6;DNAJB9;SEL1L;UFD1;OS9;RNF103;AUP1;USP19;ERLEC1;ANKZF1;RNF121;SYVN1;MAN1B1;EDEM1;UBE4A;STUB1;NPLOC4;SGTA;UBE2G2;RHBDD2;ERLIN2;FAF2;FBXO2;DNAJB14;ECPAS;FBXO17;RNF5
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.2381275573943981,-0.7333475381757966,0.8523809523809524,0.9693678808630154,1.0,5/22,15.02%,PTPN22;PTPN2;THY1;UBASH3A;FCGR2B
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.19484322400504786,0.7329658908446495,0.9552238805970149,0.9722007613483862,1.0,11/79,12.31%,GREM1;SMAD7;SKI;SHISA2;SMURF1;AGTR2;SPRY2;PTPN1;SMAD9;SKIL;PDCD6
prerank,isotype switching (GO:0045190),-0.2994922598281055,-0.732880853439629,0.8095238095238095,0.9692561130138235,1.0,4/10,28.98%,LIG4;MSH6;MSH2;HSPD1
prerank,detection of visible light (GO:0009584),0.26940841733698484,0.7325240793327029,0.8247619047619048,0.9722119606003884,1.0,3/16,29.16%,REEP6;CACNA2D4;PDE6B
prerank,pigment granule transport (GO:0051904),0.2676265347063244,0.7322992313017557,0.8311688311688312,0.9714909266751295,1.0,3/18,11.57%,MLPH;BBS2;RAB27A
prerank,melanosome transport (GO:0032402),0.2676265347063244,0.7322992313017557,0.8311688311688312,0.9714909266751295,1.0,3/18,11.57%,MLPH;BBS2;RAB27A
prerank,negative regulation of blood coagulation (GO:0030195),0.22473493575453443,0.7321130112121754,0.8772241992882562,0.9712156604832437,1.0,7/38,14.97%,F12;CD34;PDGFB;F8;APOH;SERPINE2;PLG
prerank,negative regulation of phagocytosis (GO:0050765),-0.2535309999814138,-0.732109924031456,0.8298850574712644,0.9695541051229561,1.0,5/17,16.92%,CD47;CD300LF;DYSF;FCGR2B;HMGB1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.21410604264672542,0.7314638268479622,0.8991869918699187,0.9715093365254439,1.0,4/45,3.67%,DDX5;PIK3R1;BUD23;DXO
prerank,regulation of DNA binding (GO:0051101),0.22010710554352714,0.7311243755813821,0.8883415435139573,0.9714497523762317,1.0,12/44,22.29%,SUMO1;SKI;SIRT2;MDFI;CEBPG;HMGB2;NME1;SMO;MAPK8;JUN;TFAP4;KDM1A
prerank,regulation of exosomal secretion (GO:1903541),-0.2504181032809488,-0.730873833634217,0.8618266978922716,0.9704159576687637,1.0,2/19,6.69%,SDCBP;PRKN
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.21637927974085228,-0.7307056627054309,0.8765133171912833,0.9699522116206911,1.0,7/35,14.99%,CCT2;MAPKAPK5;XRCC5;AURKB;TNKS2;PRKCQ;CTNNB1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.28755233894440124,-0.730626189353779,0.8230088495575221,0.9693939367783785,1.0,3/12,13.34%,PPARG;NFKBIA;ABCA5
prerank,regulation of cytoplasmic transport (GO:1903649),-0.2909057091690415,-0.7303627582404066,0.8125,0.9690382753092971,1.0,1/11,1.08%,LRRK2
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3115421567041833,-0.7302271343129569,0.8008658008658008,0.9678610745909184,1.0,3/10,21.48%,MYADM;KLF4;MAP2K5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3115421567041833,-0.7302271343129569,0.8008658008658008,0.9678610745909184,1.0,3/10,21.48%,MYADM;KLF4;MAP2K5
prerank,cellular polysaccharide catabolic process (GO:0044247),0.2768964688855029,0.7298074170070099,0.8262476894639557,0.9725383082113249,1.0,8/16,22.45%,PYGB;PHKB;AGL;PHKG2;MGAM;GAA;PHKA2;PYGL
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2735845256532823,-0.7295281647652537,0.8546637744034707,0.9680165693750081,1.0,5/14,27.90%,AK3;AK4;NME2;DCTPP1;SMPDL3A
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.2614390748508062,-0.7294753369533792,0.8314606741573034,0.9674076512625662,1.0,7/16,26.28%,AUTS2;DNMT3B;CTNNB1;PIH1D1;DNMT1;MYB;SNW1
prerank,gliogenesis (GO:0042063),-0.271328264060601,-0.7293218032724698,0.8225108225108225,0.9669338968645095,1.0,1/15,0.66%,NFIB
prerank,renal absorption (GO:0070293),-0.30340704032683885,-0.7291902806948487,0.8209302325581396,0.9664117356474731,1.0,2/10,14.22%,GSN;KCNQ1
prerank,chromatin assembly or disassembly (GO:0006333),0.2943862901282065,0.7290779331671353,0.8057040998217468,0.9729293697601747,1.0,4/11,22.01%,HDAC8;HIRIP3;CHAF1B;TP53
prerank,tyrosine metabolic process (GO:0006570),-0.29962414571800444,-0.7288157867783869,0.7927350427350427,0.9661742331515333,1.0,5/11,31.94%,THAP4;GSTZ1;DCT;TAT;TH
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2459900317476631,-0.7281805707355777,0.8660714285714286,0.9662568655233722,1.0,3/20,16.00%,GSS;GGCT;FPGS
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.23955923763323864,-0.7278356228702524,0.8604651162790697,0.9659857971674728,1.0,5/22,14.45%,UTP20;NOP9;EXOSC7;ERI1;ABT1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.2590559788107551,0.727787843293458,0.8584070796460177,0.9739626652735234,1.0,5/20,14.32%,MBTPS2;LDLRAP1;TTC39B;MBTPS1;FMO5
prerank,negative regulation of lipid storage (GO:0010888),-0.2586171753284647,-0.7277871121482291,0.8317972350230415,0.9653814626023589,1.0,4/19,9.03%,PPARG;OSBPL8;PTPN2;NFKBIA
prerank,neutral amino acid transport (GO:0015804),0.23853257728757016,0.7272483243757938,0.8558225508317929,0.9741101743087256,1.0,6/28,19.68%,SLC7A8;SLC36A1;SLC7A5;SLC6A9;CTNS;SLC38A1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.30385735683227755,-0.7270268460111727,0.8337129840546698,0.965619969535385,1.0,2/11,6.84%,NOVA1;PCBP3
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.20985345889236778,0.7270226512206561,0.9074074074074074,0.973879594362218,1.0,4/51,3.80%,GREM1;SMAD7;SKI;SMURF1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.31262882402189973,0.7261633007745545,0.8188539741219963,0.9744368203591048,1.0,5/10,27.92%,SETD2;SETD4;SETD3;SETD7;SETD6
prerank,actin filament network formation (GO:0051639),0.2995844412147667,0.726009915630897,0.8276481149012568,0.9741359714161453,1.0,2/11,9.79%,FHOD1;SPIRE1
prerank,cellular amino acid catabolic process (GO:0009063),-0.18110779379174008,-0.7259512676006195,0.973621103117506,0.9661906516120564,1.0,22/87,21.99%,HIBADH;GLS;GCSH;ASPA;HAL;KMO;HMGCLL1;BCAT1;HIBCH;SHMT1;AUH;SARDH;DAO;AASS;GLDC;ALDH6A1;AMT;GOT1;IDO2;BCKDHB;SHMT2;GSTZ1
prerank,mitotic spindle assembly (GO:0090307),0.21543945970125028,0.7254817098919444,0.8952879581151832,0.9742722335467583,1.0,3/42,2.50%,KIF2A;CHEK2;KIF3B
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.29667146306380443,0.7254284040650084,0.8277777777777777,0.9738395121289346,1.0,3/13,17.78%,TLR4;IL33;NOD2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.22918280319644038,-0.7253670793329238,0.9014084507042254,0.9661800883347941,1.0,2/26,6.52%,AKAP6;GSK3B
prerank,regulation of adaptive immune response (GO:0002819),0.2646062598988944,0.7252244287702787,0.8566037735849057,0.9735755793030909,1.0,6/18,23.09%,SASH3;IL6ST;IL4I1;PYCARD;ADCY7;FADD
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.22454186258917183,-0.7245521128385433,0.8638392857142857,0.9664588946233847,1.0,7/29,15.79%,PTPN2;HSP90AB1;TTLL12;UBE2K;SAMHD1;OAS3;RNASEL
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.23582931537602836,0.7244372090276124,0.8685612788632326,0.9739926948681291,1.0,6/28,13.64%,ARRDC1;GATA2;WWP2;DLL1;AKT1;NOTCH3
prerank,response to steroid hormone (GO:0048545),0.2312006368534893,0.7234868267654873,0.9064748201438849,0.9746379129589754,1.0,11/31,29.54%,PAQR7;THBS1;TFPI;CATSPER2;UBE3A;TGFB1;WBP2;AR;ATP1A2;URI1;NR1H3
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.27935171536432496,-0.7232357070612853,0.8318385650224215,0.966649934415074,1.0,1/12,6.52%,GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.27935171536432496,-0.7232357070612853,0.8318385650224215,0.966649934415074,1.0,1/12,6.52%,GSK3B
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2860507799758306,0.7226330862929105,0.833648393194707,0.9750746825736083,1.0,2/13,8.71%,YAE1;MMS19
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.28788302008158306,0.7224365180020338,0.8198529411764706,0.9748194187965118,1.0,4/13,15.10%,TRIM44;AXL;DHX9;MAVS
prerank,membrane depolarization during action potential (GO:0086010),0.2457119258199911,0.7223932757930519,0.8561278863232682,0.9743733223051249,1.0,3/26,4.86%,YWHAH;SLC8A1;SCN4B
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.1913986096903976,0.7219994142449102,0.9493087557603687,0.9743554919053893,1.0,12/87,10.30%,POLR2H;NCBP1;POLR2D;ZFP36L1;ZFP36L2;POLR2J;FRS2;TIAL1;HNRNPH1;ESRP1;GALNT3;PTPN11
prerank,positive regulation of rRNA processing (GO:2000234),-0.29805894643704495,-0.7217925106549099,0.8404255319148937,0.9676757881056306,1.0,5/10,26.82%,RIOK1;UTP15;TRMT112;DIMT1;RIOK2
prerank,negative regulation of translation (GO:0017148),0.18825154392224264,0.7214350131801853,0.9707792207792207,0.9745059379504224,1.0,29/87,28.07%,CNOT1;ENC1;GAPDH;NANOS2;RBM24;MRPL13;IGF2BP2;ROCK2;METTL14;EIF2AK2;EPRS1;CAPRIN1;PCIF1;TYMS;LARP1;EIF4EBP2;NANOS1;TOB1;CPEB2;RBM4;DDX3X;PUM1;YTHDF3;UNK;DDX6;RIDA;EIF2AK3;CPEB1;FXR2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.302824858757062,0.7207421401528055,0.8246628131021194,0.9747817169146115,1.0,11/11,69.74%,LPO;PKD1L3;PIGR;RTP3;GNAT2;TAS1R2;GNAT3;PKD2L1;RTP4;TAS1R3;RTP2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.24828560669791877,0.7205341713020392,0.8607594936708861,0.9745210850676637,1.0,4/24,13.05%,SEMA3B;SEMA4C;SEMA4D;SEMA4G
prerank,regulation of catabolic process (GO:0009894),0.2626452828531418,0.7204148914156681,0.8442028985507246,0.97416413118937,1.0,9/18,28.80%,CHEK2;HPGD;CENATAC;ZDHHC7;HGS;ZDHHC2;FAP;FURIN;ODC1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.24439292151741282,0.7200595838289408,0.8861209964412812,0.974066859854896,1.0,3/23,10.60%,HPGD;ALOXE3;FADS1
prerank,vitamin D metabolic process (GO:0042359),0.2885900114302193,0.7200518057083233,0.8359788359788359,0.973583216921694,1.0,5/13,31.79%,LGMN;CYP2R1;PIAS4;GC;CYP1A1
prerank,microtubule nucleation (GO:0007020),0.2535040823879518,0.7199901975185257,0.8715083798882681,0.9731713704725504,1.0,3/20,10.09%,TUBG1;TUBGCP5;CENPJ
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.28281776137225356,0.719391793879134,0.8362573099415205,0.9733541844545692,1.0,3/12,17.47%,PIK3R1;PTPN1;BCL2L11
prerank,phosphate ion homeostasis (GO:0055062),-0.30360668070375585,-0.7193863066025118,0.8376068376068376,0.9697247457290908,1.0,2/10,14.32%,XPR1;TFAP2B
prerank,regulation of vacuole organization (GO:0044088),-0.2457306082703244,-0.7192098958574785,0.849438202247191,0.9692694697199287,1.0,7/20,28.96%,RAB1B;ANXA2;MTMR3;UBQLN2;MTM1;NPRL3;RAB5A
prerank,mitochondrial membrane organization (GO:0007006),0.2250091237713289,0.718860160031112,0.8741379310344828,0.9734855667094287,1.0,14/32,32.14%,MICOS13;DNAJC11;TIMM50;MAIP1;PMAIP1;OPA1;TMEM11;MFN2;SAMM50;GHITM;MICOS10;RCC1L;CHCHD6;SLC25A5
prerank,cellular response to estradiol stimulus (GO:0071392),0.2574974096683366,0.7186185376350973,0.8612099644128114,0.973259813393841,1.0,8/18,28.21%,GPER1;POU4F1;CCDC62;NRIP1;NCOA3;SSTR2;KAT5;FAM210B
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.29527948242965396,-0.7184170369199104,0.8369565217391305,0.9694222006524095,1.0,1/10,1.08%,LRRK2
prerank,nucleosome assembly (GO:0006334),0.23267548941665003,0.7182824557920391,0.9140350877192982,0.9731484515452931,1.0,11/31,28.19%,UBN1;SART3;SMARCA5;IPO4;SPTY2D1;HMGB2;CHAF1B;KAT6B;ANP32B;SOX9;HIRA
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.27376216981951795,0.7178124831829045,0.8660714285714286,0.9731968463116163,1.0,5/15,24.78%,CSNK1E;RSPO3;ZNRF3;SFRP4;CSNK1D
prerank,cobalamin metabolic process (GO:0009235),-0.2532959609866523,-0.717694692669387,0.8761261261261262,0.9695511189040348,1.0,6/17,26.10%,TCN2;ABCD4;ABCC1;CUBN;LMBRD1;MMADHC
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.24682252900737087,0.7176545203397204,0.8644688644688645,0.9728708336550889,1.0,3/22,10.07%,LYN;APPL1;TICAM2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.29768471494878646,-0.7172161200877287,0.8431372549019608,0.9694224112054743,1.0,5/10,34.65%,DLGAP1;DLGAP2;NPTX1;NPTXR;CACNG5
prerank,carboxylic acid metabolic process (GO:0019752),0.23039017699619566,0.7171486378661519,0.903010033444816,0.972944878075589,1.0,5/33,14.42%,TBXAS1;HAO1;PLA2G4A;PON3;GNE
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.278911481152026,0.7167134098965753,0.848314606741573,0.9729396579310374,1.0,3/14,14.78%,IL18;CD86;NLRP3
prerank,negative regulation of immune response (GO:0050777),0.17389129978342655,0.7164363410758289,0.9841269841269841,0.9727720591633493,1.0,27/154,17.40%,PRKACA;SRC;ITCH;LYN;ADCY9;PLCG2;SIRT2;ADORA2B;CALCR;FSHR;LHCGR;NPS;ADCY4;ADCY6;PCBP2;HAVCR2;MYH9;DPEP1;MAPK14;HRH2;INSL3;VIP;ADORA2A;GPR84;SPINK5;GGT5;C1QBP
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.20849781795971364,0.7161655287221648,0.9284525790349417,0.9725740071551146,1.0,19/49,28.94%,DDIT3;SRC;NDUFS3;BMF;PINK1;BCL2L11;NDUFA13;PMAIP1;PYCARD;TP53;DDX3X;CYLD;S100A9;S100A8;PTPMT1;EIF2AK3;STYXL1;URI1;RTKN2
prerank,pre-replicative complex assembly (GO:0036388),0.19653614519140825,0.7159305829180529,0.9473684210526315,0.9723220824190945,1.0,14/64,17.92%,PSMD3;UBC;RPS27A;PSMA7;MCM2;PSMB3;PSMB9;PSMC2;MCM3;PSME4;PSMC1;PSMB7;ORC3;PSMB5
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.28310624798968187,0.7159289038631765,0.8517857142857143,0.9718333246812807,1.0,6/13,24.08%,PLEK;SOD1;DKK3;SCAP;BMP2;ERLIN2
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.1810531301189479,-0.7150923202592994,0.9678217821782178,0.9710557414309496,1.0,29/68,34.53%,SLC25A19;ALDH1L1;HLCS;MTHFD1L;TCN2;ACP5;ABCD4;SLC46A1;ABCC1;SHMT1;MTHFD2;FPGS;BTD;SLC5A6;SHMT2;FOLR2;CUBN;SLC19A2;LMBRD1;MMADHC;TPK1;MTHFD2L;SLC2A3;DHFR;THTPA;SLC25A32;MCCC1;PDXK;PDZD11
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.2848441702783717,0.7132682442934722,0.8512544802867383,0.9742865219263073,1.0,2/13,11.91%,TMEM35A;STX4
prerank,vascular process in circulatory system (GO:0003018),0.28461331043905136,0.7131392479553413,0.8659217877094972,0.9734439222125519,1.0,3/13,14.38%,ADCY6;ROCK2;GCLC
prerank,regulation of tube diameter (GO:0035296),0.28461331043905136,0.7131392479553413,0.8659217877094972,0.9734439222125519,1.0,3/13,14.38%,ADCY6;ROCK2;GCLC
prerank,telomere maintenance via recombination (GO:0000722),-0.2818863475573368,-0.713009954219419,0.8464912280701754,0.9725609915655903,1.0,3/11,16.62%,TPRKB;SMC5;RAD51D
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.2628338261126669,-0.7125214762580641,0.8786516853932584,0.9723982164143657,1.0,4/16,12.40%,PARP14;PTPN2;INPP5F;PPP2R1A
prerank,regulation of endopeptidase activity (GO:0052548),0.19751044516703106,0.7123327815537874,0.9282136894824707,0.9737982188842979,1.0,10/59,15.38%,VSIR;PICALM;GAPDH;PSENEN;AKT1;PSMB9;NRDC;SERPINF1;SERPINE2;APH1B
prerank,GPI anchor metabolic process (GO:0006505),0.23949370938144718,0.7121463017553645,0.8732394366197183,0.973491512468651,1.0,4/26,10.61%,PIGV;PGAP2;DPM3;PIGO
prerank,response to organonitrogen compound (GO:0010243),-0.20683334448706936,-0.7116769676228225,0.933806146572104,0.9726638043308001,1.0,8/38,19.68%,GLRA1;RCN3;PRKN;HLCS;GLRA2;UBXN6;NR1H4;BRSK2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.29268238237215927,0.7114399476598393,0.8481012658227848,0.9732697310354226,1.0,6/11,28.67%,IMPA1;INPP1;IMPA2;INPP5K;INPP5B;PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.29268238237215927,0.7114399476598393,0.8481012658227848,0.9732697310354226,1.0,6/11,28.67%,IMPA1;INPP1;IMPA2;INPP5K;INPP5B;PTEN
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2055144084220706,-0.7112887659025015,0.9160493827160494,0.9724125204802913,1.0,15/40,27.10%,MYC;UBE2N;ING2;NSMCE4A;SMYD2;ETAA1;USP1;CRY1;NSMCE1;SMG1;CASP9;MCL1;POLH;FMR1;ANKLE1
prerank,positive regulation of secretion by cell (GO:1903532),-0.1785666317366699,-0.7110433170370176,0.9729064039408867,0.9720058567881292,1.0,12/70,14.65%,CADPS;STXBP5;SOX11;PPIA;DNM1L;GOLPH3;UNC13B;RAB3A;DTNBP1;SNCA;ACHE;RGCC
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.27785170812204185,0.7109185206160432,0.8484288354898336,0.9733441051973535,1.0,4/14,23.72%,LPIN2;CHKB;LPIN1;PISD
prerank,positive regulation of chromatin organization (GO:1905269),0.2892292645534673,0.7104879858005613,0.8482142857142857,0.9733503919853346,1.0,4/12,20.75%,SIN3A;TERF1;TAL1;ACD
prerank,negative regulation of interferon-beta production (GO:0032688),0.2988566275882232,0.7090899814618149,0.8302919708029197,0.9743007583950011,1.0,1/10,0.72%,SIRPA
prerank,cochlea morphogenesis (GO:0090103),0.3041270653380139,0.7080505074068866,0.8515037593984962,0.974901828671361,1.0,4/10,26.87%,PAX2;HPN;POU3F4;SOX9
prerank,regulation of mitotic spindle organization (GO:0060236),-0.21334009303517726,-0.7079375415806715,0.9193548387096774,0.9745799101807061,1.0,7/35,16.08%,TPX2;CCSAP;MAP9;GNAI1;HSPA1B;GPSM2;PARP3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.2672238048452922,0.7076717806158332,0.875,0.9748084987104294,1.0,4/16,11.79%,PDGFB;RGS14;PTPN1;ABL1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.2788017751226416,-0.7075844797973869,0.8496868475991649,0.9742547761044132,1.0,5/12,24.43%,CBLB;F7;SNCA;APOD;PTGIR
prerank,cellular response to amino acid stimulus (GO:0071230),-0.21235942045440231,-0.7074713976074282,0.9178403755868545,0.9737110423201152,1.0,8/33,20.48%,CPEB3;GLRA1;RRAGB;GLRA2;LAMTOR3;SESN2;CPEB4;FYN
prerank,regulation of small molecule metabolic process (GO:0062012),-0.22313173479148754,-0.7073017853984109,0.9061032863849765,0.9732021833889651,1.0,11/28,26.78%,APOE;SIRT1;PRKN;FOXK1;PDK3;NR1H4;PDK4;ABCB11;EPHX2;RORC;PPARA
prerank,toxin transport (GO:1901998),-0.2927211533315125,-0.7071670660373836,0.8501070663811563,0.9726899989227913,1.0,2/10,8.10%,ANTXR2;RAB40B
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.24740932632818727,0.7066898714387276,0.9005524861878453,0.9753681869041988,1.0,7/21,29.31%,HK2;RPE;SHPK;HK3;TALDO1;PGM2;TKT
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.19420896131859378,-0.7061703276901976,0.9441860465116279,0.9730502165244073,1.0,17/47,30.45%,SPOCK1;SPOCK3;SERPING1;SERPINI1;SERPINH1;TIMP3;SERPINF2;LTF;SERPINB2;SORL1;ANXA8L1;ANXA8;SERPINE3;TIMP4;SERPINB5;HRG;SERPINA10
prerank,regulation of telomere capping (GO:1904353),-0.2309193531631633,-0.7059030997395495,0.8928571428571429,0.972667757644348,1.0,5/23,13.91%,SMG6;MAPKAPK5;AURKB;TNKS2;PRKCQ
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.29071222946961095,0.7057060969867425,0.8481481481481481,0.9758944046042612,1.0,2/11,13.36%,QDPR;AKT1
prerank,tRNA wobble base modification (GO:0002097),0.27589347084453414,0.7053645439675321,0.8861940298507462,0.975762258867043,1.0,7/14,27.70%,CTU2;KTI12;MTO1;MOCS3;ALKBH8;TRMT9B;ALKBH1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.2451178346700323,0.7052232876862121,0.8863232682060391,0.9754385577337915,1.0,8/21,23.34%,DDIT3;BCL2L11;SYVN1;TMBIM6;PMAIP1;OPA1;PARK7;TXNDC12
prerank,RNA stabilization (GO:0043489),0.22323968238572078,0.7046493184004853,0.8968386023294509,0.9755696432658864,1.0,10/33,25.46%,FUS;RBM24;TENT5C;VIP;LARP1;TRDMT1;SLC11A1;AXIN2;ELAVL1;PARN
prerank,ketone body metabolic process (GO:1902224),0.2983631370028416,0.704092883621816,0.8539741219963032,0.9756824078056836,1.0,1/10,5.39%,OXCT1
prerank,negative regulation of peptidase activity (GO:0010466),0.20266740530142233,0.703942850249479,0.9378151260504202,0.9753501429701157,1.0,11/47,24.40%,CST3;GAPDH;AKT1;SERPINF1;LRP1;SERPINE2;SPINK5;PARK7;SERPINE1;AGT;TIMP2
prerank,regulation of centrosome duplication (GO:0010824),-0.21939240909817373,-0.7035367304201366,0.8878048780487805,0.9743419830567088,1.0,7/30,15.88%,SIRT1;CCNF;PLK2;ALMS1;CEP76;GEN1;NPM1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2280472744654719,0.7025281044408314,0.8894736842105263,0.9763396726749989,1.0,8/29,20.75%,PPP6R3;TNKS1BP1;TERF1;RFC1;NHP2;SHQ1;TELO2;ACD
prerank,maturation of 5.8S rRNA (GO:0000460),0.25740255134843815,0.7023612484097654,0.8628571428571429,0.9760195196531685,1.0,6/17,22.79%,PES1;FTSJ3;C1D;EXOSC10;WDR12;MPHOSPH6
prerank,apoptotic DNA fragmentation (GO:0006309),0.26972933652058945,0.7022187643452823,0.8868613138686131,0.9756840550387631,1.0,7/16,36.00%,HMGB2;DNASE2;EXOG;DFFB;KPNA1;KPNB1;CASP3
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.30369427209710775,0.7021689931500216,0.8612167300380228,0.9752546773472719,1.0,2/10,5.90%,CACNB2;NOS1AP
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.24901554615440039,-0.7018994669042591,0.8817204301075269,0.975312122557147,1.0,7/16,34.20%,SOX5;HOXB4;FOXC1;SP7;SOX6;TCF15;DHX36
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.26905428524106734,0.701337184774232,0.847036328871893,0.9755818591018357,1.0,3/16,9.40%,PDK1;FOXK2;PDK2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.22097396838713113,0.7012288120758601,0.9131205673758865,0.9752098568379144,1.0,7/32,19.13%,MAP3K3;GATA2;PDCD10;TBXA2R;CIB1;THBS1;HDAC5
prerank,RNA interference (GO:0016246),-0.24871719616373042,-0.7002988431161619,0.8608695652173913,0.9762342864774634,1.0,5/17,24.01%,AGO4;DROSHA;TARBP2;TERT;AGO2
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2162875229235064,-0.7000406813594615,0.883248730964467,0.9758134042843044,1.0,5/27,12.05%,UBE2E2;PRKN;UBE2W;ANAPC10;UBE2C
prerank,regulation of chromatin binding (GO:0035561),0.29924039471014174,0.6997187742993795,0.8664259927797834,0.976230210055565,1.0,7/10,33.74%,DTX3L;MED25;GMNN;DDX11;HMBOX1;WAPL;BTAF1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.24696712626979256,0.6996218587456097,0.8844765342960289,0.9758366266561397,1.0,6/19,25.27%,NOTCH4;TJP1;PLG;DENND6A;PPM1F;NOTCH1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.21466541069166828,-0.6993104481636279,0.9234449760765551,0.9758318442030398,1.0,3/28,5.40%,MAP1B;MAP2;STMN4
prerank,L-glutamate transmembrane transport (GO:0015813),0.2936273011070752,0.699048547733001,0.8549905838041432,0.9759386406998474,1.0,1/10,1.20%,SLC1A3
prerank,cellular response to virus (GO:0098586),0.2245342436112865,0.6990279437509755,0.9050179211469535,0.9754702207436506,1.0,10/30,24.80%,LGALS9;MAPK14;IRF3;POU2F2;HIF1A;CXCL10;ARF1;DDX3X;ZC3H12A;TOMM70
prerank,cytoplasmic sequestering of protein (GO:0051220),0.2798372489097778,0.6987259581483705,0.8119180633147114,0.9752825203055074,1.0,3/13,8.44%,DBN1;MDFI;NFKBIE
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.24287128837227662,-0.6984960781229003,0.865546218487395,0.97591280149818,1.0,8/18,29.25%,RCC2;CDC25C;CCNB1;DTL;STOX1;CDK4;MECP2;CDC25B
prerank,transcription preinitiation complex assembly (GO:0070897),-0.2742813961646769,-0.6978420287457857,0.8697478991596639,0.9758972401787191,1.0,3/12,15.46%,TAF7;GTF2B;BDP1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.2514454033996004,0.6975240542925335,0.8818342151675485,0.9759494021689386,1.0,4/18,12.96%,CYRIB;PTK2B;LLGL1;ROCK2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.27757512298674314,0.6962634585376015,0.8608058608058609,0.9766351881947505,1.0,4/13,22.72%,GAD1;PM20D2;ACOT8;ACOT4
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2281575054562951,-0.6962031198969129,0.9191489361702128,0.9767288717788346,1.0,7/21,25.08%,RPS7;BTRC;UBE2C;MAD2L1;RPL23;FZR1;PLK1
prerank,aerobic respiration (GO:0009060),0.2443548889631846,0.6961357663922049,0.8821362799263351,0.9762766798780221,1.0,7/20,25.38%,UQCRC2;UQCRB;SLC25A14;ATP5F1D;MTFR1L;OXA1L;SIRT3
prerank,glutamate metabolic process (GO:0006536),0.2474556811474106,0.6959722789507375,0.8858695652173914,0.9759491041172572,1.0,4/19,20.09%,GAD1;DGLUCY;GCLC;OAT
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.25619676527207735,0.6957421503189783,0.8772241992882562,0.975700009497308,1.0,8/17,28.37%,MBTPS2;SOD1;MBTPS1;SCAP;ERLIN2;FGF1;LPCAT3;ABCG1
prerank,endoderm development (GO:0007492),0.27644231695686516,0.6955425358242375,0.8584729981378026,0.9754000860637939,1.0,7/13,38.22%,SOX17;KIF16B;LAMC1;DUSP5;DUSP1;LHX1;SOX7
prerank,negative regulation of neuron death (GO:1901215),0.18061995071737721,0.6954037129568748,0.9644588045234249,0.9750293895539034,1.0,27/93,25.81%,MEF2C;SLC30A10;LGMN;EIF4G1;CD34;CNTF;POU4F1;PTK2B;CLN3;PPT1;SOD1;PINK1;AKT1;RETREG1;GPNMB;MAG;PARK7;FGF20;HTRA2;PLA2G3;CHGA;TOX3;FZD9;VPS35;MDK;KDM2B;TYRO3
prerank,T cell migration (GO:0072678),0.2805986452154874,0.6948504256573816,0.8584729981378026,0.9750562602862597,1.0,2/13,10.22%,PIK3CG;PIK3CD
prerank,lipoprotein biosynthetic process (GO:0042158),-0.2783483690359003,-0.6945067066370224,0.8444924406047516,0.9776822275949377,1.0,3/11,14.48%,APOE;ATG7;UGCG
prerank,positive regulation of protein depolymerization (GO:1901881),0.289904269652223,0.6940018806975046,0.8382642998027613,0.9754036062032512,1.0,3/11,20.48%,PLEK;TRPV4;KATNB1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.22093291051879912,0.6935498953009845,0.8900523560209425,0.9753583000429995,1.0,9/31,25.09%,FDXR;HSD3B2;MOCS2;HSD17B1;PYCR1;SCP2;MOCS3;PYCR2;MOCS1
prerank,amino sugar biosynthetic process (GO:0046349),0.2798953489124029,0.6925445544695971,0.8605108055009824,0.9758435155701163,1.0,6/12,27.19%,GFPT1;UAP1L1;GNPNAT1;AMDHD2;PGM3;NAGK
prerank,ATP transport (GO:0015867),-0.29230717607982415,-0.692443916510231,0.8565217391304348,0.9789096809024108,1.0,2/10,9.15%,CD47;SLC25A24
prerank,cellular biogenic amine metabolic process (GO:0006576),0.2817999533762936,0.6918504166714853,0.8690702087286527,0.9760032322350838,1.0,5/12,28.80%,SLC29A4;OAZ2;HNMT;SRM;ODC1
prerank,positive regulation of chromosome organization (GO:2001252),0.2617644044807232,0.691725574416264,0.8696428571428572,0.975638328344413,1.0,2/15,5.72%,SHCBP1L;NBN
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.28462170896291716,0.6910100498060313,0.875,0.9758009810750201,1.0,4/11,23.50%,BLM;FBH1;DONSON;GMNN
prerank,regulation of T cell differentiation (GO:0045580),0.21924778336289102,0.6907090641026895,0.9230769230769231,0.9755910790908543,1.0,8/33,16.45%,RHOH;PRDM1;SOD1;ABL1;RUNX1;SPINK5;FANCA;GATA3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.27231240639344545,-0.6904568105177463,0.8778947368421053,0.9800380112751619,1.0,6/11,35.68%,PRKN;FBXO7;REST;RACK1;NR4A3;ATF4
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.2812928252436102,-0.6897803878078727,0.865546218487395,0.9799634122159243,1.0,2/11,8.17%,CCL4;CDH13
prerank,negative regulation of transposition (GO:0010529),0.25510610420350377,0.6896560246246034,0.8824626865671642,0.9760744820314773,1.0,2/16,7.87%,MOV10;PIWIL1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.255837166379352,0.6896180866986366,0.8974358974358975,0.9756211173348351,1.0,3/16,14.85%,CADM1;RAET1E;NECTIN2
prerank,neural tube development (GO:0021915),-0.256261569232559,-0.6894953359078156,0.8596881959910914,0.9795644228118522,1.0,6/15,28.57%,SOX11;PKD2;GRHL2;PKD1;HES5;STIL
prerank,pentose-phosphate shunt (GO:0006098),0.2877212321190291,0.6891913501066386,0.8604651162790697,0.9755524870589547,1.0,5/11,29.31%,RPE;SHPK;TALDO1;PGM2;TKT
prerank,histone lysine methylation (GO:0034968),0.21876454902461945,0.6890725618376538,0.924006908462867,0.975184408497197,1.0,14/33,28.83%,KMT2D;CXXC1;EHMT2;EZH2;SETD3;PRDM9;WDR5;SMYD1;DPY30;PAXIP1;KMT2B;DYDC2;SETD6;SETDB1
prerank,cellular response to hormone stimulus (GO:0032870),0.18675321785584065,0.6884803748048122,0.96875,0.9752090545177104,1.0,7/69,8.09%,BRD8;MEF2C;SRC;ZFP36L1;CTSS;GPER1;LHCGR
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.2687242526443484,-0.6880527345252324,0.8662420382165605,0.9802062884107767,1.0,3/12,19.27%,RORB;NKD1;DSCAM
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.23928787783803865,-0.6871012747910188,0.8948497854077253,0.9803684860372076,1.0,8/18,35.68%,POLR2K;UTP15;FLNA;LYAR;DHX33;MAF1;WDR43;ATF4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.2791024611804177,0.6869086613045183,0.8874045801526718,0.9761447583920715,1.0,6/12,31.09%,PLK5;RPS27L;PLK3;TP53;RFWD3;RPA2
prerank,protein localization to cell surface (GO:0034394),-0.21760301410307153,-0.6861781517278709,0.9068181818181819,0.980553598390223,1.0,8/26,22.76%,ANK2;FGF10;FGF7;CTNNB1;FLNA;JAM3;PTPRK;CD177
prerank,positive regulation of intracellular transport (GO:0032388),-0.19874135990336844,-0.6859648174059021,0.9504504504504504,0.9800971602124882,1.0,14/38,28.26%,EHD1;ACTN2;SPAG5;EHD2;OAZ1;ZFAND1;PRR5L;RUFY3;BCAS3;ATP2A1;SORL1;EIPR1;PCNT;DYNC1H1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2408024806916262,-0.6857499832144643,0.906392694063927,0.9796301107524946,1.0,10/18,39.09%,BAK1;BCL2;SPG7;SLC25A31;PPIF;HEBP2;ALKBH7;BNIP3;CAMK2A;SLC25A4
prerank,ion homeostasis (GO:0050801),0.22451069968550977,0.6856574402732029,0.9128205128205128,0.9768405794697524,1.0,9/30,21.05%,AP3D1;SLC30A8;WNK1;WNK2;WNK3;KLHL3;SLC4A4;SLC4A5;SLC4A3
prerank,secretory granule organization (GO:0033363),-0.28660593978238375,-0.6852542018285714,0.8819742489270386,0.9794090463038462,1.0,5/10,38.22%,DTNBP1;BLOC1S3;VPS33B;BLOC1S2;F2R
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.28298969176770405,0.6850838052518797,0.8669064748201439,0.976877780193415,1.0,3/11,17.36%,SMAD7;CEACAM1;IL4I1
prerank,maturation of SSU-rRNA (GO:0030490),0.21476009820351155,0.6849928469858633,0.9162011173184358,0.9764891102266073,1.0,2/34,1.66%,UTP6;WDR46
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.2213786956713145,0.6838829722549266,0.9228070175438596,0.9769793554174648,1.0,9/31,21.15%,STX1A;STXBP1;RAB3GAP1;SCAMP5;SYT12;SYT11;SYT9;KCNB1;SYT17
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.19489695387069633,0.6835399122010621,0.9533333333333334,0.9767987671979383,1.0,23/51,33.56%,SRC;CTC1;ATM;HNRNPC;CCT3;TEN1;TERF1;EXOSC10;GNL3L;ACD;CCT5;PARN;CCT8;NEK7;HNRNPA1;CCT7;TNKS;STN1;HMBOX1;PKIB;MAPK3;CCT4;TERF2
prerank,negative regulation of ATPase activity (GO:0032780),0.2550586834856212,0.6835366880555038,0.8725663716814159,0.9763210097061831,1.0,8/16,27.52%,PXK;PLN;TP53;ATP5IF1;OXA1L;TLR9;PAM16;IFIT1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.2252421328338506,0.6830522091296543,0.9103214890016921,0.976286055501237,1.0,5/28,15.88%,SMURF1;CLU;ECSCR;PSMC2;CCDC22
prerank,response to estradiol (GO:0032355),-0.20565057226095929,-0.6818492797261377,0.9289099526066351,0.9816429010863672,1.0,7/31,15.96%,EGFR;STRN3;GGT7;CTNNB1;LCOR;CRHBP;SFRP1
prerank,"phototransduction, visible light (GO:0007603)",-0.2527835117545578,-0.6807009372684917,0.8833333333333333,0.9819194251244779,1.0,3/14,25.85%,ABCA4;PDE6A;GNAQ
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.2806854956108839,0.6806540385590528,0.8910133843212237,0.9779072158778024,1.0,6/11,27.19%,GFPT1;UAP1L1;GNPNAT1;AMDHD2;PGM3;NAGK
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.25684448291735046,-0.6805399661707557,0.8881118881118881,0.9814096193578733,1.0,3/14,21.47%,POLRMT;MRPL12;TWNK
prerank,positive regulation of stem cell proliferation (GO:2000648),0.25138818468036367,0.679341725733431,0.8767857142857143,0.9785544078178675,1.0,7/17,31.17%,CCNE1;LTBP3;GJA1;KDM1A;PDCD2;HMGA2;PTPRC
prerank,regulation of cilium movement (GO:0003352),-0.285644194874246,-0.6792348892183853,0.8886554621848739,0.9817977604958955,1.0,6/10,29.48%,ODAD2;CFAP206;DNAAF1;CCDC65;CCDC39;DNAH11
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.2569593507020476,0.6790447252899492,0.9094202898550725,0.9783022666319134,1.0,4/16,21.60%,DAGLB;SCARB1;NR1H2;GPLD1
prerank,negative regulation of wound healing (GO:0061045),-0.2103267941952353,-0.6777724177081287,0.956221198156682,0.9823129184704561,1.0,4/28,11.25%,APOE;ALOX5;CASK;CD109
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.2469891724596737,-0.6777614564314082,0.8891257995735607,0.9816724773243857,1.0,9/16,34.50%,BMP5;IGFBP4;IGFBP2;IGFBP6;IGF1;CILP;MYORG;GHRH;PHIP
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.284006293597707,-0.6777578836506223,0.86652977412731,0.9810217254243876,1.0,4/11,34.89%,PRDX1;CAT;GPX3;PRDX4
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.247608615334518,-0.677442689816488,0.8846153846153846,0.9806158972126506,1.0,6/15,40.30%,RAI2;RICTOR;NR5A2;CELF4;UBR3;CAMSAP3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2281279205174734,0.6773949280270678,0.9226713532513181,0.9792679883944518,1.0,8/25,25.31%,GPER1;BMF;PINK1;BCL2L11;PMAIP1;PYCARD;TP53;PDCD5
prerank,amyloid-beta metabolic process (GO:0050435),0.25569065985741857,0.6762015517938209,0.8819188191881919,0.9798018903062388,1.0,4/16,16.85%,PSEN2;PSENEN;APH1B;DYRK1A
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.22193443481359756,-0.675779799132182,0.9406593406593406,0.9813651927306856,1.0,8/22,23.19%,RPS7;RPS15;RPL37;EIF5A;CDK5RAP3;PLA2R1;MSX1;RPL23
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.2594063814048569,-0.6756886946892245,0.8856548856548857,0.9807991486265425,1.0,6/13,29.09%,UTP20;NOP9;ABT1;RRS1;RPS21;TSR1
prerank,maintenance of protein location in nucleus (GO:0051457),-0.22830677429712704,-0.6748602976672193,0.9376558603491272,0.9808185672387784,1.0,6/20,21.79%,SYNE1;BARD1;SP100;BBS4;ARL2BP;CHCHD10
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.254374671149594,0.6747998902045587,0.8893360160965795,0.9804888652204666,1.0,2/15,5.36%,CHEK2;RAD17
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.2645553372753474,0.6740434003536829,0.8894927536231884,0.9806267371050652,1.0,2/14,10.22%,VEGFB;PIK3CD
prerank,negative regulation of immune system process (GO:0002683),0.253470224121628,0.6732322907117262,0.8994413407821229,0.9808039456121391,1.0,3/16,15.93%,LYN;GPER1;SPINK5
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.2658120862847929,0.6728543132702407,0.8716577540106952,0.9806249238843877,1.0,3/12,15.46%,RAB1A;CDC14B;GORASP1
prerank,regulation of phosphatase activity (GO:0010921),0.23004503692733247,0.6716655888979703,0.9124579124579124,0.9811159451478048,1.0,5/24,15.54%,PPP6R3;ZCCHC9;GPATCH2;SH2D4A;PPP6R1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.18579662621131982,0.6714181366125486,0.9638932496075353,0.9808556551346073,1.0,28/66,34.42%,SMAD3;PRKCD;PIK3R1;LAMTOR5;CCT3;DTX3L;AKT1;MAVS;ECT2;PARK7;CCT5;TGFB1;ZC3H12A;MCRS1;CCT8;ORMDL3;EIF2AK3;HYAL2;CCT7;TESK1;DMAP1;TPR;ZIC1;JUP;CCT4;PIK3R2;WWTR1;PSEN1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.24563185372615032,-0.6702860287607136,0.9004524886877828,0.983746507189265,1.0,7/15,27.04%,SULT2B1;NME2;BMP4;FOXC1;TRIM16;MED1;KDF1
prerank,positive regulation of transporter activity (GO:0032411),0.2607832057484438,0.6696409453950848,0.8846153846153846,0.9818207871998028,1.0,3/13,16.41%,KCTD7;STK39;WNK3
prerank,negative regulation of RNA metabolic process (GO:0051253),0.24313634742924806,0.6692736951154379,0.9052823315118397,0.9816179934833946,1.0,10/18,30.08%,NUDT16;TMBIM6;SHQ1;PTBP3;TGFB1;ZC3H12A;RPS13;KAT2B;NRDE2;RPS26
prerank,leukotriene biosynthetic process (GO:0019370),-0.2542628032913169,-0.6692297494609286,0.8814317673378076,0.9838770783334961,1.0,3/14,11.66%,ALOX5AP;ALOX5;GGT7
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.2587943082128299,0.6678121178765306,0.9057301293900185,0.9822384302599602,1.0,3/14,18.77%,LOXL3;LIMS1;DMTN
prerank,positive regulation of transmembrane transport (GO:0034764),-0.2537410399579919,-0.667769648564836,0.8997955010224948,0.9843276806739047,1.0,5/13,34.01%,ANO6;AZIN1;BRAF;NR4A3;ACSL1
prerank,response to estrogen (GO:0043627),0.21488872813001642,0.6676178960230673,0.926829268292683,0.981915161677671,1.0,9/31,28.18%,KMT2D;CITED4;BRCA1;GATA3;WBP2;AR;EP300;SRA1;CD24
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.24999631457418736,-0.6675834209655515,0.9026548672566371,0.9838111807272801,1.0,4/14,17.77%,AK3;AK4;NME2;ME1
prerank,glutathione derivative metabolic process (GO:1901685),0.23646867692269655,0.6675286990492966,0.9009174311926605,0.9810200244489362,1.0,1/20,0.60%,HPGDS
prerank,glutathione derivative biosynthetic process (GO:1901687),0.23646867692269655,0.6675286990492966,0.9009174311926605,0.9810200244489362,1.0,1/20,0.60%,HPGDS
prerank,cellular amide metabolic process (GO:0043603),-0.15710495866838564,-0.6670857134524943,1.0,0.9835557554816607,1.0,26/102,24.50%,ST3GAL1;MME;ALDH1L1;SGPL1;HLCS;MTHFD1L;NAPEPLD;ACOT13;AEBP1;PPP2R1A;CPXM1;SLC46A1;PLPP3;SHMT1;MTHFD2;FPGS;ACOT11;BTD;SLC5A6;SHMT2;GLYAT;ACOT12;ABCB9;ACSM3;CPXM2;FOLR2
prerank,aminoglycan metabolic process (GO:0006022),-0.2768815516916703,-0.6656372067455951,0.8757894736842106,0.9840193744076994,1.0,10/10,72.34%,B4GALT7;B3GAT2;XYLT1;CLN6;GAL3ST3;XYLT2;B3GALT6;CHST9;B3GAT3;B3GAT1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.19340878300253006,0.6654943240784515,0.9515570934256056,0.9821123685811532,1.0,13/44,24.63%,CH25H;CYP46A1;OSBPL3;AKR1D1;HSD17B1;CYP7B1;HSD17B10;PARK7;ACOT8;OSBP;PNPO;SCP2;INSIG2
prerank,positive regulation of cellular protein localization (GO:1903829),0.18189762903561393,0.665329218934737,0.9719934102141681,0.9817775220977776,1.0,16/69,20.59%,TMEM35A;NUMA1;LAMTOR5;ENTR1;STX4;DTX3L;AKT1;NUP62;SYT11;MARK4;GNL3L;SLC5A3;PARK7;MAPT;CROCC;CENPQ
prerank,regulation of gastrulation (GO:0010470),-0.24983938432104683,-0.6640171319392258,0.9105145413870246,0.9845768869741095,1.0,3/14,15.56%,TENM4;DAG1;SCX
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.2166878324103036,0.6624772727164044,0.9336917562724014,0.9833947557826003,1.0,12/26,31.57%,GPS2;APPL1;GPR108;FLOT2;APPL2;TLR9;TYRO3;BIRC2;BIRC3;OTUD4;TLR5;TREM2
prerank,mitotic cytokinetic process (GO:1902410),0.23585898311358516,0.6616726299028071,0.9075342465753424,0.9834920340150363,1.0,9/20,34.14%,KLHDC8B;CHMP1A;CHMP2A;CHMP7;CHMP3;PDCD6IP;CHMP6;RHOA;CHMP5
prerank,response to amino acid (GO:0043200),0.2075093433534193,0.6612025854703134,0.9434628975265018,0.9833647807890727,1.0,5/31,13.07%,LAMTOR2;LAMTOR5;RPTOR;MTOR;RRAGA
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.274347426352624,-0.6610935358412464,0.8930957683741648,0.9860487783640915,1.0,3/10,17.59%,E2F7;WIZ;DBF4
prerank,homologous chromosome segregation (GO:0045143),-0.22315915244034246,-0.6586481276253656,0.9084668192219679,0.9871770119270795,1.0,7/20,32.44%,MEI4;PTTG1;IHO1;CENPC;TERB1;MEIKIN;SYCP1
prerank,alcohol catabolic process (GO:0046164),0.27305595575108793,0.6582818900033911,0.8946322067594433,0.985016110431411,1.0,2/10,7.94%,CYP46A1;AKR1D1
prerank,relaxation of muscle (GO:0090075),0.2583601154338559,0.6575491750862453,0.9127906976744186,0.9850821067072911,1.0,6/13,29.07%,SLC8A1;PLN;PIK3CA;KCNJ2;ATP1A2;CAMK2D
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.2597484747768698,-0.6575444503122003,0.8924731182795699,0.9872526033237348,1.0,4/13,16.99%,CALM1;MTHFD1L;FPGS;PTS
prerank,negative regulation of catalytic activity (GO:0043086),0.22024284732851138,0.6566070939239043,0.9359430604982206,0.9852600939220932,1.0,11/24,30.56%,CLN3;NOS1;PLN;TP53;ATP5IF1;OXA1L;TMBIM1;NOTCH1;IFIT1;MT3;CAND1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.19617035528021462,-0.6558298349708989,0.958904109589041,0.9878039261823325,1.0,9/34,22.28%,ERN1;VEGFD;ITGB1BP1;RELA;VEGFC;SEMA6A;MAPKAPK2;FOXC1;DLL4
prerank,protein localization to lysosome (GO:0061462),0.21532961950881213,0.6557720291583599,0.9458483754512635,0.9853694364083502,1.0,7/28,22.28%,LAMTOR5;GGA3;AP4M1;MFSD1;GLMP;ZFYVE16;HGS
prerank,cardiac atrium morphogenesis (GO:0003209),0.24260586381545368,0.6554139175018785,0.9190207156308852,0.9851477223440588,1.0,6/16,28.44%,PROX1;NOG;ENG;BMP2;NOTCH1;BMPR2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2443239941627748,0.6553605731645215,0.9247706422018349,0.9847029277080075,1.0,5/16,25.80%,ACSS1;PPT1;SCD;SCD5;PPT2
prerank,erythrocyte development (GO:0048821),0.2727307732625262,0.655337338597852,0.8833034111310593,0.9842385407036107,1.0,2/10,18.77%,NCKAP1L;DMTN
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.22205560522711817,-0.6553156182234562,0.9287305122494433,0.9874963832985957,1.0,7/21,24.42%,GRIN2B;BEX3;TTBK1;FYN;LTF;EPHA7;NGFR
prerank,response to X-ray (GO:0010165),-0.24601443514070884,-0.6551744889539952,0.9197396963123644,0.9869393062516807,1.0,6/14,26.13%,LIG4;XRCC5;IKBIP;NUCKS1;MSH2;ANXA1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.22076563876181354,-0.6550433134284975,0.9260869565217391,0.9863693357683879,1.0,5/20,24.01%,AGO4;DROSHA;TARBP2;TERT;AGO2
prerank,cellular respiration (GO:0045333),-0.18631445417181525,-0.6545339830644327,0.9672897196261683,0.986072414323344,1.0,7/41,12.89%,SDHC;NDUFS1;SDHAF4;SDHA;COQ10B;MTFR2;ETFRF1
prerank,amino acid transport (GO:0006865),0.1918808341122972,0.6539272289281539,0.96875,0.9847240326544368,1.0,5/49,10.29%,SLC7A8;SLC36A1;SLC25A45;SLC7A5;SLC38A10
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.25286816830544,0.6538179584102289,0.9251336898395722,0.9843171695352831,1.0,4/15,18.69%,WHRN;COL11A1;TMEM120A;HPN
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.27174055527109353,0.6519594471995117,0.9027777777777778,0.9851449829472403,1.0,6/11,29.14%,TIMM29;TIMM10B;NDUFA13;TIMM13;TOMM70;TIMM8B
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.2551485375123894,0.6505397651386289,0.9128113879003559,0.9856610152551684,1.0,4/14,16.45%,SHISA2;SPRY2;THBS1;GATA3
prerank,protein localization to centrosome (GO:0071539),0.23695759127970167,0.6495796986800011,0.9007352941176471,0.9858408716054373,1.0,5/17,24.78%,NUDCD3;DCTN2;CCDC14;HOOK3;CSNK1D
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.2160882073950836,0.6486873918127796,0.9403508771929825,0.9859757539239618,1.0,8/26,27.04%,MLXIPL;BRCA1;CEACAM1;NR1H2;WDTC1;ERLIN2;PRKAB2;ACADVL
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.21531483633717954,-0.6480232529888696,0.9252747252747253,0.9891134486904599,1.0,6/22,24.21%,ZDHHC21;ZDHHC23;ZDHHC15;ZDHHC18;ZDHHC24;ZDHHC19
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.21531483633717954,-0.6480232529888696,0.9252747252747253,0.9891134486904599,1.0,6/22,24.21%,ZDHHC21;ZDHHC23;ZDHHC15;ZDHHC18;ZDHHC24;ZDHHC19
prerank,lymphocyte chemotaxis (GO:0048247),0.20723878023843217,0.6477363828976439,0.955595026642984,0.9861538244370746,1.0,4/34,11.14%,CH25H;PIK3CG;PIK3CD;CYP7B1
prerank,piRNA metabolic process (GO:0034587),0.23169199849265165,0.6470502362782603,0.9237588652482269,0.9861473436293401,1.0,19/19,76.86%,PIWIL1;TDRKH;DDX4;TEX15;MAEL;HENMT1;BTBD18;ASZ1;FKBP6;TDRD1;PLD6;EXD1;PIWIL4;MYBL1;MOV10L1;PIWIL2;TDRD9;GPAT2;TDRD12
prerank,embryonic heart tube development (GO:0035050),0.2492061572213586,0.6464360427585636,0.918625678119349,0.9860479944448762,1.0,2/14,10.46%,SOX17;NDRG4
prerank,inner ear morphogenesis (GO:0042472),-0.2148812326409118,-0.6448855277089162,0.9280898876404494,0.9905028634352179,1.0,10/22,32.86%,TTC39C;MYO3B;MYO6;EPHB2;TMIE;PAX8;TBX1;TFAP2A;ATP6V1B1;TBX18
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.2559326182554643,-0.64436302744996,0.9009009009009009,0.9902007833875447,1.0,2/11,7.89%,LIMD1;ZFP36
prerank,miRNA metabolic process (GO:0010586),0.22408150312011937,0.6439267385142143,0.9398797595190381,0.9871725398055526,1.0,6/20,25.46%,DIS3L2;DDX17;BCDIN3D;XPO5;SND1;PARN
prerank,aortic valve development (GO:0003176),-0.19257353811440464,-0.6416767531842229,0.9662162162162162,0.991260038938345,1.0,9/34,22.28%,ROBO1;SLIT2;JAG1;HEY2;SNAI2;ELN;BMP4;TIE1;DLL4
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.171155202374041,-0.6416069691194087,0.9948717948717949,0.9906498129008835,1.0,15/59,22.21%,CEBPB;AGO4;MED15;TNRC6A;RUNX2;THRA;RELA;CDKN2A;CTNNB1;CDKN1A;CCNB1;MED6;LEF1;CDK4;MED1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.25649881038088884,-0.6410790618349551,0.9082969432314411,0.9903559726829579,1.0,3/11,16.82%,SP100;HIPK2;ING4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.26347840835467684,-0.6399356169879455,0.8982683982683982,0.9903650003979965,1.0,3/10,16.82%,SP100;HIPK2;ING4
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.22073199570894006,-0.6386935949862288,0.9483870967741935,0.9904139776337212,1.0,3/18,12.60%,SLC45A3;TENM4;OPALIN
prerank,organophosphate biosynthetic process (GO:0090407),-0.18154073220766204,-0.6382990738301123,0.9813953488372092,0.9900107208189722,1.0,2/37,2.93%,GPHN;AGPAT4
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.25070666911521017,0.6379039854019947,0.9158699808795411,0.9904460897694545,1.0,2/13,5.67%,GFPT1;UAP1L1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.2194796271852697,0.6378329968408606,0.9571428571428572,0.9900136670542525,1.0,6/23,17.51%,MOSMO;ULK3;KCTD6;MGRN1;SUFU;PTCH1
prerank,cellular response to inorganic substance (GO:0071241),-0.21288927848475503,-0.6364993843543972,0.9434782608695652,0.9903965189468922,1.0,2/21,4.44%,KCNC2;GUCY1B1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.22833176546553718,0.6356309711417594,0.9512635379061372,0.9909046380023859,1.0,7/19,26.64%,BAG6;USP28;RPS27L;PYCARD;TP53;TMEM109;EP300
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.24133689858958493,0.6323653098455405,0.9072727272727272,0.9923079709272846,1.0,2/16,12.57%,LEPROT;VPS36
prerank,regulation of multicellular organism growth (GO:0040014),0.241916844125379,0.6323544624697586,0.9182948490230906,0.9918403673413994,1.0,5/15,22.16%,BBS2;SOD1;GHR;PTCH1;STAT5B
prerank,serine family amino acid metabolic process (GO:0009069),-0.2338326046884538,-0.6319394641413904,0.9102844638949672,0.9922620017498477,1.0,5/16,21.27%,SRR;SHMT1;DAO;SHMT2;GLYAT
prerank,DNA replication initiation (GO:0006270),0.19365944010277586,0.6318912381026964,0.976271186440678,0.9916353918043131,1.0,17/37,35.66%,CDC34;MCM2;MCM3;ORC3;RPA3;CDC7;MCM6;GMNN;TOPBP1;ORC2;MCM7;RPA1;RPA2;ORC4;NOC3L;MCM10;POLE3
prerank,megakaryocyte differentiation (GO:0030219),-0.25329526404304914,-0.6317747873835184,0.9334719334719335,0.9917156149365945,1.0,5/11,34.02%,KIT;MED1;THPO;ZFPM1;SH2B3
prerank,negative regulation of translational initiation (GO:0045947),-0.24014058309618763,-0.6306139435844168,0.9104477611940298,0.9916986692713717,1.0,5/13,26.79%,EIF3E;EIF4EBP1;EIF2AK4;AGO2;FMR1
prerank,negative regulation of DNA replication (GO:0008156),0.24672352196451697,0.6306066233165437,0.9315315315315316,0.9918922324480834,1.0,4/13,23.50%,RAD17;TERF1;TSPYL2;GMNN
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.22953605376154512,0.6304807878840655,0.9536178107606679,0.9914923153889761,1.0,4/18,17.47%,ZFP36L1;ZFP36L2;PCK2;BCL2L11
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.2518901809128481,0.6295494269474838,0.9382022471910112,0.9915312140202711,1.0,3/13,13.45%,EBI3;IL6ST;TYK2
prerank,cellular response to interferon-beta (GO:0035458),0.24498613606888203,0.6292717998972633,0.9432234432234432,0.9912150483282668,1.0,5/14,23.39%,CDC34;AIM2;NDUFA13;HTRA2;UBE2G2
prerank,protein oxidation (GO:0018158),0.2598996390650091,0.6290492851911968,0.9341864716636198,0.9908793642160454,1.0,1/11,4.57%,LOXL3
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.2482974525015011,-0.6290281426849742,0.9347826086956522,0.9919160855537404,1.0,5/12,26.28%,KLF2;CYP26C1;ASXL1;TRIM16;SNW1
prerank,cardiocyte differentiation (GO:0035051),-0.2665253207709018,-0.6287653945248343,0.9264069264069265,0.9914242397851623,1.0,5/10,32.50%,KDM6B;SIK1;CBY1;NRG1;MYOCD
prerank,tRNA methylation (GO:0030488),0.19839478065430635,0.6284890728955476,0.980836236933798,0.990706365297913,1.0,14/34,27.91%,NSUN6;BCDIN3D;HSD17B10;METTL6;TRMT61A;WDR6;TRMT1L;TRDMT1;MTO1;FTSJ1;ALKBH8;METTL2A;METTL2B;DALRD3
prerank,protein localization to Golgi apparatus (GO:0034067),0.2068176778640233,0.6279938382046344,0.9447513812154696,0.9905277362543915,1.0,16/27,35.76%,ARL5C;IFT20;GBP5;OPTN;VPS13C;VPS13D;COG7;SYS1;CSNK1D;GAK;ARFRP1;GBF1;RAB33B;ARL5A;RIPOR1;TMED10
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.2477906980287334,0.6279473270614472,0.9345454545454546,0.9900741043161108,1.0,3/14,15.70%,EDN3;EDN2;RASL10B
prerank,regulation of protein localization to nucleus (GO:1900180),0.18930462878399648,0.6264631324488609,0.9759036144578314,0.990431075054378,1.0,14/43,26.93%,FLCN;SHH;LAMTOR5;SIN3A;LATS2;DTX3L;AKT1;BYSL;PARK7;NVL;PIN1;TGFB1;ORMDL3;EIF2AK3
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.19599003090760708,-0.6260757476123809,0.9780701754385965,0.9922000330374366,1.0,2/25,4.57%,B2M;CD226
prerank,positive regulation of hormone secretion (GO:0046887),-0.22077735421041444,-0.6250159480446308,0.9558498896247241,0.9921507785400913,1.0,3/17,12.17%,SPP1;SOX11;TFR2
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.19691890591463673,-0.6244182041695305,0.9709821428571429,0.991801256586606,1.0,12/26,29.16%,ILRUN;TRAFD1;NLRC3;CARD16;LTF;RNF26;TRAF3IP1;SIGIRR;IRAK3;LYAR;MAPKBP1;NMI
prerank,regulation of rRNA processing (GO:2000232),0.23476611331321112,0.6243403104592199,0.9291044776119403,0.9911479818626608,1.0,4/16,18.26%,BUD23;USP36;NUDT16;SHQ1
prerank,retinoic acid metabolic process (GO:0042573),0.24617088546435775,0.6240328674656722,0.9443413729128015,0.9908335399381341,1.0,1/14,2.15%,BCO2
prerank,smooth muscle contraction (GO:0006939),-0.23938824285299423,-0.6238065554673934,0.9419642857142857,0.9914739451252488,1.0,2/14,6.69%,ADRA1A;PIK3C2A
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2160820804585225,0.6226885908977436,0.9614678899082569,0.9910455660874341,1.0,4/22,17.36%,VSIR;RUNX1;FANCA;IL4I1
prerank,response to interferon-alpha (GO:0035455),-0.22591682228213858,-0.6223214316676764,0.9418103448275862,0.9915883374787929,1.0,7/16,32.40%,IFITM3;IFITM2;IFITM1;ADAR;KLHL20;BST2;LAMP3
prerank,necroptotic process (GO:0070266),0.23405537518255268,0.622035861683644,0.9450757575757576,0.9909193007320057,1.0,3/16,15.65%,TLR4;TICAM2;TICAM1
prerank,regulation of urine volume (GO:0035809),0.2648811726889053,0.6212858328085493,0.9288321167883211,0.9908249269301055,1.0,4/10,28.77%,ADCY6;INPP5K;NPR1;HYAL2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.19552481599846655,-0.6205529014293225,0.9649532710280374,0.9918278503521133,1.0,11/25,33.17%,SOX11;PER2;NSD1;HEY2;NIBAN2;ZBTB7A;IGF1;H1-0;TRIM6;POU4F2;NEUROD1
prerank,regulation of calcium ion import (GO:0090279),-0.20440993931696244,-0.6203477623102251,0.9586956521739131,0.991289103437952,1.0,4/21,14.99%,PLPP4;PKD2;CCL2;CTNNB1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.2151687597131941,-0.6197449589367587,0.9517241379310345,0.990963605372092,1.0,4/18,20.32%,EGFR;NCOR1;BMP4;TERT
prerank,electron transport chain (GO:0022900),0.2403090493193919,0.6194721924380419,0.9356617647058824,0.9913128327262213,1.0,6/15,29.55%,PDIA5;ETFB;ETFA;ETFDH;NDOR1;POR
prerank,positive regulation of blood coagulation (GO:0030194),0.23233655957329913,0.6194236823685629,0.926391382405745,0.9908615194762141,1.0,6/17,21.44%,F12;APOH;PLG;THBS1;DMTN;SERPINE1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.2570982960631222,0.6193076910404721,0.9212598425196851,0.9904519759566546,1.0,6/10,35.04%,ADAM17;AREG;BTC;HBEGF;NCF1;TGFA
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2195351769084833,0.6189773728694847,0.9568345323741008,0.9901384344580498,1.0,6/20,20.83%,INCA1;CDK5RAP1;LATS2;CDKN1B;IPO7;TFAP4
prerank,regulation of inclusion body assembly (GO:0090083),0.2527642762154092,0.6187396009560462,0.9267857142857143,0.9897824511144557,1.0,1/11,3.23%,SNCAIP
prerank,regulation of extracellular matrix organization (GO:1903053),0.2395806656755592,0.6183135664050388,0.9292543021032504,0.9895252073681822,1.0,8/15,29.25%,RUNX1;LRP1;DDR2;FGFR4;AGT;NOTCH1;FAP;RB1
prerank,snRNA metabolic process (GO:0016073),0.22889393113453035,0.6180789975909767,0.9525547445255474,0.9891732131889538,1.0,6/17,26.63%,INTS11;INTS3;INTS8;RBM7;ZCCHC8;INTS5
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.24618355141939824,-0.6179125041588921,0.9342105263157895,0.9912094366424197,1.0,4/12,23.11%,CTCF;BUB1;CTNNB1;FEN1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.22248959412280173,0.6171482501752148,0.9489603024574669,0.9891975180252014,1.0,6/20,21.44%,IGFBP3;PDGFB;NDRG4;LRP1;TRIB1;SERPINE1
prerank,DNA modification (GO:0006304),0.21296945992896701,0.6119895157372293,0.9604130808950087,0.9911937140764482,1.0,5/22,20.75%,MPG;EXOSC5;TERF1;NTHL1;ACD
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.267902122192621,0.610745866536282,0.9248554913294798,0.991301834461605,1.0,3/10,20.56%,ARNT;PRKCB;HIF1A
prerank,positive regulation of telomere maintenance (GO:0032206),0.19315287531120934,0.6094967351113801,0.9706390328151986,0.9914495977161666,1.0,3/31,5.93%,ATM;NBN;SLX4
prerank,regulation of JUN kinase activity (GO:0043506),0.18852933926470616,0.6070984897092371,0.9773123909249564,0.9921222834916475,1.0,12/33,28.51%,MAP3K10;MAPK8IP1;MAP3K11;ARHGEF5;PDCD4;TRAF6;FZD10;TLR9;PPEF2;TLR6;DVL3;TAOK3
prerank,oxoacid metabolic process (GO:0043436),0.19859702191430795,0.6069134937244118,0.9736379613356766,0.9917403977745689,1.0,3/27,8.07%,TPST2;HAO1;SULT2A1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.20911514274483714,0.6069094888887435,0.9605026929982047,0.9912713672335851,1.0,9/22,32.97%,MTOR;UBTF;PHF8;SMARCA4;DDX11;EIF2AK3;HEATR1;IPPK;NCL
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.2580048944043033,0.6051459547637564,0.9334637964774951,0.9915665525860264,1.0,2/10,13.42%,OS9;ERLEC1
prerank,inositol phosphate catabolic process (GO:0071545),-0.24478995051478974,-0.6049117620001904,0.9405034324942791,0.9966191508517682,1.0,4/12,17.70%,INPP5J;NUDT3;OCRL;INPP5A
prerank,cristae formation (GO:0042407),0.1993353877818755,0.6041539453103585,0.9620034542314335,0.9915432913843286,1.0,8/27,22.10%,MICOS13;ATP5PO;DNAJC11;ATP5MC1;ATP5PD;ATP5F1D;SAMM50;AFG3L2
prerank,positive regulation of dephosphorylation (GO:0035306),0.19983648481000468,0.6039874663018584,0.9698046181172292,0.9911399609787976,1.0,2/27,2.84%,SRC;PRKCD
prerank,cGMP biosynthetic process (GO:0006182),-0.25481511996546724,-0.6035125827987433,0.9154929577464789,0.9965660621268682,1.0,3/10,19.42%,GUCY1B1;GUCY2F;GUCY2D
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.2476262124331406,-0.6022492762018855,0.9364406779661016,0.9964468294628606,1.0,2/10,13.83%,CCT2;WRAP53
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.23654350687096298,0.6016123077323763,0.9638989169675091,0.9916968134860101,1.0,5/13,26.97%,OS9;ERLEC1;EDEM1;UBE2G2;EDEM2
prerank,alpha-amino acid catabolic process (GO:1901606),-0.18595118251312853,-0.6016026577257956,0.9721030042918455,0.996075796355495,1.0,13/29,39.68%,KMO;SARDH;DAO;IDO2;GSTZ1;KYAT1;ACADSB;TAT;OTC;HOGA1;HGD;BLMH;MTRR
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.222071106177342,-0.6012057785870831,0.9492753623188406,0.9956035060642423,1.0,4/14,24.60%,LILRB1;LILRA5;TLR8;IRAK3
prerank,protein O-linked glycosylation via serine (GO:0018242),0.2515135535106784,0.6005858989237152,0.9371534195933456,0.991655395778183,1.0,3/10,17.93%,GALNT3;GALNT1;GALNT2
prerank,negative regulation of defense response to virus (GO:0050687),0.2560092462742686,0.6005858073958166,0.9583333333333334,0.9911867830109243,1.0,4/10,23.39%,ITCH;PCBP2;C1QBP;PPM1B
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.2052550282268646,0.6000419948469465,0.967680608365019,0.9909430912622539,1.0,4/24,12.60%,PTPN1;ARNT;PDCD6;PRKCB
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.2507767924552596,0.5980157224718625,0.9352380952380952,0.9913136749632199,1.0,2/10,16.07%,RYK;FZD1
prerank,apical protein localization (GO:0045176),0.2508457378812392,0.5971065808281435,0.9349112426035503,0.9912125218181523,1.0,5/10,26.86%,SHROOM2;VANGL2;CELSR1;SHROOM3;GOPC
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.20350552648051415,-0.596041620966947,0.9667405764966741,0.9970864041661048,1.0,11/18,39.21%,PRKAG2;FFAR4;TRIB3;RTN2;OCLN;BRAF;C1QTNF12;NR4A3;SLC2A1;C2CD5;IL1B
prerank,pyroptosis (GO:0070269),-0.22019384860822264,-0.5935834043745903,0.9470046082949308,0.9974154690577974,1.0,1/15,1.27%,NLRC4
prerank,protein ADP-ribosylation (GO:0006471),-0.18730056063022849,-0.59304900196776,0.9738717339667459,0.996966709021308,1.0,7/28,20.02%,SIRT1;PARP14;TNKS2;PARP10;PARP3;PARP12;TIPARP
prerank,mRNA modification (GO:0016556),0.20484129856816605,0.5920090365867856,0.9666080843585237,0.9928057515491278,1.0,5/22,21.58%,TRMT6;METTL14;PCIF1;TRMT61A;METTL8
prerank,digestive tract morphogenesis (GO:0048546),-0.21980652642365606,-0.5910385051894731,0.9471458773784355,0.9970855060106778,1.0,5/14,33.92%,SOX11;RBPMS2;GLI1;STRA6;ID2
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.23332149707749958,-0.5910320640918546,0.9457700650759219,0.9964492932945329,1.0,6/12,38.52%,ACLY;IDH2;IDH1;IDH3A;GLUD1;SIRT4
prerank,negative regulation of mitochondrion organization (GO:0010823),0.18866958171816262,0.5910162518336612,0.9795918367346939,0.9927448998330138,1.0,12/33,30.43%,FLCN;CLU;PINK1;AKT1;ACAA2;OPA1;MAPT;FZD9;GHITM;TMEM14A;OMA1;MUL1
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.24119468785387455,-0.5890466234175031,0.9352678571428571,0.9965353328526201,1.0,3/11,23.47%,ITPKC;IP6K2;IPMK
prerank,cardiac myofibril assembly (GO:0055003),0.2240670070049962,0.5886721177523079,0.9621212121212122,0.9931728932391827,1.0,3/15,17.77%,MEF2A;PROX1;NEB
prerank,regulation of protein localization to cell periphery (GO:1904375),0.21533341962962568,0.5877528804102635,0.9688073394495413,0.9930682027813111,1.0,8/18,28.11%,APPL1;CLN3;LDLRAP1;ZDHHC7;ZDHHC2;STX8;AR;STX7
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.2548133370190369,0.5854521934003194,0.9484732824427481,0.9934253365516594,1.0,1/10,3.21%,NUMA1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.24585066565687613,-0.5836154209585126,0.949685534591195,0.9978359709321246,1.0,3/10,19.22%,CCAR2;ETAA1;CRY1
prerank,base-excision repair (GO:0006284),0.1728231844026149,0.5828387206244159,0.9870340356564019,0.9939084313552403,1.0,8/48,16.84%,RFC2;MPG;PCNA;POLD2;PRMT6;RFC1;LIG1;NTHL1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.22493020806494854,-0.5789972578996808,0.9629629629629629,0.9988173877726354,1.0,2/13,11.72%,ATP1B3;ATP1A1
prerank,mitochondrion transport along microtubule (GO:0047497),0.23004559136021518,0.5789896529033124,0.9562737642585551,0.9947906667843359,1.0,5/13,24.86%,LRPPRC;OPA1;MAPT;HIF1A;UXT
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.20450165730815223,0.5787858303581879,0.9642857142857143,0.9943908372160969,1.0,7/20,27.04%,GPER1;BRCA1;CEACAM1;WDTC1;BMP2;ERLIN2;ACADVL
prerank,"base-excision repair, AP site formation (GO:0006285)",0.21592243262352184,0.5779839100048169,0.9694244604316546,0.9941639680279153,1.0,4/17,20.75%,MPG;TERF1;NTHL1;ACD
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.24097190676880353,0.5765029958040598,0.9591439688715954,0.9941709496129423,1.0,2/11,11.20%,UBN1;IPO4
prerank,cellular response to interleukin-7 (GO:0098761),-0.2030354254729388,-0.5764758431028653,0.9723404255319149,0.9983693878365016,1.0,1/17,2.83%,IRS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.2030354254729388,-0.5764758431028653,0.9723404255319149,0.9983693878365016,1.0,1/17,2.83%,IRS1
prerank,magnesium ion transport (GO:0015693),0.23493100054014154,0.5742852281039449,0.9484346224677717,0.9944844000820298,1.0,5/12,29.66%,CNNM4;NIPAL1;NIPAL3;SLC41A1;MRS2
prerank,cellular response to arsenic-containing substance (GO:0071243),0.2185362227110629,0.5732097222966966,0.960644007155635,0.9943562872347427,1.0,9/15,37.96%,CPEB2;DDX3X;ZC3H12A;HNRNPA1;GSTO1;MKNK2;VCP;HSF1;GSTO2
prerank,negative regulation of nervous system development (GO:0051961),-0.2087885659959982,-0.5731837871321089,0.9745762711864406,0.998794869821089,1.0,5/17,27.29%,B2M;REST;WNT7A;SORL1;ROBO2
prerank,vasculature development (GO:0001944),0.21849191572068477,0.5731088642535147,0.9589552238805971,0.9939216337637236,1.0,4/16,20.52%,NOTCH4;ERRFI1;PIK3CA;ACVR2B
prerank,peptidyl-amino acid modification (GO:0018193),0.24320705247944877,0.5728911833506566,0.9528130671506352,0.9935242837928647,1.0,2/10,17.82%,METAP1D;METAP2
prerank,polyol biosynthetic process (GO:0046173),0.21285759785479297,0.5708630594351496,0.9655797101449275,0.9936814260781154,1.0,3/16,16.82%,ACER3;CYP2R1;IP6K1
prerank,regulation of steroid metabolic process (GO:0019218),0.1935785671566062,0.5706963918379018,0.9787985865724381,0.9932651856572287,1.0,4/23,14.32%,ASAH1;PANK2;TTC39B;FMO5
prerank,regulation of microtubule-based process (GO:0032886),-0.17046788503688426,-0.5676531461932439,0.9924812030075187,0.9998154466256101,1.0,7/36,19.05%,BICD1;TPPP;GSK3B;EFNA5;DIAPH1;EPHA3;PRKAA1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.21003861110607058,0.5661230652627334,0.9662522202486679,0.9942361699274442,1.0,2/17,7.94%,SRC;GPER1
prerank,NAD biosynthetic process (GO:0009435),-0.1886816154764148,-0.5660122342981075,0.9743589743589743,0.9996914994436281,1.0,20/20,81.16%,PARP10;NMNAT2;NMNAT1;NUDT12;PARP9;NMNAT3;PTGIS;HAAO;NAMPT;QPRT;SLC5A8;NNMT;SLC22A13;PTGS2;NAPRT;KYNU;PARP16;NADSYN1;NAXD;NAXE
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.22919337584742025,0.5650879180166815,0.9757009345794393,0.9940684020051143,1.0,5/11,29.35%,CCT3;TERF1;CCT5;CCT8;CCT7
prerank,regulation of fatty acid oxidation (GO:0046320),-0.2058080119757263,-0.5642827561234502,0.967032967032967,0.9995355715794676,1.0,8/16,38.52%,PRKAG2;PDK4;ABCB11;PPARA;NR4A3;PPARGC1A;MLYCD;SIRT4
prerank,peptidyl-lysine methylation (GO:0018022),0.18795299166724264,0.5621607602623877,0.980565371024735,0.9944213110145124,1.0,7/26,20.54%,EEF2KMT;EHMT2;ANTKMT;SETD2;SETD4;SETD3;SMYD1
prerank,linoleic acid metabolic process (GO:0043651),0.20533096041398793,0.5615078930067391,0.9655172413793104,0.9941352187779885,1.0,3/17,18.10%,ALOXE3;FADS1;ABCD1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.1938137813268821,0.5608774869688743,0.978494623655914,0.9938409076828062,1.0,6/22,20.83%,INCA1;CDK5RAP1;LATS2;CDKN1B;IPO7;TFAP4
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.23047187959971382,0.5598928735665375,0.9716981132075472,0.99367410953127,1.0,2/12,13.61%,MBTPS2;MBTPS1
prerank,estrogen metabolic process (GO:0008210),-0.20767902028535873,-0.5587254467788769,0.9799554565701559,1.0,1.0,5/15,25.95%,HSD17B2;HSD17B11;HSD17B14;UGT1A7;UGT1A1
prerank,lysine catabolic process (GO:0006554),0.22808563361381645,0.558379717753515,0.9612546125461254,0.9931766677199992,1.0,1/12,7.71%,CRYM
prerank,lysine metabolic process (GO:0006553),0.22808563361381645,0.558379717753515,0.9612546125461254,0.9931766677199992,1.0,1/12,7.71%,CRYM
prerank,DNA geometric change (GO:0032392),0.1914112264584739,0.5580790468237887,0.9909584086799277,0.9927972355861673,1.0,10/24,29.48%,NBN;DHX9;BLM;HMGB2;HNRNPA2B1;RECQL;RTEL1;DDX11;DNA2;DDX1
prerank,programmed necrotic cell death (GO:0097300),0.20100702814936056,0.5568560774768759,0.9702048417132216,0.9926434654399209,1.0,3/18,15.65%,TLR4;TICAM2;TICAM1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.20482435893618403,0.5549363440380991,0.9720149253731343,0.9926708472390211,1.0,8/18,34.30%,PABPN1;DDX19B;ZC3H11A;POLDIP3;ENY2;IWS1;HHEX;PCID2
prerank,DNA replication checkpoint signaling (GO:0000076),0.2066023080131106,0.5534063526000483,0.9826589595375722,0.9925858895750607,1.0,5/16,29.87%,RAD17;RAD9A;TOPBP1;DNA2;TICRR
prerank,methylguanosine-cap decapping (GO:0110156),-0.22668214997598857,-0.5514156252503813,0.9578947368421052,1.0,1.0,4/10,26.15%,LSM1;PATL1;EDC3;EDC4
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.18766960390634185,-0.5504658876749879,0.9894291754756871,1.0,1.0,2/21,6.52%,YWHAE;GSK3B
prerank,positive regulation of exosomal secretion (GO:1903543),-0.1970938659358085,-0.5473617730385197,0.9789719626168224,1.0,1.0,1/15,3.42%,SDCBP
prerank,positive regulation by host of viral transcription (GO:0043923),0.21005393852222928,0.5452864045246424,0.9637681159420289,0.9940285203342464,1.0,6/15,30.98%,HPN;JUN;TFAP4;SMARCA4;EP300;RRP1B
prerank,regulation of mitotic nuclear division (GO:0007088),0.1524096159727271,0.5452396811564655,0.9983416252072969,0.9935847847577223,1.0,7/55,15.95%,LRP5;EDN3;PDGFB;ANAPC15;NME6;AURKA;NUP62
prerank,positive regulation of response to wounding (GO:1903036),0.18674155920470215,0.5421453638785984,0.9931389365351629,0.9938092427172442,1.0,5/24,18.77%,DUOX1;CNTF;INSL3;CLDN1;DMTN
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.1855855243958469,0.5417432802481537,0.9818181818181818,0.9934312212189327,1.0,5/22,23.60%,PSMC2;MED4;MED12;TP53;PAXIP1
prerank,early endosome to Golgi transport (GO:0034498),-0.21569661296951098,-0.5415382190830516,0.9771309771309772,1.0,1.0,5/11,26.20%,RAB6A;SNX8;LMAN1;SNX2;TRAPPC10
prerank,rRNA catabolic process (GO:0016075),-0.19761718740157125,-0.5388786534257451,0.9746835443037974,1.0,1.0,1/16,1.94%,DEDD2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.19826447437698377,-0.5353547323873102,0.981651376146789,1.0,1.0,5/15,26.74%,PRKN;PRELID1;NOL3;PPIF;IGF1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.19872209527087728,-0.5351051957898989,0.9744136460554371,1.0,1.0,8/14,39.04%,CARD10;COPS8;IRAK1;CARD14;TNFSF15;MAP3K7;MALT1;TRAF2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.2101796861983526,0.533886853300333,0.9721115537848606,0.9946021295714179,1.0,2/13,12.31%,PTPN1;PDCD6
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.2161785392588412,0.5335432066627523,0.9588785046728971,0.9942025343351415,1.0,5/12,28.41%,OS9;KDELR2;INSIG2;ANKRD13C;KDELR1
prerank,nucleoside salvage (GO:0043174),0.22951014211503074,0.5318452946866576,0.9726775956284153,0.9940599959600909,1.0,1/10,7.82%,UPP1
prerank,midbody abscission (GO:0061952),0.1990849321229198,0.5316598251852741,0.9775862068965517,0.993628250662752,1.0,7/17,34.14%,CHMP1A;CHMP2A;CHMP7;CHMP3;PDCD6IP;CHMP6;CHMP5
prerank,chromatin disassembly (GO:0031498),-0.2026847458328175,-0.5314043738297349,0.9844097995545658,1.0,1.0,10/14,43.72%,NFE2;SMARCE1;SMARCD2;SMARCC1;GRWD1;ARID2;SMARCB1;HMGA1;SMARCC2;SET
prerank,nucleosome disassembly (GO:0006337),-0.2026847458328175,-0.5314043738297349,0.9844097995545658,1.0,1.0,10/14,43.72%,NFE2;SMARCE1;SMARCD2;SMARCC1;GRWD1;ARID2;SMARCB1;HMGA1;SMARCC2;SET
prerank,cellular response to interleukin-4 (GO:0071353),-0.21661737212572355,-0.5253314093600658,0.9875,1.0,1.0,5/10,34.44%,TCF7;LEF1;DCSTAMP;RUFY4;XBP1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.18812010771409854,0.5249492995471329,0.9887005649717514,0.9944515318385796,1.0,6/19,27.73%,DUOX1;SOD1;PXDN;PARK7;PXDNL;ACOX1
prerank,DNA packaging (GO:0006323),-0.18682496189449574,-0.5173274319463803,0.9907621247113164,1.0,1.0,5/16,29.41%,KAT6A;BANF1;NOC2L;HAT1;H1-0
prerank,nuclear migration (GO:0007097),-0.1980702413139785,-0.5117734080458587,0.9820627802690582,1.0,1.0,5/13,28.26%,SYNE2;CEP120;FBXW11;PAFAH1B1;DYNC1H1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.2034966483053948,-0.5097322450482241,0.9894291754756871,1.0,1.0,4/11,29.00%,CCT2;TCP1;MEPCE;LARP7
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.2034966483053948,-0.5097322450482241,0.9894291754756871,1.0,1.0,4/11,29.00%,CCT2;TCP1;MEPCE;LARP7
prerank,embryonic axis specification (GO:0000578),0.19628280798693942,0.5095262146249324,0.9847908745247148,0.9964813171401129,1.0,15/15,80.39%,PTCH1;TASOR;SMAD6;RIPPLY2;COBL;FZD5;TBX3;TBXT;WNT1;MESP2;CXXC4;SMAD2;STIL;WNT7A;HOXD8
prerank,pseudouridine synthesis (GO:0001522),0.19782772476142643,0.5092585580345523,0.9876543209876543,0.9960523222858477,1.0,13/13,80.23%,NHP2;TRUB1;PUS7;PUSL1;PUS7L;DKC1;PUS3;GAR1;PUS10;NOP10;RPUSD2;PUS1;TRUB2
prerank,acyl-CoA metabolic process (GO:0006637),0.15828366535500965,0.5024092036619355,1.0,0.9965368653594349,1.0,2/35,5.17%,THEM4;SUCLA2
prerank,negative regulation of hormone secretion (GO:0046888),-0.20893651598759916,-0.4998392569801811,0.9897750511247444,1.0,1.0,4/10,39.21%,RAB11FIP1;FGF23;OSM;IL1B
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.188598694123556,-0.4931340293166551,0.9823008849557522,1.0,1.0,13/13,81.16%,PARP10;NUDT12;PARP9;PTGIS;NAMPT;SLC5A8;NNMT;SLC22A13;PTGS2;NAPRT;PARP16;NAXD;NAXE
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.1888332082528899,-0.4859784179268344,0.9959100204498977,1.0,1.0,4/12,27.79%,CCT2;WRAP53;TCP1;GNL3
prerank,regulation of trophoblast cell migration (GO:1901163),-0.1835576751047887,-0.4839838090289736,0.9979035639412998,1.0,1.0,1/14,4.59%,ACVR1C
prerank,regulation of spindle assembly (GO:0090169),0.1644769560385222,0.47901557309338705,0.9982394366197183,0.9985353035658583,1.0,5/25,21.79%,NUMA1;CHMP1A;CHMP2A;RNF4;CEP97
prerank,regulation of sensory perception of pain (GO:0051930),-0.18928944639115705,-0.47344723551756596,0.9937238493723849,1.0,1.0,5/11,38.22%,ZFHX2;CCN3;SPX;CCL3;F2R
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.19206520415879408,0.470415634309983,0.9981549815498155,0.9987670633210678,1.0,1/12,7.82%,UPP1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.18302916863429575,-0.4694526375217985,0.9957627118644068,1.0,1.0,7/12,40.20%,NCOR1;TERT;LIN28B;ESR1;ZC3H10;STAT3;TNF
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.15003490601135044,0.46362063905538153,1.0,0.998309626797578,1.0,11/29,35.19%,THEM4;CROT;ACOT8;ACOT1;ACOT4;ACOT7;ACOT2;ACBD6;ACAT1;ACOT6;DBI
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.15003490601135044,0.46362063905538153,1.0,0.998309626797578,1.0,11/29,35.19%,THEM4;CROT;ACOT8;ACOT1;ACOT4;ACOT7;ACOT2;ACBD6;ACAT1;ACOT6;DBI
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.17869539993239358,-0.45856017598081317,0.9933184855233853,1.0,1.0,1/13,5.38%,SAR1B
prerank,cellular response to interleukin-2 (GO:0071352),-0.18134007691117426,-0.4549610674207165,0.9937369519832986,1.0,1.0,4/11,28.59%,IL2RB;IL2RA;IL2;SYK
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.18134007691117426,-0.4549610674207165,0.9937369519832986,1.0,1.0,4/11,28.59%,IL2RB;IL2RA;IL2;SYK
prerank,positive regulation of lipid localization (GO:1905954),-0.18062390099686404,-0.4508171778458187,1.0,1.0,1.0,3/11,30.34%,IKBKE;VSTM2A;PLA2G10
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.17623290036229003,0.4456646293436281,0.9944547134935305,0.9988442238161243,1.0,5/13,30.97%,DUT;NTHL1;NT5M;NT5C;NEIL2
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.15223126075739124,-0.44387497763235756,0.9978165938864629,0.9999122842163444,1.0,3/19,20.11%,ASPA;AASS;GOT1
prerank,rRNA 3'-end processing (GO:0031125),-0.1824595365260606,-0.4415564163542799,0.9957805907172996,0.9993821897517176,1.0,2/10,13.84%,EXOSC7;ERI1
prerank,protein localization to microtubule organizing center (GO:1905508),0.16585518673161315,0.4343492905199674,0.9981132075471698,0.9988396049810305,1.0,4/15,24.78%,DCTN2;CCDC14;HOOK3;CSNK1D
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.1507976384876272,-0.42599996744685037,0.9977924944812362,0.9992762412091787,1.0,19/19,84.94%,CCSAP;HSPA1B;PLK1;CHMP1B;HNRNPU;DRG1;CHMP4C;CHMP2B;VPS4B;CHMP4B;HSPA1A;EML3;CHMP5;PDCD6IP;TPR;CHMP3;CEP97;CHMP2A;CHMP1A
